<!DOCTYPE html>
 <!--[if lt IE 7]> <html dir="ltr" lang="en-US" class="aui ltr no-js lt-ie9 lt-ie8 lt-ie7"> <![endif]--> <!--[if IE 7]> <html dir="ltr" lang="en-US" class="aui ltr no-js lt-ie9 lt-ie8"> <![endif]--> <!--[if IE 8]> <html dir="ltr" lang="en-US" class="aui ltr no-js lt-ie9"> <![endif]--> <!--[if gt IE 8]><!--> <html class="aui ltr" dir="ltr" lang="en-US" prefix="og: http://ogp.me/ns#"> <!--<![endif]--> <head> <title>Non‐pharmacological interventions for treating chronic prostatitis/chronic pelvic pain syndrome - Franco, JVA - 2018 | Cochrane Library</title> <meta content="Non‐pharmacological interventions for treating chronic prostatitis/chronic pelvic pain syndrome - Franco, JVA - 2018 | Cochrane Library" property="og:title"/> <meta content="https://www.cochranelibrary.com/cdsr/doi/10.1002/14651858.CD012551.pub3/full" property="og:url"/> <meta content="article" property="og:type"/> <meta content="https://www.cochranelibrary.com/cochrane-theme/images/cochrane_circulargraphic.png" property="og:image"/> <meta content="summary_large_image" name="twitter:card"/> <meta content="Non‐pharmacological interventions for treating chronic prostatitis/chronic pelvic pain syndrome - Franco, JVA - 2018 | Cochrane Library" name="twitter:title"/> <meta content="https://www.cochranelibrary.com/cdsr/doi/10.1002/14651858.CD012551.pub3/full" name="twitter:url"/> <meta content="https://www.cochranelibrary.com/cochrane-theme/images/cochrane_circulargraphic.png" name="twitter:image"/> <meta content="initial-scale=1.0, width=device-width" name="viewport"/> <meta content="10.1002/14651858.CD012551.pub3" name="dc.identifier" scheme="DOI"/> <meta content="Non‐pharmacological interventions for treating chronic prostatitis/chronic pelvic pain syndrome" name="citation_title"/> <meta content="Juan VA Franco" name="citation_author"/> <meta content="juan.franco@hospitalitaliano.org.ar" name="citation_author_email"/> <meta content="Tarek Turk" name="citation_author"/> <meta content="Damascus University" name="citation_author_institution"/> <meta content="Jae Hung Jung" name="citation_author"/> <meta content="Yu‐Tian Xiao" name="citation_author"/> <meta content="Changhai Hospital, Second Military Medical University" name="citation_author_institution"/> <meta content="Stanislav Iakhno" name="citation_author"/> <meta content="University of Tromso" name="citation_author_institution"/> <meta content="Virginia Garrote" name="citation_author"/> <meta content="Instituto Universitario Hospital Italiano" name="citation_author_institution"/> <meta content="Valeria Vietto" name="citation_author"/> <meta content="Cochrane Database of Systematic Reviews" name="citation_journal_title"/> <meta content="John Wiley &amp; Sons, Ltd" name="citation_publisher"/> <meta content="5" name="citation_issue"/> <meta content="10.1002/14651858.CD012551.pub3" name="citation_doi"/> <meta content="2018" name="citation_date"/> <meta content="2018/05/12" name="citation_online_date"/> <meta content="https://www.cochranelibrary.com/cdsr/doi/10.1002/14651858.CD012551.pub3/abstract" name="citation_abstract_html_url"/> <meta content="https://www.cochranelibrary.com/cdsr/doi/10.1002/14651858.CD012551.pub3/full" name="citation_fulltext_html_url"/> <meta content="https://www.cochranelibrary.com/cdsr/doi/10.1002/14651858.CD012551.pub3/pdf/full" name="citation_pdf_url"/> <meta content="1465-1858" name="citation_issn"/> <meta content="en" name="citation_language"/> <meta content="Acupuncture Therapy [adverse effects, methods]; Chronic Disease; Chronic Pain [*therapy]; Circumcision, Male [adverse effects]; Electromagnetic Radiation; Exercise; Extracorporeal Shockwave Therapy [adverse effects, methods]; Hyperthermia, Induced [adverse effects, methods]; Life Style; Massage [methods]; Pelvic Pain [*therapy]; Prostatitis [*therapy]; Randomized Controlled Trials as Topic" name="citation_keywords"/> <link href="https://fonts.googleapis.com/css?family=Source+Sans+Pro:400,700,600,900" rel="stylesheet"/> <script src="https://cmp.osano.com/AzZdRbSORDOOzF9W/d594efc1-9663-477d-9528-6576640e64fd/osano.js"></script> <style> .osano-cm-widget{display: none;} </style> <script src="https://static.addtoany.com/menu/page.js"></script> <script async="" charset="utf-8" src="https://platform.twitter.com/widgets.js"></script> <script async="async" src="//script.crazyegg.com/pages/scripts/0056/6375.js" type="text/javascript"></script> <script type="text/javascript">window.dataLayer={};var xtend=function(){var a={};var b=false;var c=0;var d=arguments.length;if(Object.prototype.toString.call(arguments[0])==="[object Boolean]"){b=arguments[0];c++}var f=function(g){for(var h in g){if(Object.prototype.hasOwnProperty.call(g,h)){if(b&&Object.prototype.toString.call(g[h])==="[object Object]"){a[h]=xtend(true,a[h],g[h])}else{a[h]=g[h]}}}};for(;c<d;c++){var e=arguments[c];f(e)}return a};</script> <!-- Global site tag (gtag.js) - Google Analytics --> <script src="https://www.googletagmanager.com/gtag/js?id=UA-189672-63&amp;l=gDataLayer"></script> <script>window.gDataLayer=window.gDataLayer||[];function gtag(){gDataLayer.push(arguments)}gtag("js",new Date());gtag("config","UA-189672-63");</script> <script type="text/javascript">var o={auth:{customerIds:[],individualId:null,brandedCustomer:null,roles:["Guest"]}};window.dataLayer=xtend(true,window.dataLayer,o);</script> <script type="text/javascript">var o={page:{siteSection:"Content",languageCode:"en",cms:{pageTitle:"Content"}}};window.dataLayer=xtend(true,window.dataLayer,o);</script> <meta content="text/html; charset=utf-8" http-equiv="content-type"/> <link href="https://www.cochranelibrary.com/cochrane-theme/images/favicon.ico" rel="Shortcut Icon"/> <link href="https://www.cochranelibrary.com/web/cochrane/content?templateType=full&amp;urlTitle=/cdsr/doi/10.1002/14651858.CD012551.pub3&amp;doi=10.1002/14651858.CD012551.pub3&amp;type=cdsr&amp;contentLanguage=" rel="canonical"/> <link href="https://www.cochranelibrary.com/zh/web/cochrane/content?templateType=full&amp;urlTitle=/cdsr/doi/10.1002/14651858.CD012551.pub3&amp;doi=10.1002/14651858.CD012551.pub3&amp;type=cdsr&amp;contentLanguage=" hreflang="zh-HANS" rel="alternate"/> <link href="https://www.cochranelibrary.com/zh_HANT/web/cochrane/content?templateType=full&amp;urlTitle=/cdsr/doi/10.1002/14651858.CD012551.pub3&amp;doi=10.1002/14651858.CD012551.pub3&amp;type=cdsr&amp;contentLanguage=" hreflang="zh-HANT" rel="alternate"/> <link href="https://www.cochranelibrary.com/hr/web/cochrane/content?templateType=full&amp;urlTitle=/cdsr/doi/10.1002/14651858.CD012551.pub3&amp;doi=10.1002/14651858.CD012551.pub3&amp;type=cdsr&amp;contentLanguage=" hreflang="hr-HR" rel="alternate"/> <link href="https://www.cochranelibrary.com/nl/web/cochrane/content?templateType=full&amp;urlTitle=/cdsr/doi/10.1002/14651858.CD012551.pub3&amp;doi=10.1002/14651858.CD012551.pub3&amp;type=cdsr&amp;contentLanguage=" hreflang="nl-NL" rel="alternate"/> <link href="https://www.cochranelibrary.com/web/cochrane/content?templateType=full&amp;urlTitle=/cdsr/doi/10.1002/14651858.CD012551.pub3&amp;doi=10.1002/14651858.CD012551.pub3&amp;type=cdsr&amp;contentLanguage=" hreflang="x-default" rel="alternate"/> <link href="https://www.cochranelibrary.com/web/cochrane/content?templateType=full&amp;urlTitle=/cdsr/doi/10.1002/14651858.CD012551.pub3&amp;doi=10.1002/14651858.CD012551.pub3&amp;type=cdsr&amp;contentLanguage=" hreflang="en-US" rel="alternate"/> <link href="https://www.cochranelibrary.com/fr/web/cochrane/content?templateType=full&amp;urlTitle=/cdsr/doi/10.1002/14651858.CD012551.pub3&amp;doi=10.1002/14651858.CD012551.pub3&amp;type=cdsr&amp;contentLanguage=" hreflang="fr-FR" rel="alternate"/> <link href="https://www.cochranelibrary.com/de/web/cochrane/content?templateType=full&amp;urlTitle=/cdsr/doi/10.1002/14651858.CD012551.pub3&amp;doi=10.1002/14651858.CD012551.pub3&amp;type=cdsr&amp;contentLanguage=" hreflang="de-DE" rel="alternate"/> <link href="https://www.cochranelibrary.com/hi/web/cochrane/content?templateType=full&amp;urlTitle=/cdsr/doi/10.1002/14651858.CD012551.pub3&amp;doi=10.1002/14651858.CD012551.pub3&amp;type=cdsr&amp;contentLanguage=" hreflang="hi-HI" rel="alternate"/> <link href="https://www.cochranelibrary.com/hu/web/cochrane/content?templateType=full&amp;urlTitle=/cdsr/doi/10.1002/14651858.CD012551.pub3&amp;doi=10.1002/14651858.CD012551.pub3&amp;type=cdsr&amp;contentLanguage=" hreflang="hu-HU" rel="alternate"/> <link href="https://www.cochranelibrary.com/in/web/cochrane/content?templateType=full&amp;urlTitle=/cdsr/doi/10.1002/14651858.CD012551.pub3&amp;doi=10.1002/14651858.CD012551.pub3&amp;type=cdsr&amp;contentLanguage=" hreflang="in-ID" rel="alternate"/> <link href="https://www.cochranelibrary.com/ja/web/cochrane/content?templateType=full&amp;urlTitle=/cdsr/doi/10.1002/14651858.CD012551.pub3&amp;doi=10.1002/14651858.CD012551.pub3&amp;type=cdsr&amp;contentLanguage=" hreflang="ja-JP" rel="alternate"/> <link href="https://www.cochranelibrary.com/ko/web/cochrane/content?templateType=full&amp;urlTitle=/cdsr/doi/10.1002/14651858.CD012551.pub3&amp;doi=10.1002/14651858.CD012551.pub3&amp;type=cdsr&amp;contentLanguage=" hreflang="ko-KR" rel="alternate"/> <link href="https://www.cochranelibrary.com/ms/web/cochrane/content?templateType=full&amp;urlTitle=/cdsr/doi/10.1002/14651858.CD012551.pub3&amp;doi=10.1002/14651858.CD012551.pub3&amp;type=cdsr&amp;contentLanguage=" hreflang="ms-MY" rel="alternate"/> <link href="https://www.cochranelibrary.com/fa/web/cochrane/content?templateType=full&amp;urlTitle=/cdsr/doi/10.1002/14651858.CD012551.pub3&amp;doi=10.1002/14651858.CD012551.pub3&amp;type=cdsr&amp;contentLanguage=" hreflang="fa-IR" rel="alternate"/> <link href="https://www.cochranelibrary.com/pl/web/cochrane/content?templateType=full&amp;urlTitle=/cdsr/doi/10.1002/14651858.CD012551.pub3&amp;doi=10.1002/14651858.CD012551.pub3&amp;type=cdsr&amp;contentLanguage=" hreflang="pl-PL" rel="alternate"/> <link href="https://www.cochranelibrary.com/pt/web/cochrane/content?templateType=full&amp;urlTitle=/cdsr/doi/10.1002/14651858.CD012551.pub3&amp;doi=10.1002/14651858.CD012551.pub3&amp;type=cdsr&amp;contentLanguage=" hreflang="pt-PT" rel="alternate"/> <link href="https://www.cochranelibrary.com/ro/web/cochrane/content?templateType=full&amp;urlTitle=/cdsr/doi/10.1002/14651858.CD012551.pub3&amp;doi=10.1002/14651858.CD012551.pub3&amp;type=cdsr&amp;contentLanguage=" hreflang="ro-RO" rel="alternate"/> <link href="https://www.cochranelibrary.com/ru/web/cochrane/content?templateType=full&amp;urlTitle=/cdsr/doi/10.1002/14651858.CD012551.pub3&amp;doi=10.1002/14651858.CD012551.pub3&amp;type=cdsr&amp;contentLanguage=" hreflang="ru-RU" rel="alternate"/> <link href="https://www.cochranelibrary.com/es/web/cochrane/content?templateType=full&amp;urlTitle=/cdsr/doi/10.1002/14651858.CD012551.pub3&amp;doi=10.1002/14651858.CD012551.pub3&amp;type=cdsr&amp;contentLanguage=" hreflang="es-ES" rel="alternate"/> <link href="https://www.cochranelibrary.com/ta/web/cochrane/content?templateType=full&amp;urlTitle=/cdsr/doi/10.1002/14651858.CD012551.pub3&amp;doi=10.1002/14651858.CD012551.pub3&amp;type=cdsr&amp;contentLanguage=" hreflang="ta-IN" rel="alternate"/> <link href="https://www.cochranelibrary.com/th/web/cochrane/content?templateType=full&amp;urlTitle=/cdsr/doi/10.1002/14651858.CD012551.pub3&amp;doi=10.1002/14651858.CD012551.pub3&amp;type=cdsr&amp;contentLanguage=" hreflang="th-TH" rel="alternate"/> <link class="lfr-css-file" href="https://www.cochranelibrary.com/cochrane-theme/css/main.css?browserId=other&amp;themeId=cochrane_WAR_cochranetheme&amp;minifierType=css&amp;languageId=en_US&amp;b=6210&amp;t=1738735355000" rel="stylesheet" type="text/css"/> <link class="lfr-css-file" href="https://www.cochranelibrary.com/cochrane-theme/css/aui.css?browserId=other&amp;themeId=cochrane_WAR_cochranetheme&amp;minifierType=css&amp;languageId=en_US&amp;b=6210&amp;t=1738735355000" rel="stylesheet" type="text/css"/> <link href="/html/css/main.css?browserId=other&amp;themeId=cochrane_WAR_cochranetheme&amp;minifierType=css&amp;languageId=en_US&amp;b=6210&amp;t=1739774054000" rel="stylesheet" type="text/css"/> <link href="https://www.cochranelibrary.com/scolaris-content-display/css/main.css?browserId=other&amp;themeId=cochrane_WAR_cochranetheme&amp;minifierType=css&amp;languageId=en_US&amp;b=6210&amp;t=1739773978000" rel="stylesheet" type="text/css"/> <link href="https://www.cochranelibrary.com/notifications-portlet/notifications/css/main.css?browserId=other&amp;themeId=cochrane_WAR_cochranetheme&amp;minifierType=css&amp;languageId=en_US&amp;b=6210&amp;t=1739774000000" rel="stylesheet" type="text/css"/> <link href="https://www.cochranelibrary.com/html/portlet/login/css/main.css?browserId=other&amp;themeId=cochrane_WAR_cochranetheme&amp;minifierType=css&amp;languageId=en_US&amp;b=6210&amp;t=1739774081000" rel="stylesheet" type="text/css"/> <script type="text/javascript">var Liferay={Browser:{acceptsGzip:function(){return false},getMajorVersion:function(){return 80},getRevision:function(){return"537.36"},getVersion:function(){return"80.0"},isAir:function(){return false},isChrome:function(){return true},isFirefox:function(){return false},isGecko:function(){return true},isIe:function(){return false},isIphone:function(){return false},isLinux:function(){return true},isMac:function(){return false},isMobile:function(){return false},isMozilla:function(){return false},isOpera:function(){return false},isRtf:function(){return true},isSafari:function(){return true},isSun:function(){return false},isWap:function(){return false},isWapXhtml:function(){return false},isWebKit:function(){return true},isWindows:function(){return false},isWml:function(){return false}},Data:{NAV_SELECTOR:"#navigation",isCustomizationView:function(){return false},notices:[null]},ThemeDisplay:{getLayoutId:function(){return"7"},getLayoutURL:function(){return"https://www.cochranelibrary.com/en/content"},getParentLayoutId:function(){return"0"},isPrivateLayout:function(){return"false"},isVirtualLayout:function(){return false},getBCP47LanguageId:function(){return"en-US"},getCDNBaseURL:function(){return"https://www.cochranelibrary.com"},getCDNDynamicResourcesHost:function(){return""},getCDNHost:function(){return""},getCompanyId:function(){return"20155"},getCompanyGroupId:function(){return"20195"},getDefaultLanguageId:function(){return"en_US"},getDoAsUserIdEncoded:function(){return""},getLanguageId:function(){return"en_US"},getParentGroupId:function(){return"20182"},getPathContext:function(){return""},getPathImage:function(){return"/image"},getPathJavaScript:function(){return"/html/js"},getPathMain:function(){return"/en/c"},getPathThemeImages:function(){return"https://www.cochranelibrary.com/cochrane-theme/images"},getPathThemeRoot:function(){return"/cochrane-theme"},getPlid:function(){return"20757"},getPortalURL:function(){return"https://www.cochranelibrary.com"},getPortletSetupShowBordersDefault:function(){return true},getScopeGroupId:function(){return"20182"},getScopeGroupIdOrLiveGroupId:function(){return"20182"},getSessionId:function(){return""},getSiteGroupId:function(){return"20182"},getURLControlPanel:function(){return"/group/control_panel?refererPlid=20757"},getURLHome:function(){return"https\x3a\x2f\x2fwww\x2ecochranelibrary\x2ecom\x2fweb\x2fcochrane"},getUserId:function(){return"20159"},getUserName:function(){return""},isAddSessionIdToURL:function(){return false},isFreeformLayout:function(){return false},isImpersonated:function(){return false},isSignedIn:function(){return false},isStateExclusive:function(){return false},isStateMaximized:function(){return false},isStatePopUp:function(){return false}},PropsValues:{NTLM_AUTH_ENABLED:false}};var themeDisplay=Liferay.ThemeDisplay;Liferay.AUI={getAvailableLangPath:function(){return"available_languages.jsp?browserId=other&themeId=cochrane_WAR_cochranetheme&colorSchemeId=01&minifierType=js&languageId=en_US&b=6210&t=1559916434000"},getCombine:function(){return true},getComboPath:function(){return"/combo/?browserId=other&minifierType=&languageId=en_US&b=6210&t=1559916434000&"},getFilter:function(){return"min"},getJavaScriptRootPath:function(){return"/html/js"},getLangPath:function(){return"aui_lang.jsp?browserId=other&themeId=cochrane_WAR_cochranetheme&colorSchemeId=01&minifierType=js&languageId=en_US&b=6210&t=1559916434000"},getStaticResourceURLParams:function(){return"?browserId=other&minifierType=&languageId=en_US&b=6210&t=1559916434000"}};Liferay.authToken="loVWuZlx";Liferay.currentURL="\x2fweb\x2fcochrane\x2fcontent\x3ftemplateType\x3dfull\x26urlTitle\x3d\x2fcdsr\x2fdoi\x2f10\x2e1002\x2f14651858\x2eCD012551\x2epub3\x26doi\x3d10\x2e1002\x2f14651858\x2eCD012551\x2epub3\x26type\x3dcdsr\x26contentLanguage\x3d";Liferay.currentURLEncoded="\x252Fweb\x252Fcochrane\x252Fcontent\x253FtemplateType\x253Dfull\x2526urlTitle\x253D\x252Fcdsr\x252Fdoi\x252F10\x2e1002\x252F14651858\x2eCD012551\x2epub3\x2526doi\x253D10\x2e1002\x252F14651858\x2eCD012551\x2epub3\x2526type\x253Dcdsr\x2526contentLanguage\x253D";</script> <script src="/html/js/barebone.jsp?browserId=other&amp;themeId=cochrane_WAR_cochranetheme&amp;colorSchemeId=01&amp;minifierType=js&amp;minifierBundleId=javascript.barebone.files&amp;languageId=en_US&amp;b=6210&amp;t=1559916434000" type="text/javascript"></script> <script type="text/javascript"></script> <script type="text/javascript">var o={database:"CDSR",page:{pageType:"Article Full Text HTML"},article:{availableLanguage:["en","es","zh_HANS","de","ru","fr","fa"],languageCode:"en",accessStatus:"delayed-free",doi:"10.1002/14651858.CD012551.pub3",title:"Non\\u2010pharmacological interventions for treating chronic prostatitis/chronic pelvic pain syndrome",firstPublishedDate:"May 12, 2018 12:00:00 AM",isCurrentVersion:true,editorialGroup:"Cochrane Urology Group",availableParts:["PDF Full","PDF Standard","PDF Abstract","HTML","Comments","Information","References","Stats","Related Content"]}};window.dataLayer=xtend(true,window.dataLayer,o);</script> <link class="lfr-css-file" href="https://www.cochranelibrary.com/cochrane-theme/css/custom.css?browserId=other&amp;themeId=cochrane_WAR_cochranetheme&amp;minifierType=css&amp;languageId=en_US&amp;b=6210&amp;t=1738735355000" rel="stylesheet" type="text/css"/> <style type="text/css"></style> <script async="" src="https://assets.adobedtm.com/59640f9fa510/7cad07cf7779/launch-a215d9c51521.min.js"></script> <!--[if lt IE 9]> <script src="/cochrane-theme/vendor/respond/dest/respond.min.js?t=1738735355000" type="text/javascript"></script> <![endif]--> </head> <body class="yui3-skin-sam controls-visible guest-site signed-out public-page site"> <div class="site-container"> <a href="#main-content" id="skip-to-content">Skip to Content</a> <div class="cookie-message cookie-message--hidden system-message-container" id="js-cookie-message"> <div class="container"> <a aria-label="Close cookies message" class="fa fa-times js-cookie-close pull-right" href="#"></a> <div class="system-message-wrapper container"> <i aria-hidden="true" class="fa fa-exclamation-triangle"></i> <div class="system-message-title">Cookies</div> <div class="system-message-description"> <p> Our site uses cookies to improve your experience. You can find out more about our use of cookies in About Cookies, including instructions on how to turn off cookies if you wish to do so. By continuing to browse this site you agree to us using cookies as described in <a href="http://olabout.wiley.com/WileyCDA/Section/id-813473.html">About Cookies</a>. </p> <a class="btn secondary js-cookie-close js-cookie-accept" href="#">I accept</a> </div> </div> </div> </div> <script>document.body.className=document.body.className+" js_enabled";</script><header> <div class="container"> <div class="branding"> <h1 class="brand-container"> <a href="https://www.cochranelibrary.com/en/"> <span class="brand-name">The Cochrane Library</span> <img alt="Cochrane Library logo" class="brand-logo" src="https://www.cochranelibrary.com/cochrane-theme/images/en-US_logo.png" title="Cochrane Library"/> </a> </h1> <span class="additional-branding"> <p class="brand-message"> <em>Trusted evidence.</em> <em>Informed decisions.</em> <em>Better health.</em> </p> </span> </div> <div class="desktop-search basic-search-container"> <div class="desktop-search-form"> <div class="portlet-boundary portlet-boundary_scolarissearchportlet_WAR_scolarissearch_ portlet-static portlet-static-end" id="p_p_id_scolarissearchportlet_WAR_scolarissearch_"> <span id="p_scolarissearchportlet_WAR_scolarissearch"></span> <section class="portlet" id="portlet_scolarissearchportlet_WAR_scolarissearch"> <header class="portlet-topper"> <h1 class="portlet-title"> <span class="" onmouseover="Liferay.Portal.ToolTip.show(this, 'Scolaris\x20Search\x20Portlet')"> <img alt="" id="owel__null__null" src="/scolaris-search/icon.png"/> <span class="taglib-text hide-accessible">Scolaris Search Portlet</span> </span> <span class="portlet-title-text">Scolaris Search Portlet</span> </h1> <menu class="portlet-topper-toolbar" id="portlet-topper-toolbar_scolarissearchportlet_WAR_scolarissearch" type="toolbar"> </menu> </header> <div class="portlet-content"> <div class="portlet-content-container"> <div class="portlet-body"> <div class="header-search"> <form action="https://www.cochranelibrary.com/en/content?p_auth=loVWuZlx&amp;p_p_id=scolarissearchportlet_WAR_scolarissearch&amp;p_p_lifecycle=1&amp;p_p_state=normal&amp;p_p_mode=view&amp;_scolarissearchportlet_WAR_scolarissearch_scolarisAction=redirectSearchResult" method="post"> <input name="searchType" type="hidden" value="basic"/> <input name="facetDisplayName" type="hidden" value=""/> <input name="facetQueryTerm" type="hidden" value=""/> <input name="facetQueryField" type="hidden" value=""/> <input name="facetCategory" type="hidden" value=""/> <fieldset class="fieldset"> <legend class="sr-only">Basic Search</legend> <div class="select search-by"> <select aria-label="Search by options" class="custom-select-enabled search-type" name="searchBy" title="Search by options"> <option value="1">Title Abstract Keyword</option> <option value="2">Record Title</option> <option value="3">Abstract</option> <option value="4">Author</option> <option value="5">Keyword</option> <option value="6">All Text</option> <option value="7">Publication Type</option> <option value="8">Source</option> <option value="9">DOI</option> <option value="14">Language</option> <option value="10">Accession Number</option> <option value="11">Trial Registry Number</option> <option value="12">Cochrane Group</option> <option value="13">Cochrane Topic</option> </select> </div> <div class="search-select-crg-container select" style="display: none;"> <select class="search-select-crg-list"></select> </div> <div class="search-select-topic-container select" data-topic-list-url="https://www.cochranelibrary.com/en/content?p_p_id=scolaristopics_WAR_scolaristopics&amp;p_p_lifecycle=2&amp;p_p_state=normal&amp;p_p_mode=view&amp;p_p_resource_id=topics-list&amp;p_p_cacheability=cacheLevelPage" style="display: none;"> <select class="search-select-topic-list"></select> </div> <div class="search-select-cl-container select" style="display: none;"> <select class="search-select-cl-list"></select> </div> <div class="search-text-container"> <div class="control-group control-group-inline search-input-wrapper"> <input aria-label="Enter search term" class="field browser-search search-text ui-autocomplete-input" id="searchText" name="searchText" placeholder="Search" size="30" type="text" value=""/>
<div id="autocomplete-results"></div>
</div>
<div class="control-group control-group-inline search-button-wrapper">
<button aria-label="Search" class="searchByBtn" type="submit">
<i aria-hidden="true" class="fa fa-search"></i>
</button>
</div>
</div>
</fieldset>
</form>
</div>
<script>
    window.displayResultURL = 'https://www.cochranelibrary.com/en/content?p_p_id=scolarissearchportlet_WAR_scolarissearch&p_p_lifecycle=2&p_p_state=normal&p_p_mode=view&p_p_resource_id=getSuggestions&p_p_cacheability=cacheLevelPage&_scolarissearchportlet_WAR_scolarissearch_templateType=full&_scolarissearchportlet_WAR_scolarissearch_urlTitle=%2Fcdsr%2Fdoi%2F10.1002%2F14651858.CD012551.pub3&_scolarissearchportlet_WAR_scolarissearch_contentLanguage=&_scolarissearchportlet_WAR_scolarissearch_type=cdsr&_scolarissearchportlet_WAR_scolarissearch_doi=10.1002%2F14651858.CD012551.pub3';
    window.searchByOption = '';
</script>
</div>
</div>
</div>
<div style="display:none">
<input id="freelabel" name="freelabel" type="hidden" value="Free access"/>
<input id="openlabel" name="openlabel" type="hidden" value="Open access"/>
</div>
</section>
</div>
</div>
<div class="search-tools-nav">
<a class="btn secondary" href="/en/browse-by-topic">Browse</a>
<a class="btn primary advanced-search-button" href="/en/advanced-search">Advanced search</a>
</div>
</div>
<a class="toggle-menu-switch" href="#"><i aria-hidden="true" class="fa fa-bars"></i> <div class="toggle-menu-text">Open menu</div></a>
</div>
<div class="auxiliary-container">
<div class="container">
<div class="header-auxiliary-menu">
<div class="auxiliary-menu-item language-selector">
<div class="portlet-boundary portlet-boundary_scolarislanguageselector_WAR_scolarislanguageportlet_ portlet-static portlet-static-end" id="p_p_id_scolarislanguageselector_WAR_scolarislanguageportlet_INSTANCE_header_">
<span id="p_scolarislanguageselector_WAR_scolarislanguageportlet_INSTANCE_header"></span>
<section class="portlet" id="portlet_scolarislanguageselector_WAR_scolarislanguageportlet_INSTANCE_header">
<header class="portlet-topper">
<h1 class="portlet-title">
<span class="" onmouseover="Liferay.Portal.ToolTip.show(this, 'Scolaris\x20Language\x20Selector')">
<img alt="" id="bvrs__null__null" src="/scolaris-language-portlet/icon.png"/> <span class="taglib-text hide-accessible">Scolaris Language Selector</span> </span> <span class="portlet-title-text">Scolaris Language Selector</span> </h1> <menu class="portlet-topper-toolbar" id="portlet-topper-toolbar_scolarislanguageselector_WAR_scolarislanguageportlet_INSTANCE_header" type="toolbar"> </menu> </header> <div class="portlet-content"> <div class="portlet-content-container"> <div class="portlet-body"> <div class="language-display" data-content-languages="[de, en, es, fa, fr, hi, hr, id, ja, ko, hu, ms, nl, pl, pt, ru, ro, ta, th, zh_HANT, zh_HANS]"> <a class="open-language-modal" href="#" title="Select your preferred language"> <i class="fa fa-file-text"></i> Review language : English </a> <a class="open-language-modal" href="#" title="Select your preferred language"> <i class="fa fa-globe"></i> Website language : English </a> </div> <div class="language-selector-modal-content" data-modal-title="Language selection" data-size="large" style="display: none;"> <div class="form-content language-selector-modal"> <div class="row-fluid"> <div> <table class="mytable" style="border: 1px solid #f0f0f0" width="90%"> <tbody> <tr class="row-box"> <td><i class="fa fa-file-text icon-size"></i></td> <td><h3>Cochrane review language</h3> <p>Select your preferred language for Cochrane reviews and other content. Sections without translation will be in English.</p> </td> <td> <div> <select id="contentLanguageSelector" onchange="updateLang(this.value)"> <option class="content-language-option" data-languagecode="de" value="de"> Deutsch </option> <option class="content-language-option" data-languagecode="en" selected="" value="en"> English </option> <option class="content-language-option" data-languagecode="es" value="es"> Español </option> <option class="content-language-option" data-languagecode="fa" value="fa"> فارسی </option> <option class="content-language-option" data-languagecode="fr" value="fr"> Français </option> <option class="content-language-option" data-languagecode="hi" value="hi"> हिन्दी </option> <option class="content-language-option" data-languagecode="hr" value="hr"> Hrvatski </option> <option class="content-language-option" data-languagecode="id" value="id"> Bahasa Indonesia </option> <option class="content-language-option" data-languagecode="ja" value="ja"> 日本語 </option> <option class="content-language-option" data-languagecode="ko" value="ko"> 한국어 </option> <option class="content-language-option" data-languagecode="hu" value="hu"> Magyar </option> <option class="content-language-option" data-languagecode="ms" value="ms"> Bahasa Malaysia </option> <option class="content-language-option" data-languagecode="nl" value="nl"> Nederlands </option> <option class="content-language-option" data-languagecode="pl" value="pl"> Polski </option> <option class="content-language-option" data-languagecode="pt" value="pt"> Português </option> <option class="content-language-option" data-languagecode="ru" value="ru"> Русский </option> <option class="content-language-option" data-languagecode="ro" value="ro"> Română </option> <option class="content-language-option" data-languagecode="ta" value="ta"> தமிழ் </option> <option class="content-language-option" data-languagecode="th" value="th"> ภาษาไทย </option> <option class="content-language-option" data-languagecode="zh_HANT" value="zh_HANT"> 繁體中文 </option> <option class="content-language-option" data-languagecode="zh_HANS" value="zh_HANS"> 简体中文 </option> </select> </div> </td> </tr> <tr> <td colspan="1" style="height: 10px"></td> </tr> <tr class="row-box"> <td><i class="fa fa-globe icon-size"></i></td> <td> <div class="language-info"> <h3>Website language</h3> <p>Select your preferred language for the Cochrane Library website.</p> </div> </td> <td> <div class="language-dropdown"> <select id="portalLanguageSelector"> <option class="portal-language-selector" data-portallanguage="en" selected="" value="/en/cdsr/doi/10.1002/14651858.CD012551.pub3/full/en"> English </option> <option class="portal-language-selector" data-portallanguage="es" value="/es/cdsr/doi/10.1002/14651858.CD012551.pub3/full/es"> Español </option> </select> </div> </td> </tr> <tr> <td colspan="1" style="height: 10px"></td> </tr> </tbody> </table> </div> </div> <div style="text-align: right;"> <button class="btn primary btn-cancel" style="margin-left: 10px;" type="button">Cancel</button> <a class="btn secondary ok-btn" href="https://www.cochranelibrary.com/en/content?p_p_id=scolariscontentlanguagebanner_WAR_scolarislanguageportlet&amp;p_p_lifecycle=2&amp;p_p_state=normal&amp;p_p_mode=view&amp;p_p_resource_id=set-content-language&amp;p_p_cacheability=cacheLevelPage">Save</a> </div> </div> </div> </div> </div> </div> <div style="display:none"> <input id="freelabel" name="freelabel" type="hidden" value="Free access"/>
<input id="openlabel" name="openlabel" type="hidden" value="Open access"/>
</div>
</section>
</div>
</div>
<a class="auxiliary-menu-item signin last" href="https://www.cochranelibrary.com/c/portal/login?p_l_id=20757&amp;redirect=%2Fcdsr%2Fdoi%2F10.1002%2F14651858.CD012551.pub3%2Ffull" rel="nofollow">
<i class="icon fa fa-user"></i> Sign In
    </a>
<span class="auxiliary-container-extended"></span>
</div>
</div>
</div>
</header>
<div class="main-nav-wrapper">
<span class="main-nav-left-extended"></span>
<nav class="main container">
<ul>
<li class="nav-root-item parent">
<a href="#">Cochrane reviews<span class="icon fa fa-caret-down"></span></a>
<ul class="child">
<li class="child-nav-item" id="layout_nav_child_attr_14" role="presentation">
<a aria-labelledby="layout_14" href="https://www.cochranelibrary.com/en/cdsr/reviews" role="menuitem">
            Search reviews (CDSR)
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_15" role="presentation">
<a aria-labelledby="layout_15" href="https://www.cochranelibrary.com/en/cdsr/reviews/topics" role="menuitem">
            Browse reviews
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_18" role="presentation">
<a aria-labelledby="layout_18" href="https://www.cochranelibrary.com/en/cdsr/table-of-contents" role="menuitem">
            Issues
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_17" role="presentation">
<a aria-labelledby="layout_17" href="https://www.cochranelibrary.com/en/cdsr/editorials" role="menuitem">
            Editorials
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_19" role="presentation">
<a aria-labelledby="layout_19" href="https://www.cochranelibrary.com/en/special-collections" role="menuitem">
            Special Collections
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_20" role="presentation">
<a aria-labelledby="layout_20" href="https://www.cochranelibrary.com/en/cdsr/supplements" role="menuitem">
            Supplements
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_121" role="presentation">
<a aria-labelledby="layout_121" href="https://www.cochranelibrary.com/en/about/about-cochrane-reviews" role="menuitem">
            About Cochrane reviews
        </a>
</li>
</ul>
</li>
<li class="nav-root-item parent">
<a href="#">Searching for trials<span class="icon fa fa-caret-down"></span></a>
<ul class="child">
<li class="child-nav-item" id="layout_nav_child_attr_254" role="presentation">
<a aria-labelledby="layout_254" href="https://www.cochranelibrary.com/en/search/releases" role="menuitem">
            What's new (search and CENTRAL)
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_266" role="presentation">
<a aria-labelledby="layout_266" href="https://www.cochranelibrary.com/en/search-help" role="menuitem">
            Search help
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_252" role="presentation">
<a aria-labelledby="layout_252" href="https://www.cochranelibrary.com/en/search-help-quick-guides" role="menuitem">
            Search help quick guides
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_251" role="presentation">
<a aria-labelledby="layout_251" href="https://www.cochranelibrary.com/en/search-faqs" role="menuitem">
            Search FAQs
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_114" role="presentation">
<a aria-labelledby="layout_114" href="https://www.cochranelibrary.com/en/central/about-central" role="menuitem">
            About CENTRAL
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_115" role="presentation">
<a aria-labelledby="layout_115" href="https://www.cochranelibrary.com/en/central/central-creation" role="menuitem">
            How CENTRAL is created
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_241" role="presentation">
<a aria-labelledby="layout_241" href="https://www.cochranelibrary.com/en/retracted-trials" role="menuitem">
            Retracted publications in CENTRAL
        </a>
</li>
</ul>
</li>
<li class="nav-root-item parent">
<a href="#">Clinical Answers<span class="icon fa fa-caret-down"></span></a>
<ul class="child">
<li class="child-nav-item" id="layout_nav_child_attr_29" role="presentation">
<a aria-labelledby="layout_29" href="https://www.cochranelibrary.com/en/cca" role="menuitem">
            Browse Clinical Answers
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_91" role="presentation">
<a aria-labelledby="layout_91" href="https://www.cochranelibrary.com/en/cca/about" role="menuitem">
            About Clinical Answers
        </a>
</li>
</ul>
</li>
<li class="nav-root-item parent">
<a href="#">About<span class="icon fa fa-caret-down"></span></a>
<ul class="child">
<li class="child-nav-item" id="layout_nav_child_attr_116" role="presentation">
<a aria-labelledby="layout_116" href="https://www.cochranelibrary.com/en/about/about-cochrane-library" role="menuitem">
            About the Cochrane Library
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_13" role="presentation">
<a aria-labelledby="layout_13" href="https://www.cochranelibrary.com/en/cdsr/about-cdsr" role="menuitem">
            Cochrane Database of Systematic reviews
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_198" role="presentation">
<a aria-labelledby="layout_198" href="https://www.cochranelibrary.com/en/cdsr/editorial-policies" role="menuitem">
            Editorial policies
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_92" role="presentation">
<a aria-labelledby="layout_92" href="https://www.cochranelibrary.com/en/about/author-information" role="menuitem">
            Information for authors
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_212" role="presentation">
<a aria-labelledby="layout_212" href="https://www.cochranelibrary.com/en/about-pico" role="menuitem">
            About PICO
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_207" role="presentation">
<a aria-labelledby="layout_207" href="https://www.cochranelibrary.com/en/about/about-translations" role="menuitem">
            About translations
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_188" role="presentation">
<a aria-labelledby="layout_188" href="https://www.cochranelibrary.com/en/about/releases" role="menuitem">
            What's new
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_216" role="presentation">
<a aria-labelledby="layout_216" href="https://www.cochranelibrary.com/en/data" role="menuitem">
            Data reuse
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_235" role="presentation">
<a aria-labelledby="layout_235" href="https://www.cochranelibrary.com/en/about/about-cochrane-library/editorial-board" role="menuitem">
            Cochrane Library Editorial Board
        </a>
</li>
</ul>
</li>
<li class="nav-root-item parent">
<a href="#">Help<span class="icon fa fa-caret-down"></span></a>
<ul class="child">
<li class="child-nav-item" id="layout_nav_child_attr_259" role="presentation">
<a aria-labelledby="layout_259" href="https://m.info.wiley.com/webApp/cochranenewsletter?id=0" role="menuitem">
            Newsletter
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_177" role="presentation">
<a aria-labelledby="layout_177" href="https://www.wiley.com/en-us/customer-success/cochrane-library-training-hub" role="menuitem">
            Cochrane Library Training
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_44" role="presentation">
<a aria-labelledby="layout_44" href="https://www.cochranelibrary.com/en/help/access" role="menuitem">
            Access
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_150" role="presentation">
<a aria-labelledby="layout_150" href="https://www.cochranelibrary.com/en/help/permissions" role="menuitem">
            Permissions and reprints
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_93" role="presentation">
<a aria-labelledby="layout_93" href="https://www.cochranelibrary.com/en/help/media" role="menuitem">
            Media information
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_97" role="presentation">
<a aria-labelledby="layout_97" href="https://www.cochranelibrary.com/en/help/contact-us" role="menuitem">
            Contact us
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_125" role="presentation">
<a aria-labelledby="layout_125" href="https://www.cochranelibrary.com/en/about/terms-and-conditions" role="menuitem">
            Terms and conditions
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_176" role="presentation">
<a aria-labelledby="layout_176" href="https://cochranesupport.wiley.com/s/article/cochrane-library-known-issues" role="menuitem">
            Known issues
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_270" role="presentation">
<a aria-labelledby="layout_270" href="https://www.cochranelibrary.com/search-help" role="menuitem">
            Search help
        </a>
</li>
</ul>
</li>
<li class="about-link"><a href="https://www.cochrane.org/about-us" target="_blank"><span>About Cochrane</span><i class="fa fa-caret-right"></i></a></li>
</ul>
</nav>
</div>
<div class="portlet-boundary portlet-boundary_scolariscontentlanguagebanner_WAR_scolarislanguageportlet_ portlet-static portlet-static-end" id="p_p_id_scolariscontentlanguagebanner_WAR_scolarislanguageportlet_">
<span id="p_scolariscontentlanguagebanner_WAR_scolarislanguageportlet"></span>
<section class="portlet" id="portlet_scolariscontentlanguagebanner_WAR_scolarislanguageportlet">
<header class="portlet-topper">
<h1 class="portlet-title">
<span class="" onmouseover="Liferay.Portal.ToolTip.show(this, 'Scolaris\x20Content\x20Language\x20Banner\x20Portlet')">
<img alt="" id="etlj__null__null" src="/scolaris-language-portlet/icon.png"/> <span class="taglib-text hide-accessible">Scolaris Content Language Banner Portlet</span> </span> <span class="portlet-title-text">Scolaris Content Language Banner Portlet</span> </h1> <menu class="portlet-topper-toolbar" id="portlet-topper-toolbar_scolariscontentlanguagebanner_WAR_scolarislanguageportlet" type="toolbar"> </menu> </header> <div class="portlet-content"> <div class="portlet-content-container"> <div class="portlet-body"> </div> </div> </div> <div style="display:none"> <input id="freelabel" name="freelabel" type="hidden" value="Free access"/>
<input id="openlabel" name="openlabel" type="hidden" value="Open access"/>
</div>
</section>
</div>
<div class="" id="content">
<div class="columns-1" id="main-content" role="main">
<div class="portlet-layout row-fluid">
<div class="portlet-column portlet-column-only span12" id="column-1">
<div class="portlet-dropzone portlet-column-content portlet-column-content-only" id="layout-column_column-1">
<div class="portlet-boundary portlet-boundary_scolariscontentdisplay_WAR_scolariscontentdisplay_ portlet-static portlet-static-end scolaris-content-display-portlet" id="p_p_id_scolariscontentdisplay_WAR_scolariscontentdisplay_">
<span id="p_scolariscontentdisplay_WAR_scolariscontentdisplay"></span>
<section class="portlet" id="portlet_scolariscontentdisplay_WAR_scolariscontentdisplay">
<header class="portlet-topper">
<h1 class="portlet-title">
<span class="" onmouseover="Liferay.Portal.ToolTip.show(this, 'Scolaris\x20Content\x20Display')">
<img alt="" id="rjus__column1__0" src="/scolaris-content-display/icon.png"/> <span class="taglib-text hide-accessible">Scolaris Content Display</span> </span> <span class="portlet-title-text">Scolaris Content Display</span> </h1> <menu class="portlet-topper-toolbar" id="portlet-topper-toolbar_scolariscontentdisplay_WAR_scolariscontentdisplay" type="toolbar"> </menu> </header> <div class="portlet-content"> <div class="portlet-content-container"> <div class="portlet-body"> <div class="publication cdsr container"> <div class="article-navigation-container" id="cdsr-nav"> <nav class="article-navigation"> <ul class="tools-row"> <li> <li class="tools pdf pulldown-menu readcube-menu closed en_US"> <a class="pulldown-menu-trigger" href="#0"> <span class="pdf-icon"> <i class="icon fa fa-file-pdf-o"></i> <span>Download PDF</span> </span> <i aria-hidden="true" class="fa fa-caret-down"></i> </a> <ul class="pulldown-menu-items"> <li class=""> <a class="download media pdf-link-full pdf-link" href="/cdsr/doi/10.1002/14651858.CD012551.pub3/pdf/full/en" title="Article in PDF format"> <span class="readcube-label"> Full </span> <span class="readcube-description"> All content </span> </a> <a class="download media pdf-link-full readcube-epdf-link" href="/cdsr/doi/10.1002/14651858.CD012551.pub3/epdf/full/en" title="Article in PDF format"> <span class="readcube-label"> Full </span> <span class="readcube-description"> All content </span> </a> </li> <li class=""> <a class="download media pdf-link-abstract pdf-link" href="/cdsr/doi/10.1002/14651858.CD012551.pub3/pdf/abstract/en" title="Article in PDF format"> <span class="readcube-label"> Summary </span> <span class="readcube-description"> Abstract and plain language summary only </span> </a> <a class="download media pdf-link-abstract readcube-epdf-link" href="/cdsr/doi/10.1002/14651858.CD012551.pub3/epdf/abstract/en" title="Article in PDF format"> <span class="readcube-label"> Summary </span> <span class="readcube-description"> Abstract and plain language summary only </span> </a> </li> </ul> </li> <li class="tools cite cite-article-link" data-article-id="CD012551.PUB3" data-modal-title="Cite this review"> <span><i aria-hidden="true" class="icon fa fa-share"></i></span> <span>Cite this review</span> </li> </li> </ul> <ul class="tools-row tools-secondary"> <li> <li class="tools print print-cdsr-link" data-content-language="en" data-indicator-tooltip="scolaris.print.modal.language.tooltip.en" data-print-options="[{&quot;param&quot;: &quot;abstract&quot;,&quot;titles&quot;:[{&quot;language&quot;:&quot;en&quot;,&quot;title&quot;:&quot;Abstract&quot;},{&quot;language&quot;:&quot;es&quot;,&quot;title&quot;:&quot;Resumen&quot;},{&quot;language&quot;:&quot;fa&quot;,&quot;title&quot;:&quot;چکیده&quot;},{&quot;language&quot;:&quot;fr&quot;,&quot;title&quot;:&quot;Résumé scientifique&quot;},{&quot;language&quot;:&quot;zh_HANS&quot;,&quot;title&quot;:&quot;Abstract&quot;}]},{&quot;param&quot;: &quot;pls&quot;,&quot;titles&quot;:[{&quot;language&quot;:&quot;en&quot;,&quot;title&quot;:&quot;Plain language summary&quot;},{&quot;language&quot;:&quot;de&quot;,&quot;title&quot;:&quot;Laienverständliche Zusammenfassung&quot;},{&quot;language&quot;:&quot;es&quot;,&quot;title&quot;:&quot;Resumen en términos sencillos&quot;},{&quot;language&quot;:&quot;fa&quot;,&quot;title&quot;:&quot;خلاصه به زبان ساده&quot;},{&quot;language&quot;:&quot;fr&quot;,&quot;title&quot;:&quot;Résumé simplifié&quot;},{&quot;language&quot;:&quot;ru&quot;,&quot;title&quot;:&quot;Резюме на простом языке&quot;},{&quot;language&quot;:&quot;zh_HANS&quot;,&quot;title&quot;:&quot;Plain language summary&quot;}]},{&quot;param&quot;: &quot;conclusions&quot;,&quot;titles&quot;:[{&quot;language&quot;:&quot;en&quot;,&quot;title&quot;:&quot;Authors' conclusions&quot;}]},{&quot;param&quot;: &quot;summaryOfFindings&quot;,&quot;titles&quot;:[{&quot;language&quot;:&quot;en&quot;,&quot;title&quot;:&quot;Summary of findings&quot;}]},{&quot;param&quot;: &quot;background&quot;,&quot;titles&quot;:[{&quot;language&quot;:&quot;en&quot;,&quot;title&quot;:&quot;Background&quot;}]},{&quot;param&quot;: &quot;objectives&quot;,&quot;titles&quot;:[{&quot;language&quot;:&quot;en&quot;,&quot;title&quot;:&quot;Objectives&quot;}]},{&quot;param&quot;: &quot;methods&quot;,&quot;titles&quot;:[{&quot;language&quot;:&quot;en&quot;,&quot;title&quot;:&quot;Methods&quot;}]},{&quot;param&quot;: &quot;results&quot;,&quot;titles&quot;:[{&quot;language&quot;:&quot;en&quot;,&quot;title&quot;:&quot;Results&quot;}]},{&quot;param&quot;: &quot;discussion&quot;,&quot;titles&quot;:[{&quot;language&quot;:&quot;en&quot;,&quot;title&quot;:&quot;Discussion&quot;}]},{&quot;param&quot;: &quot;references&quot;,&quot;titles&quot;:[{&quot;language&quot;:&quot;en&quot;,&quot;title&quot;:&quot;References&quot;}]},{&quot;param&quot;: &quot;appendices&quot;,&quot;titles&quot;:[{&quot;language&quot;:&quot;en&quot;,&quot;title&quot;:&quot;Appendices&quot;},{&quot;language&quot;:&quot;en&quot;,&quot;title&quot;:&quot;Search strategies&quot;}]},{&quot;param&quot;: &quot;characteristics&quot;,&quot;titles&quot;:[{&quot;language&quot;:&quot;en&quot;,&quot;title&quot;:&quot;Characteristics of studies&quot;}]},{&quot;param&quot;: &quot;data&quot;,&quot;titles&quot;:[{&quot;language&quot;:&quot;en&quot;,&quot;title&quot;:&quot;Analyses&quot;}]},{&quot;param&quot;: &quot;information&quot;,&quot;titles&quot;:[{&quot;language&quot;:&quot;en&quot;,&quot;title&quot;:&quot;Information&quot;}]},{&quot;param&quot;: &quot;authors&quot;,&quot;titles&quot;:[{&quot;language&quot;:&quot;en&quot;,&quot;title&quot;:&quot;Authors&quot;}]},{&quot;param&quot;: &quot;history&quot;,&quot;titles&quot;:[{&quot;language&quot;:&quot;en&quot;,&quot;title&quot;:&quot;History&quot;}]}]" data-print-urlbase="/cdsr/doi/10.1002/14651858.CD012551.pub3/print"> <span><i class="icon fa fa-print"></i></span> <span>Print</span> </li> <li class="js-old-version-modal-trigger tools comments comment-on-review" data-article-id="CD012551.PUB3" data-english-only-message="Please note, that commenting is available in English only. Apologies for any inconvenience." data-href="/cdsr/doi/10.1002/14651858.CD012551.pub3/read-comments" data-new-version="" id="comment-on-review"> <span class="comment-icon"><i class="icon fa fa-comment"></i></span> <span class="comments-count">0</span> <span>Comment</span> </li> <li class="tools share-cdsr-link" data-share-url="/cdsr/doi/10.1002/14651858.CD012551.pub3/full"> <span><i class="icon fa fa-share-alt"></i></span> <span>Share</span> </li> <li class="tools follow"> <span class="article-not-followed cochrane-link signin follow-wrapper"> <span> <i class="icon fa fa-plus"></i> </span> <span> Follow </span> </span> </li> </li> </ul> <div class="metrics-wrapper"> <div class="metrics-count"> <span>Full text views: </span> <span>10809 <i class="icon fa fa-info-circle custom-tooltip" style="padding-left: 2px;color: #962d91;" title="Usage represents full text views on Cochrane Library since January 2022 or 2023. For articles published after this date, the usage represents views since the article was first published on Cochrane Library."> </i> </span> </div> </div> <div class="metrics-wrapper nav-link-section"> <div class="altmetric-embed" data-badge-type="1" data-condensed="true" data-doi="10.1002/14651858.CD012551.pub3" data-link-target="_blank"></div> <div class="inline-status-wrapper guidelines-count" data-count-plural="Cited in $1 guidelines" data-count-single="Cited in 1 guideline"> <a href="related-content#guidelines_data" title="Guidelines"></a> </div> </div> <ul class="nav-section-header"> <li> <h3>Contents</h3> </li> </ul> <ul class="nav-long-form nav-link-section"> <li class="cdsr-nav-link bold-nav-link" lang="en"> <a href="/cdsr/doi/10.1002/14651858.CD012551.pub3/full"> Abstract </a> </li> <li class="cdsr-nav-link bold-nav-link" lang="en"> <a href="/cdsr/doi/10.1002/14651858.CD012551.pub3/full#pico"> PICOs </a> </li> <li class="cdsr-nav-link bold-nav-link" lang="en"> <a href="/cdsr/doi/10.1002/14651858.CD012551.pub3/full#CD012551-abs-0005"> Plain language summary </a> </li> <li class="cdsr-nav-link bold-nav-link" lang="en"> <a href="/cdsr/doi/10.1002/14651858.CD012551.pub3/full#CD012551-sec-0284"> Authors' conclusions </a> </li> <li class="cdsr-nav-link bold-nav-link" lang="en"> <a href="/cdsr/doi/10.1002/14651858.CD012551.pub3/full#CD012551-sec-0029"> Summary of findings </a> </li> <li class="cdsr-nav-link" lang="en"> <a href="/cdsr/doi/10.1002/14651858.CD012551.pub3/full#CD012551-sec-0030"> Background </a> </li> <li class="cdsr-nav-link" lang="en"> <a href="/cdsr/doi/10.1002/14651858.CD012551.pub3/full#CD012551-sec-0042"> Objectives </a> </li> <li class="cdsr-nav-link" lang="en"> <a href="/cdsr/doi/10.1002/14651858.CD012551.pub3/full#CD012551-sec-0043"> Methods </a> </li> <li class="cdsr-nav-link" lang="en"> <a href="/cdsr/doi/10.1002/14651858.CD012551.pub3/full#CD012551-sec-0080"> Results </a> </li> <li class="cdsr-nav-link" lang="en"> <a href="/cdsr/doi/10.1002/14651858.CD012551.pub3/full#CD012551-sec-0278"> Discussion </a> </li> <li class="cdsr-nav-link"> <a class="figures-and-tables-link" href="/cdsr/doi/10.1002/14651858.CD012551.pub3/#"> Figures and tables </a> </li> <li class="cdsr-nav-link" lang="en"> <a href="/cdsr/doi/10.1002/14651858.CD012551.pub3/references"> References </a> </li> </ul> <div class="nav-section-header"> <h3>Supplementary materials</h3> </div> <ul class="nav-long-form nav-link-section"> <li class="cdsr-nav-link" lang="en"> <a href="/cdsr/doi/10.1002/14651858.CD012551.pub3/appendices#CD012551-sec-0289"> Search strategies </a> </li> <li class="cdsr-nav-link" lang="en"> <a href="/cdsr/doi/10.1002/14651858.CD012551.pub3/references#characteristicStudies"> Characteristics of studies </a> </li> <li class="cdsr-nav-link" lang="en"> <a href="/cdsr/doi/10.1002/14651858.CD012551.pub3/references#dataAndAnalyses"> Analyses </a> </li> <li class="cdsr-nav-link download-stats-data-link" data-download-href="/cdsr/doi/10.1002/14651858.CD012551.pub3/media/CDSR/CD012551/table_n/CD012551StatsDataOnly.rm5?content-disposition=attachment&amp;mime-type=application/octet-stream"> <a href="/cdsr/doi/10.1002/14651858.CD012551.pub3/media/CDSR/CD012551/table_n/CD012551StatsDataOnly.rm5?content-disposition=attachment&amp;mime-type=application/octet-stream"> Download data </a> </li> </ul> <ul class="tools-row"> <li> </li> </ul> <ul class="nav-section-header"> <li><h3>Related</h3></li> </ul> <ul class="linked-content linked-content-dropdown" id="linked-content-articles" tabindex="0"> <li class="linked-cca" data-type="cca"> <div class="linked-content-section"> <span class="linked-type">Cochrane Clinical Answers<span class="count"></span></span> <i aria-hidden="true" class="fa fa-caret-down"></i> </div> <div class="articles"></div> </li> <li class="linked-editorials" data-type="editorial"> <div class="linked-content-section"> <span class="linked-type">Editorials<span class="count"></span></span> <i aria-hidden="true" class="fa fa-caret-down"></i> </div> <div class="articles"></div> </li> <li class="linked-podcasts" data-type="podcast"> <div class="linked-content-section"> <span class="linked-type">Podcasts<span class="count"></span></span> <i aria-hidden="true" class="fa fa-caret-down"></i> </div> <div class="articles"></div> </li> <li class="linked-sc" data-type="sc"> <div class="linked-content-section"> <span class="linked-type">Special Collections<span class="count"></span></span> <i aria-hidden="true" class="fa fa-caret-down"></i> </div> <div class="articles"></div> </li> </ul> <div class="nav-section-header"> <h3>About this review</h3> </div> <ul class="nav-long-form nav-info nav-link-section"> <li class="cdsr-nav-link" lang="en"> <a href="/cdsr/doi/10.1002/14651858.CD012551.pub3/information"> <i> <svg viewbox="0 0 24 24"> <path d="M11,9H13V7H11M12,20C7.59,20 4,16.41 4,12C4,7.59 7.59,4 12,4C16.41,4 20,7.59 20,12C20,16.41 16.41,20 12,20M12,2A10,10 0 0,0 2,12A10,10 0 0,0 12,22A10,10 0 0,0 22,12A10,10 0 0,0 12,2M11,17H13V11H11V17Z"></path> </svg> </i> Information </a> </li> <li class="cdsr-nav-link" lang="en"> <a href="/cdsr/doi/10.1002/14651858.CD012551.pub3/information#authors"> <i> <svg viewbox="0 0 24 24"> <path d="M12,5.5A3.5,3.5 0 0,1 15.5,9A3.5,3.5 0 0,1 12,12.5A3.5,3.5 0 0,1 8.5,9A3.5,3.5 0 0,1 12,5.5M5,8C5.56,8 6.08,8.15 6.53,8.42C6.38,9.85 6.8,11.27 7.66,12.38C7.16,13.34 6.16,14 5,14A3,3 0 0,1 2,11A3,3 0 0,1 5,8M19,8A3,3 0 0,1 22,11A3,3 0 0,1 19,14C17.84,14 16.84,13.34 16.34,12.38C17.2,11.27 17.62,9.85 17.47,8.42C17.92,8.15 18.44,8 19,8M5.5,18.25C5.5,16.18 8.41,14.5 12,14.5C15.59,14.5 18.5,16.18 18.5,18.25V20H5.5V18.25M0,20V18.5C0,17.11 1.89,15.94 4.45,15.6C3.86,16.28 3.5,17.22 3.5,18.25V20H0M24,20H20.5V18.25C20.5,17.22 20.14,16.28 19.55,15.6C22.11,15.94 24,17.11 24,18.5V20Z"></path> </svg> </i> Authors </a> </li> <li class="cdsr-nav-link" lang="en"> <a href="/cdsr/doi/10.1002/14651858.CD012551.pub3/information#history"> <i> <svg viewbox="0 0 24 24"> <path d="M13.5,8H12V13L16.28,15.54L17,14.33L13.5,12.25V8M13,3A9,9 0 0,0 4,12H1L4.96,16.03L9,12H6A7,7 0 0,1 13,5A7,7 0 0,1 20,12A7,7 0 0,1 13,19C11.07,19 9.32,18.21 8.06,16.94L6.64,18.36C8.27,20 10.5,21 13,21A9,9 0 0,0 22,12A9,9 0 0,0 13,3"></path> </svg> </i> Version history </a> </li> <li class="cdsr-nav-link"> <a href="/cdsr/doi/10.1002/14651858.CD012551.pub3/information#keywords"> <i> <svg viewbox="0 0 24 24"> <path d="M11 3C10.18 3 9.44 3.5 9.14 4.27L3.64 18.27C3.12 19.58 4.09 21 5.5 21H7.75C8.59 21 9.33 20.5 9.62 19.7L10.26 18H13.74L14.38 19.7C14.67 20.5 15.42 21 16.25 21H18.5C19.91 21 20.88 19.58 20.36 18.27L14.86 4.27C14.56 3.5 13.82 3 13 3M11 5H13L18.5 19H16.25L15.12 16H8.87L7.75 19H5.5M12 7.67L9.62 14H14.37Z"></path> </svg> </i> Keywords (MeSH, PICOs) </a> </li> <li class="cdsr-nav-link"> <a href="/cdsr/doi/10.1002/14651858.CD012551.pub3/related-content"> <i class="icon fa fa-sitemap fa-rotate-270"></i> Related content </a> </li> <li class="cdsr-nav-link translation-notes-link"> <a href="/cdsr/doi/10.1002/14651858.CD012551.pub3/#"> <i> <svg viewbox="0 0 24 24"> <path d="M12.87,15.07L10.33,12.56L10.36,12.53C12.1,10.59 13.34,8.36 14.07,6H17V4H10V2H8V4H1V6H12.17C11.5,7.92 10.44,9.75 9,11.35C8.07,10.32 7.3,9.19 6.69,8H4.69C5.42,9.63 6.42,11.17 7.67,12.56L2.58,17.58L4,19L9,14L12.11,17.11L12.87,15.07M18.5,10H16.5L12,22H14L15.12,19H19.87L21,22H23L18.5,10M15.88,17L17.5,12.67L19.12,17H15.88Z"></path> </svg> </i> Translation notes </a> </li> <li class="cdsr-nav-link"> <a class="request-permissions" data-copyright="Copyright © 2018 The Cochrane Collaboration. Published by John Wiley &amp; Sons, Ltd." data-creative-commons="false" href="/cdsr/doi/10.1002/14651858.CD012551.pub3/#"> <span class="request-permissions-icon"></span> Request permissions </a> </li> <li class="cdsr-nav-link"> <a href="/data"> <i class="icon fa fa-database"></i> Request data reuse </a> </li> </ul> </nav> </div> <article> <div class="cdsr-header-top"> <div class="cdsr-header-left"> <a class="publish-database" href="/">Cochrane Database of Systematic reviews</a> <span class="publish-type">Review - Intervention</span> </div> <div class="cdsr-header-right"> </div> </div> <header class="publication-header"> <h1 class="publication-title" lang="en">Non‐pharmacological interventions for treating chronic prostatitis/chronic pelvic pain syndrome </h1> <div class="publication-metadata-block"> <div class="publication-authors"> <div class="publish-meta-wrapper"> <ul class="authors"> <li class="author"><a href="/cdsr/doi/10.1002/14651858.CD012551.pub3/information#CD012551-cr-0002"><i class="icon corresponding-author fa fa-envelope"></i>Juan VA Franco</a></li> <li class="author"><a href="/cdsr/doi/10.1002/14651858.CD012551.pub3/information#CD012551-cr-0003">Tarek Turk</a></li> <li class="author"><a href="/cdsr/doi/10.1002/14651858.CD012551.pub3/information#CD012551-cr-0004">Jae Hung Jung</a></li> <li class="author"><a href="/cdsr/doi/10.1002/14651858.CD012551.pub3/information#CD012551-cr-0005">Yu‐Tian Xiao</a></li> <li class="author"><a href="/cdsr/doi/10.1002/14651858.CD012551.pub3/information#CD012551-cr-0006">Stanislav Iakhno</a></li> <li class="author"><a href="/cdsr/doi/10.1002/14651858.CD012551.pub3/information#CD012551-cr-0007">Virginia Garrote</a></li> <li class="author"><a href="/cdsr/doi/10.1002/14651858.CD012551.pub3/information#CD012551-cr-0008">Valeria Vietto</a></li> </ul> <span class="author declaration"> <a class="declarationsOfInterestLink" href="/cdsr/doi/10.1002/14651858.CD012551.pub3/information/en#CD012551-sec-0299">Authors' declarations of interest</a> </span> </div> </div> </div> <div class="publication-metadata-block"> <p> <span class="publish-date">Version published: 12 May 2018 </span> <a class="whatsNewLink" href="/cdsr/doi/10.1002/14651858.CD012551.pub3/information/en#versionTable">Version history</a> </p> <div class="doi-header"> <a href="https://doi.org/10.1002/14651858.CD012551.pub3">https://doi.org/10.1002/14651858.CD012551.pub3</a> </div> </div> </header> <div class="publication-control-bar"> <span class="publication-control-button publication-control-collapse"> Collapse all </span> <span class="publication-control-button publication-control-expand"> Expand all </span> </div> <section class="abstract"> <div class="section-header section-collapse-header" id="CD012551-abs-0001" lang="en"> <h2 class="title section-collapse-title"> Abstract <i aria-hidden="true" class="fa fa-caret-up section-collapse-icon"></i> </h2> <div class="section-language-toggles"> <span class="section-languages-legend">available in</span> <nav class="section-languages"> <li class="section-language"> <a class="is-active" href="full/en#CD012551-abs-0001">English</a> </li> <li class="section-language"> <a class="" href="full/es#CD012551-abs-0004">Español</a> </li> <li class="section-language"> <a class="" href="full/fa#CD012551-abs-0011">فارسی</a> </li> <li class="section-language"> <a class="" href="full/fr#CD012551-abs-0003">Français</a> </li> <li class="section-language"> <a class="" href="full/zh_HANS#CD012551-abs-0002">简体中文</a> </li> </nav> </div> </div> <div class="abstract full_abstract" id="CD012551-abs-0001" lang="en"> <section id="CD012551-sec-0001"> <h3 class="title" id="CD012551-sec-0001">Background</h3> <p>Chronic prostatitis/chronic pelvic pain syndrome (CP/CPPS) is a common disorder in which the two main clinical features are pelvic pain and lower urinary tract symptoms. There are currently many approaches for its management, using both pharmacological and non‐pharmacological interventions. The National Institute of Health ‐ Chronic Prostatitis Symptom Index (NIH‐CPSI) score is a validated measure commonly used to measure CP/CPPS symptoms. </p> </section> <section id="CD012551-sec-0002"> <h3 class="title" id="CD012551-sec-0002">Objectives</h3> <p>To assess the effects of non‐pharmacological therapies for chronic prostatitis/chronic pelvic pain syndrome (CP/CPPS). </p> </section> <section id="CD012551-sec-0003"> <h3 class="title" id="CD012551-sec-0003">Search methods</h3> <p>We performed a comprehensive search using multiple databases, trial registries, grey literature and conference proceedings with no restrictions on the language of publication or publication status. The date of the latest search of all databases was August 2017. </p> </section> <section id="CD012551-sec-0004"> <h3 class="title" id="CD012551-sec-0004">Selection criteria</h3> <p>We included randomised controlled trials. Inclusion criteria were men with a diagnosis of CP/CPPS. We included all available non‐pharmacological interventions. </p> </section> <section id="CD012551-sec-0005"> <h3 class="title" id="CD012551-sec-0005">Data collection and analysis</h3> <p>Two review authors independently classified studies and abstracted data from the included studies, performed statistical analyses and rated quality of evidence (QoE) according to the GRADE methods. </p> </section> <section id="CD012551-sec-0006"> <h3 class="title" id="CD012551-sec-0006">Main results</h3> <p>We included 38 unique studies with 3290 men with CP/CPPS across 23 comparisons.</p> <p><b>1. Acupuncture:</b> (three studies, 204 participants) based on short‐term follow‐up, acupuncture probably leads to clinically meaningful reduction in prostatitis symptoms compared with sham procedure (mean difference (MD) in total NIH‐CPSI score ‐5.79, 95% confidence interval (CI) ‐7.32 to ‐4.26, high QoE). Acupuncture may result in little to no difference in adverse events (low QoE). Acupuncture may not reduce sexual dysfunction when compared with sham procedure (MD in the International Index of Erectile Function (IIEF) Scale ‐0.50, 95% CI ‐3.46 to 2.46, low QoE). Acupuncture may also lead to a clinically meaningful reduction in prostatitis symptoms compared with standard medical therapy (MD ‐6.05, 95% CI ‐7.87 to ‐4.24, two studies, 78 participants, low QoE). We found no information regarding quality of life, depression or anxiety. </p> <p><b>2. Lifestyle modifications:</b> (one study, 100 participants) based on short‐term follow‐up, lifestyle modifications may be associated with a reduction in prostatitis symptoms compared with control (risk ratio (RR) for improvement in NIH‐CPSI scores 3.90, 95% CI 2.20 to 6.92, very low QoE). We found no information regarding adverse events, sexual dysfunction, quality of life, depression or anxiety. </p> <p><b>3. Physical activity:</b> (one study, 85 participants) based on short‐term follow‐up, a physical activity programme may cause a small reduction in prostatitis symptoms compared with control (NIH‐CPSI score MD ‐2.50, 95% CI ‐4.69 to ‐0.31, low QoE). This programme may not reduce anxiety or depression (low QoE). We found no information regarding adverse events, sexual dysfunction or quality of life. </p> <p><b>4. Prostatic massage:</b> (two studies, 115 participants) based on short‐term follow‐up, we are uncertain whether the prostatic massage reduces or increases prostatitis symptoms compared with control (very low QoE). We found no information regarding adverse events, sexual dysfunction, quality of life, depression or anxiety. </p> <p><b>5. Extracorporeal shockwave therapy:</b> (three studies, 157 participants) based on short‐term follow‐up, extracorporeal shockwave therapy reduces prostatitis symptoms compared with control (NIH‐CPSI score MD ‐6.18, 95% CI ‐7.46 to ‐4.89, high QoE). These results may not be sustained at medium‐term follow‐up (low QoE). This treatment may not be associated with a greater incidence of adverse events (low QoE). This treatment probably improves sexual dysfunction (MD in the IIEF Scale MD 3.34, 95% CI 2.68 to 4.00, one study, 60 participants, moderate QoE). We found no information regarding quality of life, depression or anxiety. </p> <p><b>6. Transrectal thermotherapy compared to medical therapy:</b> (two studies, 237 participants) based on short‐term follow‐up, transrectal thermotherapy alone or in combination with medical therapy may decrease prostatitis symptoms slightly when compared with medical therapy alone (NIH‐CPSI score MD ‐2.50, 95% CI ‐3.82 to ‐1.18, low QoE). One included study reported that participants may experience transient adverse events. We found no information regarding sexual dysfunction, quality of life, depression or anxiety. </p> <p><b>7. Other interventions:</b> there is uncertainty about the effects of most of the other interventions included in this review. We found no information regarding psychological support or prostatic surgery. </p> </section> <section id="CD012551-sec-0007"> <h3 class="title" id="CD012551-sec-0007">Authors' conclusions</h3> <p>Based on the findings of moderate quality evidence, this review found that some non‐pharmacological interventions such as acupuncture and extracorporeal shockwave therapy are likely to result in a decrease in prostatitis symptoms and may not be associated with a greater incidence of adverse event. The QoE for most other comparisons was predominantly low. Future clinical trials should include a full report of their methods including adequate masking, consistent assessment of all patient‐important outcomes including potential treatment‐related adverse events and appropriate sample sizes. </p> </section> </div> </section> <section class="pico-section" id="pico"> <h2 class="title section-collapse-title">PICOs <i class="icon fa fa-info-circle" title="The PICO model is widely used and taught in evidence-based health care as a strategy for formulating questions and search strategies and for characterizing clinical studies or meta-analyses. PICO stands for four different potential components of a clinical question: Patient, Population or Problem; Intervention; Comparison; Outcome."></i> <i aria-hidden="true" class="fa fa-caret-up section-collapse-icon"></i> </h2> <div class="section-content" style="display: block;"> <h3 class="keyword-heading">PICOs</h3> <div class="pico-table"> <div class="pico-column Population"> <h6>Population<span class="pico-count"></span></h6> <ul class="pico-terms"> </ul> </div> <div class="pico-column Intervention"> <h6>Intervention<span class="pico-count"></span></h6> <ul class="pico-terms"> </ul> </div> <div class="pico-column Comparison"> <h6>Comparison<span class="pico-count"></span></h6> <ul class="pico-terms"> </ul> </div> <div class="pico-column Outcome"> <h6>Outcome<span class="pico-count"></span></h6> <ul class="pico-terms"> </ul> </div> </div> <div class="pico-information"> <p><i class="icon fa fa-info-circle"></i> The PICO model is widely used and taught in evidence-based health care as a strategy for formulating questions and search strategies and for characterizing clinical studies or meta-analyses. PICO stands for four different potential components of a clinical question: Patient, Population or Problem; Intervention; Comparison; Outcome.</p> <p>See more on using PICO in the <a href="https://training.cochrane.org/handbook/current/chapter-02#section-2-3">Cochrane Handbook</a>.</p> </div> </div> </section> <section class="pls"> <div class="section-header section-collapse-header" id="CD012551-abs-0005" lang="en"> <h2 class="title section-collapse-title"> Plain language summary <i aria-hidden="true" class="fa fa-caret-up section-collapse-icon"></i> </h2> <div class="section-language-toggles"> <span class="section-languages-legend">available in</span> <nav class="section-languages"> <li class="section-language"> <a class="is-active" href="full/en#CD012551-abs-0005">English</a> </li> <li class="section-language"> <a class="" href="full/de#CD012551-abs-0007">Deutsch</a> </li> <li class="section-language"> <a class="" href="full/es#CD012551-abs-0010">Español</a> </li> <li class="section-language"> <a class="" href="full/fa#CD012551-abs-0012">فارسی</a> </li> <li class="section-language"> <a class="" href="full/fr#CD012551-abs-0009">Français</a> </li> <li class="section-language"> <a class="" href="full/ru#CD012551-abs-0008">Русский</a> </li> <li class="section-language"> <a class="" href="full/zh_HANS#CD012551-abs-0006">简体中文</a> </li> </nav> </div> </div> <div class="abstract abstract_plainLanguageSummary" id="CD012551-abs-0005" lang="en"> <h3>Intervention for treating chronic prostatitis and chronic pelvic pain in men</h3> <p><b>Review question</b> </p> <p>What are the effects of non‐medicine therapies in men with longstanding pain and discomfort around their prostate and pelvis, so‐called chronic prostatitis/chronic pelvic pain syndrome (CP/CPPS)? </p> <p><b>Background</b> </p> <p>CP/CPPS is a common disorder in which men feel pelvic pain or have bothersome symptoms (or both of these) when urinating. Its cause is unknown and there are many different treatments for this condition. </p> <p><b>Study characteristics</b> </p> <p>The evidence was current to August 2017. We found 38 studies that were conducted between 1993 and 2016 with 3187 participants that made 23 comparisons between different treatments in men with CP/CPPS. The evaluated interventions usually implied the use of devices, medical advice or some form of physical therapy. In many cases, these therapies were given to men in an outpatient setting. Most studies did not specify their funding sources; three studies reported funding from device makers. </p> <p><b>Key results</b> </p> <p><i>Acupuncture:</i> we found that acupuncture (an alternative medicine where thin needles are inserted into the skin at specific points) probably causes a significant decrease in symptoms of prostatitis and may not associated with side effects when compared with pretend acupuncture, however, it may not reduce sexual problems. It probably decreases symptoms when compared with standard medical therapy. We found no information on its effect on quality of life, depression or anxiety. </p> <p><i>Lifestyle modifications:</i> we are uncertain whether the recommendation of lifestyle modifications reduces symptoms when compared to the continuation of the same lifestyle. We had no information regarding side effects, sexual problems, quality of life, depression or anxiety. </p> <p><i>Physical activity:</i> we found that a physical activity programme may reduce symptoms (small effect) when compared with a non‐specific activity used as a control, however it may not reduce anxiety or depression. We have no information regarding side effects, sexual problems or quality of life. </p> <p><i>Prostatic massage:</i> we are uncertain whether the prostatic massage reduces or increases symptoms when compared with no massage. We found no information regarding side effects, sexual problems, quality of life, depression or anxiety. </p> <p><i>Extracorporeal shockwave therapy:</i> we found that extracorporeal shockwave therapy (where shock waves are passed through the skin to the prostate) causes a significant decrease in symptoms compared to a simulated procedure. These results may not be lasting after more continued treatment. This treatment may not be associated with side effects. We have no information regarding quality of life, depression or anxiety. </p> <p><i>Transrectal thermotherapy compared to medical therapy:</i> we found that transrectal thermotherapy (which applies heat to the prostate and pelvic muscle area) alone or in combination with medical therapy may cause a small decrease in symptoms compared to medical therapy alone. One of the included studies reported that participants may experience transient side effects. We have no information regarding sexual problems, quality of life, depression or anxiety. </p> <p>There is uncertainty about the effects of other interventions.</p> <p><b>Quality of the evidence</b> </p> <p>The quality of the evidence was low in most cases, meaning that there is much uncertainty surrounding the results. The included studies were not well designed, had a small sample size and had a short follow‐up time (usually 12 weeks). </p> </div> </section> <section id="vls" style="display: none"> <div class="section-header section-collapse-header"> <h2 class="title section-collapse-title">Visual summary<i aria-hidden="true" class="fa fa-caret-up section-collapse-icon"></i></h2> </div> <a href="" target="_blank"><img alt="visual summary" src=""/></a> </section> <section class="conclusions"> <div class="section-header section-collapse-header" id="CD012551-sec-0284" lang="en"> <h2 class="title section-collapse-title"> Authors' conclusions <i aria-hidden="true" class="fa fa-caret-up section-collapse-icon"></i> </h2> </div> <section class="authorsConclusions" lang="en"> <div class="section-header" id="CD012551-sec-0284"></div> <h3 class="title" id="CD012551-sec-0285">Implications for practice</h3> <section id="CD012551-sec-0285"> <p>Based on the findings of moderate quality evidence, this review found that some non‐pharmacological interventions such as acupuncture, circumcision, extracorporeal shockwave therapy and tibial nerve stimulation can cause a decrease in prostatitis symptoms and may not be associated with a greater incidence of adverse events. However, given the large qualitative differences of the interventions, they must be assessed in each clinical context, considering the men's values and preferences, their acceptability, the feasibility of their implementation and the use of resources. </p> <p>There is greater uncertainty regarding the effectiveness of other therapies such as: lifestyle modifications, physical activity, prostatic massage, electromagnetic chair, transrectal thermotherapy, sono‐electromagnetic therapy, ultrasound therapy, biofeedback, external radiofrequency, laser therapy, myofascial trigger point release, osteopathy, trans‐electrical nerve stimulation, transurethral thermotherapy, transurethral needle ablation, hypercapnic hypoxia and TaiJiQuan. While there is low‐quality evidence of the effects of some of these interventions such as lifestyle changes and physical activity, they are relatively safe and they are recommended as part of a healthy lifestyle for multiple conditions. Conversely, prostatic massage has been widely used for CP/CPPS and we still have great uncertainty about its effect and, therefore, it should be carefully assessed before being recommended. The remaining interventions are still experimental. </p> </section> <h3 class="title" id="CD012551-sec-0286">Implications for research</h3> <section id="CD012551-sec-0286"> <p>Given the low‐quality evidence of the research included in this review, there is need for additional research with regards to the effects of some of the included interventions considering that: </p> <p> <ul id="CD012551-list-0029"> <li> <p>future clinical trials should include a full report of their methods for greater transparency regarding potential sources of bias. Additionally, acknowledging the subjective nature of the participant‐reported outcomes that are critical for decision making, masking of these interventions is warranted; </p> </li> <li> <p>future studies should include a greater variety of outcomes, including sexual dysfunction, quality of life, and depression and anxiety since this would represent the actual impact of these interventions on participants with CP/CPPS. Additionally, long‐term follow‐up is needed, recognising the chronicity of this condition. It also is essential for studies to report the incidence of adverse events to assess the net benefit of the interventions; </p> </li> <li> <p>ideally, studies should include more than 74 participants to reduce imprecision of the findings when considering prostatitis symptoms using the National Institute of Health ‐ Chronic Prostatitis Symptom Index (NIH‐CPSI) score. Larger sample sizes are required when assessing the number of responders to treatment or other outcomes; </p> </li> <li> <p>it is important that future studies describe all the details and implications of the interventions, to guarantee reproducibility; </p> </li> <li> <p>considering the high comorbidity of participants with CP/CPPS, it is important for studies to include participants with comorbid conditions to assess subgroup effects. </p> </li> </ul> </p> </section> </section> </section> <section class="summaryOfFindings"> <div class="section-header section-collapse-header" id="CD012551-sec-0029" lang="en"> <h2 class="title section-collapse-title"> Summary of findings <i aria-hidden="true" class="fa fa-caret-up section-collapse-icon"></i> </h2> </div> <section class="summaryOfFindings" lang="en"> <div class="section-header" id="CD012551-sec-0029"></div> <div class="table" id="CD012551-tbl-0001"> <table class="summary-of-findings framed"><a class="open-table-viewer open-in-figure-viewer" href="#0">Open in table viewer</a><div class="table-heading"><span class="table-label">Summary of findings for the main comparison.</span> <span class="table-title">Acupuncture compared to sham procedure for treating chronic prostatitis/chronic pelvic pain syndrome</span></div> <tbody> <tr class="separated"> <td align="left" bgcolor="#ffffff" colspan="6" rowspan="1" valign="top"> <p><b>Acupuncture compared to sham procedure for chronic prostatitis/chronic pelvic pain syndrome</b> </p> </td> </tr> <tr class="separated"> <td align="left" bgcolor="#ffffff" colspan="6" rowspan="1" valign="top"> <p><b>Patient or population:</b> participants with chronic prostatitis/chronic pelvic pain syndrome<br/> <b>Setting:</b> outpatient, Korea, Malaysia, US and Turkey<br/> <b>Intervention:</b> acupuncture<br/> <b>Comparison:</b> sham procedure placing needles in different points from those used in acupuncture </p> </td> </tr> <tr class="table-header separated"> <td align="left" class="table-header" colspan="1" rowspan="2" valign="top"> <p><b>Outcomes</b> </p> </td> <td align="left" class="table-tint table-highlight" colspan="1" rowspan="2" valign="top"> <p><b>№ of participants<br/> (studies)</b> </p> </td> <td align="left" class="table-tint table-highlight" colspan="1" rowspan="2" valign="top"> <p><b>Quality of the evidence<br/> (GRADE)</b> </p> </td> <td align="left" class="table-header" colspan="1" rowspan="2" valign="top"> <p><b>Relative effect<br/> (95% CI)</b> </p> </td> <td align="left" class="table-header" colspan="2" rowspan="1" valign="top"> <p><b>Anticipated absolute effects<sup>*</sup> (95% CI)</b> </p> </td> </tr> <tr class="table-header separated"> <td align="left" class="table-header" colspan="1" rowspan="1" valign="top"> <p><b>Risk with sham procedure</b> </p> </td> <td align="left" class="table-header" colspan="1" rowspan="1" valign="top"> <p><b>Risk difference with Acupuncture</b> </p> </td> </tr> <tr class="separated"> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><b>Prostatitis Symptoms</b><br/> assessed with: NIH‐CPSI score<br/> Scale from: 0 to 43<br/> follow up: 6‐8 weeks </p> <p>Benefit is indicated by lower scores</p> </td> <td align="left" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p>204<br/> (3 RCTs) </p> </td> <td align="left" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p>⊕⊕⊕⊝<br/> <b>Moderate</b><sup>1</sup> </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>‐</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>The mean prostatitis Symptoms ranged from 17.08 to 22</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><b>MD 5.79 lower</b><br/> (7.32 lower to 4.26 lower) </p> </td> </tr> <tr class="separated"> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="2" valign="top"> <p><b>Prostatitis Symptoms</b><br/> assessed with: NIH‐CPSI score (response)<br/> follow up: 6 weeks </p> </td> <td align="left" class="table-tint table-highlight" colspan="1" rowspan="2" valign="top"> <p>113<br/> (2 RCTs) </p> </td> <td align="left" class="table-tint table-highlight" colspan="1" rowspan="2" valign="top"> <p>⊕⊝⊝⊝<br/> <b>Very low</b><sup>1 2 3</sup> </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="2" valign="top"> <p><b>RR 2.49</b><br/> (0.77 to 8.02) </p> </td> <td align="left" bgcolor="#ffffff" colspan="2" rowspan="1" valign="top"> <p>Study population</p> </td> </tr> <tr class="separated"> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>404 per 1.000</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><b>596 more per 1000</b><br/> (93 fewer to 596 more) </p> </td> </tr> <tr class="separated"> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="2" valign="top"> <p><b>Adverse events</b> </p> <p>follow up: 6‐8 weeks</p> </td> <td align="left" class="table-tint table-highlight" colspan="1" rowspan="2" valign="top"> <p>204<br/> (3 RCTs) </p> </td> <td align="left" class="table-tint table-highlight" colspan="1" rowspan="2" valign="top"> <p>⊕⊕⊝⊝<br/> <b>Low</b><sup>1 3</sup> </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="2" valign="top"> <p><b>RR 1.33</b><br/> (0.51 to 3.46) </p> </td> <td align="left" bgcolor="#ffffff" colspan="2" rowspan="1" valign="top"> <p>Study population</p> </td> </tr> <tr class="separated"> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>58 per 1.000</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><b>19 more per 1000</b><br/> (29 fewer to 143 more) </p> </td> </tr> <tr class="separated"> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><b>Sexual dysfunction</b><br/> assessed with: International Index of Erectile Function<br/> Scale from: 5 to 25<br/> follow up: 6 weeks </p> <p>Benefit is indicated by higher scores</p> </td> <td align="left" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p>89<br/> (1 RCT) </p> </td> <td align="left" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p>⊕⊕⊝⊝<br/> <b>Low</b><sup>1 4</sup> </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>‐</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>The mean sexual dysfunction was 23</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><b>MD 0.5 lower</b><br/> (3.46 lower to 2.46 higher) </p> </td> </tr> <tr class="separated"> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><b>Quality of life</b> ‐ not reported </p> </td> <td align="left" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p>‐</p> </td> <td align="left" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p>‐</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>‐</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>‐</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>‐</p> </td> </tr> <tr class="separated"> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><b>Depression and anxiety</b> ‐ not reported </p> </td> <td align="left" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p>‐</p> </td> <td align="left" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p>‐</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>‐</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>‐</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>‐</p> </td> </tr> <tr class="separated"> <td align="" bgcolor="#ffffff" colspan="6" rowspan="1" valign=""> <p>*<b>The risk in the intervention group</b> (and its 95% confidence interval) is based on the assumed risk in the comparison group and the <b>relative effect</b> of the intervention (and its 95% CI).<br/> <br/> <b>CI:</b> Confidence interval; <b>RR:</b> Risk ratio; <b>OR:</b> Odds ratio; </p> </td> </tr> <tr class="separated"> <td align="" bgcolor="#ffffff" colspan="6" rowspan="1" valign=""> <p><b>GRADE Working Group grades of evidence</b> <br/> <b>High quality:</b> We are very confident that the true effect lies close to that of the estimate of the effect<br/> <b>Moderate quality:</b> We are moderately confident in the effect estimate: The true effect is likely to be close to the estimate of the effect, but there is a possibility that it is substantially different<br/> <b>Low quality:</b> Our confidence in the effect estimate is limited: The true effect may be substantially different from the estimate of the effect<br/> <b>Very low quality:</b> We have very little confidence in the effect estimate: The true effect is likely to be substantially different from the estimate of effect </p> </td> </tr> </tbody> <tfoot> <tr> <td colspan="6"> <div class="table-footnote"> <p><sup>1</sup> Downgraded 1 level due to unclear risk of bias: insufficient information about allocation concealment </p> <p><sup>2</sup> Downgraded 1 level due to inconsistency: statistical heterogeneity (I<sup>2</sup> = 76%). </p> <p><sup>3</sup> Downgraded 1 level due to imprecision issues: wide confidence interval due to small sample size and few events. </p> <p><sup>4</sup> Downgraded 1 level for imprecision issues: wide confidence interval includes both appreciable benefit and harm. </p> </div> </td> </tr> </tfoot> </table> </div> <div class="table" id="CD012551-tbl-0002"> <table class="summary-of-findings framed"><a class="open-table-viewer open-in-figure-viewer" href="#0">Open in table viewer</a><div class="table-heading"><span class="table-label">Summary of findings 2.</span> <span class="table-title">Acupuncture compared to medical treatment for treating chronic prostatitis/chronic pelvic pain syndrome</span></div> <tbody> <tr class="separated"> <td align="left" bgcolor="#ffffff" colspan="6" rowspan="1" valign="top"> <p><b>Acupuncture compared to medical treatment for chronic prostatitis/chronic pelvic pain syndrome</b> </p> </td> </tr> <tr class="separated"> <td align="left" bgcolor="#ffffff" colspan="6" rowspan="1" valign="top"> <p><b>Patient or population:</b> treating chronic prostatitis/chronic pelvic pain syndrome<br/> <b>Setting:</b> outpatient, Korea, China and Turkey<br/> <b>Intervention:</b> acupuncture<br/> <b>Comparison:</b> medical treatment </p> </td> </tr> <tr class="table-header separated"> <td align="left" class="table-header" colspan="1" rowspan="2" valign="top"> <p><b>Outcomes</b> </p> </td> <td align="left" class="table-tint table-highlight" colspan="1" rowspan="2" valign="top"> <p><b>№ of participants<br/> (studies)</b> </p> </td> <td align="left" class="table-tint table-highlight" colspan="1" rowspan="2" valign="top"> <p><b>Quality of the evidence<br/> (GRADE)</b> </p> </td> <td align="left" class="table-header" colspan="1" rowspan="2" valign="top"> <p><b>Relative effect<br/> (95% CI)</b> </p> </td> <td align="left" class="table-header" colspan="2" rowspan="1" valign="top"> <p><b>Anticipated absolute effects* (95% CI)</b> </p> </td> </tr> <tr class="table-header separated"> <td align="left" class="table-header" colspan="1" rowspan="1" valign="top"> <p><b>Risk with medical treatment</b> </p> </td> <td align="left" class="table-header" colspan="1" rowspan="1" valign="top"> <p><b>Risk difference with acupuncture</b> </p> </td> </tr> <tr class="separated"> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><b>Prostatitis symptoms</b> (NIH‐CPSI total)<br/> assessed with: NIH‐CPSI score<br/> Scale from: 0 to 43<br/> follow‐up: 12 weeks </p> <p>Benefit is indicated by lower scores</p> </td> <td align="left" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p>78<br/> (2 RCTs) </p> </td> <td align="left" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p>⊕⊕⊕⊝<br/> <b>Moderate</b><sup>1,2</sup> </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>‐</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>The mean prostatitis symptoms (NIH‐CPSI total) ranged from 12 to 16</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><b>MD 6.05 lower</b><br/> (7.87 lower to 4.24 lower) </p> </td> </tr> <tr class="separated"> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="2" valign="top"> <p><b>Prostatitis symptoms</b>: response defined as a 6‐point decrease in NIH‐CPSI score<br/> follow‐up: 6 weeks<sup>3</sup> </p> </td> <td align="left" class="table-tint table-highlight" colspan="1" rowspan="2" valign="top"> <p>24<br/> (1 RCT) </p> </td> <td align="left" class="table-tint table-highlight" colspan="1" rowspan="2" valign="top"> <p>⊕⊕⊝⊝<br/> <b>Low</b><sup>1,3</sup> </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="2" valign="top"> <p><b>RR 3.57</b><br/> (1.45 to 8.80) </p> </td> <td align="left" bgcolor="#ffffff" colspan="2" rowspan="1" valign="top"> <p>Study population</p> </td> </tr> <tr class="separated"> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>250 per 1000</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><b>643 more per 1000</b><br/> (112 more to 1950 more) </p> </td> </tr> <tr class="separated"> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><b>Adverse events</b> </p> <p>follow‐up: 12 weeks</p> </td> <td align="left" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p>78<br/> (2 RCTs) </p> </td> <td align="left" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p>⊕⊕⊝⊝<br/> <b>Low</b><sup>1,3</sup> </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>‐</p> </td> <td align="left" bgcolor="#ffffff" colspan="2" rowspan="1" valign="top"> <p>There were no adverse events in either group.</p> </td> </tr> <tr class="separated"> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><b>Sexual dysfunction</b> ‐ not reported </p> </td> <td align="left" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p>‐</p> </td> <td align="left" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p>‐</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>‐</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>‐</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>‐</p> </td> </tr> <tr class="separated"> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><b>Quality of life</b> ‐ not reported </p> </td> <td align="left" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p>‐</p> </td> <td align="left" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p>‐</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>‐</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>‐</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>‐</p> </td> </tr> <tr class="separated"> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><b>Depression and anxiety</b> ‐ not reported </p> </td> <td align="left" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p>‐</p> </td> <td align="left" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p>‐</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>‐</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>‐</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>‐</p> </td> </tr> <tr class="separated"> <td align="" bgcolor="#ffffff" colspan="6" rowspan="1" valign=""> <p>*<b>The risk in the intervention group</b> (and its 95% confidence interval) is based on the assumed risk in the comparison group and the <b>relative effect</b> of the intervention (and its 95% CI). </p> <p><b>CI</b> : confidence interval; <b>MD</b> : mean difference; <b>NIH‐CPSI</b> : National Institutes of Health ‐ Chronic Prostatitis Symptom Index; <b>RCT</b> : randomised controlled trial; <b>RR:</b> risk ratio. </p> </td> </tr> <tr class="separated"> <td align="" bgcolor="#ffffff" colspan="6" rowspan="1" valign=""> <p><b>GRADE Working Group grades of evidence</b> <br/> <b>High quality:</b> we are very confident that the true effect lies close to that of the estimate of the effect.<br/> <b>Moderate quality:</b> we are moderately confident in the effect estimate: the true effect is likely to be close to the estimate of the effect, but there is a possibility that it is substantially different.<br/> <b>Low quality:</b> our confidence in the effect estimate is limited: the true effect may be substantially different from the estimate of the effect.<br/> <b>Very low quality:</b> we have very little confidence in the effect estimate: the true effect is likely to be substantially different from the estimate of effect. </p> </td> </tr> </tbody> <tfoot> <tr> <td colspan="6"> <div class="table-footnote"> <p><sup>1</sup>Downgraded 1 level due to risk of bias: included studies were not blinded, which affects both detection and performance bias. </p> <p><sup>2</sup>The initial analysis had greater statistical inconsistency (I<sup>2</sup> = 70%) and included one study that included people with chronic prostatitis/chronic pelvic pain syndrome using criteria that differed from that recommended by the Research Consensus (<a href="./references#CD012551-bbs2-0002" title="ChenZX . Observation on therapeutic effect of warm needle moxibustion on chronic non‐bacterial prostatitis. Zhongguo Zhen Jiu [Chinese Acupuncture &amp; Moxibustion]2009;29(4):275‐8. ">Chen 2009</a>). In a sensitivity analysis, we excluded the results from this study and found greater statistical consistency (I<sup>2</sup> = 0%), therefore, we chose to report these results in the 'Summary of findings' table. For this reason, we did not downgrade due to inconsistency. </p> <p><sup>3</sup>Downgraded 1 level due to imprecision issues: few events and wide confidence interval. </p> </div> </td> </tr> </tfoot> </table> </div> <div class="table" id="CD012551-tbl-0003"> <table class="summary-of-findings framed"><a class="open-table-viewer open-in-figure-viewer" href="#0">Open in table viewer</a><div class="table-heading"><span class="table-label">Summary of findings 3.</span> <span class="table-title">Circumcision plus usual care compared to waiting list plus usual care for chronic prostatitis/chronic pelvic pain syndrome</span></div> <tbody> <tr class="separated"> <td align="left" bgcolor="#ffffff" colspan="6" rowspan="1" valign="top"> <p><b>Circumcision plus usual care compared to waiting list plus usual care for chronic prostatitis/chronic pelvic pain syndrome</b> </p> </td> </tr> <tr class="separated"> <td align="left" bgcolor="#ffffff" colspan="6" rowspan="1" valign="top"> <p><b>Patient or population:</b> participants with chronic prostatitis/chronic pelvic pain syndrome<br/> <b>Setting:</b> hospital (surgery), China<br/> <b>Intervention:</b> circumcision at 4 weeks (outcome was assessed after circumcision)<br/> <b>Comparison:</b> waiting list for circumcision at 3 months (outcome was assessed before circumcision) </p> </td> </tr> <tr class="table-header separated"> <td align="left" class="table-header" colspan="1" rowspan="2" valign="top"> <p><b>Outcomes</b> </p> </td> <td align="left" class="table-tint table-highlight" colspan="1" rowspan="2" valign="top"> <p><b>№ of participants<br/> (studies)</b> </p> </td> <td align="left" class="table-tint table-highlight" colspan="1" rowspan="2" valign="top"> <p><b>Quality of the evidence<br/> (GRADE)</b> </p> </td> <td align="left" class="table-header" colspan="1" rowspan="2" valign="top"> <p><b>Relative effect<br/> (95% CI)</b> </p> </td> <td align="left" class="table-header" colspan="2" rowspan="1" valign="top"> <p><b>Anticipated absolute effects* (95% CI)</b> </p> </td> </tr> <tr class="table-header separated"> <td align="left" class="table-header" colspan="1" rowspan="1" valign="top"> <p><b>Risk with waiting list for circumcision</b> </p> </td> <td align="left" class="table-header" colspan="1" rowspan="1" valign="top"> <p><b>Risk difference with early circumcision</b> </p> </td> </tr> <tr class="separated"> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><b>Prostatitis symptoms</b><br/> assessed with: NIH‐CPSI score<br/> Scale from: 0 to 43<br/> follow‐up: 12 weeks </p> <p>Benefit is indicated by lower scores</p> </td> <td align="left" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p>713<br/> (1 RCT) </p> </td> <td align="left" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p>⊕⊕⊕⊝<br/> <b>Moderate</b><sup>1</sup> </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>‐</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>The mean prostatitis symptoms was 15</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><b>MD 3.00 lower</b><br/> (3.82 lower to 2.18 lower)<sup>2</sup> </p> </td> </tr> <tr class="separated"> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="2" valign="top"> <p><b>Adverse events</b><sup>3</sup> </p> <p>follow‐up: 12 weeks</p> </td> <td align="left" class="table-tint table-highlight" colspan="1" rowspan="2" valign="top"> <p>713<br/> (1 RCT) </p> </td> <td align="left" class="table-tint table-highlight" colspan="1" rowspan="2" valign="top"> <p>⊕⊕⊝⊝<br/> <b>Low</b><sup>1,4</sup> </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="2" valign="top"> <p><b>RR 1.23</b><br/> (0.86 to 1.76) </p> </td> <td align="left" bgcolor="#ffffff" colspan="2" rowspan="1" valign="top"> <p>Study population</p> </td> </tr> <tr class="separated"> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>130 per 1000</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><b>30 more per 1000</b><br/> (18 fewer to 98 more) </p> </td> </tr> <tr class="separated"> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><b>Sexual dysfunction</b> ‐ not reported </p> </td> <td align="left" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p>‐</p> </td> <td align="left" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p>‐</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>‐</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>‐</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>‐</p> </td> </tr> <tr class="separated"> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><b>Quality of life</b> ‐ not reported </p> </td> <td align="left" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p>‐</p> </td> <td align="left" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p>‐</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>‐</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>‐</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>‐</p> </td> </tr> <tr class="separated"> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><b>Depression and anxiety</b> ‐ not reported </p> </td> <td align="left" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p>‐</p> </td> <td align="left" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p>‐</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>‐</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>‐</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>‐</p> </td> </tr> <tr class="separated"> <td align="" bgcolor="#ffffff" colspan="6" rowspan="1" valign=""> <p>*<b>The risk in the intervention group</b> (and its 95% confidence interval) is based on the assumed risk in the comparison group and the <b>relative effect</b> of the intervention (and its 95% CI). </p> <p><b>CI</b> : confidence interval; <b>MD</b> : mean difference; <b>NIH‐CPSI</b> : National Institutes of Health ‐ Chronic Prostatitis Symptom Index; <b>RCT</b> : randomised controlled trial; <b>RR</b>: risk ratio. </p> </td> </tr> <tr class="separated"> <td align="" bgcolor="#ffffff" colspan="6" rowspan="1" valign=""> <p><b>GRADE Working Group grades of evidence</b> <br/> <b>High quality:</b> we are very confident that the true effect lies close to that of the estimate of the effect.<br/> <b>Moderate quality:</b> we are moderately confident in the effect estimate: the true effect is likely to be close to the estimate of the effect, but there is a possibility that it is substantially different.<br/> <b>Low quality:</b> our confidence in the effect estimate is limited: the true effect may be substantially different from the estimate of the effect.<br/> <b>Very low quality:</b> we have very little confidence in the effect estimate: the true effect is likely to be substantially different from the estimate of effect. </p> </td> </tr> </tbody> <tfoot> <tr> <td colspan="6"> <div class="table-footnote"> <p><sup>1</sup>Downgraded 1 level due to high risk of bias: study not blinded (high risk of performance and detection bias). </p> <p><sup>2</sup>Confidence intervals were constructed using transformations described in the <i>Cochrane Handbook for Systematic Reviews of Interventions</i> Section 7.7.3.5. </p> <p><sup>3</sup>All adverse events were minor. </p> <p><sup>4</sup>Downgraded 1 level due to imprecision issues: few events in each group and wide confidence interval. </p> </div> </td> </tr> </tfoot> </table> </div> <div class="table" id="CD012551-tbl-0004"> <table class="summary-of-findings framed"><a class="open-table-viewer open-in-figure-viewer" href="#0">Open in table viewer</a><div class="table-heading"><span class="table-label">Summary of findings 4.</span> <span class="table-title">Electromagnetic chair compared to control intervention for chronic prostatitis/chronic pelvic pain syndrome</span></div> <tbody> <tr class="separated"> <td align="left" bgcolor="#ffffff" colspan="6" rowspan="1" valign="top"> <p><b>Electromagnetic chair compared to control intervention for chronic prostatitis/chronic pelvic pain syndrome</b> </p> </td> </tr> <tr class="separated"> <td align="left" bgcolor="#ffffff" colspan="6" rowspan="1" valign="top"> <p><b>Patient or population:</b> participants with chronic prostatitis/chronic pelvic pain syndrome<br/> <b>Setting:</b> outpatient, South Korea and England<br/> <b>Intervention:</b> electromagnetic chair<br/> <b>Comparison:</b> control intervention in which the electromagnetic chair was switched off </p> </td> </tr> <tr class="table-header separated"> <td align="left" class="table-header" colspan="1" rowspan="2" valign="top"> <p><b>Outcomes</b> </p> </td> <td align="left" class="table-tint table-highlight" colspan="1" rowspan="2" valign="top"> <p><b>№ of participants<br/> (studies)</b> </p> </td> <td align="left" class="table-tint table-highlight" colspan="1" rowspan="2" valign="top"> <p><b>Quality of the evidence<br/> (GRADE)</b> </p> </td> <td align="left" class="table-header" colspan="1" rowspan="2" valign="top"> <p><b>Relative effect<br/> (95% CI)</b> </p> </td> <td align="left" class="table-header" colspan="2" rowspan="1" valign="top"> <p><b>Anticipated absolute effects* (95% CI)</b> </p> </td> </tr> <tr class="table-header separated"> <td align="left" class="table-header" colspan="1" rowspan="1" valign="top"> <p><b>Risk with control intervention</b> </p> </td> <td align="left" class="table-header" colspan="1" rowspan="1" valign="top"> <p><b>Risk difference with electromagnetic chair</b> </p> </td> </tr> <tr class="separated"> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><b>Prostatitis symptoms</b><br/> assessed with: NIH‐CPSI score / Prostatitis Symptom Severity Score<br/> follow‐up: 6‐12 weeks </p> <p>Benefit is indicated by lower scores</p> </td> <td align="left" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p>57<br/> (2 RCTs) </p> </td> <td align="left" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p>⊕⊝⊝⊝<br/> <b>Very low</b><sup>1,2,3</sup> </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>‐</p> </td> <td align="left" bgcolor="#ffffff" colspan="2" rowspan="1" valign="top"> <p>1 study found no differences in NIH‐CPSI score measurements at 6 weeks. The other study found a symptom score 16 points (0‐ to 90‐point scale) lower in the intervention group compared to the control group (P value not available) at 12 weeks. </p> </td> </tr> <tr class="separated"> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><b>Adverse events</b> </p> <p>follow‐up: 6‐12 weeks</p> </td> <td align="left" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p>57<br/> (2 RCTs) </p> </td> <td align="left" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p>⊕⊕⊝⊝<br/> <b>Low</b><sup>1,4</sup> </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>‐</p> </td> <td align="left" bgcolor="#ffffff" colspan="2" rowspan="1" valign="top"> <p>1 study reported a 0 incidence of adverse events and the other study reported 1 case of transient paraesthesia in the active treatment group. </p> </td> </tr> <tr class="separated"> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><b>Sexual dysfunction</b> ‐ not reported </p> </td> <td align="left" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p>‐</p> </td> <td align="left" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p>‐</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>‐</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>‐</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>‐</p> </td> </tr> <tr class="separated"> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><b>Quality of life</b> ‐ not reported </p> </td> <td align="left" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p>‐</p> </td> <td align="left" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p>‐</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>‐</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>‐</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>‐</p> </td> </tr> <tr class="separated"> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><b>Depression and anxiety</b> ‐ not reported </p> </td> <td align="left" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p>‐</p> </td> <td align="left" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p>‐</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>‐</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>‐</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>‐</p> </td> </tr> <tr class="separated"> <td align="" bgcolor="#ffffff" colspan="6" rowspan="1" valign=""> <p>*<b>The risk in the intervention group</b> (and its 95% confidence interval) is based on the assumed risk in the comparison group and the <b>relative effect</b> of the intervention (and its 95% CI). </p> <p><b>CI</b> : confidence interval; <b>NIH‐CPSI</b> : National Institutes of Health ‐ Chronic Prostatitis Symptom Index; <b>RCT</b>: randomised controlled trial. </p> </td> </tr> <tr class="separated"> <td align="" bgcolor="#ffffff" colspan="6" rowspan="1" valign=""> <p><b>GRADE Working Group grades of evidence</b> <br/> <b>High quality:</b> we are very confident that the true effect lies close to that of the estimate of the effect.<br/> <b>Moderate quality:</b> we are moderately confident in the effect estimate: the true effect is likely to be close to the estimate of the effect, but there is a possibility that it is substantially different.<br/> <b>Low quality:</b> our confidence in the effect estimate is limited: the true effect may be substantially different from the estimate of the effect.<br/> <b>Very low quality:</b> we have very little confidence in the effect estimate: the true effect is likely to be substantially different from the estimate of effect. </p> </td> </tr> </tbody> <tfoot> <tr> <td colspan="6"> <div class="table-footnote"> <p><sup>1</sup>Downgraded 1 level due to risk of bias: one study not blinded and the other study had high attrition bias and selective outcome reporting bias. </p> <p><sup>2</sup>The two included studies had inconsistent results (see narrative description). </p> <p><sup>3</sup>Downgraded 1 level for imprecision issues: optimal information size not met (OIS for a 4‐point decrease, standard deviation 6, alpha 0.05, beta 0.20 = 74); small sample size in the individual studies (meta‐analysis was not possible). </p> <p><sup>4</sup>Downgraded 1 level due to imprecision issues: rare events and wide confidence interval. </p> </div> </td> </tr> </tfoot> </table> </div> <div class="table" id="CD012551-tbl-0005"> <table class="summary-of-findings framed"><a class="open-table-viewer open-in-figure-viewer" href="#0">Open in table viewer</a><div class="table-heading"><span class="table-label">Summary of findings 5.</span> <span class="table-title">Lifestyle modifications compared to control for chronic prostatitis/chronic pelvic pain syndrome</span></div> <tbody> <tr class="separated"> <td align="left" bgcolor="#ffffff" colspan="6" rowspan="1" valign="top"> <p><b>Lifestyle modifications compared to control for chronic prostatitis/chronic pelvic pain syndrome</b> </p> </td> </tr> <tr class="separated"> <td align="left" bgcolor="#ffffff" colspan="6" rowspan="1" valign="top"> <p><b>Patient or population:</b> participants with chronic prostatitis/chronic pelvic pain syndrome<br/> <b>Setting:</b> outpatient, Italy<br/> <b>Intervention:</b> lifestyle modifications based on the assessment of risk factors for chronic prostatitis/chronic pelvic pain syndrome<br/> <b>Comparison:</b> control intervention in which participants were instructed to continue with the same lifestyle </p> </td> </tr> <tr class="table-header separated"> <td align="left" class="table-header" colspan="1" rowspan="2" valign="top"> <p><b>Outcomes</b> </p> </td> <td align="left" class="table-tint table-highlight" colspan="1" rowspan="2" valign="top"> <p><b>№ of participants<br/> (studies)<br/> Follow‐up</b> </p> </td> <td align="left" class="table-tint table-highlight" colspan="1" rowspan="2" valign="top"> <p><b>Quality of the evidence<br/> (GRADE)</b> </p> </td> <td align="left" class="table-header" colspan="1" rowspan="2" valign="top"> <p><b>Relative effect<br/> (95% CI)</b> </p> </td> <td align="left" class="table-header" colspan="2" rowspan="1" valign="top"> <p><b>Anticipated absolute effects* (95% CI)</b> </p> </td> </tr> <tr class="table-header separated"> <td align="left" class="table-header" colspan="1" rowspan="1" valign="top"> <p><b>Risk with control</b> </p> </td> <td align="left" class="table-header" colspan="1" rowspan="1" valign="top"> <p><b>Risk difference with lifestyle modifications</b> </p> </td> </tr> <tr class="separated"> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="2" valign="top"> <p><b>Prostatitis symptom</b>s: response defined as 6‐point decrease in NIH‐CPSI score<br/> follow‐up: 3 months </p> <p>Benefit is indicated by lower scores</p> </td> <td align="left" class="table-tint table-highlight" colspan="1" rowspan="2" valign="top"> <p>100<br/> (1 RCT) </p> </td> <td align="left" class="table-tint table-highlight" colspan="1" rowspan="2" valign="top"> <p>⊕⊝⊝⊝<br/> <b>Very low</b><sup>1,2</sup> </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="2" valign="top"> <p><b>RR 3.90</b><br/> (2.20 to 6.92) </p> </td> <td align="left" bgcolor="#ffffff" colspan="2" rowspan="1" valign="top"> <p>Study population</p> </td> </tr> <tr class="separated"> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>200 per 1000</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><b>580 more per 1000</b><br/> (240 more to 1184 more) </p> </td> </tr> <tr class="separated"> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><b>Adverse events</b> ‐ not reported </p> </td> <td align="left" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p>‐</p> </td> <td align="left" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p>‐</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>‐</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>‐</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>‐</p> </td> </tr> <tr class="separated"> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><b>Sexual dysfunction</b> ‐ not reported </p> </td> <td align="left" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p>‐</p> </td> <td align="left" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p>‐</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>‐</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>‐</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>‐</p> </td> </tr> <tr class="separated"> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><b>Quality of life</b> ‐ not reported </p> </td> <td align="left" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p>‐</p> </td> <td align="left" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p>‐</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>‐</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>‐</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>‐</p> </td> </tr> <tr class="separated"> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><b>Depression and anxiety</b> ‐ not reported </p> </td> <td align="left" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p>‐</p> </td> <td align="left" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p>‐</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>‐</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>‐</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>‐</p> </td> </tr> <tr class="separated"> <td align="" bgcolor="#ffffff" colspan="6" rowspan="1" valign=""> <p>*<b>The risk in the intervention group</b> (and its 95% confidence interval) is based on the assumed risk in the comparison group and the <b>relative effect</b> of the intervention (and its 95% CI). </p> <p><b>CI</b> : confidence interval; <b>NIH‐CPSI</b> : National Institutes of Health ‐ Chronic Prostatitis Symptom Index; <b>RCT</b> : randomised controlled trial; <b>RR</b>: risk ratio. </p> </td> </tr> <tr class="separated"> <td align="" bgcolor="#ffffff" colspan="6" rowspan="1" valign=""> <p><b>GRADE Working Group grades of evidence</b> <br/> <b>High quality:</b> we are very confident that the true effect lies close to that of the estimate of the effect.<br/> <b>Moderate quality:</b> we are moderately confident in the effect estimate: the true effect is likely to be close to the estimate of the effect, but there is a possibility that it is substantially different.<br/> <b>Low quality:</b> our confidence in the effect estimate is limited: the true effect may be substantially different from the estimate of the effect.<br/> <b>Very low quality:</b> we have very little confidence in the effect estimate: the true effect is likely to be substantially different from the estimate of effect. </p> </td> </tr> </tbody> <tfoot> <tr> <td colspan="6"> <div class="table-footnote"> <p><sup>1</sup>Downgraded 2 levels due to high risk of selection bias (unconcealed allocation), detection and performance bias (study not blinded), missing outcome data and suspected selective outcome reporting (data presented graphically). </p> <p><sup>2</sup>Downgraded 1 level due to imprecision issues: few events and wide confidence interval. </p> </div> </td> </tr> </tfoot> </table> </div> <div class="table" id="CD012551-tbl-0006"> <table class="summary-of-findings framed"><a class="open-table-viewer open-in-figure-viewer" href="#0">Open in table viewer</a><div class="table-heading"><span class="table-label">Summary of findings 6.</span> <span class="table-title">Physical activity compared to control intervention for chronic prostatitis/chronic pelvic pain syndrome</span></div> <tbody> <tr class="separated"> <td align="left" bgcolor="#ffffff" colspan="6" rowspan="1" valign="top"> <p><b>Physical activity compared to control intervention procedure for chronic prostatitis/chronic pelvic pain syndrome</b> </p> </td> </tr> <tr class="separated"> <td align="left" bgcolor="#ffffff" colspan="6" rowspan="1" valign="top"> <p><b>Patient or population:</b> participants with chronic prostatitis/chronic pelvic pain syndrome<br/> <b>Setting:</b> outpatient, Italy<br/> <b>Intervention:</b> physical activity programme<br/> <b>Comparison:</b> control intervention comprising a flexibility and motion low‐grade exercise programme </p> </td> </tr> <tr class="table-header separated"> <td align="left" class="table-header" colspan="1" rowspan="2" valign="top"> <p><b>Outcomes</b> </p> </td> <td align="left" class="table-tint table-highlight" colspan="1" rowspan="2" valign="top"> <p><b>№ of participants<br/> (studies)</b> </p> </td> <td align="left" class="table-tint table-highlight" colspan="1" rowspan="2" valign="top"> <p><b>Quality of the evidence<br/> (GRADE)</b> </p> </td> <td align="left" class="table-header" colspan="1" rowspan="2" valign="top"> <p><b>Relative effect<br/> (95% CI)</b> </p> </td> <td align="left" class="table-header" colspan="2" rowspan="1" valign="top"> <p><b>Anticipated absolute effects* (95% CI)</b> </p> </td> </tr> <tr class="table-header separated"> <td align="left" class="table-header" colspan="1" rowspan="1" valign="top"> <p><b>Risk with sham procedure</b> </p> </td> <td align="left" class="table-header" colspan="1" rowspan="1" valign="top"> <p><b>Risk difference with physical activity</b> </p> </td> </tr> <tr class="separated"> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><b>Prostatitis symptoms</b><br/> assessed with: NIH‐CPSI score<br/> Scale from: 0 to 43<br/> follow‐up: 6 weeks </p> <p>Benefit is indicated by lower scores</p> </td> <td align="left" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p>85<br/> (1 RCT) </p> </td> <td align="left" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p>⊕⊕⊝⊝<br/> <b>Low</b><sup>1</sup> </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>‐</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>The mean prostatitis symptom score was 20</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><b>MD 2.50 lower</b><br/> (4.69 lower to 0.31 lower) </p> </td> </tr> <tr class="separated"> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><b>Adverse events</b> ‐ not reported </p> </td> <td align="left" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p>‐</p> </td> <td align="left" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p>‐</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>‐</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>‐</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>‐</p> </td> </tr> <tr class="separated"> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><b>Sexual dysfunction</b> ‐ not reported </p> </td> <td align="left" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p>‐</p> </td> <td align="left" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p>‐</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>‐</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>‐</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>‐</p> </td> </tr> <tr class="separated"> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><b>Quality of life</b> ‐ not reported </p> </td> <td align="left" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p>‐</p> </td> <td align="left" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p>‐</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>‐</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>‐</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>‐</p> </td> </tr> <tr class="separated"> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><b>Anxiety</b><br/> assessed with: SAI‐Y score<br/> Scale from: 20 to 80<br/> follow‐up: 6 weeks </p> <p>Benefit is indicated by lower scores</p> </td> <td align="left" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p>85<br/> (1 RCT) </p> </td> <td align="left" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p>⊕⊝⊝⊝<br/> <b>Very low</b><sup>1,2</sup> </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>‐</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>The mean anxiety score was 42.1</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><b>MD 2.8 lower</b><br/> (6.78 lower to 1.18 higher) </p> </td> </tr> <tr class="separated"> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><b>Depression</b><br/> assessed with: Beck Depression Inventory<br/> Scale from: 0 to 63<br/> follow‐up: 6 weeks </p> <p>Benefit is indicated by lower scores</p> </td> <td align="left" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p>85<br/> (1 RCT) </p> </td> <td align="left" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p>⊕⊝⊝⊝<br/> <b>Very low</b><sup>1,2</sup> </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>‐</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>The mean depression score was 9.3</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><b>MD 0.5 higher</b><br/> (1.33 lower to 2.33 higher) </p> </td> </tr> <tr class="separated"> <td align="" bgcolor="#ffffff" colspan="6" rowspan="1" valign=""> <p>*<b>The risk in the intervention group</b> (and its 95% confidence interval) is based on the assumed risk in the comparison group and the <b>relative effect</b> of the intervention (and its 95% CI). </p> <p><b>CI</b> : confidence interval; <b>MD</b> : mean difference; <b>NIH‐CPSI</b> : National Institutes of Health ‐ Chronic Prostatitis Symptom Index; <b>RCT</b> : randomised controlled trial; <b>SAI‐Y</b>: State Anxiety Inventory‐Y. </p> </td> </tr> <tr class="separated"> <td align="" bgcolor="#ffffff" colspan="6" rowspan="1" valign=""> <p><b>GRADE Working Group grades of evidence</b> <br/> <b>High quality:</b> we are very confident that the true effect lies close to that of the estimate of the effect.<br/> <b>Moderate quality:</b> we are moderately confident in the effect estimate: the true effect is likely to be close to the estimate of the effect, but there is a possibility that it is substantially different.<br/> <b>Low quality:</b> our confidence in the effect estimate is limited: the true effect may be substantially different from the estimate of the effect.<br/> <b>Very low quality:</b> we have very little confidence in the effect estimate: the true effect is likely to be substantially different from the estimate of effect. </p> </td> </tr> </tbody> <tfoot> <tr> <td colspan="6"> <div class="table-footnote"> <p><sup>1</sup>Downgraded 2 levels: high risk of performance bias and detection bias (study not blinded); high risk of attrition bias at follow‐up. </p> <p><sup>2</sup>Downgraded 1 level due to imprecision issues: wide confidence intervals include both considerable benefits and harms. </p> </div> </td> </tr> </tfoot> </table> </div> <div class="table" id="CD012551-tbl-0007"> <table class="summary-of-findings framed"><a class="open-table-viewer open-in-figure-viewer" href="#0">Open in table viewer</a><div class="table-heading"><span class="table-label">Summary of findings 7.</span> <span class="table-title">Prostatic massage compared to no intervention for treating chronic prostatitis/chronic pelvic pain syndrome</span></div> <tbody> <tr class="separated"> <td align="left" bgcolor="#ffffff" colspan="6" rowspan="1" valign="top"> <p><b>Prostatic massage compared to control for treating chronic prostatitis/chronic pelvic pain syndrome</b> </p> </td> </tr> <tr class="separated"> <td align="left" bgcolor="#ffffff" colspan="6" rowspan="1" valign="top"> <p><b>Patient or population:</b> participants with chronic prostatitis/chronic pelvic pain syndrome<br/> <b>Setting:</b> outpatient, Egypt<br/> <b>Intervention:</b> prostatic massage<br/> <b>Comparison:</b> no intervention </p> </td> </tr> <tr class="table-header separated"> <td align="left" class="table-header" colspan="1" rowspan="2" valign="top"> <p><b>Outcomes</b> </p> </td> <td align="left" class="table-tint table-highlight" colspan="1" rowspan="2" valign="top"> <p><b>№ of participants<br/> (studies)</b> </p> </td> <td align="left" class="table-tint table-highlight" colspan="1" rowspan="2" valign="top"> <p><b>Quality of the evidence<br/> (GRADE)</b> </p> </td> <td align="left" class="table-header" colspan="1" rowspan="2" valign="top"> <p><b>Relative effect<br/> (95% CI)</b> </p> </td> <td align="left" class="table-header" colspan="2" rowspan="1" valign="top"> <p><b>Anticipated absolute effects* (95% CI)</b> </p> </td> </tr> <tr class="table-header separated"> <td align="left" class="table-header" colspan="1" rowspan="1" valign="top"> <p><b>Risk with control</b> </p> </td> <td align="left" class="table-header" colspan="1" rowspan="1" valign="top"> <p><b>Risk difference with prostatic massage</b> </p> </td> </tr> <tr class="separated"> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><b>Prostatitis symptoms</b><br/> assessed with: NIH‐CPSI score<br/> Scale from: 0 to 43<br/> follow‐up: 4 weeks </p> <p>Benefit is indicated by lower scores</p> </td> <td align="left" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p>44<br/> (1 RCT) </p> </td> <td align="left" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p>⊕⊝⊝⊝<br/> <b>Very low</b><sup>1,2</sup> </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>‐</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>The mean prostatitis symptom score was 12.4</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><b>MD 1.10 lower</b><br/> (5.63 lower to 3.43 higher) </p> </td> </tr> <tr class="separated"> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><b>Adverse events</b> ‐ not reported </p> </td> <td align="left" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p>‐</p> </td> <td align="left" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p>‐</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>‐</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>‐</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>‐</p> </td> </tr> <tr class="separated"> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><b>Sexual dysfunction</b> ‐ not reported </p> </td> <td align="left" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p>‐</p> </td> <td align="left" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p>‐</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>‐</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>‐</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>‐</p> </td> </tr> <tr class="separated"> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><b>Quality of life</b> ‐ not reported </p> </td> <td align="left" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p>‐</p> </td> <td align="left" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p>‐</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>‐</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>‐</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>‐</p> </td> </tr> <tr class="separated"> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><b>Depression and anxiety</b> ‐ not reported </p> </td> <td align="left" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p>‐</p> </td> <td align="left" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p>‐</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>‐</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>‐</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>‐</p> </td> </tr> <tr class="separated"> <td align="" bgcolor="#ffffff" colspan="6" rowspan="1" valign=""> <p>*<b>The risk in the intervention group</b> (and its 95% confidence interval) is based on the assumed risk in the comparison group and the <b>relative effect</b> of the intervention (and its 95% CI). </p> <p><b>CI</b> : confidence interval; <b>MD</b> : mean difference; <b>NIH‐CPSI</b> : National Institutes of Health ‐ Chronic Prostatitis Symptom Index; <b>RCT</b>: randomised controlled trial. </p> </td> </tr> <tr class="separated"> <td align="" bgcolor="#ffffff" colspan="6" rowspan="1" valign=""> <p><b>GRADE Working Group grades of evidence</b> <br/> <b>High quality:</b> we are very confident that the true effect lies close to that of the estimate of the effect.<br/> <b>Moderate quality:</b> we are moderately confident in the effect estimate: the true effect is likely to be close to the estimate of the effect, but there is a possibility that it is substantially different.<br/> <b>Low quality:</b> our confidence in the effect estimate is limited: the true effect may be substantially different from the estimate of the effect.<br/> <b>Very low quality:</b> we have very little confidence in the effect estimate: the true effect is likely to be substantially different from the estimate of effect. </p> </td> </tr> </tbody> <tfoot> <tr> <td colspan="6"> <div class="table-footnote"> <p><sup>1</sup>Downgraded 2 levels due to high risk of performance and detection bias (study not blinded), unclear risk of bias in the remaining domains. </p> <p><sup>2</sup>Downgraded 1 level for imprecision issues: optimal information size (OIS) not met (OIS for a 4‐point decrease, standard deviation 6, alpha 0.05, beta 0.20 = 74). </p> </div> </td> </tr> </tfoot> </table> </div> <div class="table" id="CD012551-tbl-0008"> <table class="summary-of-findings framed"><a class="open-table-viewer open-in-figure-viewer" href="#0">Open in table viewer</a><div class="table-heading"><span class="table-label">Summary of findings 8.</span> <span class="table-title">Extracorporeal shockwave therapy compared to control procedure for chronic prostatitis/chronic pelvic pain syndrome</span></div> <tbody> <tr class="separated"> <td align="left" bgcolor="#ffffff" colspan="6" rowspan="1" valign="top"> <p><b>Extracorporeal shockwave therapy compared to control procedure for chronic prostatitis/chronic pelvic pain syndrome</b> </p> </td> </tr> <tr class="separated"> <td align="left" bgcolor="#ffffff" colspan="6" rowspan="1" valign="top"> <p><b>Patient or population:</b> participants with chronic prostatitis/chronic pelvic pain syndrome<br/> <b>Setting:</b> outpatient, China, Austria, Iran<br/> <b>Intervention:</b> ESWT<br/> <b>Comparison:</b> 2 studies used a sham procedure (machine turned off) and 1 study compared to no ESWT </p> </td> </tr> <tr class="table-header separated"> <td align="left" class="table-header" colspan="1" rowspan="2" valign="top"> <p><b>Outcomes</b> </p> </td> <td align="left" class="table-tint table-highlight" colspan="1" rowspan="2" valign="top"> <p><b>№ of participants<br/> (studies)</b> </p> </td> <td align="left" class="table-tint table-highlight" colspan="1" rowspan="2" valign="top"> <p><b>Quality of the evidence<br/> (GRADE)</b> </p> </td> <td align="left" class="table-header" colspan="1" rowspan="2" valign="top"> <p><b>Relative effect<br/> (95% CI)</b> </p> </td> <td align="left" class="table-header" colspan="2" rowspan="1" valign="top"> <p><b>Anticipated absolute effects* (95% CI)</b> </p> </td> </tr> <tr class="table-header separated"> <td align="left" class="table-header" colspan="1" rowspan="1" valign="top"> <p><b>Risk with control</b> </p> </td> <td align="left" class="table-header" colspan="1" rowspan="1" valign="top"> <p><b>Risk difference with ESWT</b> </p> </td> </tr> <tr class="separated"> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><b>Prostatitis symptoms</b><br/> assessed with: NIH‐CPSI score<br/> Scale from: 0 to 43<br/> follow‐up: 12 weeks </p> <p>Benefit is indicated by lower scores</p> </td> <td align="left" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p>157<br/> (3 RCTs) </p> </td> <td align="left" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p>⊕⊕⊕⊕<br/> <b>High</b><sup>1</sup> </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>‐</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>The mean prostatitis symptom score ranged from 16.8 to 26.81</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><b>MD 6.18 lower</b><br/> (7.46 lower to 4.89 lower) </p> </td> </tr> <tr class="separated"> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="2" valign="top"> <p><b>Prostatitis symptoms</b>: response defined as a 6‐point decrease in NIH‐CPSI score<br/> follow‐up: 12 weeks </p> </td> <td align="left" class="table-tint table-highlight" colspan="1" rowspan="2" valign="top"> <p>135<br/> (2 RCTs) </p> </td> <td align="left" class="table-tint table-highlight" colspan="1" rowspan="2" valign="top"> <p>⊕⊝⊝⊝<br/> <b>Very low</b><sup>2,3,4</sup> </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="2" valign="top"> <p><b>RR 6.20</b><br/> (0.48 to 79.79) </p> </td> <td align="left" bgcolor="#ffffff" colspan="2" rowspan="1" valign="top"> <p>Study population</p> </td> </tr> <tr class="separated"> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>149 per 1000</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><b>776 more per 1000</b><br/> (78 fewer to 11,760 more) </p> </td> </tr> <tr class="separated"> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><b>Prostatitis symptoms</b><br/> assessed with: NIH‐CPSI score<br/> Scale from: 0 to 43<br/> follow‐up: 24 weeks </p> </td> <td align="left" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p>97<br/> (2 RCTs) </p> </td> <td align="left" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p>⊕⊕⊝⊝<br/> <b>Low</b><sup>2,5</sup> </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>‐</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>The mean prostatitis symptom score ranged from 16.1 to 27</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><b>MD 2.23 lower</b><br/> (5.98 lower to 1.53 higher) </p> </td> </tr> <tr class="separated"> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="2" valign="top"> <p><b>Adverse events</b> </p> <p>follow‐up: 24 weeks</p> </td> <td align="left" class="table-tint table-highlight" colspan="1" rowspan="2" valign="top"> <p>195<br/> (3 RCTs) </p> </td> <td align="left" class="table-tint table-highlight" colspan="1" rowspan="2" valign="top"> <p>⊕⊕⊝⊝<br/> <b>Low</b><sup>2,4</sup> </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="2" valign="top"> <p><b>RR 1.22</b><br/> (0.59 to 2.51) </p> </td> <td align="left" bgcolor="#ffffff" colspan="2" rowspan="1" valign="top"> <p>Study population</p> </td> </tr> <tr class="separated"> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>93 per 1000</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><b>20 more per 1000</b><br/> (38 fewer to 140 more) </p> </td> </tr> <tr class="separated"> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><b>Sexual dysfunction</b><br/> assessed with: International Index of Erectile Function<br/> Scale from: 5 to 25<br/> follow‐up: 12 weeks </p> <p>Benefit is indicated by higher scores</p> </td> <td align="left" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p>60<br/> (1 RCT) </p> </td> <td align="left" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p>⊕⊕⊕⊝<br/> <b>Moderate</b><sup>6</sup> </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>‐</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>The mean sexual dysfunction was 16.83</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><b>MD 3.34 higher</b><br/> (2.68 higher to 4 higher) </p> </td> </tr> <tr class="separated"> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><b>Quality of life</b> ‐ not reported </p> </td> <td align="left" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p>‐</p> </td> <td align="left" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p>‐</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>‐</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>‐</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>‐</p> </td> </tr> <tr class="separated"> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><b>Depression and anxiety</b> ‐ not reported </p> </td> <td align="left" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p>‐</p> </td> <td align="left" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p>‐</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>‐</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>‐</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>‐</p> </td> </tr> <tr class="separated"> <td align="" bgcolor="#ffffff" colspan="6" rowspan="1" valign=""> <p>*<b>The risk in the intervention group</b> (and its 95% confidence interval) is based on the assumed risk in the comparison group and the <b>relative effect</b> of the intervention (and its 95% CI). </p> <p><b>CI</b> : confidence interval; <b>ESWT</b> : extracorporeal shockwave therapy; <b>MD</b> : mean difference; <b>NIH‐CPSI</b> : National Institutes of Health ‐ Chronic Prostatitis Symptom Index; <b>RCT</b> : randomised controlled trial; <b>RR</b>: risk ratio. </p> </td> </tr> <tr class="separated"> <td align="" bgcolor="#ffffff" colspan="6" rowspan="1" valign=""> <p><b>GRADE Working Group grades of evidence</b> <br/> <b>High quality:</b> we are very confident that the true effect lies close to that of the estimate of the effect.<br/> <b>Moderate quality:</b> we are moderately confident in the effect estimate: the true effect is likely to be close to the estimate of the effect, but there is a possibility that it is substantially different.<br/> <b>Low quality:</b> our confidence in the effect estimate is limited: the true effect may be substantially different from the estimate of the effect.<br/> <b>Very low quality:</b> we have very little confidence in the effect estimate: the true effect is likely to be substantially different from the estimate of effect. </p> </td> </tr> </tbody> <tfoot> <tr> <td colspan="6"> <div class="table-footnote"> <p><sup>1</sup>Whereas one of the studies was not blinded, which could have posed a high risk of performance and detection bias, we did not downgrade for risk of bias due to the consistency with other studies with low risk of bias. </p> <p><sup>2</sup>Downgraded 1 level due to risk of bias: one of the studies that provided events for this outcome was not blinded. </p> <p><sup>3</sup>Downgraded 1 level due to inconsistency (I<sup>2</sup> = 71%). </p> <p><sup>4</sup>Downgraded 1 level due to imprecision issues: few events and wide confidence interval. </p> <p><sup>5</sup>Downgraded 1 level due to inconsistency (I<sup>2</sup> = 82%). </p> <p><sup>6</sup>Downgraded 1 level due to imprecision issues: wide confidence interval. </p> </div> </td> </tr> </tfoot> </table> </div> <div class="table" id="CD012551-tbl-0009"> <table class="summary-of-findings framed"><a class="open-table-viewer open-in-figure-viewer" href="#0">Open in table viewer</a><div class="table-heading"><span class="table-label">Summary of findings 9.</span> <span class="table-title">Transrectal thermotherapy compared to medical treatment for chronic prostatitis/chronic pelvic pain syndrome</span></div> <tbody> <tr class="separated"> <td align="left" bgcolor="#ffffff" colspan="6" rowspan="1" valign="top"> <p><b>Transrectal thermotherapy compared to medical treatment for chronic prostatitis/chronic pelvic pain syndrome</b> </p> </td> </tr> <tr class="separated"> <td align="left" bgcolor="#ffffff" colspan="6" rowspan="1" valign="top"> <p><b>Patient or population:</b> participants with chronic prostatitis/chronic pelvic pain syndrome<br/> <b>Setting:</b> outpatient, China and Korea<br/> <b>Intervention:</b> transrectal thermotherapy<br/> <b>Comparison:</b> medical treatment </p> </td> </tr> <tr class="table-header separated"> <td align="left" class="table-header" colspan="1" rowspan="2" valign="top"> <p><b>Outcomes</b> </p> </td> <td align="left" class="table-tint table-highlight" colspan="1" rowspan="2" valign="top"> <p><b>№ of participants<br/> (studies)</b> </p> </td> <td align="left" class="table-tint table-highlight" colspan="1" rowspan="2" valign="top"> <p><b>Quality of the evidence<br/> (GRADE)</b> </p> </td> <td align="left" class="table-header" colspan="1" rowspan="2" valign="top"> <p><b>Relative effect<br/> (95% CI)</b> </p> </td> <td align="left" class="table-header" colspan="2" rowspan="1" valign="top"> <p><b>Anticipated absolute effects* (95% CI)</b> </p> </td> </tr> <tr class="table-header separated"> <td align="left" class="table-header" colspan="1" rowspan="1" valign="top"> <p><b>Risk with medical treatment</b> </p> </td> <td align="left" class="table-header" colspan="1" rowspan="1" valign="top"> <p><b>Risk difference with transrectal thermotherapy</b> </p> </td> </tr> <tr class="separated"> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><b>Prostatitis symptoms</b><br/> assessed with: NIH‐CPSI score<br/> Scale from: 0 to 43<br/> follow‐up: 6 to 12 weeks </p> <p>Benefit is indicated by lower scores</p> </td> <td align="left" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p>140<br/> (2 RCTs) </p> </td> <td align="left" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p>⊕⊕⊝⊝<br/> <b>Low</b><sup>1</sup> </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>‐</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>The mean prostatitis symptom score ranged from 14.33 to 17.19</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><b>MD 2.50 lower</b><br/> (3.82 lower to 1.18 lower) </p> </td> </tr> <tr class="separated"> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><b>Adverse events</b> ‐ not reported </p> </td> <td align="left" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p>‐</p> </td> <td align="left" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p>‐</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>‐</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>‐</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>‐</p> </td> </tr> <tr class="separated"> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><b>Sexual dysfunction</b> ‐ not reported </p> </td> <td align="left" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p>‐</p> </td> <td align="left" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p>‐</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>‐</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>‐</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>‐</p> </td> </tr> <tr class="separated"> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><b>Quality of life</b> ‐ not reported </p> </td> <td align="left" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p>‐</p> </td> <td align="left" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p>‐</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>‐</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>‐</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>‐</p> </td> </tr> <tr class="separated"> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><b>Depression and anxiety</b> ‐ not reported </p> </td> <td align="left" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p>‐</p> </td> <td align="left" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p>‐</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>‐</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>‐</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>‐</p> </td> </tr> <tr class="separated"> <td align="" bgcolor="#ffffff" colspan="6" rowspan="1" valign=""> <p>*<b>The risk in the intervention group</b> (and its 95% confidence interval) is based on the assumed risk in the comparison group and the <b>relative effect</b> of the intervention (and its 95% CI). </p> <p><b>CI</b> : confidence interval; <b>MD</b> : mean difference; <b>NIH‐CPSI</b> : National Institutes of Health ‐ Chronic Prostatitis Symptom Index; <b>RCT</b>: randomised controlled trial. </p> </td> </tr> <tr class="separated"> <td align="" bgcolor="#ffffff" colspan="6" rowspan="1" valign=""> <p><b>GRADE Working Group grades of evidence</b> <br/> <b>High quality:</b> we are very confident that the true effect lies close to that of the estimate of the effect.<br/> <b>Moderate quality:</b> we are moderately confident in the effect estimate: the true effect is likely to be close to the estimate of the effect, but there is a possibility that it is substantially different.<br/> <b>Low quality:</b> our confidence in the effect estimate is limited: the true effect may be substantially different from the estimate of the effect.<br/> <b>Very low quality:</b> we have very little confidence in the effect estimate: the true effect is likely to be substantially different from the estimate of effect. </p> </td> </tr> </tbody> <tfoot> <tr> <td colspan="6"> <div class="table-footnote"> <p><sup>1</sup>Downgraded 2 levels due to high risk of allocation concealment bias, performance and detection bias (study not blinded) and high risk of attrition bias. </p> </div> </td> </tr> </tfoot> </table> </div> <div class="table" id="CD012551-tbl-0010"> <table class="summary-of-findings framed"><a class="open-table-viewer open-in-figure-viewer" href="#0">Open in table viewer</a><div class="table-heading"><span class="table-label">Summary of findings 10.</span> <span class="table-title">Transrectal thermotherapy (add‐on) compared to medical treatment alone for chronic prostatitis/chronic pelvic pain syndrome</span></div> <tbody> <tr class="separated"> <td align="left" bgcolor="#ffffff" colspan="6" rowspan="1" valign="top"> <p><b>Transrectal thermotherapy (add‐on) compared to medical treatment alone for chronic prostatitis/chronic pelvic pain syndrome</b> </p> </td> </tr> <tr class="separated"> <td align="left" bgcolor="#ffffff" colspan="6" rowspan="1" valign="top"> <p><b>Patient or population:</b> participants with chronic prostatitis/chronic pelvic pain syndrome<br/> <b>Setting:</b> outpatient, China and Korea<br/> <b>Intervention:</b> transrectal thermotherapy in addition to medical therapy<br/> <b>Comparison:</b> medical treatment alone </p> </td> </tr> <tr class="table-header separated"> <td align="left" class="table-header" colspan="1" rowspan="2" valign="top"> <p><b>Outcomes</b> </p> </td> <td align="left" class="table-tint table-highlight" colspan="1" rowspan="2" valign="top"> <p><b>№ of participants<br/> (studies)<br/> Follow‐up</b> </p> </td> <td align="left" class="table-tint table-highlight" colspan="1" rowspan="2" valign="top"> <p><b>Quality of the evidence<br/> (GRADE)</b> </p> </td> <td align="left" class="table-header" colspan="1" rowspan="2" valign="top"> <p><b>Relative effect<br/> (95% CI)</b> </p> </td> <td align="left" class="table-header" colspan="2" rowspan="1" valign="top"> <p><b>Anticipated absolute effects* (95% CI)</b> </p> </td> </tr> <tr class="table-header separated"> <td align="left" class="table-header" colspan="1" rowspan="1" valign="top"> <p><b>Risk with medical treatment alone</b> </p> </td> <td align="left" class="table-header" colspan="1" rowspan="1" valign="top"> <p><b>Risk difference with transrectal thermotherapy (add‐on)</b> </p> </td> </tr> <tr class="separated"> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><b>Prostatitis symptoms</b><br/> assessed with: NIH‐CPSI score<br/> Scale from: 0 to 43<br/> follow‐up: 6 to 12 weeks </p> <p>Benefit is indicated by lower scores</p> </td> <td align="left" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p>145<br/> (2 RCTs) </p> </td> <td align="left" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p>⊕⊕⊝⊝<br/> <b>Low</b><sup>1</sup> </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>‐</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>The mean prostatitis symptom score ranged from 14.33 to 17.19</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><b>MD 4.34 lower</b><br/> (5.65 lower to 3.04 lower) </p> </td> </tr> <tr class="separated"> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><b>Adverse events</b> ‐ not reported </p> </td> <td align="left" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p>‐</p> </td> <td align="left" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p>‐</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>‐</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>‐</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>‐</p> </td> </tr> <tr class="separated"> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><b>Sexual dysfunction</b> ‐ not reported </p> </td> <td align="left" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p>‐</p> </td> <td align="left" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p>‐</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>‐</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>‐</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>‐</p> </td> </tr> <tr class="separated"> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><b>Quality of life</b> ‐ not reported </p> </td> <td align="left" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p>‐</p> </td> <td align="left" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p>‐</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>‐</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>‐</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>‐</p> </td> </tr> <tr class="separated"> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><b>Depression and anxiety</b> ‐ not reported </p> </td> <td align="left" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p>‐</p> </td> <td align="left" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p>‐</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>‐</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>‐</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>‐</p> </td> </tr> <tr class="separated"> <td align="" bgcolor="#ffffff" colspan="6" rowspan="1" valign=""> <p>*<b>The risk in the intervention group</b> (and its 95% confidence interval) is based on the assumed risk in the comparison group and the <b>relative effect</b> of the intervention (and its 95% CI). </p> <p><b>CI</b> : confidence interval; <b>MD</b> : mean difference; <b>NIH‐CPSI</b> : National Institutes of Health ‐ Chronic Prostatitis Symptom Index; <b>RCT</b>: randomised controlled trial. </p> </td> </tr> <tr class="separated"> <td align="" bgcolor="#ffffff" colspan="6" rowspan="1" valign=""> <p><b>GRADE Working Group grades of evidence</b> <br/> <b>High quality:</b> we are very confident that the true effect lies close to that of the estimate of the effect.<br/> <b>Moderate quality:</b> we are moderately confident in the effect estimate: the true effect is likely to be close to the estimate of the effect, but there is a possibility that it is substantially different.<br/> <b>Low quality:</b> our confidence in the effect estimate is limited: the true effect may be substantially different from the estimate of the effect.<br/> <b>Very low quality:</b> we have very little confidence in the effect estimate: the true effect is likely to be substantially different from the estimate of effect. </p> </td> </tr> </tbody> <tfoot> <tr> <td colspan="6"> <div class="table-footnote"> <p><sup>1</sup>Downgraded 2 levels due to high risk of allocation concealment bias, performance and detection bias (study not blinded) and high risk of attrition bias. </p> </div> </td> </tr> </tfoot> </table> </div> </section> </section> <section class="background"> <div class="section-header section-collapse-header" id="CD012551-sec-0030" lang="en"> <h2 class="title section-collapse-title"> Background <i aria-hidden="true" class="fa fa-caret-up section-collapse-icon"></i> </h2> </div> <section class="background" lang="en"> <div class="section-header" id="CD012551-sec-0030"></div> <section id="CD012551-sec-0031"> <h3 class="title" id="CD012551-sec-0031">Description of the condition</h3> <p>Prostatitis is a common disorder affecting 10% to 14% of men in Europe and the USA (<a href="./references#CD012551-bbs2-0121" title="BajpayeeP , KumarK , SharmaS , MauryaN , KumarP , SinghR , et al. Prostatitis: prevalence, health impact and quality improvement strategies. Acta Poloniae Pharmaceutica2012;69(4):571‐9. [PUBMED: 22876597] ">Bajpayee 2012</a>). This health problem motivates 1% of primary care visits and 8% of urology consultations in the USA (<a href="./references#CD012551-bbs2-0129" title="CollinsMM , StaffordRS , O'LearyMP , BarryMJ . How common is prostatitis? A national survey of physician visits. Journal of Urology1998;159(4):1224‐8. [PUBMED: 9507840] ">Collins 1998</a>). Only 5% to 10% of prostatitis cases have a bacterial origin (<a href="./references#CD012551-bbs2-0123" title="BartolettiR , CaiT , MondainiN , DinelliN , PinziN , PavoneC , et al. Prevalence, incidence estimation, risk factors and characterization of chronic prostatitis/chronic pelvic pain syndrome in urological hospital outpatients in Italy: results of a multicenter case‐control observational study. Journal of Urology2007;178(6):2411‐5; discussion 2415. [PUBMED: 17937946] ">Bartoletti 2007</a>; <a href="./references#CD012551-bbs2-0132" title="De LaRosetteJJ , HubregtseMR , MeulemanEJ , Stolk‐EngelaarMV , DebruyneFM . Diagnosis and treatment of 409 patients with prostatitis syndromes. Urology1993;41(4):301‐7. [PUBMED: 8470312] ">De La Rosette 1993</a>). This disorder can affect men of all ages and ethnic origins, but it is more common in younger men with a mean age of onset at 42 years old (<a href="./references#CD012551-bbs2-0185" title="SchaefferAJ , LandisJR , KnaussJS , PropertKJ , AlexanderRB , LitwinMS , et al. Demographic and clinical characteristics of men with chronic prostatitis: the National Institutes of Health chronic prostatitis cohort study. Journal of Urology2002;168(2):593‐8. [PUBMED: 12131316] ">Schaeffer 2002</a>). The two main clinical features of prostatitis are pelvic pain and lower urinary tract symptoms (LUTS), even though there is a wide range of clinical presentations (<a href="./references#CD012551-bbs2-0169" title="NickelJC , NybergLM , HennenfentM . Research guidelines for chronic prostatitis: consensus report from the first National Institutes of Health International Prostatitis Collaborative Network. Urology1999;54(2):229‐33. [PUBMED: 10443716] ">Nickel 1999a</a>). </p> <p>The National Institutes of Health (NIH) classification identifies four types of prostatitis (<a href="./references#CD012551-bbs2-0169" title="NickelJC , NybergLM , HennenfentM . Research guidelines for chronic prostatitis: consensus report from the first National Institutes of Health International Prostatitis Collaborative Network. Urology1999;54(2):229‐33. [PUBMED: 10443716] ">Nickel 1999a</a>): type I, acute bacterial prostatitis; type II, chronic bacterial prostatitis; type III, chronic prostatitis/chronic pelvic pain syndrome (CP/CPPS) and type IV, asymptomatic prostatitis. It remains unclear whether type III can be linked in all cases to prostatic involvement (<a href="./references#CD012551-bbs2-0194" title="TrueLD , BergerRE , RothmanI , RossSO , KriegerJN . Prostate histopathology and the chronic prostatitis/chronic pelvic pain syndrome: a prospective biopsy study. Journal of Urology1999;162(6):2014‐8. [PUBMED: 10569559] ">True 1999</a>), thus the alternate denomination (CPPS). CP/CPPS is subclassified as type IIIa, inflammatory, and type IIIb, non‐inflammatory, depending on the presence of inflammatory cells in prostatic secretions. Before this classification, this entity was denominated chronic abacterial or non‐bacterial prostatitis (similar to type IIIa CP/CPPS) and prostatodynia (similar to type IIIb CP/CPPS) (<a href="./references#CD012551-bbs2-0158" title="KriegerJN , BergerRE , RossSO , RothmanI , MullerCH . Seminal fluid findings in men with nonbacterial prostatitis and prostatodynia. Journal of Andrology1996;17(3):310‐8. [PUBMED: 8792222] ">Krieger 1996</a>). This change in the classification might have changed the epidemiology of this condition (<a href="./references#CD012551-bbs2-0160" title="KriegerJN . Classification, epidemiology and implications of chronic prostatitis in North America, Europe and Asia. Minerva Urologica e Nefrologica [Italian Journal of Urology and Nephrology]2004;56(2):99‐107. [PUBMED: 15195020] ">Krieger 2004</a>). </p> <p>CP/CPPS is defined when pelvic pain is present for at least three of the preceding six months and no other identifiable causes have been detected (<a href="./references#CD012551-bbs2-0169" title="NickelJC , NybergLM , HennenfentM . Research guidelines for chronic prostatitis: consensus report from the first National Institutes of Health International Prostatitis Collaborative Network. Urology1999;54(2):229‐33. [PUBMED: 10443716] ">Nickel 1999a</a>). Other symptoms include obstructive or irritative voiding difficulties, ejaculatory pain, and haematospermia. Men affected by CP/CPPS have a significantly decreased quality of life (QoL) and the level of pelvic pain is strongly associated with sexual dysfunction (<a href="./references#CD012551-bbs2-0193" title="TrinchieriA , MagriV , CarianiL , BonamoreR , RestelliA , GarlaschiMC , et al. Prevalence of sexual dysfunction in men with chronic prostatitis/chronic pelvic pain syndrome. Archivio Italiano di Urologia, Andrologia2007;79(2):67‐70. [PUBMED: 17695411] ">Trinchieri 2007</a>; <a href="./references#CD012551-bbs2-0196" title="WalzJ , PerrotteP , HuttererG , SuardiN , JeldresC , BenardF , et al. Impact of chronic prostatitis‐like symptoms on the quality of life in a large group of men. BJU International2007;100(6):1307‐11. [PUBMED: 17941922] ">Walz 2007</a>). CP/CPPS is associated with other functional somatic syndromes, such as irritable bowel syndrome, interstitial cystitis, chronic fatigue syndrome and fibromyalgia (<a href="./references#CD012551-bbs2-0183" title="RodriguezMA , AfariN , BuchwaldDS . Evidence for overlap between urological and nonurological unexplained clinical conditions. Journal of Urology2009;182(5):2123‐31. [PUBMED: 19758633] ">Rodriguez 2009</a>; <a href="./references#CD012551-bbs2-0192" title="SuskindAM , BerrySH , EwingBA , ElliottMN , SuttorpMJ , ClemensJQ . The prevalence and overlap of interstitial cystitis/bladder pain syndrome and chronic prostatitis/chronic pelvic pain syndrome in men: results of the RAND Interstitial Cystitis Epidemiology male study. Journal of Urology2013;189(1):141‐5. [PUBMED: 23164386] ">Suskind 2013</a>). Diagnosis is usually based on patient history, physical examination, urinalysis and the two‐ or four‐glass test (<a href="./references#CD012551-bbs2-0173" title="NickelJC . Prostatitis and related conditions, orchitis and epididymitis. Campbell‐Walsh Urology. 10th Edition. Amsterdam: Elsevier, 2012:337‐41. ">Nickel 2012</a>). Further investigations are performed when considering differential diagnosis. </p> <p>There are different theories regarding the aetiology and pathophysiology of CP/CPPS, as follows. </p> <p> <ul id="CD012551-list-0001"> <li> <p>Infection: bacterial DNA is detected in a significant proportion of men with CP/CPPS (<a href="./references#CD012551-bbs2-0150" title="HouDS , LongWM , ShenJ , ZhaoLP , PangXY , XuC . Characterisation of the bacterial community in expressed prostatic secretions from patients with chronic prostatitis/chronic pelvic pain syndrome and infertile men: a preliminary investigation. Asian Journal of Andrology2012;14(4):566‐73. [PUBMED: 22635162] ">Hou 2012</a>). A previous history of sexually transmitted infection is more frequent in men with CP/CPPS (<a href="./references#CD012551-bbs2-0177" title="PontariMA , McNaughton‐CollinsM , O'LearyMP , CalhounEA , JangT , KusekJW , et al. A case‐control study of risk factors in men with chronic pelvic pain syndrome. BJU International2005;96(4):559‐65. [PUBMED: 16104910] ">Pontari 2005</a>). Nevertheless, the isolation of uropathogenic bacteria in prostatic fluids is similar to controls (<a href="./references#CD012551-bbs2-0171" title="NickelJC , AlexanderRB , SchaefferAJ , LandisJR , KnaussJS , PropertKJ . Leukocytes and bacteria in men with chronic prostatitis/chronic pelvic pain syndrome compared to asymptomatic controls. Journal of Urology2003;170(3):818‐22. [PUBMED: 12913707] ">Nickel 2003a</a>). </p> </li> <li> <p>Inflammation/autoimmunity: elevated concentrations of proinflammatory cytokines (interleukin 1, tumour necrosis factor, interferon‐γ) and of autoimmunity activity (T‐cell proliferation responses to prostate antigens) is found in men with CP/CPPS and in animal models (<a href="./references#CD012551-bbs2-0176" title="PontariMA , RuggieriMR . Mechanisms in prostatitis/chronic pelvic pain syndrome. Journal of Urology2004;172(3):839‐45. [PUBMED: 15310980] ">Pontari 2004</a>). </p> </li> <li> <p>Neuropsychological factors: the central nervous system might be involved through several mechanisms of pain sensitisation (<a href="./references#CD012551-bbs2-0167" title="MillerLJ , FischerKA , GoralnickSJ , LittM , BurlesonJA , AlbertsenP , et al. Nerve growth factor and chronic prostatitis/chronic pelvic pain syndrome. Urology2002;59(4):603‐8. [PUBMED: 11927336] ">Miller 2002</a>; <a href="./references#CD012551-bbs2-0197" title="YangCC , LeeJC , KrommBG , CiolMA , BergerR . Pain sensitization in male chronic pelvic pain syndrome: why are symptoms so difficult to treat?. Journal of Urology2003;170(3):823‐6; discussion 826‐7. [PUBMED: 12913708] ">Yang 2003</a>). Increased stress burden, stress response, pain catastrophising cognitions, poor social functioning and psychiatric comorbidity (anxiety and depression) are contributing factors (<a href="./references#CD012551-bbs2-0182" title="RiegelB , BruenahlCA , AhyaiS , BingelU , FischM , LoweB . Assessing psychological factors, social aspects and psychiatric co‐morbidity associated with chronic prostatitis/chronic pelvic pain syndrome (CP/CPPS) in men ‐ a systematic review. Journal of Psychosomatic Research2014;77(5):333‐50. [PUBMED: 25300538] ">Riegel 2014</a>). </p> </li> <li> <p>Dyssynergic voiding associated with bladder neck hypertrophy is detected in men with refractory CP/CPPS (<a href="./references#CD012551-bbs2-0133" title="DellabellaM , MilaneseG , MuzzonigroG . Correlation between ultrasound alterations of the preprostatic sphincter and symptoms in patients with chronic prostatitis‐chronic pelvic pain syndrome. Journal of Urology2006;176(1):112‐8. [PUBMED: 16753384] ">Dellabella 2006</a>; <a href="./references#CD012551-bbs2-0151" title="HruzP , DanuserH , StuderUE , HochreiterWW . Non‐inflammatory chronic pelvic pain syndrome can be caused by bladder neck hypertrophy. European Urology2003;44(1):106‐10; discussion 110. [PUBMED: 12814683] ">Hruz 2003</a>). Intraprostatic urinary reflux and increased intraprostatic pressure is associated with inflammation in CP/CPPS (<a href="./references#CD012551-bbs2-0157" title="KirbyRS , LoweD , BultitudeMI , ShuttleworthKE . Intra‐prostatic urinary reflux: an aetiological factor in abacterial prostatitis. British Journal of Urology1982;54(6):729‐31. [PUBMED: 7150931] ">Kirby 1982</a>; <a href="./references#CD012551-bbs2-0166" title="MehikA , HellstromP , NickelJC , KilponenA , LeskinenM , SarpolaA , et al. The chronic prostatitis‐chronic pelvic pain syndrome can be characterized by prostatic tissue pressure measurements. Journal of Urology2002;167(1):137‐40. [PUBMED: 11743292] ">Mehik 2002</a>). </p> </li> <li> <p>Other theories described for this condition include: adrenal axis abnormalities (<a href="./references#CD012551-bbs2-0118" title="AndersonRU , OrenbergEK , ChanCA , MoreyA , FloresV . Psychometric profiles and hypothalamic‐pituitary‐adrenal axis function in men with chronic prostatitis/chronic pelvic pain syndrome. Journal of Urology2008;179(3):956‐60. [PUBMED: 18207189] ">Anderson 2008</a>), pelvic floor muscles dysfunction (<a href="./references#CD012551-bbs2-0142" title="HetrickDC , GlazerH , LiuYW , TurnerJA , FrestM , BergerRE . Pelvic floor electromyography in men with chronic pelvic pain syndrome: a case‐control study. Neurourology and Urodynamics2006;25(1):46‐9. [PUBMED: 16167354] ">Hetrick 2006</a>; <a href="./references#CD012551-bbs2-0188" title="ShoskesDA , BergerR , ElmiA , LandisJR , PropertKJ , ZeitlinS . Muscle tenderness in men with chronic prostatitis/chronic pelvic pain syndrome: the chronic prostatitis cohort study. Journal of Urology2008;179(2):556‐60. [PUBMED: 18082223] ">Shoskes 2008a</a>), pelvic nerve entrapment (<a href="./references#CD012551-bbs2-0119" title="AntolakSJJr , HoughDM , PawlinaW , SpinnerRJ . Anatomical basis of chronic pelvic pain syndrome: the ischial spine and pudendal nerve entrapment. Medical Hypotheses2002;59(3):349‐53. [PUBMED: 12208168] ">Antolak 2002</a>), genetic predisposition to inflammation (<a href="./references#CD012551-bbs2-0187" title="ShoskesDA , AlbakriQ , ThomasK , CookD . Cytokine polymorphisms in men with chronic prostatitis/chronic pelvic pain syndrome: association with diagnosis and treatment response. Journal of Urology2002;168(1):331‐5. [PUBMED: 12050565] ">Shoskes 2002</a>), and oxidative stress (<a href="./references#CD012551-bbs2-0120" title="ArisanED , ArisanS , KiremitMC , TigliH , CaskurluT , Palavan‐UnsalN , et al. Manganese superoxide dismutase polymorphism in chronic pelvic pain syndrome patients. Prostate Cancer and Prostatic Diseases2006;9(4):426‐31. [PUBMED: 16847469] ">Arisan 2006</a>). </p> </li> </ul> </p> </section> <section id="CD012551-sec-0032"> <h3 class="title" id="CD012551-sec-0032">Description of the intervention</h3> <p>There is a wide variety of interventions for treating CP/CPPS, each one addressing a different pathophysiological or symptomatic framework. The diversity of available interventions reflects the complexity of the condition and how little is known about its determinants. </p> <p>Management of CP/CPPS involves a multimodal and tailored approach (<a href="./references#CD012551-bbs2-0180" title="ReesJ , AbrahamsM , DobleA , CooperA . Diagnosis and treatment of chronic bacterial prostatitis and chronic prostatitis/chronic pelvic pain syndrome: a consensus guideline. BJU International2015;116(4):509‐25. [PUBMED: 25711488] ">Rees 2015</a>; <a href="./references#CD012551-bbs2-0189" title="ShoskesDA , NickelJC , RackleyRR , PontariMA . Clinical phenotyping in chronic prostatitis/chronic pelvic pain syndrome and interstitial cystitis: a management strategy for urologic chronic pelvic pain syndromes. Prostate Cancer and Prostatic Diseases2008;12(2):177‐83. ">Shoskes 2008b</a>). Some of the strategies used alone or in combination are the following. </p> <section id="CD012551-sec-0033"> <h4 class="title">Pharmacological interventions</h4> <p> <ul id="CD012551-list-0002"> <li> <p>Alpha‐blockers.</p> </li> <li> <p>5‐alpha reductase inhibitors.</p> </li> <li> <p>Antibiotic therapy (quinolones, tetracyclines and other agents).</p> </li> <li> <p>Analgesics (non‐steroidal anti‐inflammatory drugs (NSAIDs), pregabalin).</p> </li> <li> <p>Phytotherapy (pollen extract and bioflavonoids).</p> </li> <li> <p>Botulinum toxin A.</p> </li> <li> <p>Allopurinol.</p> </li> <li> <p>Traditional medicine (traditional Chinese medicine, etc.).</p> </li> <li> <p>Other pharmacological agents.</p> </li> </ul> </p> </section> <section id="CD012551-sec-0034"> <h4 class="title">Non‐pharmacological interventions</h4> <p> <ul id="CD012551-list-0003"> <li> <p>Acupuncture and electroacupuncture.</p> </li> <li> <p>Local thermotherapy.</p> </li> <li> <p>Extracorporeal shockwave therapy.</p> </li> <li> <p>Electromagnetic chair.</p> </li> <li> <p>Myofascial trigger point release.</p> </li> <li> <p>Biofeedback.</p> </li> <li> <p>Circumcision.</p> </li> <li> <p>Lifestyle interventions.</p> </li> <li> <p>Physical activity.</p> </li> <li> <p>Psychological support.</p> </li> <li> <p>Prostatic surgery.</p> </li> <li> <p>Other miscellaneous non‐pharmacological therapies.</p> </li> </ul> </p> </section> <section id="CD012551-sec-0035"> <h4 class="title">Multimodal approaches</h4> <p> <ul id="CD012551-list-0004"> <li> <p>Combination therapy: alpha blockers plus antibiotics, antibiotics plus analgesics, etc. </p> </li> </ul> </p> </section> <section id="CD012551-sec-0036"> <h4 class="title">Adverse events</h4> <p>Common adverse effects of pharmacological regimens include the following (<a href="./references#CD012551-bbs2-0124" title="BruntonLL , ChabnerBA , KnollmannBC . Goodman and Gilman's the Pharmacological Basis of Therapeutics. 12th Edition. New York (NY): McGraw‐Hill Education, 2011. ">Brunton 2011</a>). </p> <p> <ul id="CD012551-list-0005"> <li> <p>Alpha‐blockers: hypotension, ejaculatory dysfunction, headache, dizziness and nasal congestion. </p> </li> <li> <p>5‐alpha‐reductase inhibitors: decreased libido, impotency, and potentiation of hypotension (in combination with alpha‐blockers). </p> </li> <li> <p>Quinolones: gastrointestinal discomfort, headache, dizziness, rash and tendinopathy.</p> </li> <li> <p>Tetracyclines: gastrointestinal discomfort, rash, teeth discolouration and hepatotoxicity.</p> </li> <li> <p>NSAIDs: peripheral oedema, rash, dyspepsia, peptic ulcer and bleeding, renal and hepatic injury, and increased risk of adverse cardiovascular events. </p> </li> <li> <p>Phytotherapy: gastrointestinal discomfort and allergic reactions.</p> </li> </ul> </p> <p>The most common adverse effect in physical therapies is pain worsened during or immediately after the procedure (<a href="./references#CD012551-bbs2-0004" title="BadilloSA , NevilleCE , KotarinosR , FortmanC , FraserL , CosbyA , et al. Randomized multicenter pilot trial shows benefit of manual physical therapies in treatment of urologic chronic pelvic pain. Journal of Women's Health Physical Therapy2009;33(1):23. FitzGeraldMP , AndersonRU , PottsJ , PayneCK , PetersKM , ClemensJQ , et al. Randomized multicenter feasibility trial of myofascial physical therapy for the treatment of urological chronic pelvic pain syndromes. Journal of Urology2009;182(2):570‐80. FitzgeraldMP , AndersonRU , PottsJ , PayneCK , PetersKM , ClemensJQ , et al. Randomized multicenter feasibility trial of myofascial physical therapy for the treatment of urological chronic pelvic pain syndromes. Journal of Urology2013;189(1 Suppl):S75‐85. ">Fitzgerald 2013</a>). </p> </section> <section id="CD012551-sec-0037"> <h4 class="title">Clinical phenotyping</h4> <p>Clinical phenotyping is a strategy that was developed to deliver customised treatment in an aetiological framework (<a href="./references#CD012551-bbs2-0189" title="ShoskesDA , NickelJC , RackleyRR , PontariMA . Clinical phenotyping in chronic prostatitis/chronic pelvic pain syndrome and interstitial cystitis: a management strategy for urologic chronic pelvic pain syndromes. Prostate Cancer and Prostatic Diseases2008;12(2):177‐83. ">Shoskes 2008b</a>). The UPOINT system addresses six domains: <b>U</b> rinary symptoms, <b>P</b> sychosocial dysfunction, <b>O</b> rgan‐specific findings, <b>I</b> nfection, <b>N</b> eurological dysfunction and <b>T</b> enderness of muscles, and offers an algorithmic approach for the use of the various available interventions. The number of affected domains holds a significant correlation with the prostatitis symptoms score and the addition of a <b>S</b>exual dysfunction domain (UPOINT(S)) improves accuracy in stratification of symptom severity (<a href="./references#CD012551-bbs2-0165" title="MagriV , WagenlehnerF , PerlettiG , SchneiderS , MarrasE , NaberKG , et al. Use of the UPOINT chronic prostatitis/chronic pelvic pain syndrome classification in European patient cohorts: sexual function domain improves correlations. Journal of Urology2010;184(6):2339‐45. [PUBMED: 20952019] ">Magri 2010</a>). While in itself it is not an intervention, it serves as a screening tool to select the most appropriate intervention for each patient. </p> </section> </section> <section id="CD012551-sec-0038"> <h3 class="title" id="CD012551-sec-0038">How the intervention might work</h3> <section id="CD012551-sec-0039"> <h4 class="title">Pharmacological interventions</h4> <p>Alpha‐blockers reduce the autonomic sympathetic tone in the bladder neck and prostate, improving urinary flow and LUTS. 5‐alpha‐reductase inhibitors reduce the production of dihydrotestosterone and, consequently, the size of the prostatic gland dependent on the stimulation of this hormone. This might reduce pain and impaired voiding (<a href="./references#CD012551-bbs2-0124" title="BruntonLL , ChabnerBA , KnollmannBC . Goodman and Gilman's the Pharmacological Basis of Therapeutics. 12th Edition. New York (NY): McGraw‐Hill Education, 2011. ">Brunton 2011</a>). </p> <p>NSAIDs are antagonists to the cyclo‐oxygenases (COX) enzymes type 1 and 2 and their proinflammatory subproducts (<a href="./references#CD012551-bbs2-0124" title="BruntonLL , ChabnerBA , KnollmannBC . Goodman and Gilman's the Pharmacological Basis of Therapeutics. 12th Edition. New York (NY): McGraw‐Hill Education, 2011. ">Brunton 2011</a>). Both non‐selective and selective (COX‐2) inhibitors could therefore decrease inflammatory mediated pain in CP/CPPS. </p> <p>Phytotherapy includes the use of pollen extract and bioflavonoids that appear to have anti‐inflammatory properties, decreasing acinar cell proliferation and the production of interleukin‐6, tumour necrosis factor α, and other proinflammatory cytokines (<a href="./references#CD012551-bbs2-0045" title="CapodiceJL , BemisDL , ButtyanR , KaplanSA , KatzAE . Complementary and alternative medicine for chronic prostatitis/chronic pelvic pain syndrome. Evidence‐based Complementary and Alternative Medicine : ECAM2005;2(4):495‐501. ">Capodice 2005</a>; <a href="./references#CD012551-bbs2-0155" title="KamijoT , SatoS , KitamuraT . Effect of cernitin pollen‐extract on experimental nonbacterial prostatitis in rats. Prostate2001;49(2):122‐31. [PUBMED: 11582591] ">Kamijo 2001</a>). </p> <p>Even if CP/CPPS is defined when no bacterial cause can be identified, antibiotics have been used to treat it under the assumption of the existence of an occult or undertreated infection (<a href="./references#CD012551-bbs2-0150" title="HouDS , LongWM , ShenJ , ZhaoLP , PangXY , XuC . Characterisation of the bacterial community in expressed prostatic secretions from patients with chronic prostatitis/chronic pelvic pain syndrome and infertile men: a preliminary investigation. Asian Journal of Andrology2012;14(4):566‐73. [PUBMED: 22635162] ">Hou 2012</a>). </p> <p>Allopurinol would reduce the prostatic secretions of purine and pyrimidine base‐containing metabolites in urine. These metabolites could be responsible for prostatic inflammation through urinary reflux (<a href="./references#CD012551-bbs2-0080" title="McNaughton CollinsM , WiltTJ . Allopurinol for chronic prostatitis. Cochrane Database of Systematic Reviews2002, Issue 4. [DOI: 10.1002/14651858.CD001041; CD001041] ">McNaughton 2002</a>). </p> <p>Botulinum toxin A has denervating properties and causes reduction in pain mediators when applied to the prostate in animal models. It also causes apoptosis and involution of the prostate gland (<a href="./references#CD012551-bbs2-0049" title="ChuangYC , ChancellorMB . The application of botulinum toxin in the prostate. Journal of Urology2006;176(6 Pt 1):2375‐82. ">Chuang 2006</a>). </p> </section> <section id="CD012551-sec-0040"> <h4 class="title">Non‐pharmacological interventions</h4> <p>Acupuncture targets specific cutaneous points representing various internal organs using fine needle insertion and sometimes adding electric current to increase stimulation (electroacupuncture). In animal models, electroacupuncture has anti‐inflammatory properties and activates analgesic neurotransmitters (<a href="./references#CD012551-bbs2-0156" title="KimHW , RohDH , YoonSY , KangSY , KwonYB , HanHJ , et al. The anti‐inflammatory effects of low‐ and high‐frequency electroacupuncture are mediated by peripheral opioids in a mouse air pouch inflammation model. Journal of Alternative and Complementary Medicine (New York, N.Y.)2006;12(1):39‐44. [PUBMED: 16494567] ">Kim 2006</a>). </p> <p>Locally induced hyperthermia, using transrectal or transurethral procedures, could decrease oxygen free radicals associated with prostatic inflammation (<a href="./references#CD012551-bbs2-0006" title="GaoM , DingH , ZhongG , LuJ , WangH , LiQ , et al. The effects of transrectal radiofrequency hyperthermia on patients with chronic prostatitis and the changes of MDA, NO, SOD, and Zn levels in pretreatment and posttreatment. Urology2012;79(2):391‐6. ">Gao 2012</a>). </p> <p>Myofascial trigger point release targets pelvic floor musculature dysfunction as a potential cause or contributor to CP/CPPS (<a href="./references#CD012551-bbs2-0004" title="BadilloSA , NevilleCE , KotarinosR , FortmanC , FraserL , CosbyA , et al. Randomized multicenter pilot trial shows benefit of manual physical therapies in treatment of urologic chronic pelvic pain. Journal of Women's Health Physical Therapy2009;33(1):23. FitzGeraldMP , AndersonRU , PottsJ , PayneCK , PetersKM , ClemensJQ , et al. Randomized multicenter feasibility trial of myofascial physical therapy for the treatment of urological chronic pelvic pain syndromes. Journal of Urology2009;182(2):570‐80. FitzgeraldMP , AndersonRU , PottsJ , PayneCK , PetersKM , ClemensJQ , et al. Randomized multicenter feasibility trial of myofascial physical therapy for the treatment of urological chronic pelvic pain syndromes. Journal of Urology2013;189(1 Suppl):S75‐85. ">Fitzgerald 2013</a>). Biofeedback also addresses pelvic floor muscle through initial contraction to achieve further relaxation (<a href="./references#CD012551-bbs2-0045" title="CapodiceJL , BemisDL , ButtyanR , KaplanSA , KatzAE . Complementary and alternative medicine for chronic prostatitis/chronic pelvic pain syndrome. Evidence‐based Complementary and Alternative Medicine : ECAM2005;2(4):495‐501. ">Capodice 2005</a>). </p> <p>Extracorporeal shockwave therapy could promote vascularisation of the prostatic tissue and modulate nociceptive nerve impulses and pelvic floor tone (<a href="./references#CD012551-bbs2-0023" title="PajovicB , RadojevicN , DimitrovskiA , VukovicM . Comparison of the efficiency of combined extracorporeal shock‐wave therapy and triple therapy versus triple therapy itself in Category III B chronic pelvic pain syndrome (CPPS). Aging Male2016;19(3):1‐6. ">Pajovic 2016</a>). </p> <p>The length of the foreskin is positively associated with the presence of symptoms of CP/CPPS; therefore, it has been proposed that circumcision could reduce prostatitis symptoms (<a href="./references#CD012551-bbs2-0037" title="ZhaoY , ZhaoW , LangG , ChenY , LiuJ , WangG , et al. Circumcision plus antibiotic, anti‐inflammatory, and alpha‐blocker therapy for the treatment for chronic prostatitis/chronic pelvic pain syndrome: a prospective, randomized, multicenter trial. World Journal of Urology2015;33(5):617‐22. ">Zhao 2015</a>). </p> <p>There are certain risk factors in the lifestyle of men with CP/CPPS, including alcohol consumption and smoking status, among others, that are associated with worse clinical outcomes. Interventions aimed at reducing those risk factors, including those aimed at increasing physical activity, could reduce prostatitis symptoms (<a href="./references#CD012551-bbs2-0127" title="ChenX , HuC , PengY , LuJ , YangNQ , ChenL , et al. Association of diet and lifestyle with chronic prostatitis/chronic pelvic pain syndrome and pain severity: a case‐control study. Prostate Cancer and Prostatic Diseases2016;19(1):92‐9. [PUBMED: 26666410] ">Chen 2016</a>). </p> <p>Prostatic massage has been a classical treatment for CP/CPPS aimed at relieving prostatic congestion, although the mechanisms for its therapeutic effects are controversial (<a href="./references#CD012551-bbs2-0170" title="NickelJC , AlexanderR , AndersonR , KriegerJ , MoonT , NealD , et al. Prostatitis unplugged? Prostatic massage revisited. Techniques in Urology1999;5(1):1‐7. [PUBMED: 10374787] ">Nickel 1999b</a>). </p> <p>It has been suggested that psychological treatments could be helpful in all types of chronic pain syndromes and the psychiatric comorbidity associated with the condition (e.g. depression secondary to chronic pain) (<a href="./references#CD012551-bbs2-0182" title="RiegelB , BruenahlCA , AhyaiS , BingelU , FischM , LoweB . Assessing psychological factors, social aspects and psychiatric co‐morbidity associated with chronic prostatitis/chronic pelvic pain syndrome (CP/CPPS) in men ‐ a systematic review. Journal of Psychosomatic Research2014;77(5):333‐50. [PUBMED: 25300538] ">Riegel 2014</a>). </p> </section> </section> <section id="CD012551-sec-0041"> <h3 class="title" id="CD012551-sec-0041">Why it is important to do this review</h3> <p>The Cochrane Urology Group undertook an extensive prioritisation exercise to identify a core portfolio of the most clinically important titles. Consequently, this title was identified as a clinically important priority by the urology expert panel for development, maintenance and investment of resources by the editorial base. </p> <p>CP/CPPS is a prevalent condition among men and it causes significant impairment of QoL. There was a previous Cochrane Review on the same subject but with a different methodological approach (<a href="./references#CD012551-bbs2-0078" title="McNaughton CollinsM , MacDonaldR , WiltTJ . Diagnosis and treatment of chronic abacterial prostatitis: a systematic review. Annals of Internal Medicine2000;133(5):367‐81. ">McNaughton 2000</a>). Other non‐Cochrane systematic reviews were also undertaken in previous years: some of them focused on individual interventions (<a href="./references#CD012551-bbs2-0096" title="QinZ , WuJ , ZhouJ , LiuZ . Systematic review of acupuncture for chronic prostatitis/chronic pelvic pain syndrome. Medicine (Baltimore)2016;95(11):e3095. ">Qin 2016a</a>; <a href="./references#CD012551-bbs2-0108" title="YangG , WeiQ , LiH , YangY , ZhangS , DongQ . The effect of alpha‐adrenergic antagonists in chronic prostatitis/chronic pelvic pain syndrome: a meta‐analysis of randomized controlled trials. Journal of Andrology2006;27(6):847‐52. ">Yang 2006</a>; <a href="./references#CD012551-bbs2-0198" title="ZhuY , WangC , PangX , LiF , ChenW , TanW . Antibiotics are not beneficial in the management of category III prostatitis: a meta analysis. Urology Journal2014;11(2):1377‐85. [PUBMED: 24807747] ">Zhu 2014</a>), while others had a wider scope of interventions (<a href="./references#CD012551-bbs2-0042" title="AnothaisintaweeT , AttiaJ , NickelJC , ThammakraisornS , NumthavajP , McEvoyM , et al. Management of chronic prostatitis/chronic pelvic pain syndrome: a systematic review and network meta‐analysis. JAMA2011;305(1):78‐86. ">Anothaisintawee 2011</a>; <a href="./references#CD012551-bbs2-0050" title="CohenJM , FaginAP , HaritonE , NiskaJR , PierceMW , KuriyamaA , et al. Therapeutic intervention for chronic prostatitis/chronic pelvic pain syndrome (CP/CPPS): a systematic review and meta‐analysis. PloS One2012;7(8):e41941. ">Cohen 2012</a>; <a href="./references#CD012551-bbs2-0076" title="MagistroG , WagenlehnerFM , GrabeM , WeidnerW , StiefCG , NickelJC . Contemporary management of chronic prostatitis/chronic pelvic pain syndrome. European Urology2016;69(2):286‐97. ">Magistro 2016</a>). We consider that a new and updated Cochrane Review is needed to critically summarise the body of evidence for this complex condition using the GRADE approach, thus providing key information about the best estimate of the magnitude of the effect in relative terms and absolute differences for patient‐important outcomes. Previous systematic reviews did not use this approach and had variable adherence to the rigorous methodology recommended by Cochrane. </p> <p>The protocol for this review was first published in August 2016 with the title 'Interventions for treating chronic prostatitis/chronic pelvic pain syndrome' (<a href="./references#CD012551-bbs2-0199" title="FrancoJVA , TirapeguiFI , GarroteV , ViettoV . Interventions for treating chronic prostatitis/chronic pelvic pain syndrome. Cochrane Database of Systematic Reviews2016, Issue 8. [DOI: 10.1002/14651858.CD012320] ">Franco 2016</a>). Due to the retrieval of a significant amount of included studies, the review team and the Cochrane Urology Group decided to split the review in two more narrowly defined reviews: 'Non‐pharmacological interventions for treating chronic prostatitis/chronic pelvic pain syndrome' and 'Pharmacological interventions for treating chronic prostatitis/chronic pelvic pain syndrome' (<a href="./references#CD012551-bbs2-0135" title="FrancoJVA , TirapeguiFI , TurkT , GarroteV , ViettoV . Pharmacological interventions for treating chronic prostatitis/chronic pelvic pain syndrome. Cochrane Database of Systematic Reviews2017, Issue 2. [DOI: 10.1002/14651858.CD012552; CD012552] ">Franco 2017</a>). </p> </section> </section> </section> <section class="objectives"> <div class="section-header section-collapse-header" id="CD012551-sec-0042" lang="en"> <h2 class="title section-collapse-title"> Objectives <i aria-hidden="true" class="fa fa-caret-up section-collapse-icon"></i> </h2> </div> <section class="objectives" lang="en"> <div class="section-header" id="CD012551-sec-0042"></div> <p>To assess the effects of non‐pharmacological therapies for chronic prostatitis/chronic pelvic pain syndrome (CP/CPPS). </p> </section> </section> <section class="methods"> <div class="section-header section-collapse-header" id="CD012551-sec-0043" lang="en"> <h2 class="title section-collapse-title"> Methods <i aria-hidden="true" class="fa fa-caret-up section-collapse-icon"></i> </h2> </div> <section class="methods" lang="en"> <div class="section-header" id="CD012551-sec-0043"></div> <section id="CD012551-sec-0044"> <h3 class="title">Criteria for considering studies for this review</h3> <section id="CD012551-sec-0045"> <h4 class="title">Types of studies</h4> <p>We included randomised controlled trials (RCTs) regardless of their publication status or language of publication. </p> </section> <section id="CD012551-sec-0046"> <h4 class="title">Types of participants</h4> <p>We included men of all ages, regardless of social condition or ethnic origin, with CP/CPPS according with type III prostatitis of the NIH classification. </p> <p>If we identified studies in which only a subset of participants was relevant to this review, we included such studies if data were available separately for the relevant subset. </p> </section> <section id="CD012551-sec-0047"> <h4 class="title">Types of interventions</h4> <p>We investigated the following comparisons of experimental intervention versus comparator intervention. Concomitant interventions had to be the same in the experimental and comparator groups to establish fair comparisons. We performed a condition‐based comprehensive bibliographic search to find all interventions tested so far for CP/CPPS; therefore, some of them might not be listed in this section. </p> <section id="CD012551-sec-0048"> <h5 class="title">Non‐pharmacological interventions</h5> <p> <ul id="CD012551-list-0006"> <li> <p>Acupuncture and electroacupuncture.</p> </li> <li> <p>Circumcision.</p> </li> <li> <p>Electromagnetic chair.</p> </li> <li> <p>Lifestyle interventions.</p> </li> <li> <p>Physical activity.</p> </li> <li> <p>Prostatic massage.</p> </li> <li> <p>Extracorporeal shockwave therapy.</p> </li> <li> <p>Local thermotherapy (transurethral, transrectal thermotherapy and external).</p> </li> <li> <p>Biofeedback.</p> </li> <li> <p>Myofascial trigger point release.</p> </li> <li> <p>Laser therapy.</p> </li> <li> <p>Tibial nerve stimulation.</p> </li> <li> <p>Myofascial therapy.</p> </li> <li> <p>Osteopathy.</p> </li> <li> <p>Sono‐electromagnetic therapy.</p> </li> <li> <p>Transelectrical nerve stimulation</p> </li> <li> <p>Transurethral needle ablation.</p> </li> <li> <p>Non‐intrusive ultrasound.</p> </li> <li> <p>Psychological support.</p> </li> <li> <p>Prostatic surgery.</p> </li> <li> <p>Other miscellaneous non‐pharmacological therapies.</p> </li> </ul> </p> </section> <section id="CD012551-sec-0049"> <h5 class="title">Multimodal approaches</h5> <p> <ul id="CD012551-list-0007"> <li> <p>Combination of pharmacological and non‐pharmacological therapy: acupuncture plus antibiotics, local thermotherapy plus alpha‐blockers, etc. </p> </li> <li> <p>Combination of non‐pharmacological therapies.</p> </li> </ul> </p> </section> <section id="CD012551-sec-0050"> <h5 class="title">Comparator interventions</h5> <p> <ul id="CD012551-list-0008"> <li> <p>Placebo or sham procedure.</p> </li> <li> <p>No treatment.</p> </li> <li> <p>Other types of interventions: pharmacological and non‐pharmacological.</p> </li> </ul> </p> </section> <section id="CD012551-sec-0051"> <h5 class="title">Comparisons</h5> <p>We performed head‐to‐head comparisons or intervention versus placebo or sham procedure/no treatment comparisons. </p> <p>We did not include studies evaluating only pharmacological interventions to avoid overlapping with the review 'Pharmacological interventions for treating chronic prostatitis/chronic pelvic pain syndrome' (<a href="./references#CD012551-bbs2-0135" title="FrancoJVA , TirapeguiFI , TurkT , GarroteV , ViettoV . Pharmacological interventions for treating chronic prostatitis/chronic pelvic pain syndrome. Cochrane Database of Systematic Reviews2017, Issue 2. [DOI: 10.1002/14651858.CD012552; CD012552] ">Franco 2017</a>). </p> </section> </section> <section id="CD012551-sec-0052"> <h4 class="title">Types of outcome measures</h4> <p>We did not use the measurement of the outcomes assessed in this review as an eligibility criterion. </p> <section id="CD012551-sec-0053"> <h5 class="title">Primary outcomes</h5> <p> <ul id="CD012551-list-0009"> <li> <p>Prostatitis symptoms.</p> </li> <li> <p>Adverse events.</p> </li> </ul> </p> </section> <section id="CD012551-sec-0054"> <h5 class="title">Secondary outcomes</h5> <p> <ul id="CD012551-list-0010"> <li> <p>Sexual dysfunction.</p> </li> <li> <p>Urinary symptoms.</p> </li> <li> <p>Quality of life (QoL).</p> </li> <li> <p>Depression and anxiety.</p> </li> </ul> </p> <section id="CD012551-sec-0055"> <h6 class="title">Method and timing of outcome measurement</h6> <p>We used clinically important difference for the review outcomes to rate overall quality of the evidence in 'Summary of finding' tables (<a href="./references#CD012551-bbs2-0154" title="JohnstonBC , ThorlundK , SchünemannHJ , XieF , MuradMH , MontoriVM , et al. Improving the interpretation of quality of life evidence in meta‐analyses: the application of minimal important difference units. Health and Quality of Life Outcomes2010;8:116. ">Johnston 2010</a>). When the mean difference (MD) or risk ratio (RR) was equal to or larger than the minimal clinically important difference (MCID), we assumed that many participants may have gained clinically meaningful improvement from treatment; when the MD was at least half of the MCID but less than the MCID, an appreciable number of participants had likely achieved a clinically meaningful improvement; and when the MD was less than one‐half of the MCID, it was unlikely that an appreciable number of participants achieved clinically meaningful improvement (<a href="./references#CD012551-bbs2-0154" title="JohnstonBC , ThorlundK , SchünemannHJ , XieF , MuradMH , MontoriVM , et al. Improving the interpretation of quality of life evidence in meta‐analyses: the application of minimal important difference units. Health and Quality of Life Outcomes2010;8:116. ">Johnston 2010</a>). </p> <section id="CD012551-sec-0056"> <p><b>Prostatitis symptoms</b></p> <p> <ul id="CD012551-list-0011"> <li> <p>Measured by the National Institutes of Health ‐ Chronic Prostatitis Symptom Index (NIH‐CPSI) as total score and subscore measurements, when possible, and other validated scales. </p> </li> <li> <p>We considered an MCID in NIH‐CPSI score as a 25% decrease or a 6‐point reduction from baseline (<a href="./references#CD012551-bbs2-0172" title="NickelJC , PontariM , MoonT , GittelmanM , MalekG , FarringtonJ , et al. A randomized, placebo controlled, multicenter study to evaluate the safety and efficacy of rofecoxib in the treatment of chronic nonbacterial prostatitis. Journal of Urology2003;169(4):1401‐5. [PUBMED: 12629372] ">Nickel 2003b</a>). This threshold was used to measure the 'responders rate' (<a href="./references#CD012551-bbs2-0126" title="CatesC , KarnerC . Clinical importance cannot be ruled out using mean difference alone. BMJ (Clinical Research Ed.)2015;351:h5496. [PUBMED: 26588935] ">Cates 2015</a>). </p> </li> </ul> </p> </section> <section id="CD012551-sec-0057"> <p><b>Adverse events</b></p> <p> <ul id="CD012551-list-0012"> <li> <p>Defined as treatment intolerance, adverse effects of the interventions at any time after participants were randomised to intervention/comparator groups. </p> </li> <li> <p>There was no established threshold for adverse events. We considered the clinically important differences of adverse events above as relative risk reduction of at least 25% (<a href="./references#CD012551-bbs2-0140" title="GuyattGH , OxmanAD , KunzR , BrozekJ , Alonso‐CoelloP , RindD , et al. GRADE guidelines 6. Rating the quality of evidence ‐ imprecision. Journal of Clinical Epidemiology2011;64(12):1283‐93. ">Guyatt 2011a</a>). </p> </li> </ul> </p> </section> <section id="CD012551-sec-0058"> <p><b>Sexual dysfunction</b></p> <p> <ul id="CD012551-list-0013"> <li> <p>Measured by validated scales (e.g. International Index of Erectile Function, IIEF).</p> </li> <li> <p>We considered the MCID in the erectile function domain score of the IIEF of four (<a href="./references#CD012551-bbs2-0184" title="RosenRC , AllenKR , NiX , AraujoAB . Minimal clinically important differences in the erectile function domain of the International Index of Erectile Function scale. European Urology2011;60(5):1010‐6. ">Rosen 2011</a>). We planned to use different thresholds of MCID based on the severity of erectile dysfunction, with a threshold of two for men with mild erectile dysfunction, five with moderate erectile dysfunction and seven with severe erectile dysfunction (<a href="./references#CD012551-bbs2-0184" title="RosenRC , AllenKR , NiX , AraujoAB . Minimal clinically important differences in the erectile function domain of the International Index of Erectile Function scale. European Urology2011;60(5):1010‐6. ">Rosen 2011</a>). We also considered IIEF‐5 of over five points as the MCID (<a href="./references#CD012551-bbs2-0190" title="SpalivieroM , StromKH , GuX , ArakiM , CulkinDJ , WongC . Does Greenlight HPS (™) laser photoselective vaporization prostatectomy affect sexual function?. Journal of Endourology2010;24(12):2051‐7. ">Spaliviero 2010</a>). </p> </li> </ul> </p> </section> <section id="CD012551-sec-0059"> <p><b>Urinary symptoms</b></p> <p> <ul id="CD012551-list-0014"> <li> <p>Measured by IPSS (International Prostate Symptom Score) or AUASS (American Urological Association Symptom Score). </p> </li> <li> <p>We considered improvement of the IPSS score of three points as an MCID to assess efficacy and comparative effectiveness (<a href="./references#CD012551-bbs2-0122" title="BarryMJ , WillifordWO , ChangY , MachiM , JonesK , Walker‐CorkeryE , et al. Benign prostatic hyperplasia specific health status measures in clinical research: how much change in the American Urological Association symptom index and the benign prostatic hyperplasia impact index is perceptible to patients?. Journal of Urology1995;154(5):1770‐4. ">Barry 1995</a>). We planned to use different thresholds of MCID based on the severity of IPSS, with a threshold of three for men with mild LUTS, five for moderate LUTS and eight for severe LUTS (<a href="./references#CD012551-bbs2-0122" title="BarryMJ , WillifordWO , ChangY , MachiM , JonesK , Walker‐CorkeryE , et al. Benign prostatic hyperplasia specific health status measures in clinical research: how much change in the American Urological Association symptom index and the benign prostatic hyperplasia impact index is perceptible to patients?. Journal of Urology1995;154(5):1770‐4. ">Barry 1995</a>). </p> </li> </ul> </p> </section> <section id="CD012551-sec-0060"> <p><b>Quality of life</b></p> <p> <ul id="CD012551-list-0015"> <li> <p>Assessed by the Medical Outcomes Study Short Form 12 (SF‐12) or other validated scales.</p> </li> <li> <p>We considered an MCID of SF‐12 physical component score to be 8 and SF‐12 mental component score to be 4 (<a href="./references#CD012551-bbs2-0175" title="ParkerSL , GodilSS , ShauDN , MendenhallSK , McGirtMJ . Assessment of the minimum clinically important difference in pain, disability, and quality of life after anterior cervical discectomy and fusion: clinical article. Journal of Neurosurgery Spine2013;18(2):154‐60. ">Parker 2013</a>). </p> </li> </ul> </p> </section> <section id="CD012551-sec-0061"> <p><b>Depression and anxiety</b></p> <p> <ul id="CD012551-list-0016"> <li> <p>Assessed by Beck Depression Inventory, State Anxiety Inventory‐Y or other validated scales. </p> </li> <li> <p>We considered an MCID of Beck Depression Inventory to be 11 and State Anxiety Inventory‐Y to be 10 (<a href="./references#CD012551-bbs2-0125" title="ButtonKS , KounaliD , ThomasL , WilesNJ , PetersTJ , WeltonNJ , et al. Minimal clinically important difference on the Beck Depression Inventory‐II according to the patient's perspective. Psychological Medicine2015;45(14):3269‐79. ">Button 2015</a>; <a href="./references#CD012551-bbs2-0130" title="CorsalettiBF , ProençaMDGL , BiscaGKW , LeiteJC , BellinettiLM , PittaF . Minimal important difference for anxiety and depression surveys after intervention to increase daily physical activity in smokers. Fisioterapia e Pesquisa2014;21:359‐64. ">Corsaletti 2014</a>). </p> </li> </ul> </p> <p>We considered outcomes measured up to and including 12 months after randomisation as short‐term, and later than 12 months as long‐term. </p> </section> </section> <section id="CD012551-sec-0062"> <h6 class="title">Main outcomes for 'Summary of findings' tables</h6> <p>We presented 'Summary of findings' tables reporting the following outcomes listed according to priority. </p> <p> <ul id="CD012551-list-0017"> <li> <p>Prostatitis symptoms.</p> </li> <li> <p>Adverse events.</p> </li> <li> <p>Sexual dysfunction.</p> </li> <li> <p>QoL.</p> </li> <li> <p>Depression and anxiety.</p> </li> </ul> </p> </section> </section> </section> </section> <section id="CD012551-sec-0063"> <h3 class="title">Search methods for identification of studies</h3> <p>We searched for all published and unpublished RCTs meeting our stated inclusion/exclusion criteria, without restrictions on language, publication date or publication status, and in consultation with the Cochrane Urology Information Specialist. </p> <section id="CD012551-sec-0064"> <h4 class="title">Electronic searches</h4> <p>We identified published, unpublished and ongoing studies by searching the following databases from their inception. </p> <p> <ul id="CD012551-list-0018"> <li> <p>Cochrane Central Register of Controlled Trials (CENTRAL; 2017, Issue 7) in the Cochrane Library. </p> </li> <li> <p>PubMed (1946 to 11 August 2017).</p> </li> <li> <p>Embase Elsevier (1947 to 11 August 2017).</p> </li> <li> <p>PsycINFO Ovid (1887 to 11 August 2017).</p> </li> <li> <p>CINAHL EBSCO (1937 to 11 August 2017).</p> </li> <li> <p>ClinicalTrials.gov (<a href="http://www.clinicaltrials.gov" target="_blank">www.clinicaltrials.gov</a>, 14 August 2017) </p> </li> <li> <p>ISRCTN Registry (BioMed Central; <a href="http://www.isrctn.com/" target="_blank">www.isrctn.com/</a>, 14 August 2017). </p> </li> <li> <p>World Health Organization International Clinical Trials Registry Platform (<a href="http://www.who.int/trialsearch" target="_blank">www.who.int/trialsearch</a>, 14 August 2017). </p> </li> </ul> </p> <p>The search strategies for databases were modelled on the search strategy designed for PubMed (<a href="./appendices#CD012551-sec-0290">Appendix 1</a>; <a href="./appendices#CD012551-sec-0291">Appendix 2</a>; <a href="./appendices#CD012551-sec-0292">Appendix 3</a>; <a href="./appendices#CD012551-sec-0293">Appendix 4</a>; <a href="./appendices#CD012551-sec-0294">Appendix 5</a>; <a href="./appendices#CD012551-sec-0295">Appendix 6</a>). The PubMed search utilised the Cochrane Highly Sensitive Search Strategy for identifying RCTs in MEDLINE: sensitivity maximising version (2008 revision; <a href="./references#CD012551-bbs2-0162" title="LefebvreC , ManheimerE , GlanvilleJ . Chapter 6: Searching for studies. In: Higgins JPT, Green S, editor(s). Cochrane Handbook for Systematic Reviews of Interventions Version 5.1.0 (updated March 2011). The Cochrane Collaboration, 2011. Available from handbook.cochrane.org. ">Lefebvre 2011</a>). The Embase search utilised the trial filter for therapy, maximising sensitivity developed by the Health Information Research Unit (HIRU) at McMaster University, adapted from Ovid to the Elsevier interface (<a href="./references#CD012551-bbs2-0148" title="Health Information Research Unit (HIRU). Evidence‐Based Health Informatics. Search strategies for PsycINFO in OVID syntax. Hamilton (ON): McMaster University; 2015. hiru.mcmaster.ca/hiru/HIRU_Hedges_EMBASE_Strategies.aspx (accessed prior to 18 January 2018). ">HIRU 2015</a>). For CENTRAL and clinical trials registries, filters were not applicable. We did not use filters for PsycINFO and CINAHL because the results likely to be obtained were very few. </p> </section> <section id="CD012551-sec-0065"> <h4 class="title">Searching other resources</h4> <p>We tried to identify other potentially eligible trials or ancillary publications by searching the reference lists of retrieved included trials and relevant reviews, meta‐analyses and health technology assessment reports. We contacted authors of included studies to identify any further studies that we may have missed. We contacted drug and device manufacturers for ongoing or unpublished trials. We searched abstract proceedings of the American Urological Association, European Association of Urology and Society of Sexual Medicine from 2015 to 2017 for unpublished studies (<a href="./appendices#CD012551-sec-0296">Appendix 7</a>). </p> <p>We searched other grey literature sources such as:</p> <p> <ul id="CD012551-list-0019"> <li> <p>Open Grey (<a href="http://www.opengrey.eu/" target="_blank">www.opengrey.eu/</a>); </p> </li> <li> <p>New York Academy of Medicine Grey Literature Report (<a href="http://www.greylit.org/" target="_blank">www.greylit.org/</a>); </p> </li> <li> <p>Google Scholar.</p> </li> </ul> </p> </section> </section> <section id="CD012551-sec-0066"> <h3 class="title" id="CD012551-sec-0066">Data collection and analysis</h3> <section id="CD012551-sec-0067"> <h4 class="title">Selection of studies</h4> <p>We used reference management software (<a href="./references#CD012551-bbs2-0134" title="Clarivate Analytics. EndNote. Version 7.5. Clarivate Analytics, 2016. ">EndNote</a>) and <a href="./references#CD012551-bbs2-0131" title="Veritas Health Innovation. Covidence systematic review software. Melbourne, Australia: Veritas Health Innovation, 2013. ">Covidence</a> to identify and remove duplicate records. Three review authors (JVAF, TT, VV) independently scanned in pairs the abstract, title, or both, of remaining records retrieved, to determine which studies should be assessed further. Five review authors (JVAF, TT, SI, YX, VV) investigated all potentially relevant records as full text, mapped records to studies, and classified studies as included studies, excluded studies, studies awaiting classification or ongoing studies in accordance with the criteria for each provided in the <i>Cochrane Handbook for Systematic Reviews of Interventions</i> (<a href="./references#CD012551-bbs2-0145" title="HigginsJPT , GreenS , editor(s) . Cochrane Handbook for Systematic Reviews of Interventions. Version 5.1.0 (updated March 2011). The Cochrane Collaboration, 2011. Available from handbook.cochrane.org. ">Higgins 2011a</a>). We used <a href="./references#CD012551-bbs2-0131" title="Veritas Health Innovation. Covidence systematic review software. Melbourne, Australia: Veritas Health Innovation, 2013. ">Covidence</a> for title/abstract, and full‐text screening. We resolved any discrepancies through consensus or recourse to a third review author (JHJ). If resolution of a disagreement was not possible, we designated the study as 'awaiting classification' (<a href="./references#CD012551-sec-0313" title="">Characteristics of studies awaiting classification</a>) and we contacted study authors for clarification. We documented reasons for exclusion of studies that may have reasonably been expected to be included in the review in a <a href="./references#CD012551-sec-0312" title="">Characteristics of excluded studies</a> table. We presented an adapted PRISMA flow diagram showing the process of study selection (<a href="./references#CD012551-bbs2-0163" title="LiberatiA , AltmanDG , TetzlaffJ , MulrowC , GøtzschePC , IoannidisJPA , et al. The PRISMA statement for reporting systematic reviews and meta‐analyses of studies that evaluate health care interventions: explanation and elaboration. PLoS Medicine2009;6(7):e1000100. [DOI: 10.1371/journal.pmed.1000100] ">Liberati 2009</a>). </p> </section> <section id="CD012551-sec-0068"> <h4 class="title">Data extraction and management</h4> <p>We developed a dedicated data abstraction form that we pilot tested ahead of time.</p> <p>For studies that fulfilled inclusion criteria, six review authors (JVAF, VV, TT, SI, YX, JHJ) independently abstracted in pairs the following information, which is provided in the <a href="./references#CD012551-sec-0311" title="">Characteristics of included studies</a> table. </p> <p> <ul id="CD012551-list-0020"> <li> <p>Study design.</p> </li> <li> <p>Study dates (if dates were not available then this was reported as such).</p> </li> <li> <p>Study settings and country.</p> </li> <li> <p>Participant inclusion and exclusion criteria.</p> </li> <li> <p>Participant details, baseline demographics.</p> </li> <li> <p>Number of participants by study and by study arm.</p> </li> <li> <p>Details of relevant experimental and comparator interventions such as dose, route, frequency and duration. </p> </li> <li> <p>Definitions of relevant outcomes, and method and timing of outcome measurement as well as any relevant subgroups. </p> </li> <li> <p>Study funding sources.</p> </li> <li> <p>Declarations of interest by primary investigators.</p> </li> </ul> </p> <p>We further summarised some of the characteristics of the studies, participants and interventions in additional tables (<a href="#CD012551-tbl-0011">Table 1</a>; <a href="#CD012551-tbl-0012">Table 2</a>). </p> <div class="table" id="CD012551-tbl-0011"> <table><a class="open-table-viewer open-in-figure-viewer" href="#0">Open in table viewer</a><div class="table-heading"><span class="table-label">Table 1.</span> <span class="table-title">Description of interventions</span></div> <tbody> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><b>Study ID</b> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><b>Intervention(s) (route, frequency, total dose/day)</b> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><b>Intervention(s) appropriate as applied in a clinical practice setting (description)</b> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><b>Intervention(s) duration</b> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><b>Comparator(s) (route, frequency, total dose/day)</b> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><b>Comparator(s) appropriate as applied in a clinical practice setting (description)</b> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><b>Comparator(s) duration</b> </p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><a href="./references#CD012551-bbs2-0019" title="NeimarkAI , MaksimovaSS . Effect of hypercapnic hypoxia on chronic abacterial prostatitis. Urologiia (Moscow, Russia : 1999)2016;1(3):80‐4. [PUBMED: 28247635] "><b>Neimark 2016</b> </a> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Breathing exercises using 'Karbonik' apparatus (hypercapnic hypoxia) 10‐20 min daily + medical therapy (see comparison). </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>No information regarding dose‐scaling or contraindications.</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>10 days.</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Levofloxacin 500 mg/day, tamsulosin 0.4 mg/day, Samprost daily suppository, Serenoa repens fructuum extract 1 capsule/day for 10 days, nimesulide 1‐2 tablets/day for 5‐7 days. </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>No information regarding dose‐scaling or contraindications.</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>10 days.</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><a href="./references#CD012551-bbs2-0023" title="PajovicB , RadojevicN , DimitrovskiA , VukovicM . Comparison of the efficiency of combined extracorporeal shock‐wave therapy and triple therapy versus triple therapy itself in Category III B chronic pelvic pain syndrome (CPPS). Aging Male2016;19(3):1‐6. "><b>Pajovic 2016</b> </a> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>ESWT + medical therapy:</p> <p>each session had 12‐min duration and 3000 impulses with total energy flow 0.25 mJ/mm<sup>2</sup> 3 Hz, weekly in supine position without anaesthesia. </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>No information regarding dose‐scaling or contraindications.</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>12 weeks.</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Medical therapy with doxazosin 4 mg daily, ibuprofen 400 mg daily and tiocolchicoside 12 mg daily. </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Ranitidine was allowed for gastric complaints.</p> <p>No information regarding dose‐scaling or contraindications.</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>12 weeks.</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><a href="./references#CD012551-bbs2-0012" title="KucukEV , SucekenFY , BindayiA , BoyluU , OnolFF , GumusE . Effectiveness of acupuncture on chronic prostatitis‐chronic pelvic pain syndrome category IIIB patients: a prospective, randomized, nonblinded, clinical trial. Urology2015;85(3):636‐40. "><b>Kucuk 2015</b> </a> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Acupuncture group:</p> <p>UB28 bladder meridian<br/> GB41 gallbladder meridian<br/> LIV3 liver 3 meridian<br/> LI4 large intestine 4 meridian<br/> SP6 spleen 6 meridian<br/> SP8 spleen 8 meridian </p> <p>Stimulation using disposable acupuncture needles (Hua Long, 25 40 mm Sterile Acupuncture Needles, China) and electrical pulse generator (Agistim Duo, 4 4 mA rms max/ 99 Hz max, France). </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>No information regarding dose‐scaling.</p> <p>"Localized skin infections concerning the acupoints, bleeding diathesis and use of anticoagulation" were contraindications. </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>7 weeks.</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Medical therapy levofloxacin 500 mg daily and ibuprofen 200 mg.</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Orally administrated twice daily for 7 weeks.</p> <p>No information regarding dose‐scaling or contraindications.</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>7 weeks.</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><a href="./references#CD012551-bbs2-0025" title="SahinS , BicerM , ErenGA , TasS , TugcuV , TasciAI , et al. Acupuncture relieves symptoms in chronic prostatitis/chronic pelvic pain syndrome: a randomized, sham‐controlled trial. Prostate Cancer and Prostatic Diseases2015;18(3):249‐54. "><b>Sahin 2015</b> </a> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Acupuncture, using 2 disposable stainless steel needles (0.3 mm diameter, 60 mm length, Suzhou, Jiangsu, China) that were inserted to a depth of maximum 2.5‐3 cm in 7 acupoints bilaterally: BL33 Zhongliao<br/> BL34 Xialiao<br/> BL54 Zhibian<br/> CV1 Huiyin<br/> CV4 Guanyuan<br/> SP6 Sanyinjiao<br/> SP9 Yinlingquan. Duration: 20 min (with rotation). </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Applied weekly for 6 weeks without other treatment modalities.</p> <p>No information regarding dose‐scaling or contraindications.</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>6 weeks.</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Punctures in sham group performed 1 cm left of each selected acupoint, with same type of needles, of the same duration and frequency. </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Applied weekly for 6 weeks.</p> <p>No information regarding dose‐scaling or contraindications.</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>6 weeks.</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><a href="./references#CD012551-bbs2-0037" title="ZhaoY , ZhaoW , LangG , ChenY , LiuJ , WangG , et al. Circumcision plus antibiotic, anti‐inflammatory, and alpha‐blocker therapy for the treatment for chronic prostatitis/chronic pelvic pain syndrome: a prospective, randomized, multicenter trial. World Journal of Urology2015;33(5):617‐22. "><b>Zhao 2015</b> </a> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Medical therapy (4 weeks of ciprofloxacin 500 mg bid, 3 months of ibuprofen 400 mg/day, 3 months of tamsulosin 0.4 mg/day) and scheduled for surgery during the same period in each of the sites by study clinicians; given written instructions about postoperative wound care. </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>No information regarding dose‐scaling or contraindications.</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>3 months.</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Same medications (4 weeks of ciprofloxacin 500 mg bid, 3 months of ibuprofen 400 mg/day, 3 months of tamsulosin 0.4 mg/day) and remain uncircumcised until end of 3‐month study participation, when they were scheduled to undergo circumcision. </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>No information regarding dose‐scaling or contraindications.</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>3 months.</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><a href="./references#CD012551-bbs2-0005" title="GalloL . Effectiveness of diet, sexual habits and lifestyle modifications on treatment of chronic pelvic pain syndrome. Prostate Cancer and Prostatic Diseases2014;17(3):238‐45. "><b>Gallo 2014</b> </a> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Individually discussed risk factors detected at history by the completed questionnaire, informed that such risk factors were potential causes of their disease symptoms and it was strongly recommended to avoid them, distributed a vademecum with 13 rules relating to diet, sexual habits and lifestyle. </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>No information regarding dose‐scaling or contraindications.</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>3 months.</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Followed same diet, sexual behaviours and lifestyle as those of the previous months.</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>No information regarding dose‐scaling or contraindications.</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>3 months.</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><a href="./references#CD012551-bbs2-0011" title="KesslerTM , MordasiniL , WeisstannerC , JuniP , daCostaBR , WiestR , et al. Sono‐electro‐magnetic therapy for treating chronic pelvic pain syndrome in men: a randomized, placebo‐controlled, double‐blind trial. PloS One2014;9(12):e113368. WeisstannerC , MordasiniL , ThalmannGN , VermaRK , RummelC , FederspielA , et al. Therapy‐related longitudinal brain perfusion changes in patients with chronic pelvic pain syndrome. Swiss Medical Weekly2017;147:w14454. "><b>Kessler 2014</b> </a> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Sono‐electromagnetic therapy at home using Sonodyn Device: intensity 100 mW/cm<sup>2</sup> with ultrasonic power of 12 mW and frequency 1.9 MHz, electric field force 0.3 V/m and magnetic field force 0.4 A/m; for 10 min, twice daily. </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Participants could not see settings or perceive the device. No information regarding dose‐scaling or contraindications. </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>12 weeks.</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Similar placebo device. Participants applied same procedure, but device was not active during session. </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Participants could not see settings or perceive device. No information regarding dose‐scaling or contraindications. </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>12 weeks.</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><a href="./references#CD012551-bbs2-0009" title="KaikaiC , RuiW , YongC , ZhuC , WeiH , SuogangW , et al. Combination therapy of non‐intrusive ultrasound with integrated Chinese‐western medicine for chronic prostatitis/chronic pelvic pain syndrome. Chinese Journal of Andrology2014;28(12):41‐4. "><b>Kaikai 2014</b> </a> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Non‐intrusive ultrasound. Output frequency 1.79 MHz; output power: 3.15 W/cm<sup>2</sup>. Duration: 20 min, administered every 3 days (total of 7 times) </p> <p>+ integrated Chinese‐Western medications.</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>No information regarding dose‐scaling or contraindications.</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>‐</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Integrated Chinese‐Western medications alone; QianLieShuTong Capsule, orally 3 times daily, 3 capsules each time, tamsulosin delayed‐release capsule, 0.2 mg, orally 4 times daily. </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>No information regarding dose‐scaling or contraindications.</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>1 month.</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><a href="./references#CD012551-bbs2-0030" title="MoayedniaA , HaghdaniS , KhosrawiS , YousefiE , VahdatpourB . Long‐term effect of extracorporeal shock wave therapy on the treatment of chronic pelvic pain syndrome due to non bacterial prostatitis. Journal of Research in Medical Sciences2014;19(4):293‐6. VahdatpourB , AlizadehF , MoayedniaA , EmadiM , KhoramiMH , HaghdaniS . Efficacy of extracorporeal shock wave therapy for the treatment of chronic pelvic pain syndrome: a randomized, controlled trial. ISRN Urology2013;2013:972601. "><b>Vahdatpour 2013</b> </a> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>ESWT (DUOLITH SD1, Storz Medical, Tägerwilen, Switzerland) once weekly for 4 weeks. Each time 3000 impulses, with 0.25 mJ/mm<sup>2</sup> and 3 Hz of frequency were delivered, although 0.5 mJ/mm<sup>2</sup> was added in each week (0.3 mJ/mm<sup>2</sup> in week 2, 0.35 mJ/mm<sup>2</sup> in week 3 and 0.4 mJ/mm<sup>2</sup> in week 4). After each 500 pulses, probe position was corrected, using transperineal ultrasound. </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>No information regarding dose‐scaling or contraindications.</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>4 weeks.</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>In sham group, same protocol applied but with probe being turned off.</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>No information regarding dose‐scaling or contraindications.</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>4 weeks.</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><a href="./references#CD012551-bbs2-0004" title="BadilloSA , NevilleCE , KotarinosR , FortmanC , FraserL , CosbyA , et al. Randomized multicenter pilot trial shows benefit of manual physical therapies in treatment of urologic chronic pelvic pain. Journal of Women's Health Physical Therapy2009;33(1):23. FitzGeraldMP , AndersonRU , PottsJ , PayneCK , PetersKM , ClemensJQ , et al. Randomized multicenter feasibility trial of myofascial physical therapy for the treatment of urological chronic pelvic pain syndromes. Journal of Urology2009;182(2):570‐80. FitzgeraldMP , AndersonRU , PottsJ , PayneCK , PetersKM , ClemensJQ , et al. Randomized multicenter feasibility trial of myofascial physical therapy for the treatment of urological chronic pelvic pain syndromes. Journal of Urology2013;189(1 Suppl):S75‐85. "><b>Fitzgerald 2013</b> </a> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>10 × 1‐hour sessions of myofascial physical therapy involved connective tissue manipulation of the abdominal wall, back, buttocks and thighs with connective tissue abnormalities in prone and supine position; double voiding and squatting (as home exercises); transrectal manipulation. </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>No information regarding dose‐scaling.</p> <p>"The presence of painful scars on lower abdominal wall that according to the health care personnel were unlikely to respond to physical therapy" was used as an exclusion criterion. </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>‐</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>10 × 1‐hour sessions of global therapeutic Western massage, including effleurage, petrissage, friction, tapotement, vibration and kneading, in upper and lower limbs, trunk, buttocks, abdomen, head and neck each for prescribed time periods; participants not provided with home exercise programme. </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>No information regarding dose‐scaling or contraindications.</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>‐</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><a href="./references#CD012551-bbs2-0035" title="ZengX , YeZ , YangW , ChenZ , DuG . Extracorporeal shock wave treatment for noninflammatory chronic pelvic pain syndrome: a prospective, randomized, sham‐controlled study. Journal of Urology2009;181(4):122‐3. ZengXY , LiangC , YeZQ . Extracorporeal shock wave treatment for non‐inflammatory chronic pelvic pain syndrome: a prospective, randomized and sham‐controlled study. Chinese Medical Journal2012;125(1):114‐8. "><b>Zeng 2012</b> </a> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>20,000 ESWT (HB‐ESWT‐01, Haibin Medical Equipment Co. Ltd., China) impulses in 10 sessions, applied directly to perineal area in which pain was localised (from anus to scrotum); starting energy density was 0.06 mJ/mm<sup>2</sup> and frequency of 2 Hz was used for all treatments. </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Energy density gradually increased until it reached the maximum possible tolerable pain level reported by participant (recorded and used in all subsequent sessions). </p> <p>No information regarding contraindications.</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>2 weeks.</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Sham ESWT, which was conducted by setting the energy level to 0 (no shockwave energy transmission), under conditions identical to active treatment group. </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>No information regarding dose‐scaling or contraindications.</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>2 weeks.</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="2" valign="top"> <p><a href="./references#CD012551-bbs2-0006" title="GaoM , DingH , ZhongG , LuJ , WangH , LiQ , et al. The effects of transrectal radiofrequency hyperthermia on patients with chronic prostatitis and the changes of MDA, NO, SOD, and Zn levels in pretreatment and posttreatment. Urology2012;79(2):391‐6. "><b>Gao 2012</b> </a> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>60‐min treatment with TRFH (ZRL‐II‐A cavity intervention treatment instrument provided by Shanghai Songhang Industry, Co. Ltd. (Shanghai, China), temperature 40‐43 °C) every day. </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="2" valign="top"> <p>No information regarding dose‐scaling or contraindications.</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="2" valign="top"> <p>5 days.</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="2" valign="top"> <p>Tamsulosin 0.2 mg once daily + clarithromycin 0.25 g bid.</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="2" valign="top"> <p>No information regarding dose‐scaling or contraindications.</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="2" valign="top"> <p>6 weeks.</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>TRFH + tamsulosin + clarithromycin (6 weeks).</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="3" valign="top"> <p><a href="./references#CD012551-bbs2-0033" title="YangZS , ZuXB , QiL , SongLM , LiuTR . Combination therapy of biofeedback with electrical stimulation for chronic prostatitis/chronic pelvic pain syndrome. Zhonghua Nan Ke Xue2011;17(7):611‐4. "><b>Yang 2011</b> </a> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Biofeedback group, participant displayed the electromyography of pelvic floor muscle and was instructed to contract and relax the anus according to instructions on display (20‐min sessions, 5 times weekly for 2 weeks). </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="3" valign="top"> <p>No information regarding dose‐scaling or contraindications.</p> <p>All participants received interventions in comparison group.</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="3" valign="top"> <p>2 weeks.</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="3" valign="top"> <p>All participants, including those in the "usual care group" instructed to avoid alcohol and spicy food, sitting too long and holding urine, catching a cold. Advised to be physically active and do exercise, have sex regularly, have warm sitz baths. </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="3" valign="top"> <p>They were instructed to discontinue antibiotics, alpha‐blockers and other medications during the trial. </p> <p>No information regarding dose‐scaling or contraindications.</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="3" valign="top"> <p>‐</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Electrical stimulation group, anal electrodes using intensity of 6˜23 mA, for 10˜20 s and relaxation for 10˜20 s, (20‐min sessions; 5 times each week for 2 weeks). </p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Biofeedback + electrical stimulation (factorial design).</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><a href="./references#CD012551-bbs2-0036" title="ZhangDY , PanXC . Chinese medicine union Taijiquan treatment chronicity non‐bacterial prostatitis curative effect observation. Chinese Manipulation &amp; Rehabilitation Medicine2011;15(2):181. "><b>Zhang 2011a</b> </a> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Taijiquan (Tai Chi) exercises for 20‐40 min every day. All participants received herbal therapy (no further specifications available) for 1 month after. </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>No information regarding dose‐scaling or contraindications.</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>1 month.</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>All participants received herbal therapy (no further specifications available) for 1 month after. </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>No information regarding dose‐scaling or contraindications.</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>1 month.</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><a href="./references#CD012551-bbs2-0026" title="Samhan AhmedF , Abd‐Elhalim NermeenM , Elnegmy EmamH , Roiah MohamedM . The effect of transcutaneous electrical nerve stimulation in the treatment of chronic pelvic pain syndrome: an evidence based electromyographic studies. Indian Journal of Physiotherapy &amp; Occupational Therapy2011;5(3):14‐7. "><b>Samhan 2011</b> </a> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>TENS daily for mean of 20 min in painful area, mean frequency 100 Hz, pulse width 100 μs and intensity 25 mA daily, 5 times weekly. </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>No information regarding dose‐scaling or contraindications.</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>1 month.</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Same as active treatment group but with machine turned off.</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>No information regarding dose‐scaling or contraindications.</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>1 month.</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><a href="./references#CD012551-bbs2-0014" title="LeeSH , LeeBC . Electroacupuncture relieves pain in men with chronic prostatitis/chronic pelvic pain syndrome: three‐arm randomized trial. Urology2009;73(5):1036‐41. "><b>Lee 2009</b> </a> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Advice of hot sitz baths and exercise and 12 × 20‐min sessions of electroacupuncture in 6 weeks: 6 acupoints at bilateral: </p> <p>BL32 zhongliao<br/> BL33 ciliao<br/> GB30 huantiao; preparation alcohol pads and disposable stainless steel needles (40 0.25 mm, Dongbang Acupuncture, Chungnam, Republic of Korea); at GB30, disposable stainless steel needles (70 0.30 mm, Dongbang Acupuncture) were inserted deeply to reach the myofascial trigger point of piriformis muscle. </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>No information regarding dose‐scaling or contraindications.</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>6 weeks.</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Advice and exercise and 12 sessions of sham electroacupuncture, which included the same number and type of needle, duration and frequency of sessions as for the advice and exercise treatment, but treatment was delivered superficially at non‐acupoints 15 mm to the lateral of each corresponding acupoint; points were not stimulated electrically, but sound of pulse generator was heard by the participants. </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>No information regarding dose‐scaling or contraindications.</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>6 weeks.</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="2" valign="top"> <p><a href="./references#CD012551-bbs2-0002" title="ChenZX . Observation on therapeutic effect of warm needle moxibustion on chronic non‐bacterial prostatitis. Zhongguo Zhen Jiu [Chinese Acupuncture &amp; Moxibustion]2009;29(4):275‐8. "><b>Chen 2009</b> </a> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Acupuncture + warm needle moxibustion.</p> <p>Acupuncture at acupoints:</p> <p>BI18 GanYu<br/> BI23 ShenYu<br/> BI54 ZhiBian<br/> BI26 GuanYuan<br/> Ren3 ZhongJi<br/> SP9 YinLingQuan<br/> SP6 SanYinJiao </p> <p>For 5 s each; needles were removed afterwards; once daily for 1 month.</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="2" valign="top"> <p>For those treated with moxibustion:</p> <p>needles were left afterwards and the tails of which were then covered with 2 cm moxa sticks. Moxa sticks were then ignited. Repeated moxibustion twice more for each acupoint. </p> <p>No information regarding dose‐scaling or contraindications.</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="2" valign="top"> <p>1 month.</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="2" valign="top"> <p>Prostat tablet orally twice daily: pollen extract.</p> <p>Course of treatment; 1 month.</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="2" valign="top"> <p>No information regarding dose‐scaling or contraindications.</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="2" valign="top"> <p>1 month.</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Acupuncture procedures same as acupuncture + warm needle moxibustion. Moxibustion not performed. Treated once daily. Course of treatment: 1 month. </p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><a href="./references#CD012551-bbs2-0038" title="ZimmermannR , CumpanasA , MicleaF , JanetschekG . Extracorporeal shock wave therapy for the treatment of chronic pelvic pain syndrome in males: a randomised, double‐blind, placebo‐controlled study. European Urology2009;56(3):418‐24. ZimmermannRP , CumpanasA , MicleaF , JanetschekG . One year follow up of extracorporeal shock wave therapy (ESWT) for chronic pelvic pain syndrome (CPPS) in a randomised placebo‐controlled double‐blind study. European Urology (Suppl)2010;9(2):214. "><b>Zimmermann 2009</b> </a> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Perineally applied ESWT weekly (3000 pulses each; maximum total energy flow density: 0.25 mJ/mm<sup>2</sup>; frequency: 3 Hz); position of transducer was changed after every 500 pulses to scan prostatic and pelvic floor region (Duolith SD1, Storz Medical, Tägerwilen, Switzerland); penetration depth 35‐65 mm. </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>No information regarding dose‐scaling or contraindications.</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>4 weeks.</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Placebo treatment performed with same therapy head, which was also fitted with a placebo stand‐off. Stand‐off contained shock wave‐absorbing material, layer of air and air‐filled microspheres. </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>No information regarding dose‐scaling or contraindications.</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>4 weeks.</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><a href="./references#CD012551-bbs2-0016" title="MarxS . ICAOR 2006: does osteopathic treatment have an influence on the symptoms of patients with chronic prostatitis/chronic pelvic pain syndrome (CPPS)? A randomized controlled trial. International Journal of Osteopathic Medicine2006;9(1):44. MarxS , CimniakU , BeckertR , SchwerlaF , ReschKL . Chronic prostatitis/chronic pelvic pain syndrome. Influence of osteopathic treatment ‐ a randomized controlled study [Chronische Prostatitis/chronisches Beckenschmerzsyndrom. Einfluss osteopathischer Behandlungen ‐ eine randomisiert kontrollierte Studie]. Der Urologe. Ausg. A2009;48(11):1339‐45. "><b>Marx 2009</b> </a> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Osteopathic theory of structural dysfunction using direct and indirect techniques of manipulation; including rectal manipulation of the prostate and coccyx; 45‐min sessions for 5 weeks. </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>No information regarding dose‐scaling or contraindications.</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>5 weeks.</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Sham exercise program including a warm‐up, stretching, limb, breathing and pelvic floor muscle exercises; 30 min sessions in 5 weeks. </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>No information regarding dose‐scaling or contraindications.</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>5 weeks.</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><a href="./references#CD012551-bbs2-0021" title="OhMM , JinMH , MoonDG , NamSG , BaeJH , ParkHS . A prospective, randomized, placebo controlled study of radiofrequency therapy for the treatment of chronic prostatitis/chronic pelvic pain syndrome. Journal of Urology2009;181(4):122. "><b>Oh 2009</b> </a> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>'Radiofrequency.'</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>(abstract only)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>‐</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>"Placebo therapy."</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>(abstract only)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>‐</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><a href="./references#CD012551-bbs2-0008" title="KabayS , KabaySC , YucelM , OzdenH . Efficiency of posterior tibial nerve stimulation in category IIIB chronic prostatitis/chronic pelvic pain: a Sham‐Controlled Comparative Study. Urologia Internationalis2009;83(1):33‐8. "><b>Kabay 2009</b> </a> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>PTNS applied unilaterally with 26‐gauge stainless steel needles inserted 5 cm cephalad from medial malleolus and posterior to edge of tibia with a ground neutral electrode placed on same leg near arch of foot; both connected to a stimulator at 200 µs with pulse rate 20 Hz (Medtronic Key Point Net, Medtronic), for 30 min. </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>No information regarding dose‐scaling or contraindications.</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>12 weeks.</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Same electrode procedure for PTNS; however, stimulator not connected.</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>No information regarding dose‐scaling or contraindications.</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>12 weeks.</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><a href="./references#CD012551-bbs2-0034" title="ChungH , ChoiH , YooTK , ChoJM , KimHS . The effects of microwave thermotherapy for chronic prostatitis/chronic pelvic pain syndrome: a prospective, randomized study. Urogenital Tract Infection2017;12(1):35‐41. KimH , ChungH , YangS , YooT , ChoJ . Effects of thermotherapy and medical therapy for chronic prostatitis/chronic pelvic pain syndrome: a prospective study. Urology2011;78(3):S85‐6. YooTK , MoonKT , LeeSW , KimHS , ChungH , KimJY . Effect of the combination treatment of URO‐DrG and medical therapy for chronic prostatitis/chronic pelvic pain syndrome: a prospective study. Journal of Urology2009;181(4):122. "><b>Yoo 2009</b> </a> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>TRMT alone for 12 weeks; using a Uro‐DR Device (Somang Medical; Kangreung, Korea), at intrarectal temperature of 43 °C for 30 min, at a medium heating rate. </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>No information regarding dose‐scaling or contraindications.</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>12 weeks.</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Medical therapy: ciprofloxacin 500 mg bid and NSAIDs</p> <p>C: TRMT + medical therapy.</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>No information regarding dose‐scaling or contraindications.</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>12 weeks.</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><a href="./references#CD012551-bbs2-0013" title="LeeSW , LiongML , YuenKH , KriegerJN . Acupuncture and immune function in chronic prostatitis/chronic pelvic pain syndrome: a randomized, controlled study. Complementary Therapies in Medicine2014;22(6):965‐9. LeeSW , LiongML , YuenKH , LeongWS , CheeC , CheahPY , et al. Acupuncture versus sham acupuncture for chronic prostatitis/chronic pelvic pain. American Journal of Medicine2008;121(1):79.e1‐7. LeeSW , LiongML , YuenKH , LeongWS , KhanNK , KriegerJN . Validation of a sham acupuncture procedure in a randomised, controlled clinical trial of chronic pelvic pain treatment. Acupuncture in Medicine2011;29(1):40‐6. "><b>Lee 2008</b> </a> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>4 acupoints prepared, then sterile, disposable stainless steel needles (Suzhou Huan‐Qiu Acupuncture Medical Supplies, Suzhou, China) placed perpendicularly in 30‐min sessions twice weekly in acupoints: </p> <p>CV1 Guan Yuan<br/> CV4 Huiyin<br/> SP6 Sanyinjiao<br/> SP9 Yinlingquan. </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>No information regarding dose‐scaling or contraindications.</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>10 weeks.</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Sham acupuncture included same number, duration and frequency of sessions as acupuncture group at non‐acupoints (15 mm to left). </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>No information regarding dose‐scaling or contraindications.</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>10 weeks.</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><a href="./references#CD012551-bbs2-0029" title="SikiruL , ShmailaH , MuhammedSA . Transcutaneous electrical nerve stimulation (TENS) in the symptomatic management of chronic prostatitis/chronic pelvic pain syndrome: a placebo‐control randomized trial. International Brazilian Journal of Urology2008;34(6):708‐13; discussion 714. "><b>Sikiru 2008</b> </a> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Antibiotics plus TENS; with high TENS over painful area, daily for mean of 20 min, mean frequency 100 Hz, pulse width 100 μs and intensity 25 mA, 5 times weekly. </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Contraindications: loss of skin sensation at and around painful area, cardiac pace maker, previous exposure to TENS and other electroanalgesia. </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>4 weeks.</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Ofloxacin 300 mg 3 times daily + placebo tablets.</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>No information regarding dose‐scaling or contraindication.</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>4 weeks.</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><a href="./references#CD012551-bbs2-0007" title="GiubileiG , MondainiN , MinerviniA , SaievaC , LapiniA , SerniS , et al. Physical activity of men with chronic prostatitis/chronic pelvic pain syndrome not satisfied with conventional treatments ‐ could it represent a valid option? The physical activity and male pelvic pain trial: a double‐blind, randomized study. Journal of Urology2007;177(1):159‐65. "><b>Giubilei 2007</b> </a> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Aerobic exercise group, which included an 18‐week walking programme, 3 times weekly; with a warm up and cool‐down regimen, postural muscle and isometric strengthening exercises, 40 min of fast‐paced walking on 'in‐outdoor' track (achieving 70/80% of predicted maximum heart rate for their age). </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Participants with a 'lack of interest,' 'lack of time' and 'lack of confidence' to engage physical activity excluded from study. </p> <p>No information regarding dose‐scaling.</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>18 weeks.</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Placebo/flexibility and motion exercise programme; with same period and with same frequency of aerobic exercise group, maintaining their heart rate under 100 beats per min. </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Participants with a 'lack of interest,' 'lack of time' and 'lack of confidence' to engage physical activity were excluded from the study. </p> <p>No information regarding dose‐scaling.</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>18 weeks.</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><a href="./references#CD012551-bbs2-0022" title="PaickJS , LeeSC , KuJH . More effects of extracorporeal magnetic innervation and terazosin therapy than terazosin therapy alone for non‐inflammatory chronic pelvic pain syndrome: a pilot study. Prostate Cancer and Prostatic Diseases2006;9(3):261‐5. "><b>Paick 2006</b> </a> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Extracorporeal magnetic innervation using Neoconrol system (Neotonus Inc., Marietta, GA, USA) that generates a magnetic field directed in the seat of chair and concentrated in region of pelvic muscles; 2 sessions weekly lasting 20 min each. </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>1st 10 min used 10 Hz field, 2 min rest and then 10 min of 50 Hz field.</p> <p>No information regarding contraindications.</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>6 weeks.</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Medical therapy with terazosin 4 mg daily.</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>They started 2 mg daily for 1st 7 days, and continued to receive 4 mg daily for the following 5 weeks. </p> <p>No information regarding contraindications.</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>6 weeks.</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><a href="./references#CD012551-bbs2-0001" title="AteyaA , FayezA , HaniR , ZohdyW , GabbarMA , ShamloulR . Evaluation of prostatic massage in treatment of chronic prostatitis. Urology2006;67(4):674‐8. "><b>Ateya 2006</b> </a> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Participants received antibiotics empirically and prostatic massage (3 times weekly for 4 weeks). Prostate massaged from above and lateral to gland, 6 times on each side, by gentle and firm pressure of finger directed downwards and inwards, followed by a few strokes in middle from above downwards. </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>No information regarding dose‐scaling or contraindications.</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>‐</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Empirical antibiotic therapy alone without prostatic massage.</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>'In the 44 participants with negative cultures, antibiotic selection included quinolones (28 participants), clindamycin/metronidazole (11 participants), ampicillin/<br/> clavulanic acid (2 participants), and azithromycin (1 participant). All participants continued the 1 month of<br/> treatment.' </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>‐</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><a href="./references#CD012551-bbs2-0028" title="ShenSL , HeDL , LuoY . Clinical trials of combined therapy of an oral Chinese medicine with massage for chronic nonbacterial prostatitis. Zhonghua Nan Ke Xue2006;12(9):851‐3. "><b>Shen 2006</b> </a> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Medical therapy with modified BiXieFenQing Drink in morning and evening, 200 mL each + prostate massage once weekly. </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>No information regarding dose‐scaling or contraindications.</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>‐</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Medical therapy alone.</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>No information regarding dose‐scaling or contraindications.</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>‐</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><a href="./references#CD012551-bbs2-0024" title="RoweE , SmithC , LaverickL , ElkabirJ , WitherowRO , PatelA . A prospective, randomized, placebo controlled, double‐blind study of pelvic electromagnetic therapy for the treatment of chronic pelvic pain syndrome with 1 year of followup. Journal of Urology2005;173(6):2044‐7. "><b>Rowe 2005</b> </a> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Participant seated in a Neotonus Electromagnetic Chair (Neotonus Inc., Marietta, GA, USA), for 2 consecutive 15‐min periods; 2 sessions weekly. </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>1st period 10 Hz, 2nd period 50 Hz.</p> <p>No information regarding contraindications.</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>4 weeks.</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Participants seated in chair, ventilation mechanism activated, but no active stimulation applied. </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>No information regarding dose‐scaling or contraindications.</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>4 weeks.</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><a href="./references#CD012551-bbs2-0003" title="FangJ , XuG , DingQ , ZhangY‐F . Observation on the safety and efficacy of He‐Ne laser equipment on chronic abacteria prostatitis. Fudan University Journal of Medical Sciences2005;32(2):234‐5, 252. "><b>Fang 2005</b> </a> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>He‐Ne laser directed to prostate. Optic fibre was inserted from urethra and located at prostatic urethra; 10 mW output at 18 J each time. </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>1 course of treatment: 10 doses of radiation (2 sessions weekly).</p> <p>Participants discontinued all other treatments, except for some of the participants, short‐term sulfa‐drugs were administered temporarily to prevent infection. </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>‐</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>'Routine care' for prostatitis including antibiotics, pollen extract, Chinese medicine, physical therapy and lifestyle interventions. </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Sulfamethoxazole tablets, 2 tablets, orally bid, 60 days of fluoroquinolones such as levofloxacin 0.2 g, bid, 14 days of pollen drugs such as Prostat; Chinese patent drugs such as salvianolic acid B and saponins of panax notoginseng mixture (SalB/PNS); hot water bath and advise on lifestyle. </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>‐</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><a href="./references#CD012551-bbs2-0010" title="KastnerC , HochreiterW , HuidobroC , CabezasJ , MillerP . Cooled transurethral microwave thermotherapy for intractable chronic prostatitis ‐ results of a pilot study after 1 year. Urology2004;64(6):1149‐54. "><b>Kastner 2004</b> </a> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Transurethral microwave thermotherapy through catheter connected to a Targis System estimated peak intraprostatic temperatures of 55 °C. </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>No information regarding dose‐scaling or contraindications.</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>‐</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Transurethral microwave thermotherapy through catheter connected to a Targis System estimated peak intraprostatic temperatures of 70 °C. </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>No information regarding dose‐scaling or contraindications.</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>‐</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><a href="./references#CD012551-bbs2-0032" title="WangJ , LiJ , LuR , WangJM . Treatment of external RF hyperthermia combining with alpha 1‐adrenergic receptor blocker for patients with prostatodynia and chronic non‐bacterial prostatitis. Zhonghua Nan Ke Xue2002;8(1):48‐50. "><b>Wang 2002</b> </a> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>External radiofrequency hyperthermia.</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Applied externally: 2 electrodes placed at hip and lower abdomen, 5˜7 cm away from skin, with pubic symphysis as centre (42.5˜43.5 °C), 1˜2 hours each time, course of treatment: 2˜3 times, interval: 1˜2 weeks. </p> <p>No information regarding dose‐scaling or contraindications.</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>1˜2 weeks.</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Same external radiofrequency hyperthermia + terazosin 2 mg.</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Daily for 2 days and then dose was increased to 2 mg bid for 12 weeks.</p> <p>No information regarding contraindications for terazosin.</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>12 weeks.</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><a href="./references#CD012551-bbs2-0015" title="LeskinenMJ , KilponenA , LukkarinenO , TammelaTL . Transurethral needle ablation for the treatment of chronic pelvic pain syndrome (category III prostatitis): a randomized, sham‐controlled study. Urology2002;60(2):300‐4. "><b>Leskinen 2002</b> </a> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>TUNA using 465‐kHz radiofrequency energy and formal needle insertion technique as described by <a href="./references#CD012551-bbs2-0153" title="Issa MutaM . Transurethral Needle Ablation of the Prostate: Report of Initial United States Clinical Trial. The Journal of Urology1996;156(2):413‐9. [DOI: 10.1016/S0022‐5347(01)65863‐4] ">Issa 1996</a>; treatment applied on 2 planes on both lateral lobes of prostate in all participants so target temperature of 50 °C at needle tip was achieved for ≥ 1 min; under spinal analgesia and antibiotic prophylaxis. </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>No information regarding dose‐scaling or contraindications.</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>‐</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>3 sham urethroscopy performed so it was seemingly identical to TUNA in participant's opinion; under spinal analgesia and antibiotic prophylaxis. </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>No information regarding dose‐scaling or contraindications.</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>‐</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><a href="./references#CD012551-bbs2-0031" title="VassilyO , AndreyS , EvgeniiD , OtabekI , BorisL , SergeyR . Efficacy of transrectal microwave hyperthemia (TRMH) in the treatment of chronic prostatitis. A randomized sham controlled comparative study (Abstract). Journal of Urology1999;161(4 Suppl):33A. "><b>Vassily 1999</b> </a> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>TRMT, 6 sessions over 2 weeks each.</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>No information regarding dose‐scaling or contraindications.</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>‐</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Sham procedure.</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>No information regarding dose‐scaling or contraindications.</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>‐</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><a href="./references#CD012551-bbs2-0020" title="NickelJC , SorensenR . Transurethral microwave thermotherapy for nonbacterial prostatitis: a randomized double‐blind sham controlled study using new prostatitis specific assessment questionnaires. Journal of Urology1996;155(6):1950‐4; discussion 1954. "><b>Nickel 1996</b> </a> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Transurethral microwave thermotherapy consisted of 1 × 1‐hour treatment with computer‐driven device that elevated prostate interstitial temperatures to 45‐60 °C, a range that does not cause significant necrosis of normal prostatic tissue. </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>No information regarding dose‐scaling or contraindications.</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Single session.</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Sham therapy consisted of 1 × 1‐hour session with same device using sham software.</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>No information regarding dose‐scaling or contraindications.</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Single session.</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><a href="./references#CD012551-bbs2-0018" title="MuraroGB . Clinical study on the efficacy and safety of seaprose S combined with local prostatic hyperthermia in chronic non‐bacterial prostatitis. Controlled study versus local prostatic hyperthermia [Studio clinico sull'efficacia e la tollerabilita del seaprose S associato a ipertermia locale prostatica nella prostatite cronica abatterica. Studio controllato verso ipertermia locale prostatica]. Archivio di Medicina Interna1995;47(2‐3):73‐86. "><b>Muraro 1995</b> </a> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Seaprose S (Flaminase, Formenti) 30 mg 3 times daily in combination with local hyperthermia, total of 7 sessions on alternate days of 60‐min duration, reaching local temperature of 42.5‐43.5 °C. </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>No information regarding dose‐scaling.</p> <p>Contraindication to those with hypersensitivity to the drug.</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>‐</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>7 sessions of local hyperthermia alone.</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>No information regarding dose‐scaling or contraindications.</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>‐</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><a href="./references#CD012551-bbs2-0017" title="MontorsiF , GuazzoniG , BergamaschiF , GalliL , ConsonniP , MatozzoV , et al. Is there a role for transrectal microwave hyperthermia of the prostate in the treatment of abacterial prostatitis and prostatodynia?. Prostate1993;22(2):139‐46. "><b>Montorsi 1993</b> </a> </p> </td> <td align="" bgcolor="#ffffff" colspan="6" rowspan="1" valign="top"> <p>I1: 1 session of transrectal hyperthermia weekly for 4 weeks.</p> <p>I2: 1 session of transrectal hyperthermia weekly for 6 weeks.</p> <p>I3: 2 sessions of transrectal hyperthermia weekly for 3 weeks.</p> <p>Prostathermer 99D system (Biodan Ltd, Rehovot, Israel), target temperature reached within 1st 10 min of treatment, microwaves at 915 MHz, thermosensors for monitoring rectal temperature, cooling system for anterior rectal wall, thermosensors for urethra temperatures, outpatient basis, required local anaesthesia, with 2% xylocaine jelly before insertion of the catheter. </p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><a href="./references#CD012551-bbs2-0027" title="ShahT , WatsonG , BarnesD . Microwave hyperthermia in the treatment of chronic abacterial prostatitis and prostatodynia: results of a double blind placebo controlled trial (Abstract). Journal of Urology1993;149:405A. "><b>Shah 1993</b> </a> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>TRMT, 4 × 1‐hour treatment over 2 or 3 weeks. Temperature raised to 43.8 °C with input of 40 W. </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>No information regarding dose‐scaling or contraindications.</p> <p>(abstract only)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>2˜3 weeks</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Sham group with temperature &lt; 37 °C.</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>No information regarding dose‐scaling or contraindications.</p> <p>(abstract only)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>‐</p> </td> </tr> </tbody> </table> <div class="table-footnote"> <p>‐ denotes not reported.</p> <p>bid: twice daily; C: comparator; ESWT: extracorporeal shockwave therapy; I: intervention; min: minute; NSAID: non‐steroidal anti‐inflammatory drug; PTNS: posterior tibial nerve stimulation; s: second; TENS: transcutaneous electrical nerve stimulation; TRFH: transrectal radiofrequency hyperthermia; TRMT: transrectal microwave thermotherapy; TUNA: transurethral needle ablation. </p> </div> </div> <div class="table" id="CD012551-tbl-0012"> <table><a class="open-table-viewer open-in-figure-viewer" href="#0">Open in table viewer</a><div class="table-heading"><span class="table-label">Table 2.</span> <span class="table-title">Study and participant characteristics</span></div> <tbody> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><b>Study ID</b> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><b>Intervention(s) and comparator(s)</b> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><b>Randomised (n)</b> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><b>Analysed (n)</b> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><b>Duration of intervention and follow‐up</b> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><b>Description of participants<sup>a</sup> </b> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><b>Baseline NIH‐CPSI<sup>b</sup> score</b> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><b>Trial period (year to year)</b> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><b>Country</b> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><b>Setting</b> </p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="2" valign="top"> <p><a href="./references#CD012551-bbs2-0019" title="NeimarkAI , MaksimovaSS . Effect of hypercapnic hypoxia on chronic abacterial prostatitis. Urologiia (Moscow, Russia : 1999)2016;1(3):80‐4. [PUBMED: 28247635] "><b>Neimark 2016</b> </a> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>I: hypercapnic hypoxia + medical therapy</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>17</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>17</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="2" valign="top"> <p>D: 10 days</p> <p>F: 10 days</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="2" valign="top"> <p>Age: mean 37</p> <p>No specified previous treatment</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="2" valign="top"> <p>N/A</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="2" valign="top"> <p>N/A</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="2" valign="top"> <p>Russia</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="2" valign="top"> <p>Outpatient</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>C: medical therapy</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>20</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>20</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="2" valign="top"> <p><a href="./references#CD012551-bbs2-0023" title="PajovicB , RadojevicN , DimitrovskiA , VukovicM . Comparison of the efficiency of combined extracorporeal shock‐wave therapy and triple therapy versus triple therapy itself in Category III B chronic pelvic pain syndrome (CPPS). Aging Male2016;19(3):1‐6. "><b>Pajovic 2016</b> </a> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>I: extracorporeal shockwave therapy + medical care</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>30</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>30</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="2" valign="top"> <p>D: 12 weeks</p> <p>F: 24 weeks</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="2" valign="top"> <p>Age: mean 39.4</p> <p>No specified previous treatment</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>29.3</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="2" valign="top"> <p>2013‐2015</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="2" valign="top"> <p>Montenegro</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="2" valign="top"> <p>Outpatient</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>C: medical care</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>30</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>30</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>31.06</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="2" valign="top"> <p><a href="./references#CD012551-bbs2-0012" title="KucukEV , SucekenFY , BindayiA , BoyluU , OnolFF , GumusE . Effectiveness of acupuncture on chronic prostatitis‐chronic pelvic pain syndrome category IIIB patients: a prospective, randomized, nonblinded, clinical trial. Urology2015;85(3):636‐40. "><b>Kucuk 2015</b> </a> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>I: acupuncture</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>28</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>28</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="2" valign="top"> <p>D: 7 weeks</p> <p>F: 10 weeks</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="2" valign="top"> <p>Age: mean 33</p> <p>No previous treatment</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>20.36</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="2" valign="top"> <p>2008‐2009</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="2" valign="top"> <p>Turkey</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="2" valign="top"> <p>Outpatient</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>C: medical care</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>26</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>26</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>22.92</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="2" valign="top"> <p><a href="./references#CD012551-bbs2-0025" title="SahinS , BicerM , ErenGA , TasS , TugcuV , TasciAI , et al. Acupuncture relieves symptoms in chronic prostatitis/chronic pelvic pain syndrome: a randomized, sham‐controlled trial. Prostate Cancer and Prostatic Diseases2015;18(3):249‐54. "><b>Sahin 2015</b> </a> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>I: acupuncture</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>50</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>45</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="2" valign="top"> <p>D: 6 weeks</p> <p>F: 24 weeks</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="2" valign="top"> <p>Age: 20‐50</p> <p>All had received medical therapy</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>26.5</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="2" valign="top"> <p>Not available</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="2" valign="top"> <p>Turkey</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="2" valign="top"> <p>Outpatient</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>C: sham acupuncture</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>50</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>46</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>27.0</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="2" valign="top"> <p><a href="./references#CD012551-bbs2-0037" title="ZhaoY , ZhaoW , LangG , ChenY , LiuJ , WangG , et al. Circumcision plus antibiotic, anti‐inflammatory, and alpha‐blocker therapy for the treatment for chronic prostatitis/chronic pelvic pain syndrome: a prospective, randomized, multicenter trial. World Journal of Urology2015;33(5):617‐22. "><b>Zhao 2015</b> </a> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>I: early circumcision</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>384</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>358</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="2" valign="top"> <p>D: 3 months</p> <p>F: 3 months</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="2" valign="top"> <p>Age: mean 33</p> <p>No specified previous treatment</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>21</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="2" valign="top"> <p>2013‐2014</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="2" valign="top"> <p>China</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="2" valign="top"> <p>Outpatient</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>C: delayed circumcision</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>390</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>355</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>21</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="2" valign="top"> <p><a href="./references#CD012551-bbs2-0005" title="GalloL . Effectiveness of diet, sexual habits and lifestyle modifications on treatment of chronic pelvic pain syndrome. Prostate Cancer and Prostatic Diseases2014;17(3):238‐45. "><b>Gallo 2014</b> </a> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>I: lifestyle interventions</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>50</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>39</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="2" valign="top"> <p>D: 3 months</p> <p>F: 3 months</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="2" valign="top"> <p>Age: mean 33‐34</p> <p>No specified previous treatment</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>22.1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="2" valign="top"> <p>2012‐2013</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="2" valign="top"> <p>Italy</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="2" valign="top"> <p>Outpatient</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>C: no intervention</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>50</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>50</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>21.9</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="2" valign="top"> <p><a href="./references#CD012551-bbs2-0011" title="KesslerTM , MordasiniL , WeisstannerC , JuniP , daCostaBR , WiestR , et al. Sono‐electro‐magnetic therapy for treating chronic pelvic pain syndrome in men: a randomized, placebo‐controlled, double‐blind trial. PloS One2014;9(12):e113368. WeisstannerC , MordasiniL , ThalmannGN , VermaRK , RummelC , FederspielA , et al. Therapy‐related longitudinal brain perfusion changes in patients with chronic pelvic pain syndrome. Swiss Medical Weekly2017;147:w14454. "><b>Kessler 2014</b> </a> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>I: sono‐electromagnetic therapy</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>30</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>30</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="2" valign="top"> <p>D: 12 weeks</p> <p>F: 16 weeks</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="2" valign="top"> <p>Age: mean 44‐49</p> <p>All had received medical therapy</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>25.1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="2" valign="top"> <p>2009‐2012</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="2" valign="top"> <p>Switzerland</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="2" valign="top"> <p>Outpatient</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>C: placebo device</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>30</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>30</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>25.2</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="3" valign="top"> <p><a href="./references#CD012551-bbs2-0009" title="KaikaiC , RuiW , YongC , ZhuC , WeiH , SuogangW , et al. Combination therapy of non‐intrusive ultrasound with integrated Chinese‐western medicine for chronic prostatitis/chronic pelvic pain syndrome. Chinese Journal of Andrology2014;28(12):41‐4. "><b>Kaikai 2014</b> </a> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>I: ultrasound</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>35</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>35</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="3" valign="top"> <p>D: 1 month</p> <p>F: 1 month</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="3" valign="top"> <p>Age 18‐55</p> <p>All had received medical therapy</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>25.9</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="3" valign="top"> <p>2013‐2014</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="3" valign="top"> <p>China</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="3" valign="top"> <p>Outpatient</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>C1: medical therapy</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>35</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>35</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>26.17</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>C2: ultrasound + medical therapy</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>35</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>35</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>26.85</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="2" valign="top"> <p><a href="./references#CD012551-bbs2-0030" title="MoayedniaA , HaghdaniS , KhosrawiS , YousefiE , VahdatpourB . Long‐term effect of extracorporeal shock wave therapy on the treatment of chronic pelvic pain syndrome due to non bacterial prostatitis. Journal of Research in Medical Sciences2014;19(4):293‐6. VahdatpourB , AlizadehF , MoayedniaA , EmadiM , KhoramiMH , HaghdaniS . Efficacy of extracorporeal shock wave therapy for the treatment of chronic pelvic pain syndrome: a randomized, controlled trial. ISRN Urology2013;2013:972601. "><b>Vahdatpour 2013</b> </a> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>I: extracorporeal shockwave</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>20</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="2" valign="top"> <p>N/A</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="2" valign="top"> <p>D: 4 weeks</p> <p>F: 12 weeks</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="2" valign="top"> <p>Age: 35‐37</p> <p>No specified previous treatment</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>26.5</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="2" valign="top"> <p>2011‐2012</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="2" valign="top"> <p>Iran</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="2" valign="top"> <p>Outpatient</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>C: sham procedure</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>20</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>27.1</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="2" valign="top"> <p><a href="./references#CD012551-bbs2-0035" title="ZengX , YeZ , YangW , ChenZ , DuG . Extracorporeal shock wave treatment for noninflammatory chronic pelvic pain syndrome: a prospective, randomized, sham‐controlled study. Journal of Urology2009;181(4):122‐3. ZengXY , LiangC , YeZQ . Extracorporeal shock wave treatment for non‐inflammatory chronic pelvic pain syndrome: a prospective, randomized and sham‐controlled study. Chinese Medical Journal2012;125(1):114‐8. "><b>Zeng 2012</b> </a> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>I: extracorporeal shockwave therapy</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>40</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>38</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="2" valign="top"> <p>D: 2 weeks</p> <p>F: 12 weeks</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="2" valign="top"> <p>Age: mean 46‐49</p> <p>No specified previous treatment</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>30.5</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="2" valign="top"> <p>2009‐2011</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="2" valign="top"> <p>China</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="2" valign="top"> <p>Outpatient</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>C: sham procedure</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>40</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>37</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>29.3</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="3" valign="top"> <p><a href="./references#CD012551-bbs2-0006" title="GaoM , DingH , ZhongG , LuJ , WangH , LiQ , et al. The effects of transrectal radiofrequency hyperthermia on patients with chronic prostatitis and the changes of MDA, NO, SOD, and Zn levels in pretreatment and posttreatment. Urology2012;79(2):391‐6. "><b>Gao 2012</b> </a> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>I: medical therapy</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>30</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>30</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="3" valign="top"> <p>D: 6 weeks</p> <p>F: 6 weeks</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="3" valign="top"> <p>Age: mean 35‐36</p> <p>No specified previous treatment</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>20.9/20.2</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="3" valign="top"> <p>2008‐2009</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="3" valign="top"> <p>China</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="3" valign="top"> <p>Outpatient</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>C1: transrectal hyperthermia</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>32</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>32</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>20/21.1</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>C2: transrectal hyperthermia + medical therapy</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>43</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>43</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>22.4/21.7</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="4" valign="top"> <p><a href="./references#CD012551-bbs2-0033" title="YangZS , ZuXB , QiL , SongLM , LiuTR . Combination therapy of biofeedback with electrical stimulation for chronic prostatitis/chronic pelvic pain syndrome. Zhonghua Nan Ke Xue2011;17(7):611‐4. "><b>Yang 2011</b> </a> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>I1: biofeedback</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>20</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>20</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="4" valign="top"> <p>D: 2 weeks</p> <p>F: 6 weeks</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="4" valign="top"> <p>Age: mean 30</p> <p>All had received medical therapy</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>26.92</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="4" valign="top"> <p>2007</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="4" valign="top"> <p>China</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="4" valign="top"> <p>Outpatient</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>I2: electrical stimulation</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>40</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>40</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>26.35</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>I3: biofeedback + electrical stimulation</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>40</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>40</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>25.30</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>C: usual care</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>40</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>40</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>25.82</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="2" valign="top"> <p><a href="./references#CD012551-bbs2-0036" title="ZhangDY , PanXC . Chinese medicine union Taijiquan treatment chronicity non‐bacterial prostatitis curative effect observation. Chinese Manipulation &amp; Rehabilitation Medicine2011;15(2):181. "><b>Zhang 2011a</b> </a> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>I: TaiJiQuan</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>50</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="2" valign="top"> <p>N/A</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="2" valign="top"> <p>D: 1 month</p> <p>F: 1 month</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="2" valign="top"> <p>Age: 22‐50</p> <p>No specified previous treatment</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="2" valign="top"> <p>N/A</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="2" valign="top"> <p>N/A</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="2" valign="top"> <p>China</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="2" valign="top"> <p>Outpatient</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>C: no intervention</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>46</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="2" valign="top"> <p><a href="./references#CD012551-bbs2-0026" title="Samhan AhmedF , Abd‐Elhalim NermeenM , Elnegmy EmamH , Roiah MohamedM . The effect of transcutaneous electrical nerve stimulation in the treatment of chronic pelvic pain syndrome: an evidence based electromyographic studies. Indian Journal of Physiotherapy &amp; Occupational Therapy2011;5(3):14‐7. "><b>Samhan 2011</b> </a> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>I: TENS</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>20</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>20</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="2" valign="top"> <p>D: 4 weeks</p> <p>F: 4 weeks</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="2" valign="top"> <p>Age: 30 to 55</p> <p>No specified previous treatment</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="2" valign="top"> <p>N/A</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="2" valign="top"> <p>N/A</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="2" valign="top"> <p>Egypt</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="2" valign="top"> <p>Outpatient</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>C: placebo TENS</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>20</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>20</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="3" valign="top"> <p><a href="./references#CD012551-bbs2-0014" title="LeeSH , LeeBC . Electroacupuncture relieves pain in men with chronic prostatitis/chronic pelvic pain syndrome: three‐arm randomized trial. Urology2009;73(5):1036‐41. "><b>Lee 2009</b> </a> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>I1: electroacupuncture</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>12</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>11</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="3" valign="top"> <p>D: 6 weeks</p> <p>F: 6 weeks</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="3" valign="top"> <p>Age: 36‐40</p> <p>No specified previous treatment</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>26.9</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="3" valign="top"> <p>2007</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="3" valign="top"> <p>Korea</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="3" valign="top"> <p>Outpatient</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>I2: sham procedure</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>12</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>10</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>25.5</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>C: exercise and advise alone</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>12</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>12</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>28</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="3" valign="top"> <p><a href="./references#CD012551-bbs2-0002" title="ChenZX . Observation on therapeutic effect of warm needle moxibustion on chronic non‐bacterial prostatitis. Zhongguo Zhen Jiu [Chinese Acupuncture &amp; Moxibustion]2009;29(4):275‐8. "><b>Chen 2009</b> </a> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>I1: acupuncture + moxibustion</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>42</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>42</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="3" valign="top"> <p>D: 1 month</p> <p>F: 1 month</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="3" valign="top"> <p>Age: 21‐52</p> <p>No specified previous treatment</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>22.56</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="3" valign="top"> <p>2004‐2007</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="3" valign="top"> <p>China</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="3" valign="top"> <p>Outpatient</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>I2: acupuncture</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>41</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>41</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>21.97</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>C: medical treatment</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>42</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>42</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>22.89</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="2" valign="top"> <p><a href="./references#CD012551-bbs2-0038" title="ZimmermannR , CumpanasA , MicleaF , JanetschekG . Extracorporeal shock wave therapy for the treatment of chronic pelvic pain syndrome in males: a randomised, double‐blind, placebo‐controlled study. European Urology2009;56(3):418‐24. ZimmermannRP , CumpanasA , MicleaF , JanetschekG . One year follow up of extracorporeal shock wave therapy (ESWT) for chronic pelvic pain syndrome (CPPS) in a randomised placebo‐controlled double‐blind study. European Urology (Suppl)2010;9(2):214. "><b>Zimmermann 2009</b> </a> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>I: extracorporeal shockwave therapy</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>30</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>30</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="2" valign="top"> <p>D: 4 weeks</p> <p>F: 12 weeks</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="2" valign="top"> <p>Age: 22‐61</p> <p>No specified previous treatment</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>25.07</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="2" valign="top"> <p>N/A</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="2" valign="top"> <p>Austria</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="2" valign="top"> <p>Outpatient</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>C: sham procedure</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>30</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>30</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>23.3</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="2" valign="top"> <p><a href="./references#CD012551-bbs2-0004" title="BadilloSA , NevilleCE , KotarinosR , FortmanC , FraserL , CosbyA , et al. Randomized multicenter pilot trial shows benefit of manual physical therapies in treatment of urologic chronic pelvic pain. Journal of Women's Health Physical Therapy2009;33(1):23. FitzGeraldMP , AndersonRU , PottsJ , PayneCK , PetersKM , ClemensJQ , et al. Randomized multicenter feasibility trial of myofascial physical therapy for the treatment of urological chronic pelvic pain syndromes. Journal of Urology2009;182(2):570‐80. FitzgeraldMP , AndersonRU , PottsJ , PayneCK , PetersKM , ClemensJQ , et al. Randomized multicenter feasibility trial of myofascial physical therapy for the treatment of urological chronic pelvic pain syndromes. Journal of Urology2013;189(1 Suppl):S75‐85. "><b>Fitzgerald 2013</b> </a> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>I: myofascial trigger point therapy</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>10</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>9</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="2" valign="top"> <p>D: 10 weeks</p> <p>F: 12 weeks</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="2" valign="top"> <p>Age: mean 41‐45</p> <p>All had received medical therapy</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>33.5</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="2" valign="top"> <p>N/A</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="2" valign="top"> <p>US</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="2" valign="top"> <p>Outpatient</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>C: Western massage</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>11</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>10</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>25.8</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="2" valign="top"> <p><a href="./references#CD012551-bbs2-0016" title="MarxS . ICAOR 2006: does osteopathic treatment have an influence on the symptoms of patients with chronic prostatitis/chronic pelvic pain syndrome (CPPS)? A randomized controlled trial. International Journal of Osteopathic Medicine2006;9(1):44. MarxS , CimniakU , BeckertR , SchwerlaF , ReschKL . Chronic prostatitis/chronic pelvic pain syndrome. Influence of osteopathic treatment ‐ a randomized controlled study [Chronische Prostatitis/chronisches Beckenschmerzsyndrom. Einfluss osteopathischer Behandlungen ‐ eine randomisiert kontrollierte Studie]. Der Urologe. Ausg. A2009;48(11):1339‐45. "><b>Marx 2009</b> </a> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>I: osteopathic therapy</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>20</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>20</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="2" valign="top"> <p>D: 8 weeks</p> <p>F: 14 weeks</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="2" valign="top"> <p>Age: mean 46‐48</p> <p>No specified previous treatment</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>22.85</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="2" valign="top"> <p>2003‐2005</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="2" valign="top"> <p>Germany</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="2" valign="top"> <p>Outpatient</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>C: exercise programme</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>15</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>13</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>22.95</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="2" valign="top"> <p><a href="./references#CD012551-bbs2-0021" title="OhMM , JinMH , MoonDG , NamSG , BaeJH , ParkHS . A prospective, randomized, placebo controlled study of radiofrequency therapy for the treatment of chronic prostatitis/chronic pelvic pain syndrome. Journal of Urology2009;181(4):122. "><b>Oh 2009</b> </a> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>I: radiofrequency</p> </td> <td align="" bgcolor="#ffffff" colspan="6" rowspan="2" valign="top"> <p>N/A (abstract only)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="2" valign="top"> <p>South Korea</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="2" valign="top"> <p>Outpatient</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>C: "placebo therapy"</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="2" valign="top"> <p><a href="./references#CD012551-bbs2-0008" title="KabayS , KabaySC , YucelM , OzdenH . Efficiency of posterior tibial nerve stimulation in category IIIB chronic prostatitis/chronic pelvic pain: a Sham‐Controlled Comparative Study. Urologia Internationalis2009;83(1):33‐8. "><b>Kabay 2009</b> </a> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>I: tibial nerve stimulation</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>45</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>45</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="2" valign="top"> <p>D: 12 weeks</p> <p>F: 12 weeks</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="2" valign="top"> <p>Age: mean 38‐39</p> <p>No specified previous treatment</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>23.6</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="2" valign="top"> <p>2006‐2008</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="2" valign="top"> <p>Turkey</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="2" valign="top"> <p>Outpatient</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>C: sham procedure</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>44</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>44</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>22.8</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="3" valign="top"> <p><a href="./references#CD012551-bbs2-0034" title="ChungH , ChoiH , YooTK , ChoJM , KimHS . The effects of microwave thermotherapy for chronic prostatitis/chronic pelvic pain syndrome: a prospective, randomized study. Urogenital Tract Infection2017;12(1):35‐41. KimH , ChungH , YangS , YooT , ChoJ . Effects of thermotherapy and medical therapy for chronic prostatitis/chronic pelvic pain syndrome: a prospective study. Urology2011;78(3):S85‐6. YooTK , MoonKT , LeeSW , KimHS , ChungH , KimJY . Effect of the combination treatment of URO‐DrG and medical therapy for chronic prostatitis/chronic pelvic pain syndrome: a prospective study. Journal of Urology2009;181(4):122. "><b>Yoo 2009</b> </a> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>I: medical therapy</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>44</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>37</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="3" valign="top"> <p>D: 12 weeks</p> <p>F: 12 weeks</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="3" valign="top"> <p>Age: mean 31‐38</p> <p>No specified previous treatment</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>26.27</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="3" valign="top"> <p>2005‐2010</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="3" valign="top"> <p>South Korea</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="3" valign="top"> <p>Outpatient</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>C1: transrectal thermotherapy</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>44</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>41</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>24.59</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>C2: transrectal thermotherapy + medical therapy</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>44</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>35</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>23.94</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="2" valign="top"> <p><a href="./references#CD012551-bbs2-0013" title="LeeSW , LiongML , YuenKH , KriegerJN . Acupuncture and immune function in chronic prostatitis/chronic pelvic pain syndrome: a randomized, controlled study. Complementary Therapies in Medicine2014;22(6):965‐9. LeeSW , LiongML , YuenKH , LeongWS , CheeC , CheahPY , et al. Acupuncture versus sham acupuncture for chronic prostatitis/chronic pelvic pain. American Journal of Medicine2008;121(1):79.e1‐7. LeeSW , LiongML , YuenKH , LeongWS , KhanNK , KriegerJN . Validation of a sham acupuncture procedure in a randomised, controlled clinical trial of chronic pelvic pain treatment. Acupuncture in Medicine2011;29(1):40‐6. "><b>Lee 2008</b> </a> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>I: acupuncture</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>45</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>44</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="2" valign="top"> <p>D: 10 weeks</p> <p>F: 34 weeks</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="2" valign="top"> <p>Age: 41‐43</p> <p>No specified previous treatment</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>24.8</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="2" valign="top"> <p>2004‐2005</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="2" valign="top"> <p>Malaysia and US</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="2" valign="top"> <p>Outpatient</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>C: sham acupuncture</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>45</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>45</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>25.2</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="3" valign="top"> <p><a href="./references#CD012551-bbs2-0029" title="SikiruL , ShmailaH , MuhammedSA . Transcutaneous electrical nerve stimulation (TENS) in the symptomatic management of chronic prostatitis/chronic pelvic pain syndrome: a placebo‐control randomized trial. International Brazilian Journal of Urology2008;34(6):708‐13; discussion 714. "><b>Sikiru 2008</b> </a> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>I: TENS</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>8</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>8</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="3" valign="top"> <p>D: 4 weeks</p> <p>F: 4 weeks</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="3" valign="top"> <p>Age: 24‐60</p> <p>No specified previous treatment</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="3" valign="top"> <p>N/A</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="3" valign="top"> <p>N/A</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="3" valign="top"> <p>Nigeria</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="3" valign="top"> <p>Outpatient</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>C1: analgesic</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>8</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>8</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>C2: control</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>8</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>8</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="2" valign="top"> <p><a href="./references#CD012551-bbs2-0007" title="GiubileiG , MondainiN , MinerviniA , SaievaC , LapiniA , SerniS , et al. Physical activity of men with chronic prostatitis/chronic pelvic pain syndrome not satisfied with conventional treatments ‐ could it represent a valid option? The physical activity and male pelvic pain trial: a double‐blind, randomized study. Journal of Urology2007;177(1):159‐65. "><b>Giubilei 2007</b> </a> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>I: exercise programme</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>52</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>41</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="2" valign="top"> <p>D: 18 weeks</p> <p>F: 18 weeks</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="2" valign="top"> <p>Age: mean 36‐38</p> <p>All had received medical therapy</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>23.46</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="2" valign="top"> <p>2002‐2004</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="2" valign="top"> <p>Italy</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="2" valign="top"> <p>Outpatient</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>C: flexibility programme (control intervention)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>51</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>44</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>23.55</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="2" valign="top"> <p><a href="./references#CD012551-bbs2-0022" title="PaickJS , LeeSC , KuJH . More effects of extracorporeal magnetic innervation and terazosin therapy than terazosin therapy alone for non‐inflammatory chronic pelvic pain syndrome: a pilot study. Prostate Cancer and Prostatic Diseases2006;9(3):261‐5. "><b>Paick 2006</b> </a> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>I: extracorporeal magnetic innervation</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>21</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>21</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="2" valign="top"> <p>D: 6 weeks</p> <p>F: 6 weeks</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="2" valign="top"> <p>Age: mean 42‐49</p> <p>No specified previous treatment</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>21</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="2" valign="top"> <p>2003‐2004</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="2" valign="top"> <p>South Korea</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="2" valign="top"> <p>Outpatient</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>C: medical therapy</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>19</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>19</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>17</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="2" valign="top"> <p><a href="./references#CD012551-bbs2-0001" title="AteyaA , FayezA , HaniR , ZohdyW , GabbarMA , ShamloulR . Evaluation of prostatic massage in treatment of chronic prostatitis. Urology2006;67(4):674‐8. "><b>Ateya 2006</b> </a> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>I: medical therapy + prostatic massage</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>25</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="2" valign="top"> <p>N/A</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="2" valign="top"> <p>D: 4 weeks</p> <p>F: 4 weeks</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="2" valign="top"> <p>Age: mean 35</p> <p>No specified previous treatment</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="2" valign="top"> <p>N/A</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="2" valign="top"> <p>N/A</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="2" valign="top"> <p>Egypt</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="2" valign="top"> <p>Outpatient</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>C: medical therapy</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>19</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="2" valign="top"> <p><a href="./references#CD012551-bbs2-0028" title="ShenSL , HeDL , LuoY . Clinical trials of combined therapy of an oral Chinese medicine with massage for chronic nonbacterial prostatitis. Zhonghua Nan Ke Xue2006;12(9):851‐3. "><b>Shen 2006</b> </a> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>I: medical therapy + prostatic massage</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>40</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>40</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="2" valign="top"> <p>D: N/A</p> <p>F: after treatment</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="2" valign="top"> <p>Age: 20‐46</p> <p>No specified previous treatment</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="2" valign="top"> <p>N/A</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="2" valign="top"> <p>2002‐2005</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="2" valign="top"> <p>China</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="2" valign="top"> <p>Outpatient</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>C: medical therapy</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>32</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>32</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="2" valign="top"> <p><a href="./references#CD012551-bbs2-0024" title="RoweE , SmithC , LaverickL , ElkabirJ , WitherowRO , PatelA . A prospective, randomized, placebo controlled, double‐blind study of pelvic electromagnetic therapy for the treatment of chronic pelvic pain syndrome with 1 year of followup. Journal of Urology2005;173(6):2044‐7. "><b>Rowe 2005</b> </a> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>I: electromagnetic chair</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>11</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>11</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="2" valign="top"> <p>D: 4 weeks</p> <p>F: 1 year</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="2" valign="top"> <p>Age: 25‐67</p> <p>All had received medical therapy</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>38.8/100</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="2" valign="top"> <p>N/A</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="2" valign="top"> <p>UK</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="2" valign="top"> <p>Outpatient</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>C: sham procedure</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>10</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>7</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>39.3/100</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="2" valign="top"> <p><a href="./references#CD012551-bbs2-0003" title="FangJ , XuG , DingQ , ZhangY‐F . Observation on the safety and efficacy of He‐Ne laser equipment on chronic abacteria prostatitis. Fudan University Journal of Medical Sciences2005;32(2):234‐5, 252. "><b>Fang 2005</b> </a> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>I: He‐Ne laser</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>56</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>56</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="2" valign="top"> <p>D: 5 weeks</p> <p>F: "after treatment"</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="2" valign="top"> <p>Age: mean 33‐34</p> <p>No specified previous treatment</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="2" valign="top"> <p>N/A</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="2" valign="top"> <p>2002‐2004</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="2" valign="top"> <p>China</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="2" valign="top"> <p>Outpatient</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>C: routine care</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>56</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>56</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="2" valign="top"> <p><a href="./references#CD012551-bbs2-0010" title="KastnerC , HochreiterW , HuidobroC , CabezasJ , MillerP . Cooled transurethral microwave thermotherapy for intractable chronic prostatitis ‐ results of a pilot study after 1 year. Urology2004;64(6):1149‐54. "><b>Kastner 2004</b> </a> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>I: transrectal thermotherapy 55 °C</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="2" valign="top"> <p>42</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>21</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="2" valign="top"> <p>D: once</p> <p>F: 12 months</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="2" valign="top"> <p>Age: mean 58‐62</p> <p>All had received medical therapy</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>11.5</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="2" valign="top"> <p>N/A</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="2" valign="top"> <p>Chile, Switzerland, UK</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="2" valign="top"> <p>Outpatient</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>C: transrectal thermotherapy 70 °C</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>18</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>10.9</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="2" valign="top"> <p><a href="./references#CD012551-bbs2-0032" title="WangJ , LiJ , LuR , WangJM . Treatment of external RF hyperthermia combining with alpha 1‐adrenergic receptor blocker for patients with prostatodynia and chronic non‐bacterial prostatitis. Zhonghua Nan Ke Xue2002;8(1):48‐50. "><b>Wang 2002</b> </a> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>I: radiofrequency hyperthermia</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>76</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>76</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="2" valign="top"> <p>D: 12 weeks</p> <p>F: 12 weeks</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="2" valign="top"> <p>Age: mean 34.2</p> <p>Not specified previous treatment</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="2" valign="top"> <p>N/A</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="2" valign="top"> <p>1998‐2001</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="2" valign="top"> <p>China</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="2" valign="top"> <p>Outpatient</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>C: radiofrequency hyperthermia + terazosin</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>90</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>88</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="2" valign="top"> <p><a href="./references#CD012551-bbs2-0015" title="LeskinenMJ , KilponenA , LukkarinenO , TammelaTL . Transurethral needle ablation for the treatment of chronic pelvic pain syndrome (category III prostatitis): a randomized, sham‐controlled study. Urology2002;60(2):300‐4. "><b>Leskinen 2002</b> </a> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>I: transurethral needle ablation</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>25</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>25</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="2" valign="top"> <p>D: once</p> <p>F: 12 months</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="2" valign="top"> <p>Age: mean 43‐50</p> <p>All had received medical therapy</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>37.3</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="2" valign="top"> <p>1998‐2001</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="2" valign="top"> <p>Finland</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="2" valign="top"> <p>Outpatient</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>C: sham procedure</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>8</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>8</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>33.6</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="2" valign="top"> <p><a href="./references#CD012551-bbs2-0031" title="VassilyO , AndreyS , EvgeniiD , OtabekI , BorisL , SergeyR . Efficacy of transrectal microwave hyperthemia (TRMH) in the treatment of chronic prostatitis. A randomized sham controlled comparative study (Abstract). Journal of Urology1999;161(4 Suppl):33A. "><b>Vassily 1999</b> </a> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>I: transrectal thermotherapy</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>80</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="2" valign="top"> <p>N/A</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="2" valign="top"> <p>D: 2 weeks</p> <p>F: 6 months</p> </td> <td align="" bgcolor="#ffffff" colspan="3" rowspan="2" valign="top"> <p>N/A (abstract only)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="2" valign="top"> <p>Russia</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="2" valign="top"> <p>Outpatient</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>C: sham procedure</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>20</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="2" valign="top"> <p><a href="./references#CD012551-bbs2-0020" title="NickelJC , SorensenR . Transurethral microwave thermotherapy for nonbacterial prostatitis: a randomized double‐blind sham controlled study using new prostatitis specific assessment questionnaires. Journal of Urology1996;155(6):1950‐4; discussion 1954. "><b>Nickel 1996</b> </a> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>I: transurethral thermotherapy</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>10</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>10</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="2" valign="top"> <p>D: 1 session</p> <p>F: 3 months</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="2" valign="top"> <p>Age: 45‐46</p> <p>All had received medical therapy</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="2" valign="top"> <p>N/A</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="2" valign="top"> <p>N/A</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="2" valign="top"> <p>Canada</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="2" valign="top"> <p>Outpatient</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>C: sham procedure</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>10</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>10</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="2" valign="top"> <p><a href="./references#CD012551-bbs2-0018" title="MuraroGB . Clinical study on the efficacy and safety of seaprose S combined with local prostatic hyperthermia in chronic non‐bacterial prostatitis. Controlled study versus local prostatic hyperthermia [Studio clinico sull'efficacia e la tollerabilita del seaprose S associato a ipertermia locale prostatica nella prostatite cronica abatterica. Studio controllato verso ipertermia locale prostatica]. Archivio di Medicina Interna1995;47(2‐3):73‐86. "><b>Muraro 1995</b> </a> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>I: medical therapy plus local hyperthermia</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>10</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="2" valign="top"> <p>N/A</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="2" valign="top"> <p>D: 15 days</p> <p>F: 4 weeks</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="2" valign="top"> <p>Age: mean 42.5</p> <p>Not specified previous treatment</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="2" valign="top"> <p>N/A</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="2" valign="top"> <p>N/A</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="2" valign="top"> <p>Italy</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="2" valign="top"> <p>Outpatient</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>C: local hyperthermia alone</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>10</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><a href="./references#CD012551-bbs2-0017" title="MontorsiF , GuazzoniG , BergamaschiF , GalliL , ConsonniP , MatozzoV , et al. Is there a role for transrectal microwave hyperthermia of the prostate in the treatment of abacterial prostatitis and prostatodynia?. Prostate1993;22(2):139‐46. "><b>Montorsi 1993</b> </a> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Transrectal hyperthermia in different regimens</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>54</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>54</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>D: 3 to 6 weeks</p> <p>F: 26 months</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Age: 21‐45</p> <p>All had received medical therapy</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>N/A</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>1987‐1991</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Italy</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Outpatient</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="2" valign="top"> <p><a href="./references#CD012551-bbs2-0027" title="ShahT , WatsonG , BarnesD . Microwave hyperthermia in the treatment of chronic abacterial prostatitis and prostatodynia: results of a double blind placebo controlled trial (Abstract). Journal of Urology1993;149:405A. "><b>Shah 1993</b> </a> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>I: radiofrequency</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>15</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="2" valign="top"> <p>N/A</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="2" valign="top"> <p>D: 2‐3 weeks</p> <p>F: 3 months</p> </td> <td align="" bgcolor="#ffffff" colspan="3" rowspan="2" valign="top"> <p>N/A</p> <p>(abstract only)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="2" valign="top"> <p>UK</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="2" valign="top"> <p>Outpatient</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>C: sham procedure</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>15</p> </td> </tr> </tbody> </table> <div class="table-footnote"> <p>C: comparator; D: duration of intervention; F: duration of follow‐up (might not represent the reported time points); I: intervention; N/A: not available; NIH‐CPSI: National Institutes of Health ‐ Chronic Prostatitis Symptom Index; TENS: transcutaneous electric nerve stimulation. </p> <p><sup>a</sup><b>Age</b>: measurement is in years. </p> <p><sup>b</sup><b>NIH‐CPSI</b>: scores were mean or median values. </p> </div> </div> <p>We extracted outcomes data relevant to this Cochrane Review as needed for calculation of summary statistics and measures of variance. For dichotomous outcomes, we attempted to obtain numbers of events and totals of population for a 2 × 2 table, as well as summary statistics with corresponding measures of variance. For continuous outcomes, we attempted to obtain means and standard deviations or data necessary to calculate this information. We resolved any disagreements by discussion, or, if required, by consultation with a third review author (SI or JHJ). </p> <p>We provided information, including trial identifier, about potentially relevant ongoing studies in a <a href="./references#CD012551-sec-0314" title="">Characteristics of ongoing studies</a> table. We attempted to contact authors of included studies to obtain key missing data as needed. </p> <section id="CD012551-sec-0069"> <h5 class="title">Dealing with duplicate and companion publications</h5> <p>In the event of duplicate publications, companion documents or multiple reports of a primary study, we maximised yield of information by mapping all publications to unique studies and collating all available data. We used the most complete data set aggregated across all known publications. In case of doubt, we gave priority to the publication reporting the longest follow‐up associated with our primary or secondary outcomes. </p> </section> </section> <section id="CD012551-sec-0070"> <h4 class="title">Assessment of risk of bias in included studies</h4> <p>Six review authors (JVAF, VV, TT, SI, YX, JHJ) assessed the risk of bias of each included study independently in pairs. We resolved disagreements by consensus, or by consultation with a third review author (JVAF or VV). </p> <p>We assessed risk of bias using the Cochrane 'Risk of bias' assessment tool (<a href="./references#CD012551-bbs2-0146" title="HigginsJPT , AltmanDG , SterneJAC . Chapter 8: Assessing risk of bias in included studies. In: Higgins JPT, Green S, editor(s). Cochrane Handbook for Systematic Reviews of Interventions. Version 5.1.0 (updated March 2011). The Cochrane Collaboration, 2011. Available from handbook.cochrane.org. ">Higgins 2011b</a>). We assessed the following domains. </p> <p> <ul id="CD012551-list-0021"> <li> <p>Random sequence generation (selection bias).</p> </li> <li> <p>Allocation concealment (selection bias).</p> </li> <li> <p>Blinding of participants and personnel (performance bias).</p> </li> <li> <p>Blinding of outcome assessment (detection bias).</p> </li> <li> <p>Incomplete outcome data (attrition bias).</p> </li> <li> <p>Selective reporting (reporting bias).</p> </li> <li> <p>Other sources of bias.</p> </li> </ul> </p> <p>We judged the risk of bias domains as 'low risk,' 'high risk' or 'unclear risk' and evaluated individual bias items as described in the <i>Cochrane Handbook for Systematic Reviews of Interventions</i> (<a href="./references#CD012551-bbs2-0146" title="HigginsJPT , AltmanDG , SterneJAC . Chapter 8: Assessing risk of bias in included studies. In: Higgins JPT, Green S, editor(s). Cochrane Handbook for Systematic Reviews of Interventions. Version 5.1.0 (updated March 2011). The Cochrane Collaboration, 2011. Available from handbook.cochrane.org. ">Higgins 2011b</a>). We presented a 'Risk of bias' summary figure to illustrate these findings. </p> <p>For performance bias (blinding of participants and personnel) and detection bias (blinding of outcome assessment), we evaluated the risk of bias separately for each outcome, and we grouped outcomes according to whether they were measured subjectively or objectively when reporting our findings in the 'Risk of bias' table. However, all end points were subjective outcomes. </p> <p>We assessed attrition bias (incomplete outcome data) on an outcome‐specific basis, and grouped outcomes with like judgements when reporting our findings in the 'Risk of bias' table. </p> <p>We further summarised the risk of bias across domains for each outcome in each included study, as well as across studies and domains for each outcome. </p> </section> <section id="CD012551-sec-0071"> <h4 class="title">Measures of treatment effect</h4> <p>We expressed dichotomous data as risk ratios (RR) with 95% confidence intervals (CIs). We expressed continuous data as mean differences (MD) with 95% CIs unless different studies used different measures to assess the same outcome, in which case we expressed data as standardised mean differences (SMD) with 95% CIs. </p> </section> <section id="CD012551-sec-0072"> <h4 class="title">Unit of analysis issues</h4> <p>The unit of analysis was the individual participant. If we identified cross‐over trials, cluster‐randomised trials or trials with more than two intervention groups for inclusion in the review, we handled these in accordance with guidance provided in the <i>Cochrane Handbook for Systematic Reviews of Interventions</i> (<a href="./references#CD012551-bbs2-0147" title="HigginsJPT , DeeksJJ , AltmanDG . Chapter 16: Special topics in statistics. In: Higgins JPT, Green S, editor(s). Cochrane Handbook for Systematic Reviews of Interventions. Version 5.1.0 (updated March 2011). The Cochrane Collaboration, 2011. Available from handbook.cochrane.org. ">Higgins 2011c</a>). </p> </section> <section id="CD012551-sec-0073"> <h4 class="title">Dealing with missing data</h4> <p>We obtained missing data from study authors, if feasible, and performed intention‐to‐treat analyses if data were available; otherwise, we performed available‐case analyses. We investigated attrition rates, such as dropouts, losses to follow‐up and withdrawals, and we critically appraised issues of missing data. We did not impute missing data. </p> </section> <section id="CD012551-sec-0074"> <h4 class="title">Assessment of heterogeneity</h4> <p>In the event of excessive heterogeneity unexplained by subgroup analyses, we did not report outcome results as the pooled effect estimate in a meta‐analysis, but we provided a narrative description of the results of each study. </p> <p>We identified heterogeneity (inconsistency) through visual inspection of the forest plots to assess the amount of overlap of CIs, and the I<sup>2</sup> statistic, which quantifies inconsistency across studies to assess the impact of heterogeneity on the meta‐analysis (<a href="./references#CD012551-bbs2-0143" title="HigginsJPT , ThompsonSG . Quantifying heterogeneity in a meta‐analysis. Statistics in Medicine2002;21(11):1539‐58. [DOI: 10.1002/sim.1186] ">Higgins 2002</a>; <a href="./references#CD012551-bbs2-0144" title="HigginsJPT , ThompsonSG , DeeksJJ , AltmanDG . Measuring inconsistency in meta‐analyses. BMJ (Clinical Research Ed.)2003;327(7414):557‐60. [DOI: 10.1136/bmj.327.7414.557] ">Higgins 2003</a>). We interpreted the I<sup>2</sup> statistic as follows. </p> <p> <ul id="CD012551-list-0022"> <li> <p>0% to 40%: may not be important.</p> </li> <li> <p>30% to 60%: may indicate moderate heterogeneity.</p> </li> <li> <p>50% to 90%: may indicate substantial heterogeneity.</p> </li> <li> <p>75% to 100%: considerable heterogeneity.</p> </li> </ul> </p> <p>When we found heterogeneity, we attempted to determine possible reasons for it by examining individual study and subgroup characteristics. </p> </section> <section id="CD012551-sec-0075"> <h4 class="title">Assessment of reporting biases</h4> <p>We attempted to obtain study protocols to assess for selective outcome reporting.</p> <p>If we had included 10 studies or more investigating a particular outcome, we would have used funnel plots to assess small‐study effects. Several explanations can be offered for the asymmetry of a funnel plot, including true heterogeneity of effect with respect to trial size, poor methodological design (and hence bias of small trials) and publication bias. Therefore, we would have interpreted the results carefully. </p> </section> <section id="CD012551-sec-0076"> <h4 class="title">Data synthesis</h4> <p>Unless there was good evidence for homogeneous effects across studies, we summarised data using a random‐effects model. We interpreted random‐effects meta‐analyses with due consideration of the whole distribution of effects. In addition, we performed statistical analyses according to the statistical guidelines contained in the <i>Cochrane Handbook for Systematic Reviews of Interventions</i> (<a href="./references#CD012551-bbs2-0145" title="HigginsJPT , GreenS , editor(s) . Cochrane Handbook for Systematic Reviews of Interventions. Version 5.1.0 (updated March 2011). The Cochrane Collaboration, 2011. Available from handbook.cochrane.org. ">Higgins 2011a</a>). For dichotomous outcomes, we used the Mantel‐Haenszel method; for continuous outcomes, we used the inverse variance method. We used Review Manager 5 (<a href="./references#CD012551-bbs2-0181" title="Nordic Cochrane Centre, The Cochrane Collaboration. Review Manager (RevMan). Version 5.3. Copenhagen: Nordic Cochrane Centre, The Cochrane Collaboration, 2014. ">RevMan 2014</a>) software to perform analyses. </p> </section> <section id="CD012551-sec-0077"> <h4 class="title">Subgroup analysis and investigation of heterogeneity</h4> <p>We expected the following characteristics to introduce clinical heterogeneity, and planned to carry out subgroup analyses with investigation of interactions. </p> <p> <ul id="CD012551-list-0023"> <li> <p>Participants' characteristics: symptom severity at recruitment, age, presence of clinical comorbidities (irritable bowel syndrome, fibromyalgia, interstitial cystitis). </p> </li> <li> <p>Duration of the intervention: depending on intervention type, measured in sessions (e.g. one session or repeated sessions) or weeks (e.g. less than 12 weeks or more than 12 weeks). </p> </li> </ul> </p> <p>We planned to use the test for subgroup differences in Review Manager 5 to compare subgroup analyses if there had been sufficient studies (<a href="./references#CD012551-bbs2-0181" title="Nordic Cochrane Centre, The Cochrane Collaboration. Review Manager (RevMan). Version 5.3. Copenhagen: Nordic Cochrane Centre, The Cochrane Collaboration, 2014. ">RevMan 2014</a>). </p> </section> <section id="CD012551-sec-0078"> <h4 class="title">Sensitivity analysis</h4> <p>We planned to perform sensitivity analyses to explore the influence of the following factors (when applicable) on effect sizes. </p> <p> <ul id="CD012551-list-0024"> <li> <p>Restricting the analysis by taking into account risk of bias, by excluding studies at 'high risk' or 'unclear risk.' </p> </li> <li> <p>Explore the impact of re‐expressing symptom severity as a dichotomous outcome.</p> </li> <li> <p>Excluding studies that included participants with a diagnosis of chronic non‐bacterial prostatitis or prostatodynia, not filling the criteria of the 1999 Research Consensus (<a href="./references#CD012551-bbs2-0169" title="NickelJC , NybergLM , HennenfentM . Research guidelines for chronic prostatitis: consensus report from the first National Institutes of Health International Prostatitis Collaborative Network. Urology1999;54(2):229‐33. [PUBMED: 10443716] ">Nickel 1999a</a>). </p> </li> </ul> </p> <section id="CD012551-sec-0079"> <h5 class="title">'Summary of findings' tables</h5> <p>We presented the overall quality of the evidence for each outcome according to the GRADE approach, which takes into account five criteria related to internal validity (risk of bias, inconsistency, imprecision, publication bias), and external validity, such as directness of results (<a href="./references#CD012551-bbs2-0139" title='GuyattGH , OxmanAD , VistGE , KunzR , Falck‐YtterY , SchünemannHJ , et al. GRADE: what is "quality of evidence" and why is it important to clinicians?. BMJ (Clinical Research Ed.)2008;336(7651):995‐8. [DOI: 10.1136/bmj.39490.551019.BE] '>Guyatt 2008</a>)<i>.</i> For each comparison, two review authors (JVAF, JHJ) independently rated the quality of evidence for each outcome as 'high,' 'moderate,' 'low' or 'very low' using <a href="./references#CD012551-bbs2-0138" title="GRADE Working Group, McMaster University. GRADEpro GDT. Hamilton (ON): GRADE Working Group, McMaster University, 2015. ">GRADEpro GDT</a>. We resolved any discrepancies by consensus, or, if needed, by arbitration by a third review author (VV). We presented a summary of the evidence for the main outcomes in the 'Summary of findings' tables, which provide key information about: the best estimate of the magnitude of the effect in relative terms and absolute differences for each relevant comparison of alternative management strategies; numbers of participants and studies addressing each important outcome and the rating of the overall confidence in effect estimates for each outcome (<a href="./references#CD012551-bbs2-0141" title="GuyattG , OxmanAD , AklEA , KunzR , VistG , BrozekJ , et al. GRADE guidelines: 1. Introduction ‐ GRADE evidence profiles and summary of findings tables. Journal of Clinical Epidemiology2011;64(4):383‐94. [DOI: 10.1016/j.jclinepi.2010.04.026] ">Guyatt 2011b</a>; <a href="./references#CD012551-bbs2-0186" title="SchünemannHJ , OxmanAD , HigginsJPT , VistGE , GlasziouP , GuyattGH . Chapter 11: Presenting results and 'Summary of findings' tables. In: Higgins JPT, Green S, editor(s), Cochrane Handbook for Systematic Reviews of Interventions. Version 5.1.0 (updated March 2011). The Cochrane Collaboration, 2011. Available from handbook.cochrane.org. ">Schünemann 2011</a>). If meta‐analysis was not possible, we presented results in a narrative 'Summary of findings' table. We initially planned to present 'Summary of findings' tables for all comparisons, however, given their multiplicity, we have presented only those most related to clinical practice or containing at least two clinical trials in order to highlight the evidence most relevant to clinicians, patients and other stakeholders (see <a href="#CD012551-sec-0303">Differences between protocol and review</a>). Nevertheless, all comparisons were rated using the GRADE approach and are available under the section <a href="#CD012551-sec-0102">Effects of interventions</a>. </p> <p>We used the controlled vocabulary suggested by <a href="./references#CD012551-bbs2-0137" title="GlentonC , SantessoN , RosenbaumS , NilsenES , RaderT , CiapponiA , et al. Presenting the results of Cochrane systematic reviews to a consumer audience: a qualitative study. Medical Decision Making2010;30(5):566‐77. [PUBMED: 20643912] ">Glenton 2010</a> to summarise the findings of the 'Summary of findings' tables in the 'Plain language summary.' </p> </section> </section> </section> </section> </section> <section class="results"> <div class="section-header section-collapse-header" id="CD012551-sec-0080" lang="en"> <h2 class="title section-collapse-title"> Results <i aria-hidden="true" class="fa fa-caret-up section-collapse-icon"></i> </h2> </div> <section class="results" lang="en"> <div class="section-header" id="CD012551-sec-0080"></div> <section id="CD012551-sec-0081"> <h3 class="title">Description of studies</h3> <section id="CD012551-sec-0082"> <h4 class="title">Results of the search</h4> <p>For detailed information of the results of the search see <a href="#CD012551-fig-0001">Figure 1</a>. This review shares the search strategy for the protocol 'Pharmacological Interventions for treating chronic prostatitis/chronic pelvic pain syndrome' (<a href="./references#CD012551-bbs2-0135" title="FrancoJVA , TirapeguiFI , TurkT , GarroteV , ViettoV . Pharmacological interventions for treating chronic prostatitis/chronic pelvic pain syndrome. Cochrane Database of Systematic Reviews2017, Issue 2. [DOI: 10.1002/14651858.CD012552; CD012552] ">Franco 2017</a>). In this section, we described the study flow for the studies relevant to the review question. For this review, we screened 1500 records after removing duplicates. We included two studies from other systematic reviews on this topic (<a href="./references#CD012551-bbs2-0078" title="McNaughton CollinsM , MacDonaldR , WiltTJ . Diagnosis and treatment of chronic abacterial prostatitis: a systematic review. Annals of Internal Medicine2000;133(5):367‐81. ">McNaughton 2000</a>). We excluded 1386 records and screened 130 records in the full‐text assessment. We excluded 73 studies (76 records) after full‐text assessment (see <a href="./references#CD012551-sec-0312" title="">Characteristics of excluded studies</a> table). The search identified one protocol of a completed study (<a href="./references#CD012551-bbs2-0112" title="RochesterM , ArmitageJ , SandersM , ChristmasP . Self management activation randomised trial for prostatitis (SMART‐P): study protocol for a randomised controlled trial. Trials2011;12:210. [ISRCTN21012555] ">Rochester 2011</a>), but we could not retrieve study results (see <a href="./references#CD012551-sec-0313" title="">Characteristics of studies awaiting classification</a> table). We identified four ongoing studies (see <a href="./references#CD012551-sec-0314" title="">Characteristics of ongoing studies</a> table). We included 38 studies (49 records) in this review. </p> <div class="figure" id="CD012551-fig-0001"> <div class="figure-caption-wrapper-top"> <nav class="inline-nav-list has-dividers"> <ul> <li><a class="open-in-figure-viewer" href="#0">Open in figure viewer</a></li> </ul> </nav> <div class="figure-label">Figure 1</div> </div> <hr class="top"/><img alt="Study flow diagram." data-id="CD012551-fig-0001" src="/cdsr/doi/10.1002/14651858.CD012551.pub3/media/CDSR/CD012551/image_n/nCD012551-AFig-FIG01.png"/><hr class="bottom"/> <div class="figure-caption-wrapper-bottom"> <div class="figure-caption"> <p>Study flow diagram.</p> </div> </div> </div> </section> <section id="CD012551-sec-0083"> <h4 class="title">Included studies</h4> <p>We included 38 studies (see <a href="./references#CD012551-sec-0311" title="">Characteristics of included studies</a> table). </p> <section id="CD012551-sec-0084"> <h5 class="title">Design</h5> <p>All the included studies were RCTs.</p> </section> <section id="CD012551-sec-0085"> <h5 class="title">Sample sizes</h5> <p>Median sample size was 60 (interquartile range 35 to 100). The smallest sample size was 20 and the largest sample size was 774. </p> </section> <section id="CD012551-sec-0086"> <h5 class="title">Setting</h5> <p>Since CP/CPPS is usually treated in an outpatient setting, most studies offered ambulatory care. Some studies, depending on the type of intervention (see below), required a temporary stay in hospital, particularly those studies that used therapeutic devices. The studies were conducted in Egypt (<a href="./references#CD012551-bbs2-0001" title="AteyaA , FayezA , HaniR , ZohdyW , GabbarMA , ShamloulR . Evaluation of prostatic massage in treatment of chronic prostatitis. Urology2006;67(4):674‐8. ">Ateya 2006</a>; <a href="./references#CD012551-bbs2-0026" title="Samhan AhmedF , Abd‐Elhalim NermeenM , Elnegmy EmamH , Roiah MohamedM . The effect of transcutaneous electrical nerve stimulation in the treatment of chronic pelvic pain syndrome: an evidence based electromyographic studies. Indian Journal of Physiotherapy &amp; Occupational Therapy2011;5(3):14‐7. ">Samhan 2011</a>), China (<a href="./references#CD012551-bbs2-0002" title="ChenZX . Observation on therapeutic effect of warm needle moxibustion on chronic non‐bacterial prostatitis. Zhongguo Zhen Jiu [Chinese Acupuncture &amp; Moxibustion]2009;29(4):275‐8. ">Chen 2009</a>; <a href="./references#CD012551-bbs2-0003" title="FangJ , XuG , DingQ , ZhangY‐F . Observation on the safety and efficacy of He‐Ne laser equipment on chronic abacteria prostatitis. Fudan University Journal of Medical Sciences2005;32(2):234‐5, 252. ">Fang 2005</a>; <a href="./references#CD012551-bbs2-0006" title="GaoM , DingH , ZhongG , LuJ , WangH , LiQ , et al. The effects of transrectal radiofrequency hyperthermia on patients with chronic prostatitis and the changes of MDA, NO, SOD, and Zn levels in pretreatment and posttreatment. Urology2012;79(2):391‐6. ">Gao 2012</a>; <a href="./references#CD012551-bbs2-0009" title="KaikaiC , RuiW , YongC , ZhuC , WeiH , SuogangW , et al. Combination therapy of non‐intrusive ultrasound with integrated Chinese‐western medicine for chronic prostatitis/chronic pelvic pain syndrome. Chinese Journal of Andrology2014;28(12):41‐4. ">Kaikai 2014</a>; <a href="./references#CD012551-bbs2-0028" title="ShenSL , HeDL , LuoY . Clinical trials of combined therapy of an oral Chinese medicine with massage for chronic nonbacterial prostatitis. Zhonghua Nan Ke Xue2006;12(9):851‐3. ">Shen 2006</a>; <a href="./references#CD012551-bbs2-0032" title="WangJ , LiJ , LuR , WangJM . Treatment of external RF hyperthermia combining with alpha 1‐adrenergic receptor blocker for patients with prostatodynia and chronic non‐bacterial prostatitis. Zhonghua Nan Ke Xue2002;8(1):48‐50. ">Wang 2002</a>; <a href="./references#CD012551-bbs2-0033" title="YangZS , ZuXB , QiL , SongLM , LiuTR . Combination therapy of biofeedback with electrical stimulation for chronic prostatitis/chronic pelvic pain syndrome. Zhonghua Nan Ke Xue2011;17(7):611‐4. ">Yang 2011</a>; <a href="./references#CD012551-bbs2-0035" title="ZengX , YeZ , YangW , ChenZ , DuG . Extracorporeal shock wave treatment for noninflammatory chronic pelvic pain syndrome: a prospective, randomized, sham‐controlled study. Journal of Urology2009;181(4):122‐3. ZengXY , LiangC , YeZQ . Extracorporeal shock wave treatment for non‐inflammatory chronic pelvic pain syndrome: a prospective, randomized and sham‐controlled study. Chinese Medical Journal2012;125(1):114‐8. ">Zeng 2012</a>; <a href="./references#CD012551-bbs2-0036" title="ZhangDY , PanXC . Chinese medicine union Taijiquan treatment chronicity non‐bacterial prostatitis curative effect observation. Chinese Manipulation &amp; Rehabilitation Medicine2011;15(2):181. ">Zhang 2011a</a>; <a href="./references#CD012551-bbs2-0037" title="ZhaoY , ZhaoW , LangG , ChenY , LiuJ , WangG , et al. Circumcision plus antibiotic, anti‐inflammatory, and alpha‐blocker therapy for the treatment for chronic prostatitis/chronic pelvic pain syndrome: a prospective, randomized, multicenter trial. World Journal of Urology2015;33(5):617‐22. ">Zhao 2015</a>), US (<a href="./references#CD012551-bbs2-0004" title="BadilloSA , NevilleCE , KotarinosR , FortmanC , FraserL , CosbyA , et al. Randomized multicenter pilot trial shows benefit of manual physical therapies in treatment of urologic chronic pelvic pain. Journal of Women's Health Physical Therapy2009;33(1):23. FitzGeraldMP , AndersonRU , PottsJ , PayneCK , PetersKM , ClemensJQ , et al. Randomized multicenter feasibility trial of myofascial physical therapy for the treatment of urological chronic pelvic pain syndromes. Journal of Urology2009;182(2):570‐80. FitzgeraldMP , AndersonRU , PottsJ , PayneCK , PetersKM , ClemensJQ , et al. Randomized multicenter feasibility trial of myofascial physical therapy for the treatment of urological chronic pelvic pain syndromes. Journal of Urology2013;189(1 Suppl):S75‐85. ">Fitzgerald 2013</a>), Italy (<a href="./references#CD012551-bbs2-0005" title="GalloL . Effectiveness of diet, sexual habits and lifestyle modifications on treatment of chronic pelvic pain syndrome. Prostate Cancer and Prostatic Diseases2014;17(3):238‐45. ">Gallo 2014</a>; <a href="./references#CD012551-bbs2-0007" title="GiubileiG , MondainiN , MinerviniA , SaievaC , LapiniA , SerniS , et al. Physical activity of men with chronic prostatitis/chronic pelvic pain syndrome not satisfied with conventional treatments ‐ could it represent a valid option? The physical activity and male pelvic pain trial: a double‐blind, randomized study. Journal of Urology2007;177(1):159‐65. ">Giubilei 2007</a>; <a href="./references#CD012551-bbs2-0017" title="MontorsiF , GuazzoniG , BergamaschiF , GalliL , ConsonniP , MatozzoV , et al. Is there a role for transrectal microwave hyperthermia of the prostate in the treatment of abacterial prostatitis and prostatodynia?. Prostate1993;22(2):139‐46. ">Montorsi 1993</a>; <a href="./references#CD012551-bbs2-0018" title="MuraroGB . Clinical study on the efficacy and safety of seaprose S combined with local prostatic hyperthermia in chronic non‐bacterial prostatitis. Controlled study versus local prostatic hyperthermia [Studio clinico sull'efficacia e la tollerabilita del seaprose S associato a ipertermia locale prostatica nella prostatite cronica abatterica. Studio controllato verso ipertermia locale prostatica]. Archivio di Medicina Interna1995;47(2‐3):73‐86. ">Muraro 1995</a>), Switzerland (<a href="./references#CD012551-bbs2-0011" title="KesslerTM , MordasiniL , WeisstannerC , JuniP , daCostaBR , WiestR , et al. Sono‐electro‐magnetic therapy for treating chronic pelvic pain syndrome in men: a randomized, placebo‐controlled, double‐blind trial. PloS One2014;9(12):e113368. WeisstannerC , MordasiniL , ThalmannGN , VermaRK , RummelC , FederspielA , et al. Therapy‐related longitudinal brain perfusion changes in patients with chronic pelvic pain syndrome. Swiss Medical Weekly2017;147:w14454. ">Kessler 2014</a>), Turkey (<a href="./references#CD012551-bbs2-0008" title="KabayS , KabaySC , YucelM , OzdenH . Efficiency of posterior tibial nerve stimulation in category IIIB chronic prostatitis/chronic pelvic pain: a Sham‐Controlled Comparative Study. Urologia Internationalis2009;83(1):33‐8. ">Kabay 2009</a>; <a href="./references#CD012551-bbs2-0012" title="KucukEV , SucekenFY , BindayiA , BoyluU , OnolFF , GumusE . Effectiveness of acupuncture on chronic prostatitis‐chronic pelvic pain syndrome category IIIB patients: a prospective, randomized, nonblinded, clinical trial. Urology2015;85(3):636‐40. ">Kucuk 2015</a>; <a href="./references#CD012551-bbs2-0025" title="SahinS , BicerM , ErenGA , TasS , TugcuV , TasciAI , et al. Acupuncture relieves symptoms in chronic prostatitis/chronic pelvic pain syndrome: a randomized, sham‐controlled trial. Prostate Cancer and Prostatic Diseases2015;18(3):249‐54. ">Sahin 2015</a>), Korea (<a href="./references#CD012551-bbs2-0014" title="LeeSH , LeeBC . Electroacupuncture relieves pain in men with chronic prostatitis/chronic pelvic pain syndrome: three‐arm randomized trial. Urology2009;73(5):1036‐41. ">Lee 2009</a>; <a href="./references#CD012551-bbs2-0021" title="OhMM , JinMH , MoonDG , NamSG , BaeJH , ParkHS . A prospective, randomized, placebo controlled study of radiofrequency therapy for the treatment of chronic prostatitis/chronic pelvic pain syndrome. Journal of Urology2009;181(4):122. ">Oh 2009</a>; <a href="./references#CD012551-bbs2-0022" title="PaickJS , LeeSC , KuJH . More effects of extracorporeal magnetic innervation and terazosin therapy than terazosin therapy alone for non‐inflammatory chronic pelvic pain syndrome: a pilot study. Prostate Cancer and Prostatic Diseases2006;9(3):261‐5. ">Paick 2006</a>; <a href="./references#CD012551-bbs2-0034" title="ChungH , ChoiH , YooTK , ChoJM , KimHS . The effects of microwave thermotherapy for chronic prostatitis/chronic pelvic pain syndrome: a prospective, randomized study. Urogenital Tract Infection2017;12(1):35‐41. KimH , ChungH , YangS , YooT , ChoJ . Effects of thermotherapy and medical therapy for chronic prostatitis/chronic pelvic pain syndrome: a prospective study. Urology2011;78(3):S85‐6. YooTK , MoonKT , LeeSW , KimHS , ChungH , KimJY . Effect of the combination treatment of URO‐DrG and medical therapy for chronic prostatitis/chronic pelvic pain syndrome: a prospective study. Journal of Urology2009;181(4):122. ">Yoo 2009</a>), Finland (<a href="./references#CD012551-bbs2-0015" title="LeskinenMJ , KilponenA , LukkarinenO , TammelaTL . Transurethral needle ablation for the treatment of chronic pelvic pain syndrome (category III prostatitis): a randomized, sham‐controlled study. Urology2002;60(2):300‐4. ">Leskinen 2002</a>), Germany (<a href="./references#CD012551-bbs2-0016" title="MarxS . ICAOR 2006: does osteopathic treatment have an influence on the symptoms of patients with chronic prostatitis/chronic pelvic pain syndrome (CPPS)? A randomized controlled trial. International Journal of Osteopathic Medicine2006;9(1):44. MarxS , CimniakU , BeckertR , SchwerlaF , ReschKL . Chronic prostatitis/chronic pelvic pain syndrome. Influence of osteopathic treatment ‐ a randomized controlled study [Chronische Prostatitis/chronisches Beckenschmerzsyndrom. Einfluss osteopathischer Behandlungen ‐ eine randomisiert kontrollierte Studie]. Der Urologe. Ausg. A2009;48(11):1339‐45. ">Marx 2009</a>), Canada (<a href="./references#CD012551-bbs2-0020" title="NickelJC , SorensenR . Transurethral microwave thermotherapy for nonbacterial prostatitis: a randomized double‐blind sham controlled study using new prostatitis specific assessment questionnaires. Journal of Urology1996;155(6):1950‐4; discussion 1954. ">Nickel 1996</a>), Montenegro (<a href="./references#CD012551-bbs2-0023" title="PajovicB , RadojevicN , DimitrovskiA , VukovicM . Comparison of the efficiency of combined extracorporeal shock‐wave therapy and triple therapy versus triple therapy itself in Category III B chronic pelvic pain syndrome (CPPS). Aging Male2016;19(3):1‐6. ">Pajovic 2016</a>), UK (<a href="./references#CD012551-bbs2-0024" title="RoweE , SmithC , LaverickL , ElkabirJ , WitherowRO , PatelA . A prospective, randomized, placebo controlled, double‐blind study of pelvic electromagnetic therapy for the treatment of chronic pelvic pain syndrome with 1 year of followup. Journal of Urology2005;173(6):2044‐7. ">Rowe 2005</a>; <a href="./references#CD012551-bbs2-0027" title="ShahT , WatsonG , BarnesD . Microwave hyperthermia in the treatment of chronic abacterial prostatitis and prostatodynia: results of a double blind placebo controlled trial (Abstract). Journal of Urology1993;149:405A. ">Shah 1993</a>), Nigeria (<a href="./references#CD012551-bbs2-0029" title="SikiruL , ShmailaH , MuhammedSA . Transcutaneous electrical nerve stimulation (TENS) in the symptomatic management of chronic prostatitis/chronic pelvic pain syndrome: a placebo‐control randomized trial. International Brazilian Journal of Urology2008;34(6):708‐13; discussion 714. ">Sikiru 2008</a>), Iran (<a href="./references#CD012551-bbs2-0030" title="MoayedniaA , HaghdaniS , KhosrawiS , YousefiE , VahdatpourB . Long‐term effect of extracorporeal shock wave therapy on the treatment of chronic pelvic pain syndrome due to non bacterial prostatitis. Journal of Research in Medical Sciences2014;19(4):293‐6. VahdatpourB , AlizadehF , MoayedniaA , EmadiM , KhoramiMH , HaghdaniS . Efficacy of extracorporeal shock wave therapy for the treatment of chronic pelvic pain syndrome: a randomized, controlled trial. ISRN Urology2013;2013:972601. ">Vahdatpour 2013</a>), Russia (<a href="./references#CD012551-bbs2-0019" title="NeimarkAI , MaksimovaSS . Effect of hypercapnic hypoxia on chronic abacterial prostatitis. Urologiia (Moscow, Russia : 1999)2016;1(3):80‐4. [PUBMED: 28247635] ">Neimark 2016</a>; <a href="./references#CD012551-bbs2-0031" title="VassilyO , AndreyS , EvgeniiD , OtabekI , BorisL , SergeyR . Efficacy of transrectal microwave hyperthemia (TRMH) in the treatment of chronic prostatitis. A randomized sham controlled comparative study (Abstract). Journal of Urology1999;161(4 Suppl):33A. ">Vassily 1999</a>), and Austria (<a href="./references#CD012551-bbs2-0038" title="ZimmermannR , CumpanasA , MicleaF , JanetschekG . Extracorporeal shock wave therapy for the treatment of chronic pelvic pain syndrome in males: a randomised, double‐blind, placebo‐controlled study. European Urology2009;56(3):418‐24. ZimmermannRP , CumpanasA , MicleaF , JanetschekG . One year follow up of extracorporeal shock wave therapy (ESWT) for chronic pelvic pain syndrome (CPPS) in a randomised placebo‐controlled double‐blind study. European Urology (Suppl)2010;9(2):214. ">Zimmermann 2009</a>). Two studies were conducted in more than one country (<a href="./references#CD012551-bbs2-0010" title="KastnerC , HochreiterW , HuidobroC , CabezasJ , MillerP . Cooled transurethral microwave thermotherapy for intractable chronic prostatitis ‐ results of a pilot study after 1 year. Urology2004;64(6):1149‐54. ">Kastner 2004</a>; <a href="./references#CD012551-bbs2-0013" title="LeeSW , LiongML , YuenKH , KriegerJN . Acupuncture and immune function in chronic prostatitis/chronic pelvic pain syndrome: a randomized, controlled study. Complementary Therapies in Medicine2014;22(6):965‐9. LeeSW , LiongML , YuenKH , LeongWS , CheeC , CheahPY , et al. Acupuncture versus sham acupuncture for chronic prostatitis/chronic pelvic pain. American Journal of Medicine2008;121(1):79.e1‐7. LeeSW , LiongML , YuenKH , LeongWS , KhanNK , KriegerJN . Validation of a sham acupuncture procedure in a randomised, controlled clinical trial of chronic pelvic pain treatment. Acupuncture in Medicine2011;29(1):40‐6. ">Lee 2008</a>). </p> </section> <section id="CD012551-sec-0087"> <h5 class="title">Participants</h5> <p>The median age of participants was 37 years. Three studies did not provide information regarding age (<a href="./references#CD012551-bbs2-0021" title="OhMM , JinMH , MoonDG , NamSG , BaeJH , ParkHS . A prospective, randomized, placebo controlled study of radiofrequency therapy for the treatment of chronic prostatitis/chronic pelvic pain syndrome. Journal of Urology2009;181(4):122. ">Oh 2009</a>; <a href="./references#CD012551-bbs2-0027" title="ShahT , WatsonG , BarnesD . Microwave hyperthermia in the treatment of chronic abacterial prostatitis and prostatodynia: results of a double blind placebo controlled trial (Abstract). Journal of Urology1993;149:405A. ">Shah 1993</a>; <a href="./references#CD012551-bbs2-0031" title="VassilyO , AndreyS , EvgeniiD , OtabekI , BorisL , SergeyR . Efficacy of transrectal microwave hyperthemia (TRMH) in the treatment of chronic prostatitis. A randomized sham controlled comparative study (Abstract). Journal of Urology1999;161(4 Suppl):33A. ">Vassily 1999</a>). These studies were reported in abstract form with few data available. The included studies (except <a href="./references#CD012551-bbs2-0010" title="KastnerC , HochreiterW , HuidobroC , CabezasJ , MillerP . Cooled transurethral microwave thermotherapy for intractable chronic prostatitis ‐ results of a pilot study after 1 year. Urology2004;64(6):1149‐54. ">Kastner 2004</a>) did not include participants over 50 years old to avoid symptom overlap with benign prostate hyperplasia. <a href="./references#CD012551-bbs2-0010" title="KastnerC , HochreiterW , HuidobroC , CabezasJ , MillerP . Cooled transurethral microwave thermotherapy for intractable chronic prostatitis ‐ results of a pilot study after 1 year. Urology2004;64(6):1149‐54. ">Kastner 2004</a> included participants with a mean age of 60 years. </p> <p>All studies referred to diagnostic criteria aimed at the differentiation of CP/CPPS from other forms of prostatitis and other urological diseases. Participants underwent digital rectal examination, urine cultures and 2 or 4 glass Meares‐Stamey test. They excluded participants who had recently undergone prostatic biopsy or surgery, participants with prostate cancer, participants with a recent history of sexually transmitted diseases and participants with concomitant neurological disorders or severe systemic disorders. </p> <p>Only one study included participants who had not received other previous treatment (<a href="./references#CD012551-bbs2-0012" title="KucukEV , SucekenFY , BindayiA , BoyluU , OnolFF , GumusE . Effectiveness of acupuncture on chronic prostatitis‐chronic pelvic pain syndrome category IIIB patients: a prospective, randomized, nonblinded, clinical trial. Urology2015;85(3):636‐40. ">Kucuk 2015</a>). Eleven studies specified that participants had previously received medical treatment with antibiotics or alpha blockers (or both) and had not had a positive response (<a href="./references#CD012551-bbs2-0004" title="BadilloSA , NevilleCE , KotarinosR , FortmanC , FraserL , CosbyA , et al. Randomized multicenter pilot trial shows benefit of manual physical therapies in treatment of urologic chronic pelvic pain. Journal of Women's Health Physical Therapy2009;33(1):23. FitzGeraldMP , AndersonRU , PottsJ , PayneCK , PetersKM , ClemensJQ , et al. Randomized multicenter feasibility trial of myofascial physical therapy for the treatment of urological chronic pelvic pain syndromes. Journal of Urology2009;182(2):570‐80. FitzgeraldMP , AndersonRU , PottsJ , PayneCK , PetersKM , ClemensJQ , et al. Randomized multicenter feasibility trial of myofascial physical therapy for the treatment of urological chronic pelvic pain syndromes. Journal of Urology2013;189(1 Suppl):S75‐85. ">Fitzgerald 2013</a>; <a href="./references#CD012551-bbs2-0007" title="GiubileiG , MondainiN , MinerviniA , SaievaC , LapiniA , SerniS , et al. Physical activity of men with chronic prostatitis/chronic pelvic pain syndrome not satisfied with conventional treatments ‐ could it represent a valid option? The physical activity and male pelvic pain trial: a double‐blind, randomized study. Journal of Urology2007;177(1):159‐65. ">Giubilei 2007</a>; <a href="./references#CD012551-bbs2-0009" title="KaikaiC , RuiW , YongC , ZhuC , WeiH , SuogangW , et al. Combination therapy of non‐intrusive ultrasound with integrated Chinese‐western medicine for chronic prostatitis/chronic pelvic pain syndrome. Chinese Journal of Andrology2014;28(12):41‐4. ">Kaikai 2014</a>; <a href="./references#CD012551-bbs2-0010" title="KastnerC , HochreiterW , HuidobroC , CabezasJ , MillerP . Cooled transurethral microwave thermotherapy for intractable chronic prostatitis ‐ results of a pilot study after 1 year. Urology2004;64(6):1149‐54. ">Kastner 2004</a>; <a href="./references#CD012551-bbs2-0011" title="KesslerTM , MordasiniL , WeisstannerC , JuniP , daCostaBR , WiestR , et al. Sono‐electro‐magnetic therapy for treating chronic pelvic pain syndrome in men: a randomized, placebo‐controlled, double‐blind trial. PloS One2014;9(12):e113368. WeisstannerC , MordasiniL , ThalmannGN , VermaRK , RummelC , FederspielA , et al. Therapy‐related longitudinal brain perfusion changes in patients with chronic pelvic pain syndrome. Swiss Medical Weekly2017;147:w14454. ">Kessler 2014</a>; <a href="./references#CD012551-bbs2-0013" title="LeeSW , LiongML , YuenKH , KriegerJN . Acupuncture and immune function in chronic prostatitis/chronic pelvic pain syndrome: a randomized, controlled study. Complementary Therapies in Medicine2014;22(6):965‐9. LeeSW , LiongML , YuenKH , LeongWS , CheeC , CheahPY , et al. Acupuncture versus sham acupuncture for chronic prostatitis/chronic pelvic pain. American Journal of Medicine2008;121(1):79.e1‐7. LeeSW , LiongML , YuenKH , LeongWS , KhanNK , KriegerJN . Validation of a sham acupuncture procedure in a randomised, controlled clinical trial of chronic pelvic pain treatment. Acupuncture in Medicine2011;29(1):40‐6. ">Lee 2008</a>; <a href="./references#CD012551-bbs2-0017" title="MontorsiF , GuazzoniG , BergamaschiF , GalliL , ConsonniP , MatozzoV , et al. Is there a role for transrectal microwave hyperthermia of the prostate in the treatment of abacterial prostatitis and prostatodynia?. Prostate1993;22(2):139‐46. ">Montorsi 1993</a>; <a href="./references#CD012551-bbs2-0020" title="NickelJC , SorensenR . Transurethral microwave thermotherapy for nonbacterial prostatitis: a randomized double‐blind sham controlled study using new prostatitis specific assessment questionnaires. Journal of Urology1996;155(6):1950‐4; discussion 1954. ">Nickel 1996</a>; <a href="./references#CD012551-bbs2-0024" title="RoweE , SmithC , LaverickL , ElkabirJ , WitherowRO , PatelA . A prospective, randomized, placebo controlled, double‐blind study of pelvic electromagnetic therapy for the treatment of chronic pelvic pain syndrome with 1 year of followup. Journal of Urology2005;173(6):2044‐7. ">Rowe 2005</a>; <a href="./references#CD012551-bbs2-0025" title="SahinS , BicerM , ErenGA , TasS , TugcuV , TasciAI , et al. Acupuncture relieves symptoms in chronic prostatitis/chronic pelvic pain syndrome: a randomized, sham‐controlled trial. Prostate Cancer and Prostatic Diseases2015;18(3):249‐54. ">Sahin 2015</a>; <a href="./references#CD012551-bbs2-0033" title="YangZS , ZuXB , QiL , SongLM , LiuTR . Combination therapy of biofeedback with electrical stimulation for chronic prostatitis/chronic pelvic pain syndrome. Zhonghua Nan Ke Xue2011;17(7):611‐4. ">Yang 2011</a>). The other studies did not specify whether the participants had received previous treatments for this condition. Nevertheless, a common inclusion criterion included a washout period, as stated in a protocol for medical therapy often cited as a consensus for inclusion/exclusion criteria (<a href="./references#CD012551-bbs2-0178" title="PropertKJ , AlexanderRB , NickelJC , KusekJW , LitwinMS , LandisJR , et al. Design of a multicenter randomized clinical trial for chronic prostatitis/chronic pelvic pain syndrome. Urology2002;59(6):870‐6. [PUBMED: 12031372] ">Propert 2002</a>). </p> </section> <section id="CD012551-sec-0088"> <h5 class="title">Interventions</h5> <p>We included studies assessing a wide variety of non‐pharmacological interventions.</p> <p> <ul id="CD012551-list-0025"> <li> <p>Acupuncture and electroacupuncture (<a href="./references#CD012551-bbs2-0002" title="ChenZX . Observation on therapeutic effect of warm needle moxibustion on chronic non‐bacterial prostatitis. Zhongguo Zhen Jiu [Chinese Acupuncture &amp; Moxibustion]2009;29(4):275‐8. ">Chen 2009</a>; <a href="./references#CD012551-bbs2-0012" title="KucukEV , SucekenFY , BindayiA , BoyluU , OnolFF , GumusE . Effectiveness of acupuncture on chronic prostatitis‐chronic pelvic pain syndrome category IIIB patients: a prospective, randomized, nonblinded, clinical trial. Urology2015;85(3):636‐40. ">Kucuk 2015</a>; <a href="./references#CD012551-bbs2-0013" title="LeeSW , LiongML , YuenKH , KriegerJN . Acupuncture and immune function in chronic prostatitis/chronic pelvic pain syndrome: a randomized, controlled study. Complementary Therapies in Medicine2014;22(6):965‐9. LeeSW , LiongML , YuenKH , LeongWS , CheeC , CheahPY , et al. Acupuncture versus sham acupuncture for chronic prostatitis/chronic pelvic pain. American Journal of Medicine2008;121(1):79.e1‐7. LeeSW , LiongML , YuenKH , LeongWS , KhanNK , KriegerJN . Validation of a sham acupuncture procedure in a randomised, controlled clinical trial of chronic pelvic pain treatment. Acupuncture in Medicine2011;29(1):40‐6. ">Lee 2008</a>; <a href="./references#CD012551-bbs2-0014" title="LeeSH , LeeBC . Electroacupuncture relieves pain in men with chronic prostatitis/chronic pelvic pain syndrome: three‐arm randomized trial. Urology2009;73(5):1036‐41. ">Lee 2009</a>; <a href="./references#CD012551-bbs2-0025" title="SahinS , BicerM , ErenGA , TasS , TugcuV , TasciAI , et al. Acupuncture relieves symptoms in chronic prostatitis/chronic pelvic pain syndrome: a randomized, sham‐controlled trial. Prostate Cancer and Prostatic Diseases2015;18(3):249‐54. ">Sahin 2015</a>). </p> </li> <li> <p>Local thermotherapy (<a href="./references#CD012551-bbs2-0006" title="GaoM , DingH , ZhongG , LuJ , WangH , LiQ , et al. The effects of transrectal radiofrequency hyperthermia on patients with chronic prostatitis and the changes of MDA, NO, SOD, and Zn levels in pretreatment and posttreatment. Urology2012;79(2):391‐6. ">Gao 2012</a>; <a href="./references#CD012551-bbs2-0010" title="KastnerC , HochreiterW , HuidobroC , CabezasJ , MillerP . Cooled transurethral microwave thermotherapy for intractable chronic prostatitis ‐ results of a pilot study after 1 year. Urology2004;64(6):1149‐54. ">Kastner 2004</a>; <a href="./references#CD012551-bbs2-0015" title="LeskinenMJ , KilponenA , LukkarinenO , TammelaTL . Transurethral needle ablation for the treatment of chronic pelvic pain syndrome (category III prostatitis): a randomized, sham‐controlled study. Urology2002;60(2):300‐4. ">Leskinen 2002</a>; <a href="./references#CD012551-bbs2-0017" title="MontorsiF , GuazzoniG , BergamaschiF , GalliL , ConsonniP , MatozzoV , et al. Is there a role for transrectal microwave hyperthermia of the prostate in the treatment of abacterial prostatitis and prostatodynia?. Prostate1993;22(2):139‐46. ">Montorsi 1993</a>; <a href="./references#CD012551-bbs2-0018" title="MuraroGB . Clinical study on the efficacy and safety of seaprose S combined with local prostatic hyperthermia in chronic non‐bacterial prostatitis. Controlled study versus local prostatic hyperthermia [Studio clinico sull'efficacia e la tollerabilita del seaprose S associato a ipertermia locale prostatica nella prostatite cronica abatterica. Studio controllato verso ipertermia locale prostatica]. Archivio di Medicina Interna1995;47(2‐3):73‐86. ">Muraro 1995</a>; <a href="./references#CD012551-bbs2-0020" title="NickelJC , SorensenR . Transurethral microwave thermotherapy for nonbacterial prostatitis: a randomized double‐blind sham controlled study using new prostatitis specific assessment questionnaires. Journal of Urology1996;155(6):1950‐4; discussion 1954. ">Nickel 1996</a>; <a href="./references#CD012551-bbs2-0021" title="OhMM , JinMH , MoonDG , NamSG , BaeJH , ParkHS . A prospective, randomized, placebo controlled study of radiofrequency therapy for the treatment of chronic prostatitis/chronic pelvic pain syndrome. Journal of Urology2009;181(4):122. ">Oh 2009</a>; <a href="./references#CD012551-bbs2-0027" title="ShahT , WatsonG , BarnesD . Microwave hyperthermia in the treatment of chronic abacterial prostatitis and prostatodynia: results of a double blind placebo controlled trial (Abstract). Journal of Urology1993;149:405A. ">Shah 1993</a>; <a href="./references#CD012551-bbs2-0031" title="VassilyO , AndreyS , EvgeniiD , OtabekI , BorisL , SergeyR . Efficacy of transrectal microwave hyperthemia (TRMH) in the treatment of chronic prostatitis. A randomized sham controlled comparative study (Abstract). Journal of Urology1999;161(4 Suppl):33A. ">Vassily 1999</a>; <a href="./references#CD012551-bbs2-0032" title="WangJ , LiJ , LuR , WangJM . Treatment of external RF hyperthermia combining with alpha 1‐adrenergic receptor blocker for patients with prostatodynia and chronic non‐bacterial prostatitis. Zhonghua Nan Ke Xue2002;8(1):48‐50. ">Wang 2002</a>; <a href="./references#CD012551-bbs2-0034" title="ChungH , ChoiH , YooTK , ChoJM , KimHS . The effects of microwave thermotherapy for chronic prostatitis/chronic pelvic pain syndrome: a prospective, randomized study. Urogenital Tract Infection2017;12(1):35‐41. KimH , ChungH , YangS , YooT , ChoJ . Effects of thermotherapy and medical therapy for chronic prostatitis/chronic pelvic pain syndrome: a prospective study. Urology2011;78(3):S85‐6. YooTK , MoonKT , LeeSW , KimHS , ChungH , KimJY . Effect of the combination treatment of URO‐DrG and medical therapy for chronic prostatitis/chronic pelvic pain syndrome: a prospective study. Journal of Urology2009;181(4):122. ">Yoo 2009</a>). </p> </li> <li> <p>Extracorporeal shockwave therapy (<a href="./references#CD012551-bbs2-0023" title="PajovicB , RadojevicN , DimitrovskiA , VukovicM . Comparison of the efficiency of combined extracorporeal shock‐wave therapy and triple therapy versus triple therapy itself in Category III B chronic pelvic pain syndrome (CPPS). Aging Male2016;19(3):1‐6. ">Pajovic 2016</a>; <a href="./references#CD012551-bbs2-0030" title="MoayedniaA , HaghdaniS , KhosrawiS , YousefiE , VahdatpourB . Long‐term effect of extracorporeal shock wave therapy on the treatment of chronic pelvic pain syndrome due to non bacterial prostatitis. Journal of Research in Medical Sciences2014;19(4):293‐6. VahdatpourB , AlizadehF , MoayedniaA , EmadiM , KhoramiMH , HaghdaniS . Efficacy of extracorporeal shock wave therapy for the treatment of chronic pelvic pain syndrome: a randomized, controlled trial. ISRN Urology2013;2013:972601. ">Vahdatpour 2013</a>; <a href="./references#CD012551-bbs2-0035" title="ZengX , YeZ , YangW , ChenZ , DuG . Extracorporeal shock wave treatment for noninflammatory chronic pelvic pain syndrome: a prospective, randomized, sham‐controlled study. Journal of Urology2009;181(4):122‐3. ZengXY , LiangC , YeZQ . Extracorporeal shock wave treatment for non‐inflammatory chronic pelvic pain syndrome: a prospective, randomized and sham‐controlled study. Chinese Medical Journal2012;125(1):114‐8. ">Zeng 2012</a>; <a href="./references#CD012551-bbs2-0038" title="ZimmermannR , CumpanasA , MicleaF , JanetschekG . Extracorporeal shock wave therapy for the treatment of chronic pelvic pain syndrome in males: a randomised, double‐blind, placebo‐controlled study. European Urology2009;56(3):418‐24. ZimmermannRP , CumpanasA , MicleaF , JanetschekG . One year follow up of extracorporeal shock wave therapy (ESWT) for chronic pelvic pain syndrome (CPPS) in a randomised placebo‐controlled double‐blind study. European Urology (Suppl)2010;9(2):214. ">Zimmermann 2009</a>). </p> </li> <li> <p>Myofascial trigger point release compared to control intervention (<a href="./references#CD012551-bbs2-0004" title="BadilloSA , NevilleCE , KotarinosR , FortmanC , FraserL , CosbyA , et al. Randomized multicenter pilot trial shows benefit of manual physical therapies in treatment of urologic chronic pelvic pain. Journal of Women's Health Physical Therapy2009;33(1):23. FitzGeraldMP , AndersonRU , PottsJ , PayneCK , PetersKM , ClemensJQ , et al. Randomized multicenter feasibility trial of myofascial physical therapy for the treatment of urological chronic pelvic pain syndromes. Journal of Urology2009;182(2):570‐80. FitzgeraldMP , AndersonRU , PottsJ , PayneCK , PetersKM , ClemensJQ , et al. Randomized multicenter feasibility trial of myofascial physical therapy for the treatment of urological chronic pelvic pain syndromes. Journal of Urology2013;189(1 Suppl):S75‐85. ">Fitzgerald 2013</a>). </p> </li> <li> <p>Biofeedback with or without electrical stimulation compared to control (<a href="./references#CD012551-bbs2-0033" title="YangZS , ZuXB , QiL , SongLM , LiuTR . Combination therapy of biofeedback with electrical stimulation for chronic prostatitis/chronic pelvic pain syndrome. Zhonghua Nan Ke Xue2011;17(7):611‐4. ">Yang 2011</a>). </p> </li> <li> <p>Psychological support: we found no studies for this intervention.</p> </li> <li> <p>Prostatic surgery: we found no studies for this intervention.</p> </li> <li> <p>Other miscellaneous non‐pharmacological therapies:</p> <ul id="CD012551-list-0026"> <li> <p>circumcision compared to waiting list (<a href="./references#CD012551-bbs2-0037" title="ZhaoY , ZhaoW , LangG , ChenY , LiuJ , WangG , et al. Circumcision plus antibiotic, anti‐inflammatory, and alpha‐blocker therapy for the treatment for chronic prostatitis/chronic pelvic pain syndrome: a prospective, randomized, multicenter trial. World Journal of Urology2015;33(5):617‐22. ">Zhao 2015</a>); </p> </li> <li> <p>electromagnetic chair compared to sham procedure (<a href="./references#CD012551-bbs2-0022" title="PaickJS , LeeSC , KuJH . More effects of extracorporeal magnetic innervation and terazosin therapy than terazosin therapy alone for non‐inflammatory chronic pelvic pain syndrome: a pilot study. Prostate Cancer and Prostatic Diseases2006;9(3):261‐5. ">Paick 2006</a>; <a href="./references#CD012551-bbs2-0024" title="RoweE , SmithC , LaverickL , ElkabirJ , WitherowRO , PatelA . A prospective, randomized, placebo controlled, double‐blind study of pelvic electromagnetic therapy for the treatment of chronic pelvic pain syndrome with 1 year of followup. Journal of Urology2005;173(6):2044‐7. ">Rowe 2005</a>); </p> </li> <li> <p>laser therapy compared to medical treatment (<a href="./references#CD012551-bbs2-0003" title="FangJ , XuG , DingQ , ZhangY‐F . Observation on the safety and efficacy of He‐Ne laser equipment on chronic abacteria prostatitis. Fudan University Journal of Medical Sciences2005;32(2):234‐5, 252. ">Fang 2005</a>); </p> </li> <li> <p>lifestyle modifications (<a href="./references#CD012551-bbs2-0005" title="GalloL . Effectiveness of diet, sexual habits and lifestyle modifications on treatment of chronic pelvic pain syndrome. Prostate Cancer and Prostatic Diseases2014;17(3):238‐45. ">Gallo 2014</a>); </p> </li> <li> <p>osteopathy (<a href="./references#CD012551-bbs2-0016" title="MarxS . ICAOR 2006: does osteopathic treatment have an influence on the symptoms of patients with chronic prostatitis/chronic pelvic pain syndrome (CPPS)? A randomized controlled trial. International Journal of Osteopathic Medicine2006;9(1):44. MarxS , CimniakU , BeckertR , SchwerlaF , ReschKL . Chronic prostatitis/chronic pelvic pain syndrome. Influence of osteopathic treatment ‐ a randomized controlled study [Chronische Prostatitis/chronisches Beckenschmerzsyndrom. Einfluss osteopathischer Behandlungen ‐ eine randomisiert kontrollierte Studie]. Der Urologe. Ausg. A2009;48(11):1339‐45. ">Marx 2009</a>); </p> </li> <li> <p>physical activity (<a href="./references#CD012551-bbs2-0007" title="GiubileiG , MondainiN , MinerviniA , SaievaC , LapiniA , SerniS , et al. Physical activity of men with chronic prostatitis/chronic pelvic pain syndrome not satisfied with conventional treatments ‐ could it represent a valid option? The physical activity and male pelvic pain trial: a double‐blind, randomized study. Journal of Urology2007;177(1):159‐65. ">Giubilei 2007</a>); </p> </li> <li> <p>prostatic massage (<a href="./references#CD012551-bbs2-0001" title="AteyaA , FayezA , HaniR , ZohdyW , GabbarMA , ShamloulR . Evaluation of prostatic massage in treatment of chronic prostatitis. Urology2006;67(4):674‐8. ">Ateya 2006</a>; <a href="./references#CD012551-bbs2-0028" title="ShenSL , HeDL , LuoY . Clinical trials of combined therapy of an oral Chinese medicine with massage for chronic nonbacterial prostatitis. Zhonghua Nan Ke Xue2006;12(9):851‐3. ">Shen 2006</a>); </p> </li> <li> <p>sono‐electromagnetic therapy (<a href="./references#CD012551-bbs2-0011" title="KesslerTM , MordasiniL , WeisstannerC , JuniP , daCostaBR , WiestR , et al. Sono‐electro‐magnetic therapy for treating chronic pelvic pain syndrome in men: a randomized, placebo‐controlled, double‐blind trial. PloS One2014;9(12):e113368. WeisstannerC , MordasiniL , ThalmannGN , VermaRK , RummelC , FederspielA , et al. Therapy‐related longitudinal brain perfusion changes in patients with chronic pelvic pain syndrome. Swiss Medical Weekly2017;147:w14454. ">Kessler 2014</a>); </p> </li> <li> <p>TaiJiQuan (<a href="./references#CD012551-bbs2-0036" title="ZhangDY , PanXC . Chinese medicine union Taijiquan treatment chronicity non‐bacterial prostatitis curative effect observation. Chinese Manipulation &amp; Rehabilitation Medicine2011;15(2):181. ">Zhang 2011a</a>); </p> </li> <li> <p>transelectrical nerve stimulation (TENS) (<a href="./references#CD012551-bbs2-0026" title="Samhan AhmedF , Abd‐Elhalim NermeenM , Elnegmy EmamH , Roiah MohamedM . The effect of transcutaneous electrical nerve stimulation in the treatment of chronic pelvic pain syndrome: an evidence based electromyographic studies. Indian Journal of Physiotherapy &amp; Occupational Therapy2011;5(3):14‐7. ">Samhan 2011</a>; <a href="./references#CD012551-bbs2-0029" title="SikiruL , ShmailaH , MuhammedSA . Transcutaneous electrical nerve stimulation (TENS) in the symptomatic management of chronic prostatitis/chronic pelvic pain syndrome: a placebo‐control randomized trial. International Brazilian Journal of Urology2008;34(6):708‐13; discussion 714. ">Sikiru 2008</a>); </p> </li> <li> <p>tibial nerve stimulation (<a href="./references#CD012551-bbs2-0008" title="KabayS , KabaySC , YucelM , OzdenH . Efficiency of posterior tibial nerve stimulation in category IIIB chronic prostatitis/chronic pelvic pain: a Sham‐Controlled Comparative Study. Urologia Internationalis2009;83(1):33‐8. ">Kabay 2009</a>); </p> </li> <li> <p>ultrasound (<a href="./references#CD012551-bbs2-0009" title="KaikaiC , RuiW , YongC , ZhuC , WeiH , SuogangW , et al. Combination therapy of non‐intrusive ultrasound with integrated Chinese‐western medicine for chronic prostatitis/chronic pelvic pain syndrome. Chinese Journal of Andrology2014;28(12):41‐4. ">Kaikai 2014</a>); </p> </li> <li> <p>hypercapnic hypoxia (<a href="./references#CD012551-bbs2-0019" title="NeimarkAI , MaksimovaSS . Effect of hypercapnic hypoxia on chronic abacterial prostatitis. Urologiia (Moscow, Russia : 1999)2016;1(3):80‐4. [PUBMED: 28247635] ">Neimark 2016</a>). </p> </li> </ul> </li> </ul> </p> </section> <section id="CD012551-sec-0089"> <h5 class="title">Outcomes</h5> <p>Almost all studies reported the effects of the interventions on prostatitis symptoms. All but four studies used the NIH‐CPSI score. <a href="./references#CD012551-bbs2-0015" title="LeskinenMJ , KilponenA , LukkarinenO , TammelaTL . Transurethral needle ablation for the treatment of chronic pelvic pain syndrome (category III prostatitis): a randomized, sham‐controlled study. Urology2002;60(2):300‐4. ">Leskinen 2002</a>; <a href="./references#CD012551-bbs2-0020" title="NickelJC , SorensenR . Transurethral microwave thermotherapy for nonbacterial prostatitis: a randomized double‐blind sham controlled study using new prostatitis specific assessment questionnaires. Journal of Urology1996;155(6):1950‐4; discussion 1954. ">Nickel 1996</a>; and <a href="./references#CD012551-bbs2-0024" title="RoweE , SmithC , LaverickL , ElkabirJ , WitherowRO , PatelA . A prospective, randomized, placebo controlled, double‐blind study of pelvic electromagnetic therapy for the treatment of chronic pelvic pain syndrome with 1 year of followup. Journal of Urology2005;173(6):2044‐7. ">Rowe 2005</a> used a 100‐point validated scale (Prostatitis Symptom Severity Index) and <a href="./references#CD012551-bbs2-0032" title="WangJ , LiJ , LuR , WangJM . Treatment of external RF hyperthermia combining with alpha 1‐adrenergic receptor blocker for patients with prostatodynia and chronic non‐bacterial prostatitis. Zhonghua Nan Ke Xue2002;8(1):48‐50. ">Wang 2002</a> used another validated scale (0 to 12, from <a href="./references#CD012551-bbs2-0168" title="NealDEJr , MoonTD . Use of terazosin in prostatodynia and validation of a symptom score questionnaire. Urology1994;43(4):460‐5. [PUBMED: 7512296] ">Neal 1994</a>). </p> <p>Other secondary outcomes relevant to this review were reported inconsistently. Five studies did not report any of the prespecified outcomes for this review: three studies were only available as abstracts (<a href="./references#CD012551-bbs2-0021" title="OhMM , JinMH , MoonDG , NamSG , BaeJH , ParkHS . A prospective, randomized, placebo controlled study of radiofrequency therapy for the treatment of chronic prostatitis/chronic pelvic pain syndrome. Journal of Urology2009;181(4):122. ">Oh 2009</a>; <a href="./references#CD012551-bbs2-0027" title="ShahT , WatsonG , BarnesD . Microwave hyperthermia in the treatment of chronic abacterial prostatitis and prostatodynia: results of a double blind placebo controlled trial (Abstract). Journal of Urology1993;149:405A. ">Shah 1993</a>; <a href="./references#CD012551-bbs2-0031" title="VassilyO , AndreyS , EvgeniiD , OtabekI , BorisL , SergeyR . Efficacy of transrectal microwave hyperthemia (TRMH) in the treatment of chronic prostatitis. A randomized sham controlled comparative study (Abstract). Journal of Urology1999;161(4 Suppl):33A. ">Vassily 1999</a>), one study reported the evolution of prostatitis symptoms with categorical variables (<a href="./references#CD012551-bbs2-0018" title="MuraroGB . Clinical study on the efficacy and safety of seaprose S combined with local prostatic hyperthermia in chronic non‐bacterial prostatitis. Controlled study versus local prostatic hyperthermia [Studio clinico sull'efficacia e la tollerabilita del seaprose S associato a ipertermia locale prostatica nella prostatite cronica abatterica. Studio controllato verso ipertermia locale prostatica]. Archivio di Medicina Interna1995;47(2‐3):73‐86. ">Muraro 1995</a>), and one study reported global improvement as a composite outcome of symptoms and laboratory findings (<a href="./references#CD012551-bbs2-0036" title="ZhangDY , PanXC . Chinese medicine union Taijiquan treatment chronicity non‐bacterial prostatitis curative effect observation. Chinese Manipulation &amp; Rehabilitation Medicine2011;15(2):181. ">Zhang 2011a</a>). One study described the evolution of prostatitis symptoms with categorical variables; however, it reported the incidence of adverse events (<a href="./references#CD012551-bbs2-0017" title="MontorsiF , GuazzoniG , BergamaschiF , GalliL , ConsonniP , MatozzoV , et al. Is there a role for transrectal microwave hyperthermia of the prostate in the treatment of abacterial prostatitis and prostatodynia?. Prostate1993;22(2):139‐46. ">Montorsi 1993</a>). </p> <p>We found only short‐term outcomes for all comparisons.</p> </section> <section id="CD012551-sec-0090"> <h5 class="title">Funding sources</h5> <p>Most studies (28 studies, 76%) did not specify their funding sources. Three studies received funding from the companies that manufactured the device under evaluation (<a href="./references#CD012551-bbs2-0011" title="KesslerTM , MordasiniL , WeisstannerC , JuniP , daCostaBR , WiestR , et al. Sono‐electro‐magnetic therapy for treating chronic pelvic pain syndrome in men: a randomized, placebo‐controlled, double‐blind trial. PloS One2014;9(12):e113368. WeisstannerC , MordasiniL , ThalmannGN , VermaRK , RummelC , FederspielA , et al. Therapy‐related longitudinal brain perfusion changes in patients with chronic pelvic pain syndrome. Swiss Medical Weekly2017;147:w14454. ">Kessler 2014</a>; <a href="./references#CD012551-bbs2-0019" title="NeimarkAI , MaksimovaSS . Effect of hypercapnic hypoxia on chronic abacterial prostatitis. Urologiia (Moscow, Russia : 1999)2016;1(3):80‐4. [PUBMED: 28247635] ">Neimark 2016</a>; <a href="./references#CD012551-bbs2-0024" title="RoweE , SmithC , LaverickL , ElkabirJ , WitherowRO , PatelA . A prospective, randomized, placebo controlled, double‐blind study of pelvic electromagnetic therapy for the treatment of chronic pelvic pain syndrome with 1 year of followup. Journal of Urology2005;173(6):2044‐7. ">Rowe 2005</a>). Three studies stated that they received no funding (<a href="./references#CD012551-bbs2-0015" title="LeskinenMJ , KilponenA , LukkarinenO , TammelaTL . Transurethral needle ablation for the treatment of chronic pelvic pain syndrome (category III prostatitis): a randomized, sham‐controlled study. Urology2002;60(2):300‐4. ">Leskinen 2002</a>; <a href="./references#CD012551-bbs2-0017" title="MontorsiF , GuazzoniG , BergamaschiF , GalliL , ConsonniP , MatozzoV , et al. Is there a role for transrectal microwave hyperthermia of the prostate in the treatment of abacterial prostatitis and prostatodynia?. Prostate1993;22(2):139‐46. ">Montorsi 1993</a>; <a href="./references#CD012551-bbs2-0023" title="PajovicB , RadojevicN , DimitrovskiA , VukovicM . Comparison of the efficiency of combined extracorporeal shock‐wave therapy and triple therapy versus triple therapy itself in Category III B chronic pelvic pain syndrome (CPPS). Aging Male2016;19(3):1‐6. ">Pajovic 2016</a>). Four studies received funding from public institutions (<a href="./references#CD012551-bbs2-0004" title="BadilloSA , NevilleCE , KotarinosR , FortmanC , FraserL , CosbyA , et al. Randomized multicenter pilot trial shows benefit of manual physical therapies in treatment of urologic chronic pelvic pain. Journal of Women's Health Physical Therapy2009;33(1):23. FitzGeraldMP , AndersonRU , PottsJ , PayneCK , PetersKM , ClemensJQ , et al. Randomized multicenter feasibility trial of myofascial physical therapy for the treatment of urological chronic pelvic pain syndromes. Journal of Urology2009;182(2):570‐80. FitzgeraldMP , AndersonRU , PottsJ , PayneCK , PetersKM , ClemensJQ , et al. Randomized multicenter feasibility trial of myofascial physical therapy for the treatment of urological chronic pelvic pain syndromes. Journal of Urology2013;189(1 Suppl):S75‐85. ">Fitzgerald 2013</a>; <a href="./references#CD012551-bbs2-0013" title="LeeSW , LiongML , YuenKH , KriegerJN . Acupuncture and immune function in chronic prostatitis/chronic pelvic pain syndrome: a randomized, controlled study. Complementary Therapies in Medicine2014;22(6):965‐9. LeeSW , LiongML , YuenKH , LeongWS , CheeC , CheahPY , et al. Acupuncture versus sham acupuncture for chronic prostatitis/chronic pelvic pain. American Journal of Medicine2008;121(1):79.e1‐7. LeeSW , LiongML , YuenKH , LeongWS , KhanNK , KriegerJN . Validation of a sham acupuncture procedure in a randomised, controlled clinical trial of chronic pelvic pain treatment. Acupuncture in Medicine2011;29(1):40‐6. ">Lee 2008</a>; <a href="./references#CD012551-bbs2-0014" title="LeeSH , LeeBC . Electroacupuncture relieves pain in men with chronic prostatitis/chronic pelvic pain syndrome: three‐arm randomized trial. Urology2009;73(5):1036‐41. ">Lee 2009</a>; <a href="./references#CD012551-bbs2-0037" title="ZhaoY , ZhaoW , LangG , ChenY , LiuJ , WangG , et al. Circumcision plus antibiotic, anti‐inflammatory, and alpha‐blocker therapy for the treatment for chronic prostatitis/chronic pelvic pain syndrome: a prospective, randomized, multicenter trial. World Journal of Urology2015;33(5):617‐22. ">Zhao 2015</a>). </p> </section> </section> <section id="CD012551-sec-0091"> <h4 class="title">Excluded studies</h4> <p>We excluded 73 studies for the following reasons (see <a href="./references#CD012551-sec-0312" title="">Characteristics of excluded studies</a>). </p> <p>Eleven studies evaluated a wrong participant population: eight studies included participants with bacterial prostatitis, with no disaggregated data for CP/CPPS (<a href="./references#CD012551-bbs2-0043" title="BarbaliasGA , NikiforidisG , LiatsikosEN . Alpha‐blockers for the treatment of chronic prostatitis in combination with antibiotics. Urologia Internationalis1998;159(3):883‐7. ">Barbalias 1998</a>; <a href="./references#CD012551-bbs2-0055" title="FengH , HuC , LiL . Influence of whole‐range systematic nursing intervention of therapeutic effect and compliance of patients with chronic prostatitis. Chinese Nursing Research2011;25(5A):1146‐8. ">Feng 2011</a>; <a href="./references#CD012551-bbs2-0056" title="GaleoneG , SpadavecchiaR , BalducciMT , PagliaruloV . The role of Proxelan in the treatment of chronic prostatitis. Results of a randomized trial [Ruolo di Proxelan nel trattamento delle prostatitit croniche. Risultati di un trial randomizzato]. Minerva Urologica e Nefrologica [Italian Journal of Urology and Nephrology]2012;64(2):135‐41. ">Galeone 2012</a>; <a href="./references#CD012551-bbs2-0057" title="GlybochkoPV , Alyaev YuG , ChalyjME , VoskanyanGA . Primary assessment of electrode pharmaphoresis efficacy in treatment of chronic bacterial prostatitis. European Urology Supplements2014;13(1):e571. ">Glybochko 2014</a>; <a href="./references#CD012551-bbs2-0058" title="GolubchikovVA , SitnikovNV , KochetovAG , PerekhodovSN , SidorovOV , RoiukRV , et al. Optimal treatment of benign prostatic hyperplasia (BPH) with comorbid chronic prostatitis (category IIIA). Urologiia2005;1(4):9‐12. ">Golubchikov 2005</a>; <a href="./references#CD012551-bbs2-0072" title="LokshinKL , AlyaevYG , VinarovAZ , SpivakLG . Randomized open label comparative study of efficacy and safety of combination (ciprofloxacin+doxazosin) versus monotherapy (ciprofloxacin) in patients with category II or category IIIA prostatitis. Urologiia2010;9(2):140. ">Lokshin 2010</a>; <a href="./references#CD012551-bbs2-0095" title="Pushkar'DIu , ZaitsevAV , SegalAS . Longidase in the treatment of chronic prostatitis. Urologiia2006;1(6):26‐8. ">Pushkar' 2006</a>; <a href="./references#CD012551-bbs2-0099" title="SimmonsPD , ThinRN . Minocycline in chronic abacterial prostatitis: a double‐blind prospective trial. British Journal of Urology1985;57(1):43‐5. ">Simmons 1985</a>), and three studies did not use the NIH criteria for CP/CPPS (<a href="./references#CD012551-bbs2-0091" title="NickelJC , RoehrbornC , MontorsiF , WilsonTH , RittmasterRS . Dutasteride reduces prostatitis symptoms compared with placebo in men enrolled in the REDUCE study. Journal of Urology2011;186(4):1313‐8. ">Nickel 2011</a>; <a href="./references#CD012551-bbs2-0110" title="ZhangMJ , WengJF , ShiYL , ChengWJ , RuanXJ , ZhangQY . Effect of aike mixture on the inflammatory infiltration in patients with chronic prostatitis type III A. Chinese Journal of Integrative Medicine2011;17(1):26‐30. ">Zhang 2011b</a>; <a href="./references#CD012551-bbs2-0111" title="ZhouM , YangM , ChenL , YuC , ZhangW , JiJ , et al. The effectiveness of long‐needle acupuncture at acupoints BL30 and BL35 for CP/CPPS: a randomized controlled pilot study. BMC Complementary and Alternative Medicine2017;17:1‐6. ">Zhou 2017</a>). </p> <p>We found 28 studies to have a wrong study design: 25 studies specified that they did not use randomisation or used a non‐random sequence for the allocation of participants (<a href="./references#CD012551-bbs2-0040" title="AliaevIuG , VinarovAZ , LokshinKL , SpivakLG . Efficiency and safety of prostamol‐Uno in patients with chronic abacterial prostatitis. Urologiia2006;1(1):47‐50. ">Aliaev 2006</a>; <a href="./references#CD012551-bbs2-0041" title="AllenS , AghajanyanIG . Effect of thermobalancing therapy on chronic prostatitis and chronic pelvic pain syndrome. Journal of Clinical Urology2017;10(4):347‐54. AllenS , AghajanyanIG . New independent thermobalancing treatment with therapeutic device for chronic prostatitis/chronic pelvic pain syndrome. Nephro‐Urology Monthly2017;9(2):1‐6. ">Allen 2017</a>; <a href="./references#CD012551-bbs2-0051" title="ColleenS , MrdhPA . Effect of metacycline treatment on non‐acute prostatitis. Scandinavian Journal of Urology and Nephrology1975;9(3):198‐204. ">Colleen 1975</a>; <a href="./references#CD012551-bbs2-0052" title="DRKS00009352 . Effect of the physiotherapeutic device and thermobalancing therapy compared with no therapy on pain, urinary symptoms, quality of life and prostate volume in men with chronic prostatitis / chronic pelvic pain syndrome (CP/CPPS). http://www.drks.de/drks_web/navigate.do?navigationId=trial.HTML&amp;TRIAL_ID=DRKS00009352 (accessed 22 January 2018 via http://apps.who.int/trialsearch/ search portal). ">DRKS00009352</a>; <a href="./references#CD012551-bbs2-0054" title="EvliyaogluY , BurgutR . Lower urinary tract symptoms, pain and quality of life assessment in chronic non‐bacterial prostatitis patients treated with alpha‐blocking agent doxazosin; versus placebo. International Urology and Nephrology2002;34(3):351‐6. ">Evliyaoglu 2002</a>; <a href="./references#CD012551-bbs2-0059" title="HongJY , ZhangYY . Observation on therapeutic effect of abdominal cluster‐needling on chronic non‐bacterial prostatitis. Chinese Acupuncture &amp; Moxibustion2008;28(1):24‐6. ">Hong 2008</a>; <a href="./references#CD012551-bbs2-0060" title="IkeuchiT . Clinical studies on chronic prostatitis and prostatitis‐like syndrome (4). The kampo treatment for intractable prostatitis. Hinyokika Kiyo1990;36(7):801‐6. ">Ikeuchi 1990</a>; <a href="./references#CD012551-bbs2-0061" title="ISRCTN43221600 . Pilot study for the evaluation of a combined psycho‐ and physiotherapeutic treatment program for patients with chronic pelvic pain syndrome (CPPS). www.isrctn.com/ISRCTN43221600 (accessed 4 November 2017). [ISRCTN43221600] ">ISRCTN43221600</a>; <a href="./references#CD012551-bbs2-0063" title="KalininaSN , Koren'kovDG , FesenkoVN , DemidovDA , TiktinskijNO . Pathogentic treatment of chronic nonbacterial prostatitis complicated by sperm disorders. Urologiia2015;1(4):64‐6, 68. ">Kalinina 2015</a>; <a href="./references#CD012551-bbs2-0064" title="KamalovAA , EfremovEA , DorofeevSD , PaniushkinSM . Use of oral vitaprost in the treatment of chronic abacterial prostatitis. Urologiia2006;1(5):45‐50. ">Kamalov 2006</a>; <a href="./references#CD012551-bbs2-0065" title="KoganMI , ShangichevAV , BelousovII . Efficacy of magnetolaser therapy of patients with an inflammatory form of chronic abacterial prostatitis. Urologiia2010;1(2):42‐4. ">Kogan 2010</a>; <a href="./references#CD012551-bbs2-0068" title="LeeHN , KimJS , ShimBS . The recurrence of chronic pelvic pain syndrome and the role of Uro‐Vaxom. Korean Journal of Urology2006;47(1):42‐6. ">Lee 2006</a>; <a href="./references#CD012551-bbs2-0070" title="LengJ , LvJ , DaiS , ChenB , WangY . The cocktail treatment of chronic nonbacterial prostatitis. Chinese Journal of Andrology2007;21(1):26‐8. ">Leng 2007</a>; <a href="./references#CD012551-bbs2-0073" title="LopatkinNA , KamalovAA , MazoEB , DorofeevSD , EfremovEA , KozdobaAS , et al. Administration of oral vitaprost for prevention of exacerbations of chronic abacterial prostatitis. Urologiia2009;1(1):29‐35. ">Lopatkin 2009</a>; <a href="./references#CD012551-bbs2-0074" title="LoranOB , Pushkar'DIu , TedeevVV , NosovitskiiPB . Gentos in the treatment of chronic abacterial prostatitis. Urologiia2003;1(6):30‐2. ">Loran 2003</a>; <a href="./references#CD012551-bbs2-0075" title="MaY , LiX , LiF , YuW , WangZ . Clinical research of chronic pelvic cavity pain syndrome treated with acupoint catgut embedding therapy. Zhongguo Zhen Jiu2015;35(6):561‐6. MaY , WangZL , SunZX , MenB , ShenBQ . Efficacy observation on chronic pelvic pain syndrome of damp‐heat stagnation pattern treated with acupoint catgut embedding therapy. Zhongguo Zhen Jiu2014;34(4):351‐4. ">Ma 2015</a>; <a href="./references#CD012551-bbs2-0092" title="OsbornDE , GeorgeNJR , RaoPN . Prostatodynia ‐ physiological characteristics and rational management with muscle relaxants. British Journal of Urology1981;53(6):621‐3. ">Osborn 1981</a>; <a href="./references#CD012551-bbs2-0093" title="PavoneC , AbbadessaD , TarantinoML , OxeniusI , LaganaA , LupoA , et al. Associating Serenoa repens, Urtica dioica and Pinus pinaster. Safety and efficacy in the treatment of lower urinary tract symptoms. Prospective study on 320 patients [Associazione di Serenoa repens, Urtica dioica e Pinus pinaster. Sicurezza ed efficacia]. Urologia2010;77(1):43‐51. ">Pavone 2010</a>; <a href="./references#CD012551-bbs2-0098" title="RazumovSV , EgorovAA . Validity of using physical therapy in combined treatment of chronic prostatitis. Urologiia2005;1(2):42‐6. ">Razumov 2005</a>; <a href="./references#CD012551-bbs2-0100" title="StamatiouKN , MoschourisH . A prospective interventional study in chronic prostatitis with emphasis to clinical features. Urology Journal2014;11(4):1829‐33. ">Stamatiou 2014</a>; <a href="./references#CD012551-bbs2-0101" title="TakahashiK , OzakiY , YoshidaT , FujimotoN , MatsumotoT , NakashimaM , et al. Clinical evaluation of treatment using mainly levofloxacin and cernitin pollen extract for chronic non‐bacterial prostatitis as judged by the National Institutes of Health Chronic Prostatitis Symptom Index. Nishinihon Journal of Urology2005;67(11):637‐48. ">Takahashi 2005</a>; <a href="./references#CD012551-bbs2-0103" title="ThinRN , SimmonsPD . Review of results of four regimens for treatment of chronic non‐bacterial prostatitis. British Journal of Urology1983;55(5):519‐21. ">Thin 1983</a>; <a href="./references#CD012551-bbs2-0104" title="TkachukVN , Al'‐ShukriSKh , Lotsan‐MedvedevAK . Vitaprost efficacy in patients with chronic abacterial prostatitis. Urologiia2006;1(2):71‐2, 74. ">Tkachuk 2006</a>; <a href="./references#CD012551-bbs2-0105" title="TkachukVN , Al'‐ShukriSKh , TkacukIN , KornienkoVI . Correction of erectile dysfunction in patients with chronic abacterial prostatitis. Urologiia2011;1(6):29‐31. ">Tkachuk 2011</a>; <a href="./references#CD012551-bbs2-0107" title="XuS , QiG , TangP , LiY . Combined therapy for the chronic pelvic pain syndrome. Zhonghua Nan Ke Xue2004;10(6):429‐30, 433. ">Xu 2004</a>); two studies reported the follow‐up of a single arm of RCTs (<a href="./references#CD012551-bbs2-0066" title="KotarinosR , FortmanC , NevilleC , BadilloS , O'DoughertyB , FraserL , et al. Physical findings in patients with urologic chronic pelvic pain syndromes (UCPPS). Neurourology and Urodynamics2009;28(7):911‐2. ">Kotarinos 2009</a>; <a href="./references#CD012551-bbs2-0077" title="MarxS , CimniakU , RutzM , ReschKL . Long‐term effects of osteopathic treatment of chronic prostatitis with chronic pelvic pain syndrome: a 5‐year follow‐up of a randomized controlled trial and considerations on the pathophysiological context [Langzeiteffekte osteopathischer Behandlungen bei chronischer Prostatitis/chronischem Beckenschmerzsyndrom: 5‐Jahres‐Follow‐up einer randomisiert kontrollierten Studie und Überlegungen zum pathophysiologischen Kontext]. Der Urologe. Ausg. A2013;52(3):384‐90. ">Marx 2013</a>); one study was a phase II dose‐finding study with an adaptive design (<a href="./references#CD012551-bbs2-0106" title="WagenlehnerFME , vanTillJWO , HoubiersJGA , MartinaRV , CerneusDP , MelisJHJM , et al. Fatty acid amide hydrolase inhibitor treatment in men with chronic prostatitis/chronic pelvic pain syndrome: an adaptive double‐blind, randomized controlled trial. Urology2017;103:191‐7. [PUBMED: 28254462] ">Wagenlehner 2017</a>). </p> <p>Additionally, 10 studies were terminated and there were no outcome data available, due to problems in their conduct (<a href="./references#CD012551-bbs2-0044" title="BschleipferT , WagenlehnerFM , WeidnerW . Intraprostatic botulinum toxin A injection in chronic prostatitis and chronic pelvic pain syndrome (CP/CPPS) [Intraprostatische Botulinumtoxin‐A‐Injektion bei chronischer Prostatitis und chronischem Beckenschmerzsyndrom (CP/CPPS)]. Der Urologe. Ausg. A2007;46(9):1030‐2. Department of Urology, Pediatric Urology ‐ Justus‐Liebig‐University Giessen. Intraprostatic injection of Botulinumtoxin type A in patients with chronic prostatitis / chronic pelvic pain syndrome (CP/CPPS) ‐ CP(BTX)PS. https://www.clinicaltrialsregister.eu/ctr‐search/trial/2007‐001602‐24/DE (accessed 22 January 2018)2009. ">Bschleipfer 2007</a>; <a href="./references#CD012551-bbs2-0082" title="NCT00194597 . Trial of Viagra' in men with chronic pelvic pain syndrome type III. clinicaltrials.gov/ct2/show/NCT00194597 Date first registered: 19 September 2005. ">NCT00194597</a>; <a href="./references#CD012551-bbs2-0083" title="NCT00194623 . Botox as a treatment for chronic male pelvic pain syndrome. ClinicalTrials.gov/show/NCT00194623 Date first registered: 19 September 2005. ">NCT00194623</a>; <a href="./references#CD012551-bbs2-0084" title="NCT00194636 . Effectiveness of sympathetic plexus block on male pelvic pain (prostatitis, prostatodynia). clinicaltrials.gov/ct2/show/NCT00194636 Date first registered: 19 September 2005. ">NCT00194636</a>; <a href="./references#CD012551-bbs2-0085" title="NCT00301405 . Open‐label study of thalidomide for chronic prostatitis/chronic pelvic pain. clinicaltrials.gov/ct2/show/NCT00301405 Date first registered: 10 March 2006. ">NCT00301405</a>; <a href="./references#CD012551-bbs2-0086" title="NCT00464373 . Botulinum toxin type A for the treatment of male chronic pelvic pain syndrome. clinicaltrials.gov/ct2/show/NCT00464373 Date first registered: 23 April 2007. ">NCT00464373</a>; <a href="./references#CD012551-bbs2-0087" title="NCT00529386 . Botox for chronic prostatitis/chronic pelvic pain syndrome (CP/CPPS). clinicaltrials.gov/ct2/show/NCT00529386 Date first registered: 14 September 2007. ">NCT00529386</a>; <a href="./references#CD012551-bbs2-0088" title="NCT01678911 . Efficacy of Gralise® for chronic pelvic pain. clinicaltrials.gov/ct2/show/NCT01678911 Date first registered: 5 September 2012. ">NCT01678911</a>; <a href="./references#CD012551-bbs2-0089" title="NCT01830829 . JALYN for benign prostatic hyperplasia (BPH) and chronic prostatitis/chronic pelvic pain syndrome (CP/CPPS). ClinicalTrials.gov/show/NCT01830829 Date first registered: 12 April 2013. ">NCT01830829</a>; <a href="./references#CD012551-bbs2-0090" title="NCT02042651 . A sham controlled study of the effects of ultrasonic shockwaves as a treatment for chronic pelvic pain. ClinicalTrials.gov/show/NCT02042651 Date first registered: 23 January 2014. ">NCT02042651</a>). </p> <p>Our search strategy identified 24 systematic reviews that we searched for additional studies and some of them were used in the discussion (<a href="./references#CD012551-bbs2-0039" title="AboumarzoukOM , NelsonRL . Pregabalin for chronic prostatitis. Cochrane Database of Systematic Reviews2012, Issue 8. [DOI: 10.1002/14651858.CD009063.pub2] ">Aboumarzouk 2012</a>; <a href="./references#CD012551-bbs2-0042" title="AnothaisintaweeT , AttiaJ , NickelJC , ThammakraisornS , NumthavajP , McEvoyM , et al. Management of chronic prostatitis/chronic pelvic pain syndrome: a systematic review and network meta‐analysis. JAMA2011;305(1):78‐86. ">Anothaisintawee 2011</a>; <a href="./references#CD012551-bbs2-0045" title="CapodiceJL , BemisDL , ButtyanR , KaplanSA , KatzAE . Complementary and alternative medicine for chronic prostatitis/chronic pelvic pain syndrome. Evidence‐based Complementary and Alternative Medicine : ECAM2005;2(4):495‐501. ">Capodice 2005</a>; <a href="./references#CD012551-bbs2-0046" title="ChamboRC , CarvalhoPE , CataneoAJM . Effectiveness and safety of finasteride in male chronic pelvic pain syndrome. Cochrane Database of Systematic Reviews2009, issue 2. [DOI: 10.1002/14651858.CD007723.pub2] ">Chambo 2009</a>; <a href="./references#CD012551-bbs2-0047" title="ChangSC , HsuCH , HsuCK , YangSS , ChangSJ . The efficacy of acupuncture in managing patients with chronic prostatitis/chronic pelvic pain syndrome: a systemic review and meta‐analysis. Neurourology and Urodynamics2016;1:474‐81. ">Chang 2016</a>; <a href="./references#CD012551-bbs2-0048" title="ChenJ , HuL . Traditional Chinese medicine for the treatment of chronic prostatitis in China: a systematic review and meta‐analysis. Journal of Alternative and Complementary Medicine (New York, N.Y.)2006;12(8):763‐9. ">Chen 2006</a>; <a href="./references#CD012551-bbs2-0049" title="ChuangYC , ChancellorMB . The application of botulinum toxin in the prostate. Journal of Urology2006;176(6 Pt 1):2375‐82. ">Chuang 2006</a>; <a href="./references#CD012551-bbs2-0050" title="CohenJM , FaginAP , HaritonE , NiskaJR , PierceMW , KuriyamaA , et al. Therapeutic intervention for chronic prostatitis/chronic pelvic pain syndrome (CP/CPPS): a systematic review and meta‐analysis. PloS One2012;7(8):e41941. ">Cohen 2012</a>; <a href="./references#CD012551-bbs2-0053" title="EricksonBA , SchaefferAJ , VanLeB . Chronic prostatitis. BMJ Clinical Evidence2008;2008:1802. ">Erickson 2008</a>; <a href="./references#CD012551-bbs2-0062" title="Jimenez‐PachecoA , Jimenez‐PachecoA , Nogueras‐OcañaM . Analysis of therapeutic alternatives in the treatment of chronic prostatitis/syndrome chronic pelvic pain. Urology2014;84(4):S241. ">Jimenez‐Pacheco 2014</a>; <a href="./references#CD012551-bbs2-0067" title="LeB , SchaefferAJ . Chronic prostatitis. BMJ Clinical Evidence2011;2011:1802. ">Le 2011</a>; <a href="./references#CD012551-bbs2-0069" title="LeeSW , LiongML , YuenKH , LiongYV , KriegerJN . Chronic prostatitis/chronic pelvic pain syndrome: role of alpha blocker therapy. Journal of Urology2007;78(2):97‐105. ">Lee 2007</a>; <a href="./references#CD012551-bbs2-0071" title="LiuBP , WangYT , ChenSD . Effect of acupuncture on clinical symptoms and laboratory indicators for chronic prostatitis/chronic pelvic pain syndrome: a systematic review and meta‐analysis. International Urology and Nephrology2016;48(12):1977‐91. ">Liu 2016</a>; <a href="./references#CD012551-bbs2-0076" title="MagistroG , WagenlehnerFM , GrabeM , WeidnerW , StiefCG , NickelJC . Contemporary management of chronic prostatitis/chronic pelvic pain syndrome. European Urology2016;69(2):286‐97. ">Magistro 2016</a>; <a href="./references#CD012551-bbs2-0078" title="McNaughton CollinsM , MacDonaldR , WiltTJ . Diagnosis and treatment of chronic abacterial prostatitis: a systematic review. Annals of Internal Medicine2000;133(5):367‐81. ">McNaughton 2000</a>; <a href="./references#CD012551-bbs2-0079" title="McNaughton CollinsM , MacDonaldR , WiltTJ . Interventions for chronic abacterial prostatitis. Cochrane Database of Systematic Reviews2001, Issue 1. [DOI: 10.1002/14651858.CD002080] ">McNaughton 2001</a>; <a href="./references#CD012551-bbs2-0080" title="McNaughton CollinsM , WiltTJ . Allopurinol for chronic prostatitis. Cochrane Database of Systematic Reviews2002, Issue 4. [DOI: 10.1002/14651858.CD001041; CD001041] ">McNaughton 2002</a>; <a href="./references#CD012551-bbs2-0081" title="MishraVC , BrowneJ , EmbertonM . Role of repeated prostatic massage in chronic prostatitis: a systematic review of the literature. Urology2008;72(4):731‐5. ">Mishra 2008</a>; <a href="./references#CD012551-bbs2-0094" title="PosadzkiP , ZhangJ , LeeM S , ErnstE . Acupuncture for chronic nonbacterial prostatitis/chronic pelvic pain syndrome: a systematic review. Journal of Andrology2012;33(1):15‐21. ">Posadzki 2012</a>; <a href="./references#CD012551-bbs2-0096" title="QinZ , WuJ , ZhouJ , LiuZ . Systematic review of acupuncture for chronic prostatitis/chronic pelvic pain syndrome. Medicine (Baltimore)2016;95(11):e3095. ">Qin 2016a</a>; <a href="./references#CD012551-bbs2-0097" title="QinZ , WuJ , TianJ , ZhouJ , LiuY , LiuZ . Network meta‐analysis of the efficacy of acupuncture, alpha‐blockers and antibiotics on chronic prostatitis/chronic pelvic pain syndrome. Scientific Reports2016;6:35737. ">Qin 2016b</a>; <a href="./references#CD012551-bbs2-0102" title="ThakkinstianA , AttiaJ , AnothaisintaweeT , NickelJC . Alpha‐blockers, antibiotics and anti‐inflammatories have a role in the management of chronic prostatitis/chronic pelvic pain syndrome. BJU International2012;110(7):1014‐22. ">Thakkinstian 2012</a>; <a href="./references#CD012551-bbs2-0108" title="YangG , WeiQ , LiH , YangY , ZhangS , DongQ . The effect of alpha‐adrenergic antagonists in chronic prostatitis/chronic pelvic pain syndrome: a meta‐analysis of randomized controlled trials. Journal of Andrology2006;27(6):847‐52. ">Yang 2006</a>; <a href="./references#CD012551-bbs2-0109" title="YangM , ZhaoX , HouY . Management of chronic prostatitis/chronic pelvic pain syndrome (CP/CPPS): a systematic review and meta‐analysis of randomized controlled trials (RCTs). Chinese Journal of Andrology2008;22(4):20‐6. ">Yang 2008</a>). </p> </section> </section> <section id="CD012551-sec-0092"> <h3 class="title">Risk of bias in included studies</h3> <p>See <a href="#CD012551-fig-0002">Figure 2</a> for a summary of risk of bias assessments. See <a href="#CD012551-fig-0003">Figure 3</a> for the individual assessments of the included studies. Detailed description of the supporting judgements can be found in the <a href="./references#CD012551-sec-0311" title="">Characteristics of included studies</a> table. Considering a global assessment of risk of bias for the main outcomes of this review, only one study had low risk of bias (<a href="./references#CD012551-bbs2-0011" title="KesslerTM , MordasiniL , WeisstannerC , JuniP , daCostaBR , WiestR , et al. Sono‐electro‐magnetic therapy for treating chronic pelvic pain syndrome in men: a randomized, placebo‐controlled, double‐blind trial. PloS One2014;9(12):e113368. WeisstannerC , MordasiniL , ThalmannGN , VermaRK , RummelC , FederspielA , et al. Therapy‐related longitudinal brain perfusion changes in patients with chronic pelvic pain syndrome. Swiss Medical Weekly2017;147:w14454. ">Kessler 2014</a>), 10 studies had unclear risk of bias (<a href="./references#CD012551-bbs2-0013" title="LeeSW , LiongML , YuenKH , KriegerJN . Acupuncture and immune function in chronic prostatitis/chronic pelvic pain syndrome: a randomized, controlled study. Complementary Therapies in Medicine2014;22(6):965‐9. LeeSW , LiongML , YuenKH , LeongWS , CheeC , CheahPY , et al. Acupuncture versus sham acupuncture for chronic prostatitis/chronic pelvic pain. American Journal of Medicine2008;121(1):79.e1‐7. LeeSW , LiongML , YuenKH , LeongWS , KhanNK , KriegerJN . Validation of a sham acupuncture procedure in a randomised, controlled clinical trial of chronic pelvic pain treatment. Acupuncture in Medicine2011;29(1):40‐6. ">Lee 2008</a>; <a href="./references#CD012551-bbs2-0014" title="LeeSH , LeeBC . Electroacupuncture relieves pain in men with chronic prostatitis/chronic pelvic pain syndrome: three‐arm randomized trial. Urology2009;73(5):1036‐41. ">Lee 2009</a>; <a href="./references#CD012551-bbs2-0015" title="LeskinenMJ , KilponenA , LukkarinenO , TammelaTL . Transurethral needle ablation for the treatment of chronic pelvic pain syndrome (category III prostatitis): a randomized, sham‐controlled study. Urology2002;60(2):300‐4. ">Leskinen 2002</a>; <a href="./references#CD012551-bbs2-0020" title="NickelJC , SorensenR . Transurethral microwave thermotherapy for nonbacterial prostatitis: a randomized double‐blind sham controlled study using new prostatitis specific assessment questionnaires. Journal of Urology1996;155(6):1950‐4; discussion 1954. ">Nickel 1996</a>; <a href="./references#CD012551-bbs2-0021" title="OhMM , JinMH , MoonDG , NamSG , BaeJH , ParkHS . A prospective, randomized, placebo controlled study of radiofrequency therapy for the treatment of chronic prostatitis/chronic pelvic pain syndrome. Journal of Urology2009;181(4):122. ">Oh 2009</a>; <a href="./references#CD012551-bbs2-0025" title="SahinS , BicerM , ErenGA , TasS , TugcuV , TasciAI , et al. Acupuncture relieves symptoms in chronic prostatitis/chronic pelvic pain syndrome: a randomized, sham‐controlled trial. Prostate Cancer and Prostatic Diseases2015;18(3):249‐54. ">Sahin 2015</a>; <a href="./references#CD012551-bbs2-0026" title="Samhan AhmedF , Abd‐Elhalim NermeenM , Elnegmy EmamH , Roiah MohamedM . The effect of transcutaneous electrical nerve stimulation in the treatment of chronic pelvic pain syndrome: an evidence based electromyographic studies. Indian Journal of Physiotherapy &amp; Occupational Therapy2011;5(3):14‐7. ">Samhan 2011</a>; <a href="./references#CD012551-bbs2-0030" title="MoayedniaA , HaghdaniS , KhosrawiS , YousefiE , VahdatpourB . Long‐term effect of extracorporeal shock wave therapy on the treatment of chronic pelvic pain syndrome due to non bacterial prostatitis. Journal of Research in Medical Sciences2014;19(4):293‐6. VahdatpourB , AlizadehF , MoayedniaA , EmadiM , KhoramiMH , HaghdaniS . Efficacy of extracorporeal shock wave therapy for the treatment of chronic pelvic pain syndrome: a randomized, controlled trial. ISRN Urology2013;2013:972601. ">Vahdatpour 2013</a>; <a href="./references#CD012551-bbs2-0031" title="VassilyO , AndreyS , EvgeniiD , OtabekI , BorisL , SergeyR . Efficacy of transrectal microwave hyperthemia (TRMH) in the treatment of chronic prostatitis. A randomized sham controlled comparative study (Abstract). Journal of Urology1999;161(4 Suppl):33A. ">Vassily 1999</a>; <a href="./references#CD012551-bbs2-0038" title="ZimmermannR , CumpanasA , MicleaF , JanetschekG . Extracorporeal shock wave therapy for the treatment of chronic pelvic pain syndrome in males: a randomised, double‐blind, placebo‐controlled study. European Urology2009;56(3):418‐24. ZimmermannRP , CumpanasA , MicleaF , JanetschekG . One year follow up of extracorporeal shock wave therapy (ESWT) for chronic pelvic pain syndrome (CPPS) in a randomised placebo‐controlled double‐blind study. European Urology (Suppl)2010;9(2):214. ">Zimmermann 2009</a>), and the remaining 26 studies had at least one domain with high risk of bias. </p> <div class="figure" id="CD012551-fig-0002"> <div class="figure-caption-wrapper-top"> <nav class="inline-nav-list has-dividers"> <ul> <li><a class="open-in-figure-viewer" href="#0">Open in figure viewer</a></li> </ul> </nav> <div class="figure-label">Figure 2</div> </div> <hr class="top"/><img alt="Risk of bias graph: review authors' judgements about each risk of bias item presented as percentages across all included studies." data-id="CD012551-fig-0002" src="/cdsr/doi/10.1002/14651858.CD012551.pub3/media/CDSR/CD012551/image_n/nCD012551-AFig-FIG02.png"/><hr class="bottom"/> <div class="figure-caption-wrapper-bottom"> <div class="figure-caption"> <p>Risk of bias graph: review authors' judgements about each risk of bias item presented as percentages across all included studies. </p> </div> </div> </div> <div class="figure" id="CD012551-fig-0003"> <div class="figure-caption-wrapper-top"> <nav class="inline-nav-list has-dividers"> <ul> <li><a class="open-in-figure-viewer" href="#0">Open in figure viewer</a></li> </ul> </nav> <div class="figure-label">Figure 3</div> </div> <hr class="top"/><img alt="Risk of bias summary: review authors' judgements about each risk of bias item for each study." data-id="CD012551-fig-0003" src="/cdsr/doi/10.1002/14651858.CD012551.pub3/media/CDSR/CD012551/image_n/nCD012551-AFig-FIG03.png"/><hr class="bottom"/> <div class="figure-caption-wrapper-bottom"> <div class="figure-caption"> <p>Risk of bias summary: review authors' judgements about each risk of bias item for each study. </p> </div> </div> </div> <section id="CD012551-sec-0093"> <h4 class="title">Allocation</h4> <section id="CD012551-sec-0094"> <h5 class="title">Random sequence generation</h5> <p>Thirteen studies specified an adequate method of random sequence generation (<a href="./references#CD012551-bbs2-0002" title="ChenZX . Observation on therapeutic effect of warm needle moxibustion on chronic non‐bacterial prostatitis. Zhongguo Zhen Jiu [Chinese Acupuncture &amp; Moxibustion]2009;29(4):275‐8. ">Chen 2009</a>; <a href="./references#CD012551-bbs2-0004" title="BadilloSA , NevilleCE , KotarinosR , FortmanC , FraserL , CosbyA , et al. Randomized multicenter pilot trial shows benefit of manual physical therapies in treatment of urologic chronic pelvic pain. Journal of Women's Health Physical Therapy2009;33(1):23. FitzGeraldMP , AndersonRU , PottsJ , PayneCK , PetersKM , ClemensJQ , et al. Randomized multicenter feasibility trial of myofascial physical therapy for the treatment of urological chronic pelvic pain syndromes. Journal of Urology2009;182(2):570‐80. FitzgeraldMP , AndersonRU , PottsJ , PayneCK , PetersKM , ClemensJQ , et al. Randomized multicenter feasibility trial of myofascial physical therapy for the treatment of urological chronic pelvic pain syndromes. Journal of Urology2013;189(1 Suppl):S75‐85. ">Fitzgerald 2013</a>; <a href="./references#CD012551-bbs2-0010" title="KastnerC , HochreiterW , HuidobroC , CabezasJ , MillerP . Cooled transurethral microwave thermotherapy for intractable chronic prostatitis ‐ results of a pilot study after 1 year. Urology2004;64(6):1149‐54. ">Kastner 2004</a>; <a href="./references#CD012551-bbs2-0011" title="KesslerTM , MordasiniL , WeisstannerC , JuniP , daCostaBR , WiestR , et al. Sono‐electro‐magnetic therapy for treating chronic pelvic pain syndrome in men: a randomized, placebo‐controlled, double‐blind trial. PloS One2014;9(12):e113368. WeisstannerC , MordasiniL , ThalmannGN , VermaRK , RummelC , FederspielA , et al. Therapy‐related longitudinal brain perfusion changes in patients with chronic pelvic pain syndrome. Swiss Medical Weekly2017;147:w14454. ">Kessler 2014</a>; <a href="./references#CD012551-bbs2-0013" title="LeeSW , LiongML , YuenKH , KriegerJN . Acupuncture and immune function in chronic prostatitis/chronic pelvic pain syndrome: a randomized, controlled study. Complementary Therapies in Medicine2014;22(6):965‐9. LeeSW , LiongML , YuenKH , LeongWS , CheeC , CheahPY , et al. Acupuncture versus sham acupuncture for chronic prostatitis/chronic pelvic pain. American Journal of Medicine2008;121(1):79.e1‐7. LeeSW , LiongML , YuenKH , LeongWS , KhanNK , KriegerJN . Validation of a sham acupuncture procedure in a randomised, controlled clinical trial of chronic pelvic pain treatment. Acupuncture in Medicine2011;29(1):40‐6. ">Lee 2008</a>; <a href="./references#CD012551-bbs2-0014" title="LeeSH , LeeBC . Electroacupuncture relieves pain in men with chronic prostatitis/chronic pelvic pain syndrome: three‐arm randomized trial. Urology2009;73(5):1036‐41. ">Lee 2009</a>; <a href="./references#CD012551-bbs2-0016" title="MarxS . ICAOR 2006: does osteopathic treatment have an influence on the symptoms of patients with chronic prostatitis/chronic pelvic pain syndrome (CPPS)? A randomized controlled trial. International Journal of Osteopathic Medicine2006;9(1):44. MarxS , CimniakU , BeckertR , SchwerlaF , ReschKL . Chronic prostatitis/chronic pelvic pain syndrome. Influence of osteopathic treatment ‐ a randomized controlled study [Chronische Prostatitis/chronisches Beckenschmerzsyndrom. Einfluss osteopathischer Behandlungen ‐ eine randomisiert kontrollierte Studie]. Der Urologe. Ausg. A2009;48(11):1339‐45. ">Marx 2009</a>; <a href="./references#CD012551-bbs2-0018" title="MuraroGB . Clinical study on the efficacy and safety of seaprose S combined with local prostatic hyperthermia in chronic non‐bacterial prostatitis. Controlled study versus local prostatic hyperthermia [Studio clinico sull'efficacia e la tollerabilita del seaprose S associato a ipertermia locale prostatica nella prostatite cronica abatterica. Studio controllato verso ipertermia locale prostatica]. Archivio di Medicina Interna1995;47(2‐3):73‐86. ">Muraro 1995</a>; <a href="./references#CD012551-bbs2-0023" title="PajovicB , RadojevicN , DimitrovskiA , VukovicM . Comparison of the efficiency of combined extracorporeal shock‐wave therapy and triple therapy versus triple therapy itself in Category III B chronic pelvic pain syndrome (CPPS). Aging Male2016;19(3):1‐6. ">Pajovic 2016</a>; <a href="./references#CD012551-bbs2-0024" title="RoweE , SmithC , LaverickL , ElkabirJ , WitherowRO , PatelA . A prospective, randomized, placebo controlled, double‐blind study of pelvic electromagnetic therapy for the treatment of chronic pelvic pain syndrome with 1 year of followup. Journal of Urology2005;173(6):2044‐7. ">Rowe 2005</a>; <a href="./references#CD012551-bbs2-0025" title="SahinS , BicerM , ErenGA , TasS , TugcuV , TasciAI , et al. Acupuncture relieves symptoms in chronic prostatitis/chronic pelvic pain syndrome: a randomized, sham‐controlled trial. Prostate Cancer and Prostatic Diseases2015;18(3):249‐54. ">Sahin 2015</a>; <a href="./references#CD012551-bbs2-0034" title="ChungH , ChoiH , YooTK , ChoJM , KimHS . The effects of microwave thermotherapy for chronic prostatitis/chronic pelvic pain syndrome: a prospective, randomized study. Urogenital Tract Infection2017;12(1):35‐41. KimH , ChungH , YangS , YooT , ChoJ . Effects of thermotherapy and medical therapy for chronic prostatitis/chronic pelvic pain syndrome: a prospective study. Urology2011;78(3):S85‐6. YooTK , MoonKT , LeeSW , KimHS , ChungH , KimJY . Effect of the combination treatment of URO‐DrG and medical therapy for chronic prostatitis/chronic pelvic pain syndrome: a prospective study. Journal of Urology2009;181(4):122. ">Yoo 2009</a>; <a href="./references#CD012551-bbs2-0037" title="ZhaoY , ZhaoW , LangG , ChenY , LiuJ , WangG , et al. Circumcision plus antibiotic, anti‐inflammatory, and alpha‐blocker therapy for the treatment for chronic prostatitis/chronic pelvic pain syndrome: a prospective, randomized, multicenter trial. World Journal of Urology2015;33(5):617‐22. ">Zhao 2015</a>). The remaining studies were at unclear risk of bias of random sequence generation. </p> </section> <section id="CD012551-sec-0095"> <h5 class="title">Allocation concealment</h5> <p>Six studies specified an adequate method of allocation concealment (<a href="./references#CD012551-bbs2-0004" title="BadilloSA , NevilleCE , KotarinosR , FortmanC , FraserL , CosbyA , et al. Randomized multicenter pilot trial shows benefit of manual physical therapies in treatment of urologic chronic pelvic pain. Journal of Women's Health Physical Therapy2009;33(1):23. FitzGeraldMP , AndersonRU , PottsJ , PayneCK , PetersKM , ClemensJQ , et al. Randomized multicenter feasibility trial of myofascial physical therapy for the treatment of urological chronic pelvic pain syndromes. Journal of Urology2009;182(2):570‐80. FitzgeraldMP , AndersonRU , PottsJ , PayneCK , PetersKM , ClemensJQ , et al. Randomized multicenter feasibility trial of myofascial physical therapy for the treatment of urological chronic pelvic pain syndromes. Journal of Urology2013;189(1 Suppl):S75‐85. ">Fitzgerald 2013</a>; <a href="./references#CD012551-bbs2-0010" title="KastnerC , HochreiterW , HuidobroC , CabezasJ , MillerP . Cooled transurethral microwave thermotherapy for intractable chronic prostatitis ‐ results of a pilot study after 1 year. Urology2004;64(6):1149‐54. ">Kastner 2004</a>; <a href="./references#CD012551-bbs2-0011" title="KesslerTM , MordasiniL , WeisstannerC , JuniP , daCostaBR , WiestR , et al. Sono‐electro‐magnetic therapy for treating chronic pelvic pain syndrome in men: a randomized, placebo‐controlled, double‐blind trial. PloS One2014;9(12):e113368. WeisstannerC , MordasiniL , ThalmannGN , VermaRK , RummelC , FederspielA , et al. Therapy‐related longitudinal brain perfusion changes in patients with chronic pelvic pain syndrome. Swiss Medical Weekly2017;147:w14454. ">Kessler 2014</a>; <a href="./references#CD012551-bbs2-0016" title="MarxS . ICAOR 2006: does osteopathic treatment have an influence on the symptoms of patients with chronic prostatitis/chronic pelvic pain syndrome (CPPS)? A randomized controlled trial. International Journal of Osteopathic Medicine2006;9(1):44. MarxS , CimniakU , BeckertR , SchwerlaF , ReschKL . Chronic prostatitis/chronic pelvic pain syndrome. Influence of osteopathic treatment ‐ a randomized controlled study [Chronische Prostatitis/chronisches Beckenschmerzsyndrom. Einfluss osteopathischer Behandlungen ‐ eine randomisiert kontrollierte Studie]. Der Urologe. Ausg. A2009;48(11):1339‐45. ">Marx 2009</a>; <a href="./references#CD012551-bbs2-0023" title="PajovicB , RadojevicN , DimitrovskiA , VukovicM . Comparison of the efficiency of combined extracorporeal shock‐wave therapy and triple therapy versus triple therapy itself in Category III B chronic pelvic pain syndrome (CPPS). Aging Male2016;19(3):1‐6. ">Pajovic 2016</a>; <a href="./references#CD012551-bbs2-0035" title="ZengX , YeZ , YangW , ChenZ , DuG . Extracorporeal shock wave treatment for noninflammatory chronic pelvic pain syndrome: a prospective, randomized, sham‐controlled study. Journal of Urology2009;181(4):122‐3. ZengXY , LiangC , YeZQ . Extracorporeal shock wave treatment for non‐inflammatory chronic pelvic pain syndrome: a prospective, randomized and sham‐controlled study. Chinese Medical Journal2012;125(1):114‐8. ">Zeng 2012</a>). Two studies specified that they did not conceal the allocation of participants and were deemed at high risk of bias in this domain (<a href="./references#CD012551-bbs2-0005" title="GalloL . Effectiveness of diet, sexual habits and lifestyle modifications on treatment of chronic pelvic pain syndrome. Prostate Cancer and Prostatic Diseases2014;17(3):238‐45. ">Gallo 2014</a>; <a href="./references#CD012551-bbs2-0034" title="ChungH , ChoiH , YooTK , ChoJM , KimHS . The effects of microwave thermotherapy for chronic prostatitis/chronic pelvic pain syndrome: a prospective, randomized study. Urogenital Tract Infection2017;12(1):35‐41. KimH , ChungH , YangS , YooT , ChoJ . Effects of thermotherapy and medical therapy for chronic prostatitis/chronic pelvic pain syndrome: a prospective study. Urology2011;78(3):S85‐6. YooTK , MoonKT , LeeSW , KimHS , ChungH , KimJY . Effect of the combination treatment of URO‐DrG and medical therapy for chronic prostatitis/chronic pelvic pain syndrome: a prospective study. Journal of Urology2009;181(4):122. ">Yoo 2009</a>). The remaining studies were at unclear risk of bias in allocation concealment. </p> </section> </section> <section id="CD012551-sec-0096"> <h4 class="title">Blinding</h4> <section id="CD012551-sec-0097"> <h5 class="title">Blinding of participants and personnel</h5> <p>Five studies specified an adequate method for the blinding of participants and personnel (<a href="./references#CD012551-bbs2-0011" title="KesslerTM , MordasiniL , WeisstannerC , JuniP , daCostaBR , WiestR , et al. Sono‐electro‐magnetic therapy for treating chronic pelvic pain syndrome in men: a randomized, placebo‐controlled, double‐blind trial. PloS One2014;9(12):e113368. WeisstannerC , MordasiniL , ThalmannGN , VermaRK , RummelC , FederspielA , et al. Therapy‐related longitudinal brain perfusion changes in patients with chronic pelvic pain syndrome. Swiss Medical Weekly2017;147:w14454. ">Kessler 2014</a>; <a href="./references#CD012551-bbs2-0013" title="LeeSW , LiongML , YuenKH , KriegerJN . Acupuncture and immune function in chronic prostatitis/chronic pelvic pain syndrome: a randomized, controlled study. Complementary Therapies in Medicine2014;22(6):965‐9. LeeSW , LiongML , YuenKH , LeongWS , CheeC , CheahPY , et al. Acupuncture versus sham acupuncture for chronic prostatitis/chronic pelvic pain. American Journal of Medicine2008;121(1):79.e1‐7. LeeSW , LiongML , YuenKH , LeongWS , KhanNK , KriegerJN . Validation of a sham acupuncture procedure in a randomised, controlled clinical trial of chronic pelvic pain treatment. Acupuncture in Medicine2011;29(1):40‐6. ">Lee 2008</a>; <a href="./references#CD012551-bbs2-0014" title="LeeSH , LeeBC . Electroacupuncture relieves pain in men with chronic prostatitis/chronic pelvic pain syndrome: three‐arm randomized trial. Urology2009;73(5):1036‐41. ">Lee 2009</a>; <a href="./references#CD012551-bbs2-0025" title="SahinS , BicerM , ErenGA , TasS , TugcuV , TasciAI , et al. Acupuncture relieves symptoms in chronic prostatitis/chronic pelvic pain syndrome: a randomized, sham‐controlled trial. Prostate Cancer and Prostatic Diseases2015;18(3):249‐54. ">Sahin 2015</a>; <a href="./references#CD012551-bbs2-0038" title="ZimmermannR , CumpanasA , MicleaF , JanetschekG . Extracorporeal shock wave therapy for the treatment of chronic pelvic pain syndrome in males: a randomised, double‐blind, placebo‐controlled study. European Urology2009;56(3):418‐24. ZimmermannRP , CumpanasA , MicleaF , JanetschekG . One year follow up of extracorporeal shock wave therapy (ESWT) for chronic pelvic pain syndrome (CPPS) in a randomised placebo‐controlled double‐blind study. European Urology (Suppl)2010;9(2):214. ">Zimmermann 2009</a>). Twenty‐four studies did not adequately blind participants or personnel and were deemed at high risk of bias, considering that all outcomes were subjective (<a href="./references#CD012551-bbs2-0001" title="AteyaA , FayezA , HaniR , ZohdyW , GabbarMA , ShamloulR . Evaluation of prostatic massage in treatment of chronic prostatitis. Urology2006;67(4):674‐8. ">Ateya 2006</a>; <a href="./references#CD012551-bbs2-0002" title="ChenZX . Observation on therapeutic effect of warm needle moxibustion on chronic non‐bacterial prostatitis. Zhongguo Zhen Jiu [Chinese Acupuncture &amp; Moxibustion]2009;29(4):275‐8. ">Chen 2009</a>; <a href="./references#CD012551-bbs2-0003" title="FangJ , XuG , DingQ , ZhangY‐F . Observation on the safety and efficacy of He‐Ne laser equipment on chronic abacteria prostatitis. Fudan University Journal of Medical Sciences2005;32(2):234‐5, 252. ">Fang 2005</a>; <a href="./references#CD012551-bbs2-0004" title="BadilloSA , NevilleCE , KotarinosR , FortmanC , FraserL , CosbyA , et al. Randomized multicenter pilot trial shows benefit of manual physical therapies in treatment of urologic chronic pelvic pain. Journal of Women's Health Physical Therapy2009;33(1):23. FitzGeraldMP , AndersonRU , PottsJ , PayneCK , PetersKM , ClemensJQ , et al. Randomized multicenter feasibility trial of myofascial physical therapy for the treatment of urological chronic pelvic pain syndromes. Journal of Urology2009;182(2):570‐80. FitzgeraldMP , AndersonRU , PottsJ , PayneCK , PetersKM , ClemensJQ , et al. Randomized multicenter feasibility trial of myofascial physical therapy for the treatment of urological chronic pelvic pain syndromes. Journal of Urology2013;189(1 Suppl):S75‐85. ">Fitzgerald 2013</a>; <a href="./references#CD012551-bbs2-0005" title="GalloL . Effectiveness of diet, sexual habits and lifestyle modifications on treatment of chronic pelvic pain syndrome. Prostate Cancer and Prostatic Diseases2014;17(3):238‐45. ">Gallo 2014</a>; <a href="./references#CD012551-bbs2-0006" title="GaoM , DingH , ZhongG , LuJ , WangH , LiQ , et al. The effects of transrectal radiofrequency hyperthermia on patients with chronic prostatitis and the changes of MDA, NO, SOD, and Zn levels in pretreatment and posttreatment. Urology2012;79(2):391‐6. ">Gao 2012</a>; <a href="./references#CD012551-bbs2-0007" title="GiubileiG , MondainiN , MinerviniA , SaievaC , LapiniA , SerniS , et al. Physical activity of men with chronic prostatitis/chronic pelvic pain syndrome not satisfied with conventional treatments ‐ could it represent a valid option? The physical activity and male pelvic pain trial: a double‐blind, randomized study. Journal of Urology2007;177(1):159‐65. ">Giubilei 2007</a>; <a href="./references#CD012551-bbs2-0008" title="KabayS , KabaySC , YucelM , OzdenH . Efficiency of posterior tibial nerve stimulation in category IIIB chronic prostatitis/chronic pelvic pain: a Sham‐Controlled Comparative Study. Urologia Internationalis2009;83(1):33‐8. ">Kabay 2009</a>; <a href="./references#CD012551-bbs2-0009" title="KaikaiC , RuiW , YongC , ZhuC , WeiH , SuogangW , et al. Combination therapy of non‐intrusive ultrasound with integrated Chinese‐western medicine for chronic prostatitis/chronic pelvic pain syndrome. Chinese Journal of Andrology2014;28(12):41‐4. ">Kaikai 2014</a>; <a href="./references#CD012551-bbs2-0012" title="KucukEV , SucekenFY , BindayiA , BoyluU , OnolFF , GumusE . Effectiveness of acupuncture on chronic prostatitis‐chronic pelvic pain syndrome category IIIB patients: a prospective, randomized, nonblinded, clinical trial. Urology2015;85(3):636‐40. ">Kucuk 2015</a>; <a href="./references#CD012551-bbs2-0016" title="MarxS . ICAOR 2006: does osteopathic treatment have an influence on the symptoms of patients with chronic prostatitis/chronic pelvic pain syndrome (CPPS)? A randomized controlled trial. International Journal of Osteopathic Medicine2006;9(1):44. MarxS , CimniakU , BeckertR , SchwerlaF , ReschKL . Chronic prostatitis/chronic pelvic pain syndrome. Influence of osteopathic treatment ‐ a randomized controlled study [Chronische Prostatitis/chronisches Beckenschmerzsyndrom. Einfluss osteopathischer Behandlungen ‐ eine randomisiert kontrollierte Studie]. Der Urologe. Ausg. A2009;48(11):1339‐45. ">Marx 2009</a>; <a href="./references#CD012551-bbs2-0017" title="MontorsiF , GuazzoniG , BergamaschiF , GalliL , ConsonniP , MatozzoV , et al. Is there a role for transrectal microwave hyperthermia of the prostate in the treatment of abacterial prostatitis and prostatodynia?. Prostate1993;22(2):139‐46. ">Montorsi 1993</a>; <a href="./references#CD012551-bbs2-0018" title="MuraroGB . Clinical study on the efficacy and safety of seaprose S combined with local prostatic hyperthermia in chronic non‐bacterial prostatitis. Controlled study versus local prostatic hyperthermia [Studio clinico sull'efficacia e la tollerabilita del seaprose S associato a ipertermia locale prostatica nella prostatite cronica abatterica. Studio controllato verso ipertermia locale prostatica]. Archivio di Medicina Interna1995;47(2‐3):73‐86. ">Muraro 1995</a>; <a href="./references#CD012551-bbs2-0019" title="NeimarkAI , MaksimovaSS . Effect of hypercapnic hypoxia on chronic abacterial prostatitis. Urologiia (Moscow, Russia : 1999)2016;1(3):80‐4. [PUBMED: 28247635] ">Neimark 2016;</a><a href="./references#CD012551-bbs2-0022" title="PaickJS , LeeSC , KuJH . More effects of extracorporeal magnetic innervation and terazosin therapy than terazosin therapy alone for non‐inflammatory chronic pelvic pain syndrome: a pilot study. Prostate Cancer and Prostatic Diseases2006;9(3):261‐5. ">Paick 2006</a>; <a href="./references#CD012551-bbs2-0023" title="PajovicB , RadojevicN , DimitrovskiA , VukovicM . Comparison of the efficiency of combined extracorporeal shock‐wave therapy and triple therapy versus triple therapy itself in Category III B chronic pelvic pain syndrome (CPPS). Aging Male2016;19(3):1‐6. ">Pajovic 2016</a>; <a href="./references#CD012551-bbs2-0028" title="ShenSL , HeDL , LuoY . Clinical trials of combined therapy of an oral Chinese medicine with massage for chronic nonbacterial prostatitis. Zhonghua Nan Ke Xue2006;12(9):851‐3. ">Shen 2006</a>; <a href="./references#CD012551-bbs2-0029" title="SikiruL , ShmailaH , MuhammedSA . Transcutaneous electrical nerve stimulation (TENS) in the symptomatic management of chronic prostatitis/chronic pelvic pain syndrome: a placebo‐control randomized trial. International Brazilian Journal of Urology2008;34(6):708‐13; discussion 714. ">Sikiru 2008</a>; <a href="./references#CD012551-bbs2-0032" title="WangJ , LiJ , LuR , WangJM . Treatment of external RF hyperthermia combining with alpha 1‐adrenergic receptor blocker for patients with prostatodynia and chronic non‐bacterial prostatitis. Zhonghua Nan Ke Xue2002;8(1):48‐50. ">Wang 2002</a>; <a href="./references#CD012551-bbs2-0033" title="YangZS , ZuXB , QiL , SongLM , LiuTR . Combination therapy of biofeedback with electrical stimulation for chronic prostatitis/chronic pelvic pain syndrome. Zhonghua Nan Ke Xue2011;17(7):611‐4. ">Yang 2011</a>; <a href="./references#CD012551-bbs2-0034" title="ChungH , ChoiH , YooTK , ChoJM , KimHS . The effects of microwave thermotherapy for chronic prostatitis/chronic pelvic pain syndrome: a prospective, randomized study. Urogenital Tract Infection2017;12(1):35‐41. KimH , ChungH , YangS , YooT , ChoJ . Effects of thermotherapy and medical therapy for chronic prostatitis/chronic pelvic pain syndrome: a prospective study. Urology2011;78(3):S85‐6. YooTK , MoonKT , LeeSW , KimHS , ChungH , KimJY . Effect of the combination treatment of URO‐DrG and medical therapy for chronic prostatitis/chronic pelvic pain syndrome: a prospective study. Journal of Urology2009;181(4):122. ">Yoo 2009</a>; <a href="./references#CD012551-bbs2-0035" title="ZengX , YeZ , YangW , ChenZ , DuG . Extracorporeal shock wave treatment for noninflammatory chronic pelvic pain syndrome: a prospective, randomized, sham‐controlled study. Journal of Urology2009;181(4):122‐3. ZengXY , LiangC , YeZQ . Extracorporeal shock wave treatment for non‐inflammatory chronic pelvic pain syndrome: a prospective, randomized and sham‐controlled study. Chinese Medical Journal2012;125(1):114‐8. ">Zeng 2012</a>; <a href="./references#CD012551-bbs2-0036" title="ZhangDY , PanXC . Chinese medicine union Taijiquan treatment chronicity non‐bacterial prostatitis curative effect observation. Chinese Manipulation &amp; Rehabilitation Medicine2011;15(2):181. ">Zhang 2011a</a>; <a href="./references#CD012551-bbs2-0037" title="ZhaoY , ZhaoW , LangG , ChenY , LiuJ , WangG , et al. Circumcision plus antibiotic, anti‐inflammatory, and alpha‐blocker therapy for the treatment for chronic prostatitis/chronic pelvic pain syndrome: a prospective, randomized, multicenter trial. World Journal of Urology2015;33(5):617‐22. ">Zhao 2015</a>). The remaining studies were at unclear risk of bias of blinding of participants and personnel. </p> </section> <section id="CD012551-sec-0098"> <h5 class="title">Blinding of outcome assessment</h5> <p>All the outcomes of this review were participant‐reported outcomes. Eight studies reported blinding of participants (outcome‐assessors) (<a href="./references#CD012551-bbs2-0010" title="KastnerC , HochreiterW , HuidobroC , CabezasJ , MillerP . Cooled transurethral microwave thermotherapy for intractable chronic prostatitis ‐ results of a pilot study after 1 year. Urology2004;64(6):1149‐54. ">Kastner 2004</a>; <a href="./references#CD012551-bbs2-0011" title="KesslerTM , MordasiniL , WeisstannerC , JuniP , daCostaBR , WiestR , et al. Sono‐electro‐magnetic therapy for treating chronic pelvic pain syndrome in men: a randomized, placebo‐controlled, double‐blind trial. PloS One2014;9(12):e113368. WeisstannerC , MordasiniL , ThalmannGN , VermaRK , RummelC , FederspielA , et al. Therapy‐related longitudinal brain perfusion changes in patients with chronic pelvic pain syndrome. Swiss Medical Weekly2017;147:w14454. ">Kessler 2014</a>; <a href="./references#CD012551-bbs2-0013" title="LeeSW , LiongML , YuenKH , KriegerJN . Acupuncture and immune function in chronic prostatitis/chronic pelvic pain syndrome: a randomized, controlled study. Complementary Therapies in Medicine2014;22(6):965‐9. LeeSW , LiongML , YuenKH , LeongWS , CheeC , CheahPY , et al. Acupuncture versus sham acupuncture for chronic prostatitis/chronic pelvic pain. American Journal of Medicine2008;121(1):79.e1‐7. LeeSW , LiongML , YuenKH , LeongWS , KhanNK , KriegerJN . Validation of a sham acupuncture procedure in a randomised, controlled clinical trial of chronic pelvic pain treatment. Acupuncture in Medicine2011;29(1):40‐6. ">Lee 2008</a>; <a href="./references#CD012551-bbs2-0014" title="LeeSH , LeeBC . Electroacupuncture relieves pain in men with chronic prostatitis/chronic pelvic pain syndrome: three‐arm randomized trial. Urology2009;73(5):1036‐41. ">Lee 2009</a>; <a href="./references#CD012551-bbs2-0020" title="NickelJC , SorensenR . Transurethral microwave thermotherapy for nonbacterial prostatitis: a randomized double‐blind sham controlled study using new prostatitis specific assessment questionnaires. Journal of Urology1996;155(6):1950‐4; discussion 1954. ">Nickel 1996</a>; <a href="./references#CD012551-bbs2-0024" title="RoweE , SmithC , LaverickL , ElkabirJ , WitherowRO , PatelA . A prospective, randomized, placebo controlled, double‐blind study of pelvic electromagnetic therapy for the treatment of chronic pelvic pain syndrome with 1 year of followup. Journal of Urology2005;173(6):2044‐7. ">Rowe 2005</a>; <a href="./references#CD012551-bbs2-0025" title="SahinS , BicerM , ErenGA , TasS , TugcuV , TasciAI , et al. Acupuncture relieves symptoms in chronic prostatitis/chronic pelvic pain syndrome: a randomized, sham‐controlled trial. Prostate Cancer and Prostatic Diseases2015;18(3):249‐54. ">Sahin 2015</a>; <a href="./references#CD012551-bbs2-0038" title="ZimmermannR , CumpanasA , MicleaF , JanetschekG . Extracorporeal shock wave therapy for the treatment of chronic pelvic pain syndrome in males: a randomised, double‐blind, placebo‐controlled study. European Urology2009;56(3):418‐24. ZimmermannRP , CumpanasA , MicleaF , JanetschekG . One year follow up of extracorporeal shock wave therapy (ESWT) for chronic pelvic pain syndrome (CPPS) in a randomised placebo‐controlled double‐blind study. European Urology (Suppl)2010;9(2):214. ">Zimmermann 2009</a>). Twenty‐three studies did not adequately blind participants (<a href="./references#CD012551-bbs2-0001" title="AteyaA , FayezA , HaniR , ZohdyW , GabbarMA , ShamloulR . Evaluation of prostatic massage in treatment of chronic prostatitis. Urology2006;67(4):674‐8. ">Ateya 2006</a>; <a href="./references#CD012551-bbs2-0002" title="ChenZX . Observation on therapeutic effect of warm needle moxibustion on chronic non‐bacterial prostatitis. Zhongguo Zhen Jiu [Chinese Acupuncture &amp; Moxibustion]2009;29(4):275‐8. ">Chen 2009</a>; <a href="./references#CD012551-bbs2-0003" title="FangJ , XuG , DingQ , ZhangY‐F . Observation on the safety and efficacy of He‐Ne laser equipment on chronic abacteria prostatitis. Fudan University Journal of Medical Sciences2005;32(2):234‐5, 252. ">Fang 2005</a>; <a href="./references#CD012551-bbs2-0004" title="BadilloSA , NevilleCE , KotarinosR , FortmanC , FraserL , CosbyA , et al. Randomized multicenter pilot trial shows benefit of manual physical therapies in treatment of urologic chronic pelvic pain. Journal of Women's Health Physical Therapy2009;33(1):23. FitzGeraldMP , AndersonRU , PottsJ , PayneCK , PetersKM , ClemensJQ , et al. Randomized multicenter feasibility trial of myofascial physical therapy for the treatment of urological chronic pelvic pain syndromes. Journal of Urology2009;182(2):570‐80. FitzgeraldMP , AndersonRU , PottsJ , PayneCK , PetersKM , ClemensJQ , et al. Randomized multicenter feasibility trial of myofascial physical therapy for the treatment of urological chronic pelvic pain syndromes. Journal of Urology2013;189(1 Suppl):S75‐85. ">Fitzgerald 2013</a>; <a href="./references#CD012551-bbs2-0005" title="GalloL . Effectiveness of diet, sexual habits and lifestyle modifications on treatment of chronic pelvic pain syndrome. Prostate Cancer and Prostatic Diseases2014;17(3):238‐45. ">Gallo 2014</a>; <a href="./references#CD012551-bbs2-0006" title="GaoM , DingH , ZhongG , LuJ , WangH , LiQ , et al. The effects of transrectal radiofrequency hyperthermia on patients with chronic prostatitis and the changes of MDA, NO, SOD, and Zn levels in pretreatment and posttreatment. Urology2012;79(2):391‐6. ">Gao 2012</a>; <a href="./references#CD012551-bbs2-0007" title="GiubileiG , MondainiN , MinerviniA , SaievaC , LapiniA , SerniS , et al. Physical activity of men with chronic prostatitis/chronic pelvic pain syndrome not satisfied with conventional treatments ‐ could it represent a valid option? The physical activity and male pelvic pain trial: a double‐blind, randomized study. Journal of Urology2007;177(1):159‐65. ">Giubilei 2007</a>; <a href="./references#CD012551-bbs2-0008" title="KabayS , KabaySC , YucelM , OzdenH . Efficiency of posterior tibial nerve stimulation in category IIIB chronic prostatitis/chronic pelvic pain: a Sham‐Controlled Comparative Study. Urologia Internationalis2009;83(1):33‐8. ">Kabay 2009</a>; <a href="./references#CD012551-bbs2-0009" title="KaikaiC , RuiW , YongC , ZhuC , WeiH , SuogangW , et al. Combination therapy of non‐intrusive ultrasound with integrated Chinese‐western medicine for chronic prostatitis/chronic pelvic pain syndrome. Chinese Journal of Andrology2014;28(12):41‐4. ">Kaikai 2014</a>; <a href="./references#CD012551-bbs2-0012" title="KucukEV , SucekenFY , BindayiA , BoyluU , OnolFF , GumusE . Effectiveness of acupuncture on chronic prostatitis‐chronic pelvic pain syndrome category IIIB patients: a prospective, randomized, nonblinded, clinical trial. Urology2015;85(3):636‐40. ">Kucuk 2015</a>; <a href="./references#CD012551-bbs2-0016" title="MarxS . ICAOR 2006: does osteopathic treatment have an influence on the symptoms of patients with chronic prostatitis/chronic pelvic pain syndrome (CPPS)? A randomized controlled trial. International Journal of Osteopathic Medicine2006;9(1):44. MarxS , CimniakU , BeckertR , SchwerlaF , ReschKL . Chronic prostatitis/chronic pelvic pain syndrome. Influence of osteopathic treatment ‐ a randomized controlled study [Chronische Prostatitis/chronisches Beckenschmerzsyndrom. Einfluss osteopathischer Behandlungen ‐ eine randomisiert kontrollierte Studie]. Der Urologe. Ausg. A2009;48(11):1339‐45. ">Marx 2009</a>; <a href="./references#CD012551-bbs2-0017" title="MontorsiF , GuazzoniG , BergamaschiF , GalliL , ConsonniP , MatozzoV , et al. Is there a role for transrectal microwave hyperthermia of the prostate in the treatment of abacterial prostatitis and prostatodynia?. Prostate1993;22(2):139‐46. ">Montorsi 1993</a>; <a href="./references#CD012551-bbs2-0018" title="MuraroGB . Clinical study on the efficacy and safety of seaprose S combined with local prostatic hyperthermia in chronic non‐bacterial prostatitis. Controlled study versus local prostatic hyperthermia [Studio clinico sull'efficacia e la tollerabilita del seaprose S associato a ipertermia locale prostatica nella prostatite cronica abatterica. Studio controllato verso ipertermia locale prostatica]. Archivio di Medicina Interna1995;47(2‐3):73‐86. ">Muraro 1995</a>; <a href="./references#CD012551-bbs2-0019" title="NeimarkAI , MaksimovaSS . Effect of hypercapnic hypoxia on chronic abacterial prostatitis. Urologiia (Moscow, Russia : 1999)2016;1(3):80‐4. [PUBMED: 28247635] ">Neimark 2016;</a><a href="./references#CD012551-bbs2-0022" title="PaickJS , LeeSC , KuJH . More effects of extracorporeal magnetic innervation and terazosin therapy than terazosin therapy alone for non‐inflammatory chronic pelvic pain syndrome: a pilot study. Prostate Cancer and Prostatic Diseases2006;9(3):261‐5. ">Paick 2006</a>; <a href="./references#CD012551-bbs2-0023" title="PajovicB , RadojevicN , DimitrovskiA , VukovicM . Comparison of the efficiency of combined extracorporeal shock‐wave therapy and triple therapy versus triple therapy itself in Category III B chronic pelvic pain syndrome (CPPS). Aging Male2016;19(3):1‐6. ">Pajovic 2016</a>; <a href="./references#CD012551-bbs2-0028" title="ShenSL , HeDL , LuoY . Clinical trials of combined therapy of an oral Chinese medicine with massage for chronic nonbacterial prostatitis. Zhonghua Nan Ke Xue2006;12(9):851‐3. ">Shen 2006</a>; <a href="./references#CD012551-bbs2-0029" title="SikiruL , ShmailaH , MuhammedSA . Transcutaneous electrical nerve stimulation (TENS) in the symptomatic management of chronic prostatitis/chronic pelvic pain syndrome: a placebo‐control randomized trial. International Brazilian Journal of Urology2008;34(6):708‐13; discussion 714. ">Sikiru 2008</a>; <a href="./references#CD012551-bbs2-0032" title="WangJ , LiJ , LuR , WangJM . Treatment of external RF hyperthermia combining with alpha 1‐adrenergic receptor blocker for patients with prostatodynia and chronic non‐bacterial prostatitis. Zhonghua Nan Ke Xue2002;8(1):48‐50. ">Wang 2002</a>; <a href="./references#CD012551-bbs2-0033" title="YangZS , ZuXB , QiL , SongLM , LiuTR . Combination therapy of biofeedback with electrical stimulation for chronic prostatitis/chronic pelvic pain syndrome. Zhonghua Nan Ke Xue2011;17(7):611‐4. ">Yang 2011</a>; <a href="./references#CD012551-bbs2-0034" title="ChungH , ChoiH , YooTK , ChoJM , KimHS . The effects of microwave thermotherapy for chronic prostatitis/chronic pelvic pain syndrome: a prospective, randomized study. Urogenital Tract Infection2017;12(1):35‐41. KimH , ChungH , YangS , YooT , ChoJ . Effects of thermotherapy and medical therapy for chronic prostatitis/chronic pelvic pain syndrome: a prospective study. Urology2011;78(3):S85‐6. YooTK , MoonKT , LeeSW , KimHS , ChungH , KimJY . Effect of the combination treatment of URO‐DrG and medical therapy for chronic prostatitis/chronic pelvic pain syndrome: a prospective study. Journal of Urology2009;181(4):122. ">Yoo 2009</a>; <a href="./references#CD012551-bbs2-0036" title="ZhangDY , PanXC . Chinese medicine union Taijiquan treatment chronicity non‐bacterial prostatitis curative effect observation. Chinese Manipulation &amp; Rehabilitation Medicine2011;15(2):181. ">Zhang 2011a</a>; <a href="./references#CD012551-bbs2-0037" title="ZhaoY , ZhaoW , LangG , ChenY , LiuJ , WangG , et al. Circumcision plus antibiotic, anti‐inflammatory, and alpha‐blocker therapy for the treatment for chronic prostatitis/chronic pelvic pain syndrome: a prospective, randomized, multicenter trial. World Journal of Urology2015;33(5):617‐22. ">Zhao 2015</a>). The remaining studies were at unclear risk of bias of outcome assessment. </p> </section> </section> <section id="CD012551-sec-0099"> <h4 class="title">Incomplete outcome data</h4> <p>Twenty‐five studies specified that outcome data for all outcomes were available in all or nearly all participants (<a href="./references#CD012551-bbs2-0002" title="ChenZX . Observation on therapeutic effect of warm needle moxibustion on chronic non‐bacterial prostatitis. Zhongguo Zhen Jiu [Chinese Acupuncture &amp; Moxibustion]2009;29(4):275‐8. ">Chen 2009</a>; <a href="./references#CD012551-bbs2-0003" title="FangJ , XuG , DingQ , ZhangY‐F . Observation on the safety and efficacy of He‐Ne laser equipment on chronic abacteria prostatitis. Fudan University Journal of Medical Sciences2005;32(2):234‐5, 252. ">Fang 2005</a>; <a href="./references#CD012551-bbs2-0004" title="BadilloSA , NevilleCE , KotarinosR , FortmanC , FraserL , CosbyA , et al. Randomized multicenter pilot trial shows benefit of manual physical therapies in treatment of urologic chronic pelvic pain. Journal of Women's Health Physical Therapy2009;33(1):23. FitzGeraldMP , AndersonRU , PottsJ , PayneCK , PetersKM , ClemensJQ , et al. Randomized multicenter feasibility trial of myofascial physical therapy for the treatment of urological chronic pelvic pain syndromes. Journal of Urology2009;182(2):570‐80. FitzgeraldMP , AndersonRU , PottsJ , PayneCK , PetersKM , ClemensJQ , et al. Randomized multicenter feasibility trial of myofascial physical therapy for the treatment of urological chronic pelvic pain syndromes. Journal of Urology2013;189(1 Suppl):S75‐85. ">Fitzgerald 2013</a>; <a href="./references#CD012551-bbs2-0006" title="GaoM , DingH , ZhongG , LuJ , WangH , LiQ , et al. The effects of transrectal radiofrequency hyperthermia on patients with chronic prostatitis and the changes of MDA, NO, SOD, and Zn levels in pretreatment and posttreatment. Urology2012;79(2):391‐6. ">Gao 2012</a>; <a href="./references#CD012551-bbs2-0008" title="KabayS , KabaySC , YucelM , OzdenH . Efficiency of posterior tibial nerve stimulation in category IIIB chronic prostatitis/chronic pelvic pain: a Sham‐Controlled Comparative Study. Urologia Internationalis2009;83(1):33‐8. ">Kabay 2009</a>; <a href="./references#CD012551-bbs2-0009" title="KaikaiC , RuiW , YongC , ZhuC , WeiH , SuogangW , et al. Combination therapy of non‐intrusive ultrasound with integrated Chinese‐western medicine for chronic prostatitis/chronic pelvic pain syndrome. Chinese Journal of Andrology2014;28(12):41‐4. ">Kaikai 2014</a>; <a href="./references#CD012551-bbs2-0011" title="KesslerTM , MordasiniL , WeisstannerC , JuniP , daCostaBR , WiestR , et al. Sono‐electro‐magnetic therapy for treating chronic pelvic pain syndrome in men: a randomized, placebo‐controlled, double‐blind trial. PloS One2014;9(12):e113368. WeisstannerC , MordasiniL , ThalmannGN , VermaRK , RummelC , FederspielA , et al. Therapy‐related longitudinal brain perfusion changes in patients with chronic pelvic pain syndrome. Swiss Medical Weekly2017;147:w14454. ">Kessler 2014</a>; <a href="./references#CD012551-bbs2-0012" title="KucukEV , SucekenFY , BindayiA , BoyluU , OnolFF , GumusE . Effectiveness of acupuncture on chronic prostatitis‐chronic pelvic pain syndrome category IIIB patients: a prospective, randomized, nonblinded, clinical trial. Urology2015;85(3):636‐40. ">Kucuk 2015</a>; <a href="./references#CD012551-bbs2-0013" title="LeeSW , LiongML , YuenKH , KriegerJN . Acupuncture and immune function in chronic prostatitis/chronic pelvic pain syndrome: a randomized, controlled study. Complementary Therapies in Medicine2014;22(6):965‐9. LeeSW , LiongML , YuenKH , LeongWS , CheeC , CheahPY , et al. Acupuncture versus sham acupuncture for chronic prostatitis/chronic pelvic pain. American Journal of Medicine2008;121(1):79.e1‐7. LeeSW , LiongML , YuenKH , LeongWS , KhanNK , KriegerJN . Validation of a sham acupuncture procedure in a randomised, controlled clinical trial of chronic pelvic pain treatment. Acupuncture in Medicine2011;29(1):40‐6. ">Lee 2008</a>; <a href="./references#CD012551-bbs2-0014" title="LeeSH , LeeBC . Electroacupuncture relieves pain in men with chronic prostatitis/chronic pelvic pain syndrome: three‐arm randomized trial. Urology2009;73(5):1036‐41. ">Lee 2009</a>; <a href="./references#CD012551-bbs2-0015" title="LeskinenMJ , KilponenA , LukkarinenO , TammelaTL . Transurethral needle ablation for the treatment of chronic pelvic pain syndrome (category III prostatitis): a randomized, sham‐controlled study. Urology2002;60(2):300‐4. ">Leskinen 2002</a>; <a href="./references#CD012551-bbs2-0017" title="MontorsiF , GuazzoniG , BergamaschiF , GalliL , ConsonniP , MatozzoV , et al. Is there a role for transrectal microwave hyperthermia of the prostate in the treatment of abacterial prostatitis and prostatodynia?. Prostate1993;22(2):139‐46. ">Montorsi 1993</a>; <a href="./references#CD012551-bbs2-0019" title="NeimarkAI , MaksimovaSS . Effect of hypercapnic hypoxia on chronic abacterial prostatitis. Urologiia (Moscow, Russia : 1999)2016;1(3):80‐4. [PUBMED: 28247635] ">Neimark 2016;</a><a href="./references#CD012551-bbs2-0020" title="NickelJC , SorensenR . Transurethral microwave thermotherapy for nonbacterial prostatitis: a randomized double‐blind sham controlled study using new prostatitis specific assessment questionnaires. Journal of Urology1996;155(6):1950‐4; discussion 1954. ">Nickel 1996</a>; <a href="./references#CD012551-bbs2-0022" title="PaickJS , LeeSC , KuJH . More effects of extracorporeal magnetic innervation and terazosin therapy than terazosin therapy alone for non‐inflammatory chronic pelvic pain syndrome: a pilot study. Prostate Cancer and Prostatic Diseases2006;9(3):261‐5. ">Paick 2006</a>; <a href="./references#CD012551-bbs2-0023" title="PajovicB , RadojevicN , DimitrovskiA , VukovicM . Comparison of the efficiency of combined extracorporeal shock‐wave therapy and triple therapy versus triple therapy itself in Category III B chronic pelvic pain syndrome (CPPS). Aging Male2016;19(3):1‐6. ">Pajovic 2016</a>; <a href="./references#CD012551-bbs2-0025" title="SahinS , BicerM , ErenGA , TasS , TugcuV , TasciAI , et al. Acupuncture relieves symptoms in chronic prostatitis/chronic pelvic pain syndrome: a randomized, sham‐controlled trial. Prostate Cancer and Prostatic Diseases2015;18(3):249‐54. ">Sahin 2015</a>; <a href="./references#CD012551-bbs2-0026" title="Samhan AhmedF , Abd‐Elhalim NermeenM , Elnegmy EmamH , Roiah MohamedM . The effect of transcutaneous electrical nerve stimulation in the treatment of chronic pelvic pain syndrome: an evidence based electromyographic studies. Indian Journal of Physiotherapy &amp; Occupational Therapy2011;5(3):14‐7. ">Samhan 2011</a>; <a href="./references#CD012551-bbs2-0028" title="ShenSL , HeDL , LuoY . Clinical trials of combined therapy of an oral Chinese medicine with massage for chronic nonbacterial prostatitis. Zhonghua Nan Ke Xue2006;12(9):851‐3. ">Shen 2006</a>; <a href="./references#CD012551-bbs2-0029" title="SikiruL , ShmailaH , MuhammedSA . Transcutaneous electrical nerve stimulation (TENS) in the symptomatic management of chronic prostatitis/chronic pelvic pain syndrome: a placebo‐control randomized trial. International Brazilian Journal of Urology2008;34(6):708‐13; discussion 714. ">Sikiru 2008</a>; <a href="./references#CD012551-bbs2-0032" title="WangJ , LiJ , LuR , WangJM . Treatment of external RF hyperthermia combining with alpha 1‐adrenergic receptor blocker for patients with prostatodynia and chronic non‐bacterial prostatitis. Zhonghua Nan Ke Xue2002;8(1):48‐50. ">Wang 2002</a>; <a href="./references#CD012551-bbs2-0033" title="YangZS , ZuXB , QiL , SongLM , LiuTR . Combination therapy of biofeedback with electrical stimulation for chronic prostatitis/chronic pelvic pain syndrome. Zhonghua Nan Ke Xue2011;17(7):611‐4. ">Yang 2011</a>; <a href="./references#CD012551-bbs2-0035" title="ZengX , YeZ , YangW , ChenZ , DuG . Extracorporeal shock wave treatment for noninflammatory chronic pelvic pain syndrome: a prospective, randomized, sham‐controlled study. Journal of Urology2009;181(4):122‐3. ZengXY , LiangC , YeZQ . Extracorporeal shock wave treatment for non‐inflammatory chronic pelvic pain syndrome: a prospective, randomized and sham‐controlled study. Chinese Medical Journal2012;125(1):114‐8. ">Zeng 2012</a>; <a href="./references#CD012551-bbs2-0037" title="ZhaoY , ZhaoW , LangG , ChenY , LiuJ , WangG , et al. Circumcision plus antibiotic, anti‐inflammatory, and alpha‐blocker therapy for the treatment for chronic prostatitis/chronic pelvic pain syndrome: a prospective, randomized, multicenter trial. World Journal of Urology2015;33(5):617‐22. ">Zhao 2015</a>; <a href="./references#CD012551-bbs2-0038" title="ZimmermannR , CumpanasA , MicleaF , JanetschekG . Extracorporeal shock wave therapy for the treatment of chronic pelvic pain syndrome in males: a randomised, double‐blind, placebo‐controlled study. European Urology2009;56(3):418‐24. ZimmermannRP , CumpanasA , MicleaF , JanetschekG . One year follow up of extracorporeal shock wave therapy (ESWT) for chronic pelvic pain syndrome (CPPS) in a randomised placebo‐controlled double‐blind study. European Urology (Suppl)2010;9(2):214. ">Zimmermann 2009</a>). Seven studies had unbalanced or high attrition (or both) of outcome data at follow‐up and were deemed at high risk of bias (<a href="./references#CD012551-bbs2-0005" title="GalloL . Effectiveness of diet, sexual habits and lifestyle modifications on treatment of chronic pelvic pain syndrome. Prostate Cancer and Prostatic Diseases2014;17(3):238‐45. ">Gallo 2014</a>; <a href="./references#CD012551-bbs2-0007" title="GiubileiG , MondainiN , MinerviniA , SaievaC , LapiniA , SerniS , et al. Physical activity of men with chronic prostatitis/chronic pelvic pain syndrome not satisfied with conventional treatments ‐ could it represent a valid option? The physical activity and male pelvic pain trial: a double‐blind, randomized study. Journal of Urology2007;177(1):159‐65. ">Giubilei 2007</a>; <a href="./references#CD012551-bbs2-0010" title="KastnerC , HochreiterW , HuidobroC , CabezasJ , MillerP . Cooled transurethral microwave thermotherapy for intractable chronic prostatitis ‐ results of a pilot study after 1 year. Urology2004;64(6):1149‐54. ">Kastner 2004</a>; <a href="./references#CD012551-bbs2-0016" title="MarxS . ICAOR 2006: does osteopathic treatment have an influence on the symptoms of patients with chronic prostatitis/chronic pelvic pain syndrome (CPPS)? A randomized controlled trial. International Journal of Osteopathic Medicine2006;9(1):44. MarxS , CimniakU , BeckertR , SchwerlaF , ReschKL . Chronic prostatitis/chronic pelvic pain syndrome. Influence of osteopathic treatment ‐ a randomized controlled study [Chronische Prostatitis/chronisches Beckenschmerzsyndrom. Einfluss osteopathischer Behandlungen ‐ eine randomisiert kontrollierte Studie]. Der Urologe. Ausg. A2009;48(11):1339‐45. ">Marx 2009</a>; <a href="./references#CD012551-bbs2-0024" title="RoweE , SmithC , LaverickL , ElkabirJ , WitherowRO , PatelA . A prospective, randomized, placebo controlled, double‐blind study of pelvic electromagnetic therapy for the treatment of chronic pelvic pain syndrome with 1 year of followup. Journal of Urology2005;173(6):2044‐7. ">Rowe 2005</a>; <a href="./references#CD012551-bbs2-0027" title="ShahT , WatsonG , BarnesD . Microwave hyperthermia in the treatment of chronic abacterial prostatitis and prostatodynia: results of a double blind placebo controlled trial (Abstract). Journal of Urology1993;149:405A. ">Shah 1993</a>; <a href="./references#CD012551-bbs2-0034" title="ChungH , ChoiH , YooTK , ChoJM , KimHS . The effects of microwave thermotherapy for chronic prostatitis/chronic pelvic pain syndrome: a prospective, randomized study. Urogenital Tract Infection2017;12(1):35‐41. KimH , ChungH , YangS , YooT , ChoJ . Effects of thermotherapy and medical therapy for chronic prostatitis/chronic pelvic pain syndrome: a prospective study. Urology2011;78(3):S85‐6. YooTK , MoonKT , LeeSW , KimHS , ChungH , KimJY . Effect of the combination treatment of URO‐DrG and medical therapy for chronic prostatitis/chronic pelvic pain syndrome: a prospective study. Journal of Urology2009;181(4):122. ">Yoo 2009</a>). The remaining studies were at unclear risk of bias in this domain. </p> </section> <section id="CD012551-sec-0100"> <h4 class="title">Selective reporting</h4> <p>Seven studies had low risk of reporting bias when comparing their outcomes to their protocols or trial registries (<a href="./references#CD012551-bbs2-0004" title="BadilloSA , NevilleCE , KotarinosR , FortmanC , FraserL , CosbyA , et al. Randomized multicenter pilot trial shows benefit of manual physical therapies in treatment of urologic chronic pelvic pain. Journal of Women's Health Physical Therapy2009;33(1):23. FitzGeraldMP , AndersonRU , PottsJ , PayneCK , PetersKM , ClemensJQ , et al. Randomized multicenter feasibility trial of myofascial physical therapy for the treatment of urological chronic pelvic pain syndromes. Journal of Urology2009;182(2):570‐80. FitzgeraldMP , AndersonRU , PottsJ , PayneCK , PetersKM , ClemensJQ , et al. Randomized multicenter feasibility trial of myofascial physical therapy for the treatment of urological chronic pelvic pain syndromes. Journal of Urology2013;189(1 Suppl):S75‐85. ">Fitzgerald 2013</a>; <a href="./references#CD012551-bbs2-0011" title="KesslerTM , MordasiniL , WeisstannerC , JuniP , daCostaBR , WiestR , et al. Sono‐electro‐magnetic therapy for treating chronic pelvic pain syndrome in men: a randomized, placebo‐controlled, double‐blind trial. PloS One2014;9(12):e113368. WeisstannerC , MordasiniL , ThalmannGN , VermaRK , RummelC , FederspielA , et al. Therapy‐related longitudinal brain perfusion changes in patients with chronic pelvic pain syndrome. Swiss Medical Weekly2017;147:w14454. ">Kessler 2014</a>; <a href="./references#CD012551-bbs2-0013" title="LeeSW , LiongML , YuenKH , KriegerJN . Acupuncture and immune function in chronic prostatitis/chronic pelvic pain syndrome: a randomized, controlled study. Complementary Therapies in Medicine2014;22(6):965‐9. LeeSW , LiongML , YuenKH , LeongWS , CheeC , CheahPY , et al. Acupuncture versus sham acupuncture for chronic prostatitis/chronic pelvic pain. American Journal of Medicine2008;121(1):79.e1‐7. LeeSW , LiongML , YuenKH , LeongWS , KhanNK , KriegerJN . Validation of a sham acupuncture procedure in a randomised, controlled clinical trial of chronic pelvic pain treatment. Acupuncture in Medicine2011;29(1):40‐6. ">Lee 2008</a>; <a href="./references#CD012551-bbs2-0023" title="PajovicB , RadojevicN , DimitrovskiA , VukovicM . Comparison of the efficiency of combined extracorporeal shock‐wave therapy and triple therapy versus triple therapy itself in Category III B chronic pelvic pain syndrome (CPPS). Aging Male2016;19(3):1‐6. ">Pajovic 2016</a>; <a href="./references#CD012551-bbs2-0030" title="MoayedniaA , HaghdaniS , KhosrawiS , YousefiE , VahdatpourB . Long‐term effect of extracorporeal shock wave therapy on the treatment of chronic pelvic pain syndrome due to non bacterial prostatitis. Journal of Research in Medical Sciences2014;19(4):293‐6. VahdatpourB , AlizadehF , MoayedniaA , EmadiM , KhoramiMH , HaghdaniS . Efficacy of extracorporeal shock wave therapy for the treatment of chronic pelvic pain syndrome: a randomized, controlled trial. ISRN Urology2013;2013:972601. ">Vahdatpour 2013</a>; <a href="./references#CD012551-bbs2-0037" title="ZhaoY , ZhaoW , LangG , ChenY , LiuJ , WangG , et al. Circumcision plus antibiotic, anti‐inflammatory, and alpha‐blocker therapy for the treatment for chronic prostatitis/chronic pelvic pain syndrome: a prospective, randomized, multicenter trial. World Journal of Urology2015;33(5):617‐22. ">Zhao 2015</a>; <a href="./references#CD012551-bbs2-0038" title="ZimmermannR , CumpanasA , MicleaF , JanetschekG . Extracorporeal shock wave therapy for the treatment of chronic pelvic pain syndrome in males: a randomised, double‐blind, placebo‐controlled study. European Urology2009;56(3):418‐24. ZimmermannRP , CumpanasA , MicleaF , JanetschekG . One year follow up of extracorporeal shock wave therapy (ESWT) for chronic pelvic pain syndrome (CPPS) in a randomised placebo‐controlled double‐blind study. European Urology (Suppl)2010;9(2):214. ">Zimmermann 2009</a>). Three studies reported some of their outcomes graphically or with missing data and were deemed at high risk of bias (<a href="./references#CD012551-bbs2-0005" title="GalloL . Effectiveness of diet, sexual habits and lifestyle modifications on treatment of chronic pelvic pain syndrome. Prostate Cancer and Prostatic Diseases2014;17(3):238‐45. ">Gallo 2014</a>; <a href="./references#CD012551-bbs2-0024" title="RoweE , SmithC , LaverickL , ElkabirJ , WitherowRO , PatelA . A prospective, randomized, placebo controlled, double‐blind study of pelvic electromagnetic therapy for the treatment of chronic pelvic pain syndrome with 1 year of followup. Journal of Urology2005;173(6):2044‐7. ">Rowe 2005</a>; <a href="./references#CD012551-bbs2-0035" title="ZengX , YeZ , YangW , ChenZ , DuG . Extracorporeal shock wave treatment for noninflammatory chronic pelvic pain syndrome: a prospective, randomized, sham‐controlled study. Journal of Urology2009;181(4):122‐3. ZengXY , LiangC , YeZQ . Extracorporeal shock wave treatment for non‐inflammatory chronic pelvic pain syndrome: a prospective, randomized and sham‐controlled study. Chinese Medical Journal2012;125(1):114‐8. ">Zeng 2012</a>). The remaining studies were at unclear risk of reporting bias. </p> </section> <section id="CD012551-sec-0101"> <h4 class="title">Other potential sources of bias</h4> <p>Two studies were at high risk of bias due to large baseline difference in mean symptom scores between groups (<a href="./references#CD012551-bbs2-0004" title="BadilloSA , NevilleCE , KotarinosR , FortmanC , FraserL , CosbyA , et al. Randomized multicenter pilot trial shows benefit of manual physical therapies in treatment of urologic chronic pelvic pain. Journal of Women's Health Physical Therapy2009;33(1):23. FitzGeraldMP , AndersonRU , PottsJ , PayneCK , PetersKM , ClemensJQ , et al. Randomized multicenter feasibility trial of myofascial physical therapy for the treatment of urological chronic pelvic pain syndromes. Journal of Urology2009;182(2):570‐80. FitzgeraldMP , AndersonRU , PottsJ , PayneCK , PetersKM , ClemensJQ , et al. Randomized multicenter feasibility trial of myofascial physical therapy for the treatment of urological chronic pelvic pain syndromes. Journal of Urology2013;189(1 Suppl):S75‐85. ">Fitzgerald 2013</a>; <a href="./references#CD012551-bbs2-0029" title="SikiruL , ShmailaH , MuhammedSA . Transcutaneous electrical nerve stimulation (TENS) in the symptomatic management of chronic prostatitis/chronic pelvic pain syndrome: a placebo‐control randomized trial. International Brazilian Journal of Urology2008;34(6):708‐13; discussion 714. ">Sikiru 2008</a>; see <a href="#CD012551-tbl-0012">Table 2</a>). Seven studies lacked baseline characteristics of participants (<a href="./references#CD012551-bbs2-0001" title="AteyaA , FayezA , HaniR , ZohdyW , GabbarMA , ShamloulR . Evaluation of prostatic massage in treatment of chronic prostatitis. Urology2006;67(4):674‐8. ">Ateya 2006</a>; <a href="./references#CD012551-bbs2-0017" title="MontorsiF , GuazzoniG , BergamaschiF , GalliL , ConsonniP , MatozzoV , et al. Is there a role for transrectal microwave hyperthermia of the prostate in the treatment of abacterial prostatitis and prostatodynia?. Prostate1993;22(2):139‐46. ">Montorsi 1993</a>; <a href="./references#CD012551-bbs2-0019" title="NeimarkAI , MaksimovaSS . Effect of hypercapnic hypoxia on chronic abacterial prostatitis. Urologiia (Moscow, Russia : 1999)2016;1(3):80‐4. [PUBMED: 28247635] ">Neimark 2016;</a><a href="./references#CD012551-bbs2-0020" title="NickelJC , SorensenR . Transurethral microwave thermotherapy for nonbacterial prostatitis: a randomized double‐blind sham controlled study using new prostatitis specific assessment questionnaires. Journal of Urology1996;155(6):1950‐4; discussion 1954. ">Nickel 1996</a>; <a href="./references#CD012551-bbs2-0021" title="OhMM , JinMH , MoonDG , NamSG , BaeJH , ParkHS . A prospective, randomized, placebo controlled study of radiofrequency therapy for the treatment of chronic prostatitis/chronic pelvic pain syndrome. Journal of Urology2009;181(4):122. ">Oh 2009</a>; <a href="./references#CD012551-bbs2-0027" title="ShahT , WatsonG , BarnesD . Microwave hyperthermia in the treatment of chronic abacterial prostatitis and prostatodynia: results of a double blind placebo controlled trial (Abstract). Journal of Urology1993;149:405A. ">Shah 1993</a>; <a href="./references#CD012551-bbs2-0031" title="VassilyO , AndreyS , EvgeniiD , OtabekI , BorisL , SergeyR . Efficacy of transrectal microwave hyperthemia (TRMH) in the treatment of chronic prostatitis. A randomized sham controlled comparative study (Abstract). Journal of Urology1999;161(4 Suppl):33A. ">Vassily 1999</a>), one study had some baseline differences in symptom scores (<a href="./references#CD012551-bbs2-0015" title="LeskinenMJ , KilponenA , LukkarinenO , TammelaTL . Transurethral needle ablation for the treatment of chronic pelvic pain syndrome (category III prostatitis): a randomized, sham‐controlled study. Urology2002;60(2):300‐4. ">Leskinen 2002</a>), and two studies did not specify if participants received some additional interventions planned in the protocol (<a href="./references#CD012551-bbs2-0005" title="GalloL . Effectiveness of diet, sexual habits and lifestyle modifications on treatment of chronic pelvic pain syndrome. Prostate Cancer and Prostatic Diseases2014;17(3):238‐45. ">Gallo 2014</a>) or how many participants received the planned intervention (<a href="./references#CD012551-bbs2-0037" title="ZhaoY , ZhaoW , LangG , ChenY , LiuJ , WangG , et al. Circumcision plus antibiotic, anti‐inflammatory, and alpha‐blocker therapy for the treatment for chronic prostatitis/chronic pelvic pain syndrome: a prospective, randomized, multicenter trial. World Journal of Urology2015;33(5):617‐22. ">Zhao 2015</a>). The remaining studies were at low risk of other bias. </p> </section> </section> <section id="CD012551-sec-0102"> <h3 class="title" id="CD012551-sec-0102">Effects of interventions</h3> <p>See: <a href="./full#CD012551-tbl-0001"><b>Summary of findings for the main comparison</b> Acupuncture compared to sham procedure for treating chronic prostatitis/chronic pelvic pain syndrome</a>; <a href="./full#CD012551-tbl-0002"><b>Summary of findings 2</b> Acupuncture compared to medical treatment for treating chronic prostatitis/chronic pelvic pain syndrome</a>; <a href="./full#CD012551-tbl-0003"><b>Summary of findings 3</b> Circumcision plus usual care compared to waiting list plus usual care for chronic prostatitis/chronic pelvic pain syndrome</a>; <a href="./full#CD012551-tbl-0004"><b>Summary of findings 4</b> Electromagnetic chair compared to control intervention for chronic prostatitis/chronic pelvic pain syndrome</a>; <a href="./full#CD012551-tbl-0005"><b>Summary of findings 5</b> Lifestyle modifications compared to control for chronic prostatitis/chronic pelvic pain syndrome</a>; <a href="./full#CD012551-tbl-0006"><b>Summary of findings 6</b> Physical activity compared to control intervention for chronic prostatitis/chronic pelvic pain syndrome</a>; <a href="./full#CD012551-tbl-0007"><b>Summary of findings 7</b> Prostatic massage compared to no intervention for treating chronic prostatitis/chronic pelvic pain syndrome</a>; <a href="./full#CD012551-tbl-0008"><b>Summary of findings 8</b> Extracorporeal shockwave therapy compared to control procedure for chronic prostatitis/chronic pelvic pain syndrome</a>; <a href="./full#CD012551-tbl-0009"><b>Summary of findings 9</b> Transrectal thermotherapy compared to medical treatment for chronic prostatitis/chronic pelvic pain syndrome</a>; <a href="./full#CD012551-tbl-0010"><b>Summary of findings 10</b> Transrectal thermotherapy (add‐on) compared to medical treatment alone for chronic prostatitis/chronic pelvic pain syndrome</a> </p> <section id="CD012551-sec-0103"> <h4 class="title">Acupuncture</h4> <section id="CD012551-sec-0104"> <h5 class="title">1. Acupuncture versus sham procedure</h5> <p>Three studies with 204 participants compared acupuncture versus sham procedure for short‐term follow‐up (six to 24 weeks) (<a href="./references#CD012551-bbs2-0013" title="LeeSW , LiongML , YuenKH , KriegerJN . Acupuncture and immune function in chronic prostatitis/chronic pelvic pain syndrome: a randomized, controlled study. Complementary Therapies in Medicine2014;22(6):965‐9. LeeSW , LiongML , YuenKH , LeongWS , CheeC , CheahPY , et al. Acupuncture versus sham acupuncture for chronic prostatitis/chronic pelvic pain. American Journal of Medicine2008;121(1):79.e1‐7. LeeSW , LiongML , YuenKH , LeongWS , KhanNK , KriegerJN . Validation of a sham acupuncture procedure in a randomised, controlled clinical trial of chronic pelvic pain treatment. Acupuncture in Medicine2011;29(1):40‐6. ">Lee 2008</a>; <a href="./references#CD012551-bbs2-0014" title="LeeSH , LeeBC . Electroacupuncture relieves pain in men with chronic prostatitis/chronic pelvic pain syndrome: three‐arm randomized trial. Urology2009;73(5):1036‐41. ">Lee 2009</a>; <a href="./references#CD012551-bbs2-0025" title="SahinS , BicerM , ErenGA , TasS , TugcuV , TasciAI , et al. Acupuncture relieves symptoms in chronic prostatitis/chronic pelvic pain syndrome: a randomized, sham‐controlled trial. Prostate Cancer and Prostatic Diseases2015;18(3):249‐54. ">Sahin 2015</a>). These studies compared the use of acupuncture with a sham procedure in which the acupuncture needles were placed in a point separate from those indicated by the acupuncture technique. One of these studies included the use of electric stimulation (<a href="./references#CD012551-bbs2-0014" title="LeeSH , LeeBC . Electroacupuncture relieves pain in men with chronic prostatitis/chronic pelvic pain syndrome: three‐arm randomized trial. Urology2009;73(5):1036‐41. ">Lee 2009</a>), also called electroacupuncture, in the active treatment group (see <a href="#CD012551-tbl-0011">Table 1</a> and <a href="#CD012551-tbl-0012">Table 2</a> for further details of the participants and interventions). See Summary of findings table 1. </p> <section id="CD012551-sec-0105"> <h6 class="title">1.1. Prostatitis symptoms</h6> <p>Three studies with 204 participants reported prostatitis symptoms (<a href="./references#CD012551-bbs2-0013" title="LeeSW , LiongML , YuenKH , KriegerJN . Acupuncture and immune function in chronic prostatitis/chronic pelvic pain syndrome: a randomized, controlled study. Complementary Therapies in Medicine2014;22(6):965‐9. LeeSW , LiongML , YuenKH , LeongWS , CheeC , CheahPY , et al. Acupuncture versus sham acupuncture for chronic prostatitis/chronic pelvic pain. American Journal of Medicine2008;121(1):79.e1‐7. LeeSW , LiongML , YuenKH , LeongWS , KhanNK , KriegerJN . Validation of a sham acupuncture procedure in a randomised, controlled clinical trial of chronic pelvic pain treatment. Acupuncture in Medicine2011;29(1):40‐6. ">Lee 2008</a>; <a href="./references#CD012551-bbs2-0014" title="LeeSH , LeeBC . Electroacupuncture relieves pain in men with chronic prostatitis/chronic pelvic pain syndrome: three‐arm randomized trial. Urology2009;73(5):1036‐41. ">Lee 2009</a>; <a href="./references#CD012551-bbs2-0025" title="SahinS , BicerM , ErenGA , TasS , TugcuV , TasciAI , et al. Acupuncture relieves symptoms in chronic prostatitis/chronic pelvic pain syndrome: a randomized, sham‐controlled trial. Prostate Cancer and Prostatic Diseases2015;18(3):249‐54. ">Sahin 2015</a>). Acupuncture appreciably reduced prostatitis symptoms compared to a sham procedure, measured by NIH‐CPSI score at six to eight weeks' follow‐up (fixed‐effect meta‐analysis; MD ‐5.79, 95% CI ‐7.32 to ‐4.26; <a href="./references#CD012551-fig-0005" title="">Analysis 1.1</a>). These lower scores were observed across all subscores of pain, urinary symptoms and QoL (<a href="./references#CD012551-fig-0006" title="">Analysis 1.2</a>; <a href="./references#CD012551-fig-0007" title="">Analysis 1.3</a>; <a href="./references#CD012551-fig-0008" title="">Analysis 1.4</a>). The quality of evidence was moderate due to unclear risk of bias in one domain (allocation concealment). </p> <p>Two studies with 113 participants reported the number of participants who achieved an MCID of 6‐point decrease of NIH‐CPSI score at six weeks, defined as "responders" (<a href="./references#CD012551-bbs2-0013" title="LeeSW , LiongML , YuenKH , KriegerJN . Acupuncture and immune function in chronic prostatitis/chronic pelvic pain syndrome: a randomized, controlled study. Complementary Therapies in Medicine2014;22(6):965‐9. LeeSW , LiongML , YuenKH , LeongWS , CheeC , CheahPY , et al. Acupuncture versus sham acupuncture for chronic prostatitis/chronic pelvic pain. American Journal of Medicine2008;121(1):79.e1‐7. LeeSW , LiongML , YuenKH , LeongWS , KhanNK , KriegerJN . Validation of a sham acupuncture procedure in a randomised, controlled clinical trial of chronic pelvic pain treatment. Acupuncture in Medicine2011;29(1):40‐6. ">Lee 2008</a>; <a href="./references#CD012551-bbs2-0014" title="LeeSH , LeeBC . Electroacupuncture relieves pain in men with chronic prostatitis/chronic pelvic pain syndrome: three‐arm randomized trial. Urology2009;73(5):1036‐41. ">Lee 2009</a>). Acupuncture may have resulted in little to no difference in responder rate compared to a sham procedure (random‐effects meta‐analysis; RR 2.49, 95% CI 0.77 to 8.02; <a href="./references#CD012551-fig-0009" title="">Analysis 1.5</a>). The quality of evidence was low due to imprecision issues (small sample size and few events) and inconsistency (statistical heterogeneity I<sup>2</sup> = 76%). </p> <p>One of the studies with 91 participants reported the NIH‐CPSI scores at the 24 weeks' follow‐up (<a href="./references#CD012551-bbs2-0025" title="SahinS , BicerM , ErenGA , TasS , TugcuV , TasciAI , et al. Acupuncture relieves symptoms in chronic prostatitis/chronic pelvic pain syndrome: a randomized, sham‐controlled trial. Prostate Cancer and Prostatic Diseases2015;18(3):249‐54. ">Sahin 2015</a>). Acupuncture reduced prostatitis symptoms in an appreciable number of participants (MD ‐7.36, 95% CI ‐9.93 to ‐4.79; <a href="./references#CD012551-fig-0010" title="">Analysis 1.6</a>). These lower scores were observed across all subscores of pain, urinary symptoms and QoL (see <a href="./references#CD012551-fig-0011" title="">Analysis 1.7</a>; <a href="./references#CD012551-fig-0012" title="">Analysis 1.8</a>; <a href="./references#CD012551-fig-0013" title="">Analysis 1.9</a>). The quality of evidence was high. </p> </section> <section id="CD012551-sec-0106"> <h6 class="title">1.2. Adverse events</h6> <p>Three studies with 204 participants reported adverse events (<a href="./references#CD012551-bbs2-0013" title="LeeSW , LiongML , YuenKH , KriegerJN . Acupuncture and immune function in chronic prostatitis/chronic pelvic pain syndrome: a randomized, controlled study. Complementary Therapies in Medicine2014;22(6):965‐9. LeeSW , LiongML , YuenKH , LeongWS , CheeC , CheahPY , et al. Acupuncture versus sham acupuncture for chronic prostatitis/chronic pelvic pain. American Journal of Medicine2008;121(1):79.e1‐7. LeeSW , LiongML , YuenKH , LeongWS , KhanNK , KriegerJN . Validation of a sham acupuncture procedure in a randomised, controlled clinical trial of chronic pelvic pain treatment. Acupuncture in Medicine2011;29(1):40‐6. ">Lee 2008</a>; <a href="./references#CD012551-bbs2-0014" title="LeeSH , LeeBC . Electroacupuncture relieves pain in men with chronic prostatitis/chronic pelvic pain syndrome: three‐arm randomized trial. Urology2009;73(5):1036‐41. ">Lee 2009</a>; <a href="./references#CD012551-bbs2-0025" title="SahinS , BicerM , ErenGA , TasS , TugcuV , TasciAI , et al. Acupuncture relieves symptoms in chronic prostatitis/chronic pelvic pain syndrome: a randomized, sham‐controlled trial. Prostate Cancer and Prostatic Diseases2015;18(3):249‐54. ">Sahin 2015</a>). Acupuncture likely resulted in little to no difference in adverse events (RR 1.33, 95% CI 0.51 to 3.46; <a href="./references#CD012551-fig-0014" title="">Analysis 1.10</a>). The quality of evidence was low due to imprecision (small sample size and few events) and unclear risk of bias in one domain (allocation concealment). </p> </section> <section id="CD012551-sec-0107"> <h6 class="title">1.3. Sexual dysfunction</h6> <p>One study with 89 participants reported sexual dysfunction (<a href="./references#CD012551-bbs2-0013" title="LeeSW , LiongML , YuenKH , KriegerJN . Acupuncture and immune function in chronic prostatitis/chronic pelvic pain syndrome: a randomized, controlled study. Complementary Therapies in Medicine2014;22(6):965‐9. LeeSW , LiongML , YuenKH , LeongWS , CheeC , CheahPY , et al. Acupuncture versus sham acupuncture for chronic prostatitis/chronic pelvic pain. American Journal of Medicine2008;121(1):79.e1‐7. LeeSW , LiongML , YuenKH , LeongWS , KhanNK , KriegerJN . Validation of a sham acupuncture procedure in a randomised, controlled clinical trial of chronic pelvic pain treatment. Acupuncture in Medicine2011;29(1):40‐6. ">Lee 2008</a>). Acupuncture likely resulted in little to no difference in sexual dysfunction (fixed‐effect meta‐analysis; MD ‐0.50, 95% CI ‐3.46 to 2.46; <a href="./references#CD012551-fig-0015" title="">Analysis 1.11</a>). The quality of evidence was low due to imprecision (wide CIs includes both appreciable benefit and harm) and unclear risk of bias in one domain (allocation concealment). </p> </section> <section id="CD012551-sec-0108"> <h6 class="title">1.4. Urinary symptoms</h6> <p>Two studies with 113 participants reported urinary symptoms (<a href="./references#CD012551-bbs2-0013" title="LeeSW , LiongML , YuenKH , KriegerJN . Acupuncture and immune function in chronic prostatitis/chronic pelvic pain syndrome: a randomized, controlled study. Complementary Therapies in Medicine2014;22(6):965‐9. LeeSW , LiongML , YuenKH , LeongWS , CheeC , CheahPY , et al. Acupuncture versus sham acupuncture for chronic prostatitis/chronic pelvic pain. American Journal of Medicine2008;121(1):79.e1‐7. LeeSW , LiongML , YuenKH , LeongWS , KhanNK , KriegerJN . Validation of a sham acupuncture procedure in a randomised, controlled clinical trial of chronic pelvic pain treatment. Acupuncture in Medicine2011;29(1):40‐6. ">Lee 2008</a>; <a href="./references#CD012551-bbs2-0014" title="LeeSH , LeeBC . Electroacupuncture relieves pain in men with chronic prostatitis/chronic pelvic pain syndrome: three‐arm randomized trial. Urology2009;73(5):1036‐41. ">Lee 2009</a>). Acupuncture may have resulted in a small effect on urinary symptoms (fixed‐effect meta‐analysis; MD ‐2.79, 95% CI ‐4.77 to ‐0.82; <a href="./references#CD012551-fig-0016" title="">Analysis 1.12</a>). The quality of evidence was moderate due to unclear risk of bias in one domain (allocation concealment).. </p> </section> <section id="CD012551-sec-0109"> <h6 class="title">1.5. Quality of life</h6> <p>None of the studies reported QoL.</p> </section> <section id="CD012551-sec-0110"> <h6 class="title">1.6. Depression and anxiety</h6> <p>None of the studies reported depression and anxiety.</p> </section> </section> <section id="CD012551-sec-0111"> <h5 class="title">2. Acupuncture versus medical treatment</h5> <p>Three studies with 245 participants compared acupuncture versus medical treatment (<a href="./references#CD012551-bbs2-0002" title="ChenZX . Observation on therapeutic effect of warm needle moxibustion on chronic non‐bacterial prostatitis. Zhongguo Zhen Jiu [Chinese Acupuncture &amp; Moxibustion]2009;29(4):275‐8. ">Chen 2009</a>; <a href="./references#CD012551-bbs2-0012" title="KucukEV , SucekenFY , BindayiA , BoyluU , OnolFF , GumusE . Effectiveness of acupuncture on chronic prostatitis‐chronic pelvic pain syndrome category IIIB patients: a prospective, randomized, nonblinded, clinical trial. Urology2015;85(3):636‐40. ">Kucuk 2015</a>; <a href="./references#CD012551-bbs2-0014" title="LeeSH , LeeBC . Electroacupuncture relieves pain in men with chronic prostatitis/chronic pelvic pain syndrome: three‐arm randomized trial. Urology2009;73(5):1036‐41. ">Lee 2009</a>). These studies compared the use of acupuncture with medical treatment. Medical treatment included the use of pollen extract (<a href="./references#CD012551-bbs2-0002" title="ChenZX . Observation on therapeutic effect of warm needle moxibustion on chronic non‐bacterial prostatitis. Zhongguo Zhen Jiu [Chinese Acupuncture &amp; Moxibustion]2009;29(4):275‐8. ">Chen 2009</a>), levofloxacin and ibuprofen (<a href="./references#CD012551-bbs2-0012" title="KucukEV , SucekenFY , BindayiA , BoyluU , OnolFF , GumusE . Effectiveness of acupuncture on chronic prostatitis‐chronic pelvic pain syndrome category IIIB patients: a prospective, randomized, nonblinded, clinical trial. Urology2015;85(3):636‐40. ">Kucuk 2015</a>), or exercise and medical advice (<a href="./references#CD012551-bbs2-0014" title="LeeSH , LeeBC . Electroacupuncture relieves pain in men with chronic prostatitis/chronic pelvic pain syndrome: three‐arm randomized trial. Urology2009;73(5):1036‐41. ">Lee 2009</a>). One of these studies included the use of electric stimulation, also called electroacupuncture, in the active treatment group (<a href="./references#CD012551-bbs2-0014" title="LeeSH , LeeBC . Electroacupuncture relieves pain in men with chronic prostatitis/chronic pelvic pain syndrome: three‐arm randomized trial. Urology2009;73(5):1036‐41. ">Lee 2009</a>; see <a href="#CD012551-tbl-0011">Table 1</a> and <a href="#CD012551-tbl-0012">Table 2</a> for further details of the participants and interventions). See <a href="./full#CD012551-tbl-0002">summary of findings Table 2</a>. </p> <section id="CD012551-sec-0112"> <h6 class="title">2.1. Prostatitis symptoms</h6> <p>Three studies reported prostatitis symptoms (<a href="./references#CD012551-bbs2-0002" title="ChenZX . Observation on therapeutic effect of warm needle moxibustion on chronic non‐bacterial prostatitis. Zhongguo Zhen Jiu [Chinese Acupuncture &amp; Moxibustion]2009;29(4):275‐8. ">Chen 2009</a>; <a href="./references#CD012551-bbs2-0012" title="KucukEV , SucekenFY , BindayiA , BoyluU , OnolFF , GumusE . Effectiveness of acupuncture on chronic prostatitis‐chronic pelvic pain syndrome category IIIB patients: a prospective, randomized, nonblinded, clinical trial. Urology2015;85(3):636‐40. ">Kucuk 2015</a>; <a href="./references#CD012551-bbs2-0014" title="LeeSH , LeeBC . Electroacupuncture relieves pain in men with chronic prostatitis/chronic pelvic pain syndrome: three‐arm randomized trial. Urology2009;73(5):1036‐41. ">Lee 2009</a>). Acupuncture may have reduced prostatitis symptoms compared to medical treatment, measured by NIH‐CPSI score at six to eight weeks' follow‐up (MD ‐4.09, 95% CI ‐6.87 to ‐1.30; I<sup>2</sup> = 70%, random‐effects meta‐analysis) (<a href="./references#CD012551-fig-0017" title="">Analysis 2.1</a>). These lower scores were observed across all subscores of pain, urinary symptoms and QoL (<a href="./references#CD012551-fig-0018" title="">Analysis 2.2</a>; <a href="./references#CD012551-fig-0019" title="">Analysis 2.3</a>; <a href="./references#CD012551-fig-0020" title="">Analysis 2.4</a>). Heterogeneity was predominantly attributable to one study (<a href="./references#CD012551-bbs2-0002" title="ChenZX . Observation on therapeutic effect of warm needle moxibustion on chronic non‐bacterial prostatitis. Zhongguo Zhen Jiu [Chinese Acupuncture &amp; Moxibustion]2009;29(4):275‐8. ">Chen 2009</a>), which included participants with CP/CPPS using criteria that differed from those recommended by the Research Consensus. In a sensitivity analysis (see below), we excluded the results from this study and we found greater statistical consistency (I<sup>2</sup> = 0%). Therefore, we chose to report these results in <a href="./full#CD012551-tbl-0002">summary of findings Table 2</a>. For this reason, we did not downgrade due to inconsistency. The quality of evidence was moderate due to high risk of bias (the studies were not blinded, which affected both detection and performance bias). </p> <p>One study with 24 participants reported the number of participants who achieved an MCID of 6‐point decrease of NIH‐CPSI score at six weeks, defined as "responders" (<a href="./references#CD012551-bbs2-0014" title="LeeSH , LeeBC . Electroacupuncture relieves pain in men with chronic prostatitis/chronic pelvic pain syndrome: three‐arm randomized trial. Urology2009;73(5):1036‐41. ">Lee 2009</a>). Acupuncture may have increased the number of responders compared to medical therapy (RR 3.57, 95% CI 1.45 to 8.80; <a href="./references#CD012551-fig-0021" title="">Analysis 2.5</a>). The quality of evidence was low due to high risk of bias (the studies were not blinded, which affected both detection and performance bias) and imprecision (small sample size and few events). </p> </section> <section id="CD012551-sec-0113"> <h6 class="title">2.2. Adverse events</h6> <p>Two studies with 78 participants reported adverse events (<a href="./references#CD012551-bbs2-0012" title="KucukEV , SucekenFY , BindayiA , BoyluU , OnolFF , GumusE . Effectiveness of acupuncture on chronic prostatitis‐chronic pelvic pain syndrome category IIIB patients: a prospective, randomized, nonblinded, clinical trial. Urology2015;85(3):636‐40. ">Kucuk 2015</a>; <a href="./references#CD012551-bbs2-0014" title="LeeSH , LeeBC . Electroacupuncture relieves pain in men with chronic prostatitis/chronic pelvic pain syndrome: three‐arm randomized trial. Urology2009;73(5):1036‐41. ">Lee 2009</a>). There were no adverse events in either arm (<a href="./references#CD012551-fig-0022" title="">Analysis 2.6</a>). The quality of evidence was low due to high risk of bias (the studies were not blinded, which affected both detection and performance bias) and imprecision (small sample size and no events). </p> </section> <section id="CD012551-sec-0114"> <h6 class="title">2.3. Sexual dysfunction</h6> <p>None of the studies reported sexual dysfunction.</p> </section> <section id="CD012551-sec-0115"> <h6 class="title">2.4. Urinary symptoms</h6> <p>Two studies reported urinary symptoms (<a href="./references#CD012551-bbs2-0013" title="LeeSW , LiongML , YuenKH , KriegerJN . Acupuncture and immune function in chronic prostatitis/chronic pelvic pain syndrome: a randomized, controlled study. Complementary Therapies in Medicine2014;22(6):965‐9. LeeSW , LiongML , YuenKH , LeongWS , CheeC , CheahPY , et al. Acupuncture versus sham acupuncture for chronic prostatitis/chronic pelvic pain. American Journal of Medicine2008;121(1):79.e1‐7. LeeSW , LiongML , YuenKH , LeongWS , KhanNK , KriegerJN . Validation of a sham acupuncture procedure in a randomised, controlled clinical trial of chronic pelvic pain treatment. Acupuncture in Medicine2011;29(1):40‐6. ">Lee 2008</a>; <a href="./references#CD012551-bbs2-0014" title="LeeSH , LeeBC . Electroacupuncture relieves pain in men with chronic prostatitis/chronic pelvic pain syndrome: three‐arm randomized trial. Urology2009;73(5):1036‐41. ">Lee 2009</a>). Acupuncture likely resulted in little to no difference compared to medical therapy, measured by IPSS score at six weeks (MD ‐2.70, 95% CI ‐6.00 to 0.60) (<a href="./references#CD012551-fig-0023" title="">Analysis 2.7</a>). The quality of evidence was moderate due to imprecision (wide CIs that included both appreciable benefit and harm). </p> </section> <section id="CD012551-sec-0116"> <h6 class="title">2.5. Quality of life</h6> <p>None of the studies reported QoL.</p> </section> <section id="CD012551-sec-0117"> <h6 class="title">2.6. Depression and anxiety</h6> <p>None of the studies reported depression and anxiety.</p> </section> </section> <section id="CD012551-sec-0118"> <h5 class="title">3. Acupuncture versus acupuncture with moxibustion</h5> <p>One study with 83 participants compared acupuncture versus acupuncture with moxibustion (<a href="./references#CD012551-bbs2-0002" title="ChenZX . Observation on therapeutic effect of warm needle moxibustion on chronic non‐bacterial prostatitis. Zhongguo Zhen Jiu [Chinese Acupuncture &amp; Moxibustion]2009;29(4):275‐8. ">Chen 2009</a>) (see <a href="#CD012551-tbl-0011">Table 1</a>; <a href="#CD012551-tbl-0012">Table 2</a> for further details of the participants and interventions). </p> <section id="CD012551-sec-0119"> <h6 class="title">3.1. Prostatitis symptoms</h6> <p>The study reported prostatitis symptoms. Moxibustion acupuncture probably reduced prostatitis symptoms compared to regular acupuncture, measured by NIH‐CPSI score at eight weeks' follow‐up (MD ‐4.16, 95% CI ‐7.16 to ‐1.16) (<a href="./references#CD012551-fig-0024" title="">Analysis 3.1</a>). The quality of evidence was moderate due to high risk of bias (the study was not blinded, which affected both detection and performance bias). </p> </section> <section id="CD012551-sec-0120"> <h6 class="title">3.2. Adverse events</h6> <p>The study did not report adverse events.</p> </section> <section id="CD012551-sec-0121"> <h6 class="title">3.3. Sexual dysfunction</h6> <p>The study did not report sexual dysfunction.</p> </section> <section id="CD012551-sec-0122"> <h6 class="title">3.4. Urinary symptoms</h6> <p>The study did not report urinary symptoms.</p> </section> <section id="CD012551-sec-0123"> <h6 class="title">3.5. Quality of life</h6> <p>The study did not report QoL.</p> </section> <section id="CD012551-sec-0124"> <h6 class="title">3.6. Depression and anxiety</h6> <p>The study did not report depression and anxiety.</p> </section> </section> <section id="CD012551-sec-0125"> <h5 class="title">4. Circumcision: early versus delayed circumcision</h5> <p>One study with 713 participants compared early versus delayed circumcision (<a href="./references#CD012551-bbs2-0037" title="ZhaoY , ZhaoW , LangG , ChenY , LiuJ , WangG , et al. Circumcision plus antibiotic, anti‐inflammatory, and alpha‐blocker therapy for the treatment for chronic prostatitis/chronic pelvic pain syndrome: a prospective, randomized, multicenter trial. World Journal of Urology2015;33(5):617‐22. ">Zhao 2015</a>). This study compared the effects of assigning participants to circumcision at four weeks compared with a waiting list to be circumcised at a delayed interval of three months (see <a href="#CD012551-tbl-0011">Table 1</a> and <a href="#CD012551-tbl-0012">Table 2</a> for further details of the participants and interventions). See <a href="./full#CD012551-tbl-0003">summary of findings Table 3</a>. </p> <section id="CD012551-sec-0126"> <h6 class="title">4.1. Prostatitis symptoms</h6> <p>Circumcision probably reduced prostatitis symptoms compared to delayed circumcision, measured by NIH‐CPSI score at 12 weeks' follow‐up (MD ‐3.00, 95% CI ‐3.82 to ‐2.18) (<a href="./references#CD012551-fig-0025" title="">Analysis 4.1</a>). These lower scores were observed across all subscores of pain, urinary symptoms and QoL (<a href="./references#CD012551-fig-0026" title="">Analysis 4.2</a>; <a href="./references#CD012551-fig-0027" title="">Analysis 4.3</a>; <a href="./references#CD012551-fig-0028" title="">Analysis 4.4</a>). The quality of evidence was moderate due to high risk of bias (the study was not blinded, which affected both detection and performance bias). </p> </section> <section id="CD012551-sec-0127"> <h6 class="title">4.2. Adverse events</h6> <p>Circumcision likely resulted in little to no difference in adverse events compared to delayed circumcision group (RR 1.23, 95% CI 0.86 to 1.76) (<a href="./references#CD012551-fig-0029" title="">Analysis 4.5</a>). The quality of evidence was low due to high risk of bias (the study was not blinded, which affected both detection and performance bias) and imprecision (small sample size and few events). </p> </section> <section id="CD012551-sec-0128"> <h6 class="title">4.3. Sexual dysfunction</h6> <p>The study did not report sexual dysfunction.</p> </section> <section id="CD012551-sec-0129"> <h6 class="title">4.4. Urinary symptoms</h6> <p>The study did not report urinary symptoms.</p> </section> <section id="CD012551-sec-0130"> <h6 class="title">4.5. Quality of life</h6> <p>The study did not report QoL.</p> </section> <section id="CD012551-sec-0131"> <h6 class="title">4.6. Depression and anxiety</h6> <p>The study did not report depression and anxiety.</p> </section> </section> <section id="CD012551-sec-0132"> <h5 class="title">5. Electromagnetic chair versus control intervention (inactive device)</h5> <p>Two studies with 57 participants compared electromagnetic chair versus control intervention (<a href="./references#CD012551-bbs2-0022" title="PaickJS , LeeSC , KuJH . More effects of extracorporeal magnetic innervation and terazosin therapy than terazosin therapy alone for non‐inflammatory chronic pelvic pain syndrome: a pilot study. Prostate Cancer and Prostatic Diseases2006;9(3):261‐5. ">Paick 2006</a>; <a href="./references#CD012551-bbs2-0024" title="RoweE , SmithC , LaverickL , ElkabirJ , WitherowRO , PatelA . A prospective, randomized, placebo controlled, double‐blind study of pelvic electromagnetic therapy for the treatment of chronic pelvic pain syndrome with 1 year of followup. Journal of Urology2005;173(6):2044‐7. ">Rowe 2005</a>). The control intervention was either the electromagnetic chair that was switched off or medical therapy (see <a href="#CD012551-tbl-0011">Table 1</a>; <a href="#CD012551-tbl-0012">Table 2</a> for further details of the participants and interventions). See <a href="./full#CD012551-tbl-0004">summary of findings Table 4</a>. </p> <section id="CD012551-sec-0133"> <h6 class="title">5.1. Prostatitis symptoms</h6> <p>Both studies reported prostatitis symptoms. The study by <a href="./references#CD012551-bbs2-0022" title="PaickJS , LeeSC , KuJH . More effects of extracorporeal magnetic innervation and terazosin therapy than terazosin therapy alone for non‐inflammatory chronic pelvic pain syndrome: a pilot study. Prostate Cancer and Prostatic Diseases2006;9(3):261‐5. ">Paick 2006</a> reported that the active treatment group had similar symptoms to the control group, measured by NIH‐CPSI score at six weeks' follow‐up (MD ‐3.00, 95% CI ‐7.75 to 1.75) (<a href="./references#CD012551-fig-0030" title="">Analysis 5.1</a>). This was also observed across all subscores of pain, urinary symptoms and QoL (<a href="./references#CD012551-fig-0031" title="">Analysis 5.2</a>; <a href="./references#CD012551-fig-0032" title="">Analysis 5.3</a>; <a href="./references#CD012551-fig-0033" title="">Analysis 5.4</a>). The study by <a href="./references#CD012551-bbs2-0024" title="RoweE , SmithC , LaverickL , ElkabirJ , WitherowRO , PatelA . A prospective, randomized, placebo controlled, double‐blind study of pelvic electromagnetic therapy for the treatment of chronic pelvic pain syndrome with 1 year of followup. Journal of Urology2005;173(6):2044‐7. ">Rowe 2005</a> found that the active treatment group had fewer symptoms (mean score 26.4) compared to the control group (mean score 42.4) at 12 weeks, measured by a validated 0 to 90 scale of symptoms for prostatitis. This study did not report information for effect size calculation or P value. This study also reported results at one year' follow‐up: the mean score for the active treatment group was 24 and the mean score in the control group was 33.6. Therefore, we were uncertain about the effects of the electromagnetic chair on prostatitis symptoms. The quality of evidence was very low due to high risk of bias (the studies were not blinded, which affected both detection and performance bias), attrition bias, selective reporting of outcomes for the <a href="./references#CD012551-bbs2-0024" title="RoweE , SmithC , LaverickL , ElkabirJ , WitherowRO , PatelA . A prospective, randomized, placebo controlled, double‐blind study of pelvic electromagnetic therapy for the treatment of chronic pelvic pain syndrome with 1 year of followup. Journal of Urology2005;173(6):2044‐7. ">Rowe 2005</a> study and small sample size in each study that resulted in imprecision and wide CIs. Additionally, there was inconsistency in the findings. Meta‐analysis of these studies was not possible due to missing information regarding standard deviations in <a href="./references#CD012551-bbs2-0024" title="RoweE , SmithC , LaverickL , ElkabirJ , WitherowRO , PatelA . A prospective, randomized, placebo controlled, double‐blind study of pelvic electromagnetic therapy for the treatment of chronic pelvic pain syndrome with 1 year of followup. Journal of Urology2005;173(6):2044‐7. ">Rowe 2005</a>. </p> </section> <section id="CD012551-sec-0134"> <h6 class="title">5.2. Adverse events</h6> <p>Electromagnetic chair likely resulted in little to no difference in adverse events compared to the control intervention (RR 2.18, 95% CI 0.10 to 46.92) (<a href="./references#CD012551-fig-0034" title="">Analysis 5.5</a>). The quality of evidence was low due to high risk of bias (the studies were not blinded, which affected both detection and performance bias) and imprecision (small sample size and few events). </p> </section> <section id="CD012551-sec-0135"> <h6 class="title">5.3. Sexual dysfunction</h6> <p>The studies did not report sexual dysfunction.</p> </section> <section id="CD012551-sec-0136"> <h6 class="title">5.4. Urinary symptoms</h6> <p>The study by <a href="./references#CD012551-bbs2-0022" title="PaickJS , LeeSC , KuJH . More effects of extracorporeal magnetic innervation and terazosin therapy than terazosin therapy alone for non‐inflammatory chronic pelvic pain syndrome: a pilot study. Prostate Cancer and Prostatic Diseases2006;9(3):261‐5. ">Paick 2006</a> indicated that the electromagnetic chair may have resulted in no difference in urinary symptoms compared to the control group, measured by IPSS score at six weeks' follow‐up (MD 0.00, 95% CI ‐4.13 to 4.13) (<a href="./references#CD012551-fig-0035" title="">Analysis 5.6</a>). The quality of evidence was low due to high risk of bias (the study was not blinded, which affected both detection and performance bias) and imprecision (small sample size and few events). </p> </section> <section id="CD012551-sec-0137"> <h6 class="title">5.5. Quality of life</h6> <p>The studies did not report QoL.</p> </section> <section id="CD012551-sec-0138"> <h6 class="title">5.6. Depression and anxiety</h6> <p>The studies did not report depression and anxiety.</p> </section> </section> <section id="CD012551-sec-0139"> <h5 class="title">6. Lifestyle modifications versus control (no intervention)</h5> <p>One study with 100 participants compared lifestyle modifications versus control (no intervention) (<a href="./references#CD012551-bbs2-0005" title="GalloL . Effectiveness of diet, sexual habits and lifestyle modifications on treatment of chronic pelvic pain syndrome. Prostate Cancer and Prostatic Diseases2014;17(3):238‐45. ">Gallo 2014</a>). This study compared the effects of instructing participants to change some aspects in their lifestyle related to risk factors for CP/CPPS to no intervention, that is, maintaining the same lifestyle (see <a href="#CD012551-tbl-0011">Table 1</a> and <a href="#CD012551-tbl-0012">Table 2</a> for further details of the participants and interventions). See <a href="./full#CD012551-tbl-0005">summary of findings Table 5</a>. </p> <section id="CD012551-sec-0140"> <h6 class="title">6.1. Prostatitis symptoms</h6> <p>The study analysed the number of participants who achieved a 6‐point decrease in NIH‐CPSI scores at three months ("responders"). Lifestyle modifications may have increased the number of responders in terms of prostatitis symptoms, but we were very uncertain (RR 3.90, 95% CI 2.20 to 6.92) (<a href="./references#CD012551-fig-0038" title="">Analysis 6.1</a>). The quality of evidence was very low due to high risk of selection bias (unconcealed allocation), detection and performance bias (the study was not blinded), missing outcome data and suspected selective outcome reporting (NIH‐CPSI scores were only presented graphically). Additionally, there were few response events in each group, resulting in imprecision. </p> </section> <section id="CD012551-sec-0141"> <h6 class="title">6.2. Adverse events</h6> <p>The study did not report adverse events.</p> </section> <section id="CD012551-sec-0142"> <h6 class="title">6.3. Sexual dysfunction</h6> <p>The study did not report sexual dysfunction.</p> </section> <section id="CD012551-sec-0143"> <h6 class="title">6.4. Urinary symptoms</h6> <p>The study did not report urinary symptoms.</p> </section> <section id="CD012551-sec-0144"> <h6 class="title">6.5. Quality of life</h6> <p>The study did not report QoL.</p> </section> <section id="CD012551-sec-0145"> <h6 class="title">6.6. Depression and anxiety</h6> <p>The study did not report depression and anxiety.</p> </section> </section> <section id="CD012551-sec-0146"> <h5 class="title">7. Physical activity versus control intervention</h5> <p>One study with 85 participants compared physical activity versus control intervention (<a href="./references#CD012551-bbs2-0007" title="GiubileiG , MondainiN , MinerviniA , SaievaC , LapiniA , SerniS , et al. Physical activity of men with chronic prostatitis/chronic pelvic pain syndrome not satisfied with conventional treatments ‐ could it represent a valid option? The physical activity and male pelvic pain trial: a double‐blind, randomized study. Journal of Urology2007;177(1):159‐65. ">Giubilei 2007</a>). This study compared the effects of a regular exercise programme to a control intervention (see <a href="#CD012551-tbl-0011">Table 1</a> and <a href="#CD012551-tbl-0012">Table 2</a> for further details of the participants and interventions). See <a href="./full#CD012551-tbl-0006">summary of findings Table 6</a>. </p> <section id="CD012551-sec-0147"> <h6 class="title">7.1. Prostatitis symptoms</h6> <p>Physical activity may have reduced prostatitis symptoms, measured by NIH‐CPSI score at six weeks' follow‐up, but we were very uncertain (MD ‐2.50, 95% CI ‐4.69 to ‐0.31) (<a href="./references#CD012551-fig-0039" title="">Analysis 7.1</a>). These lower scores were observed across the subscores of pain and QoL (<a href="./references#CD012551-fig-0040" title="">Analysis 7.2</a>; <a href="./references#CD012551-fig-0042" title="">Analysis 7.4</a>); however, participants in the intervention group had higher urinary symptoms (<a href="./references#CD012551-fig-0041" title="">Analysis 7.3</a>). The quality of evidence was low due to high risk of performance bias and detection bias (the study was not blinded) and high risk of attrition bias. </p> </section> <section id="CD012551-sec-0148"> <h6 class="title">7.2. Adverse events</h6> <p>The study did not report adverse events.</p> </section> <section id="CD012551-sec-0149"> <h6 class="title">7.3. Sexual dysfunction</h6> <p>The study did not report sexual dysfunction.</p> </section> <section id="CD012551-sec-0150"> <h6 class="title">7.4. Urinary symptoms</h6> <p>The study did not report urinary symptoms.</p> </section> <section id="CD012551-sec-0151"> <h6 class="title">7.5. Quality of life</h6> <p>The study did not report QoL.</p> </section> <section id="CD012551-sec-0152"> <h6 class="title">7.6. Depression and anxiety</h6> <p>The study measured symptoms of anxiety with the SAI‐Y score and symptoms of depression with the Beck Depression Inventory at six weeks' follow‐up. The scores for anxiety and depression were similar in each group (<a href="./references#CD012551-fig-0043" title="">Analysis 7.5</a>; <a href="./references#CD012551-fig-0044" title="">Analysis 7.6</a>). The quality of evidence was very low due to high risk of performance bias and detection bias (the study was not blinded), high risk of attrition bias and imprecision issues. </p> </section> </section> <section id="CD012551-sec-0153"> <h5 class="title">8. Prostatic massage versus no intervention</h5> <p>Two studies with 115 participants compared prostatic massage versus no intervention (<a href="./references#CD012551-bbs2-0001" title="AteyaA , FayezA , HaniR , ZohdyW , GabbarMA , ShamloulR . Evaluation of prostatic massage in treatment of chronic prostatitis. Urology2006;67(4):674‐8. ">Ateya 2006</a>; <a href="./references#CD012551-bbs2-0028" title="ShenSL , HeDL , LuoY . Clinical trials of combined therapy of an oral Chinese medicine with massage for chronic nonbacterial prostatitis. Zhonghua Nan Ke Xue2006;12(9):851‐3. ">Shen 2006</a>). In <a href="./references#CD012551-bbs2-0028" title="ShenSL , HeDL , LuoY . Clinical trials of combined therapy of an oral Chinese medicine with massage for chronic nonbacterial prostatitis. Zhonghua Nan Ke Xue2006;12(9):851‐3. ">Shen 2006</a>, all participants were also treated with traditional Chinese medicine as cointervention (see <a href="#CD012551-tbl-0011">Table 1</a> and <a href="#CD012551-tbl-0012">Table 2</a> for further details of the participants and interventions). See <a href="./full#CD012551-tbl-0007">summary of findings Table 7</a>. </p> <section id="CD012551-sec-0154"> <h6 class="title">8.1. Prostatitis symptoms</h6> <p>Both studies reported this outcome, however only <a href="./references#CD012551-bbs2-0001" title="AteyaA , FayezA , HaniR , ZohdyW , GabbarMA , ShamloulR . Evaluation of prostatic massage in treatment of chronic prostatitis. Urology2006;67(4):674‐8. ">Ateya 2006</a> reported the total NIH‐CPSI scores. In this study, prostatic massage may not have reduced prostatitis symptoms compared to no intervention, measured by NIH‐CPSI score at four weeks' follow‐up (MD ‐1.10, 95% CI ‐5.63 to 3.43) (<a href="./references#CD012551-fig-0045" title="">Analysis 8.1</a>). These similar scores were observed across the subscores of pain, urinary symptoms and QoL (<a href="./references#CD012551-fig-0046" title="">Analysis 8.2</a>; <a href="./references#CD012551-fig-0047" title="">Analysis 8.3</a>; <a href="./references#CD012551-fig-0048" title="">Analysis 8.4</a>). The study by <a href="./references#CD012551-bbs2-0028" title="ShenSL , HeDL , LuoY . Clinical trials of combined therapy of an oral Chinese medicine with massage for chronic nonbacterial prostatitis. Zhonghua Nan Ke Xue2006;12(9):851‐3. ">Shen 2006</a> only reported the subscores, and participants who were assigned to prostatic massage had lower subscores for pain, urinary symptoms and QoL compared to those who did not received the intervention. The quality of evidence was very low due to high risk of performance and detection bias (study not blinded), unclear risk of bias in all the remaining domains and imprecision. </p> </section> <section id="CD012551-sec-0155"> <h6 class="title">8.2. Adverse events</h6> <p>The studies did not report adverse events.</p> </section> <section id="CD012551-sec-0156"> <h6 class="title">8.3. Sexual dysfunction</h6> <p>The studies did not report sexual dysfunction.</p> </section> <section id="CD012551-sec-0157"> <h6 class="title">8.4. Urinary symptoms</h6> <p>The studies did not report urinary symptoms.</p> </section> <section id="CD012551-sec-0158"> <h6 class="title">8.5. Quality of life</h6> <p>The studies did not report QoL.</p> </section> <section id="CD012551-sec-0159"> <h6 class="title">8.6. Depression and anxiety</h6> <p>The studies did not report depression and anxiety.</p> </section> </section> <section id="CD012551-sec-0160"> <h5 class="title">9. Extracorporeal shockwave therapy versus control</h5> <p>Four studies with 237 participants compared extracorporeal shockwave therapy (ESWT) versus control (<a href="./references#CD012551-bbs2-0023" title="PajovicB , RadojevicN , DimitrovskiA , VukovicM . Comparison of the efficiency of combined extracorporeal shock‐wave therapy and triple therapy versus triple therapy itself in Category III B chronic pelvic pain syndrome (CPPS). Aging Male2016;19(3):1‐6. ">Pajovic 2016</a>; <a href="./references#CD012551-bbs2-0030" title="MoayedniaA , HaghdaniS , KhosrawiS , YousefiE , VahdatpourB . Long‐term effect of extracorporeal shock wave therapy on the treatment of chronic pelvic pain syndrome due to non bacterial prostatitis. Journal of Research in Medical Sciences2014;19(4):293‐6. VahdatpourB , AlizadehF , MoayedniaA , EmadiM , KhoramiMH , HaghdaniS . Efficacy of extracorporeal shock wave therapy for the treatment of chronic pelvic pain syndrome: a randomized, controlled trial. ISRN Urology2013;2013:972601. ">Vahdatpour 2013</a>; <a href="./references#CD012551-bbs2-0035" title="ZengX , YeZ , YangW , ChenZ , DuG . Extracorporeal shock wave treatment for noninflammatory chronic pelvic pain syndrome: a prospective, randomized, sham‐controlled study. Journal of Urology2009;181(4):122‐3. ZengXY , LiangC , YeZQ . Extracorporeal shock wave treatment for non‐inflammatory chronic pelvic pain syndrome: a prospective, randomized and sham‐controlled study. Chinese Medical Journal2012;125(1):114‐8. ">Zeng 2012</a>; <a href="./references#CD012551-bbs2-0038" title="ZimmermannR , CumpanasA , MicleaF , JanetschekG . Extracorporeal shock wave therapy for the treatment of chronic pelvic pain syndrome in males: a randomised, double‐blind, placebo‐controlled study. European Urology2009;56(3):418‐24. ZimmermannRP , CumpanasA , MicleaF , JanetschekG . One year follow up of extracorporeal shock wave therapy (ESWT) for chronic pelvic pain syndrome (CPPS) in a randomised placebo‐controlled double‐blind study. European Urology (Suppl)2010;9(2):214. ">Zimmermann 2009</a>). In three studies this included a form of blinding using a sham procedure in which the device was turned off (<a href="./references#CD012551-bbs2-0030" title="MoayedniaA , HaghdaniS , KhosrawiS , YousefiE , VahdatpourB . Long‐term effect of extracorporeal shock wave therapy on the treatment of chronic pelvic pain syndrome due to non bacterial prostatitis. Journal of Research in Medical Sciences2014;19(4):293‐6. VahdatpourB , AlizadehF , MoayedniaA , EmadiM , KhoramiMH , HaghdaniS . Efficacy of extracorporeal shock wave therapy for the treatment of chronic pelvic pain syndrome: a randomized, controlled trial. ISRN Urology2013;2013:972601. ">Vahdatpour 2013</a>; <a href="./references#CD012551-bbs2-0035" title="ZengX , YeZ , YangW , ChenZ , DuG . Extracorporeal shock wave treatment for noninflammatory chronic pelvic pain syndrome: a prospective, randomized, sham‐controlled study. Journal of Urology2009;181(4):122‐3. ZengXY , LiangC , YeZQ . Extracorporeal shock wave treatment for non‐inflammatory chronic pelvic pain syndrome: a prospective, randomized and sham‐controlled study. Chinese Medical Journal2012;125(1):114‐8. ">Zeng 2012</a>; <a href="./references#CD012551-bbs2-0038" title="ZimmermannR , CumpanasA , MicleaF , JanetschekG . Extracorporeal shock wave therapy for the treatment of chronic pelvic pain syndrome in males: a randomised, double‐blind, placebo‐controlled study. European Urology2009;56(3):418‐24. ZimmermannRP , CumpanasA , MicleaF , JanetschekG . One year follow up of extracorporeal shock wave therapy (ESWT) for chronic pelvic pain syndrome (CPPS) in a randomised placebo‐controlled double‐blind study. European Urology (Suppl)2010;9(2):214. ">Zimmermann 2009</a>). In one studies, the control group did not receive any form of ESWT (<a href="./references#CD012551-bbs2-0023" title="PajovicB , RadojevicN , DimitrovskiA , VukovicM . Comparison of the efficiency of combined extracorporeal shock‐wave therapy and triple therapy versus triple therapy itself in Category III B chronic pelvic pain syndrome (CPPS). Aging Male2016;19(3):1‐6. ">Pajovic 2016</a>; see <a href="#CD012551-tbl-0011">Table 1</a> and <a href="#CD012551-tbl-0012">Table 2</a> for further details of the participants and interventions). See <a href="./full#CD012551-tbl-0008">summary of findings Table 8</a>. </p> <section id="CD012551-sec-0161"> <h6 class="title">9.1. Prostatitis symptoms</h6> <p>Three studies with 157 participants reported the NIH‐CPSI scores for prostatitis symptoms (<a href="./references#CD012551-bbs2-0023" title="PajovicB , RadojevicN , DimitrovskiA , VukovicM . Comparison of the efficiency of combined extracorporeal shock‐wave therapy and triple therapy versus triple therapy itself in Category III B chronic pelvic pain syndrome (CPPS). Aging Male2016;19(3):1‐6. ">Pajovic 2016</a>; <a href="./references#CD012551-bbs2-0030" title="MoayedniaA , HaghdaniS , KhosrawiS , YousefiE , VahdatpourB . Long‐term effect of extracorporeal shock wave therapy on the treatment of chronic pelvic pain syndrome due to non bacterial prostatitis. Journal of Research in Medical Sciences2014;19(4):293‐6. VahdatpourB , AlizadehF , MoayedniaA , EmadiM , KhoramiMH , HaghdaniS . Efficacy of extracorporeal shock wave therapy for the treatment of chronic pelvic pain syndrome: a randomized, controlled trial. ISRN Urology2013;2013:972601. ">Vahdatpour 2013</a>; <a href="./references#CD012551-bbs2-0038" title="ZimmermannR , CumpanasA , MicleaF , JanetschekG . Extracorporeal shock wave therapy for the treatment of chronic pelvic pain syndrome in males: a randomised, double‐blind, placebo‐controlled study. European Urology2009;56(3):418‐24. ZimmermannRP , CumpanasA , MicleaF , JanetschekG . One year follow up of extracorporeal shock wave therapy (ESWT) for chronic pelvic pain syndrome (CPPS) in a randomised placebo‐controlled double‐blind study. European Urology (Suppl)2010;9(2):214. ">Zimmermann 2009</a>). We found that ESWT reduced prostatitis symptoms compared to the control intervention, measured by NIH‐CPSI score at 12 weeks' follow‐up (MD ‐6.18, 95% CI ‐7.46 to ‐4.89; I<sup>2</sup> = 34%; random‐effects meta‐analysis) (<a href="./references#CD012551-fig-0049" title="">Analysis 9.1</a>). These lower scores were observed across the subscores of pain, urinary symptoms and QoL (<a href="./references#CD012551-fig-0050" title="">Analysis 9.2</a>; <a href="./references#CD012551-fig-0051" title="">Analysis 9.3</a>; <a href="./references#CD012551-fig-0052" title="">Analysis 9.4</a>). Since one of the studies was not blinded (<a href="./references#CD012551-bbs2-0023" title="PajovicB , RadojevicN , DimitrovskiA , VukovicM . Comparison of the efficiency of combined extracorporeal shock‐wave therapy and triple therapy versus triple therapy itself in Category III B chronic pelvic pain syndrome (CPPS). Aging Male2016;19(3):1‐6. ">Pajovic 2016</a>), the evidence could have been downgraded for high risk of detection and performance bias; however, the results of this study were consistent with those with low risk of bias, therefore we did not downgrade the quality of evidence (high‐quality evidence). </p> <p>Two studies with 135 participants reported prostatitis symptoms analysing the number of participants who achieved a 6‐point decrease in NIH‐CPSI scores at 12 weeks' follow‐up (<a href="./references#CD012551-bbs2-0035" title="ZengX , YeZ , YangW , ChenZ , DuG . Extracorporeal shock wave treatment for noninflammatory chronic pelvic pain syndrome: a prospective, randomized, sham‐controlled study. Journal of Urology2009;181(4):122‐3. ZengXY , LiangC , YeZQ . Extracorporeal shock wave treatment for non‐inflammatory chronic pelvic pain syndrome: a prospective, randomized and sham‐controlled study. Chinese Medical Journal2012;125(1):114‐8. ">Zeng 2012</a>; <a href="./references#CD012551-bbs2-0038" title="ZimmermannR , CumpanasA , MicleaF , JanetschekG . Extracorporeal shock wave therapy for the treatment of chronic pelvic pain syndrome in males: a randomised, double‐blind, placebo‐controlled study. European Urology2009;56(3):418‐24. ZimmermannRP , CumpanasA , MicleaF , JanetschekG . One year follow up of extracorporeal shock wave therapy (ESWT) for chronic pelvic pain syndrome (CPPS) in a randomised placebo‐controlled double‐blind study. European Urology (Suppl)2010;9(2):214. ">Zimmermann 2009</a>). ESWT may have had little to no effect in the number of responders compared to the control intervention (RR 6.20, 95% CI 0.48 to 79.79; I<sup>2</sup> = 71%; random‐effects meta‐analysis) (<a href="./references#CD012551-fig-0053" title="">Analysis 9.5</a>). The quality of evidence was very low due to high risk of detection and performance bias (one study was not blinded), inconsistency and imprecision issues. </p> <p>Two studies with 97 participants reported prostatitis symptoms at 24 weeks' follow‐up (<a href="./references#CD012551-bbs2-0023" title="PajovicB , RadojevicN , DimitrovskiA , VukovicM . Comparison of the efficiency of combined extracorporeal shock‐wave therapy and triple therapy versus triple therapy itself in Category III B chronic pelvic pain syndrome (CPPS). Aging Male2016;19(3):1‐6. ">Pajovic 2016</a>; <a href="./references#CD012551-bbs2-0030" title="MoayedniaA , HaghdaniS , KhosrawiS , YousefiE , VahdatpourB . Long‐term effect of extracorporeal shock wave therapy on the treatment of chronic pelvic pain syndrome due to non bacterial prostatitis. Journal of Research in Medical Sciences2014;19(4):293‐6. VahdatpourB , AlizadehF , MoayedniaA , EmadiM , KhoramiMH , HaghdaniS . Efficacy of extracorporeal shock wave therapy for the treatment of chronic pelvic pain syndrome: a randomized, controlled trial. ISRN Urology2013;2013:972601. ">Vahdatpour 2013</a>). ESWT may have had little to no effect on prostatitis symptoms compared to the control intervention (MD ‐2.23, 95% CI ‐5.98 to 1.53; I<sup>2</sup> = 82%; random‐effects meta‐analysis) (<a href="./references#CD012551-fig-0054" title="">Analysis 9.6</a>). These similar scores were observed across the subscores of pain, urinary symptoms and QoL (<a href="./references#CD012551-fig-0055" title="">Analysis 9.7</a>; <a href="./references#CD012551-fig-0056" title="">Analysis 9.8</a>; <a href="./references#CD012551-fig-0057" title="">Analysis 9.9</a>). The quality of evidence was low due to high risk of performance and detection bias (one study was not blinded) and inconsistency. </p> </section> <section id="CD012551-sec-0162"> <h6 class="title">9.2. Adverse events</h6> <p>Three studies with 195 participants reported adverse events (<a href="./references#CD012551-bbs2-0023" title="PajovicB , RadojevicN , DimitrovskiA , VukovicM . Comparison of the efficiency of combined extracorporeal shock‐wave therapy and triple therapy versus triple therapy itself in Category III B chronic pelvic pain syndrome (CPPS). Aging Male2016;19(3):1‐6. ">Pajovic 2016</a>; <a href="./references#CD012551-bbs2-0035" title="ZengX , YeZ , YangW , ChenZ , DuG . Extracorporeal shock wave treatment for noninflammatory chronic pelvic pain syndrome: a prospective, randomized, sham‐controlled study. Journal of Urology2009;181(4):122‐3. ZengXY , LiangC , YeZQ . Extracorporeal shock wave treatment for non‐inflammatory chronic pelvic pain syndrome: a prospective, randomized and sham‐controlled study. Chinese Medical Journal2012;125(1):114‐8. ">Zeng 2012</a>; <a href="./references#CD012551-bbs2-0038" title="ZimmermannR , CumpanasA , MicleaF , JanetschekG . Extracorporeal shock wave therapy for the treatment of chronic pelvic pain syndrome in males: a randomised, double‐blind, placebo‐controlled study. European Urology2009;56(3):418‐24. ZimmermannRP , CumpanasA , MicleaF , JanetschekG . One year follow up of extracorporeal shock wave therapy (ESWT) for chronic pelvic pain syndrome (CPPS) in a randomised placebo‐controlled double‐blind study. European Urology (Suppl)2010;9(2):214. ">Zimmermann 2009</a>). Two studies reported no adverse events in either group (<a href="./references#CD012551-bbs2-0035" title="ZengX , YeZ , YangW , ChenZ , DuG . Extracorporeal shock wave treatment for noninflammatory chronic pelvic pain syndrome: a prospective, randomized, sham‐controlled study. Journal of Urology2009;181(4):122‐3. ZengXY , LiangC , YeZQ . Extracorporeal shock wave treatment for non‐inflammatory chronic pelvic pain syndrome: a prospective, randomized and sham‐controlled study. Chinese Medical Journal2012;125(1):114‐8. ">Zeng 2012</a>; <a href="./references#CD012551-bbs2-0038" title="ZimmermannR , CumpanasA , MicleaF , JanetschekG . Extracorporeal shock wave therapy for the treatment of chronic pelvic pain syndrome in males: a randomised, double‐blind, placebo‐controlled study. European Urology2009;56(3):418‐24. ZimmermannRP , CumpanasA , MicleaF , JanetschekG . One year follow up of extracorporeal shock wave therapy (ESWT) for chronic pelvic pain syndrome (CPPS) in a randomised placebo‐controlled double‐blind study. European Urology (Suppl)2010;9(2):214. ">Zimmermann 2009</a>). The numbers of participants who had adverse events were similar in the ESWT and control group in the third study (<a href="./references#CD012551-bbs2-0023" title="PajovicB , RadojevicN , DimitrovskiA , VukovicM . Comparison of the efficiency of combined extracorporeal shock‐wave therapy and triple therapy versus triple therapy itself in Category III B chronic pelvic pain syndrome (CPPS). Aging Male2016;19(3):1‐6. ">Pajovic 2016</a>) (RR 1.22, 95% CI 0.59 to 2.51) (<a href="./references#CD012551-fig-0058" title="">Analysis 9.10</a>). The quality of evidence was low due to high risk of performance and detection bias (one study was not blinded) and imprecision issues. </p> </section> <section id="CD012551-sec-0163"> <h6 class="title">9.3. Sexual dysfunction</h6> <p>One study with 60 participants reported sexual dysfunction (<a href="./references#CD012551-bbs2-0038" title="ZimmermannR , CumpanasA , MicleaF , JanetschekG . Extracorporeal shock wave therapy for the treatment of chronic pelvic pain syndrome in males: a randomised, double‐blind, placebo‐controlled study. European Urology2009;56(3):418‐24. ZimmermannRP , CumpanasA , MicleaF , JanetschekG . One year follow up of extracorporeal shock wave therapy (ESWT) for chronic pelvic pain syndrome (CPPS) in a randomised placebo‐controlled double‐blind study. European Urology (Suppl)2010;9(2):214. ">Zimmermann 2009</a>). ESWT probably reduced sexual dysfunction compared to control, measured by the IIEF scale at 12 weeks (MD 3.34, 95% CI 2.68 to 4.00) (<a href="./references#CD012551-fig-0059" title="">Analysis 9.11</a>). For the IIEF scale, higher scores indicated fewer symptoms. The quality of evidence was moderate due to imprecision issues. </p> </section> <section id="CD012551-sec-0164"> <h6 class="title">9.4. Urinary symptoms</h6> <p>One study with 60 participants reported urinary symptoms (<a href="./references#CD012551-bbs2-0038" title="ZimmermannR , CumpanasA , MicleaF , JanetschekG . Extracorporeal shock wave therapy for the treatment of chronic pelvic pain syndrome in males: a randomised, double‐blind, placebo‐controlled study. European Urology2009;56(3):418‐24. ZimmermannRP , CumpanasA , MicleaF , JanetschekG . One year follow up of extracorporeal shock wave therapy (ESWT) for chronic pelvic pain syndrome (CPPS) in a randomised placebo‐controlled double‐blind study. European Urology (Suppl)2010;9(2):214. ">Zimmermann 2009</a>). ESWT probably reduced urinary symptoms compared to control, measured by the IIEF scale at 12 weeks (MD ‐4.50, 95% CI ‐5.14 to ‐3.86) (<a href="./references#CD012551-fig-0060" title="">Analysis 9.12</a>). The quality of evidence was moderate due to imprecision issues. </p> </section> <section id="CD012551-sec-0165"> <h6 class="title">9.5. Quality of life</h6> <p>The studies did not report QoL.</p> </section> <section id="CD012551-sec-0166"> <h6 class="title">9.6. Depression and anxiety</h6> <p>The studies did not report depression and anxiety.</p> </section> </section> <section id="CD012551-sec-0167"> <h5 class="title">10. Transrectal thermotherapy versus medical therapy or as add‐on to medical therapy</h5> <p>Two studies with 237 participants compared transrectal thermotherapy (TRT) versus medical therapy or as add‐on to medical therapy (<a href="./references#CD012551-bbs2-0006" title="GaoM , DingH , ZhongG , LuJ , WangH , LiQ , et al. The effects of transrectal radiofrequency hyperthermia on patients with chronic prostatitis and the changes of MDA, NO, SOD, and Zn levels in pretreatment and posttreatment. Urology2012;79(2):391‐6. ">Gao 2012</a>; <a href="./references#CD012551-bbs2-0034" title="ChungH , ChoiH , YooTK , ChoJM , KimHS . The effects of microwave thermotherapy for chronic prostatitis/chronic pelvic pain syndrome: a prospective, randomized study. Urogenital Tract Infection2017;12(1):35‐41. KimH , ChungH , YangS , YooT , ChoJ . Effects of thermotherapy and medical therapy for chronic prostatitis/chronic pelvic pain syndrome: a prospective study. Urology2011;78(3):S85‐6. YooTK , MoonKT , LeeSW , KimHS , ChungH , KimJY . Effect of the combination treatment of URO‐DrG and medical therapy for chronic prostatitis/chronic pelvic pain syndrome: a prospective study. Journal of Urology2009;181(4):122. ">Yoo 2009</a>). In both studies, participants were randomised to one of the following groups: medical therapy, TRT or the combination of medical therapy and TRT. Four additional studies with 200 participants evaluated the effects of TRT (<a href="./references#CD012551-bbs2-0018" title="MuraroGB . Clinical study on the efficacy and safety of seaprose S combined with local prostatic hyperthermia in chronic non‐bacterial prostatitis. Controlled study versus local prostatic hyperthermia [Studio clinico sull'efficacia e la tollerabilita del seaprose S associato a ipertermia locale prostatica nella prostatite cronica abatterica. Studio controllato verso ipertermia locale prostatica]. Archivio di Medicina Interna1995;47(2‐3):73‐86. ">Muraro 1995</a>; <a href="./references#CD012551-bbs2-0021" title="OhMM , JinMH , MoonDG , NamSG , BaeJH , ParkHS . A prospective, randomized, placebo controlled study of radiofrequency therapy for the treatment of chronic prostatitis/chronic pelvic pain syndrome. Journal of Urology2009;181(4):122. ">Oh 2009</a>; <a href="./references#CD012551-bbs2-0027" title="ShahT , WatsonG , BarnesD . Microwave hyperthermia in the treatment of chronic abacterial prostatitis and prostatodynia: results of a double blind placebo controlled trial (Abstract). Journal of Urology1993;149:405A. ">Shah 1993</a>; <a href="./references#CD012551-bbs2-0031" title="VassilyO , AndreyS , EvgeniiD , OtabekI , BorisL , SergeyR . Efficacy of transrectal microwave hyperthemia (TRMH) in the treatment of chronic prostatitis. A randomized sham controlled comparative study (Abstract). Journal of Urology1999;161(4 Suppl):33A. ">Vassily 1999</a>), however there were no relevant outcome data available for this review. One study with 57 participants evaluated the effects of thermotherapy in three different regimens: one session weekly for four weeks, one session weekly for six weeks and two sessions weekly for three weeks (<a href="./references#CD012551-bbs2-0017" title="MontorsiF , GuazzoniG , BergamaschiF , GalliL , ConsonniP , MatozzoV , et al. Is there a role for transrectal microwave hyperthermia of the prostate in the treatment of abacterial prostatitis and prostatodynia?. Prostate1993;22(2):139‐46. ">Montorsi 1993</a>; see <a href="#CD012551-tbl-0011">Table 1</a> and <a href="#CD012551-tbl-0012">Table 2</a> for further details of the participants and interventions). See <a href="./full#CD012551-tbl-0009">summary of findings Table 9</a> and <a href="./full#CD012551-tbl-0010">summary of findings Table 10</a>. </p> <section id="CD012551-sec-0168"> <h6 class="title">10.1. Prostatitis symptoms</h6> </section> <section id="CD012551-sec-0169"> <h6 class="title">10.1.1. Transrectal thermotherapy versus medical therapy</h6> <p>Two studies compared the effect of TRT versus medical therapy on prostatitis symptoms. TRT may have decreased prostatitis symptoms compared to medical therapy, measured by NIH‐CPSI score at six to 12 weeks' follow‐up (MD ‐2.50, 95% CI ‐3.82 to ‐1.18; I<sup>2</sup> = 0%, fixed‐effect meta‐analysis) (<a href="./references#CD012551-fig-0061" title="">Analysis 10.1</a>). Only <a href="./references#CD012551-bbs2-0034" title="ChungH , ChoiH , YooTK , ChoJM , KimHS . The effects of microwave thermotherapy for chronic prostatitis/chronic pelvic pain syndrome: a prospective, randomized study. Urogenital Tract Infection2017;12(1):35‐41. KimH , ChungH , YangS , YooT , ChoJ . Effects of thermotherapy and medical therapy for chronic prostatitis/chronic pelvic pain syndrome: a prospective study. Urology2011;78(3):S85‐6. YooTK , MoonKT , LeeSW , KimHS , ChungH , KimJY . Effect of the combination treatment of URO‐DrG and medical therapy for chronic prostatitis/chronic pelvic pain syndrome: a prospective study. Journal of Urology2009;181(4):122. ">Yoo 2009</a> reported the results of the subscores; these lower scores were observed for urinary symptoms and QoL, but not in the pain domain (<a href="./references#CD012551-fig-0062" title="">Analysis 10.2</a>; <a href="./references#CD012551-fig-0063" title="">Analysis 10.3</a>; <a href="./references#CD012551-fig-0064" title="">Analysis 10.4</a>). The quality of evidence was low due to high risk of allocation concealment bias, performance and detection bias (the study was not blinded) and high risk of attrition bias. </p> </section> <section id="CD012551-sec-0170"> <h6 class="title">10.1.2. Transrectal thermotherapy plus medical therapy versus medical therapy alone</h6> <p>Both studies compared the effect of TRT plus medical therapy versus medical therapy alone on prostatitis symptoms. TRT plus medical therapy may have decreased prostatitis symptoms compared to medical therapy alone, measured by NIH‐CPSI score at six to 12 weeks' follow‐up (MD ‐4.34, 95% CI ‐5.65 to ‐3.04; I<sup>2</sup> = 0%, fixed‐effect meta‐analysis) (<a href="./references#CD012551-fig-0061" title="">Analysis 10.1</a>). Only <a href="./references#CD012551-bbs2-0034" title="ChungH , ChoiH , YooTK , ChoJM , KimHS . The effects of microwave thermotherapy for chronic prostatitis/chronic pelvic pain syndrome: a prospective, randomized study. Urogenital Tract Infection2017;12(1):35‐41. KimH , ChungH , YangS , YooT , ChoJ . Effects of thermotherapy and medical therapy for chronic prostatitis/chronic pelvic pain syndrome: a prospective study. Urology2011;78(3):S85‐6. YooTK , MoonKT , LeeSW , KimHS , ChungH , KimJY . Effect of the combination treatment of URO‐DrG and medical therapy for chronic prostatitis/chronic pelvic pain syndrome: a prospective study. Journal of Urology2009;181(4):122. ">Yoo 2009</a> reported the results of the subscores, these lower scores were observed across the subscores of pain, urinary symptoms and QoL (<a href="./references#CD012551-fig-0062" title="">Analysis 10.2</a>; <a href="./references#CD012551-fig-0063" title="">Analysis 10.3</a>; <a href="./references#CD012551-fig-0064" title="">Analysis 10.4</a>). The quality of evidence was low due to high risk of allocation concealment bias, performance and detection bias (the study was not blinded), and high risk of attrition bias. </p> </section> <section id="CD012551-sec-0171"> <h6 class="title">10.2. Adverse events</h6> <p><a href="./references#CD012551-bbs2-0017" title="MontorsiF , GuazzoniG , BergamaschiF , GalliL , ConsonniP , MatozzoV , et al. Is there a role for transrectal microwave hyperthermia of the prostate in the treatment of abacterial prostatitis and prostatodynia?. Prostate1993;22(2):139‐46. ">Montorsi 1993</a> did not compare the intervention to a control group but compared different regimens. It reported that none of the participants had from "major complications." The other studies did not report adverse effects. <a href="./references#CD012551-bbs2-0034" title="ChungH , ChoiH , YooTK , ChoJM , KimHS . The effects of microwave thermotherapy for chronic prostatitis/chronic pelvic pain syndrome: a prospective, randomized study. Urogenital Tract Infection2017;12(1):35‐41. KimH , ChungH , YangS , YooT , ChoJ . Effects of thermotherapy and medical therapy for chronic prostatitis/chronic pelvic pain syndrome: a prospective study. Urology2011;78(3):S85‐6. YooTK , MoonKT , LeeSW , KimHS , ChungH , KimJY . Effect of the combination treatment of URO‐DrG and medical therapy for chronic prostatitis/chronic pelvic pain syndrome: a prospective study. Journal of Urology2009;181(4):122. ">Yoo 2009</a> reported that participants with active treatment had itching and tenesmus, but it was not quantified. </p> </section> <section id="CD012551-sec-0172"> <h6 class="title">10.3. Sexual dysfunction</h6> <p>The studies did not report sexual dysfunction.</p> </section> <section id="CD012551-sec-0173"> <h6 class="title">10.4. Urinary symptoms</h6> <p>The studies did not report urinary symptoms.</p> </section> <section id="CD012551-sec-0174"> <h6 class="title">10.5. Quality of life</h6> <p>The studies did not report QoL.</p> </section> <section id="CD012551-sec-0175"> <h6 class="title">10.6. Depression and anxiety</h6> <p>The studies did not report depression and anxiety.</p> </section> </section> <section id="CD012551-sec-0176"> <h5 class="title">11. Biofeedback</h5> <p>One study with 140 participants used biofeedback (<a href="./references#CD012551-bbs2-0033" title="YangZS , ZuXB , QiL , SongLM , LiuTR . Combination therapy of biofeedback with electrical stimulation for chronic prostatitis/chronic pelvic pain syndrome. Zhonghua Nan Ke Xue2011;17(7):611‐4. ">Yang 2011</a>). This factorial study had four groups: biofeedback added to usual care (40 participants), biofeedback with electric stimulation added to usual care (40 participants), electrical stimulation added to usual care (40 participants) and usual care alone (20 participants). Usual care included a series of lifestyle modifications (see <a href="#CD012551-tbl-0011">Table 1</a>; <a href="#CD012551-tbl-0012">Table 2</a>). </p> <section id="CD012551-sec-0177"> <h6 class="title">11.1. Prostatitis symptoms</h6> </section> <section id="CD012551-sec-0178"> <h6 class="title">11.1.1. Biofeedback versus usual care</h6> <p>Biofeedback may have decreased prostatitis symptoms compared to usual care, measured by NIH‐CPSI scores one month after treatment (MD ‐10.42, 95% CI ‐11.93 to ‐8.91). These lower scores were observed across all subscores of pain, urinary symptoms and QoL (<a href="./references#CD012551-fig-0066" title="">Analysis 11.2</a>; <a href="./references#CD012551-fig-0067" title="">Analysis 11.3</a>; <a href="./references#CD012551-fig-0068" title="">Analysis 11.4</a>). The quality of evidence was low due to high risk of performance and detection bias (the study was not blinded) and unclear risk of bias in most of the remaining domains. </p> </section> <section id="CD012551-sec-0179"> <h6 class="title">11.1.2. Electrical stimulation versus usual care</h6> <p>Electrical stimulation may have decreased prostatitis symptoms compared to usual care, measured by NIH‐CPSI scores at one month after treatment (MD ‐10.63, 95% CI ‐12.13 to ‐9.13). These lower scores were observed across all subscores of pain, urinary symptoms and QoL domains (<a href="./references#CD012551-fig-0066" title="">Analysis 11.2</a>; <a href="./references#CD012551-fig-0067" title="">Analysis 11.3</a>; <a href="./references#CD012551-fig-0068" title="">Analysis 11.4</a>). The quality of evidence was low due to high risk of performance and detection bias (the study was not blinded) and unclear risk of bias in most of the remaining domains. </p> </section> <section id="CD012551-sec-0180"> <h6 class="title">11.1.3. Biofeedback plus electrical stimulation versus usual care</h6> <p>Biofeedback plus electric stimulation may have decreased prostatitis symptoms compared to usual care, measured by NIH‐CPSI scores at one month after treatment (MD ‐15.83, 95% CI ‐17.72 to ‐13.94). These lower scores were observed across all subscores of pain, urinary symptoms and QoL domains (<a href="./references#CD012551-fig-0066" title="">Analysis 11.2</a>; <a href="./references#CD012551-fig-0067" title="">Analysis 11.3</a>; <a href="./references#CD012551-fig-0068" title="">Analysis 11.4</a>). The quality of evidence was low due to high risk of performance and detection bias (the study was not blinded) and unclear risk of bias in most of the remaining domains. </p> </section> <section id="CD012551-sec-0181"> <h6 class="title">11.2. Adverse events</h6> <p>The study reported that no participants experienced adverse events. The quality of evidence was very low due to high risk of performance and detection bias (the study was not blinded) and unclear risk of bias in most of the remaining domains and imprecision (few events). </p> </section> <section id="CD012551-sec-0182"> <h6 class="title">11.3. Sexual dysfunction</h6> <p>The study did not report sexual dysfunction.</p> </section> <section id="CD012551-sec-0183"> <h6 class="title">11.4. Urinary symptoms</h6> <p>The study did not report urinary symptoms.</p> </section> <section id="CD012551-sec-0184"> <h6 class="title">11.5. Quality of life</h6> <p>The study did not report QoL.</p> </section> <section id="CD012551-sec-0185"> <h6 class="title">11.6. Depression and anxiety</h6> <p>The study did not report depression and anxiety.</p> </section> </section> <section id="CD012551-sec-0186"> <h5 class="title">12. External radiofrequency hyperthermia with or without terazosin</h5> <p>One study with 136 participants compared external radiofrequency hyperthermia (ERH) with terazosin versus ERH without terazosin (<a href="./references#CD012551-bbs2-0032" title="WangJ , LiJ , LuR , WangJM . Treatment of external RF hyperthermia combining with alpha 1‐adrenergic receptor blocker for patients with prostatodynia and chronic non‐bacterial prostatitis. Zhonghua Nan Ke Xue2002;8(1):48‐50. ">Wang 2002</a>) (see <a href="#CD012551-tbl-0011">Table 1</a>; <a href="#CD012551-tbl-0012">Table 2</a>). </p> <section id="CD012551-sec-0187"> <h6 class="title">12.1. Prostatitis symptoms</h6> <p>ERH with terazosin may have decreased prostatitis symptoms (validated 0 to 12 score) compared to ERH alone at 12 weeks (MD ‐2.00, 95% CI ‐2.48 to ‐1.52) (<a href="./references#CD012551-fig-0069" title="">Analysis 12.1</a>). The quality of evidence was low due to high risk of performance and detection bias (the study was not blinded) and unclear risk of bias in most of the remaining domains. </p> </section> <section id="CD012551-sec-0188"> <h6 class="title">12.2. Adverse events</h6> <p>Two participants had dizziness in the group who received the combination of ERH and terazosin in comparison to none in the ERH alone group (RR 5.91, 95% CI 0.29 to 121.23) (<a href="./references#CD012551-fig-0070" title="">Analysis 12.2</a>). The quality of evidence was very low due to high risk of performance and detection bias (the study was not blinded) and unclear risk of bias in most of the remaining domains and imprecision (few events). </p> </section> <section id="CD012551-sec-0189"> <h6 class="title">12.3. Sexual dysfunction</h6> <p>The study did not report sexual dysfunction.</p> </section> <section id="CD012551-sec-0190"> <h6 class="title">12.4. Urinary symptoms</h6> <p>The study did not report urinary symptoms.</p> </section> <section id="CD012551-sec-0191"> <h6 class="title">12.5. Quality of life</h6> <p>The study did not report QoL.</p> </section> <section id="CD012551-sec-0192"> <h6 class="title">12.6. Depression and anxiety</h6> <p>The study did not report depression and anxiety.</p> </section> </section> <section id="CD012551-sec-0193"> <h5 class="title">13. Laser therapy applied to the prostate compared with medical care</h5> <p>One study with 112 participants compared laser therapy with medical care (<a href="./references#CD012551-bbs2-0003" title="FangJ , XuG , DingQ , ZhangY‐F . Observation on the safety and efficacy of He‐Ne laser equipment on chronic abacteria prostatitis. Fudan University Journal of Medical Sciences2005;32(2):234‐5, 252. ">Fang 2005</a>) (see <a href="#CD012551-tbl-0011">Table 1</a>; <a href="#CD012551-tbl-0012">Table 2</a>). </p> <section id="CD012551-sec-0194"> <h6 class="title">13.1. Prostatitis symptoms</h6> <p>Clinical response was defined as a decrease of 60% or more in prostatitis symptoms assessed with NIH‐CPSI at six weeks. Laser therapy may have increased the response rate compared to medical treatment, but we were very uncertain (RR 2.35, 95% CI 1.53 to 3.62) (<a href="./references#CD012551-fig-0071" title="">Analysis 13.1</a>). The quality of evidence was very low due to high risk of performance and detection bias (the study was not blinded) and unclear risk of bias in most of the remaining domains and imprecision (few events). </p> </section> <section id="CD012551-sec-0195"> <h6 class="title">13.2. Adverse events</h6> <p>None of the participants in the study had adverse events (<a href="./references#CD012551-fig-0072" title="">Analysis 13.2</a>). The quality of evidence was very low due to high risk of performance and detection bias (the study was not blinded) and unclear risk of bias in most of the remaining domains and imprecision (zero events). </p> </section> <section id="CD012551-sec-0196"> <h6 class="title">13.3. Sexual dysfunction</h6> <p>The study did not report sexual dysfunction.</p> </section> <section id="CD012551-sec-0197"> <h6 class="title">13.4. Urinary symptoms</h6> <p>The study did not report urinary symptoms.</p> </section> <section id="CD012551-sec-0198"> <h6 class="title">13.5. Quality of life</h6> <p>The study did not report QoL.</p> </section> <section id="CD012551-sec-0199"> <h6 class="title">13.6. Depression and anxiety</h6> <p>The study did not report depression and anxiety.</p> </section> </section> <section id="CD012551-sec-0200"> <h5 class="title">14. Tibial nerve stimulation compared with no intervention</h5> <p>One study with 89 participants compared tibial nerve stimulation with no intervention (<a href="./references#CD012551-bbs2-0008" title="KabayS , KabaySC , YucelM , OzdenH . Efficiency of posterior tibial nerve stimulation in category IIIB chronic prostatitis/chronic pelvic pain: a Sham‐Controlled Comparative Study. Urologia Internationalis2009;83(1):33‐8. ">Kabay 2009</a>). This study compared participants who received tibial nerve stimulation compared to no active intervention (see <a href="#CD012551-tbl-0011">Table 1</a>; <a href="#CD012551-tbl-0012">Table 2</a>). </p> <section id="CD012551-sec-0201"> <h6 class="title">14.1. Prostatitis symptoms</h6> <p>Tibial nerve stimulation probably reduced prostatitis symptoms measured by NIH‐CPSI compared to no active treatment at 12 weeks (MD ‐11.20, 95% CI ‐12.92 to ‐9.48) (<a href="./references#CD012551-fig-0073" title="">Analysis 14.1</a>). These lower scores were observed across all subscores of pain, urinary symptoms and QoL (<a href="./references#CD012551-fig-0074" title="">Analysis 14.2</a>; <a href="./references#CD012551-fig-0075" title="">Analysis 14.3</a>; <a href="./references#CD012551-fig-0076" title="">Analysis 14.4</a>). The quality of evidence was moderate due to high risk of performance and detection bias. </p> </section> <section id="CD012551-sec-0202"> <h6 class="title">14.2. Adverse events</h6> <p>The study did not report adverse events.</p> </section> <section id="CD012551-sec-0203"> <h6 class="title">14.3. Sexual dysfunction</h6> <p>The study did not report sexual dysfunction.</p> </section> <section id="CD012551-sec-0204"> <h6 class="title">14.4. Urinary symptoms</h6> <p>The study did not report urinary symptoms.</p> </section> <section id="CD012551-sec-0205"> <h6 class="title">14.5. Quality of life</h6> <p>The study did not report QoL.</p> </section> <section id="CD012551-sec-0206"> <h6 class="title">14.6. Depression and anxiety</h6> <p>The study did not report depression and anxiety.</p> </section> </section> <section id="CD012551-sec-0207"> <h5 class="title">15. Sono‐electromagnetic therapy versus placebo intervention</h5> <p>One study with 60 participants compared sono‐electromagnetic therapy versus placebo intervention (<a href="./references#CD012551-bbs2-0011" title="KesslerTM , MordasiniL , WeisstannerC , JuniP , daCostaBR , WiestR , et al. Sono‐electro‐magnetic therapy for treating chronic pelvic pain syndrome in men: a randomized, placebo‐controlled, double‐blind trial. PloS One2014;9(12):e113368. WeisstannerC , MordasiniL , ThalmannGN , VermaRK , RummelC , FederspielA , et al. Therapy‐related longitudinal brain perfusion changes in patients with chronic pelvic pain syndrome. Swiss Medical Weekly2017;147:w14454. ">Kessler 2014</a>). This study had two groups: participants who were treated at home with a sono‐electromagnetic therapy device and participants treated with a 'placebo' device (see <a href="#CD012551-tbl-0011">Table 1</a>; <a href="#CD012551-tbl-0012">Table 2</a>). </p> <section id="CD012551-sec-0208"> <h6 class="title">15.1. Prostatitis symptoms</h6> <p>Sono‐electromagnetic therapy probably resulted in little to no effect on prostatitis symptoms compared to the placebo device at 16 weeks (MD ‐2.80, 95% CI ‐6.75 to 1.15). These similar scores were observed across all subscores of pain, urinary symptoms and QoL domains (<a href="./references#CD012551-fig-0089" title="">Analysis 17.3</a>; <a href="./references#CD012551-fig-0090" title="">Analysis 17.4</a>; <a href="./references#CD012551-fig-0091" title="">Analysis 17.5</a>). There was a similar number of 'responders' (defined as a drop in 4 points of NIH‐CPSI score) in each group (RR 1.40, 95% CI 0.91 to 2.15). The quality of evidence was moderate due to imprecision issues. </p> <p>The study authors presented subgroup analysis.</p> <p> <ul id="CD012551-list-0027"> <li> <p>Participants aged less than 50 and 50 years or older had similar reductions in NIH‐CPSI scores (P = 0.40). </p> </li> <li> <p>Participants with baseline NIH‐CPSI scores greater than 25 and 25 or less had similar reductions in NIH‐CPSI scores (P = 0.35). </p> </li> <li> <p>Participants with a duration of symptoms greater than 12 months had a lower reduction of NIH‐CPSI scores compared to participants who had a shorter duration of symptoms (P = 0.023). The MDs in NIH‐CPSI score were ‐0.8 (95% CI ‐4.6 to 3.1) with a duration of symptoms greater than 12 months and ‐8.5 (95% CI ‐14.3 to ‐2.6) with a shorter duration of symptoms. </p> </li> </ul> </p> </section> <section id="CD012551-sec-0209"> <h6 class="title">15.2. Adverse events</h6> <p>One participant (1/30) in the active treatment group had worsening of pain symptoms. There were no adverse events observed in the control group. The quality of evidence was low due to imprecision issues (few events). </p> </section> <section id="CD012551-sec-0210"> <h6 class="title">15.3. Sexual dysfunction</h6> <p>The study did not report sexual dysfunction.</p> </section> <section id="CD012551-sec-0211"> <h6 class="title">15.4. Urinary symptoms</h6> <p>The study did not report urinary symptoms.</p> </section> <section id="CD012551-sec-0212"> <h6 class="title">15.5. Quality of life</h6> <p>The study did not report QoL.</p> </section> <section id="CD012551-sec-0213"> <h6 class="title">15.6. Depression and anxiety</h6> <p>The study did not report depression and anxiety.</p> </section> </section> <section id="CD012551-sec-0214"> <h5 class="title">16. Myofascial trigger point release therapy compared to control intervention (massage)</h5> <p>One study with 23 men compared myofascial trigger point release therapy with control intervention (massage) (<a href="./references#CD012551-bbs2-0004" title="BadilloSA , NevilleCE , KotarinosR , FortmanC , FraserL , CosbyA , et al. Randomized multicenter pilot trial shows benefit of manual physical therapies in treatment of urologic chronic pelvic pain. Journal of Women's Health Physical Therapy2009;33(1):23. FitzGeraldMP , AndersonRU , PottsJ , PayneCK , PetersKM , ClemensJQ , et al. Randomized multicenter feasibility trial of myofascial physical therapy for the treatment of urological chronic pelvic pain syndromes. Journal of Urology2009;182(2):570‐80. FitzgeraldMP , AndersonRU , PottsJ , PayneCK , PetersKM , ClemensJQ , et al. Randomized multicenter feasibility trial of myofascial physical therapy for the treatment of urological chronic pelvic pain syndromes. Journal of Urology2013;189(1 Suppl):S75‐85. ">Fitzgerald 2013</a>). This study also included women with interstitial cystitis/painful bladder syndrome, but their results were not included in this review. This study had two groups: participants who were treated with myofascial physical therapy and participants who received therapeutic western massage as a control intervention (see <a href="#CD012551-tbl-0011">Table 1</a>; <a href="#CD012551-tbl-0012">Table 2</a>). </p> <section id="CD012551-sec-0215"> <h6 class="title">16.1. Prostatitis symptoms</h6> <p>Myofascial trigger point release therapy may have resulted in little to no effect compared to the control intervention at 12 weeks (MD 1.00, 95% CI ‐6.45 to 8.45). These similar scores were observed across all subscores of pain, urinary symptoms and QoL (<a href="./references#CD012551-fig-0078" title="">Analysis 15.2</a>; <a href="./references#CD012551-fig-0079" title="">Analysis 15.3</a>; <a href="./references#CD012551-fig-0080" title="">Analysis 15.4</a>). The quality of evidence was very low due to high risk of performance and detection bias (the study was not blinded), the presence of baseline differences and imprecision issues (wide CIs due to small sample size). </p> </section> <section id="CD012551-sec-0216"> <h6 class="title">16.2. Adverse events</h6> <p>The authors reported the incidence of adverse events globally for men and women. Even though we contacted study authors to obtain the disaggregated data for men with CP/CPPS, we received no additional information. </p> </section> <section id="CD012551-sec-0217"> <h6 class="title">16.3. Sexual dysfunction</h6> <p>Myofascial trigger point release may have resulted in little to no effect compared to the control intervention, measured by the Sexual Health Inventory for Men (MD ‐2.20, 95% CI ‐9.24 to 4.84) (<a href="./references#CD012551-fig-0081" title="">Analysis 15.5</a>). The quality of evidence was very low due to high risk of performance and detection bias (the study was not blinded), the presence of baseline differences and imprecision issues (wide confidence interval due to small sample size). </p> </section> <section id="CD012551-sec-0218"> <h6 class="title">16.4. Urinary symptoms</h6> <p>The study did not report urinary symptoms.</p> </section> <section id="CD012551-sec-0219"> <h6 class="title">16.5. Quality of life</h6> <p>Myofascial trigger point release therapy may have resulted in little to no effect on QoL compared to the control intervention, measured by the SF‐12 Health Status Questionnaire (MD ‐1.30, 95% CI ‐9.54 to 6.94 for the physical domain and 0.80, 95% CI ‐9.25 to 10.85 for the mental domain) (<a href="./references#CD012551-fig-0082" title="">Analysis 15.6</a>; <a href="./references#CD012551-fig-0083" title="">Analysis 15.7</a>). The quality of evidence was very low due to high risk of performance and detection bias (the study was not blinded), the presence of baseline differences and imprecision issues (wide CIs due to small sample size). </p> </section> <section id="CD012551-sec-0220"> <h6 class="title">16.6. Depression and anxiety</h6> <p>The study did not report depression and anxiety.</p> </section> </section> <section id="CD012551-sec-0221"> <h5 class="title">17. Osteopathy versus control intervention (exercise programme)</h5> <p>One study with 35 participants compared osteopathy versus control intervention (exercise programme) (<a href="./references#CD012551-bbs2-0016" title="MarxS . ICAOR 2006: does osteopathic treatment have an influence on the symptoms of patients with chronic prostatitis/chronic pelvic pain syndrome (CPPS)? A randomized controlled trial. International Journal of Osteopathic Medicine2006;9(1):44. MarxS , CimniakU , BeckertR , SchwerlaF , ReschKL . Chronic prostatitis/chronic pelvic pain syndrome. Influence of osteopathic treatment ‐ a randomized controlled study [Chronische Prostatitis/chronisches Beckenschmerzsyndrom. Einfluss osteopathischer Behandlungen ‐ eine randomisiert kontrollierte Studie]. Der Urologe. Ausg. A2009;48(11):1339‐45. ">Marx 2009</a>) (see <a href="#CD012551-tbl-0011">Table 1</a>; <a href="#CD012551-tbl-0012">Table 2</a>). </p> <section id="CD012551-sec-0222"> <h6 class="title">17.1. Prostatitis symptoms</h6> <p>Osteopathy may have reduced prostatitis symptoms, measured by the NIH‐CPSI score, compared the control intervention at 14 weeks (MD ‐9.67, 95% CI ‐15.15 to ‐4.19) (<a href="./references#CD012551-fig-0084" title="">Analysis 16.1</a>). The authors also reported a decrease in QoL subscore (<a href="./references#CD012551-fig-0085" title="">Analysis 16.2</a>), but did not report the other subscores. The quality of evidence was very low due to high risk of performance and detection bias (the study was not blinded), the unbalanced attrition at follow‐up and imprecision issues (wide CI due to small sample size). </p> </section> <section id="CD012551-sec-0223"> <h6 class="title">17.2. Adverse events</h6> <p>The study did not report adverse events.</p> </section> <section id="CD012551-sec-0224"> <h6 class="title">17.3. Sexual dysfunction</h6> <p>The study did not report sexual dysfunction.</p> </section> <section id="CD012551-sec-0225"> <h6 class="title">17.4. Urinary symptoms</h6> <p>Osteopathy may reduce urinary symptoms, measured by IPSS score, compared to the control intervention (MD ‐8.70, 95% CI ‐12.73 to ‐4.67). The quality of evidence was very low due to high risk of performance and detection bias (the study was not blinded), the unbalanced attrition at follow‐up and imprecision issues (wide CIs due to small sample size). </p> </section> <section id="CD012551-sec-0226"> <h6 class="title">17.5. Quality of life</h6> <p>The study did not report QoL.</p> </section> <section id="CD012551-sec-0227"> <h6 class="title">17.6. Depression and anxiety</h6> <p>The study did not report depression and anxiety.</p> </section> </section> <section id="CD012551-sec-0228"> <h5 class="title">18. Transcutaneous electrical nerve stimulation compared to control intervention</h5> <p>Two studies with 56 participants compared TENS with control (<a href="./references#CD012551-bbs2-0026" title="Samhan AhmedF , Abd‐Elhalim NermeenM , Elnegmy EmamH , Roiah MohamedM . The effect of transcutaneous electrical nerve stimulation in the treatment of chronic pelvic pain syndrome: an evidence based electromyographic studies. Indian Journal of Physiotherapy &amp; Occupational Therapy2011;5(3):14‐7. ">Samhan 2011</a>; <a href="./references#CD012551-bbs2-0029" title="SikiruL , ShmailaH , MuhammedSA . Transcutaneous electrical nerve stimulation (TENS) in the symptomatic management of chronic prostatitis/chronic pelvic pain syndrome: a placebo‐control randomized trial. International Brazilian Journal of Urology2008;34(6):708‐13; discussion 714. ">Sikiru 2008</a>). In <a href="./references#CD012551-bbs2-0026" title="Samhan AhmedF , Abd‐Elhalim NermeenM , Elnegmy EmamH , Roiah MohamedM . The effect of transcutaneous electrical nerve stimulation in the treatment of chronic pelvic pain syndrome: an evidence based electromyographic studies. Indian Journal of Physiotherapy &amp; Occupational Therapy2011;5(3):14‐7. ">Samhan 2011</a>, the control group received a sham procedure in which the TENS device was switched off, and, in <a href="./references#CD012551-bbs2-0029" title="SikiruL , ShmailaH , MuhammedSA . Transcutaneous electrical nerve stimulation (TENS) in the symptomatic management of chronic prostatitis/chronic pelvic pain syndrome: a placebo‐control randomized trial. International Brazilian Journal of Urology2008;34(6):708‐13; discussion 714. ">Sikiru 2008</a>, the control group received no intervention (see <a href="#CD012551-tbl-0011">Table 1</a>; <a href="#CD012551-tbl-0012">Table 2</a>). </p> <section id="CD012551-sec-0229"> <h6 class="title">18.1. Prostatitis symptoms</h6> <p>The studies did not report the total NIH‐CPSI scores. They reported the pain subscore at four weeks. TENS may have appreciably reduced prostatitis‐related pain compared to the control intervention, measured by the NIH‐CPSI pain subscore (MD ‐8.60, 95% CI ‐9.71 to ‐7.48; I<sup>2</sup> = 97%; random‐effects meta‐analysis) (<a href="./references#CD012551-fig-0092" title="">Analysis 18.1</a>). The quality of evidence was very low due to high risk of performance and detection bias (one study was not blinded), inconsistency and imprecision. </p> </section> <section id="CD012551-sec-0230"> <h6 class="title">18.2. Adverse events</h6> <p>The studies did not report adverse events.</p> </section> <section id="CD012551-sec-0231"> <h6 class="title">18.3. Sexual dysfunction</h6> <p>The studies did not report sexual dysfunction.</p> </section> <section id="CD012551-sec-0232"> <h6 class="title">18.4. Urinary symptoms</h6> <p>The studies did not report urinary symptoms.</p> </section> <section id="CD012551-sec-0233"> <h6 class="title">18.5. Quality of life</h6> <p>The studies did not report QoL.</p> </section> <section id="CD012551-sec-0234"> <h6 class="title">18.6. Depression and anxiety</h6> <p>The studies did not report depression and anxiety.</p> </section> </section> <section id="CD012551-sec-0235"> <h5 class="title">19. Transurethral thermotherapy compared to control intervention</h5> <p>Two studies with 62 participants compared transurethral thermotherapy with control intervention (<a href="./references#CD012551-bbs2-0010" title="KastnerC , HochreiterW , HuidobroC , CabezasJ , MillerP . Cooled transurethral microwave thermotherapy for intractable chronic prostatitis ‐ results of a pilot study after 1 year. Urology2004;64(6):1149‐54. ">Kastner 2004</a>; <a href="./references#CD012551-bbs2-0020" title="NickelJC , SorensenR . Transurethral microwave thermotherapy for nonbacterial prostatitis: a randomized double‐blind sham controlled study using new prostatitis specific assessment questionnaires. Journal of Urology1996;155(6):1950‐4; discussion 1954. ">Nickel 1996</a>). These studies assessed transurethral thermotherapy at approximately 50 °C compared to a sham procedure with no temperature elevation (<a href="./references#CD012551-bbs2-0020" title="NickelJC , SorensenR . Transurethral microwave thermotherapy for nonbacterial prostatitis: a randomized double‐blind sham controlled study using new prostatitis specific assessment questionnaires. Journal of Urology1996;155(6):1950‐4; discussion 1954. ">Nickel 1996</a>), or to a transurethral thermotherapy at 70 °C (<a href="./references#CD012551-bbs2-0010" title="KastnerC , HochreiterW , HuidobroC , CabezasJ , MillerP . Cooled transurethral microwave thermotherapy for intractable chronic prostatitis ‐ results of a pilot study after 1 year. Urology2004;64(6):1149‐54. ">Kastner 2004</a>) (see <a href="#CD012551-tbl-0011">Table 1</a>; <a href="#CD012551-tbl-0012">Table 2</a>). </p> <section id="CD012551-sec-0236"> <h6 class="title">19.1. Prostatitis symptoms</h6> </section> <section id="CD012551-sec-0237"> <h6 class="title">19.1.1. Transurethral thermotherapy at 50 °C compared to sham procedure</h6> <p><a href="./references#CD012551-bbs2-0020" title="NickelJC , SorensenR . Transurethral microwave thermotherapy for nonbacterial prostatitis: a randomized double‐blind sham controlled study using new prostatitis specific assessment questionnaires. Journal of Urology1996;155(6):1950‐4; discussion 1954. ">Nickel 1996</a> recruited 20 participants and reported that participants who received transurethral thermotherapy had fewer symptoms of prostatitis compared to participants who received the sham procedure with no temperature elevation at three months' follow‐up, using the Prostatitis Symptom Severity Index (range 0 to 100) with a mean score of 27.3 with transurethral thermotherapy and 52.9 with sham (P &lt; 0.05). The quality of evidence was low due to severe imprecision. </p> </section> <section id="CD012551-sec-0238"> <h6 class="title">19.1.2. Transurethral thermotherapy at 55 °C compared to thermotherapy at 70 °C</h6> <p><a href="./references#CD012551-bbs2-0010" title="KastnerC , HochreiterW , HuidobroC , CabezasJ , MillerP . Cooled transurethral microwave thermotherapy for intractable chronic prostatitis ‐ results of a pilot study after 1 year. Urology2004;64(6):1149‐54. ">Kastner 2004</a> recruited 42 participants and reported that participants who received transurethral thermotherapy at 70 °C had similar symptoms of prostatitis compared to participants who received the procedure at 55 °C at three months' follow‐up, using the NIH‐CPSI score (MD ‐1.10, 95% CI ‐6.50 to 4.30) (<a href="./references#CD012551-fig-0093" title="">Analysis 19.1</a>). These similar scores were observed across all subscores of pain, urinary symptoms and QoL (<a href="./references#CD012551-fig-0094" title="">Analysis 19.2</a>; <a href="./references#CD012551-fig-0095" title="">Analysis 19.3</a>; <a href="./references#CD012551-fig-0096" title="">Analysis 19.4</a>). The quality of evidence was low due to lost to follow‐up (attrition bias) and imprecision. </p> </section> <section id="CD012551-sec-0239"> <h6 class="title">19.2. Adverse events</h6> <p><a href="./references#CD012551-bbs2-0020" title="NickelJC , SorensenR . Transurethral microwave thermotherapy for nonbacterial prostatitis: a randomized double‐blind sham controlled study using new prostatitis specific assessment questionnaires. Journal of Urology1996;155(6):1950‐4; discussion 1954. ">Nickel 1996</a> recruited 20 participants and specified that four participants experienced transient adverse reactions, but there were no specifications whether they were in the active treatment group or the sham intervention group. <a href="./references#CD012551-bbs2-0010" title="KastnerC , HochreiterW , HuidobroC , CabezasJ , MillerP . Cooled transurethral microwave thermotherapy for intractable chronic prostatitis ‐ results of a pilot study after 1 year. Urology2004;64(6):1149‐54. ">Kastner 2004</a> reported that both active treatment (55 °C and 70 °C) groups had genitourinary events that resolved at six weeks, and that the proportion of events was similar across groups. The quality of evidence was very low due to high risk of performance, detection and attrition bias, and imprecision. </p> </section> <section id="CD012551-sec-0240"> <h6 class="title">19.3. Sexual dysfunction</h6> <p>The studies did not report sexual dysfunction.</p> </section> <section id="CD012551-sec-0241"> <h6 class="title">19.4. Urinary symptoms</h6> </section> <section id="CD012551-sec-0242"> <h6 class="title"><i>19.4.1. Transurethral thermotherapy at 50</i> °<i>C compared to sham procedure</i> </h6> <p><a href="./references#CD012551-bbs2-0020" title="NickelJC , SorensenR . Transurethral microwave thermotherapy for nonbacterial prostatitis: a randomized double‐blind sham controlled study using new prostatitis specific assessment questionnaires. Journal of Urology1996;155(6):1950‐4; discussion 1954. ">Nickel 1996</a> recruited 20 participants and reported that participants who received transurethral thermotherapy had fewer urinary symptoms compared to participants who received the sham procedure with no temperature elevation at three months' follow‐up, using the American Urology Association Symptom Score (range 0 to 100) with mean scores of 12.8 with transurethral thermotherapy and 21.9 with sham (P value not available). </p> </section> <section id="CD012551-sec-0243"> <h6 class="title">19.4.2. Transurethral thermotherapy at 55 °C compared to thermotherapy at 70 °C</h6> <p><a href="./references#CD012551-bbs2-0010" title="KastnerC , HochreiterW , HuidobroC , CabezasJ , MillerP . Cooled transurethral microwave thermotherapy for intractable chronic prostatitis ‐ results of a pilot study after 1 year. Urology2004;64(6):1149‐54. ">Kastner 2004</a> recruited 42 participants and reported that participants who received transurethral thermotherapy at 70 °C had similar urinary symptoms compared to participants who received the procedure at 55 °C at three months' follow‐up (MD ‐2.10, 95% CI ‐6.34 to 2.14) (<a href="./references#CD012551-fig-0097" title="">Analysis 19.5</a>). The quality of evidence was low due to lost to follow‐up (attrition bias) and imprecision. </p> </section> <section id="CD012551-sec-0244"> <h6 class="title">19.5. Quality of life</h6> <p>The studies did not report QoL.</p> </section> <section id="CD012551-sec-0245"> <h6 class="title">19.6. Depression and anxiety</h6> <p>The studies did not report depression and anxiety.</p> </section> </section> <section id="CD012551-sec-0246"> <h5 class="title">20. Transurethral needle ablation compared to sham procedure</h5> <p>One study with 33 participants compared transurethral needle ablation (TUNA) with sham procedure (<a href="./references#CD012551-bbs2-0015" title="LeskinenMJ , KilponenA , LukkarinenO , TammelaTL . Transurethral needle ablation for the treatment of chronic pelvic pain syndrome (category III prostatitis): a randomized, sham‐controlled study. Urology2002;60(2):300‐4. ">Leskinen 2002</a>). The sham procedure used urethroscopy but not ablation (see <a href="#CD012551-tbl-0011">Table 1</a>; <a href="#CD012551-tbl-0012">Table 2</a>). </p> <section id="CD012551-sec-0247"> <h6 class="title">20.1. Prostatitis symptoms</h6> <p>TUNA may have had little to no effect on prostatitis symptoms compared to a sham procedure at 12 months' follow‐up, using the Prostatitis Symptom Severity Index (range 0 to 100) (MD 2.30, 95% CI ‐8.02 to 12.62) (<a href="./references#CD012551-fig-0098" title="">Analysis 20.1</a>). The quality of evidence was very low due to severe imprecision and unclear risk of bias in almost all domains. </p> </section> <section id="CD012551-sec-0248"> <h6 class="title">20.2. Adverse events</h6> <p>The study reported that 10/25 participants in the TUNA group and 3/8 in the sham group experienced dysuria during the first month after the procedure and 3/25 participants in the TUNA group reported transient haematuria. The quality of evidence was very low due to severe imprecision and unclear risk of bias in almost all domains. </p> </section> <section id="CD012551-sec-0249"> <h6 class="title">20.3. Sexual dysfunction</h6> <p>The study did not report sexual dysfunction.</p> </section> <section id="CD012551-sec-0250"> <h6 class="title">20.4. Urinary symptoms</h6> <p>TUNA may have had little to no effect on urinary symptoms compared to a sham procedure at 12 months follow‐up, using the IPSS score (MD 0.40, 95% CI ‐5.09 to 5.89) (<a href="./references#CD012551-fig-0099" title="">Analysis 20.2</a>). The quality of evidence was very low due to severe imprecision and unclear risk of bias in almost all domains. </p> </section> <section id="CD012551-sec-0251"> <h6 class="title">20.5. Quality of life</h6> <p>The study did not report QoL.</p> </section> <section id="CD012551-sec-0252"> <h6 class="title">20.6. Depression and anxiety</h6> <p>The study did not report depression and anxiety.</p> </section> </section> <section id="CD012551-sec-0253"> <h5 class="title">21. Ultrasound compared to or as add‐on to medical therapy</h5> <p>One study with 105 participants had three groups that compared non‐intrusive ultrasound alone with Chinese‐Western medicine or non‐intrusive ultrasound plus integrated Chinese‐Western medicine (<a href="./references#CD012551-bbs2-0009" title="KaikaiC , RuiW , YongC , ZhuC , WeiH , SuogangW , et al. Combination therapy of non‐intrusive ultrasound with integrated Chinese‐western medicine for chronic prostatitis/chronic pelvic pain syndrome. Chinese Journal of Andrology2014;28(12):41‐4. ">Kaikai 2014</a>) (see <a href="#CD012551-tbl-0011">Table 1</a>; <a href="#CD012551-tbl-0012">Table 2</a>). </p> <section id="CD012551-sec-0254"> <h6 class="title">21.1. Prostatitis symptoms</h6> </section> <section id="CD012551-sec-0255"> <h6 class="title">21.1.1. Ultrasound versus medical therapy</h6> <p>Ultrasound therapy may have increased prostatitis symptoms compared to medical therapy, measured by NIH‐CPSI scores at one month after treatment (MD 1.09, 95% CI 0.16 to 2.02) (<a href="./references#CD012551-fig-0100" title="">Analysis 21.1</a>). These greater scores were observed across all subscores of pain, urinary symptoms and QoL (<a href="./references#CD012551-fig-0101" title="">Analysis 21.2</a>; <a href="./references#CD012551-fig-0102" title="">Analysis 21.3</a>; <a href="./references#CD012551-fig-0103" title="">Analysis 21.4</a>). The quality of evidence was low due to high risk of performance and detection bias (study not blinded), and imprecision. </p> </section> <section id="CD012551-sec-0256"> <h6 class="title">21.1.2. Ultrasound plus medical therapy versus medical therapy alone</h6> <p>Ultrasound plus medical therapy may have resulted in fewer prostatitis symptoms compared to medical therapy alone, measured by NIH‐CPSI score at one month after treatment (MD ‐6.67, 95% CI ‐7.62 to ‐5.72) (<a href="./references#CD012551-fig-0100" title="">Analysis 21.1</a>). These lower scores were observed across all subscores of pain, urinary symptoms and QoL (<a href="./references#CD012551-fig-0101" title="">Analysis 21.2</a>; <a href="./references#CD012551-fig-0102" title="">Analysis 21.3</a>; <a href="./references#CD012551-fig-0103" title="">Analysis 21.4</a>). The quality of evidence was low due to high risk of performance and detection bias (study not blinded), and imprecision. </p> </section> <section id="CD012551-sec-0257"> <h6 class="title">21.2. Adverse events</h6> <p>The study reported five cases of vertigo, six cases of gastrointestinal discomfort and three cases of sleepiness; however, it did not specify which group experienced them. The quality of evidence was low due to high risk of performance and detection bias (study not blinded), and imprecision. </p> </section> <section id="CD012551-sec-0258"> <h6 class="title">21.3. Sexual dysfunction</h6> <p>The study did not report sexual dysfunction.</p> </section> <section id="CD012551-sec-0259"> <h6 class="title">21.4. Urinary symptoms</h6> <p>The study did not report urinary symptoms.</p> </section> <section id="CD012551-sec-0260"> <h6 class="title">21.5. Quality of life</h6> <p>The study did not report QoL.</p> </section> <section id="CD012551-sec-0261"> <h6 class="title">21.6. Depression and anxiety</h6> <p>The study did not report depression and anxiety.</p> </section> </section> <section id="CD012551-sec-0262"> <h5 class="title">22. Hypercapnic hypoxia versus no additional intervention</h5> <p>One study with 37 participants compared hypercapnic hypoxia plus medical therapy versus medical therapy alone (<a href="./references#CD012551-bbs2-0019" title="NeimarkAI , MaksimovaSS . Effect of hypercapnic hypoxia on chronic abacterial prostatitis. Urologiia (Moscow, Russia : 1999)2016;1(3):80‐4. [PUBMED: 28247635] ">Neimark 2016</a>) (see <a href="#CD012551-tbl-0011">Table 1</a>; <a href="#CD012551-tbl-0012">Table 2</a>). </p> <section id="CD012551-sec-0263"> <h6 class="title">22.1. Prostatitis symptoms</h6> <p>The study did not report prostatitis symptoms.</p> </section> <section id="CD012551-sec-0264"> <h6 class="title">22.2. Adverse events</h6> <p>The study did not report adverse events.</p> </section> <section id="CD012551-sec-0265"> <h6 class="title">22.3. Sexual dysfunction</h6> <p>The study did not report sexual dysfunction.</p> </section> <section id="CD012551-sec-0266"> <h6 class="title">22.4. Urinary symptoms</h6> <p>The study reported that at the end of the 10 days of treatment, the mean IPSS score for the hypercapnic hypoxia plus medical therapy group was 9 and the medical therapy alone was 8 (P value not available). The quality of evidence was very low due to high risk of detection and performance bias, and imprecision. </p> </section> <section id="CD012551-sec-0267"> <h6 class="title">22.5. Quality of life</h6> <p>The study did not report QoL.</p> </section> <section id="CD012551-sec-0268"> <h6 class="title">22.6. Depression and anxiety</h6> <p>The study did not report depression and anxiety.</p> </section> </section> <section id="CD012551-sec-0269"> <h5 class="title">23. TaiJiQuan/t'ai chi ch'uan (太極拳) plus usual care versus usual care alone</h5> <p>One study with 96 participants compared TaiJiQuan/t'ai chi ch'uan (太極拳) plus usual care with usual care alone (<a href="./references#CD012551-bbs2-0036" title="ZhangDY , PanXC . Chinese medicine union Taijiquan treatment chronicity non‐bacterial prostatitis curative effect observation. Chinese Manipulation &amp; Rehabilitation Medicine2011;15(2):181. ">Zhang 2011a</a>) (see <a href="#CD012551-tbl-0011">Table 1</a>; <a href="#CD012551-tbl-0012">Table 2</a>). This study was poorly reported in the methods and results section. None of the predefined outcomes of this review were reported. The study authors reported different levels of clinical "response" (definition not available). </p> </section> <section id="CD012551-sec-0270"> <h5 class="title">24. Psychological support</h5> <p>We found no studies reporting psychological support.</p> </section> <section id="CD012551-sec-0271"> <h5 class="title">25. Prostatic surgery</h5> <p>We found no studies reporting prostatic surgery.</p> </section> </section> <section id="CD012551-sec-0272"> <h4 class="title">Sensitivity analysis</h4> <p>We performed a sensitivity analysis excluding the six studies (<a href="./references#CD012551-bbs2-0002" title="ChenZX . Observation on therapeutic effect of warm needle moxibustion on chronic non‐bacterial prostatitis. Zhongguo Zhen Jiu [Chinese Acupuncture &amp; Moxibustion]2009;29(4):275‐8. ">Chen 2009</a>; <a href="./references#CD012551-bbs2-0017" title="MontorsiF , GuazzoniG , BergamaschiF , GalliL , ConsonniP , MatozzoV , et al. Is there a role for transrectal microwave hyperthermia of the prostate in the treatment of abacterial prostatitis and prostatodynia?. Prostate1993;22(2):139‐46. ">Montorsi 1993</a>; <a href="./references#CD012551-bbs2-0018" title="MuraroGB . Clinical study on the efficacy and safety of seaprose S combined with local prostatic hyperthermia in chronic non‐bacterial prostatitis. Controlled study versus local prostatic hyperthermia [Studio clinico sull'efficacia e la tollerabilita del seaprose S associato a ipertermia locale prostatica nella prostatite cronica abatterica. Studio controllato verso ipertermia locale prostatica]. Archivio di Medicina Interna1995;47(2‐3):73‐86. ">Muraro 1995</a>; <a href="./references#CD012551-bbs2-0020" title="NickelJC , SorensenR . Transurethral microwave thermotherapy for nonbacterial prostatitis: a randomized double‐blind sham controlled study using new prostatitis specific assessment questionnaires. Journal of Urology1996;155(6):1950‐4; discussion 1954. ">Nickel 1996</a>; <a href="./references#CD012551-bbs2-0027" title="ShahT , WatsonG , BarnesD . Microwave hyperthermia in the treatment of chronic abacterial prostatitis and prostatodynia: results of a double blind placebo controlled trial (Abstract). Journal of Urology1993;149:405A. ">Shah 1993</a>; <a href="./references#CD012551-bbs2-0031" title="VassilyO , AndreyS , EvgeniiD , OtabekI , BorisL , SergeyR . Efficacy of transrectal microwave hyperthemia (TRMH) in the treatment of chronic prostatitis. A randomized sham controlled comparative study (Abstract). Journal of Urology1999;161(4 Suppl):33A. ">Vassily 1999</a>) that did not meet the Research Consensus definition for CP/CPPS (<a href="./references#CD012551-bbs2-0169" title="NickelJC , NybergLM , HennenfentM . Research guidelines for chronic prostatitis: consensus report from the first National Institutes of Health International Prostatitis Collaborative Network. Urology1999;54(2):229‐33. [PUBMED: 10443716] ">Nickel 1999a</a>). </p> <section id="CD012551-sec-0273"> <h5 class="title">1. Acupuncture</h5> <p>The study by <a href="./references#CD012551-bbs2-0002" title="ChenZX . Observation on therapeutic effect of warm needle moxibustion on chronic non‐bacterial prostatitis. Zhongguo Zhen Jiu [Chinese Acupuncture &amp; Moxibustion]2009;29(4):275‐8. ">Chen 2009</a> was involved in two comparisons. </p> <section id="CD012551-sec-0274"> <h6 class="title">1.1. Acupuncture versus medical therapy, prostatitis symptoms</h6> <p>The sensitivity analysis excluding <a href="./references#CD012551-bbs2-0002" title="ChenZX . Observation on therapeutic effect of warm needle moxibustion on chronic non‐bacterial prostatitis. Zhongguo Zhen Jiu [Chinese Acupuncture &amp; Moxibustion]2009;29(4):275‐8. ">Chen 2009</a> resulted in a reduction of the statistical heterogeneity across the studies (<a href="#CD012551-fig-0004">Figure 4</a>). The meta‐analysis of the two remaining studies showed that acupuncture probably reduced appreciably prostatitis symptoms compared with medical therapy (MD ‐6.05, 95% CI ‐7.87 to ‐4.24; 78 participants; 4 studies; I<sup>2</sup> = 0%) (<a href="./references#CD012551-bbs2-0012" title="KucukEV , SucekenFY , BindayiA , BoyluU , OnolFF , GumusE . Effectiveness of acupuncture on chronic prostatitis‐chronic pelvic pain syndrome category IIIB patients: a prospective, randomized, nonblinded, clinical trial. Urology2015;85(3):636‐40. ">Kucuk 2015</a>; <a href="./references#CD012551-bbs2-0014" title="LeeSH , LeeBC . Electroacupuncture relieves pain in men with chronic prostatitis/chronic pelvic pain syndrome: three‐arm randomized trial. Urology2009;73(5):1036‐41. ">Lee 2009</a>). The results of this sensitivity analysis were incorporated in <a href="./full#CD012551-tbl-0002">summary of findings Table 2</a> and the other sections of this review. </p> <div class="figure" id="CD012551-fig-0004"> <div class="figure-caption-wrapper-top"> <nav class="inline-nav-list has-dividers"> <ul> <li><a class="open-in-figure-viewer" href="#0">Open in figure viewer</a></li> </ul> </nav> <div class="figure-label">Figure 4</div> </div> <hr class="top"/><img alt="Forest plot of comparison: 22 Acupuncture treatments versus medical treatment. Sensitivity analysis, outcome: 22.1 Prostatitis symptoms (NIH‐CPSI total)." data-id="CD012551-fig-0004" src="/cdsr/doi/10.1002/14651858.CD012551.pub3/media/CDSR/CD012551/image_n/nCD012551-AFig-FIG04.png"/><hr class="bottom"/> <div class="figure-caption-wrapper-bottom"> <div class="figure-caption"> <p>Forest plot of comparison: 22 Acupuncture treatments versus medical treatment. Sensitivity analysis, outcome: 22.1 Prostatitis symptoms (NIH‐CPSI total). </p> </div> </div> </div> </section> <section id="CD012551-sec-0275"> <h6 class="title">1.2. Acupuncture versus acupuncture plus moxibustion</h6> <p>The exclusion of this study resulted in no evidence for this comparison (<a href="./references#CD012551-bbs2-0002" title="ChenZX . Observation on therapeutic effect of warm needle moxibustion on chronic non‐bacterial prostatitis. Zhongguo Zhen Jiu [Chinese Acupuncture &amp; Moxibustion]2009;29(4):275‐8. ">Chen 2009</a>). </p> </section> </section> <section id="CD012551-sec-0276"> <h5 class="title">2. Transrectal thermotherapy</h5> <p>The exclusion of three of the studies that did not meet the Research Consensus definition did not affect the results since they did not provide valid outcome measures (<a href="./references#CD012551-bbs2-0018" title="MuraroGB . Clinical study on the efficacy and safety of seaprose S combined with local prostatic hyperthermia in chronic non‐bacterial prostatitis. Controlled study versus local prostatic hyperthermia [Studio clinico sull'efficacia e la tollerabilita del seaprose S associato a ipertermia locale prostatica nella prostatite cronica abatterica. Studio controllato verso ipertermia locale prostatica]. Archivio di Medicina Interna1995;47(2‐3):73‐86. ">Muraro 1995</a>; <a href="./references#CD012551-bbs2-0027" title="ShahT , WatsonG , BarnesD . Microwave hyperthermia in the treatment of chronic abacterial prostatitis and prostatodynia: results of a double blind placebo controlled trial (Abstract). Journal of Urology1993;149:405A. ">Shah 1993</a>; <a href="./references#CD012551-bbs2-0031" title="VassilyO , AndreyS , EvgeniiD , OtabekI , BorisL , SergeyR . Efficacy of transrectal microwave hyperthemia (TRMH) in the treatment of chronic prostatitis. A randomized sham controlled comparative study (Abstract). Journal of Urology1999;161(4 Suppl):33A. ">Vassily 1999</a>). The exclusion of <a href="./references#CD012551-bbs2-0017" title="MontorsiF , GuazzoniG , BergamaschiF , GalliL , ConsonniP , MatozzoV , et al. Is there a role for transrectal microwave hyperthermia of the prostate in the treatment of abacterial prostatitis and prostatodynia?. Prostate1993;22(2):139‐46. ">Montorsi 1993</a> affected the incidence of adverse events. In <a href="./references#CD012551-bbs2-0017" title="MontorsiF , GuazzoniG , BergamaschiF , GalliL , ConsonniP , MatozzoV , et al. Is there a role for transrectal microwave hyperthermia of the prostate in the treatment of abacterial prostatitis and prostatodynia?. Prostate1993;22(2):139‐46. ">Montorsi 1993</a>, there were no adverse events in the participants who received the procedure (all participants received the procedure in different regimens). </p> </section> <section id="CD012551-sec-0277"> <h5 class="title">3. Transurethral thermotherapy</h5> <p>The exclusion of <a href="./references#CD012551-bbs2-0020" title="NickelJC , SorensenR . Transurethral microwave thermotherapy for nonbacterial prostatitis: a randomized double‐blind sham controlled study using new prostatitis specific assessment questionnaires. Journal of Urology1996;155(6):1950‐4; discussion 1954. ">Nickel 1996</a> resulted in no evidence for the comparison of transurethral thermotherapy versus sham procedure. </p> </section> </section> </section> </section> </section> <section class="discussion"> <div class="section-header section-collapse-header" id="CD012551-sec-0278" lang="en"> <h2 class="title section-collapse-title"> Discussion <i aria-hidden="true" class="fa fa-caret-up section-collapse-icon"></i> </h2> </div> <section class="discussion" lang="en"> <div class="section-header" id="CD012551-sec-0278"></div> <section id="CD012551-sec-0279"> <h3 class="title" id="CD012551-sec-0279">Summary of main results</h3> <p>We included 38 unique studies with 3290 men with CP/CPPS across 23 comparisons. We included all comparisons with short‐term follow‐up in the analyses. The median age of the participants was 37 years. </p> <p>We found moderate quality evidence that acupuncture and extracorporeal shockwave therapy probably leads to a clinically meaningful reduction in prostatitis symptoms based on an NIH‐CPSI reduction of greater than three (but less than six). These interventions may not have been associated with an increased incidence of adverse events. We also found that circumcision probably decreased prostatitis symptoms; however, the effect would be small. We found moderate‐quality evidence that tibial nerve stimulation probably caused an important decrease in prostatitis symptoms, but we have no information regarding adverse events. </p> <p>Additionally, we found low‐ to very low‐quality evidence that physical activity, biofeedback, ultrasound and transrectal thermotherapy may have reduced prostatitis symptoms. We were uncertain about the effects of lifestyle interventions, use of an electromagnetic chair, sono‐electromagnetic therapy, external radiofrequency hyperthermia, prostatic massage, laser therapy, myofascial trigger point release therapy, osteopathy, TENS, transurethral thermotherapy, transurethral needle ablation, hypercapnic hypoxia and TaiJiQuan. We found no information regarding psychological support or prostatic surgery. </p> </section> <section id="CD012551-sec-0280"> <h3 class="title" id="CD012551-sec-0280">Overall completeness and applicability of evidence</h3> <p>Our review focused on men with CP/CPPS. Almost all the included studies used the consistent inclusion criteria defined by the NIH (<a href="./references#CD012551-bbs2-0174" title="NybergLM , KriegerJN , NickelJC . National Institutes of Health classification of chronic prostatitis. In: NickelJC editor(s). Textbook of Prostatitis. London: CRC Press, 1999. ">Nyberg 1999</a>). These diagnostic criteria are related to clinical practice, since these participants are usually tested for urological diseases that could mimic CP/CPPS. However, some of the impact of the NIH consensus on the diagnosis of CP/CPPS might have changed the classification of participants across time (<a href="./references#CD012551-bbs2-0159" title="KriegerJN , RossSO , DeutschL , RileyDE . The NIH Consensus concept of chronic prostatitis/chronic pelvic pain syndrome compared with traditional concepts of nonbacterial prostatitis and prostatodynia. Current Urology Reports2002;3(4):301‐6. [PUBMED: 12149161] ">Krieger 2002</a>), therefore, the results of older trials must be interpreted in caution with the current diagnostic criteria. Nevertheless, we incorporated a sensitivity analysis based on this consideration. </p> <p>We maintained open inclusion criteria for the included interventions. This decision was based on the poorly understood pathophysiological determinants for CP/CPPS (see <a href="#CD012551-sec-0030">Background</a>). This led to the inclusion of a wide variety of interventions, which could relate to clinical practice, considering that people with CP/CPPS usually try different treatment options before achieving some form of relief. However, while this review can be used to discuss the different treatment options with patients, the description of some of these interventions was sometimes insufficient. This was particularly important for more complex interventions such as non‐pharmacological interventions (<a href="./references#CD012551-bbs2-0149" title="HoffmannTC , EruetiC , GlasziouPP . Poor description of non‐pharmacological interventions: analysis of consecutive sample of randomised trials. BMJ2013;347:1‐10. ">Hoffmann 2013</a>). This could pose a threat to the open discussion of the implications of implementing a certain intervention in clinical practice. </p> <p>Our review focused on critical patient‐important outcomes; however, most studies did not report them consistently, especially the incidence of adverse events. This is a common problem in clinical trials (<a href="./references#CD012551-bbs2-0152" title="IoannidisJP , LauJ . Completeness of safety reporting in randomized trials: an evaluation of 7 medical areas. JAMA2001;285(4):437‐43. [PUBMED: 11242428] ">Ioannidis 2001</a>), and poses difficulties when estimating the net benefit of the interventions. Additionally, most of the included studies did not report the effects of their interventions on QoL, sexual function and mental health, considering the important impact of CP/CPPS in these domains (<a href="./references#CD012551-bbs2-0161" title="KrsmanovicA , TrippDA , NickelJC , ShoskesDA , PontariM , LitwinMS , et al. Psychosocial mechanisms of the pain and quality of life relationship for chronic prostatitis/chronic pelvic pain syndrome (CP/CPPS). Journal de l'Association des Urologues du Canada [Canadian Urological Association Journal]2014;8(11‐12):403‐8. [PUBMED: 25553153] ">Krsmanovic 2014</a>). We acknowledge that the NIH‐CPSI score includes QoL and urinary symptoms subscores that, alongside the pain subscore, contribute to a total score that has proven to be valid and reliable (<a href="./references#CD012551-bbs2-0164" title="LitwinMS , McNaughton‐CollinsM , FowlerFJ , NickelJC , CalhounEA , PontariMA , et al. The National Institutes of Health chronic prostatitis symptom index: development and validation of a new outcome measure. Chronic Prostatitis Collaborative Research Network. Journal of Urology1999;162(2):369‐75. ">Litwin 1999</a>; <a href="./references#CD012551-bbs2-0079" title="McNaughton CollinsM , MacDonaldR , WiltTJ . Interventions for chronic abacterial prostatitis. Cochrane Database of Systematic Reviews2001, Issue 1. [DOI: 10.1002/14651858.CD002080] ">McNaughton 2001</a>; <a href="./references#CD012551-bbs2-0179" title="PropertKJ , McNaughton‐CollinsM , LeibyBE , O'LearyMP , KusekJW , LitwinMS , et al. A prospective study of symptoms and quality of life in men with chronic prostatitis/chronic pelvic pain syndrome: the National Institutes of Health chronic prostatitis cohort study. Journal of Urology2006;175(2):619‐23. ">Propert 2006</a>; <a href="./references#CD012551-bbs2-0195" title="TurnerJA , CiolMA , VonKorffM , BergerR . Validity and responsiveness of the national institutes of health chronic prostatitis symptom index. Journal of Urology2003;169(2):580‐3. ">Turner 2003</a>); however, these subscores have not been validated for these constructs individually. We acknowledge that the validated scores for QoL, urinary symptoms, sexual dysfunction, and anxiety and depression might have not been validated in the subpopulation of men with CP/CPPS, therefore their values should be carefully interpreted, specially using the assessment of the MCID. </p> <p>Furthermore, most studies reported results at four to 12 weeks' follow‐up, which might be insufficient considering that men with CP/CPPS generally have a long history of symptoms, usually for years (<a href="./references#CD012551-bbs2-0128" title="ClemensJQ , ClauwDJ , KrederK , KriegerJN , KusekJW , LaiHH , et al. Comparison of baseline urological symptoms in men and women in the MAPP research cohort. Journal of Urology2015;193(5):1554‐8. [PUBMED: 25463989] ">Clemens 2015</a>). </p> <p>We had planned to explore the effect of the interventions in subgroups of men with different degrees of disease severity and in subgroups of men with common comorbidities (<a href="./references#CD012551-bbs2-0136" title="GasperiM , KriegerJN , ForsbergC , GoldbergJ , BuchwaldD , AfariN . Chronic prostatitis and comorbid non‐urological overlapping pain conditions: a co‐twin control study. Journal of Psychosomatic Research2017;102:29‐33. [PUBMED: 28992894] ">Gasperi 2017</a>), but the included studies provided insufficient data in this regard. </p> <p>Some of the included treatments for the main comparisons expressed in the 'Summary of findings' table have not been part of routine care for CP/CPPS, especially circumcision (<a href="./full#CD012551-tbl-0003">summary of findings Table 3</a>) and the electromagnetic chair (<a href="./full#CD012551-tbl-0004">summary of findings Table 4</a>). For this statement, we used, as an example, the recommendations by the European Association of Urology, available at <a href="http://uroweb.org/guideline/chronic-pelvic-pain/" target="_blank">uroweb.org/guideline/chronic‐pelvic‐pain/</a> (last accessed December 2017). As the guideline authors stated, careful considerations should be placed when considering the applicability of these interventions in daily practice. The evidence for the electromagnetic chair is inconsistent for the main outcomes (very low‐quality evidence). For circumcision, the effect size was small for the main outcomes (moderate‐quality evidence). Furthermore, circumcision is the only intervention included in this review that entails an irreversible surgical procedure. As the Evidence to Decision Framework stated, a careful evaluation of patient's values and preferences, resource use and equity issues and the acceptability and feasibility of the interventions is warranted when drafting recommendations (<a href="./references#CD012551-bbs2-0117" title="Alonso‐CoelloP , SchünemannHJ , MobergJ , Brignardello‐PetersenR , AklEA , DavoliM , et al. GRADE Evidence to Decision (EtD) frameworks: a systematic and transparent approach to making well informed healthcare choices. 1: Introduction. BMJ (Clinical Research Ed.)2016;353:i2016. [PUBMED: 27353417] ">Alonso‐Coello 2016</a>). </p> </section> <section id="CD012551-sec-0281"> <h3 class="title" id="CD012551-sec-0281">Quality of the evidence</h3> <p>The main limitations of the body of evidence were the following.</p> <p> <ul id="CD012551-list-0028"> <li> <p>Study limitations: most studies had problems when masking the interventions to study personnel and participants. This is particularly important for this review considering that all the predefined outcomes were subjective participant‐reported outcomes. Additionally, most studies poorly reported random sequence generation and allocation concealment and most of the studies had no published protocol or analysis plan to assess the risk of selective reporting. For the comparison of ESWT, we decided not to downgrade due to study limitations since the results from studies with high risk of bias were consistent with those with low/unclear risk of bias. </p> </li> <li> <p>Inconsistency: we performed few meta‐analyses and, in many cases, we found considerable heterogeneity; only in one case we found that the inconsistency was explained to a difference in the criteria for disease definition. </p> </li> <li> <p>Imprecision: we estimated an optimal information size of 74 for the primary outcome 'prostatitis symptoms' and 50% of the studies had a smaller sample size; therefore, most studies had imprecision. Nevertheless, in some cases, meta‐analysis of some of the included studies increased the number of participants for each comparison, overcoming this limitation. This was more difficult to do for the outcome 'adverse events' in which the small number of events (in some cases there was a "zero count") resulted in considerable imprecision. </p> </li> <li> <p>Publication bias: due to the small number of studies in each comparison, we could not assess the risk of publication bias. </p> </li> </ul> </p> </section> <section id="CD012551-sec-0282"> <h3 class="title" id="CD012551-sec-0282">Potential biases in the review process</h3> <p>We strictly followed our published protocol to reduce the risk of bias in the conduct of this review. Nevertheless, we had to make further specifications due to the multiplicity of comparisons and available outcomes to review. These specifications did not imply major changes and they were done to provide clarity when summarising multiple comparisons (see <a href="#CD012551-sec-0303">Differences between protocol and review</a>), especially when drafting the 'Summary of findings' tables. We acknowledge that we might have made 'Summary of findings' tables of each comparison, but this would not have provided further clarity to the understanding of the findings. We also highlight that even though there were no 'Summary of findings' tables for some comparisons, all the findings were rated using GRADE methods. </p> <p>We performed a comprehensive search in multiple databases, trial registries and other sources to reduce the risk of meta‐bias in our review. Additionally, we did not restrict the searches or inclusion of studies on the basis of language of publication; for this purpose, we incorporated three authors with expertise in Chinese, Russian and Korean. Nevertheless, we were unable to retrieve some of the studies on acupuncture published in some Chinese journals that were included in other reviews that searched Chinese Databases (see <a href="#CD012551-sec-0283">Agreements and disagreements with other studies or reviews</a>). Should we find the report of these studies, they will be evaluated for inclusion in updates of this review, since we have no clear information regarding their eligibility. Nevertheless, the reported results of these studies in the corresponding reviews were consistent with our findings. </p> <p>We contacted study authors on multiple occasions with a variable rate of response. However, we acknowledge that many of the ratings of 'unclear' risk of bias were due to limitations in the report of the studies, rather than a true risk of bias in the conduct of these trials. </p> <p>We deleted the 'Clinical Phenotyping' item as an intervention in our review, as suggested by a peer reviewer. We acknowledge that this strategy might not constitute in itself an intervention. However, this change has not affected the results of this review since we found no trials on this subject. We also modified the presentation of some of the methods of this review (assessment of outcomes and GRADE methods), but this did not affect the results of the review either (see <a href="#CD012551-sec-0303">Differences between protocol and review</a>). </p> </section> <section id="CD012551-sec-0283"> <h3 class="title" id="CD012551-sec-0283">Agreements and disagreements with other studies or reviews</h3> <p>We found several systematic reviews addressing interventions for CP/CPPS; however, only a few of them incorporated non‐pharmacological interventions. </p> <p>A systematic review by <a href="./references#CD012551-bbs2-0053" title="EricksonBA , SchaefferAJ , VanLeB . Chronic prostatitis. BMJ Clinical Evidence2008;2008:1802. ">Erickson 2008</a> and its update by <a href="./references#CD012551-bbs2-0067" title="LeB , SchaefferAJ . Chronic prostatitis. BMJ Clinical Evidence2011;2011:1802. ">Le 2011</a> included some of the studies for non‐pharmacological interventions for CP/CPPS. These reviews indicated that there was no evidence for the use of biofeedback; however, in our review, we included a clinical trial assessing this intervention. These reviews also included some of the evidence for transurethral thermotherapy and prostatic massage with similar results to ours. </p> <p>Two systematic reviews included both pharmacological and non‐pharmacological interventions (<a href="./references#CD012551-bbs2-0078" title="McNaughton CollinsM , MacDonaldR , WiltTJ . Diagnosis and treatment of chronic abacterial prostatitis: a systematic review. Annals of Internal Medicine2000;133(5):367‐81. ">McNaughton 2000</a>; <a href="./references#CD012551-bbs2-0079" title="McNaughton CollinsM , MacDonaldR , WiltTJ . Interventions for chronic abacterial prostatitis. Cochrane Database of Systematic Reviews2001, Issue 1. [DOI: 10.1002/14651858.CD002080] ">McNaughton 2001</a>). We included two studies from these reviews that were not retrieved by our search strategy (<a href="./references#CD012551-bbs2-0027" title="ShahT , WatsonG , BarnesD . Microwave hyperthermia in the treatment of chronic abacterial prostatitis and prostatodynia: results of a double blind placebo controlled trial (Abstract). Journal of Urology1993;149:405A. ">Shah 1993</a>; <a href="./references#CD012551-bbs2-0031" title="VassilyO , AndreyS , EvgeniiD , OtabekI , BorisL , SergeyR . Efficacy of transrectal microwave hyperthemia (TRMH) in the treatment of chronic prostatitis. A randomized sham controlled comparative study (Abstract). Journal of Urology1999;161(4 Suppl):33A. ">Vassily 1999</a>); however, we did not include one study on transrectal thermotherapy since the participants in this study did not meet the CP/CPPS criteria (<a href="./references#CD012551-bbs2-0191" title="StrohmaierW , BichlerK , KieferM , LevA . Microwave hyperthermia in chronic prostatitis and prostatodynia ‐ preliminary results [Mikrowellenhyperthermie bei chronischer Prostatitis undProstatodynie ‐ vorlaufige Ergebnisse]. Helvetica Chirurgica Acta1988;55:301‐3. ">Strohmaier 1988</a>). </p> <p>The systematic reviews by <a href="./references#CD012551-bbs2-0050" title="CohenJM , FaginAP , HaritonE , NiskaJR , PierceMW , KuriyamaA , et al. Therapeutic intervention for chronic prostatitis/chronic pelvic pain syndrome (CP/CPPS): a systematic review and meta‐analysis. PloS One2012;7(8):e41941. ">Cohen 2012</a>; <a href="./references#CD012551-bbs2-0097" title="QinZ , WuJ , TianJ , ZhouJ , LiuY , LiuZ . Network meta‐analysis of the efficacy of acupuncture, alpha‐blockers and antibiotics on chronic prostatitis/chronic pelvic pain syndrome. Scientific Reports2016;6:35737. ">Qin 2016b</a>; and <a href="./references#CD012551-bbs2-0076" title="MagistroG , WagenlehnerFM , GrabeM , WeidnerW , StiefCG , NickelJC . Contemporary management of chronic prostatitis/chronic pelvic pain syndrome. European Urology2016;69(2):286‐97. ">Magistro 2016</a> included both pharmacological and non‐pharmacological interventions. They included some of the studies in this review addressing the effects of sono‐electromagnetic therapy, ESWT, acupuncture, aerobic exercise and tibial nerve stimulation, with the same results. </p> <p>The systematic review by <a href="./references#CD012551-bbs2-0081" title="MishraVC , BrowneJ , EmbertonM . Role of repeated prostatic massage in chronic prostatitis: a systematic review of the literature. Urology2008;72(4):731‐5. ">Mishra 2008</a> focused only on prostatic massage and incorporated one of the trials in our review in addition to several case series. </p> <p>The systematic review by <a href="./references#CD012551-bbs2-0047" title="ChangSC , HsuCH , HsuCK , YangSS , ChangSJ . The efficacy of acupuncture in managing patients with chronic prostatitis/chronic pelvic pain syndrome: a systemic review and meta‐analysis. Neurourology and Urodynamics2016;1:474‐81. ">Chang 2016</a> addressing acupuncture for CP/CPPS incorporated three additional studies from Chinese journals and failed to include one of the trials in our review since the review searched Chinese databases. One of these additional included studies was excluded in our review since it used a quasi‐randomised allocation (<a href="./references#CD012551-bbs2-0075" title="MaY , LiX , LiF , YuW , WangZ . Clinical research of chronic pelvic cavity pain syndrome treated with acupoint catgut embedding therapy. Zhongguo Zhen Jiu2015;35(6):561‐6. MaY , WangZL , SunZX , MenB , ShenBQ . Efficacy observation on chronic pelvic pain syndrome of damp‐heat stagnation pattern treated with acupoint catgut embedding therapy. Zhongguo Zhen Jiu2014;34(4):351‐4. ">Ma 2015</a>). We asked the study authors for the remaining two studies. Nevertheless, the two meta‐analyses reported by this review yielded similar results in terms of reduction of prostatitis symptoms (NIH‐CPSI scores) and an increased response rate with acupuncture in comparison to sham procedures or medical therapy, with a similar incidence of adverse events. Another systematic review by <a href="./references#CD012551-bbs2-0071" title="LiuBP , WangYT , ChenSD . Effect of acupuncture on clinical symptoms and laboratory indicators for chronic prostatitis/chronic pelvic pain syndrome: a systematic review and meta‐analysis. International Urology and Nephrology2016;48(12):1977‐91. ">Liu 2016</a> also focusing on acupuncture for CP/CPPS incorporated four additional studies from Chinese journals (different from those found by <a href="./references#CD012551-bbs2-0047" title="ChangSC , HsuCH , HsuCK , YangSS , ChangSJ . The efficacy of acupuncture in managing patients with chronic prostatitis/chronic pelvic pain syndrome: a systemic review and meta‐analysis. Neurourology and Urodynamics2016;1:474‐81. ">Chang 2016</a>) and failed to include one of the trials in our review. One of these additional included studies was also <a href="./references#CD012551-bbs2-0075" title="MaY , LiX , LiF , YuW , WangZ . Clinical research of chronic pelvic cavity pain syndrome treated with acupoint catgut embedding therapy. Zhongguo Zhen Jiu2015;35(6):561‐6. MaY , WangZL , SunZX , MenB , ShenBQ . Efficacy observation on chronic pelvic pain syndrome of damp‐heat stagnation pattern treated with acupoint catgut embedding therapy. Zhongguo Zhen Jiu2014;34(4):351‐4. ">Ma 2015</a>. We asked the study authors for the remaining three studies. Nevertheless, the two meta‐analysis reported by this review yielded similar results in terms of reduction of prostatitis symptoms (NIH‐CPSI scores) and an increased response rate with acupuncture in comparison to sham procedures or medical therapy, with a similar incidence of adverse events. Furthermore, a systematic review by <a href="./references#CD012551-bbs2-0096" title="QinZ , WuJ , ZhouJ , LiuZ . Systematic review of acupuncture for chronic prostatitis/chronic pelvic pain syndrome. Medicine (Baltimore)2016;95(11):e3095. ">Qin 2016a</a> included three additional trials (one of them not identified in the previous review); however, the reported meta‐analysis yielded similar results in terms of reduction of prostatitis symptoms (NIH‐CPSI scores). We asked the study authors for the remaining studies. Finally, a review by <a href="./references#CD012551-bbs2-0094" title="PosadzkiP , ZhangJ , LeeM S , ErnstE . Acupuncture for chronic nonbacterial prostatitis/chronic pelvic pain syndrome: a systematic review. Journal of Andrology2012;33(1):15‐21. ">Posadzki 2012</a> on acupuncture for CP/CPPS included six additional studies (different from those found in <a href="./references#CD012551-bbs2-0047" title="ChangSC , HsuCH , HsuCK , YangSS , ChangSJ . The efficacy of acupuncture in managing patients with chronic prostatitis/chronic pelvic pain syndrome: a systemic review and meta‐analysis. Neurourology and Urodynamics2016;1:474‐81. ">Chang 2016</a>; <a href="./references#CD012551-bbs2-0071" title="LiuBP , WangYT , ChenSD . Effect of acupuncture on clinical symptoms and laboratory indicators for chronic prostatitis/chronic pelvic pain syndrome: a systematic review and meta‐analysis. International Urology and Nephrology2016;48(12):1977‐91. ">Liu 2016</a>; and <a href="./references#CD012551-bbs2-0096" title="QinZ , WuJ , ZhouJ , LiuZ . Systematic review of acupuncture for chronic prostatitis/chronic pelvic pain syndrome. Medicine (Baltimore)2016;95(11):e3095. ">Qin 2016a</a>). We asked the study authors for the remaining studies. Nevertheless, the meta‐analysis reported by this review yielded similar results in terms of an increased response rate with acupuncture in comparison to sham procedures or medical therapy, with a similar incidence of adverse events (this review also highlighted the poor reporting of adverse events in the literature). </p> </section> </section> </section> <div class="figures-list"> <div class="figure" id="CD012551-fig-0001"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD012551.pub3/media/CDSR/CD012551/urn:x-wiley:14651858:media:CD012551:CD012551-AFig-FIG01" target="_blank"><b></b></a></p> </div> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD012551.pub3/media/CDSR/CD012551/image_t/tCD012551-AFig-FIG01.png" target="_blank"><b></b></a></p> </div><img alt="Study flow diagram." data-id="CD012551-fig-0001" src="/cdsr/doi/10.1002/14651858.CD012551.pub3/media/CDSR/CD012551/image_n/nCD012551-AFig-FIG01.png"/> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Figure 1</div> <div class="figure-caption"> <p>Study flow diagram.</p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD012551.pub3/full#CD012551-fig-0001">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD012551.pub3/media/CDSR/CD012551/image_n/nCD012551-AFig-FIG01.png" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD012551-fig-0002"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD012551.pub3/media/CDSR/CD012551/urn:x-wiley:14651858:media:CD012551:CD012551-AFig-FIG02" target="_blank"><b></b></a></p> </div> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD012551.pub3/media/CDSR/CD012551/image_t/tCD012551-AFig-FIG02.png" target="_blank"><b></b></a></p> </div><img alt="Risk of bias graph: review authors' judgements about each risk of bias item presented as percentages across all included studies." data-id="CD012551-fig-0002" src="/cdsr/doi/10.1002/14651858.CD012551.pub3/media/CDSR/CD012551/image_n/nCD012551-AFig-FIG02.png"/> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Figure 2</div> <div class="figure-caption"> <p>Risk of bias graph: review authors' judgements about each risk of bias item presented as percentages across all included studies. </p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD012551.pub3/full#CD012551-fig-0002">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD012551.pub3/media/CDSR/CD012551/image_n/nCD012551-AFig-FIG02.png" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD012551-fig-0003"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD012551.pub3/media/CDSR/CD012551/urn:x-wiley:14651858:media:CD012551:CD012551-AFig-FIG03" target="_blank"><b></b></a></p> </div> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD012551.pub3/media/CDSR/CD012551/image_t/tCD012551-AFig-FIG03.png" target="_blank"><b></b></a></p> </div><img alt="Risk of bias summary: review authors' judgements about each risk of bias item for each study." data-id="CD012551-fig-0003" src="/cdsr/doi/10.1002/14651858.CD012551.pub3/media/CDSR/CD012551/image_n/nCD012551-AFig-FIG03.png"/> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Figure 3</div> <div class="figure-caption"> <p>Risk of bias summary: review authors' judgements about each risk of bias item for each study. </p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD012551.pub3/full#CD012551-fig-0003">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD012551.pub3/media/CDSR/CD012551/image_n/nCD012551-AFig-FIG03.png" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD012551-fig-0004"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD012551.pub3/media/CDSR/CD012551/urn:x-wiley:14651858:media:CD012551:CD012551-AFig-FIG04" target="_blank"><b></b></a></p> </div> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD012551.pub3/media/CDSR/CD012551/image_t/tCD012551-AFig-FIG04.png" target="_blank"><b></b></a></p> </div><img alt="Forest plot of comparison: 22 Acupuncture treatments versus medical treatment. Sensitivity analysis, outcome: 22.1 Prostatitis symptoms (NIH‐CPSI total)." data-id="CD012551-fig-0004" src="/cdsr/doi/10.1002/14651858.CD012551.pub3/media/CDSR/CD012551/image_n/nCD012551-AFig-FIG04.png"/> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Figure 4</div> <div class="figure-caption"> <p>Forest plot of comparison: 22 Acupuncture treatments versus medical treatment. Sensitivity analysis, outcome: 22.1 Prostatitis symptoms (NIH‐CPSI total). </p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD012551.pub3/full#CD012551-fig-0004">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD012551.pub3/media/CDSR/CD012551/image_n/nCD012551-AFig-FIG04.png" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD012551-fig-0005"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD012551.pub3/media/CDSR/CD012551/urn:x-wiley:14651858:media:CD012551:CD012551-CMP-001-01" target="_blank"><b></b></a></p> </div> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD012551.pub3/media/CDSR/CD012551/image_t/tCD012551-CMP-001-01.xxx" target="_blank"><b></b></a></p> </div><img alt="Comparison 1 Acupuncture versus sham procedure, Outcome 1 Prostatitis symptoms (NIH‐CPSI total)." data-id="CD012551-fig-0005" src="/cdsr/doi/10.1002/14651858.CD012551.pub3/media/CDSR/CD012551/image_n/nCD012551-CMP-001-01.png"/> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 1.1</div> <div class="figure-caption"> <p>Comparison 1 Acupuncture versus sham procedure, Outcome 1 Prostatitis symptoms (NIH‐CPSI total). </p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD012551.pub3/references#CD012551-fig-0005">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD012551.pub3/media/CDSR/CD012551/image_n/nCD012551-CMP-001-01.png" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD012551-fig-0006"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD012551.pub3/media/CDSR/CD012551/urn:x-wiley:14651858:media:CD012551:CD012551-CMP-001-02" target="_blank"><b></b></a></p> </div> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD012551.pub3/media/CDSR/CD012551/image_t/tCD012551-CMP-001-02.xxx" target="_blank"><b></b></a></p> </div><img alt="Comparison 1 Acupuncture versus sham procedure, Outcome 2 Prostatitis symptoms: pain subscore." data-id="CD012551-fig-0006" src="/cdsr/doi/10.1002/14651858.CD012551.pub3/media/CDSR/CD012551/image_n/nCD012551-CMP-001-02.png"/> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 1.2</div> <div class="figure-caption"> <p>Comparison 1 Acupuncture versus sham procedure, Outcome 2 Prostatitis symptoms: pain subscore. </p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD012551.pub3/references#CD012551-fig-0006">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD012551.pub3/media/CDSR/CD012551/image_n/nCD012551-CMP-001-02.png" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD012551-fig-0007"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD012551.pub3/media/CDSR/CD012551/urn:x-wiley:14651858:media:CD012551:CD012551-CMP-001-03" target="_blank"><b></b></a></p> </div> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD012551.pub3/media/CDSR/CD012551/image_t/tCD012551-CMP-001-03.xxx" target="_blank"><b></b></a></p> </div><img alt="Comparison 1 Acupuncture versus sham procedure, Outcome 3 Prostatitis symptoms: micturition subscore." data-id="CD012551-fig-0007" src="/cdsr/doi/10.1002/14651858.CD012551.pub3/media/CDSR/CD012551/image_n/nCD012551-CMP-001-03.png"/> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 1.3</div> <div class="figure-caption"> <p>Comparison 1 Acupuncture versus sham procedure, Outcome 3 Prostatitis symptoms: micturition subscore. </p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD012551.pub3/references#CD012551-fig-0007">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD012551.pub3/media/CDSR/CD012551/image_n/nCD012551-CMP-001-03.png" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD012551-fig-0008"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD012551.pub3/media/CDSR/CD012551/urn:x-wiley:14651858:media:CD012551:CD012551-CMP-001-04" target="_blank"><b></b></a></p> </div> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD012551.pub3/media/CDSR/CD012551/image_t/tCD012551-CMP-001-04.xxx" target="_blank"><b></b></a></p> </div><img alt="Comparison 1 Acupuncture versus sham procedure, Outcome 4 Prostatitis symptoms: quality of life subscore." data-id="CD012551-fig-0008" src="/cdsr/doi/10.1002/14651858.CD012551.pub3/media/CDSR/CD012551/image_n/nCD012551-CMP-001-04.png"/> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 1.4</div> <div class="figure-caption"> <p>Comparison 1 Acupuncture versus sham procedure, Outcome 4 Prostatitis symptoms: quality of life subscore. </p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD012551.pub3/references#CD012551-fig-0008">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD012551.pub3/media/CDSR/CD012551/image_n/nCD012551-CMP-001-04.png" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD012551-fig-0009"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD012551.pub3/media/CDSR/CD012551/urn:x-wiley:14651858:media:CD012551:CD012551-CMP-001-05" target="_blank"><b></b></a></p> </div> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD012551.pub3/media/CDSR/CD012551/image_t/tCD012551-CMP-001-05.xxx" target="_blank"><b></b></a></p> </div><img alt="Comparison 1 Acupuncture versus sham procedure, Outcome 5 Prostatitis symptoms." data-id="CD012551-fig-0009" src="/cdsr/doi/10.1002/14651858.CD012551.pub3/media/CDSR/CD012551/image_n/nCD012551-CMP-001-05.png"/> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 1.5</div> <div class="figure-caption"> <p>Comparison 1 Acupuncture versus sham procedure, Outcome 5 Prostatitis symptoms.</p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD012551.pub3/references#CD012551-fig-0009">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD012551.pub3/media/CDSR/CD012551/image_n/nCD012551-CMP-001-05.png" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD012551-fig-0010"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD012551.pub3/media/CDSR/CD012551/urn:x-wiley:14651858:media:CD012551:CD012551-CMP-001-06" target="_blank"><b></b></a></p> </div> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD012551.pub3/media/CDSR/CD012551/image_t/tCD012551-CMP-001-06.xxx" target="_blank"><b></b></a></p> </div><img alt="Comparison 1 Acupuncture versus sham procedure, Outcome 6 Prostatitis symptoms (NIH‐CPSI total) ‐ medium term." data-id="CD012551-fig-0010" src="/cdsr/doi/10.1002/14651858.CD012551.pub3/media/CDSR/CD012551/image_n/nCD012551-CMP-001-06.png"/> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 1.6</div> <div class="figure-caption"> <p>Comparison 1 Acupuncture versus sham procedure, Outcome 6 Prostatitis symptoms (NIH‐CPSI total) ‐ medium term. </p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD012551.pub3/references#CD012551-fig-0010">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD012551.pub3/media/CDSR/CD012551/image_n/nCD012551-CMP-001-06.png" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD012551-fig-0011"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD012551.pub3/media/CDSR/CD012551/urn:x-wiley:14651858:media:CD012551:CD012551-CMP-001-07" target="_blank"><b></b></a></p> </div> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD012551.pub3/media/CDSR/CD012551/image_t/tCD012551-CMP-001-07.xxx" target="_blank"><b></b></a></p> </div><img alt="Comparison 1 Acupuncture versus sham procedure, Outcome 7 Prostatitis symptoms: pain subscore ‐ medium term." data-id="CD012551-fig-0011" src="/cdsr/doi/10.1002/14651858.CD012551.pub3/media/CDSR/CD012551/image_n/nCD012551-CMP-001-07.png"/> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 1.7</div> <div class="figure-caption"> <p>Comparison 1 Acupuncture versus sham procedure, Outcome 7 Prostatitis symptoms: pain subscore ‐ medium term. </p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD012551.pub3/references#CD012551-fig-0011">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD012551.pub3/media/CDSR/CD012551/image_n/nCD012551-CMP-001-07.png" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD012551-fig-0012"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD012551.pub3/media/CDSR/CD012551/urn:x-wiley:14651858:media:CD012551:CD012551-CMP-001-08" target="_blank"><b></b></a></p> </div> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD012551.pub3/media/CDSR/CD012551/image_t/tCD012551-CMP-001-08.xxx" target="_blank"><b></b></a></p> </div><img alt="Comparison 1 Acupuncture versus sham procedure, Outcome 8 Prostatitis symptoms: micturition subscore ‐ medium term." data-id="CD012551-fig-0012" src="/cdsr/doi/10.1002/14651858.CD012551.pub3/media/CDSR/CD012551/image_n/nCD012551-CMP-001-08.png"/> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 1.8</div> <div class="figure-caption"> <p>Comparison 1 Acupuncture versus sham procedure, Outcome 8 Prostatitis symptoms: micturition subscore ‐ medium term. </p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD012551.pub3/references#CD012551-fig-0012">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD012551.pub3/media/CDSR/CD012551/image_n/nCD012551-CMP-001-08.png" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD012551-fig-0013"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD012551.pub3/media/CDSR/CD012551/urn:x-wiley:14651858:media:CD012551:CD012551-CMP-001-09" target="_blank"><b></b></a></p> </div> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD012551.pub3/media/CDSR/CD012551/image_t/tCD012551-CMP-001-09.xxx" target="_blank"><b></b></a></p> </div><img alt="Comparison 1 Acupuncture versus sham procedure, Outcome 9 Prostatitis symptoms: quality of life subscore ‐ medium term." data-id="CD012551-fig-0013" src="/cdsr/doi/10.1002/14651858.CD012551.pub3/media/CDSR/CD012551/image_n/nCD012551-CMP-001-09.png"/> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 1.9</div> <div class="figure-caption"> <p>Comparison 1 Acupuncture versus sham procedure, Outcome 9 Prostatitis symptoms: quality of life subscore ‐ medium term. </p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD012551.pub3/references#CD012551-fig-0013">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD012551.pub3/media/CDSR/CD012551/image_n/nCD012551-CMP-001-09.png" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD012551-fig-0014"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD012551.pub3/media/CDSR/CD012551/urn:x-wiley:14651858:media:CD012551:CD012551-CMP-001-10" target="_blank"><b></b></a></p> </div> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD012551.pub3/media/CDSR/CD012551/image_t/tCD012551-CMP-001-10.xxx" target="_blank"><b></b></a></p> </div><img alt="Comparison 1 Acupuncture versus sham procedure, Outcome 10 Adverse events." data-id="CD012551-fig-0014" src="/cdsr/doi/10.1002/14651858.CD012551.pub3/media/CDSR/CD012551/image_n/nCD012551-CMP-001-10.png"/> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 1.10</div> <div class="figure-caption"> <p>Comparison 1 Acupuncture versus sham procedure, Outcome 10 Adverse events.</p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD012551.pub3/references#CD012551-fig-0014">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD012551.pub3/media/CDSR/CD012551/image_n/nCD012551-CMP-001-10.png" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD012551-fig-0015"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD012551.pub3/media/CDSR/CD012551/urn:x-wiley:14651858:media:CD012551:CD012551-CMP-001-11" target="_blank"><b></b></a></p> </div> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD012551.pub3/media/CDSR/CD012551/image_t/tCD012551-CMP-001-11.xxx" target="_blank"><b></b></a></p> </div><img alt="Comparison 1 Acupuncture versus sham procedure, Outcome 11 Sexual dysfunction." data-id="CD012551-fig-0015" src="/cdsr/doi/10.1002/14651858.CD012551.pub3/media/CDSR/CD012551/image_n/nCD012551-CMP-001-11.png"/> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 1.11</div> <div class="figure-caption"> <p>Comparison 1 Acupuncture versus sham procedure, Outcome 11 Sexual dysfunction.</p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD012551.pub3/references#CD012551-fig-0015">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD012551.pub3/media/CDSR/CD012551/image_n/nCD012551-CMP-001-11.png" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD012551-fig-0016"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD012551.pub3/media/CDSR/CD012551/urn:x-wiley:14651858:media:CD012551:CD012551-CMP-001-12" target="_blank"><b></b></a></p> </div> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD012551.pub3/media/CDSR/CD012551/image_t/tCD012551-CMP-001-12.xxx" target="_blank"><b></b></a></p> </div><img alt="Comparison 1 Acupuncture versus sham procedure, Outcome 12 Urinary symptoms." data-id="CD012551-fig-0016" src="/cdsr/doi/10.1002/14651858.CD012551.pub3/media/CDSR/CD012551/image_n/nCD012551-CMP-001-12.png"/> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 1.12</div> <div class="figure-caption"> <p>Comparison 1 Acupuncture versus sham procedure, Outcome 12 Urinary symptoms.</p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD012551.pub3/references#CD012551-fig-0016">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD012551.pub3/media/CDSR/CD012551/image_n/nCD012551-CMP-001-12.png" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD012551-fig-0017"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD012551.pub3/media/CDSR/CD012551/urn:x-wiley:14651858:media:CD012551:CD012551-CMP-002-01" target="_blank"><b></b></a></p> </div> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD012551.pub3/media/CDSR/CD012551/image_t/tCD012551-CMP-002-01.xxx" target="_blank"><b></b></a></p> </div><img alt="Comparison 2 Acupuncture treatments versus medical treatment, Outcome 1 Prostatitis symptoms (NIH‐CPSI total)." data-id="CD012551-fig-0017" src="/cdsr/doi/10.1002/14651858.CD012551.pub3/media/CDSR/CD012551/image_n/nCD012551-CMP-002-01.png"/> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 2.1</div> <div class="figure-caption"> <p>Comparison 2 Acupuncture treatments versus medical treatment, Outcome 1 Prostatitis symptoms (NIH‐CPSI total). </p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD012551.pub3/references#CD012551-fig-0017">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD012551.pub3/media/CDSR/CD012551/image_n/nCD012551-CMP-002-01.png" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD012551-fig-0018"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD012551.pub3/media/CDSR/CD012551/urn:x-wiley:14651858:media:CD012551:CD012551-CMP-002-02" target="_blank"><b></b></a></p> </div> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD012551.pub3/media/CDSR/CD012551/image_t/tCD012551-CMP-002-02.xxx" target="_blank"><b></b></a></p> </div><img alt="Comparison 2 Acupuncture treatments versus medical treatment, Outcome 2 Prostatitis symptoms: pain subscore." data-id="CD012551-fig-0018" src="/cdsr/doi/10.1002/14651858.CD012551.pub3/media/CDSR/CD012551/image_n/nCD012551-CMP-002-02.png"/> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 2.2</div> <div class="figure-caption"> <p>Comparison 2 Acupuncture treatments versus medical treatment, Outcome 2 Prostatitis symptoms: pain subscore. </p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD012551.pub3/references#CD012551-fig-0018">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD012551.pub3/media/CDSR/CD012551/image_n/nCD012551-CMP-002-02.png" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD012551-fig-0019"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD012551.pub3/media/CDSR/CD012551/urn:x-wiley:14651858:media:CD012551:CD012551-CMP-002-03" target="_blank"><b></b></a></p> </div> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD012551.pub3/media/CDSR/CD012551/image_t/tCD012551-CMP-002-03.xxx" target="_blank"><b></b></a></p> </div><img alt="Comparison 2 Acupuncture treatments versus medical treatment, Outcome 3 Prostatitis symptoms: micturition subscore." data-id="CD012551-fig-0019" src="/cdsr/doi/10.1002/14651858.CD012551.pub3/media/CDSR/CD012551/image_n/nCD012551-CMP-002-03.png"/> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 2.3</div> <div class="figure-caption"> <p>Comparison 2 Acupuncture treatments versus medical treatment, Outcome 3 Prostatitis symptoms: micturition subscore. </p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD012551.pub3/references#CD012551-fig-0019">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD012551.pub3/media/CDSR/CD012551/image_n/nCD012551-CMP-002-03.png" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD012551-fig-0020"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD012551.pub3/media/CDSR/CD012551/urn:x-wiley:14651858:media:CD012551:CD012551-CMP-002-04" target="_blank"><b></b></a></p> </div> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD012551.pub3/media/CDSR/CD012551/image_t/tCD012551-CMP-002-04.xxx" target="_blank"><b></b></a></p> </div><img alt="Comparison 2 Acupuncture treatments versus medical treatment, Outcome 4 Prostatitis symptoms: quality of life subscore." data-id="CD012551-fig-0020" src="/cdsr/doi/10.1002/14651858.CD012551.pub3/media/CDSR/CD012551/image_n/nCD012551-CMP-002-04.png"/> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 2.4</div> <div class="figure-caption"> <p>Comparison 2 Acupuncture treatments versus medical treatment, Outcome 4 Prostatitis symptoms: quality of life subscore. </p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD012551.pub3/references#CD012551-fig-0020">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD012551.pub3/media/CDSR/CD012551/image_n/nCD012551-CMP-002-04.png" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD012551-fig-0021"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD012551.pub3/media/CDSR/CD012551/urn:x-wiley:14651858:media:CD012551:CD012551-CMP-002-05" target="_blank"><b></b></a></p> </div> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD012551.pub3/media/CDSR/CD012551/image_t/tCD012551-CMP-002-05.xxx" target="_blank"><b></b></a></p> </div><img alt="Comparison 2 Acupuncture treatments versus medical treatment, Outcome 5 Prostatitis symptoms." data-id="CD012551-fig-0021" src="/cdsr/doi/10.1002/14651858.CD012551.pub3/media/CDSR/CD012551/image_n/nCD012551-CMP-002-05.png"/> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 2.5</div> <div class="figure-caption"> <p>Comparison 2 Acupuncture treatments versus medical treatment, Outcome 5 Prostatitis symptoms. </p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD012551.pub3/references#CD012551-fig-0021">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD012551.pub3/media/CDSR/CD012551/image_n/nCD012551-CMP-002-05.png" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD012551-fig-0022"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD012551.pub3/media/CDSR/CD012551/urn:x-wiley:14651858:media:CD012551:CD012551-CMP-002-06" target="_blank"><b></b></a></p> </div> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD012551.pub3/media/CDSR/CD012551/image_t/tCD012551-CMP-002-06.xxx" target="_blank"><b></b></a></p> </div><img alt="Comparison 2 Acupuncture treatments versus medical treatment, Outcome 6 Adverse events." data-id="CD012551-fig-0022" src="/cdsr/doi/10.1002/14651858.CD012551.pub3/media/CDSR/CD012551/image_n/nCD012551-CMP-002-06.png"/> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 2.6</div> <div class="figure-caption"> <p>Comparison 2 Acupuncture treatments versus medical treatment, Outcome 6 Adverse events.</p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD012551.pub3/references#CD012551-fig-0022">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD012551.pub3/media/CDSR/CD012551/image_n/nCD012551-CMP-002-06.png" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD012551-fig-0023"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD012551.pub3/media/CDSR/CD012551/urn:x-wiley:14651858:media:CD012551:CD012551-CMP-002-07" target="_blank"><b></b></a></p> </div> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD012551.pub3/media/CDSR/CD012551/image_t/tCD012551-CMP-002-07.xxx" target="_blank"><b></b></a></p> </div><img alt="Comparison 2 Acupuncture treatments versus medical treatment, Outcome 7 Urinary symptoms." data-id="CD012551-fig-0023" src="/cdsr/doi/10.1002/14651858.CD012551.pub3/media/CDSR/CD012551/image_n/nCD012551-CMP-002-07.png"/> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 2.7</div> <div class="figure-caption"> <p>Comparison 2 Acupuncture treatments versus medical treatment, Outcome 7 Urinary symptoms.</p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD012551.pub3/references#CD012551-fig-0023">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD012551.pub3/media/CDSR/CD012551/image_n/nCD012551-CMP-002-07.png" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD012551-fig-0024"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD012551.pub3/media/CDSR/CD012551/urn:x-wiley:14651858:media:CD012551:CD012551-CMP-003-01" target="_blank"><b></b></a></p> </div> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD012551.pub3/media/CDSR/CD012551/image_t/tCD012551-CMP-003-01.xxx" target="_blank"><b></b></a></p> </div><img alt="Comparison 3 Acupuncture with or without moxibustion, Outcome 1 Prostatitis symptoms (NIH‐CPSI total)." data-id="CD012551-fig-0024" src="/cdsr/doi/10.1002/14651858.CD012551.pub3/media/CDSR/CD012551/image_n/nCD012551-CMP-003-01.png"/> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 3.1</div> <div class="figure-caption"> <p>Comparison 3 Acupuncture with or without moxibustion, Outcome 1 Prostatitis symptoms (NIH‐CPSI total). </p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD012551.pub3/references#CD012551-fig-0024">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD012551.pub3/media/CDSR/CD012551/image_n/nCD012551-CMP-003-01.png" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD012551-fig-0025"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD012551.pub3/media/CDSR/CD012551/urn:x-wiley:14651858:media:CD012551:CD012551-CMP-004-01" target="_blank"><b></b></a></p> </div> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD012551.pub3/media/CDSR/CD012551/image_t/tCD012551-CMP-004-01.xxx" target="_blank"><b></b></a></p> </div><img alt="Comparison 4 Circumcision versus waiting list, Outcome 1 Prostatitis symptoms." data-id="CD012551-fig-0025" src="/cdsr/doi/10.1002/14651858.CD012551.pub3/media/CDSR/CD012551/image_n/nCD012551-CMP-004-01.png"/> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 4.1</div> <div class="figure-caption"> <p>Comparison 4 Circumcision versus waiting list, Outcome 1 Prostatitis symptoms.</p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD012551.pub3/references#CD012551-fig-0025">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD012551.pub3/media/CDSR/CD012551/image_n/nCD012551-CMP-004-01.png" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD012551-fig-0026"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD012551.pub3/media/CDSR/CD012551/urn:x-wiley:14651858:media:CD012551:CD012551-CMP-004-02" target="_blank"><b></b></a></p> </div> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD012551.pub3/media/CDSR/CD012551/image_t/tCD012551-CMP-004-02.xxx" target="_blank"><b></b></a></p> </div><img alt="Comparison 4 Circumcision versus waiting list, Outcome 2 Prostatitis symptoms: pain subscore." data-id="CD012551-fig-0026" src="/cdsr/doi/10.1002/14651858.CD012551.pub3/media/CDSR/CD012551/image_n/nCD012551-CMP-004-02.png"/> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 4.2</div> <div class="figure-caption"> <p>Comparison 4 Circumcision versus waiting list, Outcome 2 Prostatitis symptoms: pain subscore. </p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD012551.pub3/references#CD012551-fig-0026">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD012551.pub3/media/CDSR/CD012551/image_n/nCD012551-CMP-004-02.png" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD012551-fig-0027"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD012551.pub3/media/CDSR/CD012551/urn:x-wiley:14651858:media:CD012551:CD012551-CMP-004-03" target="_blank"><b></b></a></p> </div> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD012551.pub3/media/CDSR/CD012551/image_t/tCD012551-CMP-004-03.xxx" target="_blank"><b></b></a></p> </div><img alt="Comparison 4 Circumcision versus waiting list, Outcome 3 Prostatitis symptoms: micturition subscore." data-id="CD012551-fig-0027" src="/cdsr/doi/10.1002/14651858.CD012551.pub3/media/CDSR/CD012551/image_n/nCD012551-CMP-004-03.png"/> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 4.3</div> <div class="figure-caption"> <p>Comparison 4 Circumcision versus waiting list, Outcome 3 Prostatitis symptoms: micturition subscore. </p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD012551.pub3/references#CD012551-fig-0027">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD012551.pub3/media/CDSR/CD012551/image_n/nCD012551-CMP-004-03.png" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD012551-fig-0028"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD012551.pub3/media/CDSR/CD012551/urn:x-wiley:14651858:media:CD012551:CD012551-CMP-004-04" target="_blank"><b></b></a></p> </div> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD012551.pub3/media/CDSR/CD012551/image_t/tCD012551-CMP-004-04.xxx" target="_blank"><b></b></a></p> </div><img alt="Comparison 4 Circumcision versus waiting list, Outcome 4 Prostatitis symptoms: quality of life subscore." data-id="CD012551-fig-0028" src="/cdsr/doi/10.1002/14651858.CD012551.pub3/media/CDSR/CD012551/image_n/nCD012551-CMP-004-04.png"/> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 4.4</div> <div class="figure-caption"> <p>Comparison 4 Circumcision versus waiting list, Outcome 4 Prostatitis symptoms: quality of life subscore. </p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD012551.pub3/references#CD012551-fig-0028">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD012551.pub3/media/CDSR/CD012551/image_n/nCD012551-CMP-004-04.png" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD012551-fig-0029"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD012551.pub3/media/CDSR/CD012551/urn:x-wiley:14651858:media:CD012551:CD012551-CMP-004-05" target="_blank"><b></b></a></p> </div> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD012551.pub3/media/CDSR/CD012551/image_t/tCD012551-CMP-004-05.xxx" target="_blank"><b></b></a></p> </div><img alt="Comparison 4 Circumcision versus waiting list, Outcome 5 Adverse events." data-id="CD012551-fig-0029" src="/cdsr/doi/10.1002/14651858.CD012551.pub3/media/CDSR/CD012551/image_n/nCD012551-CMP-004-05.png"/> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 4.5</div> <div class="figure-caption"> <p>Comparison 4 Circumcision versus waiting list, Outcome 5 Adverse events.</p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD012551.pub3/references#CD012551-fig-0029">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD012551.pub3/media/CDSR/CD012551/image_n/nCD012551-CMP-004-05.png" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD012551-fig-0030"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD012551.pub3/media/CDSR/CD012551/urn:x-wiley:14651858:media:CD012551:CD012551-CMP-005-01" target="_blank"><b></b></a></p> </div> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD012551.pub3/media/CDSR/CD012551/image_t/tCD012551-CMP-005-01.xxx" target="_blank"><b></b></a></p> </div><img alt="Comparison 5 Electromagnetic chair versus sham procedure, Outcome 1 Prostatitis symptoms (NIH‐CPSI total)." data-id="CD012551-fig-0030" src="/cdsr/doi/10.1002/14651858.CD012551.pub3/media/CDSR/CD012551/image_n/nCD012551-CMP-005-01.png"/> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 5.1</div> <div class="figure-caption"> <p>Comparison 5 Electromagnetic chair versus sham procedure, Outcome 1 Prostatitis symptoms (NIH‐CPSI total). </p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD012551.pub3/references#CD012551-fig-0030">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD012551.pub3/media/CDSR/CD012551/image_n/nCD012551-CMP-005-01.png" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD012551-fig-0031"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD012551.pub3/media/CDSR/CD012551/urn:x-wiley:14651858:media:CD012551:CD012551-CMP-005-02" target="_blank"><b></b></a></p> </div> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD012551.pub3/media/CDSR/CD012551/image_t/tCD012551-CMP-005-02.xxx" target="_blank"><b></b></a></p> </div><img alt="Comparison 5 Electromagnetic chair versus sham procedure, Outcome 2 Prostatitis symptoms: pain subscore." data-id="CD012551-fig-0031" src="/cdsr/doi/10.1002/14651858.CD012551.pub3/media/CDSR/CD012551/image_n/nCD012551-CMP-005-02.png"/> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 5.2</div> <div class="figure-caption"> <p>Comparison 5 Electromagnetic chair versus sham procedure, Outcome 2 Prostatitis symptoms: pain subscore. </p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD012551.pub3/references#CD012551-fig-0031">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD012551.pub3/media/CDSR/CD012551/image_n/nCD012551-CMP-005-02.png" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD012551-fig-0032"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD012551.pub3/media/CDSR/CD012551/urn:x-wiley:14651858:media:CD012551:CD012551-CMP-005-03" target="_blank"><b></b></a></p> </div> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD012551.pub3/media/CDSR/CD012551/image_t/tCD012551-CMP-005-03.xxx" target="_blank"><b></b></a></p> </div><img alt="Comparison 5 Electromagnetic chair versus sham procedure, Outcome 3 Prostatitis symptoms: micturition subscore." data-id="CD012551-fig-0032" src="/cdsr/doi/10.1002/14651858.CD012551.pub3/media/CDSR/CD012551/image_n/nCD012551-CMP-005-03.png"/> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 5.3</div> <div class="figure-caption"> <p>Comparison 5 Electromagnetic chair versus sham procedure, Outcome 3 Prostatitis symptoms: micturition subscore. </p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD012551.pub3/references#CD012551-fig-0032">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD012551.pub3/media/CDSR/CD012551/image_n/nCD012551-CMP-005-03.png" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD012551-fig-0033"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD012551.pub3/media/CDSR/CD012551/urn:x-wiley:14651858:media:CD012551:CD012551-CMP-005-04" target="_blank"><b></b></a></p> </div> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD012551.pub3/media/CDSR/CD012551/image_t/tCD012551-CMP-005-04.xxx" target="_blank"><b></b></a></p> </div><img alt="Comparison 5 Electromagnetic chair versus sham procedure, Outcome 4 Prostatitis symptoms: quality of life subscore." data-id="CD012551-fig-0033" src="/cdsr/doi/10.1002/14651858.CD012551.pub3/media/CDSR/CD012551/image_n/nCD012551-CMP-005-04.png"/> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 5.4</div> <div class="figure-caption"> <p>Comparison 5 Electromagnetic chair versus sham procedure, Outcome 4 Prostatitis symptoms: quality of life subscore. </p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD012551.pub3/references#CD012551-fig-0033">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD012551.pub3/media/CDSR/CD012551/image_n/nCD012551-CMP-005-04.png" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD012551-fig-0034"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD012551.pub3/media/CDSR/CD012551/urn:x-wiley:14651858:media:CD012551:CD012551-CMP-005-05" target="_blank"><b></b></a></p> </div> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD012551.pub3/media/CDSR/CD012551/image_t/tCD012551-CMP-005-05.xxx" target="_blank"><b></b></a></p> </div><img alt="Comparison 5 Electromagnetic chair versus sham procedure, Outcome 5 Adverse events." data-id="CD012551-fig-0034" src="/cdsr/doi/10.1002/14651858.CD012551.pub3/media/CDSR/CD012551/image_n/nCD012551-CMP-005-05.png"/> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 5.5</div> <div class="figure-caption"> <p>Comparison 5 Electromagnetic chair versus sham procedure, Outcome 5 Adverse events.</p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD012551.pub3/references#CD012551-fig-0034">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD012551.pub3/media/CDSR/CD012551/image_n/nCD012551-CMP-005-05.png" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD012551-fig-0035"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD012551.pub3/media/CDSR/CD012551/urn:x-wiley:14651858:media:CD012551:CD012551-CMP-005-06" target="_blank"><b></b></a></p> </div> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD012551.pub3/media/CDSR/CD012551/image_t/tCD012551-CMP-005-06.xxx" target="_blank"><b></b></a></p> </div><img alt="Comparison 5 Electromagnetic chair versus sham procedure, Outcome 6 Urinary symptoms." data-id="CD012551-fig-0035" src="/cdsr/doi/10.1002/14651858.CD012551.pub3/media/CDSR/CD012551/image_n/nCD012551-CMP-005-06.png"/> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 5.6</div> <div class="figure-caption"> <p>Comparison 5 Electromagnetic chair versus sham procedure, Outcome 6 Urinary symptoms.</p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD012551.pub3/references#CD012551-fig-0035">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD012551.pub3/media/CDSR/CD012551/image_n/nCD012551-CMP-005-06.png" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD012551-fig-0036"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD012551.pub3/media/CDSR/CD012551/urn:x-wiley:14651858:media:CD012551:CD012551-CMP-005-07" target="_blank"><b></b></a></p> </div> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD012551.pub3/media/CDSR/CD012551/image_t/tCD012551-CMP-005-07.xxx" target="_blank"><b></b></a></p> </div><img alt="Comparison 5 Electromagnetic chair versus sham procedure, Outcome 7 Prostatitis symptoms (NIH‐CPSI total) ‐ medium term." data-id="CD012551-fig-0036" src="/cdsr/doi/10.1002/14651858.CD012551.pub3/media/CDSR/CD012551/image_n/nCD012551-CMP-005-07.png"/> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 5.7</div> <div class="figure-caption"> <p>Comparison 5 Electromagnetic chair versus sham procedure, Outcome 7 Prostatitis symptoms (NIH‐CPSI total) ‐ medium term. </p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD012551.pub3/references#CD012551-fig-0036">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD012551.pub3/media/CDSR/CD012551/image_n/nCD012551-CMP-005-07.png" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD012551-fig-0037"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD012551.pub3/media/CDSR/CD012551/urn:x-wiley:14651858:media:CD012551:CD012551-CMP-005-08" target="_blank"><b></b></a></p> </div> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD012551.pub3/media/CDSR/CD012551/image_t/tCD012551-CMP-005-08.xxx" target="_blank"><b></b></a></p> </div><img alt="Comparison 5 Electromagnetic chair versus sham procedure, Outcome 8 Prostatitis symptoms: pain subscore ‐ medium term." data-id="CD012551-fig-0037" src="/cdsr/doi/10.1002/14651858.CD012551.pub3/media/CDSR/CD012551/image_n/nCD012551-CMP-005-08.png"/> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 5.8</div> <div class="figure-caption"> <p>Comparison 5 Electromagnetic chair versus sham procedure, Outcome 8 Prostatitis symptoms: pain subscore ‐ medium term. </p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD012551.pub3/references#CD012551-fig-0037">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD012551.pub3/media/CDSR/CD012551/image_n/nCD012551-CMP-005-08.png" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD012551-fig-0038"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD012551.pub3/media/CDSR/CD012551/urn:x-wiley:14651858:media:CD012551:CD012551-CMP-006-01" target="_blank"><b></b></a></p> </div> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD012551.pub3/media/CDSR/CD012551/image_t/tCD012551-CMP-006-01.xxx" target="_blank"><b></b></a></p> </div><img alt="Comparison 6 Lifestyle modifications versus control, Outcome 1 Prostatitis symptoms." data-id="CD012551-fig-0038" src="/cdsr/doi/10.1002/14651858.CD012551.pub3/media/CDSR/CD012551/image_n/nCD012551-CMP-006-01.png"/> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 6.1</div> <div class="figure-caption"> <p>Comparison 6 Lifestyle modifications versus control, Outcome 1 Prostatitis symptoms.</p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD012551.pub3/references#CD012551-fig-0038">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD012551.pub3/media/CDSR/CD012551/image_n/nCD012551-CMP-006-01.png" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD012551-fig-0039"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD012551.pub3/media/CDSR/CD012551/urn:x-wiley:14651858:media:CD012551:CD012551-CMP-007-01" target="_blank"><b></b></a></p> </div> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD012551.pub3/media/CDSR/CD012551/image_t/tCD012551-CMP-007-01.xxx" target="_blank"><b></b></a></p> </div><img alt="Comparison 7 Physical activity versus control, Outcome 1 Prostatitis symptoms." data-id="CD012551-fig-0039" src="/cdsr/doi/10.1002/14651858.CD012551.pub3/media/CDSR/CD012551/image_n/nCD012551-CMP-007-01.png"/> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 7.1</div> <div class="figure-caption"> <p>Comparison 7 Physical activity versus control, Outcome 1 Prostatitis symptoms.</p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD012551.pub3/references#CD012551-fig-0039">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD012551.pub3/media/CDSR/CD012551/image_n/nCD012551-CMP-007-01.png" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD012551-fig-0040"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD012551.pub3/media/CDSR/CD012551/urn:x-wiley:14651858:media:CD012551:CD012551-CMP-007-02" target="_blank"><b></b></a></p> </div> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD012551.pub3/media/CDSR/CD012551/image_t/tCD012551-CMP-007-02.xxx" target="_blank"><b></b></a></p> </div><img alt="Comparison 7 Physical activity versus control, Outcome 2 Prostatitis symptoms: pain subscore." data-id="CD012551-fig-0040" src="/cdsr/doi/10.1002/14651858.CD012551.pub3/media/CDSR/CD012551/image_n/nCD012551-CMP-007-02.png"/> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 7.2</div> <div class="figure-caption"> <p>Comparison 7 Physical activity versus control, Outcome 2 Prostatitis symptoms: pain subscore. </p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD012551.pub3/references#CD012551-fig-0040">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD012551.pub3/media/CDSR/CD012551/image_n/nCD012551-CMP-007-02.png" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD012551-fig-0041"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD012551.pub3/media/CDSR/CD012551/urn:x-wiley:14651858:media:CD012551:CD012551-CMP-007-03" target="_blank"><b></b></a></p> </div> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD012551.pub3/media/CDSR/CD012551/image_t/tCD012551-CMP-007-03.xxx" target="_blank"><b></b></a></p> </div><img alt="Comparison 7 Physical activity versus control, Outcome 3 Prostatitis symptoms: micturition subscore." data-id="CD012551-fig-0041" src="/cdsr/doi/10.1002/14651858.CD012551.pub3/media/CDSR/CD012551/image_n/nCD012551-CMP-007-03.png"/> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 7.3</div> <div class="figure-caption"> <p>Comparison 7 Physical activity versus control, Outcome 3 Prostatitis symptoms: micturition subscore. </p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD012551.pub3/references#CD012551-fig-0041">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD012551.pub3/media/CDSR/CD012551/image_n/nCD012551-CMP-007-03.png" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD012551-fig-0042"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD012551.pub3/media/CDSR/CD012551/urn:x-wiley:14651858:media:CD012551:CD012551-CMP-007-04" target="_blank"><b></b></a></p> </div> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD012551.pub3/media/CDSR/CD012551/image_t/tCD012551-CMP-007-04.xxx" target="_blank"><b></b></a></p> </div><img alt="Comparison 7 Physical activity versus control, Outcome 4 Prostatitis symptoms: quality of life subscore." data-id="CD012551-fig-0042" src="/cdsr/doi/10.1002/14651858.CD012551.pub3/media/CDSR/CD012551/image_n/nCD012551-CMP-007-04.png"/> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 7.4</div> <div class="figure-caption"> <p>Comparison 7 Physical activity versus control, Outcome 4 Prostatitis symptoms: quality of life subscore. </p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD012551.pub3/references#CD012551-fig-0042">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD012551.pub3/media/CDSR/CD012551/image_n/nCD012551-CMP-007-04.png" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD012551-fig-0043"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD012551.pub3/media/CDSR/CD012551/urn:x-wiley:14651858:media:CD012551:CD012551-CMP-007-05" target="_blank"><b></b></a></p> </div> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD012551.pub3/media/CDSR/CD012551/image_t/tCD012551-CMP-007-05.xxx" target="_blank"><b></b></a></p> </div><img alt="Comparison 7 Physical activity versus control, Outcome 5 Anxiety." data-id="CD012551-fig-0043" src="/cdsr/doi/10.1002/14651858.CD012551.pub3/media/CDSR/CD012551/image_n/nCD012551-CMP-007-05.png"/> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 7.5</div> <div class="figure-caption"> <p>Comparison 7 Physical activity versus control, Outcome 5 Anxiety.</p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD012551.pub3/references#CD012551-fig-0043">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD012551.pub3/media/CDSR/CD012551/image_n/nCD012551-CMP-007-05.png" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD012551-fig-0044"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD012551.pub3/media/CDSR/CD012551/urn:x-wiley:14651858:media:CD012551:CD012551-CMP-007-06" target="_blank"><b></b></a></p> </div> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD012551.pub3/media/CDSR/CD012551/image_t/tCD012551-CMP-007-06.xxx" target="_blank"><b></b></a></p> </div><img alt="Comparison 7 Physical activity versus control, Outcome 6 Depression." data-id="CD012551-fig-0044" src="/cdsr/doi/10.1002/14651858.CD012551.pub3/media/CDSR/CD012551/image_n/nCD012551-CMP-007-06.png"/> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 7.6</div> <div class="figure-caption"> <p>Comparison 7 Physical activity versus control, Outcome 6 Depression.</p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD012551.pub3/references#CD012551-fig-0044">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD012551.pub3/media/CDSR/CD012551/image_n/nCD012551-CMP-007-06.png" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD012551-fig-0045"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD012551.pub3/media/CDSR/CD012551/urn:x-wiley:14651858:media:CD012551:CD012551-CMP-008-01" target="_blank"><b></b></a></p> </div> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD012551.pub3/media/CDSR/CD012551/image_t/tCD012551-CMP-008-01.xxx" target="_blank"><b></b></a></p> </div><img alt="Comparison 8 Prostatic massage versus control, Outcome 1 Prostatitis symptoms." data-id="CD012551-fig-0045" src="/cdsr/doi/10.1002/14651858.CD012551.pub3/media/CDSR/CD012551/image_n/nCD012551-CMP-008-01.png"/> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 8.1</div> <div class="figure-caption"> <p>Comparison 8 Prostatic massage versus control, Outcome 1 Prostatitis symptoms.</p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD012551.pub3/references#CD012551-fig-0045">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD012551.pub3/media/CDSR/CD012551/image_n/nCD012551-CMP-008-01.png" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD012551-fig-0046"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD012551.pub3/media/CDSR/CD012551/urn:x-wiley:14651858:media:CD012551:CD012551-CMP-008-02" target="_blank"><b></b></a></p> </div> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD012551.pub3/media/CDSR/CD012551/image_t/tCD012551-CMP-008-02.xxx" target="_blank"><b></b></a></p> </div><img alt="Comparison 8 Prostatic massage versus control, Outcome 2 Prostatitis symptoms: pain subscore." data-id="CD012551-fig-0046" src="/cdsr/doi/10.1002/14651858.CD012551.pub3/media/CDSR/CD012551/image_n/nCD012551-CMP-008-02.png"/> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 8.2</div> <div class="figure-caption"> <p>Comparison 8 Prostatic massage versus control, Outcome 2 Prostatitis symptoms: pain subscore. </p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD012551.pub3/references#CD012551-fig-0046">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD012551.pub3/media/CDSR/CD012551/image_n/nCD012551-CMP-008-02.png" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD012551-fig-0047"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD012551.pub3/media/CDSR/CD012551/urn:x-wiley:14651858:media:CD012551:CD012551-CMP-008-03" target="_blank"><b></b></a></p> </div> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD012551.pub3/media/CDSR/CD012551/image_t/tCD012551-CMP-008-03.xxx" target="_blank"><b></b></a></p> </div><img alt="Comparison 8 Prostatic massage versus control, Outcome 3 Prostatitis symptoms: micturition subscore." data-id="CD012551-fig-0047" src="/cdsr/doi/10.1002/14651858.CD012551.pub3/media/CDSR/CD012551/image_n/nCD012551-CMP-008-03.png"/> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 8.3</div> <div class="figure-caption"> <p>Comparison 8 Prostatic massage versus control, Outcome 3 Prostatitis symptoms: micturition subscore. </p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD012551.pub3/references#CD012551-fig-0047">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD012551.pub3/media/CDSR/CD012551/image_n/nCD012551-CMP-008-03.png" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD012551-fig-0048"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD012551.pub3/media/CDSR/CD012551/urn:x-wiley:14651858:media:CD012551:CD012551-CMP-008-04" target="_blank"><b></b></a></p> </div> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD012551.pub3/media/CDSR/CD012551/image_t/tCD012551-CMP-008-04.xxx" target="_blank"><b></b></a></p> </div><img alt="Comparison 8 Prostatic massage versus control, Outcome 4 Prostatitis symptoms: quality of life subscore." data-id="CD012551-fig-0048" src="/cdsr/doi/10.1002/14651858.CD012551.pub3/media/CDSR/CD012551/image_n/nCD012551-CMP-008-04.png"/> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 8.4</div> <div class="figure-caption"> <p>Comparison 8 Prostatic massage versus control, Outcome 4 Prostatitis symptoms: quality of life subscore. </p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD012551.pub3/references#CD012551-fig-0048">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD012551.pub3/media/CDSR/CD012551/image_n/nCD012551-CMP-008-04.png" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD012551-fig-0049"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD012551.pub3/media/CDSR/CD012551/urn:x-wiley:14651858:media:CD012551:CD012551-CMP-009-01" target="_blank"><b></b></a></p> </div> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD012551.pub3/media/CDSR/CD012551/image_t/tCD012551-CMP-009-01.xxx" target="_blank"><b></b></a></p> </div><img alt="Comparison 9 Extracorporeal shockwave therapy (ESWT) versus control, Outcome 1 Prostatitis symptoms (NIH‐CPSI total)." data-id="CD012551-fig-0049" src="/cdsr/doi/10.1002/14651858.CD012551.pub3/media/CDSR/CD012551/image_n/nCD012551-CMP-009-01.png"/> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 9.1</div> <div class="figure-caption"> <p>Comparison 9 Extracorporeal shockwave therapy (ESWT) versus control, Outcome 1 Prostatitis symptoms (NIH‐CPSI total). </p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD012551.pub3/references#CD012551-fig-0049">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD012551.pub3/media/CDSR/CD012551/image_n/nCD012551-CMP-009-01.png" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD012551-fig-0050"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD012551.pub3/media/CDSR/CD012551/urn:x-wiley:14651858:media:CD012551:CD012551-CMP-009-02" target="_blank"><b></b></a></p> </div> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD012551.pub3/media/CDSR/CD012551/image_t/tCD012551-CMP-009-02.xxx" target="_blank"><b></b></a></p> </div><img alt="Comparison 9 Extracorporeal shockwave therapy (ESWT) versus control, Outcome 2 Prostatitis symptoms: pain subscore." data-id="CD012551-fig-0050" src="/cdsr/doi/10.1002/14651858.CD012551.pub3/media/CDSR/CD012551/image_n/nCD012551-CMP-009-02.png"/> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 9.2</div> <div class="figure-caption"> <p>Comparison 9 Extracorporeal shockwave therapy (ESWT) versus control, Outcome 2 Prostatitis symptoms: pain subscore. </p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD012551.pub3/references#CD012551-fig-0050">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD012551.pub3/media/CDSR/CD012551/image_n/nCD012551-CMP-009-02.png" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD012551-fig-0051"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD012551.pub3/media/CDSR/CD012551/urn:x-wiley:14651858:media:CD012551:CD012551-CMP-009-03" target="_blank"><b></b></a></p> </div> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD012551.pub3/media/CDSR/CD012551/image_t/tCD012551-CMP-009-03.xxx" target="_blank"><b></b></a></p> </div><img alt="Comparison 9 Extracorporeal shockwave therapy (ESWT) versus control, Outcome 3 Prostatitis symptoms: micturition subscore." data-id="CD012551-fig-0051" src="/cdsr/doi/10.1002/14651858.CD012551.pub3/media/CDSR/CD012551/image_n/nCD012551-CMP-009-03.png"/> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 9.3</div> <div class="figure-caption"> <p>Comparison 9 Extracorporeal shockwave therapy (ESWT) versus control, Outcome 3 Prostatitis symptoms: micturition subscore. </p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD012551.pub3/references#CD012551-fig-0051">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD012551.pub3/media/CDSR/CD012551/image_n/nCD012551-CMP-009-03.png" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD012551-fig-0052"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD012551.pub3/media/CDSR/CD012551/urn:x-wiley:14651858:media:CD012551:CD012551-CMP-009-04" target="_blank"><b></b></a></p> </div> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD012551.pub3/media/CDSR/CD012551/image_t/tCD012551-CMP-009-04.xxx" target="_blank"><b></b></a></p> </div><img alt="Comparison 9 Extracorporeal shockwave therapy (ESWT) versus control, Outcome 4 Prostatitis symptoms: quality of life subscore." data-id="CD012551-fig-0052" src="/cdsr/doi/10.1002/14651858.CD012551.pub3/media/CDSR/CD012551/image_n/nCD012551-CMP-009-04.png"/> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 9.4</div> <div class="figure-caption"> <p>Comparison 9 Extracorporeal shockwave therapy (ESWT) versus control, Outcome 4 Prostatitis symptoms: quality of life subscore. </p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD012551.pub3/references#CD012551-fig-0052">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD012551.pub3/media/CDSR/CD012551/image_n/nCD012551-CMP-009-04.png" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD012551-fig-0053"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD012551.pub3/media/CDSR/CD012551/urn:x-wiley:14651858:media:CD012551:CD012551-CMP-009-05" target="_blank"><b></b></a></p> </div> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD012551.pub3/media/CDSR/CD012551/image_t/tCD012551-CMP-009-05.xxx" target="_blank"><b></b></a></p> </div><img alt="Comparison 9 Extracorporeal shockwave therapy (ESWT) versus control, Outcome 5 Prostatitis symptoms." data-id="CD012551-fig-0053" src="/cdsr/doi/10.1002/14651858.CD012551.pub3/media/CDSR/CD012551/image_n/nCD012551-CMP-009-05.png"/> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 9.5</div> <div class="figure-caption"> <p>Comparison 9 Extracorporeal shockwave therapy (ESWT) versus control, Outcome 5 Prostatitis symptoms. </p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD012551.pub3/references#CD012551-fig-0053">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD012551.pub3/media/CDSR/CD012551/image_n/nCD012551-CMP-009-05.png" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD012551-fig-0054"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD012551.pub3/media/CDSR/CD012551/urn:x-wiley:14651858:media:CD012551:CD012551-CMP-009-06" target="_blank"><b></b></a></p> </div> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD012551.pub3/media/CDSR/CD012551/image_t/tCD012551-CMP-009-06.xxx" target="_blank"><b></b></a></p> </div><img alt="Comparison 9 Extracorporeal shockwave therapy (ESWT) versus control, Outcome 6 Prostatitis symptoms (total score) ‐ long term." data-id="CD012551-fig-0054" src="/cdsr/doi/10.1002/14651858.CD012551.pub3/media/CDSR/CD012551/image_n/nCD012551-CMP-009-06.png"/> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 9.6</div> <div class="figure-caption"> <p>Comparison 9 Extracorporeal shockwave therapy (ESWT) versus control, Outcome 6 Prostatitis symptoms (total score) ‐ long term. </p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD012551.pub3/references#CD012551-fig-0054">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD012551.pub3/media/CDSR/CD012551/image_n/nCD012551-CMP-009-06.png" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD012551-fig-0055"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD012551.pub3/media/CDSR/CD012551/urn:x-wiley:14651858:media:CD012551:CD012551-CMP-009-07" target="_blank"><b></b></a></p> </div> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD012551.pub3/media/CDSR/CD012551/image_t/tCD012551-CMP-009-07.xxx" target="_blank"><b></b></a></p> </div><img alt="Comparison 9 Extracorporeal shockwave therapy (ESWT) versus control, Outcome 7 Prostatitis symptoms: pain subscore ‐ long term." data-id="CD012551-fig-0055" src="/cdsr/doi/10.1002/14651858.CD012551.pub3/media/CDSR/CD012551/image_n/nCD012551-CMP-009-07.png"/> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 9.7</div> <div class="figure-caption"> <p>Comparison 9 Extracorporeal shockwave therapy (ESWT) versus control, Outcome 7 Prostatitis symptoms: pain subscore ‐ long term. </p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD012551.pub3/references#CD012551-fig-0055">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD012551.pub3/media/CDSR/CD012551/image_n/nCD012551-CMP-009-07.png" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD012551-fig-0056"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD012551.pub3/media/CDSR/CD012551/urn:x-wiley:14651858:media:CD012551:CD012551-CMP-009-08" target="_blank"><b></b></a></p> </div> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD012551.pub3/media/CDSR/CD012551/image_t/tCD012551-CMP-009-08.xxx" target="_blank"><b></b></a></p> </div><img alt="Comparison 9 Extracorporeal shockwave therapy (ESWT) versus control, Outcome 8 Prostatitis symptoms: micturition subscore ‐ long term." data-id="CD012551-fig-0056" src="/cdsr/doi/10.1002/14651858.CD012551.pub3/media/CDSR/CD012551/image_n/nCD012551-CMP-009-08.png"/> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 9.8</div> <div class="figure-caption"> <p>Comparison 9 Extracorporeal shockwave therapy (ESWT) versus control, Outcome 8 Prostatitis symptoms: micturition subscore ‐ long term. </p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD012551.pub3/references#CD012551-fig-0056">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD012551.pub3/media/CDSR/CD012551/image_n/nCD012551-CMP-009-08.png" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD012551-fig-0057"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD012551.pub3/media/CDSR/CD012551/urn:x-wiley:14651858:media:CD012551:CD012551-CMP-009-09" target="_blank"><b></b></a></p> </div> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD012551.pub3/media/CDSR/CD012551/image_t/tCD012551-CMP-009-09.xxx" target="_blank"><b></b></a></p> </div><img alt="Comparison 9 Extracorporeal shockwave therapy (ESWT) versus control, Outcome 9 Prostatitis symptoms: quality of life subscore ‐ long term." data-id="CD012551-fig-0057" src="/cdsr/doi/10.1002/14651858.CD012551.pub3/media/CDSR/CD012551/image_n/nCD012551-CMP-009-09.png"/> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 9.9</div> <div class="figure-caption"> <p>Comparison 9 Extracorporeal shockwave therapy (ESWT) versus control, Outcome 9 Prostatitis symptoms: quality of life subscore ‐ long term. </p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD012551.pub3/references#CD012551-fig-0057">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD012551.pub3/media/CDSR/CD012551/image_n/nCD012551-CMP-009-09.png" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD012551-fig-0058"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD012551.pub3/media/CDSR/CD012551/urn:x-wiley:14651858:media:CD012551:CD012551-CMP-009-10" target="_blank"><b></b></a></p> </div> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD012551.pub3/media/CDSR/CD012551/image_t/tCD012551-CMP-009-10.xxx" target="_blank"><b></b></a></p> </div><img alt="Comparison 9 Extracorporeal shockwave therapy (ESWT) versus control, Outcome 10 Adverse events." data-id="CD012551-fig-0058" src="/cdsr/doi/10.1002/14651858.CD012551.pub3/media/CDSR/CD012551/image_n/nCD012551-CMP-009-10.png"/> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 9.10</div> <div class="figure-caption"> <p>Comparison 9 Extracorporeal shockwave therapy (ESWT) versus control, Outcome 10 Adverse events. </p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD012551.pub3/references#CD012551-fig-0058">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD012551.pub3/media/CDSR/CD012551/image_n/nCD012551-CMP-009-10.png" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD012551-fig-0059"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD012551.pub3/media/CDSR/CD012551/urn:x-wiley:14651858:media:CD012551:CD012551-CMP-009-11" target="_blank"><b></b></a></p> </div> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD012551.pub3/media/CDSR/CD012551/image_t/tCD012551-CMP-009-11.xxx" target="_blank"><b></b></a></p> </div><img alt="Comparison 9 Extracorporeal shockwave therapy (ESWT) versus control, Outcome 11 Sexual dysfunction." data-id="CD012551-fig-0059" src="/cdsr/doi/10.1002/14651858.CD012551.pub3/media/CDSR/CD012551/image_n/nCD012551-CMP-009-11.png"/> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 9.11</div> <div class="figure-caption"> <p>Comparison 9 Extracorporeal shockwave therapy (ESWT) versus control, Outcome 11 Sexual dysfunction. </p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD012551.pub3/references#CD012551-fig-0059">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD012551.pub3/media/CDSR/CD012551/image_n/nCD012551-CMP-009-11.png" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD012551-fig-0060"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD012551.pub3/media/CDSR/CD012551/urn:x-wiley:14651858:media:CD012551:CD012551-CMP-009-12" target="_blank"><b></b></a></p> </div> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD012551.pub3/media/CDSR/CD012551/image_t/tCD012551-CMP-009-12.xxx" target="_blank"><b></b></a></p> </div><img alt="Comparison 9 Extracorporeal shockwave therapy (ESWT) versus control, Outcome 12 Urinary symptoms." data-id="CD012551-fig-0060" src="/cdsr/doi/10.1002/14651858.CD012551.pub3/media/CDSR/CD012551/image_n/nCD012551-CMP-009-12.png"/> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 9.12</div> <div class="figure-caption"> <p>Comparison 9 Extracorporeal shockwave therapy (ESWT) versus control, Outcome 12 Urinary symptoms. </p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD012551.pub3/references#CD012551-fig-0060">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD012551.pub3/media/CDSR/CD012551/image_n/nCD012551-CMP-009-12.png" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD012551-fig-0061"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD012551.pub3/media/CDSR/CD012551/urn:x-wiley:14651858:media:CD012551:CD012551-CMP-010-01" target="_blank"><b></b></a></p> </div> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD012551.pub3/media/CDSR/CD012551/image_t/tCD012551-CMP-010-01.xxx" target="_blank"><b></b></a></p> </div><img alt="Comparison 10 Transrectal thermotherapy (TRT) versus medical treatment, Outcome 1 Prostatitis symptoms (NIH‐CPSI total)." data-id="CD012551-fig-0061" src="/cdsr/doi/10.1002/14651858.CD012551.pub3/media/CDSR/CD012551/image_n/nCD012551-CMP-010-01.png"/> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 10.1</div> <div class="figure-caption"> <p>Comparison 10 Transrectal thermotherapy (TRT) versus medical treatment, Outcome 1 Prostatitis symptoms (NIH‐CPSI total). </p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD012551.pub3/references#CD012551-fig-0061">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD012551.pub3/media/CDSR/CD012551/image_n/nCD012551-CMP-010-01.png" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD012551-fig-0062"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD012551.pub3/media/CDSR/CD012551/urn:x-wiley:14651858:media:CD012551:CD012551-CMP-010-02" target="_blank"><b></b></a></p> </div> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD012551.pub3/media/CDSR/CD012551/image_t/tCD012551-CMP-010-02.xxx" target="_blank"><b></b></a></p> </div><img alt="Comparison 10 Transrectal thermotherapy (TRT) versus medical treatment, Outcome 2 Prostatitis symptoms: pain subscore." data-id="CD012551-fig-0062" src="/cdsr/doi/10.1002/14651858.CD012551.pub3/media/CDSR/CD012551/image_n/nCD012551-CMP-010-02.png"/> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 10.2</div> <div class="figure-caption"> <p>Comparison 10 Transrectal thermotherapy (TRT) versus medical treatment, Outcome 2 Prostatitis symptoms: pain subscore. </p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD012551.pub3/references#CD012551-fig-0062">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD012551.pub3/media/CDSR/CD012551/image_n/nCD012551-CMP-010-02.png" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD012551-fig-0063"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD012551.pub3/media/CDSR/CD012551/urn:x-wiley:14651858:media:CD012551:CD012551-CMP-010-03" target="_blank"><b></b></a></p> </div> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD012551.pub3/media/CDSR/CD012551/image_t/tCD012551-CMP-010-03.xxx" target="_blank"><b></b></a></p> </div><img alt="Comparison 10 Transrectal thermotherapy (TRT) versus medical treatment, Outcome 3 Prostatitis symptoms: micturition subscore." data-id="CD012551-fig-0063" src="/cdsr/doi/10.1002/14651858.CD012551.pub3/media/CDSR/CD012551/image_n/nCD012551-CMP-010-03.png"/> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 10.3</div> <div class="figure-caption"> <p>Comparison 10 Transrectal thermotherapy (TRT) versus medical treatment, Outcome 3 Prostatitis symptoms: micturition subscore. </p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD012551.pub3/references#CD012551-fig-0063">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD012551.pub3/media/CDSR/CD012551/image_n/nCD012551-CMP-010-03.png" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD012551-fig-0064"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD012551.pub3/media/CDSR/CD012551/urn:x-wiley:14651858:media:CD012551:CD012551-CMP-010-04" target="_blank"><b></b></a></p> </div> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD012551.pub3/media/CDSR/CD012551/image_t/tCD012551-CMP-010-04.xxx" target="_blank"><b></b></a></p> </div><img alt="Comparison 10 Transrectal thermotherapy (TRT) versus medical treatment, Outcome 4 Prostatitis symptoms: quality of life subscore." data-id="CD012551-fig-0064" src="/cdsr/doi/10.1002/14651858.CD012551.pub3/media/CDSR/CD012551/image_n/nCD012551-CMP-010-04.png"/> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 10.4</div> <div class="figure-caption"> <p>Comparison 10 Transrectal thermotherapy (TRT) versus medical treatment, Outcome 4 Prostatitis symptoms: quality of life subscore. </p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD012551.pub3/references#CD012551-fig-0064">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD012551.pub3/media/CDSR/CD012551/image_n/nCD012551-CMP-010-04.png" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD012551-fig-0065"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD012551.pub3/media/CDSR/CD012551/urn:x-wiley:14651858:media:CD012551:CD012551-CMP-011-01" target="_blank"><b></b></a></p> </div> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD012551.pub3/media/CDSR/CD012551/image_t/tCD012551-CMP-011-01.xxx" target="_blank"><b></b></a></p> </div><img alt="Comparison 11 Biofeedback with or without electrical stimulation versus usual care, Outcome 1 Prostatitis symptoms (NIH‐CPSI total)." data-id="CD012551-fig-0065" src="/cdsr/doi/10.1002/14651858.CD012551.pub3/media/CDSR/CD012551/image_n/nCD012551-CMP-011-01.png"/> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 11.1</div> <div class="figure-caption"> <p>Comparison 11 Biofeedback with or without electrical stimulation versus usual care, Outcome 1 Prostatitis symptoms (NIH‐CPSI total). </p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD012551.pub3/references#CD012551-fig-0065">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD012551.pub3/media/CDSR/CD012551/image_n/nCD012551-CMP-011-01.png" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD012551-fig-0066"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD012551.pub3/media/CDSR/CD012551/urn:x-wiley:14651858:media:CD012551:CD012551-CMP-011-02" target="_blank"><b></b></a></p> </div> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD012551.pub3/media/CDSR/CD012551/image_t/tCD012551-CMP-011-02.xxx" target="_blank"><b></b></a></p> </div><img alt="Comparison 11 Biofeedback with or without electrical stimulation versus usual care, Outcome 2 Prostatitis symptoms: pain subscore." data-id="CD012551-fig-0066" src="/cdsr/doi/10.1002/14651858.CD012551.pub3/media/CDSR/CD012551/image_n/nCD012551-CMP-011-02.png"/> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 11.2</div> <div class="figure-caption"> <p>Comparison 11 Biofeedback with or without electrical stimulation versus usual care, Outcome 2 Prostatitis symptoms: pain subscore. </p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD012551.pub3/references#CD012551-fig-0066">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD012551.pub3/media/CDSR/CD012551/image_n/nCD012551-CMP-011-02.png" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD012551-fig-0067"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD012551.pub3/media/CDSR/CD012551/urn:x-wiley:14651858:media:CD012551:CD012551-CMP-011-03" target="_blank"><b></b></a></p> </div> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD012551.pub3/media/CDSR/CD012551/image_t/tCD012551-CMP-011-03.xxx" target="_blank"><b></b></a></p> </div><img alt="Comparison 11 Biofeedback with or without electrical stimulation versus usual care, Outcome 3 Prostatitis symptoms: micturition subscore." data-id="CD012551-fig-0067" src="/cdsr/doi/10.1002/14651858.CD012551.pub3/media/CDSR/CD012551/image_n/nCD012551-CMP-011-03.png"/> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 11.3</div> <div class="figure-caption"> <p>Comparison 11 Biofeedback with or without electrical stimulation versus usual care, Outcome 3 Prostatitis symptoms: micturition subscore. </p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD012551.pub3/references#CD012551-fig-0067">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD012551.pub3/media/CDSR/CD012551/image_n/nCD012551-CMP-011-03.png" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD012551-fig-0068"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD012551.pub3/media/CDSR/CD012551/urn:x-wiley:14651858:media:CD012551:CD012551-CMP-011-04" target="_blank"><b></b></a></p> </div> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD012551.pub3/media/CDSR/CD012551/image_t/tCD012551-CMP-011-04.xxx" target="_blank"><b></b></a></p> </div><img alt="Comparison 11 Biofeedback with or without electrical stimulation versus usual care, Outcome 4 Prostatitis symptoms: quality of life subscore." data-id="CD012551-fig-0068" src="/cdsr/doi/10.1002/14651858.CD012551.pub3/media/CDSR/CD012551/image_n/nCD012551-CMP-011-04.png"/> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 11.4</div> <div class="figure-caption"> <p>Comparison 11 Biofeedback with or without electrical stimulation versus usual care, Outcome 4 Prostatitis symptoms: quality of life subscore. </p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD012551.pub3/references#CD012551-fig-0068">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD012551.pub3/media/CDSR/CD012551/image_n/nCD012551-CMP-011-04.png" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD012551-fig-0069"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD012551.pub3/media/CDSR/CD012551/urn:x-wiley:14651858:media:CD012551:CD012551-CMP-012-01" target="_blank"><b></b></a></p> </div> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD012551.pub3/media/CDSR/CD012551/image_t/tCD012551-CMP-012-01.xxx" target="_blank"><b></b></a></p> </div><img alt="Comparison 12 External radiofrequency hyperthermia with or without terazosin, Outcome 1 Prostatitis symptoms." data-id="CD012551-fig-0069" src="/cdsr/doi/10.1002/14651858.CD012551.pub3/media/CDSR/CD012551/image_n/nCD012551-CMP-012-01.png"/> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 12.1</div> <div class="figure-caption"> <p>Comparison 12 External radiofrequency hyperthermia with or without terazosin, Outcome 1 Prostatitis symptoms. </p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD012551.pub3/references#CD012551-fig-0069">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD012551.pub3/media/CDSR/CD012551/image_n/nCD012551-CMP-012-01.png" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD012551-fig-0070"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD012551.pub3/media/CDSR/CD012551/urn:x-wiley:14651858:media:CD012551:CD012551-CMP-012-02" target="_blank"><b></b></a></p> </div> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD012551.pub3/media/CDSR/CD012551/image_t/tCD012551-CMP-012-02.xxx" target="_blank"><b></b></a></p> </div><img alt="Comparison 12 External radiofrequency hyperthermia with or without terazosin, Outcome 2 Adverse events." data-id="CD012551-fig-0070" src="/cdsr/doi/10.1002/14651858.CD012551.pub3/media/CDSR/CD012551/image_n/nCD012551-CMP-012-02.png"/> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 12.2</div> <div class="figure-caption"> <p>Comparison 12 External radiofrequency hyperthermia with or without terazosin, Outcome 2 Adverse events. </p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD012551.pub3/references#CD012551-fig-0070">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD012551.pub3/media/CDSR/CD012551/image_n/nCD012551-CMP-012-02.png" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD012551-fig-0071"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD012551.pub3/media/CDSR/CD012551/urn:x-wiley:14651858:media:CD012551:CD012551-CMP-013-01" target="_blank"><b></b></a></p> </div> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD012551.pub3/media/CDSR/CD012551/image_t/tCD012551-CMP-013-01.xxx" target="_blank"><b></b></a></p> </div><img alt="Comparison 13 Laser therapy versus medical treatment, Outcome 1 Prostatitis symptoms." data-id="CD012551-fig-0071" src="/cdsr/doi/10.1002/14651858.CD012551.pub3/media/CDSR/CD012551/image_n/nCD012551-CMP-013-01.png"/> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 13.1</div> <div class="figure-caption"> <p>Comparison 13 Laser therapy versus medical treatment, Outcome 1 Prostatitis symptoms.</p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD012551.pub3/references#CD012551-fig-0071">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD012551.pub3/media/CDSR/CD012551/image_n/nCD012551-CMP-013-01.png" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD012551-fig-0072"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD012551.pub3/media/CDSR/CD012551/urn:x-wiley:14651858:media:CD012551:CD012551-CMP-013-02" target="_blank"><b></b></a></p> </div> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD012551.pub3/media/CDSR/CD012551/image_t/tCD012551-CMP-013-02.xxx" target="_blank"><b></b></a></p> </div><img alt="Comparison 13 Laser therapy versus medical treatment, Outcome 2 Adverse events." data-id="CD012551-fig-0072" src="/cdsr/doi/10.1002/14651858.CD012551.pub3/media/CDSR/CD012551/image_n/nCD012551-CMP-013-02.png"/> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 13.2</div> <div class="figure-caption"> <p>Comparison 13 Laser therapy versus medical treatment, Outcome 2 Adverse events.</p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD012551.pub3/references#CD012551-fig-0072">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD012551.pub3/media/CDSR/CD012551/image_n/nCD012551-CMP-013-02.png" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD012551-fig-0073"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD012551.pub3/media/CDSR/CD012551/urn:x-wiley:14651858:media:CD012551:CD012551-CMP-014-01" target="_blank"><b></b></a></p> </div> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD012551.pub3/media/CDSR/CD012551/image_t/tCD012551-CMP-014-01.xxx" target="_blank"><b></b></a></p> </div><img alt="Comparison 14 Tibial nerve stimulation versus no intervention, Outcome 1 Prostatitis symptoms (NIH‐CPSI total)." data-id="CD012551-fig-0073" src="/cdsr/doi/10.1002/14651858.CD012551.pub3/media/CDSR/CD012551/image_n/nCD012551-CMP-014-01.png"/> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 14.1</div> <div class="figure-caption"> <p>Comparison 14 Tibial nerve stimulation versus no intervention, Outcome 1 Prostatitis symptoms (NIH‐CPSI total). </p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD012551.pub3/references#CD012551-fig-0073">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD012551.pub3/media/CDSR/CD012551/image_n/nCD012551-CMP-014-01.png" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD012551-fig-0074"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD012551.pub3/media/CDSR/CD012551/urn:x-wiley:14651858:media:CD012551:CD012551-CMP-014-02" target="_blank"><b></b></a></p> </div> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD012551.pub3/media/CDSR/CD012551/image_t/tCD012551-CMP-014-02.xxx" target="_blank"><b></b></a></p> </div><img alt="Comparison 14 Tibial nerve stimulation versus no intervention, Outcome 2 Prostatitis symptoms: pain subscore." data-id="CD012551-fig-0074" src="/cdsr/doi/10.1002/14651858.CD012551.pub3/media/CDSR/CD012551/image_n/nCD012551-CMP-014-02.png"/> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 14.2</div> <div class="figure-caption"> <p>Comparison 14 Tibial nerve stimulation versus no intervention, Outcome 2 Prostatitis symptoms: pain subscore. </p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD012551.pub3/references#CD012551-fig-0074">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD012551.pub3/media/CDSR/CD012551/image_n/nCD012551-CMP-014-02.png" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD012551-fig-0075"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD012551.pub3/media/CDSR/CD012551/urn:x-wiley:14651858:media:CD012551:CD012551-CMP-014-03" target="_blank"><b></b></a></p> </div> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD012551.pub3/media/CDSR/CD012551/image_t/tCD012551-CMP-014-03.xxx" target="_blank"><b></b></a></p> </div><img alt="Comparison 14 Tibial nerve stimulation versus no intervention, Outcome 3 Prostatitis symptoms: micturition subscore." data-id="CD012551-fig-0075" src="/cdsr/doi/10.1002/14651858.CD012551.pub3/media/CDSR/CD012551/image_n/nCD012551-CMP-014-03.png"/> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 14.3</div> <div class="figure-caption"> <p>Comparison 14 Tibial nerve stimulation versus no intervention, Outcome 3 Prostatitis symptoms: micturition subscore. </p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD012551.pub3/references#CD012551-fig-0075">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD012551.pub3/media/CDSR/CD012551/image_n/nCD012551-CMP-014-03.png" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD012551-fig-0076"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD012551.pub3/media/CDSR/CD012551/urn:x-wiley:14651858:media:CD012551:CD012551-CMP-014-04" target="_blank"><b></b></a></p> </div> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD012551.pub3/media/CDSR/CD012551/image_t/tCD012551-CMP-014-04.xxx" target="_blank"><b></b></a></p> </div><img alt="Comparison 14 Tibial nerve stimulation versus no intervention, Outcome 4 Prostatitis symptoms: quality of life subscore." data-id="CD012551-fig-0076" src="/cdsr/doi/10.1002/14651858.CD012551.pub3/media/CDSR/CD012551/image_n/nCD012551-CMP-014-04.png"/> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 14.4</div> <div class="figure-caption"> <p>Comparison 14 Tibial nerve stimulation versus no intervention, Outcome 4 Prostatitis symptoms: quality of life subscore. </p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD012551.pub3/references#CD012551-fig-0076">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD012551.pub3/media/CDSR/CD012551/image_n/nCD012551-CMP-014-04.png" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD012551-fig-0077"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD012551.pub3/media/CDSR/CD012551/urn:x-wiley:14651858:media:CD012551:CD012551-CMP-015-01" target="_blank"><b></b></a></p> </div> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD012551.pub3/media/CDSR/CD012551/image_t/tCD012551-CMP-015-01.xxx" target="_blank"><b></b></a></p> </div><img alt="Comparison 15 Myofascial therapy versus control intervention, Outcome 1 Prostatitis symptoms (NIH‐CPSI total)." data-id="CD012551-fig-0077" src="/cdsr/doi/10.1002/14651858.CD012551.pub3/media/CDSR/CD012551/image_n/nCD012551-CMP-015-01.png"/> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 15.1</div> <div class="figure-caption"> <p>Comparison 15 Myofascial therapy versus control intervention, Outcome 1 Prostatitis symptoms (NIH‐CPSI total). </p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD012551.pub3/references#CD012551-fig-0077">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD012551.pub3/media/CDSR/CD012551/image_n/nCD012551-CMP-015-01.png" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD012551-fig-0078"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD012551.pub3/media/CDSR/CD012551/urn:x-wiley:14651858:media:CD012551:CD012551-CMP-015-02" target="_blank"><b></b></a></p> </div> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD012551.pub3/media/CDSR/CD012551/image_t/tCD012551-CMP-015-02.xxx" target="_blank"><b></b></a></p> </div><img alt="Comparison 15 Myofascial therapy versus control intervention, Outcome 2 Prostatitis symptoms: pain subscore." data-id="CD012551-fig-0078" src="/cdsr/doi/10.1002/14651858.CD012551.pub3/media/CDSR/CD012551/image_n/nCD012551-CMP-015-02.png"/> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 15.2</div> <div class="figure-caption"> <p>Comparison 15 Myofascial therapy versus control intervention, Outcome 2 Prostatitis symptoms: pain subscore. </p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD012551.pub3/references#CD012551-fig-0078">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD012551.pub3/media/CDSR/CD012551/image_n/nCD012551-CMP-015-02.png" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD012551-fig-0079"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD012551.pub3/media/CDSR/CD012551/urn:x-wiley:14651858:media:CD012551:CD012551-CMP-015-03" target="_blank"><b></b></a></p> </div> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD012551.pub3/media/CDSR/CD012551/image_t/tCD012551-CMP-015-03.xxx" target="_blank"><b></b></a></p> </div><img alt="Comparison 15 Myofascial therapy versus control intervention, Outcome 3 Prostatitis symptoms: micturition subscore." data-id="CD012551-fig-0079" src="/cdsr/doi/10.1002/14651858.CD012551.pub3/media/CDSR/CD012551/image_n/nCD012551-CMP-015-03.png"/> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 15.3</div> <div class="figure-caption"> <p>Comparison 15 Myofascial therapy versus control intervention, Outcome 3 Prostatitis symptoms: micturition subscore. </p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD012551.pub3/references#CD012551-fig-0079">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD012551.pub3/media/CDSR/CD012551/image_n/nCD012551-CMP-015-03.png" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD012551-fig-0080"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD012551.pub3/media/CDSR/CD012551/urn:x-wiley:14651858:media:CD012551:CD012551-CMP-015-04" target="_blank"><b></b></a></p> </div> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD012551.pub3/media/CDSR/CD012551/image_t/tCD012551-CMP-015-04.xxx" target="_blank"><b></b></a></p> </div><img alt="Comparison 15 Myofascial therapy versus control intervention, Outcome 4 Prostatitis symptoms: quality of life subscore." data-id="CD012551-fig-0080" src="/cdsr/doi/10.1002/14651858.CD012551.pub3/media/CDSR/CD012551/image_n/nCD012551-CMP-015-04.png"/> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 15.4</div> <div class="figure-caption"> <p>Comparison 15 Myofascial therapy versus control intervention, Outcome 4 Prostatitis symptoms: quality of life subscore. </p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD012551.pub3/references#CD012551-fig-0080">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD012551.pub3/media/CDSR/CD012551/image_n/nCD012551-CMP-015-04.png" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD012551-fig-0081"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD012551.pub3/media/CDSR/CD012551/urn:x-wiley:14651858:media:CD012551:CD012551-CMP-015-05" target="_blank"><b></b></a></p> </div> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD012551.pub3/media/CDSR/CD012551/image_t/tCD012551-CMP-015-05.xxx" target="_blank"><b></b></a></p> </div><img alt="Comparison 15 Myofascial therapy versus control intervention, Outcome 5 Sexual dysfunction." data-id="CD012551-fig-0081" src="/cdsr/doi/10.1002/14651858.CD012551.pub3/media/CDSR/CD012551/image_n/nCD012551-CMP-015-05.png"/> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 15.5</div> <div class="figure-caption"> <p>Comparison 15 Myofascial therapy versus control intervention, Outcome 5 Sexual dysfunction.</p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD012551.pub3/references#CD012551-fig-0081">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD012551.pub3/media/CDSR/CD012551/image_n/nCD012551-CMP-015-05.png" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD012551-fig-0082"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD012551.pub3/media/CDSR/CD012551/urn:x-wiley:14651858:media:CD012551:CD012551-CMP-015-06" target="_blank"><b></b></a></p> </div> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD012551.pub3/media/CDSR/CD012551/image_t/tCD012551-CMP-015-06.xxx" target="_blank"><b></b></a></p> </div><img alt="Comparison 15 Myofascial therapy versus control intervention, Outcome 6 Quality of life ‐ physical." data-id="CD012551-fig-0082" src="/cdsr/doi/10.1002/14651858.CD012551.pub3/media/CDSR/CD012551/image_n/nCD012551-CMP-015-06.png"/> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 15.6</div> <div class="figure-caption"> <p>Comparison 15 Myofascial therapy versus control intervention, Outcome 6 Quality of life ‐ physical. </p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD012551.pub3/references#CD012551-fig-0082">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD012551.pub3/media/CDSR/CD012551/image_n/nCD012551-CMP-015-06.png" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD012551-fig-0083"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD012551.pub3/media/CDSR/CD012551/urn:x-wiley:14651858:media:CD012551:CD012551-CMP-015-07" target="_blank"><b></b></a></p> </div> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD012551.pub3/media/CDSR/CD012551/image_t/tCD012551-CMP-015-07.xxx" target="_blank"><b></b></a></p> </div><img alt="Comparison 15 Myofascial therapy versus control intervention, Outcome 7 Quality of life ‐ mental." data-id="CD012551-fig-0083" src="/cdsr/doi/10.1002/14651858.CD012551.pub3/media/CDSR/CD012551/image_n/nCD012551-CMP-015-07.png"/> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 15.7</div> <div class="figure-caption"> <p>Comparison 15 Myofascial therapy versus control intervention, Outcome 7 Quality of life ‐ mental. </p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD012551.pub3/references#CD012551-fig-0083">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD012551.pub3/media/CDSR/CD012551/image_n/nCD012551-CMP-015-07.png" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD012551-fig-0084"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD012551.pub3/media/CDSR/CD012551/urn:x-wiley:14651858:media:CD012551:CD012551-CMP-016-01" target="_blank"><b></b></a></p> </div> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD012551.pub3/media/CDSR/CD012551/image_t/tCD012551-CMP-016-01.xxx" target="_blank"><b></b></a></p> </div><img alt="Comparison 16 Osteopathy versus sham procedure, Outcome 1 Prostatitis symptoms (NIH‐CPSI total)." data-id="CD012551-fig-0084" src="/cdsr/doi/10.1002/14651858.CD012551.pub3/media/CDSR/CD012551/image_n/nCD012551-CMP-016-01.png"/> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 16.1</div> <div class="figure-caption"> <p>Comparison 16 Osteopathy versus sham procedure, Outcome 1 Prostatitis symptoms (NIH‐CPSI total). </p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD012551.pub3/references#CD012551-fig-0084">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD012551.pub3/media/CDSR/CD012551/image_n/nCD012551-CMP-016-01.png" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD012551-fig-0085"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD012551.pub3/media/CDSR/CD012551/urn:x-wiley:14651858:media:CD012551:CD012551-CMP-016-02" target="_blank"><b></b></a></p> </div> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD012551.pub3/media/CDSR/CD012551/image_t/tCD012551-CMP-016-02.xxx" target="_blank"><b></b></a></p> </div><img alt="Comparison 16 Osteopathy versus sham procedure, Outcome 2 Prostatitis symptoms: quality of life subscore." data-id="CD012551-fig-0085" src="/cdsr/doi/10.1002/14651858.CD012551.pub3/media/CDSR/CD012551/image_n/nCD012551-CMP-016-02.png"/> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 16.2</div> <div class="figure-caption"> <p>Comparison 16 Osteopathy versus sham procedure, Outcome 2 Prostatitis symptoms: quality of life subscore. </p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD012551.pub3/references#CD012551-fig-0085">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD012551.pub3/media/CDSR/CD012551/image_n/nCD012551-CMP-016-02.png" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD012551-fig-0086"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD012551.pub3/media/CDSR/CD012551/urn:x-wiley:14651858:media:CD012551:CD012551-CMP-016-03" target="_blank"><b></b></a></p> </div> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD012551.pub3/media/CDSR/CD012551/image_t/tCD012551-CMP-016-03.xxx" target="_blank"><b></b></a></p> </div><img alt="Comparison 16 Osteopathy versus sham procedure, Outcome 3 Urinary symptoms." data-id="CD012551-fig-0086" src="/cdsr/doi/10.1002/14651858.CD012551.pub3/media/CDSR/CD012551/image_n/nCD012551-CMP-016-03.png"/> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 16.3</div> <div class="figure-caption"> <p>Comparison 16 Osteopathy versus sham procedure, Outcome 3 Urinary symptoms.</p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD012551.pub3/references#CD012551-fig-0086">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD012551.pub3/media/CDSR/CD012551/image_n/nCD012551-CMP-016-03.png" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD012551-fig-0087"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD012551.pub3/media/CDSR/CD012551/urn:x-wiley:14651858:media:CD012551:CD012551-CMP-017-01" target="_blank"><b></b></a></p> </div> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD012551.pub3/media/CDSR/CD012551/image_t/tCD012551-CMP-017-01.xxx" target="_blank"><b></b></a></p> </div><img alt="Comparison 17 Sono‐electromagnetic therapy versus placebo, Outcome 1 Prostatitis symptoms (NIH‐CPSI total)." data-id="CD012551-fig-0087" src="/cdsr/doi/10.1002/14651858.CD012551.pub3/media/CDSR/CD012551/image_n/nCD012551-CMP-017-01.png"/> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 17.1</div> <div class="figure-caption"> <p>Comparison 17 Sono‐electromagnetic therapy versus placebo, Outcome 1 Prostatitis symptoms (NIH‐CPSI total). </p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD012551.pub3/references#CD012551-fig-0087">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD012551.pub3/media/CDSR/CD012551/image_n/nCD012551-CMP-017-01.png" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD012551-fig-0088"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD012551.pub3/media/CDSR/CD012551/urn:x-wiley:14651858:media:CD012551:CD012551-CMP-017-02" target="_blank"><b></b></a></p> </div> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD012551.pub3/media/CDSR/CD012551/image_t/tCD012551-CMP-017-02.xxx" target="_blank"><b></b></a></p> </div><img alt="Comparison 17 Sono‐electromagnetic therapy versus placebo, Outcome 2 Prostatitis symptoms." data-id="CD012551-fig-0088" src="/cdsr/doi/10.1002/14651858.CD012551.pub3/media/CDSR/CD012551/image_n/nCD012551-CMP-017-02.png"/> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 17.2</div> <div class="figure-caption"> <p>Comparison 17 Sono‐electromagnetic therapy versus placebo, Outcome 2 Prostatitis symptoms.</p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD012551.pub3/references#CD012551-fig-0088">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD012551.pub3/media/CDSR/CD012551/image_n/nCD012551-CMP-017-02.png" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD012551-fig-0089"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD012551.pub3/media/CDSR/CD012551/urn:x-wiley:14651858:media:CD012551:CD012551-CMP-017-03" target="_blank"><b></b></a></p> </div> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD012551.pub3/media/CDSR/CD012551/image_t/tCD012551-CMP-017-03.xxx" target="_blank"><b></b></a></p> </div><img alt="Comparison 17 Sono‐electromagnetic therapy versus placebo, Outcome 3 Prostatitis symptoms: pain subscore." data-id="CD012551-fig-0089" src="/cdsr/doi/10.1002/14651858.CD012551.pub3/media/CDSR/CD012551/image_n/nCD012551-CMP-017-03.png"/> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 17.3</div> <div class="figure-caption"> <p>Comparison 17 Sono‐electromagnetic therapy versus placebo, Outcome 3 Prostatitis symptoms: pain subscore. </p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD012551.pub3/references#CD012551-fig-0089">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD012551.pub3/media/CDSR/CD012551/image_n/nCD012551-CMP-017-03.png" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD012551-fig-0090"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD012551.pub3/media/CDSR/CD012551/urn:x-wiley:14651858:media:CD012551:CD012551-CMP-017-04" target="_blank"><b></b></a></p> </div> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD012551.pub3/media/CDSR/CD012551/image_t/tCD012551-CMP-017-04.xxx" target="_blank"><b></b></a></p> </div><img alt="Comparison 17 Sono‐electromagnetic therapy versus placebo, Outcome 4 Prostatitis symptoms: micturition subscore." data-id="CD012551-fig-0090" src="/cdsr/doi/10.1002/14651858.CD012551.pub3/media/CDSR/CD012551/image_n/nCD012551-CMP-017-04.png"/> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 17.4</div> <div class="figure-caption"> <p>Comparison 17 Sono‐electromagnetic therapy versus placebo, Outcome 4 Prostatitis symptoms: micturition subscore. </p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD012551.pub3/references#CD012551-fig-0090">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD012551.pub3/media/CDSR/CD012551/image_n/nCD012551-CMP-017-04.png" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD012551-fig-0091"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD012551.pub3/media/CDSR/CD012551/urn:x-wiley:14651858:media:CD012551:CD012551-CMP-017-05" target="_blank"><b></b></a></p> </div> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD012551.pub3/media/CDSR/CD012551/image_t/tCD012551-CMP-017-05.xxx" target="_blank"><b></b></a></p> </div><img alt="Comparison 17 Sono‐electromagnetic therapy versus placebo, Outcome 5 Prostatitis symptoms: quality of life subscore." data-id="CD012551-fig-0091" src="/cdsr/doi/10.1002/14651858.CD012551.pub3/media/CDSR/CD012551/image_n/nCD012551-CMP-017-05.png"/> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 17.5</div> <div class="figure-caption"> <p>Comparison 17 Sono‐electromagnetic therapy versus placebo, Outcome 5 Prostatitis symptoms: quality of life subscore. </p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD012551.pub3/references#CD012551-fig-0091">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD012551.pub3/media/CDSR/CD012551/image_n/nCD012551-CMP-017-05.png" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD012551-fig-0092"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD012551.pub3/media/CDSR/CD012551/urn:x-wiley:14651858:media:CD012551:CD012551-CMP-018-01" target="_blank"><b></b></a></p> </div> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD012551.pub3/media/CDSR/CD012551/image_t/tCD012551-CMP-018-01.xxx" target="_blank"><b></b></a></p> </div><img alt="Comparison 18 Transelectrical nerve stimulation (TENS) versus control, Outcome 1 Prostatitis symptoms: pain subscore." data-id="CD012551-fig-0092" src="/cdsr/doi/10.1002/14651858.CD012551.pub3/media/CDSR/CD012551/image_n/nCD012551-CMP-018-01.png"/> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 18.1</div> <div class="figure-caption"> <p>Comparison 18 Transelectrical nerve stimulation (TENS) versus control, Outcome 1 Prostatitis symptoms: pain subscore. </p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD012551.pub3/references#CD012551-fig-0092">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD012551.pub3/media/CDSR/CD012551/image_n/nCD012551-CMP-018-01.png" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD012551-fig-0093"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD012551.pub3/media/CDSR/CD012551/urn:x-wiley:14651858:media:CD012551:CD012551-CMP-019-01" target="_blank"><b></b></a></p> </div> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD012551.pub3/media/CDSR/CD012551/image_t/tCD012551-CMP-019-01.xxx" target="_blank"><b></b></a></p> </div><img alt="Comparison 19 Transurethral microwave thermotherapy, Outcome 1 Prostatitis symptoms (NIH‐CPSI total)." data-id="CD012551-fig-0093" src="/cdsr/doi/10.1002/14651858.CD012551.pub3/media/CDSR/CD012551/image_n/nCD012551-CMP-019-01.png"/> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 19.1</div> <div class="figure-caption"> <p>Comparison 19 Transurethral microwave thermotherapy, Outcome 1 Prostatitis symptoms (NIH‐CPSI total). </p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD012551.pub3/references#CD012551-fig-0093">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD012551.pub3/media/CDSR/CD012551/image_n/nCD012551-CMP-019-01.png" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD012551-fig-0094"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD012551.pub3/media/CDSR/CD012551/urn:x-wiley:14651858:media:CD012551:CD012551-CMP-019-02" target="_blank"><b></b></a></p> </div> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD012551.pub3/media/CDSR/CD012551/image_t/tCD012551-CMP-019-02.xxx" target="_blank"><b></b></a></p> </div><img alt="Comparison 19 Transurethral microwave thermotherapy, Outcome 2 Prostatitis symptoms: pain subscore." data-id="CD012551-fig-0094" src="/cdsr/doi/10.1002/14651858.CD012551.pub3/media/CDSR/CD012551/image_n/nCD012551-CMP-019-02.png"/> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 19.2</div> <div class="figure-caption"> <p>Comparison 19 Transurethral microwave thermotherapy, Outcome 2 Prostatitis symptoms: pain subscore. </p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD012551.pub3/references#CD012551-fig-0094">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD012551.pub3/media/CDSR/CD012551/image_n/nCD012551-CMP-019-02.png" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD012551-fig-0095"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD012551.pub3/media/CDSR/CD012551/urn:x-wiley:14651858:media:CD012551:CD012551-CMP-019-03" target="_blank"><b></b></a></p> </div> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD012551.pub3/media/CDSR/CD012551/image_t/tCD012551-CMP-019-03.xxx" target="_blank"><b></b></a></p> </div><img alt="Comparison 19 Transurethral microwave thermotherapy, Outcome 3 Prostatitis symptoms: micturition subscore." data-id="CD012551-fig-0095" src="/cdsr/doi/10.1002/14651858.CD012551.pub3/media/CDSR/CD012551/image_n/nCD012551-CMP-019-03.png"/> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 19.3</div> <div class="figure-caption"> <p>Comparison 19 Transurethral microwave thermotherapy, Outcome 3 Prostatitis symptoms: micturition subscore. </p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD012551.pub3/references#CD012551-fig-0095">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD012551.pub3/media/CDSR/CD012551/image_n/nCD012551-CMP-019-03.png" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD012551-fig-0096"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD012551.pub3/media/CDSR/CD012551/urn:x-wiley:14651858:media:CD012551:CD012551-CMP-019-04" target="_blank"><b></b></a></p> </div> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD012551.pub3/media/CDSR/CD012551/image_t/tCD012551-CMP-019-04.xxx" target="_blank"><b></b></a></p> </div><img alt="Comparison 19 Transurethral microwave thermotherapy, Outcome 4 Prostatitis symptoms: quality of life subscore." data-id="CD012551-fig-0096" src="/cdsr/doi/10.1002/14651858.CD012551.pub3/media/CDSR/CD012551/image_n/nCD012551-CMP-019-04.png"/> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 19.4</div> <div class="figure-caption"> <p>Comparison 19 Transurethral microwave thermotherapy, Outcome 4 Prostatitis symptoms: quality of life subscore. </p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD012551.pub3/references#CD012551-fig-0096">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD012551.pub3/media/CDSR/CD012551/image_n/nCD012551-CMP-019-04.png" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD012551-fig-0097"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD012551.pub3/media/CDSR/CD012551/urn:x-wiley:14651858:media:CD012551:CD012551-CMP-019-05" target="_blank"><b></b></a></p> </div> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD012551.pub3/media/CDSR/CD012551/image_t/tCD012551-CMP-019-05.xxx" target="_blank"><b></b></a></p> </div><img alt="Comparison 19 Transurethral microwave thermotherapy, Outcome 5 Urinary symptoms." data-id="CD012551-fig-0097" src="/cdsr/doi/10.1002/14651858.CD012551.pub3/media/CDSR/CD012551/image_n/nCD012551-CMP-019-05.png"/> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 19.5</div> <div class="figure-caption"> <p>Comparison 19 Transurethral microwave thermotherapy, Outcome 5 Urinary symptoms.</p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD012551.pub3/references#CD012551-fig-0097">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD012551.pub3/media/CDSR/CD012551/image_n/nCD012551-CMP-019-05.png" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD012551-fig-0098"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD012551.pub3/media/CDSR/CD012551/urn:x-wiley:14651858:media:CD012551:CD012551-CMP-020-01" target="_blank"><b></b></a></p> </div> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD012551.pub3/media/CDSR/CD012551/image_t/tCD012551-CMP-020-01.xxx" target="_blank"><b></b></a></p> </div><img alt="Comparison 20 Transurethral needle ablation (TUNA) versus sham procedure, Outcome 1 Prostatitis symptoms (NIH‐CPSI total)." data-id="CD012551-fig-0098" src="/cdsr/doi/10.1002/14651858.CD012551.pub3/media/CDSR/CD012551/image_n/nCD012551-CMP-020-01.png"/> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 20.1</div> <div class="figure-caption"> <p>Comparison 20 Transurethral needle ablation (TUNA) versus sham procedure, Outcome 1 Prostatitis symptoms (NIH‐CPSI total). </p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD012551.pub3/references#CD012551-fig-0098">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD012551.pub3/media/CDSR/CD012551/image_n/nCD012551-CMP-020-01.png" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD012551-fig-0099"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD012551.pub3/media/CDSR/CD012551/urn:x-wiley:14651858:media:CD012551:CD012551-CMP-020-02" target="_blank"><b></b></a></p> </div> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD012551.pub3/media/CDSR/CD012551/image_t/tCD012551-CMP-020-02.xxx" target="_blank"><b></b></a></p> </div><img alt="Comparison 20 Transurethral needle ablation (TUNA) versus sham procedure, Outcome 2 Urinary symptoms." data-id="CD012551-fig-0099" src="/cdsr/doi/10.1002/14651858.CD012551.pub3/media/CDSR/CD012551/image_n/nCD012551-CMP-020-02.png"/> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 20.2</div> <div class="figure-caption"> <p>Comparison 20 Transurethral needle ablation (TUNA) versus sham procedure, Outcome 2 Urinary symptoms. </p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD012551.pub3/references#CD012551-fig-0099">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD012551.pub3/media/CDSR/CD012551/image_n/nCD012551-CMP-020-02.png" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD012551-fig-0100"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD012551.pub3/media/CDSR/CD012551/urn:x-wiley:14651858:media:CD012551:CD012551-CMP-021-01" target="_blank"><b></b></a></p> </div> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD012551.pub3/media/CDSR/CD012551/image_t/tCD012551-CMP-021-01.xxx" target="_blank"><b></b></a></p> </div><img alt="Comparison 21 Ultrasound (non‐intrusive), Outcome 1 Prostatitis symptoms (NIH‐CPSI total)." data-id="CD012551-fig-0100" src="/cdsr/doi/10.1002/14651858.CD012551.pub3/media/CDSR/CD012551/image_n/nCD012551-CMP-021-01.png"/> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 21.1</div> <div class="figure-caption"> <p>Comparison 21 Ultrasound (non‐intrusive), Outcome 1 Prostatitis symptoms (NIH‐CPSI total). </p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD012551.pub3/references#CD012551-fig-0100">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD012551.pub3/media/CDSR/CD012551/image_n/nCD012551-CMP-021-01.png" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD012551-fig-0101"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD012551.pub3/media/CDSR/CD012551/urn:x-wiley:14651858:media:CD012551:CD012551-CMP-021-02" target="_blank"><b></b></a></p> </div> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD012551.pub3/media/CDSR/CD012551/image_t/tCD012551-CMP-021-02.xxx" target="_blank"><b></b></a></p> </div><img alt="Comparison 21 Ultrasound (non‐intrusive), Outcome 2 Prostatitis symptoms: pain subscore." data-id="CD012551-fig-0101" src="/cdsr/doi/10.1002/14651858.CD012551.pub3/media/CDSR/CD012551/image_n/nCD012551-CMP-021-02.png"/> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 21.2</div> <div class="figure-caption"> <p>Comparison 21 Ultrasound (non‐intrusive), Outcome 2 Prostatitis symptoms: pain subscore.</p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD012551.pub3/references#CD012551-fig-0101">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD012551.pub3/media/CDSR/CD012551/image_n/nCD012551-CMP-021-02.png" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD012551-fig-0102"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD012551.pub3/media/CDSR/CD012551/urn:x-wiley:14651858:media:CD012551:CD012551-CMP-021-03" target="_blank"><b></b></a></p> </div> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD012551.pub3/media/CDSR/CD012551/image_t/tCD012551-CMP-021-03.xxx" target="_blank"><b></b></a></p> </div><img alt="Comparison 21 Ultrasound (non‐intrusive), Outcome 3 Prostatitis symptoms: micturition subscore." data-id="CD012551-fig-0102" src="/cdsr/doi/10.1002/14651858.CD012551.pub3/media/CDSR/CD012551/image_n/nCD012551-CMP-021-03.png"/> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 21.3</div> <div class="figure-caption"> <p>Comparison 21 Ultrasound (non‐intrusive), Outcome 3 Prostatitis symptoms: micturition subscore. </p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD012551.pub3/references#CD012551-fig-0102">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD012551.pub3/media/CDSR/CD012551/image_n/nCD012551-CMP-021-03.png" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD012551-fig-0103"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD012551.pub3/media/CDSR/CD012551/urn:x-wiley:14651858:media:CD012551:CD012551-CMP-021-04" target="_blank"><b></b></a></p> </div> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD012551.pub3/media/CDSR/CD012551/image_t/tCD012551-CMP-021-04.xxx" target="_blank"><b></b></a></p> </div><img alt="Comparison 21 Ultrasound (non‐intrusive), Outcome 4 Prostatitis symptoms: quality of life subscore." data-id="CD012551-fig-0103" src="/cdsr/doi/10.1002/14651858.CD012551.pub3/media/CDSR/CD012551/image_n/nCD012551-CMP-021-04.png"/> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 21.4</div> <div class="figure-caption"> <p>Comparison 21 Ultrasound (non‐intrusive), Outcome 4 Prostatitis symptoms: quality of life subscore. </p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD012551.pub3/references#CD012551-fig-0103">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD012551.pub3/media/CDSR/CD012551/image_n/nCD012551-CMP-021-04.png" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD012551-fig-0104"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD012551.pub3/media/CDSR/CD012551/urn:x-wiley:14651858:media:CD012551:CD012551-CMP-021-05" target="_blank"><b></b></a></p> </div> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD012551.pub3/media/CDSR/CD012551/image_t/tCD012551-CMP-021-05.xxx" target="_blank"><b></b></a></p> </div><img alt="Comparison 21 Ultrasound (non‐intrusive), Outcome 5 Prostatitis symptoms." data-id="CD012551-fig-0104" src="/cdsr/doi/10.1002/14651858.CD012551.pub3/media/CDSR/CD012551/image_n/nCD012551-CMP-021-05.png"/> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 21.5</div> <div class="figure-caption"> <p>Comparison 21 Ultrasound (non‐intrusive), Outcome 5 Prostatitis symptoms.</p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD012551.pub3/references#CD012551-fig-0104">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD012551.pub3/media/CDSR/CD012551/image_n/nCD012551-CMP-021-05.png" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD012551-fig-0105"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD012551.pub3/media/CDSR/CD012551/urn:x-wiley:14651858:media:CD012551:CD012551-CMP-022-01" target="_blank"><b></b></a></p> </div> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD012551.pub3/media/CDSR/CD012551/image_t/tCD012551-CMP-022-01.png" target="_blank"><b></b></a></p> </div><img alt="Comparison 22 Acupuncture treatments versus medical treatment ‐ sensitivity analysis, Outcome 1 Prostatitis symptoms (NIH‐CPSI total)." data-id="CD012551-fig-0105" src="/cdsr/doi/10.1002/14651858.CD012551.pub3/media/CDSR/CD012551/image_n/nCD012551-CMP-022-01.png"/> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 22.1</div> <div class="figure-caption"> <p>Comparison 22 Acupuncture treatments versus medical treatment ‐ sensitivity analysis, Outcome 1 Prostatitis symptoms (NIH‐CPSI total). </p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD012551.pub3/references#CD012551-fig-0105">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD012551.pub3/media/CDSR/CD012551/image_n/nCD012551-CMP-022-01.png" target="_blank">Open in new tab</a></div> </div> </div> <div class="tables-list"> <div class="table"> <table class="summary-of-findings framed" data-id="CD012551-tbl-0001"> <div class="table-heading"><span class="table-label">Summary of findings for the main comparison.</span> <span class="table-title">Acupuncture compared to sham procedure for treating chronic prostatitis/chronic pelvic pain syndrome</span></div> <tbody> <tr class="separated"> <td align="left" bgcolor="#ffffff" colspan="6" rowspan="1" valign="top"> <p><b>Acupuncture compared to sham procedure for chronic prostatitis/chronic pelvic pain syndrome</b> </p> </td> </tr> <tr class="separated"> <td align="left" bgcolor="#ffffff" colspan="6" rowspan="1" valign="top"> <p><b>Patient or population:</b> participants with chronic prostatitis/chronic pelvic pain syndrome<br/> <b>Setting:</b> outpatient, Korea, Malaysia, US and Turkey<br/> <b>Intervention:</b> acupuncture<br/> <b>Comparison:</b> sham procedure placing needles in different points from those used in acupuncture </p> </td> </tr> <tr class="table-header separated"> <td align="left" class="table-header" colspan="1" rowspan="2" valign="top"> <p><b>Outcomes</b> </p> </td> <td align="left" class="table-tint table-highlight" colspan="1" rowspan="2" valign="top"> <p><b>№ of participants<br/> (studies)</b> </p> </td> <td align="left" class="table-tint table-highlight" colspan="1" rowspan="2" valign="top"> <p><b>Quality of the evidence<br/> (GRADE)</b> </p> </td> <td align="left" class="table-header" colspan="1" rowspan="2" valign="top"> <p><b>Relative effect<br/> (95% CI)</b> </p> </td> <td align="left" class="table-header" colspan="2" rowspan="1" valign="top"> <p><b>Anticipated absolute effects<sup>*</sup> (95% CI)</b> </p> </td> </tr> <tr class="table-header separated"> <td align="left" class="table-header" colspan="1" rowspan="1" valign="top"> <p><b>Risk with sham procedure</b> </p> </td> <td align="left" class="table-header" colspan="1" rowspan="1" valign="top"> <p><b>Risk difference with Acupuncture</b> </p> </td> </tr> <tr class="separated"> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><b>Prostatitis Symptoms</b><br/> assessed with: NIH‐CPSI score<br/> Scale from: 0 to 43<br/> follow up: 6‐8 weeks </p> <p>Benefit is indicated by lower scores</p> </td> <td align="left" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p>204<br/> (3 RCTs) </p> </td> <td align="left" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p>⊕⊕⊕⊝<br/> <b>Moderate</b><sup>1</sup> </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>‐</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>The mean prostatitis Symptoms ranged from 17.08 to 22</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><b>MD 5.79 lower</b><br/> (7.32 lower to 4.26 lower) </p> </td> </tr> <tr class="separated"> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="2" valign="top"> <p><b>Prostatitis Symptoms</b><br/> assessed with: NIH‐CPSI score (response)<br/> follow up: 6 weeks </p> </td> <td align="left" class="table-tint table-highlight" colspan="1" rowspan="2" valign="top"> <p>113<br/> (2 RCTs) </p> </td> <td align="left" class="table-tint table-highlight" colspan="1" rowspan="2" valign="top"> <p>⊕⊝⊝⊝<br/> <b>Very low</b><sup>1 2 3</sup> </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="2" valign="top"> <p><b>RR 2.49</b><br/> (0.77 to 8.02) </p> </td> <td align="left" bgcolor="#ffffff" colspan="2" rowspan="1" valign="top"> <p>Study population</p> </td> </tr> <tr class="separated"> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>404 per 1.000</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><b>596 more per 1000</b><br/> (93 fewer to 596 more) </p> </td> </tr> <tr class="separated"> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="2" valign="top"> <p><b>Adverse events</b> </p> <p>follow up: 6‐8 weeks</p> </td> <td align="left" class="table-tint table-highlight" colspan="1" rowspan="2" valign="top"> <p>204<br/> (3 RCTs) </p> </td> <td align="left" class="table-tint table-highlight" colspan="1" rowspan="2" valign="top"> <p>⊕⊕⊝⊝<br/> <b>Low</b><sup>1 3</sup> </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="2" valign="top"> <p><b>RR 1.33</b><br/> (0.51 to 3.46) </p> </td> <td align="left" bgcolor="#ffffff" colspan="2" rowspan="1" valign="top"> <p>Study population</p> </td> </tr> <tr class="separated"> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>58 per 1.000</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><b>19 more per 1000</b><br/> (29 fewer to 143 more) </p> </td> </tr> <tr class="separated"> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><b>Sexual dysfunction</b><br/> assessed with: International Index of Erectile Function<br/> Scale from: 5 to 25<br/> follow up: 6 weeks </p> <p>Benefit is indicated by higher scores</p> </td> <td align="left" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p>89<br/> (1 RCT) </p> </td> <td align="left" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p>⊕⊕⊝⊝<br/> <b>Low</b><sup>1 4</sup> </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>‐</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>The mean sexual dysfunction was 23</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><b>MD 0.5 lower</b><br/> (3.46 lower to 2.46 higher) </p> </td> </tr> <tr class="separated"> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><b>Quality of life</b> ‐ not reported </p> </td> <td align="left" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p>‐</p> </td> <td align="left" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p>‐</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>‐</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>‐</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>‐</p> </td> </tr> <tr class="separated"> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><b>Depression and anxiety</b> ‐ not reported </p> </td> <td align="left" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p>‐</p> </td> <td align="left" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p>‐</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>‐</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>‐</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>‐</p> </td> </tr> <tr class="separated"> <td align="" bgcolor="#ffffff" colspan="6" rowspan="1" valign=""> <p>*<b>The risk in the intervention group</b> (and its 95% confidence interval) is based on the assumed risk in the comparison group and the <b>relative effect</b> of the intervention (and its 95% CI).<br/> <br/> <b>CI:</b> Confidence interval; <b>RR:</b> Risk ratio; <b>OR:</b> Odds ratio; </p> </td> </tr> <tr class="separated"> <td align="" bgcolor="#ffffff" colspan="6" rowspan="1" valign=""> <p><b>GRADE Working Group grades of evidence</b> <br/> <b>High quality:</b> We are very confident that the true effect lies close to that of the estimate of the effect<br/> <b>Moderate quality:</b> We are moderately confident in the effect estimate: The true effect is likely to be close to the estimate of the effect, but there is a possibility that it is substantially different<br/> <b>Low quality:</b> Our confidence in the effect estimate is limited: The true effect may be substantially different from the estimate of the effect<br/> <b>Very low quality:</b> We have very little confidence in the effect estimate: The true effect is likely to be substantially different from the estimate of effect </p> </td> </tr> </tbody> <tfoot> <tr> <td colspan="6"> <div class="table-footnote"> <p><sup>1</sup> Downgraded 1 level due to unclear risk of bias: insufficient information about allocation concealment </p> <p><sup>2</sup> Downgraded 1 level due to inconsistency: statistical heterogeneity (I<sup>2</sup> = 76%). </p> <p><sup>3</sup> Downgraded 1 level due to imprecision issues: wide confidence interval due to small sample size and few events. </p> <p><sup>4</sup> Downgraded 1 level for imprecision issues: wide confidence interval includes both appreciable benefit and harm. </p> </div> </td> </tr> </tfoot> </table> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="table-viewer-caption"> <div class="table-heading"><span class="table-label">Summary of findings for the main comparison.</span> <span class="table-title">Acupuncture compared to sham procedure for treating chronic prostatitis/chronic pelvic pain syndrome</span></div> </div> <div class="tools"><a class="tableList" href="/cdsr/doi/10.1002/14651858.CD012551.pub3/full#CD012551-tbl-0001">Navigate to table in review</a></div> </div> <div class="table"> <table class="summary-of-findings framed" data-id="CD012551-tbl-0002"> <div class="table-heading"><span class="table-label">Summary of findings 2.</span> <span class="table-title">Acupuncture compared to medical treatment for treating chronic prostatitis/chronic pelvic pain syndrome</span></div> <tbody> <tr class="separated"> <td align="left" bgcolor="#ffffff" colspan="6" rowspan="1" valign="top"> <p><b>Acupuncture compared to medical treatment for chronic prostatitis/chronic pelvic pain syndrome</b> </p> </td> </tr> <tr class="separated"> <td align="left" bgcolor="#ffffff" colspan="6" rowspan="1" valign="top"> <p><b>Patient or population:</b> treating chronic prostatitis/chronic pelvic pain syndrome<br/> <b>Setting:</b> outpatient, Korea, China and Turkey<br/> <b>Intervention:</b> acupuncture<br/> <b>Comparison:</b> medical treatment </p> </td> </tr> <tr class="table-header separated"> <td align="left" class="table-header" colspan="1" rowspan="2" valign="top"> <p><b>Outcomes</b> </p> </td> <td align="left" class="table-tint table-highlight" colspan="1" rowspan="2" valign="top"> <p><b>№ of participants<br/> (studies)</b> </p> </td> <td align="left" class="table-tint table-highlight" colspan="1" rowspan="2" valign="top"> <p><b>Quality of the evidence<br/> (GRADE)</b> </p> </td> <td align="left" class="table-header" colspan="1" rowspan="2" valign="top"> <p><b>Relative effect<br/> (95% CI)</b> </p> </td> <td align="left" class="table-header" colspan="2" rowspan="1" valign="top"> <p><b>Anticipated absolute effects* (95% CI)</b> </p> </td> </tr> <tr class="table-header separated"> <td align="left" class="table-header" colspan="1" rowspan="1" valign="top"> <p><b>Risk with medical treatment</b> </p> </td> <td align="left" class="table-header" colspan="1" rowspan="1" valign="top"> <p><b>Risk difference with acupuncture</b> </p> </td> </tr> <tr class="separated"> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><b>Prostatitis symptoms</b> (NIH‐CPSI total)<br/> assessed with: NIH‐CPSI score<br/> Scale from: 0 to 43<br/> follow‐up: 12 weeks </p> <p>Benefit is indicated by lower scores</p> </td> <td align="left" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p>78<br/> (2 RCTs) </p> </td> <td align="left" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p>⊕⊕⊕⊝<br/> <b>Moderate</b><sup>1,2</sup> </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>‐</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>The mean prostatitis symptoms (NIH‐CPSI total) ranged from 12 to 16</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><b>MD 6.05 lower</b><br/> (7.87 lower to 4.24 lower) </p> </td> </tr> <tr class="separated"> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="2" valign="top"> <p><b>Prostatitis symptoms</b>: response defined as a 6‐point decrease in NIH‐CPSI score<br/> follow‐up: 6 weeks<sup>3</sup> </p> </td> <td align="left" class="table-tint table-highlight" colspan="1" rowspan="2" valign="top"> <p>24<br/> (1 RCT) </p> </td> <td align="left" class="table-tint table-highlight" colspan="1" rowspan="2" valign="top"> <p>⊕⊕⊝⊝<br/> <b>Low</b><sup>1,3</sup> </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="2" valign="top"> <p><b>RR 3.57</b><br/> (1.45 to 8.80) </p> </td> <td align="left" bgcolor="#ffffff" colspan="2" rowspan="1" valign="top"> <p>Study population</p> </td> </tr> <tr class="separated"> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>250 per 1000</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><b>643 more per 1000</b><br/> (112 more to 1950 more) </p> </td> </tr> <tr class="separated"> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><b>Adverse events</b> </p> <p>follow‐up: 12 weeks</p> </td> <td align="left" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p>78<br/> (2 RCTs) </p> </td> <td align="left" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p>⊕⊕⊝⊝<br/> <b>Low</b><sup>1,3</sup> </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>‐</p> </td> <td align="left" bgcolor="#ffffff" colspan="2" rowspan="1" valign="top"> <p>There were no adverse events in either group.</p> </td> </tr> <tr class="separated"> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><b>Sexual dysfunction</b> ‐ not reported </p> </td> <td align="left" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p>‐</p> </td> <td align="left" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p>‐</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>‐</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>‐</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>‐</p> </td> </tr> <tr class="separated"> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><b>Quality of life</b> ‐ not reported </p> </td> <td align="left" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p>‐</p> </td> <td align="left" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p>‐</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>‐</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>‐</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>‐</p> </td> </tr> <tr class="separated"> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><b>Depression and anxiety</b> ‐ not reported </p> </td> <td align="left" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p>‐</p> </td> <td align="left" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p>‐</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>‐</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>‐</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>‐</p> </td> </tr> <tr class="separated"> <td align="" bgcolor="#ffffff" colspan="6" rowspan="1" valign=""> <p>*<b>The risk in the intervention group</b> (and its 95% confidence interval) is based on the assumed risk in the comparison group and the <b>relative effect</b> of the intervention (and its 95% CI). </p> <p><b>CI</b> : confidence interval; <b>MD</b> : mean difference; <b>NIH‐CPSI</b> : National Institutes of Health ‐ Chronic Prostatitis Symptom Index; <b>RCT</b> : randomised controlled trial; <b>RR:</b> risk ratio. </p> </td> </tr> <tr class="separated"> <td align="" bgcolor="#ffffff" colspan="6" rowspan="1" valign=""> <p><b>GRADE Working Group grades of evidence</b> <br/> <b>High quality:</b> we are very confident that the true effect lies close to that of the estimate of the effect.<br/> <b>Moderate quality:</b> we are moderately confident in the effect estimate: the true effect is likely to be close to the estimate of the effect, but there is a possibility that it is substantially different.<br/> <b>Low quality:</b> our confidence in the effect estimate is limited: the true effect may be substantially different from the estimate of the effect.<br/> <b>Very low quality:</b> we have very little confidence in the effect estimate: the true effect is likely to be substantially different from the estimate of effect. </p> </td> </tr> </tbody> <tfoot> <tr> <td colspan="6"> <div class="table-footnote"> <p><sup>1</sup>Downgraded 1 level due to risk of bias: included studies were not blinded, which affects both detection and performance bias. </p> <p><sup>2</sup>The initial analysis had greater statistical inconsistency (I<sup>2</sup> = 70%) and included one study that included people with chronic prostatitis/chronic pelvic pain syndrome using criteria that differed from that recommended by the Research Consensus (<a href="./references#CD012551-bbs2-0002" title="ChenZX . Observation on therapeutic effect of warm needle moxibustion on chronic non‐bacterial prostatitis. Zhongguo Zhen Jiu [Chinese Acupuncture &amp; Moxibustion]2009;29(4):275‐8. ">Chen 2009</a>). In a sensitivity analysis, we excluded the results from this study and found greater statistical consistency (I<sup>2</sup> = 0%), therefore, we chose to report these results in the 'Summary of findings' table. For this reason, we did not downgrade due to inconsistency. </p> <p><sup>3</sup>Downgraded 1 level due to imprecision issues: few events and wide confidence interval. </p> </div> </td> </tr> </tfoot> </table> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="table-viewer-caption"> <div class="table-heading"><span class="table-label">Summary of findings 2.</span> <span class="table-title">Acupuncture compared to medical treatment for treating chronic prostatitis/chronic pelvic pain syndrome</span></div> </div> <div class="tools"><a class="tableList" href="/cdsr/doi/10.1002/14651858.CD012551.pub3/full#CD012551-tbl-0002">Navigate to table in review</a></div> </div> <div class="table"> <table class="summary-of-findings framed" data-id="CD012551-tbl-0003"> <div class="table-heading"><span class="table-label">Summary of findings 3.</span> <span class="table-title">Circumcision plus usual care compared to waiting list plus usual care for chronic prostatitis/chronic pelvic pain syndrome</span></div> <tbody> <tr class="separated"> <td align="left" bgcolor="#ffffff" colspan="6" rowspan="1" valign="top"> <p><b>Circumcision plus usual care compared to waiting list plus usual care for chronic prostatitis/chronic pelvic pain syndrome</b> </p> </td> </tr> <tr class="separated"> <td align="left" bgcolor="#ffffff" colspan="6" rowspan="1" valign="top"> <p><b>Patient or population:</b> participants with chronic prostatitis/chronic pelvic pain syndrome<br/> <b>Setting:</b> hospital (surgery), China<br/> <b>Intervention:</b> circumcision at 4 weeks (outcome was assessed after circumcision)<br/> <b>Comparison:</b> waiting list for circumcision at 3 months (outcome was assessed before circumcision) </p> </td> </tr> <tr class="table-header separated"> <td align="left" class="table-header" colspan="1" rowspan="2" valign="top"> <p><b>Outcomes</b> </p> </td> <td align="left" class="table-tint table-highlight" colspan="1" rowspan="2" valign="top"> <p><b>№ of participants<br/> (studies)</b> </p> </td> <td align="left" class="table-tint table-highlight" colspan="1" rowspan="2" valign="top"> <p><b>Quality of the evidence<br/> (GRADE)</b> </p> </td> <td align="left" class="table-header" colspan="1" rowspan="2" valign="top"> <p><b>Relative effect<br/> (95% CI)</b> </p> </td> <td align="left" class="table-header" colspan="2" rowspan="1" valign="top"> <p><b>Anticipated absolute effects* (95% CI)</b> </p> </td> </tr> <tr class="table-header separated"> <td align="left" class="table-header" colspan="1" rowspan="1" valign="top"> <p><b>Risk with waiting list for circumcision</b> </p> </td> <td align="left" class="table-header" colspan="1" rowspan="1" valign="top"> <p><b>Risk difference with early circumcision</b> </p> </td> </tr> <tr class="separated"> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><b>Prostatitis symptoms</b><br/> assessed with: NIH‐CPSI score<br/> Scale from: 0 to 43<br/> follow‐up: 12 weeks </p> <p>Benefit is indicated by lower scores</p> </td> <td align="left" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p>713<br/> (1 RCT) </p> </td> <td align="left" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p>⊕⊕⊕⊝<br/> <b>Moderate</b><sup>1</sup> </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>‐</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>The mean prostatitis symptoms was 15</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><b>MD 3.00 lower</b><br/> (3.82 lower to 2.18 lower)<sup>2</sup> </p> </td> </tr> <tr class="separated"> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="2" valign="top"> <p><b>Adverse events</b><sup>3</sup> </p> <p>follow‐up: 12 weeks</p> </td> <td align="left" class="table-tint table-highlight" colspan="1" rowspan="2" valign="top"> <p>713<br/> (1 RCT) </p> </td> <td align="left" class="table-tint table-highlight" colspan="1" rowspan="2" valign="top"> <p>⊕⊕⊝⊝<br/> <b>Low</b><sup>1,4</sup> </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="2" valign="top"> <p><b>RR 1.23</b><br/> (0.86 to 1.76) </p> </td> <td align="left" bgcolor="#ffffff" colspan="2" rowspan="1" valign="top"> <p>Study population</p> </td> </tr> <tr class="separated"> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>130 per 1000</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><b>30 more per 1000</b><br/> (18 fewer to 98 more) </p> </td> </tr> <tr class="separated"> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><b>Sexual dysfunction</b> ‐ not reported </p> </td> <td align="left" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p>‐</p> </td> <td align="left" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p>‐</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>‐</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>‐</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>‐</p> </td> </tr> <tr class="separated"> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><b>Quality of life</b> ‐ not reported </p> </td> <td align="left" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p>‐</p> </td> <td align="left" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p>‐</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>‐</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>‐</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>‐</p> </td> </tr> <tr class="separated"> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><b>Depression and anxiety</b> ‐ not reported </p> </td> <td align="left" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p>‐</p> </td> <td align="left" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p>‐</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>‐</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>‐</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>‐</p> </td> </tr> <tr class="separated"> <td align="" bgcolor="#ffffff" colspan="6" rowspan="1" valign=""> <p>*<b>The risk in the intervention group</b> (and its 95% confidence interval) is based on the assumed risk in the comparison group and the <b>relative effect</b> of the intervention (and its 95% CI). </p> <p><b>CI</b> : confidence interval; <b>MD</b> : mean difference; <b>NIH‐CPSI</b> : National Institutes of Health ‐ Chronic Prostatitis Symptom Index; <b>RCT</b> : randomised controlled trial; <b>RR</b>: risk ratio. </p> </td> </tr> <tr class="separated"> <td align="" bgcolor="#ffffff" colspan="6" rowspan="1" valign=""> <p><b>GRADE Working Group grades of evidence</b> <br/> <b>High quality:</b> we are very confident that the true effect lies close to that of the estimate of the effect.<br/> <b>Moderate quality:</b> we are moderately confident in the effect estimate: the true effect is likely to be close to the estimate of the effect, but there is a possibility that it is substantially different.<br/> <b>Low quality:</b> our confidence in the effect estimate is limited: the true effect may be substantially different from the estimate of the effect.<br/> <b>Very low quality:</b> we have very little confidence in the effect estimate: the true effect is likely to be substantially different from the estimate of effect. </p> </td> </tr> </tbody> <tfoot> <tr> <td colspan="6"> <div class="table-footnote"> <p><sup>1</sup>Downgraded 1 level due to high risk of bias: study not blinded (high risk of performance and detection bias). </p> <p><sup>2</sup>Confidence intervals were constructed using transformations described in the <i>Cochrane Handbook for Systematic Reviews of Interventions</i> Section 7.7.3.5. </p> <p><sup>3</sup>All adverse events were minor. </p> <p><sup>4</sup>Downgraded 1 level due to imprecision issues: few events in each group and wide confidence interval. </p> </div> </td> </tr> </tfoot> </table> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="table-viewer-caption"> <div class="table-heading"><span class="table-label">Summary of findings 3.</span> <span class="table-title">Circumcision plus usual care compared to waiting list plus usual care for chronic prostatitis/chronic pelvic pain syndrome</span></div> </div> <div class="tools"><a class="tableList" href="/cdsr/doi/10.1002/14651858.CD012551.pub3/full#CD012551-tbl-0003">Navigate to table in review</a></div> </div> <div class="table"> <table class="summary-of-findings framed" data-id="CD012551-tbl-0004"> <div class="table-heading"><span class="table-label">Summary of findings 4.</span> <span class="table-title">Electromagnetic chair compared to control intervention for chronic prostatitis/chronic pelvic pain syndrome</span></div> <tbody> <tr class="separated"> <td align="left" bgcolor="#ffffff" colspan="6" rowspan="1" valign="top"> <p><b>Electromagnetic chair compared to control intervention for chronic prostatitis/chronic pelvic pain syndrome</b> </p> </td> </tr> <tr class="separated"> <td align="left" bgcolor="#ffffff" colspan="6" rowspan="1" valign="top"> <p><b>Patient or population:</b> participants with chronic prostatitis/chronic pelvic pain syndrome<br/> <b>Setting:</b> outpatient, South Korea and England<br/> <b>Intervention:</b> electromagnetic chair<br/> <b>Comparison:</b> control intervention in which the electromagnetic chair was switched off </p> </td> </tr> <tr class="table-header separated"> <td align="left" class="table-header" colspan="1" rowspan="2" valign="top"> <p><b>Outcomes</b> </p> </td> <td align="left" class="table-tint table-highlight" colspan="1" rowspan="2" valign="top"> <p><b>№ of participants<br/> (studies)</b> </p> </td> <td align="left" class="table-tint table-highlight" colspan="1" rowspan="2" valign="top"> <p><b>Quality of the evidence<br/> (GRADE)</b> </p> </td> <td align="left" class="table-header" colspan="1" rowspan="2" valign="top"> <p><b>Relative effect<br/> (95% CI)</b> </p> </td> <td align="left" class="table-header" colspan="2" rowspan="1" valign="top"> <p><b>Anticipated absolute effects* (95% CI)</b> </p> </td> </tr> <tr class="table-header separated"> <td align="left" class="table-header" colspan="1" rowspan="1" valign="top"> <p><b>Risk with control intervention</b> </p> </td> <td align="left" class="table-header" colspan="1" rowspan="1" valign="top"> <p><b>Risk difference with electromagnetic chair</b> </p> </td> </tr> <tr class="separated"> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><b>Prostatitis symptoms</b><br/> assessed with: NIH‐CPSI score / Prostatitis Symptom Severity Score<br/> follow‐up: 6‐12 weeks </p> <p>Benefit is indicated by lower scores</p> </td> <td align="left" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p>57<br/> (2 RCTs) </p> </td> <td align="left" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p>⊕⊝⊝⊝<br/> <b>Very low</b><sup>1,2,3</sup> </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>‐</p> </td> <td align="left" bgcolor="#ffffff" colspan="2" rowspan="1" valign="top"> <p>1 study found no differences in NIH‐CPSI score measurements at 6 weeks. The other study found a symptom score 16 points (0‐ to 90‐point scale) lower in the intervention group compared to the control group (P value not available) at 12 weeks. </p> </td> </tr> <tr class="separated"> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><b>Adverse events</b> </p> <p>follow‐up: 6‐12 weeks</p> </td> <td align="left" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p>57<br/> (2 RCTs) </p> </td> <td align="left" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p>⊕⊕⊝⊝<br/> <b>Low</b><sup>1,4</sup> </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>‐</p> </td> <td align="left" bgcolor="#ffffff" colspan="2" rowspan="1" valign="top"> <p>1 study reported a 0 incidence of adverse events and the other study reported 1 case of transient paraesthesia in the active treatment group. </p> </td> </tr> <tr class="separated"> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><b>Sexual dysfunction</b> ‐ not reported </p> </td> <td align="left" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p>‐</p> </td> <td align="left" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p>‐</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>‐</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>‐</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>‐</p> </td> </tr> <tr class="separated"> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><b>Quality of life</b> ‐ not reported </p> </td> <td align="left" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p>‐</p> </td> <td align="left" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p>‐</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>‐</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>‐</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>‐</p> </td> </tr> <tr class="separated"> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><b>Depression and anxiety</b> ‐ not reported </p> </td> <td align="left" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p>‐</p> </td> <td align="left" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p>‐</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>‐</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>‐</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>‐</p> </td> </tr> <tr class="separated"> <td align="" bgcolor="#ffffff" colspan="6" rowspan="1" valign=""> <p>*<b>The risk in the intervention group</b> (and its 95% confidence interval) is based on the assumed risk in the comparison group and the <b>relative effect</b> of the intervention (and its 95% CI). </p> <p><b>CI</b> : confidence interval; <b>NIH‐CPSI</b> : National Institutes of Health ‐ Chronic Prostatitis Symptom Index; <b>RCT</b>: randomised controlled trial. </p> </td> </tr> <tr class="separated"> <td align="" bgcolor="#ffffff" colspan="6" rowspan="1" valign=""> <p><b>GRADE Working Group grades of evidence</b> <br/> <b>High quality:</b> we are very confident that the true effect lies close to that of the estimate of the effect.<br/> <b>Moderate quality:</b> we are moderately confident in the effect estimate: the true effect is likely to be close to the estimate of the effect, but there is a possibility that it is substantially different.<br/> <b>Low quality:</b> our confidence in the effect estimate is limited: the true effect may be substantially different from the estimate of the effect.<br/> <b>Very low quality:</b> we have very little confidence in the effect estimate: the true effect is likely to be substantially different from the estimate of effect. </p> </td> </tr> </tbody> <tfoot> <tr> <td colspan="6"> <div class="table-footnote"> <p><sup>1</sup>Downgraded 1 level due to risk of bias: one study not blinded and the other study had high attrition bias and selective outcome reporting bias. </p> <p><sup>2</sup>The two included studies had inconsistent results (see narrative description). </p> <p><sup>3</sup>Downgraded 1 level for imprecision issues: optimal information size not met (OIS for a 4‐point decrease, standard deviation 6, alpha 0.05, beta 0.20 = 74); small sample size in the individual studies (meta‐analysis was not possible). </p> <p><sup>4</sup>Downgraded 1 level due to imprecision issues: rare events and wide confidence interval. </p> </div> </td> </tr> </tfoot> </table> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="table-viewer-caption"> <div class="table-heading"><span class="table-label">Summary of findings 4.</span> <span class="table-title">Electromagnetic chair compared to control intervention for chronic prostatitis/chronic pelvic pain syndrome</span></div> </div> <div class="tools"><a class="tableList" href="/cdsr/doi/10.1002/14651858.CD012551.pub3/full#CD012551-tbl-0004">Navigate to table in review</a></div> </div> <div class="table"> <table class="summary-of-findings framed" data-id="CD012551-tbl-0005"> <div class="table-heading"><span class="table-label">Summary of findings 5.</span> <span class="table-title">Lifestyle modifications compared to control for chronic prostatitis/chronic pelvic pain syndrome</span></div> <tbody> <tr class="separated"> <td align="left" bgcolor="#ffffff" colspan="6" rowspan="1" valign="top"> <p><b>Lifestyle modifications compared to control for chronic prostatitis/chronic pelvic pain syndrome</b> </p> </td> </tr> <tr class="separated"> <td align="left" bgcolor="#ffffff" colspan="6" rowspan="1" valign="top"> <p><b>Patient or population:</b> participants with chronic prostatitis/chronic pelvic pain syndrome<br/> <b>Setting:</b> outpatient, Italy<br/> <b>Intervention:</b> lifestyle modifications based on the assessment of risk factors for chronic prostatitis/chronic pelvic pain syndrome<br/> <b>Comparison:</b> control intervention in which participants were instructed to continue with the same lifestyle </p> </td> </tr> <tr class="table-header separated"> <td align="left" class="table-header" colspan="1" rowspan="2" valign="top"> <p><b>Outcomes</b> </p> </td> <td align="left" class="table-tint table-highlight" colspan="1" rowspan="2" valign="top"> <p><b>№ of participants<br/> (studies)<br/> Follow‐up</b> </p> </td> <td align="left" class="table-tint table-highlight" colspan="1" rowspan="2" valign="top"> <p><b>Quality of the evidence<br/> (GRADE)</b> </p> </td> <td align="left" class="table-header" colspan="1" rowspan="2" valign="top"> <p><b>Relative effect<br/> (95% CI)</b> </p> </td> <td align="left" class="table-header" colspan="2" rowspan="1" valign="top"> <p><b>Anticipated absolute effects* (95% CI)</b> </p> </td> </tr> <tr class="table-header separated"> <td align="left" class="table-header" colspan="1" rowspan="1" valign="top"> <p><b>Risk with control</b> </p> </td> <td align="left" class="table-header" colspan="1" rowspan="1" valign="top"> <p><b>Risk difference with lifestyle modifications</b> </p> </td> </tr> <tr class="separated"> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="2" valign="top"> <p><b>Prostatitis symptom</b>s: response defined as 6‐point decrease in NIH‐CPSI score<br/> follow‐up: 3 months </p> <p>Benefit is indicated by lower scores</p> </td> <td align="left" class="table-tint table-highlight" colspan="1" rowspan="2" valign="top"> <p>100<br/> (1 RCT) </p> </td> <td align="left" class="table-tint table-highlight" colspan="1" rowspan="2" valign="top"> <p>⊕⊝⊝⊝<br/> <b>Very low</b><sup>1,2</sup> </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="2" valign="top"> <p><b>RR 3.90</b><br/> (2.20 to 6.92) </p> </td> <td align="left" bgcolor="#ffffff" colspan="2" rowspan="1" valign="top"> <p>Study population</p> </td> </tr> <tr class="separated"> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>200 per 1000</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><b>580 more per 1000</b><br/> (240 more to 1184 more) </p> </td> </tr> <tr class="separated"> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><b>Adverse events</b> ‐ not reported </p> </td> <td align="left" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p>‐</p> </td> <td align="left" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p>‐</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>‐</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>‐</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>‐</p> </td> </tr> <tr class="separated"> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><b>Sexual dysfunction</b> ‐ not reported </p> </td> <td align="left" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p>‐</p> </td> <td align="left" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p>‐</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>‐</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>‐</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>‐</p> </td> </tr> <tr class="separated"> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><b>Quality of life</b> ‐ not reported </p> </td> <td align="left" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p>‐</p> </td> <td align="left" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p>‐</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>‐</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>‐</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>‐</p> </td> </tr> <tr class="separated"> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><b>Depression and anxiety</b> ‐ not reported </p> </td> <td align="left" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p>‐</p> </td> <td align="left" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p>‐</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>‐</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>‐</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>‐</p> </td> </tr> <tr class="separated"> <td align="" bgcolor="#ffffff" colspan="6" rowspan="1" valign=""> <p>*<b>The risk in the intervention group</b> (and its 95% confidence interval) is based on the assumed risk in the comparison group and the <b>relative effect</b> of the intervention (and its 95% CI). </p> <p><b>CI</b> : confidence interval; <b>NIH‐CPSI</b> : National Institutes of Health ‐ Chronic Prostatitis Symptom Index; <b>RCT</b> : randomised controlled trial; <b>RR</b>: risk ratio. </p> </td> </tr> <tr class="separated"> <td align="" bgcolor="#ffffff" colspan="6" rowspan="1" valign=""> <p><b>GRADE Working Group grades of evidence</b> <br/> <b>High quality:</b> we are very confident that the true effect lies close to that of the estimate of the effect.<br/> <b>Moderate quality:</b> we are moderately confident in the effect estimate: the true effect is likely to be close to the estimate of the effect, but there is a possibility that it is substantially different.<br/> <b>Low quality:</b> our confidence in the effect estimate is limited: the true effect may be substantially different from the estimate of the effect.<br/> <b>Very low quality:</b> we have very little confidence in the effect estimate: the true effect is likely to be substantially different from the estimate of effect. </p> </td> </tr> </tbody> <tfoot> <tr> <td colspan="6"> <div class="table-footnote"> <p><sup>1</sup>Downgraded 2 levels due to high risk of selection bias (unconcealed allocation), detection and performance bias (study not blinded), missing outcome data and suspected selective outcome reporting (data presented graphically). </p> <p><sup>2</sup>Downgraded 1 level due to imprecision issues: few events and wide confidence interval. </p> </div> </td> </tr> </tfoot> </table> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="table-viewer-caption"> <div class="table-heading"><span class="table-label">Summary of findings 5.</span> <span class="table-title">Lifestyle modifications compared to control for chronic prostatitis/chronic pelvic pain syndrome</span></div> </div> <div class="tools"><a class="tableList" href="/cdsr/doi/10.1002/14651858.CD012551.pub3/full#CD012551-tbl-0005">Navigate to table in review</a></div> </div> <div class="table"> <table class="summary-of-findings framed" data-id="CD012551-tbl-0006"> <div class="table-heading"><span class="table-label">Summary of findings 6.</span> <span class="table-title">Physical activity compared to control intervention for chronic prostatitis/chronic pelvic pain syndrome</span></div> <tbody> <tr class="separated"> <td align="left" bgcolor="#ffffff" colspan="6" rowspan="1" valign="top"> <p><b>Physical activity compared to control intervention procedure for chronic prostatitis/chronic pelvic pain syndrome</b> </p> </td> </tr> <tr class="separated"> <td align="left" bgcolor="#ffffff" colspan="6" rowspan="1" valign="top"> <p><b>Patient or population:</b> participants with chronic prostatitis/chronic pelvic pain syndrome<br/> <b>Setting:</b> outpatient, Italy<br/> <b>Intervention:</b> physical activity programme<br/> <b>Comparison:</b> control intervention comprising a flexibility and motion low‐grade exercise programme </p> </td> </tr> <tr class="table-header separated"> <td align="left" class="table-header" colspan="1" rowspan="2" valign="top"> <p><b>Outcomes</b> </p> </td> <td align="left" class="table-tint table-highlight" colspan="1" rowspan="2" valign="top"> <p><b>№ of participants<br/> (studies)</b> </p> </td> <td align="left" class="table-tint table-highlight" colspan="1" rowspan="2" valign="top"> <p><b>Quality of the evidence<br/> (GRADE)</b> </p> </td> <td align="left" class="table-header" colspan="1" rowspan="2" valign="top"> <p><b>Relative effect<br/> (95% CI)</b> </p> </td> <td align="left" class="table-header" colspan="2" rowspan="1" valign="top"> <p><b>Anticipated absolute effects* (95% CI)</b> </p> </td> </tr> <tr class="table-header separated"> <td align="left" class="table-header" colspan="1" rowspan="1" valign="top"> <p><b>Risk with sham procedure</b> </p> </td> <td align="left" class="table-header" colspan="1" rowspan="1" valign="top"> <p><b>Risk difference with physical activity</b> </p> </td> </tr> <tr class="separated"> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><b>Prostatitis symptoms</b><br/> assessed with: NIH‐CPSI score<br/> Scale from: 0 to 43<br/> follow‐up: 6 weeks </p> <p>Benefit is indicated by lower scores</p> </td> <td align="left" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p>85<br/> (1 RCT) </p> </td> <td align="left" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p>⊕⊕⊝⊝<br/> <b>Low</b><sup>1</sup> </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>‐</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>The mean prostatitis symptom score was 20</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><b>MD 2.50 lower</b><br/> (4.69 lower to 0.31 lower) </p> </td> </tr> <tr class="separated"> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><b>Adverse events</b> ‐ not reported </p> </td> <td align="left" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p>‐</p> </td> <td align="left" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p>‐</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>‐</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>‐</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>‐</p> </td> </tr> <tr class="separated"> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><b>Sexual dysfunction</b> ‐ not reported </p> </td> <td align="left" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p>‐</p> </td> <td align="left" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p>‐</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>‐</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>‐</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>‐</p> </td> </tr> <tr class="separated"> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><b>Quality of life</b> ‐ not reported </p> </td> <td align="left" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p>‐</p> </td> <td align="left" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p>‐</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>‐</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>‐</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>‐</p> </td> </tr> <tr class="separated"> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><b>Anxiety</b><br/> assessed with: SAI‐Y score<br/> Scale from: 20 to 80<br/> follow‐up: 6 weeks </p> <p>Benefit is indicated by lower scores</p> </td> <td align="left" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p>85<br/> (1 RCT) </p> </td> <td align="left" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p>⊕⊝⊝⊝<br/> <b>Very low</b><sup>1,2</sup> </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>‐</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>The mean anxiety score was 42.1</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><b>MD 2.8 lower</b><br/> (6.78 lower to 1.18 higher) </p> </td> </tr> <tr class="separated"> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><b>Depression</b><br/> assessed with: Beck Depression Inventory<br/> Scale from: 0 to 63<br/> follow‐up: 6 weeks </p> <p>Benefit is indicated by lower scores</p> </td> <td align="left" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p>85<br/> (1 RCT) </p> </td> <td align="left" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p>⊕⊝⊝⊝<br/> <b>Very low</b><sup>1,2</sup> </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>‐</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>The mean depression score was 9.3</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><b>MD 0.5 higher</b><br/> (1.33 lower to 2.33 higher) </p> </td> </tr> <tr class="separated"> <td align="" bgcolor="#ffffff" colspan="6" rowspan="1" valign=""> <p>*<b>The risk in the intervention group</b> (and its 95% confidence interval) is based on the assumed risk in the comparison group and the <b>relative effect</b> of the intervention (and its 95% CI). </p> <p><b>CI</b> : confidence interval; <b>MD</b> : mean difference; <b>NIH‐CPSI</b> : National Institutes of Health ‐ Chronic Prostatitis Symptom Index; <b>RCT</b> : randomised controlled trial; <b>SAI‐Y</b>: State Anxiety Inventory‐Y. </p> </td> </tr> <tr class="separated"> <td align="" bgcolor="#ffffff" colspan="6" rowspan="1" valign=""> <p><b>GRADE Working Group grades of evidence</b> <br/> <b>High quality:</b> we are very confident that the true effect lies close to that of the estimate of the effect.<br/> <b>Moderate quality:</b> we are moderately confident in the effect estimate: the true effect is likely to be close to the estimate of the effect, but there is a possibility that it is substantially different.<br/> <b>Low quality:</b> our confidence in the effect estimate is limited: the true effect may be substantially different from the estimate of the effect.<br/> <b>Very low quality:</b> we have very little confidence in the effect estimate: the true effect is likely to be substantially different from the estimate of effect. </p> </td> </tr> </tbody> <tfoot> <tr> <td colspan="6"> <div class="table-footnote"> <p><sup>1</sup>Downgraded 2 levels: high risk of performance bias and detection bias (study not blinded); high risk of attrition bias at follow‐up. </p> <p><sup>2</sup>Downgraded 1 level due to imprecision issues: wide confidence intervals include both considerable benefits and harms. </p> </div> </td> </tr> </tfoot> </table> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="table-viewer-caption"> <div class="table-heading"><span class="table-label">Summary of findings 6.</span> <span class="table-title">Physical activity compared to control intervention for chronic prostatitis/chronic pelvic pain syndrome</span></div> </div> <div class="tools"><a class="tableList" href="/cdsr/doi/10.1002/14651858.CD012551.pub3/full#CD012551-tbl-0006">Navigate to table in review</a></div> </div> <div class="table"> <table class="summary-of-findings framed" data-id="CD012551-tbl-0007"> <div class="table-heading"><span class="table-label">Summary of findings 7.</span> <span class="table-title">Prostatic massage compared to no intervention for treating chronic prostatitis/chronic pelvic pain syndrome</span></div> <tbody> <tr class="separated"> <td align="left" bgcolor="#ffffff" colspan="6" rowspan="1" valign="top"> <p><b>Prostatic massage compared to control for treating chronic prostatitis/chronic pelvic pain syndrome</b> </p> </td> </tr> <tr class="separated"> <td align="left" bgcolor="#ffffff" colspan="6" rowspan="1" valign="top"> <p><b>Patient or population:</b> participants with chronic prostatitis/chronic pelvic pain syndrome<br/> <b>Setting:</b> outpatient, Egypt<br/> <b>Intervention:</b> prostatic massage<br/> <b>Comparison:</b> no intervention </p> </td> </tr> <tr class="table-header separated"> <td align="left" class="table-header" colspan="1" rowspan="2" valign="top"> <p><b>Outcomes</b> </p> </td> <td align="left" class="table-tint table-highlight" colspan="1" rowspan="2" valign="top"> <p><b>№ of participants<br/> (studies)</b> </p> </td> <td align="left" class="table-tint table-highlight" colspan="1" rowspan="2" valign="top"> <p><b>Quality of the evidence<br/> (GRADE)</b> </p> </td> <td align="left" class="table-header" colspan="1" rowspan="2" valign="top"> <p><b>Relative effect<br/> (95% CI)</b> </p> </td> <td align="left" class="table-header" colspan="2" rowspan="1" valign="top"> <p><b>Anticipated absolute effects* (95% CI)</b> </p> </td> </tr> <tr class="table-header separated"> <td align="left" class="table-header" colspan="1" rowspan="1" valign="top"> <p><b>Risk with control</b> </p> </td> <td align="left" class="table-header" colspan="1" rowspan="1" valign="top"> <p><b>Risk difference with prostatic massage</b> </p> </td> </tr> <tr class="separated"> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><b>Prostatitis symptoms</b><br/> assessed with: NIH‐CPSI score<br/> Scale from: 0 to 43<br/> follow‐up: 4 weeks </p> <p>Benefit is indicated by lower scores</p> </td> <td align="left" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p>44<br/> (1 RCT) </p> </td> <td align="left" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p>⊕⊝⊝⊝<br/> <b>Very low</b><sup>1,2</sup> </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>‐</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>The mean prostatitis symptom score was 12.4</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><b>MD 1.10 lower</b><br/> (5.63 lower to 3.43 higher) </p> </td> </tr> <tr class="separated"> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><b>Adverse events</b> ‐ not reported </p> </td> <td align="left" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p>‐</p> </td> <td align="left" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p>‐</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>‐</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>‐</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>‐</p> </td> </tr> <tr class="separated"> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><b>Sexual dysfunction</b> ‐ not reported </p> </td> <td align="left" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p>‐</p> </td> <td align="left" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p>‐</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>‐</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>‐</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>‐</p> </td> </tr> <tr class="separated"> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><b>Quality of life</b> ‐ not reported </p> </td> <td align="left" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p>‐</p> </td> <td align="left" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p>‐</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>‐</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>‐</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>‐</p> </td> </tr> <tr class="separated"> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><b>Depression and anxiety</b> ‐ not reported </p> </td> <td align="left" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p>‐</p> </td> <td align="left" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p>‐</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>‐</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>‐</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>‐</p> </td> </tr> <tr class="separated"> <td align="" bgcolor="#ffffff" colspan="6" rowspan="1" valign=""> <p>*<b>The risk in the intervention group</b> (and its 95% confidence interval) is based on the assumed risk in the comparison group and the <b>relative effect</b> of the intervention (and its 95% CI). </p> <p><b>CI</b> : confidence interval; <b>MD</b> : mean difference; <b>NIH‐CPSI</b> : National Institutes of Health ‐ Chronic Prostatitis Symptom Index; <b>RCT</b>: randomised controlled trial. </p> </td> </tr> <tr class="separated"> <td align="" bgcolor="#ffffff" colspan="6" rowspan="1" valign=""> <p><b>GRADE Working Group grades of evidence</b> <br/> <b>High quality:</b> we are very confident that the true effect lies close to that of the estimate of the effect.<br/> <b>Moderate quality:</b> we are moderately confident in the effect estimate: the true effect is likely to be close to the estimate of the effect, but there is a possibility that it is substantially different.<br/> <b>Low quality:</b> our confidence in the effect estimate is limited: the true effect may be substantially different from the estimate of the effect.<br/> <b>Very low quality:</b> we have very little confidence in the effect estimate: the true effect is likely to be substantially different from the estimate of effect. </p> </td> </tr> </tbody> <tfoot> <tr> <td colspan="6"> <div class="table-footnote"> <p><sup>1</sup>Downgraded 2 levels due to high risk of performance and detection bias (study not blinded), unclear risk of bias in the remaining domains. </p> <p><sup>2</sup>Downgraded 1 level for imprecision issues: optimal information size (OIS) not met (OIS for a 4‐point decrease, standard deviation 6, alpha 0.05, beta 0.20 = 74). </p> </div> </td> </tr> </tfoot> </table> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="table-viewer-caption"> <div class="table-heading"><span class="table-label">Summary of findings 7.</span> <span class="table-title">Prostatic massage compared to no intervention for treating chronic prostatitis/chronic pelvic pain syndrome</span></div> </div> <div class="tools"><a class="tableList" href="/cdsr/doi/10.1002/14651858.CD012551.pub3/full#CD012551-tbl-0007">Navigate to table in review</a></div> </div> <div class="table"> <table class="summary-of-findings framed" data-id="CD012551-tbl-0008"> <div class="table-heading"><span class="table-label">Summary of findings 8.</span> <span class="table-title">Extracorporeal shockwave therapy compared to control procedure for chronic prostatitis/chronic pelvic pain syndrome</span></div> <tbody> <tr class="separated"> <td align="left" bgcolor="#ffffff" colspan="6" rowspan="1" valign="top"> <p><b>Extracorporeal shockwave therapy compared to control procedure for chronic prostatitis/chronic pelvic pain syndrome</b> </p> </td> </tr> <tr class="separated"> <td align="left" bgcolor="#ffffff" colspan="6" rowspan="1" valign="top"> <p><b>Patient or population:</b> participants with chronic prostatitis/chronic pelvic pain syndrome<br/> <b>Setting:</b> outpatient, China, Austria, Iran<br/> <b>Intervention:</b> ESWT<br/> <b>Comparison:</b> 2 studies used a sham procedure (machine turned off) and 1 study compared to no ESWT </p> </td> </tr> <tr class="table-header separated"> <td align="left" class="table-header" colspan="1" rowspan="2" valign="top"> <p><b>Outcomes</b> </p> </td> <td align="left" class="table-tint table-highlight" colspan="1" rowspan="2" valign="top"> <p><b>№ of participants<br/> (studies)</b> </p> </td> <td align="left" class="table-tint table-highlight" colspan="1" rowspan="2" valign="top"> <p><b>Quality of the evidence<br/> (GRADE)</b> </p> </td> <td align="left" class="table-header" colspan="1" rowspan="2" valign="top"> <p><b>Relative effect<br/> (95% CI)</b> </p> </td> <td align="left" class="table-header" colspan="2" rowspan="1" valign="top"> <p><b>Anticipated absolute effects* (95% CI)</b> </p> </td> </tr> <tr class="table-header separated"> <td align="left" class="table-header" colspan="1" rowspan="1" valign="top"> <p><b>Risk with control</b> </p> </td> <td align="left" class="table-header" colspan="1" rowspan="1" valign="top"> <p><b>Risk difference with ESWT</b> </p> </td> </tr> <tr class="separated"> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><b>Prostatitis symptoms</b><br/> assessed with: NIH‐CPSI score<br/> Scale from: 0 to 43<br/> follow‐up: 12 weeks </p> <p>Benefit is indicated by lower scores</p> </td> <td align="left" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p>157<br/> (3 RCTs) </p> </td> <td align="left" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p>⊕⊕⊕⊕<br/> <b>High</b><sup>1</sup> </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>‐</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>The mean prostatitis symptom score ranged from 16.8 to 26.81</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><b>MD 6.18 lower</b><br/> (7.46 lower to 4.89 lower) </p> </td> </tr> <tr class="separated"> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="2" valign="top"> <p><b>Prostatitis symptoms</b>: response defined as a 6‐point decrease in NIH‐CPSI score<br/> follow‐up: 12 weeks </p> </td> <td align="left" class="table-tint table-highlight" colspan="1" rowspan="2" valign="top"> <p>135<br/> (2 RCTs) </p> </td> <td align="left" class="table-tint table-highlight" colspan="1" rowspan="2" valign="top"> <p>⊕⊝⊝⊝<br/> <b>Very low</b><sup>2,3,4</sup> </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="2" valign="top"> <p><b>RR 6.20</b><br/> (0.48 to 79.79) </p> </td> <td align="left" bgcolor="#ffffff" colspan="2" rowspan="1" valign="top"> <p>Study population</p> </td> </tr> <tr class="separated"> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>149 per 1000</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><b>776 more per 1000</b><br/> (78 fewer to 11,760 more) </p> </td> </tr> <tr class="separated"> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><b>Prostatitis symptoms</b><br/> assessed with: NIH‐CPSI score<br/> Scale from: 0 to 43<br/> follow‐up: 24 weeks </p> </td> <td align="left" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p>97<br/> (2 RCTs) </p> </td> <td align="left" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p>⊕⊕⊝⊝<br/> <b>Low</b><sup>2,5</sup> </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>‐</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>The mean prostatitis symptom score ranged from 16.1 to 27</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><b>MD 2.23 lower</b><br/> (5.98 lower to 1.53 higher) </p> </td> </tr> <tr class="separated"> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="2" valign="top"> <p><b>Adverse events</b> </p> <p>follow‐up: 24 weeks</p> </td> <td align="left" class="table-tint table-highlight" colspan="1" rowspan="2" valign="top"> <p>195<br/> (3 RCTs) </p> </td> <td align="left" class="table-tint table-highlight" colspan="1" rowspan="2" valign="top"> <p>⊕⊕⊝⊝<br/> <b>Low</b><sup>2,4</sup> </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="2" valign="top"> <p><b>RR 1.22</b><br/> (0.59 to 2.51) </p> </td> <td align="left" bgcolor="#ffffff" colspan="2" rowspan="1" valign="top"> <p>Study population</p> </td> </tr> <tr class="separated"> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>93 per 1000</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><b>20 more per 1000</b><br/> (38 fewer to 140 more) </p> </td> </tr> <tr class="separated"> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><b>Sexual dysfunction</b><br/> assessed with: International Index of Erectile Function<br/> Scale from: 5 to 25<br/> follow‐up: 12 weeks </p> <p>Benefit is indicated by higher scores</p> </td> <td align="left" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p>60<br/> (1 RCT) </p> </td> <td align="left" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p>⊕⊕⊕⊝<br/> <b>Moderate</b><sup>6</sup> </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>‐</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>The mean sexual dysfunction was 16.83</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><b>MD 3.34 higher</b><br/> (2.68 higher to 4 higher) </p> </td> </tr> <tr class="separated"> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><b>Quality of life</b> ‐ not reported </p> </td> <td align="left" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p>‐</p> </td> <td align="left" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p>‐</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>‐</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>‐</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>‐</p> </td> </tr> <tr class="separated"> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><b>Depression and anxiety</b> ‐ not reported </p> </td> <td align="left" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p>‐</p> </td> <td align="left" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p>‐</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>‐</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>‐</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>‐</p> </td> </tr> <tr class="separated"> <td align="" bgcolor="#ffffff" colspan="6" rowspan="1" valign=""> <p>*<b>The risk in the intervention group</b> (and its 95% confidence interval) is based on the assumed risk in the comparison group and the <b>relative effect</b> of the intervention (and its 95% CI). </p> <p><b>CI</b> : confidence interval; <b>ESWT</b> : extracorporeal shockwave therapy; <b>MD</b> : mean difference; <b>NIH‐CPSI</b> : National Institutes of Health ‐ Chronic Prostatitis Symptom Index; <b>RCT</b> : randomised controlled trial; <b>RR</b>: risk ratio. </p> </td> </tr> <tr class="separated"> <td align="" bgcolor="#ffffff" colspan="6" rowspan="1" valign=""> <p><b>GRADE Working Group grades of evidence</b> <br/> <b>High quality:</b> we are very confident that the true effect lies close to that of the estimate of the effect.<br/> <b>Moderate quality:</b> we are moderately confident in the effect estimate: the true effect is likely to be close to the estimate of the effect, but there is a possibility that it is substantially different.<br/> <b>Low quality:</b> our confidence in the effect estimate is limited: the true effect may be substantially different from the estimate of the effect.<br/> <b>Very low quality:</b> we have very little confidence in the effect estimate: the true effect is likely to be substantially different from the estimate of effect. </p> </td> </tr> </tbody> <tfoot> <tr> <td colspan="6"> <div class="table-footnote"> <p><sup>1</sup>Whereas one of the studies was not blinded, which could have posed a high risk of performance and detection bias, we did not downgrade for risk of bias due to the consistency with other studies with low risk of bias. </p> <p><sup>2</sup>Downgraded 1 level due to risk of bias: one of the studies that provided events for this outcome was not blinded. </p> <p><sup>3</sup>Downgraded 1 level due to inconsistency (I<sup>2</sup> = 71%). </p> <p><sup>4</sup>Downgraded 1 level due to imprecision issues: few events and wide confidence interval. </p> <p><sup>5</sup>Downgraded 1 level due to inconsistency (I<sup>2</sup> = 82%). </p> <p><sup>6</sup>Downgraded 1 level due to imprecision issues: wide confidence interval. </p> </div> </td> </tr> </tfoot> </table> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="table-viewer-caption"> <div class="table-heading"><span class="table-label">Summary of findings 8.</span> <span class="table-title">Extracorporeal shockwave therapy compared to control procedure for chronic prostatitis/chronic pelvic pain syndrome</span></div> </div> <div class="tools"><a class="tableList" href="/cdsr/doi/10.1002/14651858.CD012551.pub3/full#CD012551-tbl-0008">Navigate to table in review</a></div> </div> <div class="table"> <table class="summary-of-findings framed" data-id="CD012551-tbl-0009"> <div class="table-heading"><span class="table-label">Summary of findings 9.</span> <span class="table-title">Transrectal thermotherapy compared to medical treatment for chronic prostatitis/chronic pelvic pain syndrome</span></div> <tbody> <tr class="separated"> <td align="left" bgcolor="#ffffff" colspan="6" rowspan="1" valign="top"> <p><b>Transrectal thermotherapy compared to medical treatment for chronic prostatitis/chronic pelvic pain syndrome</b> </p> </td> </tr> <tr class="separated"> <td align="left" bgcolor="#ffffff" colspan="6" rowspan="1" valign="top"> <p><b>Patient or population:</b> participants with chronic prostatitis/chronic pelvic pain syndrome<br/> <b>Setting:</b> outpatient, China and Korea<br/> <b>Intervention:</b> transrectal thermotherapy<br/> <b>Comparison:</b> medical treatment </p> </td> </tr> <tr class="table-header separated"> <td align="left" class="table-header" colspan="1" rowspan="2" valign="top"> <p><b>Outcomes</b> </p> </td> <td align="left" class="table-tint table-highlight" colspan="1" rowspan="2" valign="top"> <p><b>№ of participants<br/> (studies)</b> </p> </td> <td align="left" class="table-tint table-highlight" colspan="1" rowspan="2" valign="top"> <p><b>Quality of the evidence<br/> (GRADE)</b> </p> </td> <td align="left" class="table-header" colspan="1" rowspan="2" valign="top"> <p><b>Relative effect<br/> (95% CI)</b> </p> </td> <td align="left" class="table-header" colspan="2" rowspan="1" valign="top"> <p><b>Anticipated absolute effects* (95% CI)</b> </p> </td> </tr> <tr class="table-header separated"> <td align="left" class="table-header" colspan="1" rowspan="1" valign="top"> <p><b>Risk with medical treatment</b> </p> </td> <td align="left" class="table-header" colspan="1" rowspan="1" valign="top"> <p><b>Risk difference with transrectal thermotherapy</b> </p> </td> </tr> <tr class="separated"> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><b>Prostatitis symptoms</b><br/> assessed with: NIH‐CPSI score<br/> Scale from: 0 to 43<br/> follow‐up: 6 to 12 weeks </p> <p>Benefit is indicated by lower scores</p> </td> <td align="left" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p>140<br/> (2 RCTs) </p> </td> <td align="left" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p>⊕⊕⊝⊝<br/> <b>Low</b><sup>1</sup> </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>‐</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>The mean prostatitis symptom score ranged from 14.33 to 17.19</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><b>MD 2.50 lower</b><br/> (3.82 lower to 1.18 lower) </p> </td> </tr> <tr class="separated"> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><b>Adverse events</b> ‐ not reported </p> </td> <td align="left" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p>‐</p> </td> <td align="left" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p>‐</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>‐</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>‐</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>‐</p> </td> </tr> <tr class="separated"> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><b>Sexual dysfunction</b> ‐ not reported </p> </td> <td align="left" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p>‐</p> </td> <td align="left" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p>‐</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>‐</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>‐</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>‐</p> </td> </tr> <tr class="separated"> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><b>Quality of life</b> ‐ not reported </p> </td> <td align="left" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p>‐</p> </td> <td align="left" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p>‐</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>‐</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>‐</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>‐</p> </td> </tr> <tr class="separated"> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><b>Depression and anxiety</b> ‐ not reported </p> </td> <td align="left" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p>‐</p> </td> <td align="left" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p>‐</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>‐</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>‐</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>‐</p> </td> </tr> <tr class="separated"> <td align="" bgcolor="#ffffff" colspan="6" rowspan="1" valign=""> <p>*<b>The risk in the intervention group</b> (and its 95% confidence interval) is based on the assumed risk in the comparison group and the <b>relative effect</b> of the intervention (and its 95% CI). </p> <p><b>CI</b> : confidence interval; <b>MD</b> : mean difference; <b>NIH‐CPSI</b> : National Institutes of Health ‐ Chronic Prostatitis Symptom Index; <b>RCT</b>: randomised controlled trial. </p> </td> </tr> <tr class="separated"> <td align="" bgcolor="#ffffff" colspan="6" rowspan="1" valign=""> <p><b>GRADE Working Group grades of evidence</b> <br/> <b>High quality:</b> we are very confident that the true effect lies close to that of the estimate of the effect.<br/> <b>Moderate quality:</b> we are moderately confident in the effect estimate: the true effect is likely to be close to the estimate of the effect, but there is a possibility that it is substantially different.<br/> <b>Low quality:</b> our confidence in the effect estimate is limited: the true effect may be substantially different from the estimate of the effect.<br/> <b>Very low quality:</b> we have very little confidence in the effect estimate: the true effect is likely to be substantially different from the estimate of effect. </p> </td> </tr> </tbody> <tfoot> <tr> <td colspan="6"> <div class="table-footnote"> <p><sup>1</sup>Downgraded 2 levels due to high risk of allocation concealment bias, performance and detection bias (study not blinded) and high risk of attrition bias. </p> </div> </td> </tr> </tfoot> </table> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="table-viewer-caption"> <div class="table-heading"><span class="table-label">Summary of findings 9.</span> <span class="table-title">Transrectal thermotherapy compared to medical treatment for chronic prostatitis/chronic pelvic pain syndrome</span></div> </div> <div class="tools"><a class="tableList" href="/cdsr/doi/10.1002/14651858.CD012551.pub3/full#CD012551-tbl-0009">Navigate to table in review</a></div> </div> <div class="table"> <table class="summary-of-findings framed" data-id="CD012551-tbl-0010"> <div class="table-heading"><span class="table-label">Summary of findings 10.</span> <span class="table-title">Transrectal thermotherapy (add‐on) compared to medical treatment alone for chronic prostatitis/chronic pelvic pain syndrome</span></div> <tbody> <tr class="separated"> <td align="left" bgcolor="#ffffff" colspan="6" rowspan="1" valign="top"> <p><b>Transrectal thermotherapy (add‐on) compared to medical treatment alone for chronic prostatitis/chronic pelvic pain syndrome</b> </p> </td> </tr> <tr class="separated"> <td align="left" bgcolor="#ffffff" colspan="6" rowspan="1" valign="top"> <p><b>Patient or population:</b> participants with chronic prostatitis/chronic pelvic pain syndrome<br/> <b>Setting:</b> outpatient, China and Korea<br/> <b>Intervention:</b> transrectal thermotherapy in addition to medical therapy<br/> <b>Comparison:</b> medical treatment alone </p> </td> </tr> <tr class="table-header separated"> <td align="left" class="table-header" colspan="1" rowspan="2" valign="top"> <p><b>Outcomes</b> </p> </td> <td align="left" class="table-tint table-highlight" colspan="1" rowspan="2" valign="top"> <p><b>№ of participants<br/> (studies)<br/> Follow‐up</b> </p> </td> <td align="left" class="table-tint table-highlight" colspan="1" rowspan="2" valign="top"> <p><b>Quality of the evidence<br/> (GRADE)</b> </p> </td> <td align="left" class="table-header" colspan="1" rowspan="2" valign="top"> <p><b>Relative effect<br/> (95% CI)</b> </p> </td> <td align="left" class="table-header" colspan="2" rowspan="1" valign="top"> <p><b>Anticipated absolute effects* (95% CI)</b> </p> </td> </tr> <tr class="table-header separated"> <td align="left" class="table-header" colspan="1" rowspan="1" valign="top"> <p><b>Risk with medical treatment alone</b> </p> </td> <td align="left" class="table-header" colspan="1" rowspan="1" valign="top"> <p><b>Risk difference with transrectal thermotherapy (add‐on)</b> </p> </td> </tr> <tr class="separated"> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><b>Prostatitis symptoms</b><br/> assessed with: NIH‐CPSI score<br/> Scale from: 0 to 43<br/> follow‐up: 6 to 12 weeks </p> <p>Benefit is indicated by lower scores</p> </td> <td align="left" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p>145<br/> (2 RCTs) </p> </td> <td align="left" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p>⊕⊕⊝⊝<br/> <b>Low</b><sup>1</sup> </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>‐</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>The mean prostatitis symptom score ranged from 14.33 to 17.19</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><b>MD 4.34 lower</b><br/> (5.65 lower to 3.04 lower) </p> </td> </tr> <tr class="separated"> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><b>Adverse events</b> ‐ not reported </p> </td> <td align="left" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p>‐</p> </td> <td align="left" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p>‐</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>‐</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>‐</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>‐</p> </td> </tr> <tr class="separated"> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><b>Sexual dysfunction</b> ‐ not reported </p> </td> <td align="left" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p>‐</p> </td> <td align="left" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p>‐</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>‐</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>‐</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>‐</p> </td> </tr> <tr class="separated"> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><b>Quality of life</b> ‐ not reported </p> </td> <td align="left" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p>‐</p> </td> <td align="left" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p>‐</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>‐</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>‐</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>‐</p> </td> </tr> <tr class="separated"> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><b>Depression and anxiety</b> ‐ not reported </p> </td> <td align="left" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p>‐</p> </td> <td align="left" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p>‐</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>‐</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>‐</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>‐</p> </td> </tr> <tr class="separated"> <td align="" bgcolor="#ffffff" colspan="6" rowspan="1" valign=""> <p>*<b>The risk in the intervention group</b> (and its 95% confidence interval) is based on the assumed risk in the comparison group and the <b>relative effect</b> of the intervention (and its 95% CI). </p> <p><b>CI</b> : confidence interval; <b>MD</b> : mean difference; <b>NIH‐CPSI</b> : National Institutes of Health ‐ Chronic Prostatitis Symptom Index; <b>RCT</b>: randomised controlled trial. </p> </td> </tr> <tr class="separated"> <td align="" bgcolor="#ffffff" colspan="6" rowspan="1" valign=""> <p><b>GRADE Working Group grades of evidence</b> <br/> <b>High quality:</b> we are very confident that the true effect lies close to that of the estimate of the effect.<br/> <b>Moderate quality:</b> we are moderately confident in the effect estimate: the true effect is likely to be close to the estimate of the effect, but there is a possibility that it is substantially different.<br/> <b>Low quality:</b> our confidence in the effect estimate is limited: the true effect may be substantially different from the estimate of the effect.<br/> <b>Very low quality:</b> we have very little confidence in the effect estimate: the true effect is likely to be substantially different from the estimate of effect. </p> </td> </tr> </tbody> <tfoot> <tr> <td colspan="6"> <div class="table-footnote"> <p><sup>1</sup>Downgraded 2 levels due to high risk of allocation concealment bias, performance and detection bias (study not blinded) and high risk of attrition bias. </p> </div> </td> </tr> </tfoot> </table> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="table-viewer-caption"> <div class="table-heading"><span class="table-label">Summary of findings 10.</span> <span class="table-title">Transrectal thermotherapy (add‐on) compared to medical treatment alone for chronic prostatitis/chronic pelvic pain syndrome</span></div> </div> <div class="tools"><a class="tableList" href="/cdsr/doi/10.1002/14651858.CD012551.pub3/full#CD012551-tbl-0010">Navigate to table in review</a></div> </div> <div class="table"> <table data-id="CD012551-tbl-0011"> <div class="table-heading"><span class="table-label">Table 1.</span> <span class="table-title">Description of interventions</span></div> <tbody> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><b>Study ID</b> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><b>Intervention(s) (route, frequency, total dose/day)</b> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><b>Intervention(s) appropriate as applied in a clinical practice setting (description)</b> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><b>Intervention(s) duration</b> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><b>Comparator(s) (route, frequency, total dose/day)</b> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><b>Comparator(s) appropriate as applied in a clinical practice setting (description)</b> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><b>Comparator(s) duration</b> </p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><a href="./references#CD012551-bbs2-0019" title="NeimarkAI , MaksimovaSS . Effect of hypercapnic hypoxia on chronic abacterial prostatitis. Urologiia (Moscow, Russia : 1999)2016;1(3):80‐4. [PUBMED: 28247635] "><b>Neimark 2016</b> </a> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Breathing exercises using 'Karbonik' apparatus (hypercapnic hypoxia) 10‐20 min daily + medical therapy (see comparison). </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>No information regarding dose‐scaling or contraindications.</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>10 days.</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Levofloxacin 500 mg/day, tamsulosin 0.4 mg/day, Samprost daily suppository, Serenoa repens fructuum extract 1 capsule/day for 10 days, nimesulide 1‐2 tablets/day for 5‐7 days. </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>No information regarding dose‐scaling or contraindications.</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>10 days.</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><a href="./references#CD012551-bbs2-0023" title="PajovicB , RadojevicN , DimitrovskiA , VukovicM . Comparison of the efficiency of combined extracorporeal shock‐wave therapy and triple therapy versus triple therapy itself in Category III B chronic pelvic pain syndrome (CPPS). Aging Male2016;19(3):1‐6. "><b>Pajovic 2016</b> </a> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>ESWT + medical therapy:</p> <p>each session had 12‐min duration and 3000 impulses with total energy flow 0.25 mJ/mm<sup>2</sup> 3 Hz, weekly in supine position without anaesthesia. </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>No information regarding dose‐scaling or contraindications.</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>12 weeks.</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Medical therapy with doxazosin 4 mg daily, ibuprofen 400 mg daily and tiocolchicoside 12 mg daily. </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Ranitidine was allowed for gastric complaints.</p> <p>No information regarding dose‐scaling or contraindications.</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>12 weeks.</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><a href="./references#CD012551-bbs2-0012" title="KucukEV , SucekenFY , BindayiA , BoyluU , OnolFF , GumusE . Effectiveness of acupuncture on chronic prostatitis‐chronic pelvic pain syndrome category IIIB patients: a prospective, randomized, nonblinded, clinical trial. Urology2015;85(3):636‐40. "><b>Kucuk 2015</b> </a> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Acupuncture group:</p> <p>UB28 bladder meridian<br/> GB41 gallbladder meridian<br/> LIV3 liver 3 meridian<br/> LI4 large intestine 4 meridian<br/> SP6 spleen 6 meridian<br/> SP8 spleen 8 meridian </p> <p>Stimulation using disposable acupuncture needles (Hua Long, 25 40 mm Sterile Acupuncture Needles, China) and electrical pulse generator (Agistim Duo, 4 4 mA rms max/ 99 Hz max, France). </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>No information regarding dose‐scaling.</p> <p>"Localized skin infections concerning the acupoints, bleeding diathesis and use of anticoagulation" were contraindications. </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>7 weeks.</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Medical therapy levofloxacin 500 mg daily and ibuprofen 200 mg.</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Orally administrated twice daily for 7 weeks.</p> <p>No information regarding dose‐scaling or contraindications.</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>7 weeks.</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><a href="./references#CD012551-bbs2-0025" title="SahinS , BicerM , ErenGA , TasS , TugcuV , TasciAI , et al. Acupuncture relieves symptoms in chronic prostatitis/chronic pelvic pain syndrome: a randomized, sham‐controlled trial. Prostate Cancer and Prostatic Diseases2015;18(3):249‐54. "><b>Sahin 2015</b> </a> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Acupuncture, using 2 disposable stainless steel needles (0.3 mm diameter, 60 mm length, Suzhou, Jiangsu, China) that were inserted to a depth of maximum 2.5‐3 cm in 7 acupoints bilaterally: BL33 Zhongliao<br/> BL34 Xialiao<br/> BL54 Zhibian<br/> CV1 Huiyin<br/> CV4 Guanyuan<br/> SP6 Sanyinjiao<br/> SP9 Yinlingquan. Duration: 20 min (with rotation). </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Applied weekly for 6 weeks without other treatment modalities.</p> <p>No information regarding dose‐scaling or contraindications.</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>6 weeks.</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Punctures in sham group performed 1 cm left of each selected acupoint, with same type of needles, of the same duration and frequency. </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Applied weekly for 6 weeks.</p> <p>No information regarding dose‐scaling or contraindications.</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>6 weeks.</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><a href="./references#CD012551-bbs2-0037" title="ZhaoY , ZhaoW , LangG , ChenY , LiuJ , WangG , et al. Circumcision plus antibiotic, anti‐inflammatory, and alpha‐blocker therapy for the treatment for chronic prostatitis/chronic pelvic pain syndrome: a prospective, randomized, multicenter trial. World Journal of Urology2015;33(5):617‐22. "><b>Zhao 2015</b> </a> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Medical therapy (4 weeks of ciprofloxacin 500 mg bid, 3 months of ibuprofen 400 mg/day, 3 months of tamsulosin 0.4 mg/day) and scheduled for surgery during the same period in each of the sites by study clinicians; given written instructions about postoperative wound care. </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>No information regarding dose‐scaling or contraindications.</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>3 months.</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Same medications (4 weeks of ciprofloxacin 500 mg bid, 3 months of ibuprofen 400 mg/day, 3 months of tamsulosin 0.4 mg/day) and remain uncircumcised until end of 3‐month study participation, when they were scheduled to undergo circumcision. </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>No information regarding dose‐scaling or contraindications.</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>3 months.</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><a href="./references#CD012551-bbs2-0005" title="GalloL . Effectiveness of diet, sexual habits and lifestyle modifications on treatment of chronic pelvic pain syndrome. Prostate Cancer and Prostatic Diseases2014;17(3):238‐45. "><b>Gallo 2014</b> </a> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Individually discussed risk factors detected at history by the completed questionnaire, informed that such risk factors were potential causes of their disease symptoms and it was strongly recommended to avoid them, distributed a vademecum with 13 rules relating to diet, sexual habits and lifestyle. </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>No information regarding dose‐scaling or contraindications.</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>3 months.</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Followed same diet, sexual behaviours and lifestyle as those of the previous months.</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>No information regarding dose‐scaling or contraindications.</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>3 months.</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><a href="./references#CD012551-bbs2-0011" title="KesslerTM , MordasiniL , WeisstannerC , JuniP , daCostaBR , WiestR , et al. Sono‐electro‐magnetic therapy for treating chronic pelvic pain syndrome in men: a randomized, placebo‐controlled, double‐blind trial. PloS One2014;9(12):e113368. WeisstannerC , MordasiniL , ThalmannGN , VermaRK , RummelC , FederspielA , et al. Therapy‐related longitudinal brain perfusion changes in patients with chronic pelvic pain syndrome. Swiss Medical Weekly2017;147:w14454. "><b>Kessler 2014</b> </a> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Sono‐electromagnetic therapy at home using Sonodyn Device: intensity 100 mW/cm<sup>2</sup> with ultrasonic power of 12 mW and frequency 1.9 MHz, electric field force 0.3 V/m and magnetic field force 0.4 A/m; for 10 min, twice daily. </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Participants could not see settings or perceive the device. No information regarding dose‐scaling or contraindications. </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>12 weeks.</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Similar placebo device. Participants applied same procedure, but device was not active during session. </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Participants could not see settings or perceive device. No information regarding dose‐scaling or contraindications. </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>12 weeks.</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><a href="./references#CD012551-bbs2-0009" title="KaikaiC , RuiW , YongC , ZhuC , WeiH , SuogangW , et al. Combination therapy of non‐intrusive ultrasound with integrated Chinese‐western medicine for chronic prostatitis/chronic pelvic pain syndrome. Chinese Journal of Andrology2014;28(12):41‐4. "><b>Kaikai 2014</b> </a> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Non‐intrusive ultrasound. Output frequency 1.79 MHz; output power: 3.15 W/cm<sup>2</sup>. Duration: 20 min, administered every 3 days (total of 7 times) </p> <p>+ integrated Chinese‐Western medications.</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>No information regarding dose‐scaling or contraindications.</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>‐</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Integrated Chinese‐Western medications alone; QianLieShuTong Capsule, orally 3 times daily, 3 capsules each time, tamsulosin delayed‐release capsule, 0.2 mg, orally 4 times daily. </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>No information regarding dose‐scaling or contraindications.</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>1 month.</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><a href="./references#CD012551-bbs2-0030" title="MoayedniaA , HaghdaniS , KhosrawiS , YousefiE , VahdatpourB . Long‐term effect of extracorporeal shock wave therapy on the treatment of chronic pelvic pain syndrome due to non bacterial prostatitis. Journal of Research in Medical Sciences2014;19(4):293‐6. VahdatpourB , AlizadehF , MoayedniaA , EmadiM , KhoramiMH , HaghdaniS . Efficacy of extracorporeal shock wave therapy for the treatment of chronic pelvic pain syndrome: a randomized, controlled trial. ISRN Urology2013;2013:972601. "><b>Vahdatpour 2013</b> </a> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>ESWT (DUOLITH SD1, Storz Medical, Tägerwilen, Switzerland) once weekly for 4 weeks. Each time 3000 impulses, with 0.25 mJ/mm<sup>2</sup> and 3 Hz of frequency were delivered, although 0.5 mJ/mm<sup>2</sup> was added in each week (0.3 mJ/mm<sup>2</sup> in week 2, 0.35 mJ/mm<sup>2</sup> in week 3 and 0.4 mJ/mm<sup>2</sup> in week 4). After each 500 pulses, probe position was corrected, using transperineal ultrasound. </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>No information regarding dose‐scaling or contraindications.</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>4 weeks.</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>In sham group, same protocol applied but with probe being turned off.</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>No information regarding dose‐scaling or contraindications.</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>4 weeks.</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><a href="./references#CD012551-bbs2-0004" title="BadilloSA , NevilleCE , KotarinosR , FortmanC , FraserL , CosbyA , et al. Randomized multicenter pilot trial shows benefit of manual physical therapies in treatment of urologic chronic pelvic pain. Journal of Women's Health Physical Therapy2009;33(1):23. FitzGeraldMP , AndersonRU , PottsJ , PayneCK , PetersKM , ClemensJQ , et al. Randomized multicenter feasibility trial of myofascial physical therapy for the treatment of urological chronic pelvic pain syndromes. Journal of Urology2009;182(2):570‐80. FitzgeraldMP , AndersonRU , PottsJ , PayneCK , PetersKM , ClemensJQ , et al. Randomized multicenter feasibility trial of myofascial physical therapy for the treatment of urological chronic pelvic pain syndromes. Journal of Urology2013;189(1 Suppl):S75‐85. "><b>Fitzgerald 2013</b> </a> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>10 × 1‐hour sessions of myofascial physical therapy involved connective tissue manipulation of the abdominal wall, back, buttocks and thighs with connective tissue abnormalities in prone and supine position; double voiding and squatting (as home exercises); transrectal manipulation. </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>No information regarding dose‐scaling.</p> <p>"The presence of painful scars on lower abdominal wall that according to the health care personnel were unlikely to respond to physical therapy" was used as an exclusion criterion. </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>‐</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>10 × 1‐hour sessions of global therapeutic Western massage, including effleurage, petrissage, friction, tapotement, vibration and kneading, in upper and lower limbs, trunk, buttocks, abdomen, head and neck each for prescribed time periods; participants not provided with home exercise programme. </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>No information regarding dose‐scaling or contraindications.</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>‐</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><a href="./references#CD012551-bbs2-0035" title="ZengX , YeZ , YangW , ChenZ , DuG . Extracorporeal shock wave treatment for noninflammatory chronic pelvic pain syndrome: a prospective, randomized, sham‐controlled study. Journal of Urology2009;181(4):122‐3. ZengXY , LiangC , YeZQ . Extracorporeal shock wave treatment for non‐inflammatory chronic pelvic pain syndrome: a prospective, randomized and sham‐controlled study. Chinese Medical Journal2012;125(1):114‐8. "><b>Zeng 2012</b> </a> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>20,000 ESWT (HB‐ESWT‐01, Haibin Medical Equipment Co. Ltd., China) impulses in 10 sessions, applied directly to perineal area in which pain was localised (from anus to scrotum); starting energy density was 0.06 mJ/mm<sup>2</sup> and frequency of 2 Hz was used for all treatments. </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Energy density gradually increased until it reached the maximum possible tolerable pain level reported by participant (recorded and used in all subsequent sessions). </p> <p>No information regarding contraindications.</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>2 weeks.</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Sham ESWT, which was conducted by setting the energy level to 0 (no shockwave energy transmission), under conditions identical to active treatment group. </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>No information regarding dose‐scaling or contraindications.</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>2 weeks.</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="2" valign="top"> <p><a href="./references#CD012551-bbs2-0006" title="GaoM , DingH , ZhongG , LuJ , WangH , LiQ , et al. The effects of transrectal radiofrequency hyperthermia on patients with chronic prostatitis and the changes of MDA, NO, SOD, and Zn levels in pretreatment and posttreatment. Urology2012;79(2):391‐6. "><b>Gao 2012</b> </a> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>60‐min treatment with TRFH (ZRL‐II‐A cavity intervention treatment instrument provided by Shanghai Songhang Industry, Co. Ltd. (Shanghai, China), temperature 40‐43 °C) every day. </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="2" valign="top"> <p>No information regarding dose‐scaling or contraindications.</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="2" valign="top"> <p>5 days.</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="2" valign="top"> <p>Tamsulosin 0.2 mg once daily + clarithromycin 0.25 g bid.</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="2" valign="top"> <p>No information regarding dose‐scaling or contraindications.</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="2" valign="top"> <p>6 weeks.</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>TRFH + tamsulosin + clarithromycin (6 weeks).</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="3" valign="top"> <p><a href="./references#CD012551-bbs2-0033" title="YangZS , ZuXB , QiL , SongLM , LiuTR . Combination therapy of biofeedback with electrical stimulation for chronic prostatitis/chronic pelvic pain syndrome. Zhonghua Nan Ke Xue2011;17(7):611‐4. "><b>Yang 2011</b> </a> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Biofeedback group, participant displayed the electromyography of pelvic floor muscle and was instructed to contract and relax the anus according to instructions on display (20‐min sessions, 5 times weekly for 2 weeks). </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="3" valign="top"> <p>No information regarding dose‐scaling or contraindications.</p> <p>All participants received interventions in comparison group.</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="3" valign="top"> <p>2 weeks.</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="3" valign="top"> <p>All participants, including those in the "usual care group" instructed to avoid alcohol and spicy food, sitting too long and holding urine, catching a cold. Advised to be physically active and do exercise, have sex regularly, have warm sitz baths. </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="3" valign="top"> <p>They were instructed to discontinue antibiotics, alpha‐blockers and other medications during the trial. </p> <p>No information regarding dose‐scaling or contraindications.</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="3" valign="top"> <p>‐</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Electrical stimulation group, anal electrodes using intensity of 6˜23 mA, for 10˜20 s and relaxation for 10˜20 s, (20‐min sessions; 5 times each week for 2 weeks). </p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Biofeedback + electrical stimulation (factorial design).</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><a href="./references#CD012551-bbs2-0036" title="ZhangDY , PanXC . Chinese medicine union Taijiquan treatment chronicity non‐bacterial prostatitis curative effect observation. Chinese Manipulation &amp; Rehabilitation Medicine2011;15(2):181. "><b>Zhang 2011a</b> </a> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Taijiquan (Tai Chi) exercises for 20‐40 min every day. All participants received herbal therapy (no further specifications available) for 1 month after. </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>No information regarding dose‐scaling or contraindications.</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>1 month.</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>All participants received herbal therapy (no further specifications available) for 1 month after. </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>No information regarding dose‐scaling or contraindications.</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>1 month.</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><a href="./references#CD012551-bbs2-0026" title="Samhan AhmedF , Abd‐Elhalim NermeenM , Elnegmy EmamH , Roiah MohamedM . The effect of transcutaneous electrical nerve stimulation in the treatment of chronic pelvic pain syndrome: an evidence based electromyographic studies. Indian Journal of Physiotherapy &amp; Occupational Therapy2011;5(3):14‐7. "><b>Samhan 2011</b> </a> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>TENS daily for mean of 20 min in painful area, mean frequency 100 Hz, pulse width 100 μs and intensity 25 mA daily, 5 times weekly. </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>No information regarding dose‐scaling or contraindications.</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>1 month.</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Same as active treatment group but with machine turned off.</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>No information regarding dose‐scaling or contraindications.</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>1 month.</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><a href="./references#CD012551-bbs2-0014" title="LeeSH , LeeBC . Electroacupuncture relieves pain in men with chronic prostatitis/chronic pelvic pain syndrome: three‐arm randomized trial. Urology2009;73(5):1036‐41. "><b>Lee 2009</b> </a> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Advice of hot sitz baths and exercise and 12 × 20‐min sessions of electroacupuncture in 6 weeks: 6 acupoints at bilateral: </p> <p>BL32 zhongliao<br/> BL33 ciliao<br/> GB30 huantiao; preparation alcohol pads and disposable stainless steel needles (40 0.25 mm, Dongbang Acupuncture, Chungnam, Republic of Korea); at GB30, disposable stainless steel needles (70 0.30 mm, Dongbang Acupuncture) were inserted deeply to reach the myofascial trigger point of piriformis muscle. </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>No information regarding dose‐scaling or contraindications.</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>6 weeks.</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Advice and exercise and 12 sessions of sham electroacupuncture, which included the same number and type of needle, duration and frequency of sessions as for the advice and exercise treatment, but treatment was delivered superficially at non‐acupoints 15 mm to the lateral of each corresponding acupoint; points were not stimulated electrically, but sound of pulse generator was heard by the participants. </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>No information regarding dose‐scaling or contraindications.</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>6 weeks.</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="2" valign="top"> <p><a href="./references#CD012551-bbs2-0002" title="ChenZX . Observation on therapeutic effect of warm needle moxibustion on chronic non‐bacterial prostatitis. Zhongguo Zhen Jiu [Chinese Acupuncture &amp; Moxibustion]2009;29(4):275‐8. "><b>Chen 2009</b> </a> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Acupuncture + warm needle moxibustion.</p> <p>Acupuncture at acupoints:</p> <p>BI18 GanYu<br/> BI23 ShenYu<br/> BI54 ZhiBian<br/> BI26 GuanYuan<br/> Ren3 ZhongJi<br/> SP9 YinLingQuan<br/> SP6 SanYinJiao </p> <p>For 5 s each; needles were removed afterwards; once daily for 1 month.</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="2" valign="top"> <p>For those treated with moxibustion:</p> <p>needles were left afterwards and the tails of which were then covered with 2 cm moxa sticks. Moxa sticks were then ignited. Repeated moxibustion twice more for each acupoint. </p> <p>No information regarding dose‐scaling or contraindications.</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="2" valign="top"> <p>1 month.</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="2" valign="top"> <p>Prostat tablet orally twice daily: pollen extract.</p> <p>Course of treatment; 1 month.</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="2" valign="top"> <p>No information regarding dose‐scaling or contraindications.</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="2" valign="top"> <p>1 month.</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Acupuncture procedures same as acupuncture + warm needle moxibustion. Moxibustion not performed. Treated once daily. Course of treatment: 1 month. </p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><a href="./references#CD012551-bbs2-0038" title="ZimmermannR , CumpanasA , MicleaF , JanetschekG . Extracorporeal shock wave therapy for the treatment of chronic pelvic pain syndrome in males: a randomised, double‐blind, placebo‐controlled study. European Urology2009;56(3):418‐24. ZimmermannRP , CumpanasA , MicleaF , JanetschekG . One year follow up of extracorporeal shock wave therapy (ESWT) for chronic pelvic pain syndrome (CPPS) in a randomised placebo‐controlled double‐blind study. European Urology (Suppl)2010;9(2):214. "><b>Zimmermann 2009</b> </a> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Perineally applied ESWT weekly (3000 pulses each; maximum total energy flow density: 0.25 mJ/mm<sup>2</sup>; frequency: 3 Hz); position of transducer was changed after every 500 pulses to scan prostatic and pelvic floor region (Duolith SD1, Storz Medical, Tägerwilen, Switzerland); penetration depth 35‐65 mm. </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>No information regarding dose‐scaling or contraindications.</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>4 weeks.</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Placebo treatment performed with same therapy head, which was also fitted with a placebo stand‐off. Stand‐off contained shock wave‐absorbing material, layer of air and air‐filled microspheres. </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>No information regarding dose‐scaling or contraindications.</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>4 weeks.</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><a href="./references#CD012551-bbs2-0016" title="MarxS . ICAOR 2006: does osteopathic treatment have an influence on the symptoms of patients with chronic prostatitis/chronic pelvic pain syndrome (CPPS)? A randomized controlled trial. International Journal of Osteopathic Medicine2006;9(1):44. MarxS , CimniakU , BeckertR , SchwerlaF , ReschKL . Chronic prostatitis/chronic pelvic pain syndrome. Influence of osteopathic treatment ‐ a randomized controlled study [Chronische Prostatitis/chronisches Beckenschmerzsyndrom. Einfluss osteopathischer Behandlungen ‐ eine randomisiert kontrollierte Studie]. Der Urologe. Ausg. A2009;48(11):1339‐45. "><b>Marx 2009</b> </a> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Osteopathic theory of structural dysfunction using direct and indirect techniques of manipulation; including rectal manipulation of the prostate and coccyx; 45‐min sessions for 5 weeks. </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>No information regarding dose‐scaling or contraindications.</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>5 weeks.</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Sham exercise program including a warm‐up, stretching, limb, breathing and pelvic floor muscle exercises; 30 min sessions in 5 weeks. </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>No information regarding dose‐scaling or contraindications.</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>5 weeks.</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><a href="./references#CD012551-bbs2-0021" title="OhMM , JinMH , MoonDG , NamSG , BaeJH , ParkHS . A prospective, randomized, placebo controlled study of radiofrequency therapy for the treatment of chronic prostatitis/chronic pelvic pain syndrome. Journal of Urology2009;181(4):122. "><b>Oh 2009</b> </a> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>'Radiofrequency.'</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>(abstract only)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>‐</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>"Placebo therapy."</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>(abstract only)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>‐</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><a href="./references#CD012551-bbs2-0008" title="KabayS , KabaySC , YucelM , OzdenH . Efficiency of posterior tibial nerve stimulation in category IIIB chronic prostatitis/chronic pelvic pain: a Sham‐Controlled Comparative Study. Urologia Internationalis2009;83(1):33‐8. "><b>Kabay 2009</b> </a> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>PTNS applied unilaterally with 26‐gauge stainless steel needles inserted 5 cm cephalad from medial malleolus and posterior to edge of tibia with a ground neutral electrode placed on same leg near arch of foot; both connected to a stimulator at 200 µs with pulse rate 20 Hz (Medtronic Key Point Net, Medtronic), for 30 min. </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>No information regarding dose‐scaling or contraindications.</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>12 weeks.</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Same electrode procedure for PTNS; however, stimulator not connected.</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>No information regarding dose‐scaling or contraindications.</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>12 weeks.</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><a href="./references#CD012551-bbs2-0034" title="ChungH , ChoiH , YooTK , ChoJM , KimHS . The effects of microwave thermotherapy for chronic prostatitis/chronic pelvic pain syndrome: a prospective, randomized study. Urogenital Tract Infection2017;12(1):35‐41. KimH , ChungH , YangS , YooT , ChoJ . Effects of thermotherapy and medical therapy for chronic prostatitis/chronic pelvic pain syndrome: a prospective study. Urology2011;78(3):S85‐6. YooTK , MoonKT , LeeSW , KimHS , ChungH , KimJY . Effect of the combination treatment of URO‐DrG and medical therapy for chronic prostatitis/chronic pelvic pain syndrome: a prospective study. Journal of Urology2009;181(4):122. "><b>Yoo 2009</b> </a> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>TRMT alone for 12 weeks; using a Uro‐DR Device (Somang Medical; Kangreung, Korea), at intrarectal temperature of 43 °C for 30 min, at a medium heating rate. </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>No information regarding dose‐scaling or contraindications.</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>12 weeks.</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Medical therapy: ciprofloxacin 500 mg bid and NSAIDs</p> <p>C: TRMT + medical therapy.</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>No information regarding dose‐scaling or contraindications.</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>12 weeks.</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><a href="./references#CD012551-bbs2-0013" title="LeeSW , LiongML , YuenKH , KriegerJN . Acupuncture and immune function in chronic prostatitis/chronic pelvic pain syndrome: a randomized, controlled study. Complementary Therapies in Medicine2014;22(6):965‐9. LeeSW , LiongML , YuenKH , LeongWS , CheeC , CheahPY , et al. Acupuncture versus sham acupuncture for chronic prostatitis/chronic pelvic pain. American Journal of Medicine2008;121(1):79.e1‐7. LeeSW , LiongML , YuenKH , LeongWS , KhanNK , KriegerJN . Validation of a sham acupuncture procedure in a randomised, controlled clinical trial of chronic pelvic pain treatment. Acupuncture in Medicine2011;29(1):40‐6. "><b>Lee 2008</b> </a> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>4 acupoints prepared, then sterile, disposable stainless steel needles (Suzhou Huan‐Qiu Acupuncture Medical Supplies, Suzhou, China) placed perpendicularly in 30‐min sessions twice weekly in acupoints: </p> <p>CV1 Guan Yuan<br/> CV4 Huiyin<br/> SP6 Sanyinjiao<br/> SP9 Yinlingquan. </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>No information regarding dose‐scaling or contraindications.</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>10 weeks.</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Sham acupuncture included same number, duration and frequency of sessions as acupuncture group at non‐acupoints (15 mm to left). </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>No information regarding dose‐scaling or contraindications.</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>10 weeks.</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><a href="./references#CD012551-bbs2-0029" title="SikiruL , ShmailaH , MuhammedSA . Transcutaneous electrical nerve stimulation (TENS) in the symptomatic management of chronic prostatitis/chronic pelvic pain syndrome: a placebo‐control randomized trial. International Brazilian Journal of Urology2008;34(6):708‐13; discussion 714. "><b>Sikiru 2008</b> </a> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Antibiotics plus TENS; with high TENS over painful area, daily for mean of 20 min, mean frequency 100 Hz, pulse width 100 μs and intensity 25 mA, 5 times weekly. </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Contraindications: loss of skin sensation at and around painful area, cardiac pace maker, previous exposure to TENS and other electroanalgesia. </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>4 weeks.</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Ofloxacin 300 mg 3 times daily + placebo tablets.</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>No information regarding dose‐scaling or contraindication.</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>4 weeks.</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><a href="./references#CD012551-bbs2-0007" title="GiubileiG , MondainiN , MinerviniA , SaievaC , LapiniA , SerniS , et al. Physical activity of men with chronic prostatitis/chronic pelvic pain syndrome not satisfied with conventional treatments ‐ could it represent a valid option? The physical activity and male pelvic pain trial: a double‐blind, randomized study. Journal of Urology2007;177(1):159‐65. "><b>Giubilei 2007</b> </a> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Aerobic exercise group, which included an 18‐week walking programme, 3 times weekly; with a warm up and cool‐down regimen, postural muscle and isometric strengthening exercises, 40 min of fast‐paced walking on 'in‐outdoor' track (achieving 70/80% of predicted maximum heart rate for their age). </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Participants with a 'lack of interest,' 'lack of time' and 'lack of confidence' to engage physical activity excluded from study. </p> <p>No information regarding dose‐scaling.</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>18 weeks.</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Placebo/flexibility and motion exercise programme; with same period and with same frequency of aerobic exercise group, maintaining their heart rate under 100 beats per min. </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Participants with a 'lack of interest,' 'lack of time' and 'lack of confidence' to engage physical activity were excluded from the study. </p> <p>No information regarding dose‐scaling.</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>18 weeks.</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><a href="./references#CD012551-bbs2-0022" title="PaickJS , LeeSC , KuJH . More effects of extracorporeal magnetic innervation and terazosin therapy than terazosin therapy alone for non‐inflammatory chronic pelvic pain syndrome: a pilot study. Prostate Cancer and Prostatic Diseases2006;9(3):261‐5. "><b>Paick 2006</b> </a> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Extracorporeal magnetic innervation using Neoconrol system (Neotonus Inc., Marietta, GA, USA) that generates a magnetic field directed in the seat of chair and concentrated in region of pelvic muscles; 2 sessions weekly lasting 20 min each. </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>1st 10 min used 10 Hz field, 2 min rest and then 10 min of 50 Hz field.</p> <p>No information regarding contraindications.</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>6 weeks.</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Medical therapy with terazosin 4 mg daily.</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>They started 2 mg daily for 1st 7 days, and continued to receive 4 mg daily for the following 5 weeks. </p> <p>No information regarding contraindications.</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>6 weeks.</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><a href="./references#CD012551-bbs2-0001" title="AteyaA , FayezA , HaniR , ZohdyW , GabbarMA , ShamloulR . Evaluation of prostatic massage in treatment of chronic prostatitis. Urology2006;67(4):674‐8. "><b>Ateya 2006</b> </a> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Participants received antibiotics empirically and prostatic massage (3 times weekly for 4 weeks). Prostate massaged from above and lateral to gland, 6 times on each side, by gentle and firm pressure of finger directed downwards and inwards, followed by a few strokes in middle from above downwards. </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>No information regarding dose‐scaling or contraindications.</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>‐</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Empirical antibiotic therapy alone without prostatic massage.</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>'In the 44 participants with negative cultures, antibiotic selection included quinolones (28 participants), clindamycin/metronidazole (11 participants), ampicillin/<br/> clavulanic acid (2 participants), and azithromycin (1 participant). All participants continued the 1 month of<br/> treatment.' </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>‐</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><a href="./references#CD012551-bbs2-0028" title="ShenSL , HeDL , LuoY . Clinical trials of combined therapy of an oral Chinese medicine with massage for chronic nonbacterial prostatitis. Zhonghua Nan Ke Xue2006;12(9):851‐3. "><b>Shen 2006</b> </a> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Medical therapy with modified BiXieFenQing Drink in morning and evening, 200 mL each + prostate massage once weekly. </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>No information regarding dose‐scaling or contraindications.</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>‐</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Medical therapy alone.</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>No information regarding dose‐scaling or contraindications.</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>‐</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><a href="./references#CD012551-bbs2-0024" title="RoweE , SmithC , LaverickL , ElkabirJ , WitherowRO , PatelA . A prospective, randomized, placebo controlled, double‐blind study of pelvic electromagnetic therapy for the treatment of chronic pelvic pain syndrome with 1 year of followup. Journal of Urology2005;173(6):2044‐7. "><b>Rowe 2005</b> </a> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Participant seated in a Neotonus Electromagnetic Chair (Neotonus Inc., Marietta, GA, USA), for 2 consecutive 15‐min periods; 2 sessions weekly. </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>1st period 10 Hz, 2nd period 50 Hz.</p> <p>No information regarding contraindications.</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>4 weeks.</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Participants seated in chair, ventilation mechanism activated, but no active stimulation applied. </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>No information regarding dose‐scaling or contraindications.</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>4 weeks.</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><a href="./references#CD012551-bbs2-0003" title="FangJ , XuG , DingQ , ZhangY‐F . Observation on the safety and efficacy of He‐Ne laser equipment on chronic abacteria prostatitis. Fudan University Journal of Medical Sciences2005;32(2):234‐5, 252. "><b>Fang 2005</b> </a> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>He‐Ne laser directed to prostate. Optic fibre was inserted from urethra and located at prostatic urethra; 10 mW output at 18 J each time. </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>1 course of treatment: 10 doses of radiation (2 sessions weekly).</p> <p>Participants discontinued all other treatments, except for some of the participants, short‐term sulfa‐drugs were administered temporarily to prevent infection. </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>‐</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>'Routine care' for prostatitis including antibiotics, pollen extract, Chinese medicine, physical therapy and lifestyle interventions. </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Sulfamethoxazole tablets, 2 tablets, orally bid, 60 days of fluoroquinolones such as levofloxacin 0.2 g, bid, 14 days of pollen drugs such as Prostat; Chinese patent drugs such as salvianolic acid B and saponins of panax notoginseng mixture (SalB/PNS); hot water bath and advise on lifestyle. </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>‐</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><a href="./references#CD012551-bbs2-0010" title="KastnerC , HochreiterW , HuidobroC , CabezasJ , MillerP . Cooled transurethral microwave thermotherapy for intractable chronic prostatitis ‐ results of a pilot study after 1 year. Urology2004;64(6):1149‐54. "><b>Kastner 2004</b> </a> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Transurethral microwave thermotherapy through catheter connected to a Targis System estimated peak intraprostatic temperatures of 55 °C. </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>No information regarding dose‐scaling or contraindications.</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>‐</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Transurethral microwave thermotherapy through catheter connected to a Targis System estimated peak intraprostatic temperatures of 70 °C. </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>No information regarding dose‐scaling or contraindications.</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>‐</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><a href="./references#CD012551-bbs2-0032" title="WangJ , LiJ , LuR , WangJM . Treatment of external RF hyperthermia combining with alpha 1‐adrenergic receptor blocker for patients with prostatodynia and chronic non‐bacterial prostatitis. Zhonghua Nan Ke Xue2002;8(1):48‐50. "><b>Wang 2002</b> </a> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>External radiofrequency hyperthermia.</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Applied externally: 2 electrodes placed at hip and lower abdomen, 5˜7 cm away from skin, with pubic symphysis as centre (42.5˜43.5 °C), 1˜2 hours each time, course of treatment: 2˜3 times, interval: 1˜2 weeks. </p> <p>No information regarding dose‐scaling or contraindications.</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>1˜2 weeks.</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Same external radiofrequency hyperthermia + terazosin 2 mg.</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Daily for 2 days and then dose was increased to 2 mg bid for 12 weeks.</p> <p>No information regarding contraindications for terazosin.</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>12 weeks.</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><a href="./references#CD012551-bbs2-0015" title="LeskinenMJ , KilponenA , LukkarinenO , TammelaTL . Transurethral needle ablation for the treatment of chronic pelvic pain syndrome (category III prostatitis): a randomized, sham‐controlled study. Urology2002;60(2):300‐4. "><b>Leskinen 2002</b> </a> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>TUNA using 465‐kHz radiofrequency energy and formal needle insertion technique as described by <a href="./references#CD012551-bbs2-0153" title="Issa MutaM . Transurethral Needle Ablation of the Prostate: Report of Initial United States Clinical Trial. The Journal of Urology1996;156(2):413‐9. [DOI: 10.1016/S0022‐5347(01)65863‐4] ">Issa 1996</a>; treatment applied on 2 planes on both lateral lobes of prostate in all participants so target temperature of 50 °C at needle tip was achieved for ≥ 1 min; under spinal analgesia and antibiotic prophylaxis. </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>No information regarding dose‐scaling or contraindications.</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>‐</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>3 sham urethroscopy performed so it was seemingly identical to TUNA in participant's opinion; under spinal analgesia and antibiotic prophylaxis. </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>No information regarding dose‐scaling or contraindications.</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>‐</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><a href="./references#CD012551-bbs2-0031" title="VassilyO , AndreyS , EvgeniiD , OtabekI , BorisL , SergeyR . Efficacy of transrectal microwave hyperthemia (TRMH) in the treatment of chronic prostatitis. A randomized sham controlled comparative study (Abstract). Journal of Urology1999;161(4 Suppl):33A. "><b>Vassily 1999</b> </a> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>TRMT, 6 sessions over 2 weeks each.</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>No information regarding dose‐scaling or contraindications.</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>‐</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Sham procedure.</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>No information regarding dose‐scaling or contraindications.</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>‐</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><a href="./references#CD012551-bbs2-0020" title="NickelJC , SorensenR . Transurethral microwave thermotherapy for nonbacterial prostatitis: a randomized double‐blind sham controlled study using new prostatitis specific assessment questionnaires. Journal of Urology1996;155(6):1950‐4; discussion 1954. "><b>Nickel 1996</b> </a> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Transurethral microwave thermotherapy consisted of 1 × 1‐hour treatment with computer‐driven device that elevated prostate interstitial temperatures to 45‐60 °C, a range that does not cause significant necrosis of normal prostatic tissue. </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>No information regarding dose‐scaling or contraindications.</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Single session.</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Sham therapy consisted of 1 × 1‐hour session with same device using sham software.</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>No information regarding dose‐scaling or contraindications.</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Single session.</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><a href="./references#CD012551-bbs2-0018" title="MuraroGB . Clinical study on the efficacy and safety of seaprose S combined with local prostatic hyperthermia in chronic non‐bacterial prostatitis. Controlled study versus local prostatic hyperthermia [Studio clinico sull'efficacia e la tollerabilita del seaprose S associato a ipertermia locale prostatica nella prostatite cronica abatterica. Studio controllato verso ipertermia locale prostatica]. Archivio di Medicina Interna1995;47(2‐3):73‐86. "><b>Muraro 1995</b> </a> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Seaprose S (Flaminase, Formenti) 30 mg 3 times daily in combination with local hyperthermia, total of 7 sessions on alternate days of 60‐min duration, reaching local temperature of 42.5‐43.5 °C. </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>No information regarding dose‐scaling.</p> <p>Contraindication to those with hypersensitivity to the drug.</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>‐</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>7 sessions of local hyperthermia alone.</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>No information regarding dose‐scaling or contraindications.</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>‐</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><a href="./references#CD012551-bbs2-0017" title="MontorsiF , GuazzoniG , BergamaschiF , GalliL , ConsonniP , MatozzoV , et al. Is there a role for transrectal microwave hyperthermia of the prostate in the treatment of abacterial prostatitis and prostatodynia?. Prostate1993;22(2):139‐46. "><b>Montorsi 1993</b> </a> </p> </td> <td align="" bgcolor="#ffffff" colspan="6" rowspan="1" valign="top"> <p>I1: 1 session of transrectal hyperthermia weekly for 4 weeks.</p> <p>I2: 1 session of transrectal hyperthermia weekly for 6 weeks.</p> <p>I3: 2 sessions of transrectal hyperthermia weekly for 3 weeks.</p> <p>Prostathermer 99D system (Biodan Ltd, Rehovot, Israel), target temperature reached within 1st 10 min of treatment, microwaves at 915 MHz, thermosensors for monitoring rectal temperature, cooling system for anterior rectal wall, thermosensors for urethra temperatures, outpatient basis, required local anaesthesia, with 2% xylocaine jelly before insertion of the catheter. </p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><a href="./references#CD012551-bbs2-0027" title="ShahT , WatsonG , BarnesD . Microwave hyperthermia in the treatment of chronic abacterial prostatitis and prostatodynia: results of a double blind placebo controlled trial (Abstract). Journal of Urology1993;149:405A. "><b>Shah 1993</b> </a> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>TRMT, 4 × 1‐hour treatment over 2 or 3 weeks. Temperature raised to 43.8 °C with input of 40 W. </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>No information regarding dose‐scaling or contraindications.</p> <p>(abstract only)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>2˜3 weeks</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Sham group with temperature &lt; 37 °C.</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>No information regarding dose‐scaling or contraindications.</p> <p>(abstract only)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>‐</p> </td> </tr> </tbody> <tfoot> <tr> <td colspan="7"> <div class="table-footnote"> <p>‐ denotes not reported.</p> <p>bid: twice daily; C: comparator; ESWT: extracorporeal shockwave therapy; I: intervention; min: minute; NSAID: non‐steroidal anti‐inflammatory drug; PTNS: posterior tibial nerve stimulation; s: second; TENS: transcutaneous electrical nerve stimulation; TRFH: transrectal radiofrequency hyperthermia; TRMT: transrectal microwave thermotherapy; TUNA: transurethral needle ablation. </p> </div> </td> </tr> </tfoot> </table> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="table-viewer-caption"> <div class="table-heading"><span class="table-label">Table 1.</span> <span class="table-title">Description of interventions</span></div> </div> <div class="tools"><a class="tableList" href="/cdsr/doi/10.1002/14651858.CD012551.pub3/full#CD012551-tbl-0011">Navigate to table in review</a></div> </div> <div class="table"> <table data-id="CD012551-tbl-0012"> <div class="table-heading"><span class="table-label">Table 2.</span> <span class="table-title">Study and participant characteristics</span></div> <tbody> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><b>Study ID</b> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><b>Intervention(s) and comparator(s)</b> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><b>Randomised (n)</b> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><b>Analysed (n)</b> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><b>Duration of intervention and follow‐up</b> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><b>Description of participants<sup>a</sup> </b> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><b>Baseline NIH‐CPSI<sup>b</sup> score</b> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><b>Trial period (year to year)</b> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><b>Country</b> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><b>Setting</b> </p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="2" valign="top"> <p><a href="./references#CD012551-bbs2-0019" title="NeimarkAI , MaksimovaSS . Effect of hypercapnic hypoxia on chronic abacterial prostatitis. Urologiia (Moscow, Russia : 1999)2016;1(3):80‐4. [PUBMED: 28247635] "><b>Neimark 2016</b> </a> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>I: hypercapnic hypoxia + medical therapy</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>17</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>17</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="2" valign="top"> <p>D: 10 days</p> <p>F: 10 days</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="2" valign="top"> <p>Age: mean 37</p> <p>No specified previous treatment</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="2" valign="top"> <p>N/A</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="2" valign="top"> <p>N/A</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="2" valign="top"> <p>Russia</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="2" valign="top"> <p>Outpatient</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>C: medical therapy</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>20</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>20</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="2" valign="top"> <p><a href="./references#CD012551-bbs2-0023" title="PajovicB , RadojevicN , DimitrovskiA , VukovicM . Comparison of the efficiency of combined extracorporeal shock‐wave therapy and triple therapy versus triple therapy itself in Category III B chronic pelvic pain syndrome (CPPS). Aging Male2016;19(3):1‐6. "><b>Pajovic 2016</b> </a> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>I: extracorporeal shockwave therapy + medical care</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>30</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>30</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="2" valign="top"> <p>D: 12 weeks</p> <p>F: 24 weeks</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="2" valign="top"> <p>Age: mean 39.4</p> <p>No specified previous treatment</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>29.3</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="2" valign="top"> <p>2013‐2015</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="2" valign="top"> <p>Montenegro</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="2" valign="top"> <p>Outpatient</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>C: medical care</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>30</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>30</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>31.06</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="2" valign="top"> <p><a href="./references#CD012551-bbs2-0012" title="KucukEV , SucekenFY , BindayiA , BoyluU , OnolFF , GumusE . Effectiveness of acupuncture on chronic prostatitis‐chronic pelvic pain syndrome category IIIB patients: a prospective, randomized, nonblinded, clinical trial. Urology2015;85(3):636‐40. "><b>Kucuk 2015</b> </a> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>I: acupuncture</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>28</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>28</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="2" valign="top"> <p>D: 7 weeks</p> <p>F: 10 weeks</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="2" valign="top"> <p>Age: mean 33</p> <p>No previous treatment</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>20.36</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="2" valign="top"> <p>2008‐2009</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="2" valign="top"> <p>Turkey</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="2" valign="top"> <p>Outpatient</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>C: medical care</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>26</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>26</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>22.92</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="2" valign="top"> <p><a href="./references#CD012551-bbs2-0025" title="SahinS , BicerM , ErenGA , TasS , TugcuV , TasciAI , et al. Acupuncture relieves symptoms in chronic prostatitis/chronic pelvic pain syndrome: a randomized, sham‐controlled trial. Prostate Cancer and Prostatic Diseases2015;18(3):249‐54. "><b>Sahin 2015</b> </a> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>I: acupuncture</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>50</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>45</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="2" valign="top"> <p>D: 6 weeks</p> <p>F: 24 weeks</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="2" valign="top"> <p>Age: 20‐50</p> <p>All had received medical therapy</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>26.5</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="2" valign="top"> <p>Not available</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="2" valign="top"> <p>Turkey</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="2" valign="top"> <p>Outpatient</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>C: sham acupuncture</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>50</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>46</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>27.0</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="2" valign="top"> <p><a href="./references#CD012551-bbs2-0037" title="ZhaoY , ZhaoW , LangG , ChenY , LiuJ , WangG , et al. Circumcision plus antibiotic, anti‐inflammatory, and alpha‐blocker therapy for the treatment for chronic prostatitis/chronic pelvic pain syndrome: a prospective, randomized, multicenter trial. World Journal of Urology2015;33(5):617‐22. "><b>Zhao 2015</b> </a> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>I: early circumcision</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>384</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>358</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="2" valign="top"> <p>D: 3 months</p> <p>F: 3 months</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="2" valign="top"> <p>Age: mean 33</p> <p>No specified previous treatment</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>21</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="2" valign="top"> <p>2013‐2014</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="2" valign="top"> <p>China</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="2" valign="top"> <p>Outpatient</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>C: delayed circumcision</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>390</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>355</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>21</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="2" valign="top"> <p><a href="./references#CD012551-bbs2-0005" title="GalloL . Effectiveness of diet, sexual habits and lifestyle modifications on treatment of chronic pelvic pain syndrome. Prostate Cancer and Prostatic Diseases2014;17(3):238‐45. "><b>Gallo 2014</b> </a> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>I: lifestyle interventions</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>50</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>39</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="2" valign="top"> <p>D: 3 months</p> <p>F: 3 months</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="2" valign="top"> <p>Age: mean 33‐34</p> <p>No specified previous treatment</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>22.1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="2" valign="top"> <p>2012‐2013</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="2" valign="top"> <p>Italy</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="2" valign="top"> <p>Outpatient</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>C: no intervention</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>50</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>50</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>21.9</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="2" valign="top"> <p><a href="./references#CD012551-bbs2-0011" title="KesslerTM , MordasiniL , WeisstannerC , JuniP , daCostaBR , WiestR , et al. Sono‐electro‐magnetic therapy for treating chronic pelvic pain syndrome in men: a randomized, placebo‐controlled, double‐blind trial. PloS One2014;9(12):e113368. WeisstannerC , MordasiniL , ThalmannGN , VermaRK , RummelC , FederspielA , et al. Therapy‐related longitudinal brain perfusion changes in patients with chronic pelvic pain syndrome. Swiss Medical Weekly2017;147:w14454. "><b>Kessler 2014</b> </a> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>I: sono‐electromagnetic therapy</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>30</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>30</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="2" valign="top"> <p>D: 12 weeks</p> <p>F: 16 weeks</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="2" valign="top"> <p>Age: mean 44‐49</p> <p>All had received medical therapy</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>25.1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="2" valign="top"> <p>2009‐2012</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="2" valign="top"> <p>Switzerland</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="2" valign="top"> <p>Outpatient</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>C: placebo device</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>30</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>30</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>25.2</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="3" valign="top"> <p><a href="./references#CD012551-bbs2-0009" title="KaikaiC , RuiW , YongC , ZhuC , WeiH , SuogangW , et al. Combination therapy of non‐intrusive ultrasound with integrated Chinese‐western medicine for chronic prostatitis/chronic pelvic pain syndrome. Chinese Journal of Andrology2014;28(12):41‐4. "><b>Kaikai 2014</b> </a> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>I: ultrasound</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>35</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>35</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="3" valign="top"> <p>D: 1 month</p> <p>F: 1 month</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="3" valign="top"> <p>Age 18‐55</p> <p>All had received medical therapy</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>25.9</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="3" valign="top"> <p>2013‐2014</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="3" valign="top"> <p>China</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="3" valign="top"> <p>Outpatient</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>C1: medical therapy</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>35</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>35</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>26.17</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>C2: ultrasound + medical therapy</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>35</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>35</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>26.85</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="2" valign="top"> <p><a href="./references#CD012551-bbs2-0030" title="MoayedniaA , HaghdaniS , KhosrawiS , YousefiE , VahdatpourB . Long‐term effect of extracorporeal shock wave therapy on the treatment of chronic pelvic pain syndrome due to non bacterial prostatitis. Journal of Research in Medical Sciences2014;19(4):293‐6. VahdatpourB , AlizadehF , MoayedniaA , EmadiM , KhoramiMH , HaghdaniS . Efficacy of extracorporeal shock wave therapy for the treatment of chronic pelvic pain syndrome: a randomized, controlled trial. ISRN Urology2013;2013:972601. "><b>Vahdatpour 2013</b> </a> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>I: extracorporeal shockwave</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>20</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="2" valign="top"> <p>N/A</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="2" valign="top"> <p>D: 4 weeks</p> <p>F: 12 weeks</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="2" valign="top"> <p>Age: 35‐37</p> <p>No specified previous treatment</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>26.5</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="2" valign="top"> <p>2011‐2012</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="2" valign="top"> <p>Iran</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="2" valign="top"> <p>Outpatient</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>C: sham procedure</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>20</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>27.1</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="2" valign="top"> <p><a href="./references#CD012551-bbs2-0035" title="ZengX , YeZ , YangW , ChenZ , DuG . Extracorporeal shock wave treatment for noninflammatory chronic pelvic pain syndrome: a prospective, randomized, sham‐controlled study. Journal of Urology2009;181(4):122‐3. ZengXY , LiangC , YeZQ . Extracorporeal shock wave treatment for non‐inflammatory chronic pelvic pain syndrome: a prospective, randomized and sham‐controlled study. Chinese Medical Journal2012;125(1):114‐8. "><b>Zeng 2012</b> </a> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>I: extracorporeal shockwave therapy</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>40</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>38</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="2" valign="top"> <p>D: 2 weeks</p> <p>F: 12 weeks</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="2" valign="top"> <p>Age: mean 46‐49</p> <p>No specified previous treatment</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>30.5</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="2" valign="top"> <p>2009‐2011</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="2" valign="top"> <p>China</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="2" valign="top"> <p>Outpatient</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>C: sham procedure</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>40</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>37</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>29.3</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="3" valign="top"> <p><a href="./references#CD012551-bbs2-0006" title="GaoM , DingH , ZhongG , LuJ , WangH , LiQ , et al. The effects of transrectal radiofrequency hyperthermia on patients with chronic prostatitis and the changes of MDA, NO, SOD, and Zn levels in pretreatment and posttreatment. Urology2012;79(2):391‐6. "><b>Gao 2012</b> </a> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>I: medical therapy</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>30</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>30</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="3" valign="top"> <p>D: 6 weeks</p> <p>F: 6 weeks</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="3" valign="top"> <p>Age: mean 35‐36</p> <p>No specified previous treatment</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>20.9/20.2</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="3" valign="top"> <p>2008‐2009</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="3" valign="top"> <p>China</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="3" valign="top"> <p>Outpatient</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>C1: transrectal hyperthermia</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>32</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>32</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>20/21.1</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>C2: transrectal hyperthermia + medical therapy</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>43</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>43</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>22.4/21.7</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="4" valign="top"> <p><a href="./references#CD012551-bbs2-0033" title="YangZS , ZuXB , QiL , SongLM , LiuTR . Combination therapy of biofeedback with electrical stimulation for chronic prostatitis/chronic pelvic pain syndrome. Zhonghua Nan Ke Xue2011;17(7):611‐4. "><b>Yang 2011</b> </a> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>I1: biofeedback</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>20</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>20</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="4" valign="top"> <p>D: 2 weeks</p> <p>F: 6 weeks</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="4" valign="top"> <p>Age: mean 30</p> <p>All had received medical therapy</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>26.92</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="4" valign="top"> <p>2007</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="4" valign="top"> <p>China</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="4" valign="top"> <p>Outpatient</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>I2: electrical stimulation</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>40</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>40</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>26.35</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>I3: biofeedback + electrical stimulation</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>40</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>40</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>25.30</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>C: usual care</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>40</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>40</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>25.82</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="2" valign="top"> <p><a href="./references#CD012551-bbs2-0036" title="ZhangDY , PanXC . Chinese medicine union Taijiquan treatment chronicity non‐bacterial prostatitis curative effect observation. Chinese Manipulation &amp; Rehabilitation Medicine2011;15(2):181. "><b>Zhang 2011a</b> </a> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>I: TaiJiQuan</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>50</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="2" valign="top"> <p>N/A</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="2" valign="top"> <p>D: 1 month</p> <p>F: 1 month</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="2" valign="top"> <p>Age: 22‐50</p> <p>No specified previous treatment</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="2" valign="top"> <p>N/A</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="2" valign="top"> <p>N/A</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="2" valign="top"> <p>China</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="2" valign="top"> <p>Outpatient</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>C: no intervention</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>46</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="2" valign="top"> <p><a href="./references#CD012551-bbs2-0026" title="Samhan AhmedF , Abd‐Elhalim NermeenM , Elnegmy EmamH , Roiah MohamedM . The effect of transcutaneous electrical nerve stimulation in the treatment of chronic pelvic pain syndrome: an evidence based electromyographic studies. Indian Journal of Physiotherapy &amp; Occupational Therapy2011;5(3):14‐7. "><b>Samhan 2011</b> </a> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>I: TENS</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>20</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>20</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="2" valign="top"> <p>D: 4 weeks</p> <p>F: 4 weeks</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="2" valign="top"> <p>Age: 30 to 55</p> <p>No specified previous treatment</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="2" valign="top"> <p>N/A</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="2" valign="top"> <p>N/A</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="2" valign="top"> <p>Egypt</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="2" valign="top"> <p>Outpatient</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>C: placebo TENS</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>20</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>20</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="3" valign="top"> <p><a href="./references#CD012551-bbs2-0014" title="LeeSH , LeeBC . Electroacupuncture relieves pain in men with chronic prostatitis/chronic pelvic pain syndrome: three‐arm randomized trial. Urology2009;73(5):1036‐41. "><b>Lee 2009</b> </a> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>I1: electroacupuncture</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>12</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>11</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="3" valign="top"> <p>D: 6 weeks</p> <p>F: 6 weeks</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="3" valign="top"> <p>Age: 36‐40</p> <p>No specified previous treatment</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>26.9</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="3" valign="top"> <p>2007</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="3" valign="top"> <p>Korea</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="3" valign="top"> <p>Outpatient</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>I2: sham procedure</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>12</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>10</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>25.5</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>C: exercise and advise alone</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>12</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>12</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>28</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="3" valign="top"> <p><a href="./references#CD012551-bbs2-0002" title="ChenZX . Observation on therapeutic effect of warm needle moxibustion on chronic non‐bacterial prostatitis. Zhongguo Zhen Jiu [Chinese Acupuncture &amp; Moxibustion]2009;29(4):275‐8. "><b>Chen 2009</b> </a> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>I1: acupuncture + moxibustion</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>42</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>42</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="3" valign="top"> <p>D: 1 month</p> <p>F: 1 month</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="3" valign="top"> <p>Age: 21‐52</p> <p>No specified previous treatment</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>22.56</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="3" valign="top"> <p>2004‐2007</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="3" valign="top"> <p>China</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="3" valign="top"> <p>Outpatient</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>I2: acupuncture</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>41</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>41</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>21.97</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>C: medical treatment</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>42</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>42</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>22.89</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="2" valign="top"> <p><a href="./references#CD012551-bbs2-0038" title="ZimmermannR , CumpanasA , MicleaF , JanetschekG . Extracorporeal shock wave therapy for the treatment of chronic pelvic pain syndrome in males: a randomised, double‐blind, placebo‐controlled study. European Urology2009;56(3):418‐24. ZimmermannRP , CumpanasA , MicleaF , JanetschekG . One year follow up of extracorporeal shock wave therapy (ESWT) for chronic pelvic pain syndrome (CPPS) in a randomised placebo‐controlled double‐blind study. European Urology (Suppl)2010;9(2):214. "><b>Zimmermann 2009</b> </a> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>I: extracorporeal shockwave therapy</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>30</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>30</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="2" valign="top"> <p>D: 4 weeks</p> <p>F: 12 weeks</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="2" valign="top"> <p>Age: 22‐61</p> <p>No specified previous treatment</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>25.07</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="2" valign="top"> <p>N/A</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="2" valign="top"> <p>Austria</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="2" valign="top"> <p>Outpatient</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>C: sham procedure</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>30</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>30</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>23.3</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="2" valign="top"> <p><a href="./references#CD012551-bbs2-0004" title="BadilloSA , NevilleCE , KotarinosR , FortmanC , FraserL , CosbyA , et al. Randomized multicenter pilot trial shows benefit of manual physical therapies in treatment of urologic chronic pelvic pain. Journal of Women's Health Physical Therapy2009;33(1):23. FitzGeraldMP , AndersonRU , PottsJ , PayneCK , PetersKM , ClemensJQ , et al. Randomized multicenter feasibility trial of myofascial physical therapy for the treatment of urological chronic pelvic pain syndromes. Journal of Urology2009;182(2):570‐80. FitzgeraldMP , AndersonRU , PottsJ , PayneCK , PetersKM , ClemensJQ , et al. Randomized multicenter feasibility trial of myofascial physical therapy for the treatment of urological chronic pelvic pain syndromes. Journal of Urology2013;189(1 Suppl):S75‐85. "><b>Fitzgerald 2013</b> </a> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>I: myofascial trigger point therapy</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>10</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>9</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="2" valign="top"> <p>D: 10 weeks</p> <p>F: 12 weeks</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="2" valign="top"> <p>Age: mean 41‐45</p> <p>All had received medical therapy</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>33.5</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="2" valign="top"> <p>N/A</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="2" valign="top"> <p>US</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="2" valign="top"> <p>Outpatient</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>C: Western massage</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>11</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>10</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>25.8</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="2" valign="top"> <p><a href="./references#CD012551-bbs2-0016" title="MarxS . ICAOR 2006: does osteopathic treatment have an influence on the symptoms of patients with chronic prostatitis/chronic pelvic pain syndrome (CPPS)? A randomized controlled trial. International Journal of Osteopathic Medicine2006;9(1):44. MarxS , CimniakU , BeckertR , SchwerlaF , ReschKL . Chronic prostatitis/chronic pelvic pain syndrome. Influence of osteopathic treatment ‐ a randomized controlled study [Chronische Prostatitis/chronisches Beckenschmerzsyndrom. Einfluss osteopathischer Behandlungen ‐ eine randomisiert kontrollierte Studie]. Der Urologe. Ausg. A2009;48(11):1339‐45. "><b>Marx 2009</b> </a> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>I: osteopathic therapy</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>20</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>20</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="2" valign="top"> <p>D: 8 weeks</p> <p>F: 14 weeks</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="2" valign="top"> <p>Age: mean 46‐48</p> <p>No specified previous treatment</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>22.85</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="2" valign="top"> <p>2003‐2005</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="2" valign="top"> <p>Germany</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="2" valign="top"> <p>Outpatient</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>C: exercise programme</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>15</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>13</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>22.95</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="2" valign="top"> <p><a href="./references#CD012551-bbs2-0021" title="OhMM , JinMH , MoonDG , NamSG , BaeJH , ParkHS . A prospective, randomized, placebo controlled study of radiofrequency therapy for the treatment of chronic prostatitis/chronic pelvic pain syndrome. Journal of Urology2009;181(4):122. "><b>Oh 2009</b> </a> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>I: radiofrequency</p> </td> <td align="" bgcolor="#ffffff" colspan="6" rowspan="2" valign="top"> <p>N/A (abstract only)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="2" valign="top"> <p>South Korea</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="2" valign="top"> <p>Outpatient</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>C: "placebo therapy"</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="2" valign="top"> <p><a href="./references#CD012551-bbs2-0008" title="KabayS , KabaySC , YucelM , OzdenH . Efficiency of posterior tibial nerve stimulation in category IIIB chronic prostatitis/chronic pelvic pain: a Sham‐Controlled Comparative Study. Urologia Internationalis2009;83(1):33‐8. "><b>Kabay 2009</b> </a> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>I: tibial nerve stimulation</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>45</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>45</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="2" valign="top"> <p>D: 12 weeks</p> <p>F: 12 weeks</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="2" valign="top"> <p>Age: mean 38‐39</p> <p>No specified previous treatment</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>23.6</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="2" valign="top"> <p>2006‐2008</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="2" valign="top"> <p>Turkey</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="2" valign="top"> <p>Outpatient</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>C: sham procedure</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>44</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>44</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>22.8</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="3" valign="top"> <p><a href="./references#CD012551-bbs2-0034" title="ChungH , ChoiH , YooTK , ChoJM , KimHS . The effects of microwave thermotherapy for chronic prostatitis/chronic pelvic pain syndrome: a prospective, randomized study. Urogenital Tract Infection2017;12(1):35‐41. KimH , ChungH , YangS , YooT , ChoJ . Effects of thermotherapy and medical therapy for chronic prostatitis/chronic pelvic pain syndrome: a prospective study. Urology2011;78(3):S85‐6. YooTK , MoonKT , LeeSW , KimHS , ChungH , KimJY . Effect of the combination treatment of URO‐DrG and medical therapy for chronic prostatitis/chronic pelvic pain syndrome: a prospective study. Journal of Urology2009;181(4):122. "><b>Yoo 2009</b> </a> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>I: medical therapy</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>44</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>37</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="3" valign="top"> <p>D: 12 weeks</p> <p>F: 12 weeks</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="3" valign="top"> <p>Age: mean 31‐38</p> <p>No specified previous treatment</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>26.27</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="3" valign="top"> <p>2005‐2010</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="3" valign="top"> <p>South Korea</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="3" valign="top"> <p>Outpatient</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>C1: transrectal thermotherapy</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>44</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>41</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>24.59</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>C2: transrectal thermotherapy + medical therapy</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>44</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>35</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>23.94</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="2" valign="top"> <p><a href="./references#CD012551-bbs2-0013" title="LeeSW , LiongML , YuenKH , KriegerJN . Acupuncture and immune function in chronic prostatitis/chronic pelvic pain syndrome: a randomized, controlled study. Complementary Therapies in Medicine2014;22(6):965‐9. LeeSW , LiongML , YuenKH , LeongWS , CheeC , CheahPY , et al. Acupuncture versus sham acupuncture for chronic prostatitis/chronic pelvic pain. American Journal of Medicine2008;121(1):79.e1‐7. LeeSW , LiongML , YuenKH , LeongWS , KhanNK , KriegerJN . Validation of a sham acupuncture procedure in a randomised, controlled clinical trial of chronic pelvic pain treatment. Acupuncture in Medicine2011;29(1):40‐6. "><b>Lee 2008</b> </a> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>I: acupuncture</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>45</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>44</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="2" valign="top"> <p>D: 10 weeks</p> <p>F: 34 weeks</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="2" valign="top"> <p>Age: 41‐43</p> <p>No specified previous treatment</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>24.8</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="2" valign="top"> <p>2004‐2005</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="2" valign="top"> <p>Malaysia and US</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="2" valign="top"> <p>Outpatient</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>C: sham acupuncture</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>45</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>45</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>25.2</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="3" valign="top"> <p><a href="./references#CD012551-bbs2-0029" title="SikiruL , ShmailaH , MuhammedSA . Transcutaneous electrical nerve stimulation (TENS) in the symptomatic management of chronic prostatitis/chronic pelvic pain syndrome: a placebo‐control randomized trial. International Brazilian Journal of Urology2008;34(6):708‐13; discussion 714. "><b>Sikiru 2008</b> </a> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>I: TENS</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>8</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>8</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="3" valign="top"> <p>D: 4 weeks</p> <p>F: 4 weeks</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="3" valign="top"> <p>Age: 24‐60</p> <p>No specified previous treatment</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="3" valign="top"> <p>N/A</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="3" valign="top"> <p>N/A</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="3" valign="top"> <p>Nigeria</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="3" valign="top"> <p>Outpatient</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>C1: analgesic</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>8</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>8</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>C2: control</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>8</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>8</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="2" valign="top"> <p><a href="./references#CD012551-bbs2-0007" title="GiubileiG , MondainiN , MinerviniA , SaievaC , LapiniA , SerniS , et al. Physical activity of men with chronic prostatitis/chronic pelvic pain syndrome not satisfied with conventional treatments ‐ could it represent a valid option? The physical activity and male pelvic pain trial: a double‐blind, randomized study. Journal of Urology2007;177(1):159‐65. "><b>Giubilei 2007</b> </a> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>I: exercise programme</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>52</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>41</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="2" valign="top"> <p>D: 18 weeks</p> <p>F: 18 weeks</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="2" valign="top"> <p>Age: mean 36‐38</p> <p>All had received medical therapy</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>23.46</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="2" valign="top"> <p>2002‐2004</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="2" valign="top"> <p>Italy</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="2" valign="top"> <p>Outpatient</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>C: flexibility programme (control intervention)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>51</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>44</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>23.55</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="2" valign="top"> <p><a href="./references#CD012551-bbs2-0022" title="PaickJS , LeeSC , KuJH . More effects of extracorporeal magnetic innervation and terazosin therapy than terazosin therapy alone for non‐inflammatory chronic pelvic pain syndrome: a pilot study. Prostate Cancer and Prostatic Diseases2006;9(3):261‐5. "><b>Paick 2006</b> </a> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>I: extracorporeal magnetic innervation</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>21</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>21</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="2" valign="top"> <p>D: 6 weeks</p> <p>F: 6 weeks</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="2" valign="top"> <p>Age: mean 42‐49</p> <p>No specified previous treatment</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>21</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="2" valign="top"> <p>2003‐2004</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="2" valign="top"> <p>South Korea</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="2" valign="top"> <p>Outpatient</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>C: medical therapy</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>19</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>19</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>17</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="2" valign="top"> <p><a href="./references#CD012551-bbs2-0001" title="AteyaA , FayezA , HaniR , ZohdyW , GabbarMA , ShamloulR . Evaluation of prostatic massage in treatment of chronic prostatitis. Urology2006;67(4):674‐8. "><b>Ateya 2006</b> </a> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>I: medical therapy + prostatic massage</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>25</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="2" valign="top"> <p>N/A</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="2" valign="top"> <p>D: 4 weeks</p> <p>F: 4 weeks</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="2" valign="top"> <p>Age: mean 35</p> <p>No specified previous treatment</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="2" valign="top"> <p>N/A</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="2" valign="top"> <p>N/A</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="2" valign="top"> <p>Egypt</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="2" valign="top"> <p>Outpatient</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>C: medical therapy</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>19</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="2" valign="top"> <p><a href="./references#CD012551-bbs2-0028" title="ShenSL , HeDL , LuoY . Clinical trials of combined therapy of an oral Chinese medicine with massage for chronic nonbacterial prostatitis. Zhonghua Nan Ke Xue2006;12(9):851‐3. "><b>Shen 2006</b> </a> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>I: medical therapy + prostatic massage</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>40</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>40</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="2" valign="top"> <p>D: N/A</p> <p>F: after treatment</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="2" valign="top"> <p>Age: 20‐46</p> <p>No specified previous treatment</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="2" valign="top"> <p>N/A</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="2" valign="top"> <p>2002‐2005</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="2" valign="top"> <p>China</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="2" valign="top"> <p>Outpatient</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>C: medical therapy</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>32</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>32</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="2" valign="top"> <p><a href="./references#CD012551-bbs2-0024" title="RoweE , SmithC , LaverickL , ElkabirJ , WitherowRO , PatelA . A prospective, randomized, placebo controlled, double‐blind study of pelvic electromagnetic therapy for the treatment of chronic pelvic pain syndrome with 1 year of followup. Journal of Urology2005;173(6):2044‐7. "><b>Rowe 2005</b> </a> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>I: electromagnetic chair</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>11</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>11</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="2" valign="top"> <p>D: 4 weeks</p> <p>F: 1 year</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="2" valign="top"> <p>Age: 25‐67</p> <p>All had received medical therapy</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>38.8/100</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="2" valign="top"> <p>N/A</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="2" valign="top"> <p>UK</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="2" valign="top"> <p>Outpatient</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>C: sham procedure</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>10</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>7</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>39.3/100</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="2" valign="top"> <p><a href="./references#CD012551-bbs2-0003" title="FangJ , XuG , DingQ , ZhangY‐F . Observation on the safety and efficacy of He‐Ne laser equipment on chronic abacteria prostatitis. Fudan University Journal of Medical Sciences2005;32(2):234‐5, 252. "><b>Fang 2005</b> </a> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>I: He‐Ne laser</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>56</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>56</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="2" valign="top"> <p>D: 5 weeks</p> <p>F: "after treatment"</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="2" valign="top"> <p>Age: mean 33‐34</p> <p>No specified previous treatment</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="2" valign="top"> <p>N/A</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="2" valign="top"> <p>2002‐2004</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="2" valign="top"> <p>China</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="2" valign="top"> <p>Outpatient</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>C: routine care</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>56</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>56</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="2" valign="top"> <p><a href="./references#CD012551-bbs2-0010" title="KastnerC , HochreiterW , HuidobroC , CabezasJ , MillerP . Cooled transurethral microwave thermotherapy for intractable chronic prostatitis ‐ results of a pilot study after 1 year. Urology2004;64(6):1149‐54. "><b>Kastner 2004</b> </a> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>I: transrectal thermotherapy 55 °C</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="2" valign="top"> <p>42</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>21</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="2" valign="top"> <p>D: once</p> <p>F: 12 months</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="2" valign="top"> <p>Age: mean 58‐62</p> <p>All had received medical therapy</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>11.5</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="2" valign="top"> <p>N/A</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="2" valign="top"> <p>Chile, Switzerland, UK</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="2" valign="top"> <p>Outpatient</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>C: transrectal thermotherapy 70 °C</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>18</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>10.9</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="2" valign="top"> <p><a href="./references#CD012551-bbs2-0032" title="WangJ , LiJ , LuR , WangJM . Treatment of external RF hyperthermia combining with alpha 1‐adrenergic receptor blocker for patients with prostatodynia and chronic non‐bacterial prostatitis. Zhonghua Nan Ke Xue2002;8(1):48‐50. "><b>Wang 2002</b> </a> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>I: radiofrequency hyperthermia</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>76</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>76</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="2" valign="top"> <p>D: 12 weeks</p> <p>F: 12 weeks</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="2" valign="top"> <p>Age: mean 34.2</p> <p>Not specified previous treatment</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="2" valign="top"> <p>N/A</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="2" valign="top"> <p>1998‐2001</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="2" valign="top"> <p>China</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="2" valign="top"> <p>Outpatient</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>C: radiofrequency hyperthermia + terazosin</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>90</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>88</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="2" valign="top"> <p><a href="./references#CD012551-bbs2-0015" title="LeskinenMJ , KilponenA , LukkarinenO , TammelaTL . Transurethral needle ablation for the treatment of chronic pelvic pain syndrome (category III prostatitis): a randomized, sham‐controlled study. Urology2002;60(2):300‐4. "><b>Leskinen 2002</b> </a> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>I: transurethral needle ablation</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>25</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>25</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="2" valign="top"> <p>D: once</p> <p>F: 12 months</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="2" valign="top"> <p>Age: mean 43‐50</p> <p>All had received medical therapy</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>37.3</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="2" valign="top"> <p>1998‐2001</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="2" valign="top"> <p>Finland</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="2" valign="top"> <p>Outpatient</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>C: sham procedure</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>8</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>8</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>33.6</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="2" valign="top"> <p><a href="./references#CD012551-bbs2-0031" title="VassilyO , AndreyS , EvgeniiD , OtabekI , BorisL , SergeyR . Efficacy of transrectal microwave hyperthemia (TRMH) in the treatment of chronic prostatitis. A randomized sham controlled comparative study (Abstract). Journal of Urology1999;161(4 Suppl):33A. "><b>Vassily 1999</b> </a> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>I: transrectal thermotherapy</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>80</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="2" valign="top"> <p>N/A</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="2" valign="top"> <p>D: 2 weeks</p> <p>F: 6 months</p> </td> <td align="" bgcolor="#ffffff" colspan="3" rowspan="2" valign="top"> <p>N/A (abstract only)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="2" valign="top"> <p>Russia</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="2" valign="top"> <p>Outpatient</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>C: sham procedure</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>20</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="2" valign="top"> <p><a href="./references#CD012551-bbs2-0020" title="NickelJC , SorensenR . Transurethral microwave thermotherapy for nonbacterial prostatitis: a randomized double‐blind sham controlled study using new prostatitis specific assessment questionnaires. Journal of Urology1996;155(6):1950‐4; discussion 1954. "><b>Nickel 1996</b> </a> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>I: transurethral thermotherapy</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>10</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>10</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="2" valign="top"> <p>D: 1 session</p> <p>F: 3 months</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="2" valign="top"> <p>Age: 45‐46</p> <p>All had received medical therapy</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="2" valign="top"> <p>N/A</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="2" valign="top"> <p>N/A</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="2" valign="top"> <p>Canada</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="2" valign="top"> <p>Outpatient</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>C: sham procedure</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>10</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>10</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="2" valign="top"> <p><a href="./references#CD012551-bbs2-0018" title="MuraroGB . Clinical study on the efficacy and safety of seaprose S combined with local prostatic hyperthermia in chronic non‐bacterial prostatitis. Controlled study versus local prostatic hyperthermia [Studio clinico sull'efficacia e la tollerabilita del seaprose S associato a ipertermia locale prostatica nella prostatite cronica abatterica. Studio controllato verso ipertermia locale prostatica]. Archivio di Medicina Interna1995;47(2‐3):73‐86. "><b>Muraro 1995</b> </a> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>I: medical therapy plus local hyperthermia</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>10</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="2" valign="top"> <p>N/A</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="2" valign="top"> <p>D: 15 days</p> <p>F: 4 weeks</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="2" valign="top"> <p>Age: mean 42.5</p> <p>Not specified previous treatment</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="2" valign="top"> <p>N/A</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="2" valign="top"> <p>N/A</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="2" valign="top"> <p>Italy</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="2" valign="top"> <p>Outpatient</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>C: local hyperthermia alone</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>10</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><a href="./references#CD012551-bbs2-0017" title="MontorsiF , GuazzoniG , BergamaschiF , GalliL , ConsonniP , MatozzoV , et al. Is there a role for transrectal microwave hyperthermia of the prostate in the treatment of abacterial prostatitis and prostatodynia?. Prostate1993;22(2):139‐46. "><b>Montorsi 1993</b> </a> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Transrectal hyperthermia in different regimens</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>54</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>54</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>D: 3 to 6 weeks</p> <p>F: 26 months</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Age: 21‐45</p> <p>All had received medical therapy</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>N/A</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>1987‐1991</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Italy</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Outpatient</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="2" valign="top"> <p><a href="./references#CD012551-bbs2-0027" title="ShahT , WatsonG , BarnesD . Microwave hyperthermia in the treatment of chronic abacterial prostatitis and prostatodynia: results of a double blind placebo controlled trial (Abstract). Journal of Urology1993;149:405A. "><b>Shah 1993</b> </a> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>I: radiofrequency</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>15</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="2" valign="top"> <p>N/A</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="2" valign="top"> <p>D: 2‐3 weeks</p> <p>F: 3 months</p> </td> <td align="" bgcolor="#ffffff" colspan="3" rowspan="2" valign="top"> <p>N/A</p> <p>(abstract only)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="2" valign="top"> <p>UK</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="2" valign="top"> <p>Outpatient</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>C: sham procedure</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>15</p> </td> </tr> </tbody> <tfoot> <tr> <td colspan="10"> <div class="table-footnote"> <p>C: comparator; D: duration of intervention; F: duration of follow‐up (might not represent the reported time points); I: intervention; N/A: not available; NIH‐CPSI: National Institutes of Health ‐ Chronic Prostatitis Symptom Index; TENS: transcutaneous electric nerve stimulation. </p> <p><sup>a</sup><b>Age</b>: measurement is in years. </p> <p><sup>b</sup><b>NIH‐CPSI</b>: scores were mean or median values. </p> </div> </td> </tr> </tfoot> </table> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="table-viewer-caption"> <div class="table-heading"><span class="table-label">Table 2.</span> <span class="table-title">Study and participant characteristics</span></div> </div> <div class="tools"><a class="tableList" href="/cdsr/doi/10.1002/14651858.CD012551.pub3/full#CD012551-tbl-0012">Navigate to table in review</a></div> </div> <div class="table"> <table class="comparison" data-id="CD012551-tbl-0013"> <div class="table-heading"><span class="table-label">Comparison 1.</span> <span class="table-title">Acupuncture versus sham procedure</span></div> <thead> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>Outcome or subgroup title</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>No. of studies</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>No. of participants</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Statistical method</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>Effect size</p> </td> </tr> </thead> <tbody> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">1 Prostatitis symptoms (NIH‐CPSI total) <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>3</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>204</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Mean Difference (IV, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>‐5.79 [‐7.32, ‐4.26]</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>1.1 Acupuncture</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>2</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>180</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Mean Difference (IV, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>‐5.71 [‐7.50, ‐3.91]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>1.2 Electroacupuncture</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>24</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Mean Difference (IV, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>‐6.0 [‐8.92, ‐3.08]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">2 Prostatitis symptoms: pain subscore <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>3</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>204</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Mean Difference (IV, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>‐2.43 [‐3.21, ‐1.66]</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>2.1 Acupuncture</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>2</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>180</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Mean Difference (IV, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>‐2.00 [‐2.90, ‐1.10]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>2.2 Electroacupuncture</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>24</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Mean Difference (IV, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>‐3.6 [‐5.08, ‐2.12]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">3 Prostatitis symptoms: micturition subscore <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>3</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>204</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Mean Difference (IV, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>‐1.45 [‐1.83, ‐1.06]</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>3.1 Acupuncture</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>2</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>180</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Mean Difference (IV, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>‐1.49 [‐1.89, ‐1.08]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>3.2 Electroacupuncture</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>24</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Mean Difference (IV, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>‐1.1 [‐2.26, 0.06]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">4 Prostatitis symptoms: quality of life subscore <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>3</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>204</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Mean Difference (IV, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>‐2.40 [‐3.09, ‐1.71]</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>4.1 Acupuncture</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>2</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>180</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Mean Difference (IV, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>‐2.62 [‐3.37, ‐1.86]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>4.2 Electroacupuncture</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>24</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Mean Difference (IV, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>‐1.3 [‐1.00, 0.40]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">5 Prostatitis symptoms <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>2</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>113</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Random, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>2.49 [0.77, 8.02]</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>5.1 Acupuncture</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>89</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Random, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>1.56 [1.09, 2.24]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>5.2 Electroacupuncture</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>24</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Random, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>5.00 [1.63, 15.31]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">6 Prostatitis symptoms (NIH‐CPSI total) ‐ medium term <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>91</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Mean Difference (IV, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>‐7.36 [‐9.93, ‐4.79]</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">7 Prostatitis symptoms: pain subscore ‐ medium term <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>91</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Mean Difference (IV, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>‐3.25 [‐4.45, ‐2.05]</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">8 Prostatitis symptoms: micturition subscore ‐ medium term <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>91</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Mean Difference (IV, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>‐1.02 [‐1.54, ‐0.50]</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">9 Prostatitis symptoms: quality of life subscore ‐ medium term <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>91</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Mean Difference (IV, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>‐3.07 [‐4.14, ‐2.00]</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">10 Adverse events <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>3</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>204</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>1.33 [0.51, 3.46]</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>10.1 Acupuncture</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>2</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>180</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>1.64 [0.58, 4.62]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>10.2 Electroacupuncture</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>24</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>0.33 [0.01, 7.45]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">11 Sexual dysfunction <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>89</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Mean Difference (IV, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>‐0.5 [‐3.46, 2.46]</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">12 Urinary symptoms <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>2</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>113</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Mean Difference (IV, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>‐2.79 [‐4.77, ‐0.82]</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>12.1 Acupuncture</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>89</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Mean Difference (IV, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>‐2.5 [‐4.98, ‐0.02]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>12.2 Electroacupuncture</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>24</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Mean Difference (IV, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>‐3.30 [‐6.56, ‐0.04]</p> </td> </tr> </tbody> </table> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="table-viewer-caption"> <div class="table-heading"><span class="table-label">Comparison 1.</span> <span class="table-title">Acupuncture versus sham procedure</span></div> </div> <div class="tools"><a class="tableList" href="/cdsr/doi/10.1002/14651858.CD012551.pub3/references#CD012551-tbl-0013">Navigate to table in review</a></div> </div> <div class="table"> <table class="comparison" data-id="CD012551-tbl-0014"> <div class="table-heading"><span class="table-label">Comparison 2.</span> <span class="table-title">Acupuncture treatments versus medical treatment</span></div> <thead> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>Outcome or subgroup title</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>No. of studies</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>No. of participants</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Statistical method</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>Effect size</p> </td> </tr> </thead> <tbody> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">1 Prostatitis symptoms (NIH‐CPSI total) <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>3</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>203</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Mean Difference (IV, Random, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>‐4.09 [‐6.87, ‐1.30]</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>1.1 Acupuncture</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>2</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>116</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Mean Difference (IV, Random, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>‐2.97 [‐9.36, 3.43]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>1.2 Electroacupuncture</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>24</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Mean Difference (IV, Random, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>‐6.0 [‐8.50, ‐3.50]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>1.3 Acupuncture (Moxibustion)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>63</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Mean Difference (IV, Random, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>‐3.74 [‐7.41, ‐0.07]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">2 Prostatitis symptoms: pain subscore <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>2</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>78</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Mean Difference (IV, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>‐2.90 [‐4.05, ‐1.76]</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>2.1 Acupuncture</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>54</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Mean Difference (IV, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>‐2.76 [‐4.57, ‐0.95]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>2.2 Electroacupuncture</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>24</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Mean Difference (IV, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>‐3.00 [‐4.48, ‐1.52]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">3 Prostatitis symptoms: micturition subscore <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>2</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>78</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Mean Difference (IV, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>‐1.15 [‐1.96, ‐0.35]</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>3.1 Acupuncture</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>54</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Mean Difference (IV, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>‐0.95 [‐2.03, 0.13]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>3.2 Electroacupuncture</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>24</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Mean Difference (IV, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>‐1.4 [‐2.60, ‐0.20]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">4 Prostatitis symptoms: quality of life subscore <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>2</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>78</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Mean Difference (IV, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>‐1.41 [‐2.41, ‐0.41]</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>4.1 Acupuncture</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>54</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Mean Difference (IV, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>‐1.18 [‐2.52, 0.16]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>4.2 Electroacupuncture</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>24</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Mean Difference (IV, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>‐1.70 [‐3.19, ‐0.21]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">5 Prostatitis symptoms <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>24</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>3.57 [1.45, 8.80]</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>5.1 Electroacupuncture</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>24</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>3.57 [1.45, 8.80]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">6 Adverse events <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>2</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""></td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>Totals not selected</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>6.1 Acupuncture</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""></td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>0.0 [0.0, 0.0]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>6.2 Electroacupuncture</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""></td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>0.0 [0.0, 0.0]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">7 Urinary symptoms <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>24</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Mean Difference (IV, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>‐2.7 [‐4.00, 0.60]</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>7.1 Electroacupuncture</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>24</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Mean Difference (IV, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>‐2.7 [‐4.00, 0.60]</p> </td> </tr> </tbody> </table> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="table-viewer-caption"> <div class="table-heading"><span class="table-label">Comparison 2.</span> <span class="table-title">Acupuncture treatments versus medical treatment</span></div> </div> <div class="tools"><a class="tableList" href="/cdsr/doi/10.1002/14651858.CD012551.pub3/references#CD012551-tbl-0014">Navigate to table in review</a></div> </div> <div class="table"> <table class="comparison" data-id="CD012551-tbl-0015"> <div class="table-heading"><span class="table-label">Comparison 3.</span> <span class="table-title">Acupuncture with or without moxibustion</span></div> <thead> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>Outcome or subgroup title</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>No. of studies</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>No. of participants</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Statistical method</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>Effect size</p> </td> </tr> </thead> <tbody> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">1 Prostatitis symptoms (NIH‐CPSI total) <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>83</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Mean Difference (IV, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>‐4.16 [‐7.16, ‐1.16]</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> </tbody> </table> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="table-viewer-caption"> <div class="table-heading"><span class="table-label">Comparison 3.</span> <span class="table-title">Acupuncture with or without moxibustion</span></div> </div> <div class="tools"><a class="tableList" href="/cdsr/doi/10.1002/14651858.CD012551.pub3/references#CD012551-tbl-0015">Navigate to table in review</a></div> </div> <div class="table"> <table class="comparison" data-id="CD012551-tbl-0016"> <div class="table-heading"><span class="table-label">Comparison 4.</span> <span class="table-title">Circumcision versus waiting list</span></div> <thead> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>Outcome or subgroup title</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>No. of studies</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>No. of participants</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Statistical method</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>Effect size</p> </td> </tr> </thead> <tbody> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">1 Prostatitis symptoms <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>713</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Mean Difference (IV, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>‐3.0 [‐3.82, ‐2.18]</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">2 Prostatitis symptoms: pain subscore <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>713</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Mean Difference (IV, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>‐1.0 [‐1.33, ‐0.67]</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">3 Prostatitis symptoms: micturition subscore <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>713</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Mean Difference (IV, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>‐1.0 [‐1.22, ‐0.78]</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">4 Prostatitis symptoms: quality of life subscore <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>713</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Mean Difference (IV, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>‐3.0 [‐3.38, ‐2.62]</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">5 Adverse events <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>713</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>1.23 [0.86, 1.76]</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> </tbody> </table> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="table-viewer-caption"> <div class="table-heading"><span class="table-label">Comparison 4.</span> <span class="table-title">Circumcision versus waiting list</span></div> </div> <div class="tools"><a class="tableList" href="/cdsr/doi/10.1002/14651858.CD012551.pub3/references#CD012551-tbl-0016">Navigate to table in review</a></div> </div> <div class="table"> <table class="comparison" data-id="CD012551-tbl-0017"> <div class="table-heading"><span class="table-label">Comparison 5.</span> <span class="table-title">Electromagnetic chair versus sham procedure</span></div> <thead> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>Outcome or subgroup title</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>No. of studies</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>No. of participants</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Statistical method</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>Effect size</p> </td> </tr> </thead> <tbody> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">1 Prostatitis symptoms (NIH‐CPSI total) <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>2</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>57</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Mean Difference (IV, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>‐3.0 [‐7.75, 1.75]</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">2 Prostatitis symptoms: pain subscore <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>2</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>57</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Std. Mean Difference (IV, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>‐0.44 [‐1.07, 0.19]</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">3 Prostatitis symptoms: micturition subscore <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>2</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>57</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Std. Mean Difference (IV, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>0.22 [‐0.40, 0.84]</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">4 Prostatitis symptoms: quality of life subscore <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""></td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Mean Difference (IV, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>Totals not selected</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">5 Adverse events <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>2</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>57</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>2.18 [0.10, 46.92]</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">6 Urinary symptoms <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>40</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Mean Difference (IV, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>0.0 [‐4.13, 4.13]</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">7 Prostatitis symptoms (NIH‐CPSI total) ‐ medium term <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""></td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Mean Difference (IV, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>Totals not selected</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">8 Prostatitis symptoms: pain subscore ‐ medium term <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""></td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Mean Difference (IV, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>Totals not selected</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> </tbody> </table> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="table-viewer-caption"> <div class="table-heading"><span class="table-label">Comparison 5.</span> <span class="table-title">Electromagnetic chair versus sham procedure</span></div> </div> <div class="tools"><a class="tableList" href="/cdsr/doi/10.1002/14651858.CD012551.pub3/references#CD012551-tbl-0017">Navigate to table in review</a></div> </div> <div class="table"> <table class="comparison" data-id="CD012551-tbl-0018"> <div class="table-heading"><span class="table-label">Comparison 6.</span> <span class="table-title">Lifestyle modifications versus control</span></div> <thead> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>Outcome or subgroup title</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>No. of studies</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>No. of participants</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Statistical method</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>Effect size</p> </td> </tr> </thead> <tbody> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">1 Prostatitis symptoms <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>100</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>3.9 [2.20, 6.92]</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> </tbody> </table> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="table-viewer-caption"> <div class="table-heading"><span class="table-label">Comparison 6.</span> <span class="table-title">Lifestyle modifications versus control</span></div> </div> <div class="tools"><a class="tableList" href="/cdsr/doi/10.1002/14651858.CD012551.pub3/references#CD012551-tbl-0018">Navigate to table in review</a></div> </div> <div class="table"> <table class="comparison" data-id="CD012551-tbl-0019"> <div class="table-heading"><span class="table-label">Comparison 7.</span> <span class="table-title">Physical activity versus control</span></div> <thead> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>Outcome or subgroup title</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>No. of studies</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>No. of participants</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Statistical method</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>Effect size</p> </td> </tr> </thead> <tbody> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">1 Prostatitis symptoms <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>85</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Mean Difference (IV, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>‐2.50 [‐4.69, ‐0.31]</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">2 Prostatitis symptoms: pain subscore <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""></td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Mean Difference (IV, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>Totals not selected</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">3 Prostatitis symptoms: micturition subscore <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""></td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Mean Difference (IV, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>Totals not selected</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">4 Prostatitis symptoms: quality of life subscore <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""></td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Mean Difference (IV, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>Totals not selected</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">5 Anxiety <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""></td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Mean Difference (IV, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>Totals not selected</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">6 Depression <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""></td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Mean Difference (IV, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>Totals not selected</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> </tbody> </table> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="table-viewer-caption"> <div class="table-heading"><span class="table-label">Comparison 7.</span> <span class="table-title">Physical activity versus control</span></div> </div> <div class="tools"><a class="tableList" href="/cdsr/doi/10.1002/14651858.CD012551.pub3/references#CD012551-tbl-0019">Navigate to table in review</a></div> </div> <div class="table"> <table class="comparison" data-id="CD012551-tbl-0020"> <div class="table-heading"><span class="table-label">Comparison 8.</span> <span class="table-title">Prostatic massage versus control</span></div> <thead> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>Outcome or subgroup title</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>No. of studies</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>No. of participants</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Statistical method</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>Effect size</p> </td> </tr> </thead> <tbody> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">1 Prostatitis symptoms <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>44</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Mean Difference (IV, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>‐1.10 [‐5.63, 3.43]</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">2 Prostatitis symptoms: pain subscore <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>2</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""></td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Mean Difference (IV, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>Totals not selected</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">3 Prostatitis symptoms: micturition subscore <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>2</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""></td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Mean Difference (IV, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>Totals not selected</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">4 Prostatitis symptoms: quality of life subscore <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>2</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""></td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Mean Difference (IV, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>Totals not selected</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> </tbody> </table> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="table-viewer-caption"> <div class="table-heading"><span class="table-label">Comparison 8.</span> <span class="table-title">Prostatic massage versus control</span></div> </div> <div class="tools"><a class="tableList" href="/cdsr/doi/10.1002/14651858.CD012551.pub3/references#CD012551-tbl-0020">Navigate to table in review</a></div> </div> <div class="table"> <table class="comparison" data-id="CD012551-tbl-0021"> <div class="table-heading"><span class="table-label">Comparison 9.</span> <span class="table-title">Extracorporeal shockwave therapy (ESWT) versus control</span></div> <thead> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>Outcome or subgroup title</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>No. of studies</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>No. of participants</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Statistical method</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>Effect size</p> </td> </tr> </thead> <tbody> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">1 Prostatitis symptoms (NIH‐CPSI total) <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>3</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>157</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Mean Difference (IV, Random, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>‐6.18 [‐7.46, ‐4.89]</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>1.1 Compared to sham procedure</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>2</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>97</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Mean Difference (IV, Random, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>‐6.14 [‐7.87, ‐4.41]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>1.2 Compared to no intervention</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>60</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Mean Difference (IV, Random, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>‐6.64 [‐10.17, ‐3.11]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">2 Prostatitis symptoms: pain subscore <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>2</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>97</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Mean Difference (IV, Random, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>‐4.64 [‐5.38, ‐3.89]</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>2.1 Compared to sham procedure</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>37</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Mean Difference (IV, Random, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>‐4.74 [‐5.54, ‐3.94]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>2.2 Compared to no intervention</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>60</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Mean Difference (IV, Random, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>‐3.83 [‐6.03, ‐1.63]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">3 Prostatitis symptoms: micturition subscore <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>2</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>97</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Mean Difference (IV, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>‐0.53 [1.00, ‐0.07]</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>3.1 Compared to sham procedure</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>37</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Mean Difference (IV, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>‐1.79 [‐2.59, ‐0.99]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>3.2 Compared to no intervention</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>60</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Mean Difference (IV, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>0.10 [‐0.47, 0.67]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">4 Prostatitis symptoms: quality of life subscore <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>2</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>97</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Mean Difference (IV, Random, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>‐1.84 [‐2.41, ‐1.27]</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>4.1 Compared to sham procedure</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>37</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Mean Difference (IV, Random, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>‐1.73 [‐2.35, ‐1.11]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>4.2 Compared to no intervention</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>60</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Mean Difference (IV, Random, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>‐2.46 [‐3.94, ‐0.98]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">5 Prostatitis symptoms <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>2</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>135</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Random, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>6.20 [0.48, 79.79]</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">6 Prostatitis symptoms (total score) ‐ long term <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>2</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>97</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Mean Difference (IV, Random, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>‐2.23 [‐5.98, 1.53]</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>6.1 Compared to sham procedure</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>37</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Mean Difference (IV, Random, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>‐0.59 [‐1.42, 0.24]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>6.2 Compared to no intervention</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>60</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Mean Difference (IV, Random, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>‐4.47 [‐7.60, ‐1.34]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">7 Prostatitis symptoms: pain subscore ‐ long term <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>2</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>97</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Mean Difference (IV, Random, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>‐2.08 [‐6.25, 2.09]</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>7.1 Compared to sham procedure</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>37</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Mean Difference (IV, Random, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>‐0.01 [‐1.26, 1.24]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>7.2 Compared to no intervention</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>60</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Mean Difference (IV, Random, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>‐4.27 [‐6.15, ‐2.39]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">8 Prostatitis symptoms: micturition subscore ‐ long term <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>2</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>97</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Mean Difference (IV, Random, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>‐0.64 [‐1.19, ‐0.10]</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>8.1 Compared to sham procedure</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>37</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Mean Difference (IV, Random, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>‐0.35 [‐1.50, 0.80]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>8.2 Compared to no intervention</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>60</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Mean Difference (IV, Random, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>‐0.73 [‐1.35, ‐0.11]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">9 Prostatitis symptoms: quality of life subscore ‐ long term <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>2</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>97</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Mean Difference (IV, Random, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>‐0.97 [‐2.78, 0.85]</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>9.1 Compared to sham procedure</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>37</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Mean Difference (IV, Random, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>‐0.16 [‐0.98, 0.66]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>9.2 Compared to no intervention</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>60</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Mean Difference (IV, Random, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>‐2.03 [‐3.62, ‐0.44]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">10 Adverse events <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>3</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>195</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>1.22 [0.59, 2.51]</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">11 Sexual dysfunction <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>60</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Mean Difference (IV, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>3.34 [2.68, 4.00]</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">12 Urinary symptoms <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>60</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Mean Difference (IV, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>‐4.50 [‐5.14, ‐3.86]</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> </tbody> </table> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="table-viewer-caption"> <div class="table-heading"><span class="table-label">Comparison 9.</span> <span class="table-title">Extracorporeal shockwave therapy (ESWT) versus control</span></div> </div> <div class="tools"><a class="tableList" href="/cdsr/doi/10.1002/14651858.CD012551.pub3/references#CD012551-tbl-0021">Navigate to table in review</a></div> </div> <div class="table"> <table class="comparison" data-id="CD012551-tbl-0022"> <div class="table-heading"><span class="table-label">Comparison 10.</span> <span class="table-title">Transrectal thermotherapy (TRT) versus medical treatment</span></div> <thead> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>Outcome or subgroup title</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>No. of studies</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>No. of participants</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Statistical method</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>Effect size</p> </td> </tr> </thead> <tbody> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">1 Prostatitis symptoms (NIH‐CPSI total) <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>2</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""></td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Mean Difference (IV, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>Subtotals only</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>1.1 Compared to medical therapy</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>2</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>140</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Mean Difference (IV, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>‐2.50 [‐3.82, ‐1.18]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>1.2 Add‐on to medical therapy vs medical therapy alone</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>2</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>145</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Mean Difference (IV, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>‐4.34 [‐5.65, ‐3.04]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">2 Prostatitis symptoms: pain subscore <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""></td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Mean Difference (IV, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>Totals not selected</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>2.1 Compared to medical therapy</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""></td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Mean Difference (IV, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>0.0 [0.0, 0.0]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>2.2 Add‐on to medical therapy vs medical therapy alone</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""></td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Mean Difference (IV, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>0.0 [0.0, 0.0]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">3 Prostatitis symptoms: micturition subscore <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""></td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Mean Difference (IV, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>Totals not selected</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>3.1 Compared to medical therapy</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""></td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Mean Difference (IV, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>0.0 [0.0, 0.0]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>3.2 Add‐on to medical therapy vs medical therapy alone</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""></td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Mean Difference (IV, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>0.0 [0.0, 0.0]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">4 Prostatitis symptoms: quality of life subscore <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""></td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Mean Difference (IV, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>Totals not selected</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>4.1 Compared to medical therapy</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""></td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Mean Difference (IV, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>0.0 [0.0, 0.0]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>4.2 Add‐on to medical therapy vs medical therapy alone</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""></td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Mean Difference (IV, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>0.0 [0.0, 0.0]</p> </td> </tr> </tbody> </table> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="table-viewer-caption"> <div class="table-heading"><span class="table-label">Comparison 10.</span> <span class="table-title">Transrectal thermotherapy (TRT) versus medical treatment</span></div> </div> <div class="tools"><a class="tableList" href="/cdsr/doi/10.1002/14651858.CD012551.pub3/references#CD012551-tbl-0022">Navigate to table in review</a></div> </div> <div class="table"> <table class="comparison" data-id="CD012551-tbl-0023"> <div class="table-heading"><span class="table-label">Comparison 11.</span> <span class="table-title">Biofeedback with or without electrical stimulation versus usual care</span></div> <thead> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>Outcome or subgroup title</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>No. of studies</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>No. of participants</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Statistical method</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>Effect size</p> </td> </tr> </thead> <tbody> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">1 Prostatitis symptoms (NIH‐CPSI total) <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""></td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Mean Difference (IV, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>Totals not selected</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>1.1 Biofeedback + electrical stimulation vs usual care</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""></td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Mean Difference (IV, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>0.0 [0.0, 0.0]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>1.2 Biofeedback vs usual care</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""></td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Mean Difference (IV, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>0.0 [0.0, 0.0]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>1.3 Electrical stimulation vs usual care</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""></td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Mean Difference (IV, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>0.0 [0.0, 0.0]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">2 Prostatitis symptoms: pain subscore <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""></td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Mean Difference (IV, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>Totals not selected</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>2.1 Biofeedback + electrical stimulation vs usual care</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""></td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Mean Difference (IV, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>0.0 [0.0, 0.0]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>2.2 Biofeedback vs usual care</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""></td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Mean Difference (IV, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>0.0 [0.0, 0.0]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>2.3 Electrical stimulation vs usual care</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""></td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Mean Difference (IV, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>0.0 [0.0, 0.0]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">3 Prostatitis symptoms: micturition subscore <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""></td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Mean Difference (IV, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>Totals not selected</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>3.1 Biofeedback + electrical Stimulation vs usual care</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""></td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Mean Difference (IV, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>0.0 [0.0, 0.0]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>3.2 Biofeedback vs usual care</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""></td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Mean Difference (IV, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>0.0 [0.0, 0.0]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>3.3 Electrical stimulation vs usual care</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""></td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Mean Difference (IV, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>0.0 [0.0, 0.0]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">4 Prostatitis symptoms: quality of life subscore <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""></td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Mean Difference (IV, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>Totals not selected</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>4.1 Biofeedback + electrical stimulation vs usual care</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""></td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Mean Difference (IV, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>0.0 [0.0, 0.0]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>4.2 Biofeedback vs usual care</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""></td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Mean Difference (IV, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>0.0 [0.0, 0.0]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>4.3 Electrical stimulation vs usual care</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""></td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Mean Difference (IV, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>0.0 [0.0, 0.0]</p> </td> </tr> </tbody> </table> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="table-viewer-caption"> <div class="table-heading"><span class="table-label">Comparison 11.</span> <span class="table-title">Biofeedback with or without electrical stimulation versus usual care</span></div> </div> <div class="tools"><a class="tableList" href="/cdsr/doi/10.1002/14651858.CD012551.pub3/references#CD012551-tbl-0023">Navigate to table in review</a></div> </div> <div class="table"> <table class="comparison" data-id="CD012551-tbl-0024"> <div class="table-heading"><span class="table-label">Comparison 12.</span> <span class="table-title">External radiofrequency hyperthermia with or without terazosin</span></div> <thead> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>Outcome or subgroup title</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>No. of studies</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>No. of participants</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Statistical method</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>Effect size</p> </td> </tr> </thead> <tbody> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">1 Prostatitis symptoms <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""></td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Mean Difference (IV, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>Totals not selected</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">2 Adverse events <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""></td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>Totals not selected</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> </tbody> </table> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="table-viewer-caption"> <div class="table-heading"><span class="table-label">Comparison 12.</span> <span class="table-title">External radiofrequency hyperthermia with or without terazosin</span></div> </div> <div class="tools"><a class="tableList" href="/cdsr/doi/10.1002/14651858.CD012551.pub3/references#CD012551-tbl-0024">Navigate to table in review</a></div> </div> <div class="table"> <table class="comparison" data-id="CD012551-tbl-0025"> <div class="table-heading"><span class="table-label">Comparison 13.</span> <span class="table-title">Laser therapy versus medical treatment</span></div> <thead> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>Outcome or subgroup title</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>No. of studies</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>No. of participants</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Statistical method</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>Effect size</p> </td> </tr> </thead> <tbody> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">1 Prostatitis symptoms <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""></td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>Totals not selected</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">2 Adverse events <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>112</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Odds Ratio (M‐H, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>0.0 [0.0, 0.0]</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> </tbody> </table> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="table-viewer-caption"> <div class="table-heading"><span class="table-label">Comparison 13.</span> <span class="table-title">Laser therapy versus medical treatment</span></div> </div> <div class="tools"><a class="tableList" href="/cdsr/doi/10.1002/14651858.CD012551.pub3/references#CD012551-tbl-0025">Navigate to table in review</a></div> </div> <div class="table"> <table class="comparison" data-id="CD012551-tbl-0026"> <div class="table-heading"><span class="table-label">Comparison 14.</span> <span class="table-title">Tibial nerve stimulation versus no intervention</span></div> <thead> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>Outcome or subgroup title</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>No. of studies</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>No. of participants</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Statistical method</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>Effect size</p> </td> </tr> </thead> <tbody> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">1 Prostatitis symptoms (NIH‐CPSI total) <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>89</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Mean Difference (IV, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>‐11.2 [‐12.92, ‐9.48]</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">2 Prostatitis symptoms: pain subscore <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>89</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Mean Difference (IV, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>‐5.70 [‐6.90, ‐4.50]</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">3 Prostatitis symptoms: micturition subscore <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>89</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Mean Difference (IV, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>‐3.20 [‐3.77, ‐2.63]</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">4 Prostatitis symptoms: quality of life subscore <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>89</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Mean Difference (IV, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>‐4.6 [‐5.27, ‐3.93]</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> </tbody> </table> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="table-viewer-caption"> <div class="table-heading"><span class="table-label">Comparison 14.</span> <span class="table-title">Tibial nerve stimulation versus no intervention</span></div> </div> <div class="tools"><a class="tableList" href="/cdsr/doi/10.1002/14651858.CD012551.pub3/references#CD012551-tbl-0026">Navigate to table in review</a></div> </div> <div class="table"> <table class="comparison" data-id="CD012551-tbl-0027"> <div class="table-heading"><span class="table-label">Comparison 15.</span> <span class="table-title">Myofascial therapy versus control intervention</span></div> <thead> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>Outcome or subgroup title</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>No. of studies</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>No. of participants</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Statistical method</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>Effect size</p> </td> </tr> </thead> <tbody> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">1 Prostatitis symptoms (NIH‐CPSI total) <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>21</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Mean Difference (IV, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>1.0 [‐6.45, 8.45]</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">2 Prostatitis symptoms: pain subscore <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>21</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Mean Difference (IV, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>‐0.20 [‐5.04, 4.64]</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">3 Prostatitis symptoms: micturition subscore <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>21</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Mean Difference (IV, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>1.1 [‐1.12, 3.32]</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">4 Prostatitis symptoms: quality of life subscore <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>21</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Mean Difference (IV, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>0.10 [‐2.90, 3.10]</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">5 Sexual dysfunction <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>21</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Mean Difference (IV, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>‐2.20 [‐9.24, 4.84]</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">6 Quality of life ‐ physical <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""></td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Mean Difference (IV, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>Totals not selected</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">7 Quality of life ‐ mental <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>19</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Mean Difference (IV, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>0.80 [‐9.25, 10.85]</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> </tbody> </table> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="table-viewer-caption"> <div class="table-heading"><span class="table-label">Comparison 15.</span> <span class="table-title">Myofascial therapy versus control intervention</span></div> </div> <div class="tools"><a class="tableList" href="/cdsr/doi/10.1002/14651858.CD012551.pub3/references#CD012551-tbl-0027">Navigate to table in review</a></div> </div> <div class="table"> <table class="comparison" data-id="CD012551-tbl-0028"> <div class="table-heading"><span class="table-label">Comparison 16.</span> <span class="table-title">Osteopathy versus sham procedure</span></div> <thead> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>Outcome or subgroup title</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>No. of studies</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>No. of participants</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Statistical method</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>Effect size</p> </td> </tr> </thead> <tbody> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">1 Prostatitis symptoms (NIH‐CPSI total) <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""></td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Mean Difference (IV, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>Totals not selected</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">2 Prostatitis symptoms: quality of life subscore <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""></td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Mean Difference (IV, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>Totals not selected</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">3 Urinary symptoms <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""></td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Mean Difference (IV, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>Totals not selected</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> </tbody> </table> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="table-viewer-caption"> <div class="table-heading"><span class="table-label">Comparison 16.</span> <span class="table-title">Osteopathy versus sham procedure</span></div> </div> <div class="tools"><a class="tableList" href="/cdsr/doi/10.1002/14651858.CD012551.pub3/references#CD012551-tbl-0028">Navigate to table in review</a></div> </div> <div class="table"> <table class="comparison" data-id="CD012551-tbl-0029"> <div class="table-heading"><span class="table-label">Comparison 17.</span> <span class="table-title">Sono‐electromagnetic therapy versus placebo</span></div> <thead> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>Outcome or subgroup title</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>No. of studies</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>No. of participants</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Statistical method</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>Effect size</p> </td> </tr> </thead> <tbody> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">1 Prostatitis symptoms (NIH‐CPSI total) <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>60</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Mean Difference (IV, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>‐2.80 [‐6.75, 1.15]</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">2 Prostatitis symptoms <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>60</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>1.4 [0.91, 2.15]</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">3 Prostatitis symptoms: pain subscore <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>60</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Mean Difference (IV, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>‐1.30 [‐3.44, 0.84]</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">4 Prostatitis symptoms: micturition subscore <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>60</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Mean Difference (IV, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>0.0 [‐1.26, 1.26]</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">5 Prostatitis symptoms: quality of life subscore <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>60</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Mean Difference (IV, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>‐1.40 [‐2.76, ‐0.04]</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> </tbody> </table> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="table-viewer-caption"> <div class="table-heading"><span class="table-label">Comparison 17.</span> <span class="table-title">Sono‐electromagnetic therapy versus placebo</span></div> </div> <div class="tools"><a class="tableList" href="/cdsr/doi/10.1002/14651858.CD012551.pub3/references#CD012551-tbl-0029">Navigate to table in review</a></div> </div> <div class="table"> <table class="comparison" data-id="CD012551-tbl-0030"> <div class="table-heading"><span class="table-label">Comparison 18.</span> <span class="table-title">Transelectrical nerve stimulation (TENS) versus control</span></div> <thead> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>Outcome or subgroup title</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>No. of studies</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>No. of participants</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Statistical method</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>Effect size</p> </td> </tr> </thead> <tbody> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">1 Prostatitis symptoms: pain subscore <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>2</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""></td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Mean Difference (IV, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>Subtotals only</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>1.1 Compared to sham procedure</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>40</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Mean Difference (IV, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>‐15.25 [‐17.71, ‐12.79]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>1.2 Compared to no intervention</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>16</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Mean Difference (IV, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>‐6.88 [‐8.13, ‐5.63]</p> </td> </tr> </tbody> </table> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="table-viewer-caption"> <div class="table-heading"><span class="table-label">Comparison 18.</span> <span class="table-title">Transelectrical nerve stimulation (TENS) versus control</span></div> </div> <div class="tools"><a class="tableList" href="/cdsr/doi/10.1002/14651858.CD012551.pub3/references#CD012551-tbl-0030">Navigate to table in review</a></div> </div> <div class="table"> <table class="comparison" data-id="CD012551-tbl-0031"> <div class="table-heading"><span class="table-label">Comparison 19.</span> <span class="table-title">Transurethral microwave thermotherapy</span></div> <thead> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>Outcome or subgroup title</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>No. of studies</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>No. of participants</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Statistical method</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>Effect size</p> </td> </tr> </thead> <tbody> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">1 Prostatitis symptoms (NIH‐CPSI total) <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>2</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""></td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Mean Difference (IV, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>Subtotals only</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>1.1 70 °C vs 55 °C</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>39</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Mean Difference (IV, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>‐1.10 [‐6.50, 4.30]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>1.2 Compared to control</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>20</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Mean Difference (IV, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>0.0 [0.0, 0.0]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">2 Prostatitis symptoms: pain subscore <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""></td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Mean Difference (IV, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>Totals not selected</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">3 Prostatitis symptoms: micturition subscore <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""></td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Mean Difference (IV, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>Totals not selected</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">4 Prostatitis symptoms: quality of life subscore <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""></td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Mean Difference (IV, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>Totals not selected</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">5 Urinary symptoms <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>2</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""></td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Mean Difference (IV, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>Subtotals only</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>5.1 70 °C vs 55 °C</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>39</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Mean Difference (IV, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>‐2.10 [‐6.34, 2.14]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>5.2 Compared to control</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>20</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Mean Difference (IV, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>0.0 [0.0, 0.0]</p> </td> </tr> </tbody> </table> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="table-viewer-caption"> <div class="table-heading"><span class="table-label">Comparison 19.</span> <span class="table-title">Transurethral microwave thermotherapy</span></div> </div> <div class="tools"><a class="tableList" href="/cdsr/doi/10.1002/14651858.CD012551.pub3/references#CD012551-tbl-0031">Navigate to table in review</a></div> </div> <div class="table"> <table class="comparison" data-id="CD012551-tbl-0032"> <div class="table-heading"><span class="table-label">Comparison 20.</span> <span class="table-title">Transurethral needle ablation (TUNA) versus sham procedure</span></div> <thead> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>Outcome or subgroup title</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>No. of studies</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>No. of participants</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Statistical method</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>Effect size</p> </td> </tr> </thead> <tbody> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">1 Prostatitis symptoms (NIH‐CPSI total) <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>33</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Mean Difference (IV, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>2.30 [‐8.02, 12.62]</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">2 Urinary symptoms <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>33</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Mean Difference (IV, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>0.40 [‐5.09, 5.89]</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> </tbody> </table> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="table-viewer-caption"> <div class="table-heading"><span class="table-label">Comparison 20.</span> <span class="table-title">Transurethral needle ablation (TUNA) versus sham procedure</span></div> </div> <div class="tools"><a class="tableList" href="/cdsr/doi/10.1002/14651858.CD012551.pub3/references#CD012551-tbl-0032">Navigate to table in review</a></div> </div> <div class="table"> <table class="comparison" data-id="CD012551-tbl-0033"> <div class="table-heading"><span class="table-label">Comparison 21.</span> <span class="table-title">Ultrasound (non‐intrusive)</span></div> <thead> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>Outcome or subgroup title</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>No. of studies</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>No. of participants</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Statistical method</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>Effect size</p> </td> </tr> </thead> <tbody> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">1 Prostatitis symptoms (NIH‐CPSI total) <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""></td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Mean Difference (IV, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>Subtotals only</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>1.1 Ultrasound vs medical therapy</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>70</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Mean Difference (IV, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>1.09 [0.16, 2.02]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>1.2 Ultrasound in combination with medical therapy vs medical therapy alone</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>70</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Mean Difference (IV, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>‐6.67 [‐7.62, ‐5.72]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">2 Prostatitis symptoms: pain subscore <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""></td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Mean Difference (IV, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>Totals not selected</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>2.1 Ultrasound vs medical therapy</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""></td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Mean Difference (IV, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>0.0 [0.0, 0.0]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>2.2 Ultrasound in combination with medical therapy vs medical therapy alone</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""></td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Mean Difference (IV, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>0.0 [0.0, 0.0]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">3 Prostatitis symptoms: micturition subscore <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""></td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Mean Difference (IV, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>Totals not selected</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>3.1 Ultrasound vs medical therapy</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""></td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Mean Difference (IV, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>0.0 [0.0, 0.0]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>3.2 Ultrasound in combination with medical therapy vs medical therapy alone</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""></td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Mean Difference (IV, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>0.0 [0.0, 0.0]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">4 Prostatitis symptoms: quality of life subscore <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""></td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Mean Difference (IV, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>Totals not selected</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>4.1 Ultrasound vs medical therapy</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""></td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Mean Difference (IV, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>0.0 [0.0, 0.0]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>4.2 Ultrasound in combination with medical therapy vs medical therapy alone</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""></td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Mean Difference (IV, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>0.0 [0.0, 0.0]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">5 Prostatitis symptoms <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""></td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>Totals not selected</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>5.1 Ultrasound vs medical therapy</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""></td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>0.0 [0.0, 0.0]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>5.2 Ultrasound in combination with medical therapy vs medical therapy alone</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""></td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>0.0 [0.0, 0.0]</p> </td> </tr> </tbody> </table> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="table-viewer-caption"> <div class="table-heading"><span class="table-label">Comparison 21.</span> <span class="table-title">Ultrasound (non‐intrusive)</span></div> </div> <div class="tools"><a class="tableList" href="/cdsr/doi/10.1002/14651858.CD012551.pub3/references#CD012551-tbl-0033">Navigate to table in review</a></div> </div> <div class="table"> <table class="comparison" data-id="CD012551-tbl-0034"> <div class="table-heading"><span class="table-label">Comparison 22.</span> <span class="table-title">Acupuncture treatments versus medical treatment ‐ sensitivity analysis</span></div> <thead> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>Outcome or subgroup title</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>No. of studies</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>No. of participants</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Statistical method</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>Effect size</p> </td> </tr> </thead> <tbody> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">1 Prostatitis symptoms (NIH‐CPSI total) <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>2</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>78</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Mean Difference (IV, Random, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>‐6.05 [‐7.87, ‐4.24]</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>1.1 Acupuncture</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>54</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Mean Difference (IV, Random, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>‐6.11 [‐8.75, ‐3.47]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>1.2 Electroacupuncture</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>24</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Mean Difference (IV, Random, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>‐6.0 [‐8.50, ‐3.50]</p> </td> </tr> </tbody> </table> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="table-viewer-caption"> <div class="table-heading"><span class="table-label">Comparison 22.</span> <span class="table-title">Acupuncture treatments versus medical treatment ‐ sensitivity analysis</span></div> </div> <div class="tools"><a class="tableList" href="/cdsr/doi/10.1002/14651858.CD012551.pub3/references#CD012551-tbl-0034">Navigate to table in review</a></div> </div> </div> <noscript> <img height="1" src="/scolaris-auth/report/nonjs/fulltexthtmlreg?doi=10.1002%2F14651858.CD012551.pub3&amp;rf=&amp;articleType=CDSR" style="display:none" width="1"> </img></noscript> <section class="translation-notes-modal" data-modal-class="translation-notes" data-modal-title="Translation notes" data-ok-btn-selector=".ok-btn" style="display: none"> <div class="translation-notes"> <div class="section-language-toggles"> <nav class="section-languages"> <ul> <li class="section-languages-legend">Available in</li> <li class="section-language"> <a class="" href="de#CD012551-note-0002">Deutsch</a> </li> <li class="section-language"> <a class="" href="es#CD012551-note-0005">Español</a> </li> <li class="section-language"> <a class="" href="fa#CD012551-note-0022">فارسی</a> </li> <li class="section-language"> <a class="" href="fr#CD012551-note-0004">Français</a> </li> <li class="section-language"> <a class="" href="ru#CD012551-note-0003">Русский</a> </li> <li class="section-language"> <a class="" href="zh_HANS#CD012551-note-0001">简体中文</a> </li> </ul> </nav> </div> <section class="translation-notes-content"> </section> <button class="btn primary ok-btn pull-right" type="button">Close</button> </div> </section></article> </div> <div class="citation-modal" style="display: none"> <div class="export-citation-header"> <p class="inset-message" data-load-error="Unable to load citation data" id="citeProcText"></p> </div> <div class="export-citation-body row-fluid"> <div class="span12"> <div class="addthis_toolbox addthis_default_style addthis_16x16_style"> <nav class="inline-nav-list is-bordered"> <li> <h4 class="heading">Save citation to:</h4> </li> <li><a class="citation-btn-refworks at300b btn btn-link" href="#" id="refWorksCitationBtn"><span class="citation-icon refworks"></span>RefWorks</a></li> <li><a class="citation-btn-sciwheel at300b btn btn-link disabled" href="#" id="sciWheelCitationBtn" target="_blank"><span class="citation-icon sciwheel"></span>SciWheel</a></li> </nav> </div> </div> </div> <div class="row-fluid"> <div class="span12"> <div class="citation-format"> <h4>Copy or download citation</h4> <a href="/en/help/exporting-search-results" rel="noopener noreferrer" target="_blank">Export help</a> </div> <nav class="inline-nav-list has-dividers"> <li class="citation-option" data-option="plain"><button class="btn btn-link" type="button">Plain text</button></li> <li class="citation-option" data-option="endnote"><button class="btn btn-link" type="button">EndNote</button></li> <li class="citation-option" data-option="refmanager"><button class="btn btn-link" type="button">Reference Manager</button></li> <li class="citation-option" data-option="procite"><button class="btn btn-link" type="button">ProCite</button></li> <li class="citation-option" data-option="bibtex"><button class="btn btn-link" type="button">BibteX</button></li> <li class="citation-option" data-option="csv"><button class="btn btn-link" type="button">CSV (Excel)</button></li> </nav> <div class="citation-content"> <pre data-load-error="Unable to load citation data" id="citationContent" tabindex="0"></pre> </div> <div class="clearfix"> <form class="download-citation-form" data-citation-citeproc-url="https://www.cochranelibrary.com/en/content?p_p_id=scolariscontentdisplay_WAR_scolariscontentdisplay&amp;p_p_lifecycle=2&amp;p_p_state=normal&amp;p_p_mode=view&amp;p_p_resource_id=citation-citeproc&amp;p_p_cacheability=cacheLevelPage&amp;p_p_col_id=column-1&amp;p_p_col_count=1" method="GET" target="citation-download-iframe"> <input id="siteId" name="siteId" type="hidden" value=""> <input id="downloadType" name="downloadType" type="hidden" value=""> <input id="style" name="style" type="hidden" value=""> <input id="articleId" name="articleId" type="hidden" value=""> <input name="p_p_id" type="hidden" value="scolariscontentdisplay_WAR_scolariscontentdisplay"><input name="p_p_lifecycle" type="hidden" value="2"><input name="p_p_state" type="hidden" value="normal"><input name="p_p_mode" type="hidden" value="view"/><input name="p_p_resource_id" type="hidden" value="citation-download"/><input name="p_p_cacheability" type="hidden" value="cacheLevelPage"/><input name="p_p_col_id" type="hidden" value="column-1"/><input name="p_p_col_count" type="hidden" value="1"/> <button class="btn primary wide pull-right" type="submit">Download</button> <div class="inline-checkbox pull-right"> <label title=" for=" withabstract"=""> <input checked="" class="checkbox" name="withAbstract" type="checkbox"/> <span class="checkbox-label">Include abstract</span> </label> </div> </input></input></input></input></input></input></input></form> <iframe aria-hidden="true" name="citation-download-iframe" src="" style="display: none; visibility: hidden" title="Citation download frame"></iframe> </div> </div> </div> </div> <div class="print-modal" data-modal-title="Print this review" style="display: none;"> <div class="print-options-wrapper"> <p><strong>All sections are selected by default</strong>, please select the sections you do not wish to print or use the select or deselect all button to add or remove sections.</p> <div class="print-options-controls"> <input checked="checked" class="print-options-select-all" title="Select/deselect all" type="checkbox"/> <span class="checkbox-label">Select/deselect all</span> </div> <ul class="print-options checkbox-list"> </ul> <button class="btn primary print-article pull-right"><i aria-hidden="true" class="fa fa-print"></i> Print</button> </div> </div> <div class="download-stats-data-modal" data-modal-title="Download data package" style="display: none;"> <div> <p> The data available are protected by copyright and may only be used in accordance with the <a class="external" href="/about/data-download" target="_blank">Terms and Conditions.</a> </p> <div class="hide-for-zip"> <p> <a class="external" href="https://revman.cochrane.org/#/rm5Converter" target="_blank">RevMan 5 files</a> can be converted to a <a class="external" href="https://links.cochrane.org/review-datapack-userguide" target="_blank">data package.</a> </p> </div> <p> Files in the data package can be imported to <a class="external" href="https://revman.cochrane.org/info" target="_blank">Review Manager software</a> or opened in other tools that support CSV and RIS. </p> <form class="download-stats-data-form" method="GET" target="_blank"> <input name="content-disposition" type="hidden" value="attachment"/> <input name="mime-type" type="hidden" value="application/octet-stream"/> <p class="print-options-controls"> <input aria-label="I agree to these terms and conditions" class="download-stats-data-toc-check-box" type="checkbox"/> <span aria-hidden="true" class="checkbox-label">I agree to these terms and conditions</span> <button class="btn primary download-stats-data pull-right" disabled=""><i aria-hidden="true" class="fa fa-download"></i> Download data</button> </p> </form> </div> </div> <div class="share-modal" data-modal-title="Share this review" style="display:none;"> </div> <div class="viewer-thumbnail-pane-html" style="display:none;"> <div class="figure-viewer-options"> <nav class="inline-nav-list"> <li class="figure-options-btn-container"><button class="btn btn-link" id="figureOptionBtn" type="button">Figures</button></li> <li class="table-options-btn-container"><button class="btn btn-link" id="tableOptionBtn" type="button">Tables</button></li> </nav> </div> <div class="figure-viewer-thumbnails"> <div class="figure-thumbnails is-visible" id="figureThumbnails"></div> <div class="table-thumbnails" id="tableThumbnails"></div> </div> </div> <div class="utilities-html" style="display:none;"> <div class="figure-viewer-utilities"> <a class="figure-viewer-menu-toggle" href="#"> <i class="fa fa-chevron-left"></i><span class="toggle-label" data-figure-hide-text="Hide thumbnails" data-figure-show-text="Show thumbnails" data-table-hide-text="Hide table list" data-table-show-text="Show table list">Hide thumbnails</span> </a> <a class="figure-viewer-navigateback" href="#"> <i class="fa fa-chevron-left"></i> </a> <a class="figure-viewer-rotate" href="#"> <i class="fa fa-undo"></i> </a> <a class="figure-viewer-download" href="#"> <i class="fa fa-download"></i> </a> <a class="figure-viewer-share" href="#"> <i class="fa fa-share-alt"></i> </a> <a class="figure-viewer-zoomin" href="#"> <i class="fa fa-plus"></i><span>zoom in</span> </a> <a class="figure-viewer-zoomout" href="#"> <i class="fa fa-minus"></i><span>zoom out</span> </a> </div> </div> <div class="controls-html" style="display:none;"> <div class="figure-viewer-navigation"> <a class="figure-viewer-nav previous" href="#"> <i class="fa fa-chevron-left"></i><span>left</span> </a> <a class="figure-viewer-nav next" href="#"> <i class="fa fa-chevron-right"></i><span>right</span> </a> </div> </div> <div class="mobile-thumbnail-selector-html" style="display:none;"> <div class="figure-viewer-mobile-thumbnails"> <select class="figure-selection"> <option>Figures</option> </select> <select class="table-selection"> <option>Tables</option> </select> </div> </div> </div> </div> </div> <div style="display:none"> <input id="freelabel" name="freelabel" type="hidden" value="Free access"/>
<input id="openlabel" name="openlabel" type="hidden" value="Open access"/>
</div>
</section>
</div>
</div>
</div>
</div>
</div>
<div class="portlet-boundary portlet-boundary_1_WAR_kaleodesignerportlet_ portlet-static portlet-static-end kaleo-designer-portlet" id="p_p_id_1_WAR_kaleodesignerportlet_">
<span id="p_1_WAR_kaleodesignerportlet"></span>
</div>
<form action="#" id="hrefFm" method="post" name="hrefFm">
<span></span>
</form>
</div>
<footer class="footer">
<div class="main-footer">
<div class="main-footer-wrapper container">
<div class="brand">
<p class="brand-name">Cochrane</p>
<a href="http://www.cochrane.org/" title="Cochrane logo">
<img alt="Cochrane logo" class="footer-logo logo-part-1" src="https://www.cochranelibrary.com/cochrane-theme/images/footer-logo-part-1.png"> <img alt="" class="footer-logo logo-part-2" src="https://www.cochranelibrary.com/cochrane-theme/images/footer-logo-part-2.png"> </img></img></a> </div> </div> </div> <div class="aux-footer"> <div class="aux-footer-nav-container container"> <nav class="aux-footer-nav"> <ul class="aux-footer-nav-list"> <li><a class="aux-footer-nav-link" href="https://onlinelibrary.wiley.com/">Browse Publications</a></li> <li><a class="aux-footer-nav-link" href="https://onlinelibrary.wiley.com/">Browse by Subject</a></li> </ul> <ul class="aux-footer-nav-list"> <li><a class="aux-footer-nav-link" href="https://onlinelibrary.wiley.com/advertisers">Advertisers &amp; Agents</a></li> <li><a class="aux-footer-nav-link" href="https://hub.wiley.com/community/support/cochrane-library">Contact Us</a></li> </ul> <ul class="aux-footer-nav-list"> <li><a class="aux-footer-nav-link" href="https://hub.wiley.com/community/support/cochrane-library">Help &amp; Support</a></li> <li><a class="aux-footer-nav-link" href="https://onlinelibrary.wiley.com/terms-and-conditions">Terms &amp; Conditions</a></li> </ul> </nav> </div> <div class="brand"> <div class="brand-container container"> <p class="copyright"> Copyright © 2000 - 2025 by <a class="" href="http://www.wiley.com">John Wiley &amp; Sons, Inc.</a> All Rights Reserved <br> Review our <a href="https://www.wiley.com/privacy"><strong>Privacy Policy</strong></a> <a href="https://www.wiley.com/cookies"><strong>Cookie Policy</strong></a> <a href="#" onclick="Osano.cm.showDrawer('osano-cm-dom-info-dialog-open')"><strong>Cookie Preferences</strong></a> </br></p> <a href="http://eu.wiley.com/"><img alt="Wiley logo" class="logo" src="https://www.cochranelibrary.com/cochrane-theme/images/en-US_wiley-footer-logo.png"/></a> </div> </div> <span class="wiley-semi-circle"></span> </div> <!--BEGIN QUALTRICS WEBSITE FEEDBACK SNIPPET--> <script type="text/javascript"> (function(){var g=function(e,h,f,g){ this.get=function(a){for(var a=a+"=",c=document.cookie.split(";"),b=0,e=c.length;b<e;b++){for(var d=c[b];" "==d.charAt(0);)d=d.substring(1,d.length);if(0==d.indexOf(a))return d.substring(a.length,d.length)}return null}; this.set=function(a,c){var b="",b=new Date;b.setTime(b.getTime()+6048E5);b="; expires="+b.toGMTString();document.cookie=a+"="+c+b+"; path=/; "}; this.check=function(){var a=this.get(f);if(a)a=a.split(":");else if(100!=e)"v"==h&&(e=Math.random()>=e/100?0:100),a=[h,e,0],this.set(f,a.join(":"));else return!0;var c=a[1];if(100==c)return!0;switch(a[0]){case "v":return!1;case "r":return c=a[2]%Math.floor(100/c),a[2]++,this.set(f,a.join(":")),!c}return!0}; this.go=function(){if(this.check()){var a=document.createElement("script");a.type="text/javascript";a.src=g;document.body&&document.body.appendChild(a)}}; this.start=function(){var t=this;"complete"!==document.readyState?window.addEventListener?window.addEventListener("load",function(){t.go()},!1):window.attachEvent&&window.attachEvent("onload",function(){t.go()}):t.go()};}; try{(new g(100,"r","QSI_S_ZN_cGCHHvWNpnJb1zf","https://zncgchhvwnpnjb1zf-wiley.siteintercept.qualtrics.com/SIE/?Q_ZID=ZN_cGCHHvWNpnJb1zf")).start()}catch(i){}})(); </script><div id="ZN_cGCHHvWNpnJb1zf"><!--DO NOT REMOVE-CONTENTS PLACED HERE--></div> <!--END WEBSITE FEEDBACK SNIPPET--> </footer> <div class="scolaris-modal-overlay"></div> <div class="scolaris-modal"> <div class="scolaris-modal-titlebar clearfix"> <p class="scolaris-modal-title"></p> <a class="scolaris-modal-close" href="#"><span>close</span><span class="icon fa fa-times"></span></a> <div class="scolaris-modal-ui"></div> </div> <!-- Static injection of addtoAny as dynamic injection not working properly--> <div class="scolaris-share-modal-content clearfix"> <div class="scolaris-modal-ui clearfix"> <div class="a2a_kit a2a_kit_size_32 a2a_default_style"> <a class="a2a_button_facebook share-button">  Facebook</a> <a class="a2a_button_x share-button">  X(Twitter)</a> <a class="a2a_button_whatsapp share-button">  WhatsApp</a> <a class="a2a_dd share-button">  View more</a> </div> </div> </div> <div class="scolaris-modal-content clearfix"> <div class="scolaris-modal-ui clearfix"></div> </div> <div class="scolaris-modal-ui clearfix"></div> </div> <div class="english-only-modal-wrapper" data-modal-class="english-only-modal" data-modal-title="Feature in English only" style="display: none"> <div class="english-only-modal"> <p class="message"></p> <button class="btn primary ok-btn pull-right" type="button">OK</button> <button class="btn primary border-only cancel-btn pull-right" type="button">Cancel</button> </div> </div> <!--[if gte IE 9]><!--> <script src="/cochrane-theme/vendor/ie9.js?t=1738735355000" type="text/javascript"></script> <!--<![endif]--> <script src="https://www.cochranelibrary.com/cochrane-theme/js/theme.js?t=1738735355000" type="text/javascript"></script> <script src="https://content.readcube.com/cochrane/checkout.js"></script> <script src="https://content.readcube.com/cochrane/epdf_linker.js" type="text/javascript"></script> <script src="https://crossmark-cdn.crossref.org/widget/v2.0/widget.js" type="text/javascript"></script> <script src="https://d1bxh8uas1mnw7.cloudfront.net/assets/embed.js" type="text/javascript"></script> <script src="https://www.cochranelibrary.com/scolaris-content-display/js/hit-highlighting.js?browserId=other&amp;minifierType=js&amp;languageId=en_US&amp;b=6210&amp;t=1739773978000" type="text/javascript"></script> <script src="https://www.cochranelibrary.com/scolaris-content-display/js/topics-lookup.js?browserId=other&amp;minifierType=js&amp;languageId=en_US&amp;b=6210&amp;t=1739773978000" type="text/javascript"></script> <script src="https://www.cochranelibrary.com/scolaris-content-display/js/institution.js?browserId=other&amp;minifierType=js&amp;languageId=en_US&amp;b=6210&amp;t=1739773978000" type="text/javascript"></script> <script src="https://www.cochranelibrary.com/scolaris-content-display/js/api-manager.js?browserId=other&amp;minifierType=js&amp;languageId=en_US&amp;b=6210&amp;t=1739773978000" type="text/javascript"></script> <script src="https://www.cochranelibrary.com/scolaris-content-display/js/pico.js?browserId=other&amp;minifierType=js&amp;languageId=en_US&amp;b=6210&amp;t=1739773978000" type="text/javascript"></script> <script src="https://www.cochranelibrary.com/scolaris-content-display/js/reference-linking.js?browserId=other&amp;minifierType=js&amp;languageId=en_US&amp;b=6210&amp;t=1739773978000" type="text/javascript"></script> <script src="https://www.cochranelibrary.com/scolaris-content-display/js/rightsLink.js?browserId=other&amp;minifierType=js&amp;languageId=en_US&amp;b=6210&amp;t=1739773978000" type="text/javascript"></script> <script src="https://www.cochranelibrary.com/scolaris-content-display/js/ui.submit.failed.js?browserId=other&amp;minifierType=js&amp;languageId=en_US&amp;b=6210&amp;t=1739773978000" type="text/javascript"></script> <script src="https://www.cochranelibrary.com/scolaris-content-display/js/ui.comment.form.js?browserId=other&amp;minifierType=js&amp;languageId=en_US&amp;b=6210&amp;t=1739773978000" type="text/javascript"></script> <script src="https://www.cochranelibrary.com/scolaris-content-display/js/safety-alerts.js?browserId=other&amp;minifierType=js&amp;languageId=en_US&amp;b=6210&amp;t=1739773978000" type="text/javascript"></script> <script src="https://www.cochranelibrary.com/scolaris-content-display/js/ui.translation-notes-modal.js?browserId=other&amp;minifierType=js&amp;languageId=en_US&amp;b=6210&amp;t=1739773978000" type="text/javascript"></script> <script src="https://www.cochranelibrary.com/scolaris-content-display/js/main.js?browserId=other&amp;minifierType=js&amp;languageId=en_US&amp;b=6210&amp;t=1739773978000" type="text/javascript"></script> <script src="https://www.cochranelibrary.com/notifications-portlet/notifications/js/main.js?browserId=other&amp;minifierType=js&amp;languageId=en_US&amp;b=6210&amp;t=1739774000000" type="text/javascript"></script> <script src="https://www.cochranelibrary.com/scolaris-search/js/main.js?browserId=other&amp;minifierType=js&amp;languageId=en_US&amp;b=6210&amp;t=1739774074000" type="text/javascript"></script> <script src="https://www.cochranelibrary.com/scolaris-topics/js/main.js?browserId=other&amp;minifierType=js&amp;languageId=en_US&amp;b=6210&amp;t=1739774074000" type="text/javascript"></script> <script src="https://www.cochranelibrary.com/scolaris-language-portlet/js/main.js?browserId=other&amp;minifierType=js&amp;languageId=en_US&amp;b=6210&amp;t=1739774000000" type="text/javascript"></script> <script type="text/javascript">Liferay.Util.addInputFocus();</script> <script type="text/javascript">Liferay.Portlet.register("scolarislanguageselector_WAR_scolarislanguageportlet_INSTANCE_header");Liferay.Portlet.onLoad({canEditTitle:false,columnPos:0,isStatic:"end",namespacedId:"p_p_id_scolarislanguageselector_WAR_scolarislanguageportlet_INSTANCE_header_",portletId:"scolarislanguageselector_WAR_scolarislanguageportlet_INSTANCE_header",refreshURL:"\x2fen\x2fc\x2fportal\x2frender_portlet\x3fp_l_id\x3d20757\x26p_p_id\x3dscolarislanguageselector_WAR_scolarislanguageportlet_INSTANCE_header\x26p_p_lifecycle\x3d0\x26p_t_lifecycle\x3d0\x26p_p_state\x3dnormal\x26p_p_mode\x3dview\x26p_p_col_id\x3dnull\x26p_p_col_pos\x3dnull\x26p_p_col_count\x3dnull\x26p_p_static\x3d1\x26p_p_isolated\x3d1\x26currentURL\x3d\x252Fweb\x252Fcochrane\x252Fcontent\x253FtemplateType\x253Dfull\x2526urlTitle\x253D\x252Fcdsr\x252Fdoi\x252F10\x2e1002\x252F14651858\x2eCD012551\x2epub3\x2526doi\x253D10\x2e1002\x252F14651858\x2eCD012551\x2epub3\x2526type\x253Dcdsr\x2526contentLanguage\x253D\x26templateType\x3dfull\x26urlTitle\x3d\x252Fcdsr\x252Fdoi\x252F10\x2e1002\x252F14651858\x2eCD012551\x2epub3\x26contentLanguage\x3d\x26type\x3dcdsr\x26doi\x3d10\x2e1002\x252F14651858\x2eCD012551\x2epub3"});Liferay.Portlet.register("scolariscontentdisplay_WAR_scolariscontentdisplay");Liferay.Portlet.onLoad({canEditTitle:false,columnPos:0,isStatic:"end",namespacedId:"p_p_id_scolariscontentdisplay_WAR_scolariscontentdisplay_",portletId:"scolariscontentdisplay_WAR_scolariscontentdisplay",refreshURL:"\x2fen\x2fc\x2fportal\x2frender_portlet\x3fp_l_id\x3d20757\x26p_p_id\x3dscolariscontentdisplay_WAR_scolariscontentdisplay\x26p_p_lifecycle\x3d0\x26p_t_lifecycle\x3d0\x26p_p_state\x3dnormal\x26p_p_mode\x3dview\x26p_p_col_id\x3dcolumn-1\x26p_p_col_pos\x3d0\x26p_p_col_count\x3d1\x26p_p_isolated\x3d1\x26currentURL\x3d\x252Fweb\x252Fcochrane\x252Fcontent\x253FtemplateType\x253Dfull\x2526urlTitle\x253D\x252Fcdsr\x252Fdoi\x252F10\x2e1002\x252F14651858\x2eCD012551\x2epub3\x2526doi\x253D10\x2e1002\x252F14651858\x2eCD012551\x2epub3\x2526type\x253Dcdsr\x2526contentLanguage\x253D"});Liferay.provide(Liferay.Util,"openKaleoDesignerPortlet",function(c){var b=AUI();var e=Liferay.PortletURL.createURL("https://www.cochranelibrary.com/en/content?p_p_id=2_WAR_kaleodesignerportlet&p_p_lifecycle=0");e.setParameter("mvcPath","/designer/edit_kaleo_draft_definition.jsp");e.setParameter("availableFields",c.availableFields);e.setParameter("availablePropertyModels",c.availablePropertyModels);e.setParameter("ddmStructureId",c.ddmStructureId);e.setParameter("draftVersion",c.draftVersion);e.setParameter("kaleoProcessId",c.kaleoProcessId);e.setParameter("name",c.name);e.setParameter("openerWindowName",c.openerWindowName);e.setParameter("portletResourceNamespace",c.portletResourceNamespace);e.setParameter("propertiesSaveCallback",c.propertiesSaveCallback);e.setParameter("refreshOpenerOnClose",c.refreshOpenerOnClose);e.setParameter("saveCallback",c.saveCallback);e.setParameter("version",c.version);e.setWindowState("pop_up");c.uri=e.toString();var d=c.dialog;if(!d){var f=b.one(Liferay.Util.getOpener()).get("region");d={destroyOnHide:true};c.dialog=d}if(!("align" in d)){d.align=Liferay.Util.Window.ALIGN_CENTER}var a=c.dialogIframe;if(!a){a={closeOnEscape:false};c.dialogIframe=a}Liferay.Util.openWindow(c)},["liferay-portlet-url"]);Liferay.Portlet.register("1_WAR_kaleodesignerportlet");Liferay.Portlet.onLoad({canEditTitle:false,columnPos:0,isStatic:"end",namespacedId:"p_p_id_1_WAR_kaleodesignerportlet_",portletId:"1_WAR_kaleodesignerportlet",refreshURL:"\x2fen\x2fc\x2fportal\x2frender_portlet\x3fp_l_id\x3d20757\x26p_p_id\x3d1_WAR_kaleodesignerportlet\x26p_p_lifecycle\x3d0\x26p_t_lifecycle\x3d0\x26p_p_state\x3dnormal\x26p_p_mode\x3dview\x26p_p_col_id\x3dnull\x26p_p_col_pos\x3dnull\x26p_p_col_count\x3dnull\x26p_p_static\x3d1\x26p_p_isolated\x3d1\x26currentURL\x3d\x252Fweb\x252Fcochrane\x252Fcontent\x253FtemplateType\x253Dfull\x2526urlTitle\x253D\x252Fcdsr\x252Fdoi\x252F10\x2e1002\x252F14651858\x2eCD012551\x2epub3\x2526doi\x253D10\x2e1002\x252F14651858\x2eCD012551\x2epub3\x2526type\x253Dcdsr\x2526contentLanguage\x253D\x26templateType\x3dfull\x26urlTitle\x3d\x252Fcdsr\x252Fdoi\x252F10\x2e1002\x252F14651858\x2eCD012551\x2epub3\x26contentLanguage\x3d\x26type\x3dcdsr\x26doi\x3d10\x2e1002\x252F14651858\x2eCD012551\x2epub3"});Liferay.Portlet.register("scolarissearchportlet_WAR_scolarissearch");Liferay.Portlet.onLoad({canEditTitle:false,columnPos:0,isStatic:"end",namespacedId:"p_p_id_scolarissearchportlet_WAR_scolarissearch_",portletId:"scolarissearchportlet_WAR_scolarissearch",refreshURL:"\x2fen\x2fc\x2fportal\x2frender_portlet\x3fp_l_id\x3d20757\x26p_p_id\x3dscolarissearchportlet_WAR_scolarissearch\x26p_p_lifecycle\x3d0\x26p_t_lifecycle\x3d0\x26p_p_state\x3dnormal\x26p_p_mode\x3dview\x26p_p_col_id\x3dnull\x26p_p_col_pos\x3dnull\x26p_p_col_count\x3dnull\x26p_p_static\x3d1\x26p_p_isolated\x3d1\x26currentURL\x3d\x252Fweb\x252Fcochrane\x252Fcontent\x253FtemplateType\x253Dfull\x2526urlTitle\x253D\x252Fcdsr\x252Fdoi\x252F10\x2e1002\x252F14651858\x2eCD012551\x2epub3\x2526doi\x253D10\x2e1002\x252F14651858\x2eCD012551\x2epub3\x2526type\x253Dcdsr\x2526contentLanguage\x253D\x26templateType\x3dfull\x26urlTitle\x3d\x252Fcdsr\x252Fdoi\x252F10\x2e1002\x252F14651858\x2eCD012551\x2epub3\x26contentLanguage\x3d\x26type\x3dcdsr\x26doi\x3d10\x2e1002\x252F14651858\x2eCD012551\x2epub3"});Liferay.Portlet.register("scolariscontentlanguagebanner_WAR_scolarislanguageportlet");Liferay.Portlet.onLoad({canEditTitle:false,columnPos:0,isStatic:"end",namespacedId:"p_p_id_scolariscontentlanguagebanner_WAR_scolarislanguageportlet_",portletId:"scolariscontentlanguagebanner_WAR_scolarislanguageportlet",refreshURL:"\x2fen\x2fc\x2fportal\x2frender_portlet\x3fp_l_id\x3d20757\x26p_p_id\x3dscolariscontentlanguagebanner_WAR_scolarislanguageportlet\x26p_p_lifecycle\x3d0\x26p_t_lifecycle\x3d0\x26p_p_state\x3dnormal\x26p_p_mode\x3dview\x26p_p_col_id\x3dnull\x26p_p_col_pos\x3dnull\x26p_p_col_count\x3dnull\x26p_p_static\x3d1\x26p_p_isolated\x3d1\x26currentURL\x3d\x252Fweb\x252Fcochrane\x252Fcontent\x253FtemplateType\x253Dfull\x2526urlTitle\x253D\x252Fcdsr\x252Fdoi\x252F10\x2e1002\x252F14651858\x2eCD012551\x2epub3\x2526doi\x253D10\x2e1002\x252F14651858\x2eCD012551\x2epub3\x2526type\x253Dcdsr\x2526contentLanguage\x253D\x26templateType\x3dfull\x26urlTitle\x3d\x252Fcdsr\x252Fdoi\x252F10\x2e1002\x252F14651858\x2eCD012551\x2epub3\x26contentLanguage\x3d\x26type\x3dcdsr\x26doi\x3d10\x2e1002\x252F14651858\x2eCD012551\x2epub3"});AUI().use("aui-base","liferay-menu","liferay-notice","liferay-poller","liferay-session",function(a){(function(){Liferay.Util.addInputType();Liferay.Portlet.ready(function(b,c){Liferay.Util.addInputType(c)});if(a.UA.mobile){Liferay.Util.addInputCancel()}})();(function(){new Liferay.Menu();var b=Liferay.Data.notices;for(var c=1;c<b.length;c++){new Liferay.Notice(b[c])}})();(function(){Liferay.Session=new Liferay.SessionBase({autoExtend:true,sessionLength:1800,redirectOnExpire:false,redirectUrl:"https\x3a\x2f\x2fwww\x2ecochranelibrary\x2ecom\x2fweb\x2fcochrane",warningLength:0})})()});</script> <script src="https://www.cochranelibrary.com/cochrane-theme/js/main.js?browserId=other&amp;minifierType=js&amp;languageId=en_US&amp;b=6210&amp;t=1738735355000" type="text/javascript"></script> <script type="text/javascript"></script> <div class="mobile-righthand-nav"> <a class="rh-nav-close-btn" href="#"> <span>Close</span> <span class="fa fa-chevron-down"></span> </a> <div class="wrapper"> </div> <a class="rh-nav-open-btn" href="#"> <span>Review tools &amp; navigation</span> </a> </div> <iframe aria-hidden="true" id="printframe" name="printframe" style="position: absolute; left: -2000px; top: 0;" title="Print frame"></iframe> <iframe aria-hidden="true" id="citationExportFrame" name="citationExportFrame" style="position: absolute; left: -2000px; top: 0;" title="scolaris.citation.export.frame"></iframe> <nav> <div class="mobile-navigation"> <div class="close-container"> <a aria-label="Navigate back" class="main-nav-back-btn" href="#"><i class="fa fa-chevron-left"></i></a> <a class="main-nav-close-btn" href="#" title="Close menu">Close menu <i class="fa fa-times"></i></a> </div> <div class="mobile-search basic-search-container"> <div class="portlet-boundary portlet-boundary_scolarissearchportlet_WAR_scolarissearch_ portlet-static portlet-static-end" id="p_p_id_scolarissearchportlet_WAR_scolarissearch_"> <span id="p_scolarissearchportlet_WAR_scolarissearch"></span> <section class="portlet" id="portlet_scolarissearchportlet_WAR_scolarissearch"> <header class="portlet-topper"> <h1 class="portlet-title"> <span class="" onmouseover="Liferay.Portal.ToolTip.show(this, 'Scolaris\x20Search\x20Portlet')"> <img alt="" id="ymag__null__null" src="/scolaris-search/icon.png"> <span class="taglib-text hide-accessible">Scolaris Search Portlet</span> </img></span> <span class="portlet-title-text">Scolaris Search Portlet</span> </h1> <menu class="portlet-topper-toolbar" id="portlet-topper-toolbar_scolarissearchportlet_WAR_scolarissearch" type="toolbar"> </menu> </header> <div class="portlet-content"> <div class="portlet-content-container"> <div class="portlet-body"> <div class="header-search"> <form action="https://www.cochranelibrary.com/en/content?p_auth=loVWuZlx&amp;p_p_id=scolarissearchportlet_WAR_scolarissearch&amp;p_p_lifecycle=1&amp;p_p_state=normal&amp;p_p_mode=view&amp;_scolarissearchportlet_WAR_scolarissearch_scolarisAction=redirectSearchResult" method="post"> <input name="searchType" type="hidden" value="basic"> <input name="facetDisplayName" type="hidden" value=""> <input name="facetQueryTerm" type="hidden" value=""/> <input name="facetQueryField" type="hidden" value=""/> <input name="facetCategory" type="hidden" value=""/> <fieldset class="fieldset"> <legend class="sr-only">Basic Search</legend> <div class="select search-by"> <select aria-label="Search by options" class="custom-select-enabled search-type" name="searchBy" title="Search by options"> <option value="1">Title Abstract Keyword</option> <option value="2">Record Title</option> <option value="3">Abstract</option> <option value="4">Author</option> <option value="5">Keyword</option> <option value="6">All Text</option> <option value="7">Publication Type</option> <option value="8">Source</option> <option value="9">DOI</option> <option value="14">Language</option> <option value="10">Accession Number</option> <option value="11">Trial Registry Number</option> <option value="12">Cochrane Group</option> <option value="13">Cochrane Topic</option> </select> </div> <div class="search-select-crg-container select" style="display: none;"> <select class="search-select-crg-list"></select> </div> <div class="search-select-topic-container select" data-topic-list-url="https://www.cochranelibrary.com/en/content?p_p_id=scolaristopics_WAR_scolaristopics&amp;p_p_lifecycle=2&amp;p_p_state=normal&amp;p_p_mode=view&amp;p_p_resource_id=topics-list&amp;p_p_cacheability=cacheLevelPage" style="display: none;"> <select class="search-select-topic-list"></select> </div> <div class="search-select-cl-container select" style="display: none;"> <select class="search-select-cl-list"></select> </div> <div class="search-text-container"> <div class="control-group control-group-inline search-input-wrapper"> <input aria-label="Enter search term" class="field browser-search search-text ui-autocomplete-input" id="searchText" name="searchText" placeholder="Search" size="30" type="text" value=""/>
<div id="autocomplete-results"></div>
</div>
<div class="control-group control-group-inline search-button-wrapper">
<button aria-label="Search" class="searchByBtn" type="submit">
<i aria-hidden="true" class="fa fa-search"></i>
</button>
</div>
</div>
</fieldset>
</input></input></form>
</div>
<script>
    window.displayResultURL = 'https://www.cochranelibrary.com/en/content?p_p_id=scolarissearchportlet_WAR_scolarissearch&p_p_lifecycle=2&p_p_state=normal&p_p_mode=view&p_p_resource_id=getSuggestions&p_p_cacheability=cacheLevelPage&_scolarissearchportlet_WAR_scolarissearch_templateType=full&_scolarissearchportlet_WAR_scolarissearch_urlTitle=%2Fcdsr%2Fdoi%2F10.1002%2F14651858.CD012551.pub3&_scolarissearchportlet_WAR_scolarissearch_contentLanguage=&_scolarissearchportlet_WAR_scolarissearch_type=cdsr&_scolarissearchportlet_WAR_scolarissearch_doi=10.1002%2F14651858.CD012551.pub3';
    window.searchByOption = '';
</script>
</div>
</div>
</div>
<div style="display:none">
<input id="freelabel" name="freelabel" type="hidden" value="Free access"/>
<input id="openlabel" name="openlabel" type="hidden" value="Open access"/>
</div>
</section>
</div>
<a class="btn secondary" href="/en/browse-by-topic">Browse </a>
<a class="btn secondary advanced-search-button" href="/en/advanced-search">Advanced search</a>
</div>
<div class="menu-items parent">
<div>
<div class="nav-root-item parent">
<a class="language-selection-title-link" href="#" title="Select language">
<span class="mobile-nav-language-title">Select your preferred language </span></a> <span class="icon fa fa-caret-down"></span>
<div class="mob-child">
<div class="portlet-boundary portlet-boundary_scolarislanguageselector_WAR_scolarislanguageportlet_ portlet-static portlet-static-end" id="p_p_id_scolarislanguageselector_WAR_scolarislanguageportlet_INSTANCE_mobilenav_">
<span id="p_scolarislanguageselector_WAR_scolarislanguageportlet_INSTANCE_mobilenav"></span>
<section class="portlet" id="portlet_scolarislanguageselector_WAR_scolarislanguageportlet_INSTANCE_mobilenav">
<header class="portlet-topper">
<h1 class="portlet-title">
<span class="" onmouseover="Liferay.Portal.ToolTip.show(this, 'Scolaris\x20Language\x20Selector')">
<img alt="" id="fdkn__null__null" src="/scolaris-language-portlet/icon.png"> <span class="taglib-text hide-accessible">Scolaris Language Selector</span> </img></span> <span class="portlet-title-text">Scolaris Language Selector</span> </h1> <menu class="portlet-topper-toolbar" id="portlet-topper-toolbar_scolarislanguageselector_WAR_scolarislanguageportlet_INSTANCE_mobilenav" type="toolbar"> </menu> </header> <div class="portlet-content"> <div class="portlet-content-container"> <div class="portlet-body"> <div class="language-display" data-content-languages="[de, en, es, fa, fr, hi, hr, id, ja, ko, hu, ms, nl, pl, pt, ru, ro, ta, th, zh_HANT, zh_HANS]"> <a class="language-select-mobile" href="#" title="Select your preferred language"> <i class="fa fa-file-text"></i> English </a> <a class="language-select-mobile" href="#" title="Select your preferred language"> <i class="fa fa-globe"></i> English </a> </div> <div class="form-content language-selector-modal child"> <div class="row-fluid"> <h3><i class="fa fa-file-text"></i> Cochrane review language</h3> <p>Select your preferred language for Cochrane reviews and other content. Sections without translation will be in English.</p> <div class="dropdown-trigger" id="active-content-language"> <span>English</span> <i aria-hidden="true" class="fa fa-caret-down"></i> </div> <div class="language-selector-dropdown"> <a class="content-language-selector" data-languagecode="de" href="https://www.cochranelibrary.com/en/content?p_p_id=scolariscontentlanguagebanner_WAR_scolarislanguageportlet&amp;p_p_lifecycle=2&amp;p_p_state=normal&amp;p_p_mode=view&amp;p_p_resource_id=set-content-language&amp;p_p_cacheability=cacheLevelPage&amp;_scolariscontentlanguagebanner_WAR_scolarislanguageportlet_contentLanguage=de">Deutsch</a> <a class="content-language-selector is-active" data-languagecode="en" href="https://www.cochranelibrary.com/en/content?p_p_id=scolariscontentlanguagebanner_WAR_scolarislanguageportlet&amp;p_p_lifecycle=2&amp;p_p_state=normal&amp;p_p_mode=view&amp;p_p_resource_id=set-content-language&amp;p_p_cacheability=cacheLevelPage&amp;_scolariscontentlanguagebanner_WAR_scolarislanguageportlet_contentLanguage=en">English</a> <a class="content-language-selector" data-languagecode="es" href="https://www.cochranelibrary.com/en/content?p_p_id=scolariscontentlanguagebanner_WAR_scolarislanguageportlet&amp;p_p_lifecycle=2&amp;p_p_state=normal&amp;p_p_mode=view&amp;p_p_resource_id=set-content-language&amp;p_p_cacheability=cacheLevelPage&amp;_scolariscontentlanguagebanner_WAR_scolarislanguageportlet_contentLanguage=es">Español</a> <a class="content-language-selector" data-languagecode="fa" href="https://www.cochranelibrary.com/en/content?p_p_id=scolariscontentlanguagebanner_WAR_scolarislanguageportlet&amp;p_p_lifecycle=2&amp;p_p_state=normal&amp;p_p_mode=view&amp;p_p_resource_id=set-content-language&amp;p_p_cacheability=cacheLevelPage&amp;_scolariscontentlanguagebanner_WAR_scolarislanguageportlet_contentLanguage=fa">فارسی</a> <a class="content-language-selector" data-languagecode="fr" href="https://www.cochranelibrary.com/en/content?p_p_id=scolariscontentlanguagebanner_WAR_scolarislanguageportlet&amp;p_p_lifecycle=2&amp;p_p_state=normal&amp;p_p_mode=view&amp;p_p_resource_id=set-content-language&amp;p_p_cacheability=cacheLevelPage&amp;_scolariscontentlanguagebanner_WAR_scolarislanguageportlet_contentLanguage=fr">Français</a> <a class="content-language-selector" data-languagecode="hi" href="https://www.cochranelibrary.com/en/content?p_p_id=scolariscontentlanguagebanner_WAR_scolarislanguageportlet&amp;p_p_lifecycle=2&amp;p_p_state=normal&amp;p_p_mode=view&amp;p_p_resource_id=set-content-language&amp;p_p_cacheability=cacheLevelPage&amp;_scolariscontentlanguagebanner_WAR_scolarislanguageportlet_contentLanguage=hi">हिन्दी</a> <a class="content-language-selector" data-languagecode="hr" href="https://www.cochranelibrary.com/en/content?p_p_id=scolariscontentlanguagebanner_WAR_scolarislanguageportlet&amp;p_p_lifecycle=2&amp;p_p_state=normal&amp;p_p_mode=view&amp;p_p_resource_id=set-content-language&amp;p_p_cacheability=cacheLevelPage&amp;_scolariscontentlanguagebanner_WAR_scolarislanguageportlet_contentLanguage=hr">Hrvatski</a> <a class="content-language-selector" data-languagecode="id" href="https://www.cochranelibrary.com/en/content?p_p_id=scolariscontentlanguagebanner_WAR_scolarislanguageportlet&amp;p_p_lifecycle=2&amp;p_p_state=normal&amp;p_p_mode=view&amp;p_p_resource_id=set-content-language&amp;p_p_cacheability=cacheLevelPage&amp;_scolariscontentlanguagebanner_WAR_scolarislanguageportlet_contentLanguage=id">Bahasa Indonesia</a> <a class="content-language-selector" data-languagecode="ja" href="https://www.cochranelibrary.com/en/content?p_p_id=scolariscontentlanguagebanner_WAR_scolarislanguageportlet&amp;p_p_lifecycle=2&amp;p_p_state=normal&amp;p_p_mode=view&amp;p_p_resource_id=set-content-language&amp;p_p_cacheability=cacheLevelPage&amp;_scolariscontentlanguagebanner_WAR_scolarislanguageportlet_contentLanguage=ja">日本語</a> <a class="content-language-selector" data-languagecode="ko" href="https://www.cochranelibrary.com/en/content?p_p_id=scolariscontentlanguagebanner_WAR_scolarislanguageportlet&amp;p_p_lifecycle=2&amp;p_p_state=normal&amp;p_p_mode=view&amp;p_p_resource_id=set-content-language&amp;p_p_cacheability=cacheLevelPage&amp;_scolariscontentlanguagebanner_WAR_scolarislanguageportlet_contentLanguage=ko">한국어</a> <a class="content-language-selector" data-languagecode="hu" href="https://www.cochranelibrary.com/en/content?p_p_id=scolariscontentlanguagebanner_WAR_scolarislanguageportlet&amp;p_p_lifecycle=2&amp;p_p_state=normal&amp;p_p_mode=view&amp;p_p_resource_id=set-content-language&amp;p_p_cacheability=cacheLevelPage&amp;_scolariscontentlanguagebanner_WAR_scolarislanguageportlet_contentLanguage=hu">Magyar</a> <a class="content-language-selector" data-languagecode="ms" href="https://www.cochranelibrary.com/en/content?p_p_id=scolariscontentlanguagebanner_WAR_scolarislanguageportlet&amp;p_p_lifecycle=2&amp;p_p_state=normal&amp;p_p_mode=view&amp;p_p_resource_id=set-content-language&amp;p_p_cacheability=cacheLevelPage&amp;_scolariscontentlanguagebanner_WAR_scolarislanguageportlet_contentLanguage=ms">Bahasa Malaysia</a> <a class="content-language-selector" data-languagecode="nl" href="https://www.cochranelibrary.com/en/content?p_p_id=scolariscontentlanguagebanner_WAR_scolarislanguageportlet&amp;p_p_lifecycle=2&amp;p_p_state=normal&amp;p_p_mode=view&amp;p_p_resource_id=set-content-language&amp;p_p_cacheability=cacheLevelPage&amp;_scolariscontentlanguagebanner_WAR_scolarislanguageportlet_contentLanguage=nl">Nederlands</a> <a class="content-language-selector" data-languagecode="pl" href="https://www.cochranelibrary.com/en/content?p_p_id=scolariscontentlanguagebanner_WAR_scolarislanguageportlet&amp;p_p_lifecycle=2&amp;p_p_state=normal&amp;p_p_mode=view&amp;p_p_resource_id=set-content-language&amp;p_p_cacheability=cacheLevelPage&amp;_scolariscontentlanguagebanner_WAR_scolarislanguageportlet_contentLanguage=pl">Polski</a> <a class="content-language-selector" data-languagecode="pt" href="https://www.cochranelibrary.com/en/content?p_p_id=scolariscontentlanguagebanner_WAR_scolarislanguageportlet&amp;p_p_lifecycle=2&amp;p_p_state=normal&amp;p_p_mode=view&amp;p_p_resource_id=set-content-language&amp;p_p_cacheability=cacheLevelPage&amp;_scolariscontentlanguagebanner_WAR_scolarislanguageportlet_contentLanguage=pt">Português</a> <a class="content-language-selector" data-languagecode="ru" href="https://www.cochranelibrary.com/en/content?p_p_id=scolariscontentlanguagebanner_WAR_scolarislanguageportlet&amp;p_p_lifecycle=2&amp;p_p_state=normal&amp;p_p_mode=view&amp;p_p_resource_id=set-content-language&amp;p_p_cacheability=cacheLevelPage&amp;_scolariscontentlanguagebanner_WAR_scolarislanguageportlet_contentLanguage=ru">Русский</a> <a class="content-language-selector" data-languagecode="ro" href="https://www.cochranelibrary.com/en/content?p_p_id=scolariscontentlanguagebanner_WAR_scolarislanguageportlet&amp;p_p_lifecycle=2&amp;p_p_state=normal&amp;p_p_mode=view&amp;p_p_resource_id=set-content-language&amp;p_p_cacheability=cacheLevelPage&amp;_scolariscontentlanguagebanner_WAR_scolarislanguageportlet_contentLanguage=ro">Română</a> <a class="content-language-selector" data-languagecode="ta" href="https://www.cochranelibrary.com/en/content?p_p_id=scolariscontentlanguagebanner_WAR_scolarislanguageportlet&amp;p_p_lifecycle=2&amp;p_p_state=normal&amp;p_p_mode=view&amp;p_p_resource_id=set-content-language&amp;p_p_cacheability=cacheLevelPage&amp;_scolariscontentlanguagebanner_WAR_scolarislanguageportlet_contentLanguage=ta">தமிழ்</a> <a class="content-language-selector" data-languagecode="th" href="https://www.cochranelibrary.com/en/content?p_p_id=scolariscontentlanguagebanner_WAR_scolarislanguageportlet&amp;p_p_lifecycle=2&amp;p_p_state=normal&amp;p_p_mode=view&amp;p_p_resource_id=set-content-language&amp;p_p_cacheability=cacheLevelPage&amp;_scolariscontentlanguagebanner_WAR_scolarislanguageportlet_contentLanguage=th">ภาษาไทย</a> <a class="content-language-selector" data-languagecode="zh_HANT" href="https://www.cochranelibrary.com/en/content?p_p_id=scolariscontentlanguagebanner_WAR_scolarislanguageportlet&amp;p_p_lifecycle=2&amp;p_p_state=normal&amp;p_p_mode=view&amp;p_p_resource_id=set-content-language&amp;p_p_cacheability=cacheLevelPage&amp;_scolariscontentlanguagebanner_WAR_scolarislanguageportlet_contentLanguage=zh_HANT">繁體中文</a> <a class="content-language-selector" data-languagecode="zh_HANS" href="https://www.cochranelibrary.com/en/content?p_p_id=scolariscontentlanguagebanner_WAR_scolarislanguageportlet&amp;p_p_lifecycle=2&amp;p_p_state=normal&amp;p_p_mode=view&amp;p_p_resource_id=set-content-language&amp;p_p_cacheability=cacheLevelPage&amp;_scolariscontentlanguagebanner_WAR_scolarislanguageportlet_contentLanguage=zh_HANS">简体中文</a> </div> </div> <div class="row-fluid"> <h3 class="portal-language-header"><i class="fa fa-globe"></i> Website language</h3> <p>Select your preferred language for the Cochrane Library website.</p> <div class="dropdown-trigger" id="active-portal-language"> <span>English</span> <i aria-hidden="true" class="fa fa-caret-down"></i> </div> <div class="language-selector-dropdown"> <a class="portal-language-selector is-active" data-portallanguage="en" href="/en/cdsr/doi/10.1002/14651858.CD012551.pub3/full/en">English</a> <a class="portal-language-selector" data-portallanguage="es" href="/es/cdsr/doi/10.1002/14651858.CD012551.pub3/full/es">Español</a> </div> </div> <a class="btn secondary ok-btn pull-right" href="https://www.cochranelibrary.com/en/content?p_p_id=scolariscontentlanguagebanner_WAR_scolarislanguageportlet&amp;p_p_lifecycle=2&amp;p_p_state=normal&amp;p_p_mode=view&amp;p_p_resource_id=set-content-language&amp;p_p_cacheability=cacheLevelPage">Save</a> </div> </div> </div> </div> <div style="display:none"> <input id="freelabel" name="freelabel" type="hidden" value="Free access"/>
<input id="openlabel" name="openlabel" type="hidden" value="Open access"/>
</div>
</section>
</div>
</div>
</div>
<div class="parent">
<a class="mobile-link signin" data-redirect="false" href="https://www.cochranelibrary.com/c/portal/login?p_l_id=20757&amp;redirect=%2Fcdsr%2Fdoi%2F10.1002%2F14651858.CD012551.pub3%2Ffull" rel="nofollow">
                        Sign In
                    </a>
</div>
</div>
<div class="menu-items-footer">
<div class="utility-links">
<a class="cochrane-link" href="http://www.cochrane.org/" target="_blank">Visit Cochrane.org</a>
</div>
</div>
</div>
<div class="menu-items child"></div>
</div>
</nav><div class="basic-login-form-content" data-modal-title="Sign in" style="display: none;">
<div class="form-content">
<div class="row-fluid">
<div class="span12">
<div class="portlet-boundary portlet-boundary_58_ portlet-static portlet-static-end portlet-login" id="p_p_id_58_INSTANCE_MODAL_">
<span id="p_58_INSTANCE_MODAL"></span>
<section class="portlet" id="portlet_58_INSTANCE_MODAL">
<header class="portlet-topper">
<h1 class="portlet-title">
<span class="" onmouseover="Liferay.Portal.ToolTip.show(this, 'Sign\x20In')">
<img alt="" id="dbam__null__null" src="https://www.cochranelibrary.com/cochrane-theme/images/spacer.png" style="background-image: url('https://www.cochranelibrary.com/sprite/html/icons/_sprite.png'); background-position: 50% -592px; background-repeat: no-repeat; height: 16px; width: 16px;"> <span class="taglib-text hide-accessible">Sign In</span> </img></span> <span class="portlet-title-text">Sign In</span> </h1> <menu class="portlet-topper-toolbar" id="portlet-topper-toolbar_58_INSTANCE_MODAL" type="toolbar"> </menu> </header> <div class="portlet-content"> <div class="portlet-content-container"> <div class="portlet-body"> <form action="https://www.cochranelibrary.com/en/content?p_p_id=58_INSTANCE_MODAL&amp;p_p_lifecycle=1&amp;p_p_state=normal&amp;p_p_mode=view&amp;_58_INSTANCE_MODAL_struts_action=%2Flogin%2Flogin" autocomplete="on" class="form sign-in-form" id="_58_INSTANCE_MODAL_fm" method="post" name="_58_INSTANCE_MODAL_fm"> <fieldset class="input-container" disabled="disabled"> <legend class="sr-only">Cochrane Login</legend> <input name="_58_INSTANCE_MODAL_formDate" type="hidden" value="1740719899452"> <input class="field" id="_58_INSTANCE_MODAL_saveLastPath" name="_58_INSTANCE_MODAL_saveLastPath" type="hidden" value="false"> <input class="field" id="_58_INSTANCE_MODAL_redirect" name="_58_INSTANCE_MODAL_redirect" type="hidden" value="/cdsr/doi/10.1002/14651858.CD012551.pub3/full"> <input class="field" id="_58_INSTANCE_MODAL_doActionAfterLogin" name="_58_INSTANCE_MODAL_doActionAfterLogin" type="hidden" value="false"> <div class="control-group input-text-wrapper"> <label class="control-label" for="_58_INSTANCE_MODAL_login"> Email Address </label> <input class="field clearable" id="_58_INSTANCE_MODAL_login" name="_58_INSTANCE_MODAL_login" type="text" value=""> </input></div> <div class="control-group input-text-wrapper"> <label class="control-label" for="_58_INSTANCE_MODAL_password"> Password </label> <input class="field" id="_58_INSTANCE_MODAL_password" name="_58_INSTANCE_MODAL_password" type="password" value=""/> </div> <span id="_58_INSTANCE_MODAL_passwordCapsLockSpan" style="display: none;"> Caps Lock is on. </span> <div class="clearfix"> <div class="checkbox-list pull-left"> <div class="checkbox-list-item"> <div class="control-group form-inline input-checkbox-wrapper"> <label for="_58_INSTANCE_MODAL_rememberMeCheckbox"> <input id="_58_INSTANCE_MODAL_rememberMe" name="_58_INSTANCE_MODAL_rememberMe" type="hidden" value="true"/> <input checked="" class="field" id="_58_INSTANCE_MODAL_rememberMeCheckbox" name="_58_INSTANCE_MODAL_rememberMeCheckbox" onclick="Liferay.Util.updateCheckboxValue(this); " type="checkbox" value="true"/> Remember Me </label> </div> </div> </div> <div class="pull-right"> <a href="https://onlinelibrary.wiley.com/user/forgottenpassword" target="_blank">Forgotten password?</a> </div> </div> <div class="login-form-footer clearfix"> <div class="pull-left"> <button class="btn primary" type="submit">Sign in</button> <a class="btn secondary" href="https://onlinelibrary.wiley.com/user-registration" target="_blank">Register</a> </div> <div class="pull-right"> <a class="institutional-login-form-button" href="https://www.cochranelibrary.com/en/content?p_p_id=scolariscontentdisplay_WAR_scolariscontentdisplay&amp;p_p_lifecycle=0&amp;p_p_state=normal&amp;p_p_mode=view&amp;_scolariscontentdisplay_WAR_scolariscontentdisplay_action=institution-access">Institutional login</a> </div> </div> </input></input></input></input></fieldset> </form> </div> </div> </div> <div style="display:none"> <input id="freelabel" name="freelabel" type="hidden" value="Free access"/>
<input id="openlabel" name="openlabel" type="hidden" value="Open access"/>
</div>
</section>
</div>
</div>
</div>
</div></div>
<div class="institution-login-form-content" data-modal-title="Institutional login" style="display: none;">
<div class="form-content">
<div class="row-fluid access-content-wrapper">
<div class="span12">
<div class="section">
<div class="portlet-boundary portlet-boundary_scolariscontentdisplay_WAR_scolariscontentdisplay_ portlet-static portlet-static-end scolaris-content-display-portlet" id="p_p_id_scolariscontentdisplay_WAR_scolariscontentdisplay_INSTANCE_combinedloginform_">
<span id="p_scolariscontentdisplay_WAR_scolariscontentdisplay_INSTANCE_combinedloginform"></span>
<section class="portlet" id="portlet_scolariscontentdisplay_WAR_scolariscontentdisplay_INSTANCE_combinedloginform">
<header class="portlet-topper">
<h1 class="portlet-title">
<span class="" onmouseover="Liferay.Portal.ToolTip.show(this, 'Scolaris\x20Content\x20Display')">
<img alt="" id="obft__null__null" src="/scolaris-content-display/icon.png"> <span class="taglib-text hide-accessible">Scolaris Content Display</span> </img></span> <span class="portlet-title-text">Scolaris Content Display</span> </h1> <menu class="portlet-topper-toolbar" id="portlet-topper-toolbar_scolariscontentdisplay_WAR_scolariscontentdisplay_INSTANCE_combinedloginform" type="toolbar"> </menu> </header> <div class="portlet-content"> <div class="portlet-content-container"> <div class="portlet-body"> <div class="access-content-section"> <div class="section-content"> <p>Search for your institution's name below to login via Shibboleth</p> <form action="/shibboleth" id="institutionLoginForm" method="post"> <div class="fieldset"> <div class="form-group access-input-wrapper"> <div class="ui-widget ui-front"> <label class="sr-only" for="institutionName">Institution name</label> <input class="field" id="institutionName" name="institutionName" type="text" value=""/>
</div>
<button class="btn primary" name="button" type="submit">Go</button>
</div>
<div class="message error" id="institutionLookupErrorDiv" style="display:none">
                        '<span id="enteredInstitionNameSpan"></span>' is not set up for this type of access on Wiley Online Library. Please contact your institution's administrator to ask about access.
                    </div>
</div>
<input id="entityId" name="entityId" type="hidden" value=""/>
</form>
<h4>Previously accessed institutions</h4>
<ul class="plain" id="previousInstitutions">
<li>(none)</li>
</ul>
</div>
<div class="section-content">
<div class="open-athens-login">
                Login using <a href="/openathens">OpenAthens</a>
</div>
</div>
</div>
</div>
</div>
</div>
<div style="display:none">
<input id="freelabel" name="freelabel" type="hidden" value="Free access"/>
<input id="openlabel" name="openlabel" type="hidden" value="Open access"/>
</div>
</section>
</div>
<div class="portlet-boundary portlet-boundary_58_ portlet-static portlet-static-end portlet-login" id="p_p_id_58_INSTANCE_4_">
<span id="p_58_INSTANCE_4"></span>
<section class="portlet" id="portlet_58_INSTANCE_4">
<header class="portlet-topper">
<h1 class="portlet-title">
<span class="" onmouseover="Liferay.Portal.ToolTip.show(this, 'Sign\x20In')">
<img alt="" id="joiu__null__null" src="https://www.cochranelibrary.com/cochrane-theme/images/spacer.png" style="background-image: url('https://www.cochranelibrary.com/sprite/html/icons/_sprite.png'); background-position: 50% -592px; background-repeat: no-repeat; height: 16px; width: 16px;"> <span class="taglib-text hide-accessible">Sign In</span> </img></span> <span class="portlet-title-text">Sign In</span> </h1> <menu class="portlet-topper-toolbar" id="portlet-topper-toolbar_58_INSTANCE_4" type="toolbar"> </menu> </header> <div class="portlet-content"> <div class="portlet-content-container"> <div class="portlet-body"> <p>If you have a <strong>Wiley Online Library</strong> institutional username and password, enter them here.</p> <form action="https://www.cochranelibrary.com/en/content?p_p_id=58_INSTANCE_4&amp;p_p_lifecycle=1&amp;p_p_state=normal&amp;p_p_mode=view&amp;_58_INSTANCE_4_struts_action=%2Flogin%2Flogin" autocomplete="on" class="form sign-in-form" id="_58_INSTANCE_4_fm" method="post" name="_58_INSTANCE_4_fm"> <fieldset class="input-container" disabled="disabled"> <legend class="sr-only">Cochrane Login</legend> <input name="_58_INSTANCE_4_formDate" type="hidden" value="1740719899456"> <input class="field" id="_58_INSTANCE_4_saveLastPath" name="_58_INSTANCE_4_saveLastPath" type="hidden" value="false"> <input class="field" id="_58_INSTANCE_4_redirect" name="_58_INSTANCE_4_redirect" type="hidden" value="/cdsr/doi/10.1002/14651858.CD012551.pub3/full"> <input class="field" id="_58_INSTANCE_4_doActionAfterLogin" name="_58_INSTANCE_4_doActionAfterLogin" type="hidden" value="false"> <div class="control-group input-text-wrapper"> <label class="control-label" for="_58_INSTANCE_4_login"> Username </label> <input class="field clearable" id="_58_INSTANCE_4_login" name="_58_INSTANCE_4_login" type="text" value=""> </input></div> <div class="control-group input-text-wrapper"> <label class="control-label" for="_58_INSTANCE_4_password"> Password </label> <input class="field" id="_58_INSTANCE_4_password" name="_58_INSTANCE_4_password" type="password" value=""> </input></div> <input class="field" id="_58_INSTANCE_4_institutionalLogin" name="_58_INSTANCE_4_institutionalLogin" type="hidden" value="true"/> <span id="_58_INSTANCE_4_passwordCapsLockSpan" style="display: none;"> Caps Lock is on. </span> <div class="login-form-footer clearfix"> <div class="pull-left"> <button class="btn primary" type="submit">Sign in</button> </div> </div> </input></input></input></input></fieldset> </form> </div> </div> </div> <div style="display:none"> <input id="freelabel" name="freelabel" type="hidden" value="Free access"/>
<input id="openlabel" name="openlabel" type="hidden" value="Open access"/>
</div>
</section>
</div>
</div>
</div>
</div>
</div></div>
<div class="get-access-form-content" data-modal-title="Unlock gold-standard Cochrane evidence" style="display: none;">
<div class="portlet-boundary portlet-boundary_scolariscontentdisplay_WAR_scolariscontentdisplay_ portlet-static portlet-static-end scolaris-content-display-portlet" id="p_p_id_scolariscontentdisplay_WAR_scolariscontentdisplay_INSTANCE_getaccessform_">
<span id="p_scolariscontentdisplay_WAR_scolariscontentdisplay_INSTANCE_getaccessform"></span>
<section class="portlet" id="portlet_scolariscontentdisplay_WAR_scolariscontentdisplay_INSTANCE_getaccessform">
<header class="portlet-topper">
<h1 class="portlet-title">
<span class="" onmouseover="Liferay.Portal.ToolTip.show(this, 'Scolaris\x20Content\x20Display')">
<img alt="" id="wpdq__null__null" src="/scolaris-content-display/icon.png"> <span class="taglib-text hide-accessible">Scolaris Content Display</span> </img></span> <span class="portlet-title-text">Scolaris Content Display</span> </h1> <menu class="portlet-topper-toolbar" id="portlet-topper-toolbar_scolariscontentdisplay_WAR_scolariscontentdisplay_INSTANCE_getaccessform" type="toolbar"> </menu> </header> <div class="portlet-content"> <div class="portlet-content-container"> <div class="portlet-body"> <div class="readcube-checkout-container-outer"> <div class="row-fluid access-content-wrapper"> <div class="span6 access-left-content"> <div class="section"> <div class="section-content"> <p>Improve your health decisions with access to trusted, independent evidence from the Cochrane Library. Unlock this review for uninterrupted access.</p> <p>Still deciding? <a href="https://m.info.wiley.com/webApp/cochranenewsletter"> Sign up to our newsletter to learn more </a> </p> </div> </div> <div class="section"> <div class="access-content-section"> <h3 class="title">Institutional users</h3> <div class="section-content"> <p>Search for your institution's name below to login via Shibboleth</p> <form action="/shibboleth" id="institutionLoginForm" method="post"> <div class="fieldset"> <div class="form-group access-input-wrapper"> <div class="ui-widget ui-front"> <label class="sr-only" for="institutionName">Institution name</label> <input class="field" id="institutionName" name="institutionName" type="text" value=""/> </div> <button class="btn primary" name="button" type="submit">Go</button> </div> <div class="message error" id="institutionLookupErrorDiv" style="display:none"> '<span id="enteredInstitionNameSpan"></span>' is not set up for this type of access on Wiley Online Library. Please contact your institution's administrator to ask about access. </div> </div> <input id="entityId" name="entityId" type="hidden" value=""/> </form> <h4>Previously accessed institutions</h4> <ul class="plain" id="previousInstitutions"> <li>(none)</li> </ul> </div> <div class="section-content"> <div class="open-athens-login"> Login using <a href="/openathens">OpenAthens</a> </div> </div> </div> </div> <div class="section"> <div class="access-content-section"> <h3 class="title"> Other access options </h3> <div class="section-content"> <ul class="plain"> <li> <a class="get-access-individual-login-button" href="/c/portal/login"> Individual access - via Wiley Online Library </a> </li> </ul> </div> </div> </div> </div> <div class="span6 access-right-content readcube-checkout-container"> <div class="section"> </div> </div> </div> </div> </div> </div> </div> <div style="display:none"> <input id="freelabel" name="freelabel" type="hidden" value="Free access"/> <input id="openlabel" name="openlabel" type="hidden" value="Open access"/> </div> </section> </div> </div> <!-- Scolaris Version: --> <script type="text/javascript">if(window._satellite){_satellite.pageBottom()};</script> </div> <script>(function(){function c(){var b=a.contentDocument||a.contentWindow.document;if(b){var d=b.createElement('script');d.innerHTML="window.__CF$cv$params={r:'918df4014836937f',t:'MTc0MDcxOTkwMC4wMDAwMDA='};var a=document.createElement('script');a.nonce='';a.src='/cdn-cgi/challenge-platform/scripts/jsd/main.js';document.getElementsByTagName('head')[0].appendChild(a);";b.getElementsByTagName('head')[0].appendChild(d)}}if(document.body){var a=document.createElement('iframe');a.height=1;a.width=1;a.style.position='absolute';a.style.top=0;a.style.left=0;a.style.border='none';a.style.visibility='hidden';document.body.appendChild(a);if('loading'!==document.readyState)c();else if(window.addEventListener)document.addEventListener('DOMContentLoaded',c);else{var e=document.onreadystatechange||function(){};document.onreadystatechange=function(b){e(b);'loading'!==document.readyState&&(document.onreadystatechange=e,c())}}}})();</script></body> </html> 